Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABCB7	"ABC7, ASAT, Atm1p, EST140535"	ENSG00000131269	"ATP binding cassette subfamily B member 7"	O75027	X	75051048-75156732	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034982	Approved		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA034982: AB_10601010"	"unprognostic (1.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (5.31e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	12.6	13.5	5.0	7.7	5.9	11.1	11.8	8.2	7.6	11.4	9.8	13.8	16.0	10.9	5.0	11.6	11.2	7.4	22.0	5.5	6.1	10.1	14.8	9.8	12.0	6.4	6.0	12.3	9.6	11.0	8.6	7.5	6.2	8.5	9.6	9.8	10.0	6.9	31.4	12.9	11.8	8.8	6.1	10.9	12.3	4.1	5.4	14.0	9.5	22.2	11.1	10.5	10.9	6.8	17.0	16.2	12.2	20.9	14.1	25.5	7.0	8.9	14.6	12.3	22.4	18.5	24.5	25.8	22.8	9.2	21.2	18.8	25.6	18.5	12.0	26.0	33.2	16.8	29.2	17.3	8.2	24.7	13.7	15.9	16.3	12.8	16.7	21.3	23.1	26.2	18.9	31.1	9.8	10.5	24.4	26.1	26.8	26.3	30.5	21.4	26.9	30.5	12.7	13.2	17.7	14.1	27.4	23.5	17.8	20.0	10.2	22.9	10.3	11.3	22.9	23.2	12.4	10.1	27.5	21.2	10.1	35.8	9.4	9.6	26.9	10.0	15.7	25.6	16.6	24.7	16.7	16.7	29.0	28.2	28.7	21.1	2.4	17.5	20.4	18.2	27.2	19.2	5.0	5.9	8.2	7.6	5.5	6.1	6.4	6.0	6.2	6.1	5.4	6.8	12.0	9.6	10.4	48.0	26.6	15.8	14.5	16.0	19.9	10.9	10.9	9.9	46.8	14.3	14.2	11.0	6.2	23.0	19.0	8.2	11.7	17.5	0.4	8.4	12.8	11.9	13.8	26.9	37.9	13.5	11.6	13.9	9.7	10.1	22.2	20.6	9.3	11.8	20.1	25.2	39.0	10.5	8.2	26.1	16.7	0.8	14.6	19.2	10.6	45.0	22.9	12.4	6.2	43.7	46.6	11.6	7.9	13.2	14.3	10.6	15.9	19.9	10.7	7.9	32.9	19.6	13.8	5.5	10.9	16.1	16.1	22.3	14.5	19.2	17.9	11.9
ABHD16A	"BAT5, D6S82E, NG26"	ENSG00000204427	"Abhydrolase domain containing 16A, phospholipase"	O95870	6	31686955-31703356	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.2;OE19: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058606	Approved					NA	NA		37000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"			"HPA058606: AB_2683774"	"unprognostic (1.44e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.26e-2)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (3.14e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.97e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.60e-3)"	16.2	22.1	1.1	11.7	1.3	6.7	13.3	1.2	4.1	20.5	0.9	20.9	0.0	21.5	19.0	21.1	18.9	9.9	17.4	1.2	1.2	17.0	30.0	16.0	13.0	1.6	2.0	15.0	18.7	5.8	40.0	7.9	1.4	19.6	7.3	6.7	17.4	4.2	35.0	12.9	17.6	0.0	1.5	18.5	21.5	31.6	1.5	4.5	21.3	0.0	0.0	20.7	15.0	1.5	0.0	15.7	0.0	41.2	29.0	11.7	0.0	14.5	16.2	16.5	15.6	0.0	26.1	16.5	33.7	21.2	0.0	0.0	0.0	19.7	9.0	16.0	12.7	0.0	0.0	0.0	34.7	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.3	0.0	0.0	0.0	0.5	0.0	42.4	0.0	0.7	0.0	29.3	21.0	0.0	0.2	20.0	0.9	0.5	0.4	0.0	0.0	0.0	14.9	19.6	14.5	0.0	0.0	10.5	21.1	8.5	13.6	0.1	16.1	2.5	6.8	8.4	4.1	8.9	1.9	2.8	1.2	4.2	6.2	2.8	3.5	2.7	13.3	5.9	0.5	4.1	4.1	6.3	1.1	1.3	1.2	4.1	1.2	1.2	1.6	2.0	1.4	1.5	1.5	1.5	1.2	0.0	8.2	11.4	10.7	0.4	0.3	1.7	15.4	1.2	1.5	1.0	0.5	0.0	1.6	0.0	0.0	3.9	2.2	12.0	3.9	18.3	1.3	1.4	1.7	2.7	12.5	14.9	13.4	13.3	1.5	5.3	12.2	1.2	1.3	0.5	0.7	0.8	3.3	0.0	14.6	9.7	2.0	2.2	2.1	0.4	0.9	8.8	3.6	13.1	8.1	1.0	5.2	15.6	21.1	12.7	16.0	0.4	16.4	0.4	16.5	0.7	1.7	1.4	0.0	0.7	4.9	2.5	1.6	16.8	1.0	5.3	7.6	0.2	12.1	0.3
ABHD18	"C4orf29, FLJ21106"	ENSG00000164074	"Abhydrolase domain containing 18"	Q0P651	4	127965306-128039953	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050168, HPA051676"	Approved		Approved	"Nuclear membrane"	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA050168: AB_2681040, HPA051676: AB_2681571"	"unprognostic (1.91e-1)"	"unprognostic (8.66e-2)"	"prognostic favorable (5.35e-4)"	"unprognostic (1.74e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.32e-2)"	"prognostic favorable (9.13e-4)"	4.3	4.2	2.4	5.3	3.0	5.8	4.0	6.5	3.3	4.3	2.0	5.3	7.1	4.0	4.2	4.0	4.5	2.4	13.5	2.5	3.7	4.6	8.4	3.9	5.8	2.4	2.2	5.1	8.9	3.3	5.2	2.9	2.6	3.6	5.1	5.4	4.8	2.2	10.9	5.5	7.0	3.2	1.8	4.8	4.6	1.9	2.9	5.9	4.8	11.7	4.9	4.1	4.1	3.2	4.2	3.5	4.1	5.3	3.2	4.4	6.1	4.0	3.2	3.5	4.6	7.8	7.7	11.1	6.5	2.0	3.3	4.0	8.7	4.7	3.8	9.2	2.8	8.2	5.1	6.7	4.4	13.9	10.1	3.4	3.2	3.7	2.4	4.1	6.3	8.4	13.8	8.0	3.3	7.4	18.7	6.8	4.3	8.7	3.1	10.2	1.4	7.2	5.2	4.2	9.4	3.4	4.1	6.8	4.1	5.8	6.0	5.7	5.4	2.3	3.1	5.7	4.0	14.8	15.4	13.2	4.0	14.7	3.7	13.6	5.7	8.7	5.0	5.0	3.9	6.3	6.3	6.0	4.7	7.8	7.2	7.1	12.1	4.5	3.7	7.8	7.2	2.9	2.4	3.0	6.5	3.3	2.5	3.7	2.4	2.2	2.6	1.8	2.9	3.2	8.4	6.4	15.4	0.0	17.6	0.0	8.7	0.0	17.1	13.5	5.9	3.7	0.0	8.6	5.6	7.3	20.9	5.5	13.5	7.9	0.0	5.1	3.5	6.3	5.7	6.9	6.1	27.3	0.0	7.3	4.7	4.8	23.4	8.2	1.3	10.6	11.4	23.4	7.8	18.5	0.0	9.6	0.0	17.6	0.0	1.6	6.2	12.9	0.0	0.0	15.9	5.1	12.3	0.0	0.0	7.5	5.6	5.7	21.3	10.2	13.9	8.5	3.6	19.8	13.1	8.0	4.2	9.2	4.8	12.0	0.0	9.2	14.5	7.8	8.4	9.4
ACAD11	FLJ12592	ENSG00000240303	"Acyl-CoA dehydrogenase family member 11"	Q709F0	3	132558138-132660082	"Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 64.4;liver: 103.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 6.4;Erythroid cells: 5.7;Plasma cells: 7.6;Syncytiotrophoblasts: 9.7"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048317	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"			"HPA048317: AB_2680354"	"unprognostic (5.04e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.69e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.93e-1)"	16.2	7.6	8.6	2.8	11.3	7.8	6.1	9.3	13.3	8.5	23.3	7.7	17.0	8.0	6.7	4.0	8.5	4.0	15.4	8.8	9.0	64.4	103.6	5.8	3.3	10.2	9.9	9.9	8.2	8.8	9.8	9.8	10.0	6.6	3.4	11.7	5.7	6.0	4.3	6.3	15.8	6.4	9.6	4.3	4.8	8.2	10.3	4.6	6.4	2.0	3.2	5.5	6.5	11.5	5.8	5.2	10.5	13.6	23.2	17.9	10.5	13.6	21.0	8.0	10.5	19.3	2.1	3.9	7.6	7.7	9.0	4.3	8.0	11.9	12.7	6.7	5.6	4.3	5.5	18.1	23.0	4.7	4.1	12.2	8.9	11.0	27.2	18.6	7.9	5.0	2.3	8.2	11.2	7.8	3.0	3.2	6.2	2.8	5.2	3.3	8.4	6.4	18.0	3.8	4.1	6.7	10.5	5.0	28.5	10.9	10.5	3.4	6.5	6.3	3.9	3.6	4.8	6.7	2.3	4.0	8.4	1.6	5.2	0.0	0.2	0.0	0.6	0.4	0.5	0.6	0.6	0.3	0.2	0.6	1.4	0.7	0.0	0.9	0.3	0.9	0.3	0.2	8.6	11.3	9.3	13.3	8.8	9.0	10.2	9.9	10.0	9.6	10.3	11.5	1.4	6.4	3.2	0.0	2.1	0.1	0.2	0.7	2.8	0.9	0.6	0.4	0.0	0.0	0.8	0.0	0.0	4.2	0.8	0.4	0.0	0.8	0.6	1.5	2.0	1.0	4.8	5.7	0.0	1.1	0.9	1.6	0.0	0.8	1.3	1.5	0.4	3.9	0.7	0.0	0.0	0.5	0.0	0.8	0.2	0.2	0.6	0.8	0.0	0.0	2.3	0.6	4.1	0.0	0.0	0.4	0.2	0.7	7.6	0.2	4.4	1.6	1.0	2.9	0.0	0.9	1.1	0.1	0.3	0.9	0.3	9.7	2.2	1.1	0.7	0.1
ACOT2	"Mte1, ZAP128"	ENSG00000119673	"Acyl-CoA thioesterase 2"	P49753	14	73567620-73575658	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 118.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 50.0;Exocrine glandular cells: 33.2;Proximal tubular cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 62.4"									"HPA043705, HPA060170"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA043705: AB_2678626, HPA060170: AB_2732642"	"unprognostic (4.44e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.10e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.28e-6)"	"unprognostic (1.66e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.35e-1)"	92.3	47.7	10.0	7.0	10.3	5.6	48.9	9.2	12.4	17.1	12.2	42.2	24.7	42.9	10.7	10.9	24.1	6.1	94.5	10.1	9.5	49.4	118.9	17.3	4.7	8.8	9.4	11.7	12.8	22.4	8.3	4.4	8.2	17.8	11.1	4.1	17.8	11.1	114.0	13.1	24.5	22.8	9.2	11.4	22.5	12.0	13.0	3.7	14.5	50.0	3.3	31.2	13.3	9.0	22.8	25.0	4.9	22.1	21.3	7.9	1.0	13.7	31.5	21.9	28.6	18.1	12.6	0.1	9.7	7.0	10.3	12.7	0.0	1.2	11.4	33.1	31.6	16.0	7.6	62.4	14.5	0.1	43.3	19.5	0.0	7.6	0.1	21.0	9.5	0.0	0.0	0.1	18.7	7.4	2.5	18.2	7.5	2.3	37.8	37.2	21.9	0.3	8.0	9.5	21.6	27.3	33.1	24.3	29.6	2.1	51.1	12.7	17.0	17.9	47.2	11.8	13.0	0.0	0.1	9.5	15.8	0.1	18.2	3.5	5.9	3.1	22.1	7.0	15.8	15.0	20.2	16.6	21.9	12.4	17.8	19.9	0.2	15.3	6.5	13.6	31.3	13.6	10.0	10.3	9.2	12.4	10.1	9.5	8.8	9.4	8.2	9.2	13.0	9.0	4.3	0.0	6.4	3.3	6.6	1.7	1.0	5.9	16.5	1.1	5.2	4.2	50.0	7.2	3.0	7.3	10.4	6.1	3.0	20.1	13.7	20.9	1.5	1.4	1.9	4.0	15.7	8.4	2.9	33.2	3.2	7.0	11.7	2.1	13.4	1.9	4.2	27.7	14.9	1.7	3.1	15.5	10.2	3.8	1.6	1.1	5.9	5.6	5.4	1.0	18.5	5.5	7.2	3.0	1.7	21.8	8.6	8.2	7.9	0.4	27.5	36.5	3.3	4.9	6.6	1.4	9.8	0.3	4.8	8.5	0.4	8.2	5.8	1.7	18.8	0.4
AFTPH	"FLJ20080, FLJ23793, MGC33965, Nbla10388"	ENSG00000119844	Aftiphilin	Q6ULP2	2	64524305-64593005	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034990, HPA034991"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Golgi apparatus, Vesicles"	"HPA034990: AB_2674398, HPA034991: AB_10603577"	"unprognostic (7.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (9.16e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.65e-2)"	"prognostic favorable (2.37e-5)"	"prognostic favorable (8.44e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.83e-4)"	15.9	20.2	24.6	21.1	24.9	21.3	32.4	31.2	38.4	22.5	28.3	30.5	23.1	18.8	43.7	29.6	22.9	21.9	12.0	25.3	25.6	56.1	33.6	21.9	37.2	24.6	24.6	19.3	31.6	38.0	25.1	15.0	24.5	34.5	33.7	36.8	28.9	18.6	15.4	33.2	24.5	17.3	24.8	26.4	33.7	24.6	25.4	29.3	25.3	12.9	41.4	25.5	22.4	26.2	29.8	19.3	14.1	17.1	17.8	15.1	23.4	16.7	24.9	26.9	20.1	22.4	21.9	43.9	16.0	20.7	31.1	23.5	24.6	23.3	34.8	42.8	13.5	21.0	12.0	26.5	18.8	40.5	34.5	7.5	48.6	17.4	39.6	19.8	21.4	21.8	16.0	38.7	16.8	16.9	21.9	49.1	13.0	55.9	14.3	17.7	22.6	28.8	48.9	31.5	25.9	13.1	17.7	39.9	35.7	18.0	24.0	30.6	18.5	20.0	23.0	17.0	18.8	43.3	27.8	66.7	15.1	45.3	22.6	40.5	9.3	16.6	7.4	9.3	8.7	21.8	9.3	9.1	12.2	20.3	8.8	6.9	16.3	7.1	14.7	15.8	12.8	5.9	24.6	24.9	31.2	38.4	25.3	25.6	24.6	24.6	24.5	24.8	25.4	26.2	24.6	25.6	39.7	43.1	75.4	122.6	29.6	21.5	55.8	24.2	43.8	23.0	16.0	40.0	33.6	20.2	20.9	13.8	40.5	60.7	37.2	25.5	34.8	44.6	17.8	27.1	46.6	52.0	72.1	25.7	12.4	23.6	35.2	55.9	46.9	17.8	17.5	36.8	20.8	37.0	62.9	40.3	20.3	45.2	77.9	55.1	15.8	52.1	23.2	65.6	60.8	35.0	26.8	52.3	67.0	27.3	43.0	20.7	60.5	42.6	29.0	70.5	40.2	32.9	26.3	25.3	21.2	43.1	21.9	59.0	123.5	27.2	36.5	10.2	40.3	46.1
AGGF1	"FLJ10283, GPATC7, GPATCH7, HSU84971, VG5Q"	ENSG00000164252	"Angiogenic factor with G-patch and FHA domains 1"	Q8N302	5	77029251-77065234	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																"Secreted to blood"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"				"unprognostic (7.13e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (2.87e-4)"	"unprognostic (1.67e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.27e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.21e-2)"	9.8	10.5	11.0	11.5	11.1	9.2	10.5	11.2	11.8	9.1	9.5	10.5	14.1	9.1	21.4	8.7	7.7	8.6	10.0	11.1	11.3	12.9	13.7	9.4	13.6	12.0	12.0	10.6	8.1	16.0	6.1	10.9	12.1	9.7	11.5	22.3	8.6	8.8	13.0	12.5	13.3	8.9	11.0	12.6	10.1	16.2	12.4	14.4	11.0	11.1	14.1	9.4	6.6	13.1	21.6	14.5	18.4	23.2	20.8	21.5	17.9	17.7	18.8	12.9	16.3	9.6	23.2	14.4	21.7	12.4	22.6	19.2	9.9	18.1	20.0	21.9	17.2	14.6	16.8	13.2	15.6	15.6	22.8	15.3	22.0	13.3	15.3	17.4	15.9	21.4	17.7	11.9	18.5	21.6	27.3	15.7	0.0	9.0	10.4	21.5	30.2	34.1	21.9	17.1	18.5	22.5	19.0	14.7	21.9	15.8	28.3	20.1	15.2	11.6	14.6	19.1	20.5	23.5	28.6	3.3	21.1	24.5	22.0	17.5	14.0	28.9	14.8	12.6	11.8	13.2	13.6	13.8	13.0	13.5	15.8	13.2	12.7	14.9	12.6	14.3	15.8	9.7	11.0	11.1	11.2	11.8	11.1	11.3	12.0	12.0	12.1	11.0	12.4	13.1	9.0	28.9	21.7	22.5	28.2	7.1	16.9	20.4	39.3	49.2	9.2	9.0	45.0	22.8	10.0	5.5	35.5	29.5	14.0	26.6	7.9	12.8	44.5	8.5	10.2	22.9	15.0	47.1	23.6	14.5	19.9	21.6	30.5	8.6	14.0	15.3	34.2	34.0	32.1	33.7	26.0	32.3	10.2	41.1	15.6	14.0	29.2	26.6	10.6	20.6	34.1	42.2	38.1	19.1	30.1	12.3	25.5	31.6	36.5	28.2	37.3	15.3	18.0	61.7	32.9	27.2	15.5	69.8	52.0	37.9	9.8	12.9	23.2	13.8	30.1	19.7
ALG11	"CDG1P, KIAA0266"	ENSG00000253710	"ALG11 alpha-1,2-mannosyltransferase"	Q2TAA5	13	52012391-52079232	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047214	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA047214: AB_10961640"	"unprognostic (9.21e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.97e-3)"	"unprognostic (8.89e-3)"	"unprognostic (7.47e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.03e-2)"	"unprognostic (9.71e-3)"	10.1	9.5	7.4	8.3	8.4	4.1	12.1	9.5	9.7	12.1	1.9	11.0	10.1	11.0	9.4	7.5	10.8	8.9	10.4	7.5	4.8	14.6	19.2	9.1	8.1	4.8	4.0	11.6	8.6	17.2	2.4	12.7	4.6	12.1	11.8	9.0	10.9	10.9	6.5	7.2	9.7	11.4	2.9	10.1	11.6	6.2	4.7	9.5	16.8	8.8	8.6	8.7	2.5	9.6	6.7	10.5	17.8	15.2	18.6	13.3	14.2	17.7	16.3	12.9	10.3	8.5	14.5	16.2	4.2	18.4	15.8	15.3	18.2	12.0	17.0	16.7	12.9	31.0	8.8	11.4	14.1	28.3	31.0	12.9	17.8	10.1	18.4	14.1	11.5	18.5	17.8	10.4	19.4	5.7	14.7	9.7	19.2	28.8	7.5	15.2	11.9	8.9	16.7	10.8	6.9	15.2	11.9	17.1	11.9	15.0	11.9	20.8	17.8	10.4	11.5	13.6	11.8	9.1	13.5	17.7	6.4	11.7	18.0	13.2	5.4	7.2	7.7	4.5	7.6	5.1	7.0	6.6	6.9	7.1	8.9	8.9	2.2	7.3	12.0	9.8	7.2	4.9	7.4	8.4	9.5	9.7	7.5	4.8	4.8	4.0	4.6	2.9	4.7	9.6	5.3	19.2	8.2	5.5	7.1	2.4	3.2	7.8	8.0	6.8	4.2	3.2	7.5	5.7	9.3	3.7	6.2	3.4	6.2	2.1	1.9	2.9	0.9	5.1	7.3	5.2	3.0	12.6	9.3	2.2	3.9	8.2	9.7	5.4	3.8	6.5	6.1	4.0	2.5	5.0	8.1	2.7	6.1	2.2	3.1	0.5	3.4	3.5	1.8	5.6	2.6	2.8	11.3	13.0	8.9	2.7	1.7	1.2	14.0	2.6	3.5	1.7	13.5	7.5	0.0	4.2	6.4	4.8	3.5	7.8	2.4	4.8	7.2	3.7	2.1	4.0
ALG9	DIBD1	ENSG00000086848	"ALG9 alpha-1,2-mannosyltransferase"	Q9H6U8	11	111782195-111871581	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 26.6;Inhibitory neurons: 31.8;Oligodendrocytes: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA038575	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA038575: AB_10672718"	"unprognostic (1.48e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.34e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.07e-3)"	"unprognostic (5.11e-2)"	"unprognostic (8.75e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (9.15e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.10e-2)"	14.0	9.7	6.3	8.6	7.1	7.8	12.4	8.2	7.8	12.9	6.3	10.9	12.1	11.5	10.9	11.4	9.2	7.9	10.1	6.3	6.6	9.5	13.4	9.6	6.6	6.5	6.8	12.5	19.7	12.7	10.0	9.6	6.7	9.6	10.3	12.0	17.5	11.3	9.1	15.2	10.2	11.1	5.6	8.4	12.0	13.6	6.1	9.8	12.3	8.3	9.2	11.3	11.1	6.4	16.6	16.5	30.7	31.1	19.0	18.0	23.7	20.5	16.5	16.4	17.9	28.7	27.4	27.1	28.7	23.8	21.4	29.8	16.6	25.4	23.4	20.2	12.2	19.7	8.6	21.2	22.0	22.2	13.6	15.5	17.2	17.7	17.8	24.2	16.2	20.2	20.3	41.0	28.4	12.5	22.2	20.3	10.7	23.3	15.9	20.4	26.9	51.5	18.5	13.7	15.0	25.4	18.0	28.0	11.4	21.6	29.0	9.3	16.9	35.0	25.2	17.1	22.6	13.3	10.2	24.4	15.1	27.4	24.7	4.5	3.1	3.8	4.0	4.5	4.7	4.0	4.1	4.6	5.2	3.1	5.8	3.6	1.1	4.2	4.0	5.6	4.5	3.3	6.3	7.1	8.2	7.8	6.3	6.6	6.5	6.8	6.7	5.6	6.1	6.4	3.2	0.0	4.4	21.5	5.9	2.0	1.5	3.2	9.6	8.9	3.8	3.4	5.6	1.5	3.9	7.3	8.4	3.5	4.6	3.2	3.9	7.5	5.1	2.0	5.2	4.1	4.2	6.3	26.6	7.1	12.6	4.7	4.6	3.8	0.0	5.5	2.2	6.8	3.2	15.2	31.8	4.0	4.1	1.9	1.9	4.3	4.7	3.5	0.0	12.2	3.1	4.9	3.1	21.1	31.8	6.5	2.9	3.8	22.8	1.3	4.6	2.3	2.2	9.7	6.6	3.5	5.4	4.2	5.7	8.6	1.6	9.0	5.8	2.5	4.4	0.8
ANGEL2	"Ccr4d, FLJ12793, KIAA0759L"	ENSG00000174606	"Angel homolog 2"	Q5VTE6	1	212992182-213015867	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030795, HPA030796"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitochondria"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies, Mitochondria"	"HPA030795: , HPA030796: AB_10600979"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.70e-3)"	"unprognostic (6.46e-2)"	"prognostic unfavorable (8.39e-6)"	"unprognostic (9.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.20e-4)"	7.5	6.6	13.1	6.9	14.9	6.4	10.4	11.1	14.7	7.9	9.2	6.6	5.2	8.6	8.1	5.9	7.4	6.1	5.8	12.8	11.1	7.7	8.0	6.6	10.5	10.6	10.8	10.8	6.7	7.8	6.2	6.5	10.1	8.2	6.4	9.2	6.0	6.2	7.3	9.1	7.2	7.1	10.1	9.8	6.3	5.5	13.1	10.2	8.1	7.1	9.2	7.1	6.3	11.6	12.2	9.6	15.2	13.2	11.5	16.8	13.6	9.8	16.3	15.4	15.3	6.3	8.9	11.8	8.8	9.7	8.5	9.4	17.8	9.4	15.5	22.3	10.6	11.9	7.4	6.3	12.5	11.8	13.6	10.4	11.9	12.1	12.2	13.1	13.2	10.4	13.9	11.8	18.0	4.0	13.6	7.9	36.4	6.6	6.8	6.9	27.4	12.4	12.1	8.2	7.5	21.7	11.9	15.7	18.3	16.2	12.2	8.6	9.8	12.7	6.7	15.7	15.1	8.6	8.9	7.9	14.2	8.7	11.9	6.6	4.4	5.9	5.1	4.3	6.5	5.7	6.4	5.4	5.5	3.5	6.7	5.7	2.7	10.9	3.5	3.3	8.9	5.2	13.1	14.9	11.1	14.7	12.8	11.1	10.6	10.8	10.1	10.1	13.1	11.6	23.1	48.1	9.8	26.8	23.8	6.9	8.5	11.7	12.5	21.2	14.6	10.2	15.2	17.2	14.5	12.9	10.4	14.8	26.2	7.6	11.7	10.3	1.5	11.3	19.8	15.9	6.7	18.1	33.2	10.5	15.0	18.0	14.3	11.7	17.1	28.8	16.1	12.5	11.8	28.6	26.3	8.4	14.2	20.4	10.5	2.6	15.5	17.1	3.6	30.0	17.3	11.6	16.5	30.2	49.3	10.2	6.4	13.9	24.2	10.8	10.7	16.9	22.5	17.8	19.7	21.7	16.1	9.5	16.6	12.7	7.0	10.9	25.8	17.9	8.0	7.4
ANKHD1	"FLJ10042, FLJ11979, FLJ14127, FLJ20288, KIAA1085, MASK, MASK1"	ENSG00000131503	"Ankyrin repeat and KH domain containing 1"	Q8IWZ3	5	140401814-140539856	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA008718	Approved					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"			"HPA008718: AB_1078162"	"unprognostic (1.62e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.56e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.05e-2)"	39.3	43.3	24.4	37.0	30.2	74.1	39.6	34.2	41.0	47.2	30.9	40.4	31.7	41.3	48.3	44.6	41.3	24.9	36.0	24.4	25.4	36.7	54.3	40.3	41.3	27.7	28.0	52.3	60.6	37.9	42.4	28.5	28.5	37.0	33.2	40.4	42.4	27.7	71.4	50.7	46.3	26.1	24.7	48.4	41.8	30.7	28.5	48.8	46.8	27.9	41.4	36.3	43.9	36.4	58.6	56.5	69.8	95.9	44.3	42.8	74.0	32.4	35.1	45.0	56.0	138.1	51.6	86.5	50.6	29.8	91.6	58.5	67.4	63.4	58.2	65.3	65.1	67.8	77.7	77.3	43.8	132.6	64.3	37.5	41.7	61.9	75.5	31.0	49.3	61.5	69.4	91.5	34.6	62.6	70.4	70.6	42.5	36.7	56.9	89.3	87.1	60.6	23.8	74.2	58.5	40.7	73.1	74.6	75.4	33.6	77.3	69.5	46.4	48.8	28.3	49.5	53.8	83.6	88.5	108.3	38.0	85.3	35.2	25.2	8.2	10.4	10.5	6.3	9.3	10.5	10.6	10.9	7.2	9.2	9.4	9.7	17.9	15.6	8.8	11.3	7.8	3.4	24.4	30.2	34.2	41.0	24.4	25.4	27.7	28.0	28.5	24.7	28.5	36.4	13.0	12.8	45.5	0.0	34.7	18.6	18.6	7.2	44.9	13.6	9.0	7.5	5.4	18.6	20.5	9.2	16.7	12.0	17.7	10.7	3.9	11.8	13.2	7.9	8.0	13.5	4.2	21.0	0.0	19.2	13.5	13.7	27.5	11.7	12.7	8.3	15.0	10.9	13.0	11.8	0.0	10.1	8.2	19.8	20.8	4.2	10.8	19.7	17.8	0.0	18.5	8.4	11.3	0.0	0.0	13.8	12.1	9.1	41.6	14.0	12.5	5.2	16.3	13.2	19.7	15.3	12.9	31.6	31.6	39.2	21.6	30.8	31.2	6.5	11.8	21.5
ANKRD27	"DKFZp434L0718, FLJ00040, VARP"	ENSG00000105186	"Ankyrin repeat domain 27"	Q96NW4	19	32597006-32676597	"Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 137.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042769	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	Vesicles	Cytosol	"HPA042769: AB_10796584"	"unprognostic (2.16e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (9.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.90e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.26e-2)"	8.9	7.4	10.8	8.9	12.9	10.4	8.7	12.1	12.6	10.3	21.5	17.2	7.6	10.0	8.8	14.3	8.0	7.7	9.6	11.8	9.8	9.7	4.4	10.3	11.1	12.0	12.9	8.3	7.2	9.3	6.8	13.6	12.4	12.3	11.9	11.7	9.7	13.5	20.7	12.4	10.7	11.6	8.9	9.0	11.0	17.3	12.1	16.7	13.3	10.8	11.5	16.9	11.1	11.8	32.0	36.0	11.5	20.8	23.5	18.0	28.1	18.0	18.0	19.4	25.4	28.8	19.0	34.7	16.5	23.0	20.4	19.4	29.6	22.3	32.0	47.3	15.1	137.9	13.7	23.9	29.4	53.5	47.6	13.1	28.8	20.9	33.8	13.5	19.7	25.3	37.5	76.3	15.1	31.5	20.8	46.2	6.0	40.2	13.8	30.6	15.6	12.7	15.6	30.5	21.3	8.6	17.6	29.6	21.0	15.2	12.4	25.7	18.5	21.1	22.4	19.6	28.0	19.7	12.7	23.8	21.0	51.8	13.8	36.5	11.1	28.5	13.9	15.7	17.5	7.5	14.3	15.6	12.6	6.9	10.9	11.7	9.0	30.6	13.3	6.2	13.2	13.3	10.8	12.9	12.1	12.6	11.8	9.8	12.0	12.9	12.4	8.9	12.1	11.8	6.8	16.0	9.4	18.3	10.0	15.6	5.5	5.6	14.2	9.4	9.0	5.1	9.2	7.2	5.7	9.2	20.9	14.9	9.7	9.3	0.0	3.3	5.1	7.5	9.4	7.1	9.1	26.5	35.5	5.9	10.6	7.6	5.6	11.6	12.0	10.1	4.6	4.8	8.4	11.8	16.3	9.6	8.2	12.0	12.1	16.2	10.8	8.7	16.0	12.2	6.0	5.8	9.2	11.1	18.7	7.1	10.3	9.4	8.0	10.0	10.8	7.7	7.1	14.7	0.0	6.8	9.3	4.1	17.1	14.7	15.5	15.2	14.0	7.2	8.9	8.4
ANKRD36B	"FLJ21281, KIAA1641"	ENSG00000196912	"Ankyrin repeat domain 36B"	Q8N2N9	2	97492663-97589965	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.5"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 73.4;Oligodendrocytes: 71.1;Plasma cells: 81.7;Spermatocytes: 76.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA051757, HPA057661"			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA051757: AB_2681594, HPA057661: AB_2683494"	"unprognostic (2.07e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.72e-3)"	"unprognostic (5.03e-2)"	"unprognostic (7.17e-3)"	"unprognostic (4.20e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.13e-6)"	"unprognostic (1.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.71e-3)"	"unprognostic (6.98e-2)"	4.4	1.8	3.0	1.6	4.8	21.5	4.7	13.7	5.8	4.7	0.0	3.2	1.0	4.1	2.3	1.8	5.0	1.7	2.7	3.1	2.5	2.4	1.1	3.0	2.6	4.7	1.2	5.3	6.1	1.0	2.9	0.8	5.3	3.4	2.8	10.1	4.3	1.4	1.3	4.1	3.5	2.8	1.0	3.1	3.2	13.1	4.1	2.9	2.7	0.2	1.9	3.1	3.1	7.2	2.9	1.4	1.4	1.7	1.1	2.8	1.8	1.5	1.2	1.0	1.1	1.8	3.2	4.7	1.1	1.5	1.0	0.4	1.1	1.1	1.1	1.5	2.2	3.6	3.5	1.3	0.8	2.6	1.6	1.5	1.5	1.5	2.4	2.8	1.4	7.1	3.8	5.0	1.2	0.5	3.0	3.3	0.9	0.5	1.4	3.2	0.6	0.7	1.4	2.1	1.8	2.3	1.2	0.7	0.9	3.1	1.6	2.0	2.6	1.5	1.8	2.5	2.8	3.9	5.7	3.3	1.9	3.9	1.3	1.9	0.1	0.2	0.6	0.1	0.6	0.6	0.8	0.5	0.1	1.0	0.9	0.6	0.1	0.8	0.0	0.8	0.4	0.1	3.0	4.8	13.7	5.8	3.1	2.5	4.7	1.2	5.3	1.0	4.1	7.2	14.6	12.8	15.0	27.1	28.3	0.0	6.9	0.0	20.5	36.7	5.4	7.4	15.4	5.7	17.3	9.2	20.9	1.4	15.4	5.9	0.0	9.4	48.9	29.6	10.1	12.5	14.4	16.4	68.5	14.0	3.9	11.4	73.4	14.1	22.8	23.4	4.2	0.7	3.4	16.8	68.7	12.6	0.0	1.2	0.0	7.3	12.8	9.5	0.0	19.7	7.3	6.8	12.3	42.3	71.1	9.7	3.6	7.5	81.7	5.0	2.5	1.3	16.8	34.1	6.6	25.2	9.9	76.4	11.1	24.0	0.0	0.1	35.2	7.1	6.7	12.4
ANKRD52	"FLJ34236, PP6-ARS-C"	ENSG00000139645	"Ankyrin repeat domain 52"	Q8NB46	12	56237807-56258384	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043815	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"		"HPA043815: AB_10961762"	"unprognostic (6.25e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (9.84e-2)"	"unprognostic (9.46e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.70e-2)"	"unprognostic (6.31e-2)"	8.4	21.5	10.9	9.8	11.3	9.6	8.7	9.3	12.9	11.9	4.9	12.3	8.4	12.4	5.7	10.5	11.0	6.1	12.9	9.6	13.3	11.6	7.9	9.4	9.2	17.7	16.2	12.9	12.9	19.8	13.2	7.1	21.4	11.2	8.1	9.6	10.9	7.9	25.0	11.2	12.8	11.0	9.2	10.9	10.5	7.4	15.4	8.8	11.2	17.0	9.6	12.0	9.8	10.3	24.7	58.5	25.9	47.4	20.7	16.2	18.2	48.1	20.9	42.1	18.9	39.0	13.4	26.1	29.9	47.3	14.8	31.5	29.0	21.0	24.2	25.3	29.1	46.9	38.6	15.0	14.3	37.3	26.2	16.7	23.2	39.0	19.7	30.9	24.8	21.1	19.6	13.8	40.1	34.2	30.0	12.3	10.9	16.1	27.4	23.4	17.8	10.4	27.7	30.0	19.6	17.8	52.2	33.1	18.9	19.9	26.5	14.3	34.4	43.4	38.1	24.7	30.4	12.7	18.0	12.4	45.0	12.2	29.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.9	11.3	9.3	12.9	9.6	13.3	17.7	16.2	21.4	9.2	15.4	10.3	4.1	6.4	5.3	9.1	7.8	11.2	3.6	8.4	10.2	5.0	9.1	6.9	6.7	4.3	4.3	12.9	27.1	5.8	7.9	12.6	0.0	10.4	0.5	5.8	9.7	5.7	9.6	5.5	12.8	9.5	7.4	5.4	8.2	9.0	1.3	8.6	6.8	6.5	7.0	8.4	12.5	6.6	20.3	7.1	7.5	1.1	6.2	4.8	10.6	7.5	4.6	3.4	7.2	7.5	8.4	15.7	7.0	4.9	8.7	5.7	9.2	6.4	4.2	6.0	0.0	5.6	7.6	6.4	8.8	10.0	10.9	3.7	6.0	5.5	8.9	4.4
AP3B1	"ADTB3A, HPS2"	ENSG00000132842	"Adaptor related protein complex 3 subunit beta 1"	O00203	5	78002326-78294698	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Albinism, Disease variant, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 231.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038737, HPA045458"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		38000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA038737: AB_10670788, HPA045458: AB_2679333"	"unprognostic (9.14e-2)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.37e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.18e-3)"	"unprognostic (7.47e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.97e-2)"	"prognostic favorable (7.97e-6)"	"unprognostic (1.65e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.39e-2)"	21.5	21.5	21.1	19.6	26.1	21.9	21.3	22.3	26.4	20.7	23.0	24.1	19.8	17.8	53.9	30.8	15.8	15.9	19.0	19.6	23.4	30.3	15.9	17.2	22.5	23.4	24.4	13.0	24.9	29.3	40.4	19.6	24.5	16.9	28.3	8.8	26.4	16.4	15.8	22.5	20.8	20.5	23.3	21.6	23.0	13.2	23.6	23.2	27.2	13.0	24.8	20.1	21.9	26.5	51.3	40.3	45.4	63.1	53.2	64.5	39.5	56.3	66.1	50.1	67.5	31.4	44.1	53.7	32.5	69.4	41.7	36.6	45.0	94.1	62.7	61.7	31.7	37.4	33.9	55.5	31.1	33.7	47.1	46.2	34.0	42.3	42.5	47.7	64.1	10.9	27.3	34.3	86.9	31.6	43.4	52.2	24.1	37.4	23.9	45.2	80.2	74.4	72.7	47.5	16.0	25.7	52.3	33.7	49.7	37.1	40.9	55.6	65.0	37.4	29.1	45.4	57.4	26.3	43.3	36.3	48.5	48.5	48.4	18.3	12.6	11.3	9.6	12.5	10.6	31.3	8.0	10.0	17.2	40.1	6.6	8.8	15.4	9.6	17.3	14.2	10.4	8.1	21.1	26.1	22.3	26.4	19.6	23.4	23.4	24.4	24.5	23.3	23.6	26.5	31.6	44.8	33.7	82.3	59.0	15.8	22.1	28.1	22.8	16.2	18.8	14.1	29.0	10.0	37.5	31.3	22.9	30.9	37.1	36.9	25.4	35.8	12.0	27.7	38.8	33.3	19.2	27.3	59.7	38.0	38.7	32.0	35.2	40.8	32.9	26.1	23.2	17.0	39.5	20.2	57.3	34.1	26.4	41.9	24.8	20.2	15.8	47.3	26.6	118.0	66.5	21.5	32.0	86.5	231.0	43.5	25.0	16.6	44.0	20.7	30.0	27.2	29.8	27.5	26.3	36.2	28.5	16.1	10.1	28.9	23.4	29.8	39.9	31.2	28.0	22.2
AP4B1	"BETA-4, SPG47"	ENSG00000134262	"Adaptor related protein complex 4 subunit beta 1"	Q9Y6B7	1	113894194-113905201	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028162, HPA028652"	Approved		Approved	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA028162: AB_10610976, HPA028652: AB_10601451"	"unprognostic (8.90e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.01e-2)"	"prognostic unfavorable (8.60e-7)"	"unprognostic (3.45e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (3.73e-6)"	"unprognostic (5.08e-3)"	"unprognostic (7.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.55e-2)"	9.7	8.5	12.5	11.1	13.1	20.5	9.3	14.6	14.6	11.9	10.9	11.5	10.6	9.7	14.2	12.1	11.0	7.0	11.2	13.0	13.0	9.7	8.4	9.5	14.3	11.6	11.4	13.7	14.0	4.8	13.7	5.9	11.8	9.6	12.7	20.0	7.6	6.2	11.7	11.5	12.8	9.1	11.5	20.1	10.4	11.1	13.3	16.1	11.0	9.1	13.9	9.2	10.0	13.3	11.0	9.8	10.0	11.8	15.7	14.1	6.4	10.1	9.8	13.0	14.0	6.8	7.7	21.5	15.9	12.4	6.5	9.7	11.3	13.4	16.5	16.6	9.8	17.6	13.6	8.3	9.5	19.6	17.3	16.1	6.7	25.5	15.3	7.8	22.7	20.9	12.3	18.5	17.6	65.2	15.6	21.6	9.4	7.7	19.0	15.0	19.5	13.3	13.2	5.5	10.2	8.5	10.1	19.1	7.8	9.5	5.7	15.4	21.8	15.0	13.9	17.4	20.8	15.2	15.8	21.3	24.6	26.0	25.1	15.9	10.5	8.6	14.7	10.8	15.6	9.5	11.7	12.6	12.9	11.9	12.7	11.1	1.2	12.2	8.5	9.1	10.4	9.5	12.5	13.1	14.6	14.6	13.0	13.0	11.6	11.4	11.8	11.5	13.3	13.3	7.2	3.2	6.7	7.5	12.3	3.6	3.3	5.4	4.6	6.8	3.2	4.3	8.7	5.7	11.9	3.7	31.3	3.8	12.0	7.8	1.9	7.7	3.6	4.6	4.7	7.6	3.0	18.1	11.4	26.8	3.5	7.0	11.2	5.2	2.5	4.5	7.5	4.1	5.2	8.4	11.6	5.3	6.1	7.3	4.9	2.3	2.8	6.9	7.2	7.5	6.1	4.7	3.1	11.6	10.0	10.9	6.9	4.9	7.4	2.8	6.5	3.3	5.2	21.0	13.1	6.1	6.2	16.4	11.5	5.7	3.7	1.6	14.8	6.4	9.0	3.3
AP4E1	"AP-4-EPSILON, SPG51"	ENSG00000081014	"Adaptor related protein complex 4 subunit epsilon 1"	Q9UPM8	15	50908672-51005895	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041749, HPA041891"	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA041749: AB_10794490, HPA041891: AB_10796462"	"unprognostic (1.72e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.46e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.40e-1)"	"unprognostic (2.03e-2)"	3.7	3.0	2.5	4.4	2.9	3.1	3.0	3.3	2.7	3.7	3.2	3.6	3.0	4.3	2.1	4.7	3.2	2.6	3.9	2.4	2.6	2.8	2.9	3.1	5.5	2.9	2.8	2.9	2.2	5.1	2.4	4.7	2.9	2.7	3.4	3.8	3.3	2.6	8.2	5.4	3.2	4.5	2.6	4.6	2.9	3.9	3.0	6.5	3.8	6.3	4.7	4.0	4.1	3.5	11.5	8.7	6.0	7.1	7.9	12.0	11.7	11.1	8.9	10.7	11.1	10.7	1.8	11.2	4.3	12.5	10.8	13.7	9.0	9.6	12.4	12.3	4.6	9.8	14.5	4.3	11.1	12.1	8.2	12.2	11.6	13.4	21.0	6.6	7.2	8.8	9.1	6.3	14.7	15.4	7.1	6.9	3.9	5.2	4.4	9.7	8.5	6.9	7.9	10.4	4.1	6.7	11.8	8.4	8.7	10.7	7.6	11.7	10.0	15.7	5.8	9.5	15.9	9.6	11.7	14.1	12.3	26.1	7.3	2.7	0.6	0.3	0.8	0.9	0.5	0.5	0.6	0.7	0.6	0.3	0.4	0.9	0.1	0.5	0.5	0.4	0.3	0.4	2.5	2.9	3.3	2.7	2.4	2.6	2.9	2.8	2.9	2.6	3.0	3.5	6.6	6.4	6.1	17.6	8.7	5.7	1.5	3.8	4.0	9.8	4.9	3.7	10.4	2.8	8.4	5.5	18.8	7.3	7.7	7.9	0.0	4.9	2.0	5.9	10.0	7.8	3.0	6.9	26.7	4.8	5.7	4.7	7.1	6.2	10.2	7.2	6.8	8.1	7.2	8.4	27.0	5.3	2.0	17.0	4.1	1.4	5.9	10.2	1.8	25.3	6.5	3.9	8.2	19.1	36.0	10.6	2.4	4.1	9.6	2.2	6.2	3.6	4.8	11.2	6.6	7.1	6.6	10.2	7.7	6.6	7.0	7.3	9.6	4.8	5.5	2.4
API5	"AAC-11, AAC11, API5L1"	ENSG00000166181	"Apoptosis inhibitor 5"	Q9BZZ5	11	43311963-43344529	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026598	Approved		Enhanced	"Nuclear speckles"		NA	NA		31000	"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA026598: AB_1844927"	"unprognostic (4.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.58e-3)"	"unprognostic (6.08e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.69e-3)"	"unprognostic (1.45e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (1.06e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.05e-2)"	37.6	33.1	29.2	43.4	31.1	35.3	45.7	38.5	37.4	39.3	25.9	44.3	42.8	42.1	34.5	44.6	36.6	32.4	28.2	32.0	30.6	49.1	57.7	34.8	53.5	29.2	28.5	35.1	45.9	46.6	19.0	29.9	30.8	40.4	46.6	44.1	39.0	39.5	37.1	40.0	45.5	46.6	32.8	40.3	41.1	26.8	29.9	62.1	51.4	35.9	57.2	44.2	27.6	38.6	90.2	93.0	119.4	75.2	82.7	82.4	82.9	83.8	89.4	116.3	110.2	69.4	38.8	106.4	67.2	90.2	86.9	107.7	143.2	99.7	160.6	122.4	134.9	96.5	53.0	60.8	74.8	165.6	88.9	64.2	104.6	59.0	102.9	72.4	98.9	65.8	160.3	93.9	82.1	57.0	141.2	71.1	214.6	111.1	86.0	145.2	126.3	85.3	89.5	103.8	95.5	64.2	100.7	88.7	81.4	88.4	109.1	76.6	86.5	102.0	78.3	139.8	144.5	77.5	122.7	172.1	88.8	95.0	62.3	61.3	47.3	51.5	66.5	64.5	75.1	61.7	64.8	69.3	62.1	60.4	66.3	68.7	9.9	116.3	67.3	40.0	61.4	88.4	29.2	31.1	38.5	37.4	32.0	30.6	29.2	28.5	30.8	32.8	29.9	38.6	26.4	16.0	27.3	30.0	35.9	43.8	16.6	21.6	47.3	23.8	27.8	17.8	14.4	31.5	28.0	20.2	10.4	30.4	31.8	20.1	31.3	21.3	13.6	23.5	25.8	26.2	24.0	48.0	40.2	19.7	30.4	28.3	35.2	28.2	32.3	25.9	22.1	48.0	26.3	28.6	33.5	27.5	12.2	33.6	28.8	6.5	18.6	30.0	32.0	27.2	41.7	21.1	17.5	25.1	45.4	24.9	19.8	20.3	44.2	24.0	29.4	37.3	20.8	19.0	6.6	28.9	31.1	28.4	26.6	43.1	51.9	38.9	33.8	26.6	31.4	19.2
ARMCX5	"FLJ12969, GASP5"	ENSG00000125962	"Armadillo repeat containing X-linked 5"	Q6P1M9	X	102599168-102604159	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 88.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000996	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles, Cytosol"	"Plasma membrane"	"HPA000996: AB_1078212"	"unprognostic (7.71e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.07e-2)"	"prognostic favorable (6.58e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.24e-2)"	8.2	11.0	10.4	8.8	10.6	10.3	17.8	10.0	11.5	13.7	6.9	12.8	10.8	15.2	15.5	11.0	15.0	10.0	10.7	11.4	9.3	12.6	11.3	11.2	10.4	7.7	7.0	20.3	14.7	19.9	7.2	8.4	7.6	20.6	15.3	10.6	15.7	13.5	9.3	11.2	12.3	13.9	7.3	8.0	13.5	5.4	9.6	16.2	19.5	10.1	13.3	11.2	6.5	11.4	17.8	15.7	36.4	19.4	15.9	17.8	20.4	17.1	13.1	19.5	34.5	18.7	21.5	0.0	20.3	17.2	22.3	15.1	32.8	16.3	22.1	0.0	13.1	17.9	19.2	15.6	20.6	32.7	20.0	22.3	20.7	16.9	20.3	15.5	20.0	0.0	17.6	0.1	26.3	15.8	23.3	3.9	16.4	30.3	29.5	22.7	88.9	0.1	14.5	24.2	17.1	15.4	30.5	15.7	24.7	10.4	10.8	15.4	20.3	14.5	12.8	16.5	12.3	0.0	13.0	0.0	11.4	32.7	37.8	0.1	11.8	3.2	13.9	12.3	13.3	12.5	12.8	10.9	11.3	6.4	17.8	14.0	1.0	9.3	7.8	10.0	9.7	11.1	10.4	10.6	10.0	11.5	11.4	9.3	7.7	7.0	7.6	7.3	9.6	11.4	6.9	6.4	6.9	0.0	9.0	5.6	11.7	8.0	19.4	16.5	8.9	7.7	4.4	7.2	10.3	9.2	20.9	5.7	9.2	6.8	21.5	10.0	0.3	5.9	8.3	9.6	9.6	3.4	0.0	9.7	2.6	9.9	10.7	5.7	1.3	7.8	5.7	9.6	6.0	1.7	0.0	9.8	4.1	7.2	3.5	0.5	8.4	6.6	8.8	0.0	4.6	6.5	10.3	0.0	0.0	9.3	3.8	6.0	12.0	9.3	9.6	10.6	13.7	20.8	0.0	6.7	7.8	3.0	5.3	14.5	5.7	3.7	9.5	7.5	9.7	11.1
ARPC4-TTLL3		ENSG00000250151	"ARPC4-TTLL3 readthrough"		3	9793082-9835401	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.4;B-cells: 1.8;Basal squamous epithelial cells: 1.8;Erythroid cells: 3.0;Gastric mucus-secreting cells: 2.0;Macrophages: 1.5;Plasma cells: 1.7;T-cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"													NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"				"unprognostic (9.59e-3)"	"unprognostic (7.61e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.31e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.42e-4)"	"unprognostic (5.49e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.37e-4)"	2.0	1.6	1.4	2.9	1.4	6.7	1.5	1.4	3.2	2.0	1.4	1.5	2.2	1.2	0.6	2.0	1.4	1.3	1.5	1.4	1.6	1.6	1.0	1.9	2.2	1.7	1.5	1.5	0.8	1.0	1.6	1.1	1.5	1.3	0.9	0.6	1.3	0.7	1.6	2.0	2.0	1.5	1.4	3.2	1.3	1.6	1.9	2.3	1.3	0.5	2.1	1.6	1.6	1.7	2.9	0.4	3.0	1.2	3.1	4.6	8.0	3.1	3.3	2.1	2.3	1.4	1.0	3.8	1.4	9.6	4.2	1.5	3.1	2.5	2.6	6.8	1.5	6.1	1.5	0.9	4.3	6.1	9.4	5.6	3.5	5.5	2.4	2.8	3.1	5.8	4.7	4.1	3.1	0.0	3.8	4.9	3.3	1.7	2.1	5.6	2.5	0.1	4.0	3.1	1.6	2.6	2.1	4.3	3.1	1.7	0.8	13.4	4.0	1.8	2.1	3.7	4.5	4.6	6.7	9.6	3.9	5.7	3.9	0.8	2.9	3.0	2.7	2.8	1.7	1.3	1.8	1.4	3.0	1.3	1.4	1.5	3.2	1.3	3.3	2.7	1.4	3.8	1.4	1.4	1.4	3.2	1.4	1.6	1.7	1.5	1.5	1.4	1.9	1.7	0.1	0.0	2.4	0.0	1.8	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.3	0.0	3.0	0.2	0.0	0.1	1.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	1.5	0.0	0.0	0.1
ASB3	ASB-3	ENSG00000115239	"Ankyrin repeat and SOCS box containing 3"	Q9Y575	2	53532672-53860160	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003940	Uncertain					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 6: Brain - Smell perception"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"			"HPA003940: AB_1845067"	"unprognostic (8.32e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.31e-3)"	"unprognostic (4.77e-1)"	"unprognostic (1.64e-4)"	"unprognostic (5.45e-5)"	"unprognostic (6.73e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.82e-1)"	"unprognostic (1.43e-5)"	"unprognostic (3.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.82e-1)"	8.4	11.5	28.1	8.3	29.9	15.0	10.3	32.0	32.8	10.4	14.3	7.6	6.7	11.4	14.0	8.4	9.5	7.8	9.6	29.1	23.8	9.0	10.8	10.0	11.0	18.9	25.9	12.2	7.4	10.3	14.5	11.5	18.4	13.0	8.0	23.4	8.8	10.2	7.2	9.6	8.6	8.2	17.5	12.7	7.1	11.5	24.7	17.2	11.6	7.7	12.2	7.9	9.8	27.9	15.4	12.5	26.8	10.6	17.6	14.7	23.0	16.3	11.5	12.2	15.2	10.8	10.9	14.5	26.1	11.6	22.6	9.4	19.6	12.1	18.0	29.0	17.6	16.0	16.2	21.2	13.7	20.7	12.2	12.3	8.0	11.4	22.4	21.1	15.1	18.9	17.6	17.9	18.1	9.9	23.4	27.3	20.7	14.3	10.8	21.5	20.2	11.9	13.9	12.8	19.1	15.0	18.8	17.4	15.3	23.2	6.8	11.4	13.9	19.0	11.3	15.1	18.8	26.4	13.3	8.1	16.3	15.5	16.3	16.6	6.9	12.9	9.0	6.6	12.7	12.2	10.4	10.2	7.5	10.4	11.1	11.1	5.0	11.2	7.5	6.2	11.6	6.8	28.1	29.9	32.0	32.8	29.1	23.8	18.9	25.9	18.4	17.5	24.7	27.9	5.9	25.6	23.2	16.3	14.4	0.0	6.3	0.0	12.5	16.1	5.1	6.1	0.0	5.7	14.9	1.8	4.2	11.6	6.4	1.5	0.0	4.8	5.0	6.6	7.2	6.0	1.2	9.0	3.6	2.7	10.0	9.1	7.1	3.1	16.4	5.5	4.6	4.4	4.6	3.3	3.1	3.6	0.0	5.7	0.0	2.5	9.6	5.9	0.0	3.7	4.0	10.1	9.2	26.7	3.5	4.4	1.5	9.8	18.9	3.2	3.3	3.9	12.4	10.3	6.6	6.5	5.7	16.8	14.5	8.9	0.0	7.7	11.3	6.5	3.0	3.4
ASB7		ENSG00000183475	"Ankyrin repeat and SOCS box containing 7"	Q9H672	15	100602589-100651701	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003300	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA003300: AB_1845071"	"unprognostic (1.38e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.91e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.46e-2)"	4.6	3.6	4.2	4.5	4.7	12.8	5.1	4.9	4.6	5.2	5.6	6.8	4.6	5.3	6.5	4.6	5.7	3.8	3.9	4.2	4.1	6.7	6.8	4.9	6.3	4.5	4.3	5.7	3.5	6.7	3.1	4.3	4.2	4.7	6.3	4.9	4.5	4.3	3.1	4.4	4.4	6.0	4.2	5.9	4.3	6.8	4.9	7.0	6.2	4.7	6.3	5.1	3.5	5.0	6.7	14.5	6.6	7.9	8.6	9.2	7.5	7.2	13.0	11.8	12.3	8.8	13.2	10.9	6.4	9.2	11.6	14.5	9.2	9.4	12.2	7.6	9.8	14.4	9.0	8.8	13.0	8.6	12.3	8.9	10.3	9.6	15.8	11.4	11.0	11.7	8.6	8.9	6.8	7.2	6.7	8.7	6.3	14.9	6.9	9.0	14.1	9.2	11.8	14.8	6.5	9.2	11.1	10.8	15.0	12.5	7.6	10.7	8.4	10.3	9.5	7.3	10.2	10.6	23.5	10.4	8.0	7.8	8.3	1.2	5.8	10.2	5.2	4.7	4.2	4.3	4.5	6.4	5.1	4.2	6.2	4.4	5.2	4.3	3.1	3.3	5.7	4.8	4.2	4.7	4.9	4.6	4.2	4.1	4.5	4.3	4.2	4.2	4.9	5.0	4.6	0.0	5.4	14.7	6.6	6.5	2.3	3.5	13.1	4.9	6.2	4.1	3.4	12.8	6.4	3.7	6.2	3.8	9.9	12.9	1.9	5.7	4.0	8.1	8.3	6.7	8.4	3.0	20.6	4.9	3.0	4.0	7.1	8.1	10.8	7.3	4.2	8.0	6.0	13.5	15.0	6.2	4.1	7.8	4.3	2.1	5.0	5.2	3.6	20.6	7.8	3.1	6.2	16.6	17.4	6.5	9.7	5.3	4.9	5.5	5.4	7.1	10.3	5.0	0.0	4.3	4.3	9.9	8.2	10.8	4.5	5.9	8.2	6.7	5.8	5.6
ASCC1	"ASC1p50, CGI-18, Em:AC022392.3, p50"	ENSG00000138303	"Activating signal cointegrator 1 complex subunit 1"	Q8N9N2	10	72096032-72217134	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"		Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038038, HPA057567"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA038038: AB_10674544, HPA057567: "	"unprognostic (1.96e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.34e-2)"	"prognostic unfavorable (3.52e-4)"	"unprognostic (1.22e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.64e-2)"	19.0	24.9	18.3	13.9	23.5	7.3	16.4	22.4	24.5	16.1	18.8	14.4	9.0	17.1	16.4	14.3	15.3	13.7	24.8	17.2	20.7	15.2	21.6	13.5	18.5	23.4	20.6	17.9	22.7	14.2	11.9	13.0	23.6	11.9	9.9	15.7	12.8	14.5	29.7	17.1	14.6	12.4	21.7	17.1	14.4	18.4	20.4	22.3	13.4	17.3	16.8	15.7	13.6	30.4	29.3	40.3	25.8	58.1	34.0	37.9	21.1	18.0	33.5	26.5	30.7	31.4	105.3	37.0	35.6	26.3	17.9	38.4	21.1	30.6	26.5	27.2	20.1	24.1	29.1	36.4	32.7	25.2	24.1	33.3	68.9	26.7	45.0	38.1	36.4	40.4	34.8	51.8	35.0	25.7	34.2	36.1	15.7	18.8	8.8	20.1	21.1	27.4	49.8	21.0	27.1	16.9	26.1	65.7	49.4	23.9	21.7	18.5	32.0	15.2	27.1	11.6	19.4	28.4	40.4	45.5	24.6	55.9	10.8	20.4	19.0	35.0	16.5	20.3	17.0	31.4	19.4	17.7	21.0	32.5	27.2	25.8	12.5	26.6	15.4	28.9	29.2	19.0	18.3	23.5	22.4	24.5	17.2	20.7	23.4	20.6	23.6	21.7	20.4	30.4	16.7	9.6	5.8	25.5	20.5	6.2	14.0	22.8	9.6	12.9	9.0	6.3	23.6	10.0	13.4	12.9	14.6	17.7	18.6	4.7	23.5	20.4	27.5	12.1	13.8	13.9	3.6	11.1	33.1	20.0	19.5	16.5	6.6	12.1	12.7	12.6	10.4	22.0	18.2	25.2	42.9	5.2	16.2	24.1	8.7	14.2	20.5	12.7	19.6	27.2	21.4	19.9	16.5	35.7	52.8	14.7	8.4	20.7	14.5	8.0	9.5	11.4	9.8	14.3	13.1	10.8	15.9	27.8	28.2	10.9	7.0	15.2	17.9	18.9	6.5	9.2
ASTL	"ovastacin, SAS1B"	ENSG00000188886	"Astacin like metalloendopeptidase"	Q6HA08	2	96123850-96138436	"Predicted intracellular proteins"	Fertilization	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 4.1;brain: 4.3"	"Cell type enhanced"	"Detected in some"		"Glandular and luminal cells: 1.0;Macrophages: 1.2;T-cells: 1.7"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Region enriched"	"Detected in single"	5	"cerebral cortex: 4.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RT4: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015620	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 59: Non-specific - Transcription"			"HPA015620: AB_1845121"	"unprognostic (3.21e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.45e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.03e-2)"		"unprognostic (3.53e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.61e-5)"	"unprognostic (3.41e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.93e-3)"	0.1	0.0	0.9	0.3	0.2	4.1	0.1	0.7	4.3	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.2	0.5	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.3	0.1	0.0	0.2	1.0	0.0	0.9	0.4	0.0	0.0	0.7	0.2	0.3	0.0	0.7	0.0	0.0	0.3	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.2	0.7	4.3	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.5	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0
ASXL2	"ASXH2, FLJ10898, KIAA1685"	ENSG00000143970	"ASXL transcriptional regulator 2"	Q76L83	2	25733753-25878487	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034646, HPA058040"			Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA034646: AB_2674261, HPA058040: AB_2683586"	"unprognostic (4.78e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.68e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.75e-2)"	6.8	6.2	3.8	9.5	5.1	8.3	7.2	4.8	3.9	8.2	4.5	9.1	6.4	7.1	5.0	7.7	7.2	6.8	7.1	3.5	7.7	8.7	6.1	6.9	11.1	7.5	5.0	6.6	7.7	14.1	3.5	7.1	7.5	6.3	8.9	8.8	6.6	6.3	8.0	7.6	7.1	8.2	3.6	9.9	7.8	17.7	6.3	13.9	10.5	7.3	10.5	7.5	4.2	6.4	25.1	23.1	11.0	7.8	9.8	13.7	12.9	16.0	19.0	12.4	10.5	19.4	12.6	14.8	9.7	13.9	13.8	14.1	21.1	14.9	16.9	22.5	10.2	32.9	20.1	16.6	8.3	42.2	25.1	6.8	15.2	17.9	15.3	10.4	15.2	8.8	29.0	12.2	12.5	9.2	15.5	9.2	14.4	13.2	9.4	15.4	48.2	11.4	10.7	30.1	11.3	12.5	22.2	13.9	13.5	10.4	8.9	12.3	31.4	16.6	22.0	15.9	22.4	26.8	39.8	41.0	15.5	27.4	13.2	1.7	2.7	4.2	2.7	1.4	2.3	2.2	1.9	1.9	1.5	2.0	2.2	2.5	6.0	1.2	3.3	2.3	2.2	0.8	3.8	5.1	4.8	3.9	3.5	7.7	7.5	5.0	7.5	3.6	6.3	6.4	16.1	25.6	24.1	54.2	25.9	32.4	8.9	15.9	29.0	22.3	19.1	10.8	27.0	14.3	19.1	9.2	25.0	10.2	22.5	20.1	15.6	15.7	48.9	25.8	20.4	22.0	10.3	33.6	62.5	14.4	9.4	17.3	24.5	19.8	23.5	12.6	28.5	12.6	18.2	25.2	47.6	16.8	18.3	25.7	23.6	26.9	19.6	25.2	23.2	68.4	34.4	12.4	12.3	46.3	72.8	18.4	14.2	13.2	29.8	13.4	12.4	14.3	41.3	24.9	39.5	20.6	16.8	34.4	26.6	29.7	41.1	14.6	45.0	17.2	19.7	19.3
ATP11B	"ATPIF, ATPIR, KIAA0956"	ENSG00000058063	"ATPase phospholipid transporting 11B (putative)"	Q9Y2G3	3	182793503-182921629	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 132.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036237, HPA036238"	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Centriolar satellite, Cytosol"		"HPA036237: AB_10673123, HPA036238: AB_10670792"	"unprognostic (4.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.03e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.35e-1)"	20.6	10.7	4.7	24.9	6.9	70.6	17.4	15.9	7.6	19.1	13.8	26.3	24.3	18.7	14.6	45.4	13.7	21.1	14.1	6.0	6.3	18.0	18.3	16.5	27.9	7.5	6.1	20.5	21.0	29.4	10.3	14.5	7.3	28.3	29.0	30.8	19.4	13.4	11.4	28.2	24.0	19.5	5.6	21.8	51.1	31.6	6.6	44.6	16.8	16.8	28.4	25.7	22.5	15.8	69.7	9.7	20.5	28.7	42.6	46.1	19.3	32.8	41.6	23.2	27.1	23.7	34.0	31.3	53.5	44.0	48.2	40.4	24.6	31.3	40.2	73.9	20.9	76.7	13.1	5.2	24.8	62.3	47.3	31.5	34.7	26.1	37.4	34.1	37.0	48.7	27.7	94.3	37.8	22.9	50.3	19.1	14.5	38.1	19.2	21.2	59.8	37.8	28.1	55.8	12.5	22.0	86.2	10.7	36.9	18.3	11.9	43.7	36.6	35.0	38.7	30.5	56.2	131.0	125.5	58.1	24.1	25.3	20.9	5.5	1.0	4.3	1.7	1.0	1.7	2.1	1.4	1.7	1.1	1.3	1.2	1.8	3.8	1.8	1.0	2.4	1.2	0.8	4.7	6.9	15.9	7.6	6.0	6.3	7.5	6.1	7.3	5.6	6.6	15.8	26.8	16.0	13.2	34.6	27.8	34.3	25.7	15.9	26.2	12.2	13.8	9.7	15.6	18.6	16.5	20.2	14.6	12.8	43.0	44.6	0.0	12.5	34.1	19.0	22.9	15.7	6.7	26.1	81.6	16.5	3.8	19.5	46.4	22.1	11.4	14.0	16.1	16.4	10.4	38.7	64.3	30.5	16.2	19.4	26.4	23.8	19.3	29.3	14.2	45.9	19.9	8.4	27.8	67.8	132.6	25.2	27.0	21.1	55.5	35.8	24.3	7.8	19.8	31.4	19.7	24.1	17.7	18.7	11.4	43.8	44.6	9.6	40.9	7.0	27.3	45.4
ATP6V0C	"ATP6C, ATP6L, ATPL, VATL, Vma3"	ENSG00000185883	"ATPase H+ transporting V0 subunit c"	P27449	16	2513952-2520218	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 115.3;Basal squamous epithelial cells: 363.7;Gastric mucus-secreting cells: 128.0;Macrophages: 152.4;Plasma cells: 235.0;Squamous epithelial cells: 385.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065100			Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA065100: AB_2685421"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.96e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.44e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	"prognostic favorable (1.07e-6)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.04e-2)"	203.2	247.2	150.2	95.4	176.0	182.7	165.2	82.8	252.8	178.7	66.7	172.0	95.0	154.8	32.9	337.0	147.8	23.2	211.8	204.1	196.7	414.4	207.1	230.5	50.8	136.5	139.7	154.3	140.5	103.9	327.2	62.1	141.6	144.2	29.7	110.5	214.2	48.3	301.0	281.2	164.4	30.0	72.4	222.0	175.7	143.9	147.5	44.9	166.8	54.0	31.0	134.4	207.4	135.7	154.4	174.5	84.6	125.9	105.3	54.3	203.5	234.4	72.1	98.2	90.4	163.9	206.4	81.8	209.3	106.0	154.2	193.4	90.7	137.6	45.1	207.1	295.5	95.2	128.1	201.7	152.6	139.9	274.3	98.2	104.4	118.6	59.6	90.8	68.5	88.2	214.5	143.0	80.0	323.5	141.3	363.3	176.3	99.4	211.4	240.8	73.5	251.1	163.8	97.4	277.6	224.4	201.3	215.5	204.4	74.8	222.5	175.9	171.4	154.3	184.6	229.6	160.1	280.9	351.5	146.5	137.1	105.3	161.4	89.4	123.2	203.4	51.4	139.4	53.3	58.5	46.8	56.5	76.6	55.0	52.1	47.0	165.8	52.7	171.7	105.1	50.8	78.8	150.2	176.0	82.8	252.8	204.1	196.7	136.5	139.7	141.6	72.4	147.5	135.7	1.8	25.6	49.2	38.2	115.3	1.0	0.2	0.4	363.7	0.5	1.1	0.6	0.1	0.0	18.3	1.8	0.0	0.5	3.4	3.4	0.0	0.8	0.0	4.3	2.6	12.7	0.0	73.4	72.7	0.2	1.0	48.8	128.0	3.6	17.7	0.6	1.4	0.7	1.0	0.0	107.3	0.7	0.0	1.3	0.8	0.2	0.6	152.4	0.0	39.4	0.3	0.4	0.0	36.7	53.0	0.6	0.2	0.0	235.0	0.2	2.4	1.1	25.1	0.8	0.0	0.7	17.0	0.8	1.1	385.2	1.0	1.2	72.7	0.4	2.3	0.2
ATP7A	MNK	ENSG00000165240	"ATPase copper transporting alpha"	Q04656	X	77910656-78050395	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Translocase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ionocytes: 61.1;Microglial cells: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012887, HPA048107"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 31: Skin - Epidermis development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA012887: AB_1845205, HPA048107: AB_2680266"	"unprognostic (3.14e-2)"	"unprognostic (3.48e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.38e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.52e-1)"	3.0	4.3	1.2	3.6	1.7	5.9	6.3	2.3	2.1	3.9	1.6	3.4	3.9	3.6	5.0	4.9	3.5	3.6	2.5	1.3	2.1	4.4	2.3	4.5	4.1	2.1	2.1	3.6	2.4	7.3	2.5	4.0	3.8	5.3	3.4	3.0	5.1	3.4	1.8	11.1	3.4	3.2	1.1	4.7	5.5	1.6	1.6	4.7	4.6	2.9	4.6	3.9	2.8	2.9	3.2	8.3	5.4	5.5	5.0	5.3	0.9	4.8	6.6	2.8	5.7	1.0	3.6	4.7	6.9	4.8	3.3	3.8	7.1	3.9	5.2	7.0	4.8	2.4	7.8	0.8	6.3	4.1	4.1	5.6	1.6	5.9	1.8	6.5	7.3	4.7	19.6	17.4	5.2	2.8	4.6	1.4	1.5	11.2	1.7	3.7	9.0	15.8	4.6	8.8	1.6	20.4	11.9	2.8	6.0	3.3	2.2	1.3	9.4	3.7	3.6	5.2	1.9	5.6	10.7	5.2	6.0	2.5	5.7	7.1	1.5	4.5	1.8	1.5	0.9	1.8	1.2	1.2	1.0	1.4	1.4	2.1	8.1	1.2	1.9	1.0	0.4	1.0	1.2	1.7	2.3	2.1	1.3	2.1	2.1	2.1	3.8	1.1	1.6	2.9	14.3	0.0	8.4	15.7	12.6	7.4	5.1	5.8	13.1	6.4	17.3	10.0	5.1	1.5	8.2	9.2	4.2	2.0	15.0	4.5	1.9	5.6	0.5	5.3	9.2	9.7	4.8	22.5	11.1	13.6	2.2	9.4	20.4	8.8	9.5	6.4	14.6	3.6	14.3	1.7	12.5	4.8	61.1	11.7	6.7	1.1	7.2	12.6	19.6	44.0	5.5	4.4	11.3	37.7	35.0	6.2	4.1	9.8	10.5	4.8	4.1	5.5	10.2	4.1	32.9	10.3	8.7	1.8	5.4	20.5	16.6	2.2	13.8	6.7	5.2	6.6
BAG4	SODD	ENSG00000156735	"BAG cochaperone 4"	O95429	8	38176533-38213301	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013716, HPA018951"	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"			"CAB013716: , HPA018951: AB_1845260"	"unprognostic (2.25e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.44e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.50e-3)"	"unprognostic (4.83e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.70e-2)"	10.3	5.7	10.8	5.9	12.5	28.6	7.8	10.8	17.8	7.3	3.3	5.5	5.8	6.7	6.8	6.7	5.2	5.5	4.9	13.6	9.0	9.6	16.8	5.7	7.3	9.0	7.5	11.0	5.2	8.0	4.6	11.4	9.0	7.5	5.8	9.6	6.7	7.8	14.4	7.3	5.6	6.0	4.8	6.5	5.5	4.3	10.0	7.5	6.8	6.8	7.6	6.3	5.6	9.8	16.3	18.4	14.9	22.7	27.8	18.5	13.8	16.5	20.3	17.6	19.4	19.0	9.5	19.5	18.1	14.2	11.9	16.4	25.0	14.4	24.2	9.0	14.0	32.8	10.6	27.3	14.0	15.3	13.4	15.5	16.1	18.4	17.7	12.1	10.1	14.0	34.8	11.5	14.7	9.7	27.3	18.0	32.5	12.7	8.2	18.9	17.7	8.9	16.1	17.8	11.4	15.6	13.7	8.9	13.5	13.4	10.7	9.0	14.4	16.3	16.9	27.6	11.1	10.4	16.5	22.9	9.7	17.4	17.2	17.1	13.9	15.1	8.2	11.6	9.7	7.5	7.2	7.9	12.5	7.4	9.3	8.6	8.7	5.6	21.3	6.5	8.4	9.4	10.8	12.5	10.8	17.8	13.6	9.0	9.0	7.5	9.0	4.8	10.0	9.8	10.6	12.8	12.4	15.3	14.7	43.1	13.2	12.7	38.1	18.9	13.1	10.8	11.1	12.8	12.1	20.2	27.1	23.5	10.8	10.4	17.6	11.0	4.0	13.5	14.6	10.9	5.4	19.4	30.6	11.6	19.0	16.2	13.7	16.0	7.6	11.4	12.8	25.5	24.5	13.5	27.5	8.9	6.1	26.7	30.8	4.4	15.2	19.4	37.4	13.1	23.9	10.4	9.2	7.5	20.8	9.1	8.3	13.2	20.6	19.2	15.3	21.1	10.9	11.8	6.6	16.1	12.7	13.3	11.5	24.0	33.8	12.2	14.8	15.7	12.0	18.7
BCKDHA	"MSU, OVD1A"	ENSG00000248098	"Branched chain keto acid dehydrogenase E1 subunit alpha"	P12694	19	41397808-41425002	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 26.2;Gastric mucus-secreting cells: 23.4;Plasma cells: 25.0;Squamous epithelial cells: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036640	Supported					NA	NA		7700	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"			"HPA036640: AB_10671964"	"unprognostic (4.50e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.26e-2)"	"prognostic favorable (9.37e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (5.33e-10)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.27e-5)"	"unprognostic (9.66e-2)"	33.8	78.4	32.0	19.3	35.5	32.4	25.2	37.0	39.3	24.6	37.0	20.9	19.9	17.9	14.1	65.1	28.8	15.4	90.4	32.5	35.1	44.3	110.0	22.4	24.5	34.4	33.8	25.4	46.1	56.3	24.0	19.0	36.2	23.8	15.0	21.7	40.9	23.1	110.0	31.8	18.7	12.7	33.9	24.4	52.5	27.1	35.7	27.0	41.7	122.0	21.2	21.7	31.9	40.0	42.7	75.1	14.2	44.1	22.2	12.8	17.1	11.9	25.3	24.4	29.9	18.2	36.0	34.6	23.7	15.1	11.0	17.1	15.0	25.9	12.1	36.0	41.0	27.1	35.2	21.3	51.5	25.5	17.7	27.6	37.6	16.9	38.2	36.0	45.0	50.9	25.9	68.9	17.6	41.5	28.0	20.0	12.8	61.1	21.1	27.1	22.8	89.6	29.8	19.8	32.5	38.6	39.6	84.7	34.1	12.1	45.4	81.0	29.3	22.2	23.0	12.0	22.0	131.9	55.1	34.1	81.8	56.6	24.6	61.4	149.4	59.7	49.5	123.9	56.7	46.0	47.0	49.1	154.6	49.5	43.2	44.9	46.4	82.4	95.5	62.6	63.9	125.6	32.0	35.5	37.0	39.3	32.5	35.1	34.4	33.8	36.2	33.9	35.7	40.0	0.6	0.0	13.1	4.9	10.0	0.3	0.1	2.6	26.2	0.2	1.5	0.4	0.1	1.5	5.3	5.5	0.0	1.9	0.9	3.8	3.9	14.7	0.7	0.5	0.6	2.4	6.1	15.5	5.8	11.8	1.7	3.7	23.4	0.7	5.1	0.4	2.5	2.4	2.7	0.0	6.2	7.6	8.2	2.2	0.8	0.9	0.6	6.6	3.6	3.7	12.4	0.4	5.2	4.0	5.7	8.4	3.8	0.4	25.0	0.2	6.7	2.3	1.2	1.2	0.0	0.2	3.6	1.8	0.9	27.2	0.9	2.1	6.3	0.3	7.3	0.1
BCL3	"BCL4, D19S37"	ENSG00000069399	"BCL3 transcription coactivator"	P20749	19	44747705-44760044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 161.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 172.4;Squamous epithelial cells: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 5.5;neutrophil: 19.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 19.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 67.3;Karpas-707: 54.1;SiHa: 69.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002051, HPA047514"	Approved		Supported	Nucleoplasm,Vesicles,Midbody		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Vesicles, Midbody"	"CAB002051: AB_563428, HPA047514: AB_2680074"	"prognostic favorable (9.67e-4)"	"unprognostic (8.82e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (2.09e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.13e-14)"	"unprognostic (8.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.04e-2)"	65.1	43.6	6.7	25.0	6.3	54.0	37.2	6.4	7.8	26.8	7.9	39.7	32.2	26.8	1.7	67.5	35.9	13.4	36.3	5.9	7.2	56.6	161.8	87.3	11.6	11.6	7.8	23.7	37.4	3.1	25.2	7.9	8.1	43.4	9.3	1.3	40.9	8.9	17.8	28.3	44.2	11.7	8.0	58.7	35.9	9.6	8.5	6.6	36.8	4.9	12.7	37.6	37.7	6.4	9.8	33.5	0.7	17.5	6.1	12.6	1.7	5.8	6.3	3.7	5.3	6.9	17.8	9.5	13.4	11.5	18.5	10.5	2.4	9.9	2.3	67.3	0.6	1.1	18.9	9.3	14.6	0.7	28.2	22.5	7.8	8.1	9.9	16.6	10.0	0.0	1.2	54.1	2.2	8.4	0.0	7.4	0.9	15.1	12.8	4.3	6.5	3.4	16.5	19.9	0.0	0.9	69.7	35.7	1.9	1.1	12.7	7.6	16.8	11.8	11.6	18.5	2.2	50.1	21.4	10.1	22.1	1.2	9.2	0.4	2.7	5.5	0.8	1.8	1.1	1.5	1.0	1.3	2.6	1.3	0.5	0.7	19.8	2.3	1.1	3.1	1.7	1.0	6.7	6.3	6.4	7.8	5.9	7.2	11.6	7.8	8.1	8.0	8.5	6.4	56.3	19.2	51.3	2.6	43.9	46.7	38.8	22.4	172.4	2.3	106.8	62.0	3.0	42.9	28.6	12.9	0.0	0.6	33.4	60.6	9.8	31.8	11.8	49.4	34.2	76.3	21.5	4.2	0.5	68.7	6.8	47.8	128.0	70.0	38.0	1.4	38.9	35.5	16.1	8.4	0.8	56.2	8.2	30.5	110.8	2.7	13.4	86.6	40.9	1.0	28.4	2.2	2.1	0.0	0.1	43.0	40.0	4.5	100.4	58.9	56.6	17.7	20.5	0.6	6.6	43.3	40.1	0.5	2.0	146.0	61.1	1.4	46.2	0.3	34.5	51.2
BIRC6	BRUCE	ENSG00000115760	"Baculoviral IAP repeat containing 6"	Q9NR09	2	32357028-32618899	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 272.0;Inhibitory neurons: 291.3;Oligodendrocytes: 361.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 9.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 9.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074409, HPA074738"	Approved		Supported	"Golgi apparatus,Vesicles,Mitotic spindle"		Yes	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus, Vesicles"	"Mitotic spindle"	"HPA074409: , HPA074738: AB_2686710"	"unprognostic (3.38e-2)"	"unprognostic (8.13e-3)"	"unprognostic (8.88e-2)"	"unprognostic (7.06e-3)"	"unprognostic (6.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.49e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.32e-2)"	"unprognostic (3.37e-1)"	4.6	4.7	3.1	6.7	9.7	11.3	8.9	13.9	5.7	7.7	6.3	7.6	5.0	6.8	5.2	5.3	6.2	5.8	4.9	4.6	3.7	7.6	8.9	5.4	9.6	6.4	5.5	12.0	14.7	10.9	2.9	6.9	7.3	6.2	7.5	15.5	5.5	5.9	6.1	6.7	5.4	6.1	4.4	8.5	7.1	6.8	5.6	14.7	11.4	8.8	9.7	7.2	3.1	16.3	21.7	17.8	16.1	7.9	14.9	19.1	11.3	10.8	14.1	11.0	11.3	14.2	5.7	23.6	7.3	19.7	13.2	10.1	22.9	15.1	13.9	18.8	10.5	31.2	11.3	10.7	7.9	32.4	11.9	12.4	6.9	18.0	16.2	10.1	17.7	5.4	25.6	10.0	11.9	9.3	15.5	7.5	11.7	9.2	10.5	14.6	26.6	8.2	9.2	23.4	11.7	18.4	18.6	10.8	8.2	12.5	6.4	11.5	28.7	13.0	13.3	9.1	15.3	13.9	20.0	30.6	10.1	15.1	8.7	9.7	0.9	0.6	1.3	0.7	1.8	0.8	1.0	1.2	0.7	1.8	1.1	1.4	1.5	1.6	1.5	1.6	1.0	0.5	3.1	9.7	13.9	5.7	4.6	3.7	6.4	5.5	7.3	4.4	5.6	16.3	53.9	32.1	30.5	239.3	74.8	46.0	28.6	34.7	41.5	60.8	40.0	23.4	45.8	38.6	42.7	36.8	191.8	35.0	93.4	70.1	1.9	26.9	45.9	39.3	58.0	49.8	32.5	34.3	272.0	31.2	22.0	39.7	68.3	63.1	29.9	52.1	45.7	47.5	29.8	69.0	291.3	43.3	26.4	54.7	60.0	17.6	45.4	59.1	23.2	202.4	67.2	34.9	64.9	231.8	361.3	34.3	30.3	59.0	70.9	46.4	48.5	22.6	30.6	88.2	39.5	56.0	49.1	53.7	46.2	49.7	54.8	38.0	72.4	52.8	45.3	44.0
BORCS8-MEF2B	MEF2BNB-MEF2B	ENSG00000064489	"BORCS8-MEF2B readthrough"		19	19145569-19192158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 2.2;dendritic cells: 1.4;Gastric mucus-secreting cells: 1.5;Late spermatids: 1.1;Plasma cells: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 2.0;U-266/70: 3.1"									HPA004734	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"		"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA004734: AB_10963939"	"unprognostic (2.74e-1)"	"unprognostic (5.77e-3)"	"unprognostic (8.67e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.46e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.33e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.29e-2)"	0.2	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.6	0.3	0.1	0.2	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.6	0.2	0.2	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.0	0.6	0.2	0.2	0.1	0.3	0.2	0.3	0.2	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.8	0.0	0.1	0.1	0.7	0.2	0.1	0.1	0.4	0.3	0.4	0.0	1.4	0.3	0.1	0.0	0.5	0.5	0.2	0.1	0.2	0.1	0.5	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.9	0.1	2.0	0.5	0.2	1.3	0.1	0.6	0.0	0.7	0.7	0.1	0.0	0.1	1.6	0.1	0.5	1.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.5	0.3	0.0	0.0	1.5	0.0	3.1	0.6	1.7	0.3	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	0.1	1.4	0.8	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.2	0.1	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.5	0.0	1.2	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.6	0.0
BRWD1	"C21orf107, DCAF19, FLJ11315, N143, WDR9"	ENSG00000185658	"Bromodomain and WD repeat domain containing 1"	Q9NSI6	21	39184176-39321559	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030943, HPA030944, HPA030945, CAB034184"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	Cytosol	"CAB034184: AB_2243666, HPA030943: AB_2673666, HPA030944: AB_2673667, HPA030945: AB_10670161"	"unprognostic (6.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.39e-3)"	"unprognostic (4.94e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.82e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.58e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.56e-2)"	13.6	18.8	35.7	10.2	37.5	18.6	17.5	40.9	37.3	12.9	27.2	12.5	9.7	14.5	22.6	11.9	13.1	11.0	15.5	37.6	32.9	15.7	25.8	13.2	15.7	23.4	27.5	17.7	19.9	13.1	13.3	17.4	24.8	14.3	12.3	38.6	11.7	11.5	21.9	14.6	11.4	11.1	27.2	10.9	12.1	21.0	40.4	14.9	19.7	24.0	15.0	12.5	12.5	34.4	19.3	7.8	18.6	9.5	10.4	17.2	17.9	11.0	12.7	8.5	9.7	7.1	12.5	59.8	11.0	15.0	9.9	9.1	17.5	12.3	12.9	14.8	14.2	40.9	13.6	12.3	13.7	23.4	11.1	11.2	19.0	11.2	29.0	18.1	11.9	38.7	32.4	30.7	11.5	13.4	15.8	26.8	19.5	23.1	10.7	28.5	14.4	19.4	9.5	12.2	13.9	18.0	23.8	25.0	15.7	6.2	20.7	31.8	14.3	10.6	5.2	6.2	8.1	32.7	24.5	30.1	12.5	24.3	8.7	3.5	4.2	9.7	8.0	5.0	6.1	7.3	6.8	8.3	5.8	4.8	8.2	6.8	4.3	8.4	3.1	5.4	8.5	3.4	35.7	37.5	40.9	37.3	37.6	32.9	23.4	27.5	24.8	27.2	40.4	34.4	42.5	48.1	49.9	147.6	46.1	63.2	43.8	26.6	52.9	65.5	43.2	24.9	59.0	34.3	39.2	18.4	116.7	64.6	45.0	40.1	45.0	28.9	53.5	46.0	48.2	41.6	35.4	37.6	213.9	34.5	45.2	43.3	57.6	54.8	32.9	42.7	32.2	41.1	24.8	74.0	190.0	34.7	48.8	36.8	52.2	20.7	43.2	35.0	30.2	127.4	37.5	43.1	51.5	170.9	201.9	37.8	34.1	44.8	63.2	63.0	39.2	33.1	48.3	109.1	26.3	47.8	41.4	86.1	81.9	52.8	70.3	99.9	51.1	51.1	36.6	67.1
C11orf98	C11orf48	ENSG00000278615	"Chromosome 11 open reading frame 98"	E9PRG8	11	62662817-62665210	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 33.6;Erythroid cells: 25.2;Gastric mucus-secreting cells: 50.0;Plasma cells: 58.3;Squamous epithelial cells: 57.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"				"unprognostic (3.52e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (3.73e-1)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (3.30e-1)"	"unprognostic (8.35e-2)"	"unprognostic (3.02e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (4.02e-6)"	"unprognostic (2.14e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.70e-3)"	48.9	63.4	71.5	57.3	73.8	38.0	45.9	75.1	109.4	41.9	70.7	56.9	45.5	37.7	31.6	66.8	41.0	27.2	65.9	70.5	73.8	77.3	74.0	44.3	72.5	74.3	75.6	35.1	47.6	29.8	35.7	29.8	74.9	55.6	50.6	80.2	43.3	29.2	67.6	52.3	57.1	30.2	72.0	68.7	62.1	65.9	74.6	63.7	41.3	35.9	69.3	50.3	41.2	75.3	265.0	162.8	115.3	140.6	66.5	74.8	63.6	129.6	89.1	145.8	100.2	172.8	144.2	164.3	191.8	81.2	100.6	173.8	115.0	130.5	104.5	178.3	69.2	162.7	101.3	174.9	96.0	254.9	143.0	78.6	150.6	151.7	150.5	87.0	117.1	137.3	202.9	76.1	124.0	337.9	185.1	230.6	188.8	194.6	140.8	139.3	106.1	206.2	163.5	135.0	98.4	110.4	102.5	283.2	182.2	89.4	304.4	91.0	99.4	109.3	147.1	278.7	234.1	74.8	123.9	153.7	141.9	101.4	140.1	340.2	187.3	388.7	202.5	206.3	223.2	352.0	224.4	252.2	166.0	313.6	202.5	250.1	201.9	273.2	217.0	279.3	331.4	288.3	71.5	73.8	75.1	109.4	70.5	73.8	74.3	75.6	74.9	72.0	74.6	75.3	3.0	9.6	5.1	0.0	20.0	0.0	0.3	0.0	33.6	0.1	2.9	2.2	0.1	2.8	5.6	1.8	0.0	1.6	3.6	0.8	1.9	4.2	1.6	5.2	4.8	4.0	0.0	25.2	0.0	2.3	2.1	6.5	50.0	4.3	11.4	0.7	2.9	12.0	1.5	0.0	0.0	0.9	0.0	5.0	0.0	1.3	1.2	11.3	0.0	0.0	8.2	0.2	2.1	0.0	0.0	4.7	1.7	0.7	58.3	0.3	3.1	7.1	13.1	0.7	6.6	0.2	3.7	1.2	0.8	57.1	0.0	1.8	19.6	1.0	0.8	0.6
C15orf40	MGC29937	ENSG00000169609	"Chromosome 15 open reading frame 40"	Q8WUR7	15	82988441-83011641	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041947, HPA042980"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus"		"HPA041947: , HPA042980: AB_10964298"	"unprognostic (8.30e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.55e-3)"	"unprognostic (7.71e-2)"	"prognostic favorable (4.35e-4)"	"unprognostic (2.83e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.51e-2)"	13.4	13.5	8.3	10.1	8.1	13.9	13.2	12.4	10.8	11.0	6.1	12.4	13.7	9.2	19.8	12.1	9.0	6.5	8.1	8.1	6.7	19.1	13.0	8.2	13.5	8.1	6.3	10.5	12.4	9.7	9.3	7.6	7.6	9.4	8.2	10.2	12.4	5.8	12.4	14.7	12.9	6.1	4.2	11.9	11.2	13.9	7.0	10.7	10.3	6.7	11.2	10.1	10.7	15.3	16.8	19.7	12.8	17.4	15.9	14.4	11.6	10.1	16.0	9.7	10.9	13.7	26.6	16.6	13.4	7.6	23.8	29.5	28.5	20.2	10.9	32.1	19.0	15.7	26.4	15.9	15.3	26.6	15.6	12.1	28.8	16.1	18.1	12.8	16.8	43.6	22.1	26.6	9.3	15.7	22.6	14.3	21.4	23.8	12.5	30.5	17.3	22.7	16.7	23.5	29.7	18.2	26.0	20.4	40.8	16.2	23.3	15.4	10.4	20.0	29.1	15.5	17.7	25.4	42.0	31.8	26.0	26.4	22.4	58.0	20.9	31.2	28.1	22.0	31.4	46.7	29.7	29.5	21.2	38.8	34.7	29.9	20.6	42.2	21.4	29.6	41.1	20.5	8.3	8.1	12.4	10.8	8.1	6.7	8.1	6.3	7.6	4.2	7.0	15.3	27.3	28.9	32.5	16.6	41.1	12.0	27.8	45.2	51.2	28.9	33.6	41.0	11.6	38.6	46.2	25.8	12.5	46.6	22.3	42.3	93.9	47.3	36.7	30.0	21.1	27.2	28.8	32.4	11.6	56.1	30.0	29.9	32.1	19.0	27.8	33.7	26.0	37.7	30.0	30.3	14.3	26.4	34.6	28.4	12.0	30.8	33.2	28.0	26.6	8.4	42.7	32.1	63.8	11.6	19.9	62.7	29.6	36.1	41.2	26.7	77.6	127.3	51.2	30.1	19.7	28.6	25.9	107.3	66.8	46.5	15.3	35.6	39.3	39.9	29.9	26.3
C5orf22	FLJ11193	ENSG00000082213	"Chromosome 5 open reading frame 22"	Q49AR2	5	31532287-31555053	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 28.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 28.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043062	Approved		Approved	"Nuclear membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA043062: AB_10795766"	"unprognostic (2.58e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.73e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.65e-1)"	"unprognostic (7.30e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	4.3	3.7	2.0	5.6	2.9	5.8	6.5	2.4	3.0	6.0	1.6	6.7	4.6	6.0	3.4	6.5	5.9	5.6	10.2	2.4	3.2	7.6	7.0	6.6	7.3	2.3	3.2	4.1	11.0	8.2	1.4	5.7	2.9	5.9	7.6	4.8	5.4	5.3	13.7	3.9	5.9	8.2	2.4	5.1	5.2	3.6	2.5	7.2	6.6	15.1	8.7	7.0	2.8	3.0	10.0	7.2	18.4	25.3	13.0	10.7	20.9	16.2	12.2	18.1	13.4	8.7	10.7	8.2	23.4	14.7	15.7	7.3	22.2	13.4	19.2	11.8	11.9	15.7	23.9	12.6	20.9	24.3	51.8	14.6	16.6	12.2	18.9	7.4	15.4	11.5	21.2	12.9	19.6	10.3	13.1	6.1	11.0	10.1	10.7	12.2	30.7	11.7	12.7	15.5	12.3	17.1	45.1	19.9	32.9	11.6	15.9	16.4	13.0	13.6	15.5	16.7	16.4	8.7	18.7	15.0	7.9	42.5	20.7	28.0	2.5	2.4	2.6	2.9	2.8	2.9	3.4	2.8	2.4	2.4	3.2	3.4	0.9	3.8	5.2	1.4	2.1	1.5	2.0	2.9	2.4	3.0	2.4	3.2	2.3	3.2	2.9	2.4	2.5	3.0	6.0	3.2	5.3	10.1	9.6	4.5	3.3	4.0	10.8	4.1	5.6	2.8	23.5	4.3	4.9	12.9	0.0	5.3	9.2	8.8	1.9	4.3	2.9	6.9	7.3	6.2	6.7	7.2	16.5	6.0	6.2	6.4	10.2	7.6	7.6	5.5	6.1	10.2	6.4	6.7	17.7	9.2	12.2	10.7	2.5	1.7	4.7	7.7	8.8	8.4	10.7	4.8	2.1	15.1	15.5	6.8	5.7	3.4	12.8	5.1	5.9	7.9	7.9	4.9	6.6	3.9	5.6	6.1	6.5	10.3	4.0	5.3	9.5	6.3	6.9	4.3
C5orf51	LOC285636	ENSG00000205765	"Chromosome 5 open reading frame 51"	A6NDU8	5	41904188-41921636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 34.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043779, HPA063816"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA043779: AB_2678666, HPA063816: AB_2685130"	"unprognostic (6.64e-2)"	"unprognostic (2.24e-2)"	"unprognostic (9.92e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.93e-2)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.90e-3)"	"unprognostic (2.10e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.67e-2)"	11.0	8.7	10.4	9.8	13.2	2.7	11.5	12.6	14.3	9.9	6.0	8.0	7.8	10.2	15.3	10.8	7.9	8.8	9.6	10.1	12.3	10.9	10.4	7.9	10.5	12.4	12.4	15.5	8.8	15.3	5.0	12.9	12.4	11.5	9.0	15.6	8.9	10.5	4.5	9.1	7.8	12.2	12.0	9.8	7.5	7.1	12.0	15.9	13.7	7.5	10.6	10.5	7.4	16.7	14.8	11.2	22.3	46.9	44.7	35.0	24.3	17.1	29.6	23.7	25.2	11.3	14.9	15.9	20.7	19.2	41.3	9.4	29.8	16.2	34.2	21.4	9.1	15.4	33.0	17.0	54.0	19.8	11.2	34.2	23.0	27.9	31.9	15.1	20.8	19.0	27.8	26.5	25.4	15.5	18.7	20.2	22.4	9.0	6.0	16.2	31.0	24.7	15.9	14.1	13.5	21.2	54.9	25.9	29.0	19.9	28.9	20.0	15.1	28.0	16.7	21.5	16.8	13.3	23.2	15.7	31.2	34.1	20.4	34.3	8.0	7.8	4.9	6.2	6.4	5.6	5.7	5.4	7.8	5.8	7.6	5.2	5.3	6.5	9.2	4.5	4.4	9.8	10.4	13.2	12.6	14.3	10.1	12.3	12.4	12.4	12.4	12.0	12.0	16.7	13.3	32.1	11.5	12.7	16.6	9.9	8.7	10.4	21.6	11.5	13.9	12.4	14.5	8.6	9.5	14.7	6.2	12.5	10.4	7.1	9.8	12.0	13.1	8.1	14.4	11.9	10.8	14.1	11.8	7.6	12.4	19.2	11.2	10.0	5.1	10.3	10.4	20.2	15.0	8.4	13.8	9.1	6.1	17.6	7.9	11.8	9.0	13.0	7.2	4.7	13.8	18.6	10.3	16.6	20.9	8.1	7.3	7.9	11.0	11.6	5.7	12.8	9.6	11.2	13.1	12.8	16.5	9.0	8.3	30.1	13.2	16.8	10.6	9.0	7.1	9.9
CBLL1	"FLJ23109, HAKAI, RNF188"	ENSG00000105879	"Cbl proto-oncogene like 1"	Q75N03	7	107743949-107761667	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021773, HPA026699"	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA021773: AB_1846103, HPA026699: AB_1846104"	"unprognostic (1.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.16e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.96e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.12e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.71e-2)"	11.2	8.1	3.1	12.5	5.3	40.0	15.1	7.8	9.5	12.0	3.0	11.3	9.5	13.5	8.4	11.3	11.2	8.7	10.4	4.2	5.8	10.0	11.2	10.3	16.1	4.1	3.7	14.3	11.7	14.1	5.1	12.0	4.1	16.5	11.1	14.4	8.9	12.7	29.0	10.7	10.3	13.4	3.0	14.2	9.2	19.7	3.7	20.2	13.8	21.0	17.8	11.9	7.2	6.6	27.8	31.1	23.7	30.7	21.7	18.6	16.2	20.5	21.6	22.8	22.5	21.4	27.9	40.6	28.5	23.5	37.6	19.3	33.4	25.0	31.0	28.4	21.1	32.5	23.0	18.2	24.9	49.1	30.9	19.6	22.7	30.7	33.0	17.6	23.8	27.8	53.0	33.3	22.4	48.0	66.5	34.4	34.4	23.3	21.3	30.6	25.4	42.0	17.4	25.5	25.4	39.6	30.7	44.9	23.4	27.7	15.1	24.7	23.4	35.0	25.0	33.4	32.0	53.0	62.3	64.1	21.3	29.8	30.3	88.8	31.1	53.3	39.5	32.0	58.2	39.0	61.9	45.8	36.9	39.8	41.8	40.0	48.9	55.1	38.0	20.1	92.6	48.4	3.1	5.3	7.8	9.5	4.2	5.8	4.1	3.7	4.1	3.0	3.7	6.6	18.2	19.2	11.0	6.5	29.6	23.6	16.7	10.5	27.3	12.2	15.9	13.7	16.4	17.2	10.7	3.7	4.2	10.3	27.6	9.9	7.9	9.7	12.4	15.6	19.8	13.5	16.8	39.1	13.9	10.8	9.5	12.6	10.7	13.7	13.3	16.6	12.5	11.0	10.7	10.1	13.1	8.0	8.2	23.3	12.4	5.4	9.3	15.1	19.6	15.9	15.0	7.6	25.7	10.1	20.5	10.1	15.0	11.7	17.3	16.2	8.5	11.2	8.9	14.4	19.7	13.2	14.5	27.2	14.3	19.5	19.9	10.3	27.3	9.5	10.0	18.4
CBWD1		ENSG00000172785	"COBW domain containing 1"	Q9BRT8	9	121038-179147	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 185.1"									"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (3.75e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.23e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.80e-7)"	"unprognostic (7.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.94e-2)"	"unprognostic (4.98e-3)"	18.6	34.4	8.7	15.3	9.2	13.0	19.9	10.6	11.1	14.3	13.0	16.9	13.3	13.7	20.8	26.8	14.6	10.6	20.7	9.0	10.2	40.1	26.8	16.1	13.4	9.0	9.0	15.4	30.0	38.3	19.4	22.2	9.2	19.9	15.2	27.5	23.7	12.2	21.8	22.3	14.1	12.2	9.0	16.9	19.1	16.4	9.1	13.2	25.4	17.6	20.1	23.4	17.1	9.9	43.3	16.1	22.7	12.2	29.1	26.2	50.3	22.2	14.6	30.4	23.0	23.4	16.1	39.4	28.3	8.2	18.4	7.3	11.3	21.1	32.4	67.8	38.9	0.4	39.1	72.6	31.5	115.1	17.2	23.5	9.9	7.3	59.0	19.5	32.9	19.7	13.6	84.3	25.2	52.1	25.1	185.1	22.9	37.6	34.6	47.7	34.6	75.8	39.4	120.7	40.8	24.8	45.8	16.8	17.8	55.5	35.6	109.2	34.4	16.0	22.9	20.8	19.7	10.1	14.6	44.6	39.6	60.6	19.2	3.6	65.7	19.3	10.3	75.6	16.9	21.1	18.6	16.8	74.1	15.7	16.2	17.7	10.2	12.8	60.8	19.6	18.1	48.3	8.7	9.2	10.6	11.1	9.0	10.2	9.0	9.0	9.2	9.0	9.1	9.9	19.5	54.5	50.1	8.1	41.2	47.7	29.9	47.6	97.9	50.8	49.4	37.6	51.8	30.0	49.8	35.0	108.4	96.3	17.7	20.4	35.2	79.9	51.7	14.9	10.1	23.0	31.2	44.6	17.0	118.5	41.2	23.0	34.7	11.9	32.8	26.7	20.7	19.0	32.0	38.7	17.1	39.0	50.8	25.1	38.0	16.4	18.0	37.9	32.0	18.7	81.5	32.2	18.6	5.5	16.7	66.9	38.2	13.2	90.0	32.0	49.5	73.6	31.0	63.5	32.9	20.2	27.8	48.6	28.1	83.8	50.6	124.8	23.5	24.1	62.3	24.9
CBWD5		ENSG00000147996	"COBW domain containing 5"	Q5RIA9	9	65668805-65734041	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 178.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042759, HPA042813"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA042759: AB_2678149, HPA042813: AB_2678181"	"unprognostic (1.34e-1)"	"unprognostic (3.62e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.23e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.02e-3)"	"unprognostic (5.32e-3)"	"unprognostic (9.24e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.87e-1)"	9.8	15.2	20.7	8.4	21.1	7.0	17.0	21.7	25.8	11.2	20.6	11.4	11.0	6.5	9.0	15.5	10.9	5.2	12.5	21.1	22.3	26.0	41.9	9.6	6.6	21.1	21.3	10.6	19.4	7.8	16.8	6.7	21.5	17.4	10.5	8.7	9.6	7.7	8.4	11.0	13.9	5.9	20.7	21.2	11.4	11.4	21.0	4.6	15.6	4.2	9.7	12.7	9.8	21.8	37.7	40.1	14.0	17.3	20.8	9.5	16.4	26.0	17.6	20.2	20.6	5.2	33.6	51.2	16.2	15.3	29.1	27.2	64.1	21.3	38.2	8.4	15.4	14.4	69.3	91.0	16.2	32.8	8.9	16.9	23.9	18.7	14.8	25.0	37.3	19.4	20.5	36.9	21.1	45.8	16.4	34.2	16.3	64.4	42.4	28.1	19.2	49.9	32.4	23.9	18.1	18.3	21.2	16.1	8.0	24.5	76.4	21.3	10.6	9.1	33.6	27.7	30.2	12.0	34.8	11.8	37.4	35.9	35.3	1.7	11.8	8.8	3.2	15.0	3.7	5.3	5.3	4.6	12.4	3.0	4.8	4.0	7.8	2.8	9.8	5.2	4.4	10.6	20.7	21.1	21.7	25.8	21.1	22.3	21.1	21.3	21.5	20.7	21.0	21.8	17.8	41.7	51.8	13.4	58.4	65.1	31.8	24.6	178.7	37.7	59.4	36.7	33.6	25.8	38.5	20.2	68.8	44.0	10.6	33.2	21.5	33.1	10.5	17.4	8.4	22.8	16.8	25.9	60.6	39.0	23.0	20.1	49.5	15.4	10.1	16.3	16.4	48.0	15.9	35.3	60.8	32.6	12.2	25.1	36.6	4.6	21.1	27.5	30.2	20.6	45.2	13.5	7.2	37.2	32.2	33.7	51.1	17.3	143.5	32.3	76.9	42.7	27.8	62.4	6.6	10.4	18.8	35.2	25.5	119.4	85.5	50.5	29.6	12.3	34.2	30.5
CCZ1B	"C7orf28B, DKFZP586I1023, H_NH0577018.2, MGC19819"	ENSG00000146574	"CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated"	P86790	7	6794134-6826770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045114, HPA050006"	Uncertain		Enhanced	Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 32: U-937 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA045114: AB_2679219, HPA050006: AB_2680989"	"unprognostic (8.06e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.74e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.96e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.24e-1)"	28.9	40.3	19.6	25.1	20.0	37.1	28.8	20.6	26.2	18.5	22.4	31.3	27.5	28.5	40.3	42.5	25.6	28.4	28.6	19.5	20.3	28.8	24.1	23.5	38.0	19.8	19.6	18.2	21.1	73.1	9.1	26.7	19.8	20.8	27.2	32.4	32.9	19.0	35.8	30.2	22.0	22.5	20.7	25.4	30.8	23.5	20.5	38.8	24.6	53.5	35.5	39.4	9.3	21.6	120.6	31.6	66.8	138.5	49.7	51.5	67.2	64.1	69.4	58.1	61.4	32.4	65.7	52.2	57.0	72.0	132.5	68.7	87.9	60.5	62.4	31.1	51.8	33.6	40.7	72.0	54.3	165.4	104.1	37.9	37.6	51.1	30.2	40.0	57.9	108.6	63.5	49.2	62.6	124.7	84.2	81.5	171.2	78.2	66.7	67.3	123.1	59.4	41.8	66.4	87.1	161.5	62.4	117.6	78.8	65.9	94.0	185.0	71.1	27.7	93.7	78.2	116.5	52.9	104.8	45.6	53.9	176.4	120.9	21.8	5.5	10.2	5.3	8.0	6.3	6.1	6.7	7.8	8.3	5.1	4.5	5.8	4.6	10.6	15.5	6.3	15.7	3.4	19.6	20.0	20.6	26.2	19.5	20.3	19.8	19.6	19.8	20.7	20.5	21.6	9.5	6.4	12.7	11.1	17.4	8.4	7.8	8.6	8.0	10.4	10.9	10.0	7.3	2.8	10.7	3.7	14.6	8.0	12.9	18.7	15.6	20.1	3.7	16.0	11.1	8.9	18.6	9.0	19.6	28.1	11.7	9.2	9.2	10.3	2.5	6.6	15.7	7.1	9.8	16.8	19.0	17.5	6.1	11.1	22.8	2.2	7.2	11.2	14.2	8.4	24.7	11.5	17.5	14.6	23.6	24.8	11.9	10.5	7.6	9.6	7.1	12.4	23.7	11.4	19.7	8.1	9.0	12.0	8.9	11.0	12.5	7.9	11.1	5.7	15.3	11.9
CDK17	"PCTAIRE2, PCTK2"	ENSG00000059758	"Cyclin dependent kinase 17"	Q00537	12	96278261-96400480	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 101.5;Oligodendrocytes: 259.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 134.8;TIME: 160.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015325	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA015325: AB_1855090"	"unprognostic (4.35e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.09e-6)"	"unprognostic (4.97e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.70e-2)"	21.4	11.2	26.3	18.9	45.9	48.1	18.4	23.0	34.7	13.2	8.3	17.0	11.9	26.2	9.1	14.6	13.9	16.2	11.4	36.7	28.6	11.6	16.3	20.6	21.7	23.2	23.0	15.7	10.5	10.6	8.0	31.8	23.0	14.0	12.2	19.3	8.7	11.1	8.8	11.0	11.5	29.5	27.4	21.8	10.5	26.6	28.5	24.8	11.6	12.3	22.2	17.1	12.8	54.0	15.4	12.5	32.5	8.9	15.9	41.2	24.1	34.8	46.9	29.1	27.2	7.7	8.8	22.7	23.0	24.5	15.6	13.8	19.8	20.9	39.5	24.9	15.5	32.7	8.5	10.9	34.4	17.9	18.4	30.0	21.3	43.0	77.1	51.8	134.8	18.9	24.7	18.1	66.8	9.5	17.0	28.1	14.4	7.6	22.8	29.2	18.0	19.8	35.1	12.7	17.1	11.7	19.9	18.4	25.9	24.7	14.0	15.7	160.5	25.6	10.0	13.8	18.7	26.0	21.1	24.1	9.6	7.6	19.2	66.7	6.4	17.1	22.2	9.3	24.0	17.5	17.9	25.1	10.0	16.6	25.0	21.7	23.2	31.4	9.0	7.3	15.8	16.6	26.3	45.9	23.0	34.7	36.7	28.6	23.2	23.0	23.0	27.4	28.5	54.0	58.1	16.0	6.5	54.5	37.3	26.8	10.7	8.6	19.4	11.8	13.8	9.8	11.9	7.2	10.3	9.2	16.7	12.0	64.4	7.2	0.0	4.9	3.3	17.6	10.0	51.7	15.0	17.9	101.5	3.6	27.9	24.0	21.4	17.2	18.3	8.9	34.2	10.8	12.1	5.0	59.2	7.9	4.1	14.5	20.7	4.1	9.9	16.7	17.8	64.6	8.6	22.6	32.0	52.3	259.2	7.4	3.4	9.4	64.7	12.5	6.5	8.6	15.4	9.6	6.6	22.7	22.0	8.8	21.6	24.2	25.9	13.7	63.2	10.7	6.0	15.1
CEP120	"CCDC100, FLJ36090"	ENSG00000168944	"Centrosomal protein 120"	Q8N960	5	123344890-123423592	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028823, HPA051556"	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"			"HPA028823: AB_10601355, HPA051556: AB_2681533"	"unprognostic (3.65e-1)"	"unprognostic (9.94e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.97e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.58e-1)"	8.3	7.1	1.6	7.1	1.9	3.0	7.2	2.0	2.6	8.8	2.1	7.2	4.9	9.3	3.6	4.5	9.4	7.2	6.2	2.1	2.1	7.0	7.9	7.3	9.6	2.0	2.1	15.5	6.3	7.6	6.5	6.0	1.9	6.9	5.1	11.6	5.2	7.7	4.4	4.1	7.3	8.0	1.7	9.1	5.1	13.8	1.9	14.1	8.2	6.2	10.9	6.7	6.1	2.3	8.5	7.7	10.6	12.7	11.9	13.7	9.1	11.4	14.1	10.8	19.3	5.7	7.2	11.9	9.7	6.7	17.6	5.3	9.2	10.0	18.5	27.1	4.1	6.2	2.7	6.9	12.8	7.0	11.1	11.5	12.3	14.8	19.3	9.2	9.7	9.8	6.0	20.5	12.6	3.0	13.3	2.8	5.8	3.8	7.1	7.2	15.5	8.9	5.8	2.9	11.3	8.1	9.1	4.0	13.8	12.4	5.8	16.3	8.3	11.7	9.5	5.8	13.7	12.4	11.5	8.3	10.8	14.2	12.3	0.8	0.2	0.6	0.4	0.4	0.5	0.7	1.0	0.7	0.3	0.3	0.6	1.0	0.1	0.3	0.1	0.0	1.7	0.4	1.6	1.9	2.0	2.6	2.1	2.1	2.0	2.1	1.9	1.7	1.9	2.3	15.1	12.8	10.3	8.8	24.5	5.9	4.1	5.0	15.4	10.2	6.3	4.8	10.0	1.5	10.3	7.3	29.2	4.3	12.4	4.2	1.9	2.8	9.4	12.4	7.8	10.8	2.4	7.2	22.8	4.7	4.3	10.8	9.7	5.7	2.5	20.9	4.6	7.2	5.6	8.4	28.2	3.9	4.1	12.0	4.3	6.4	11.8	9.9	8.8	29.0	9.4	7.6	7.2	19.1	24.2	4.2	3.1	13.9	19.1	3.1	7.1	3.3	26.2	17.4	6.6	10.3	8.9	17.4	9.9	6.3	1.8	2.3	23.0	8.2	3.9	3.2
CGGBP1	"CGGBP, p20-CGGBP"	ENSG00000163320	"CGG triplet repeat binding protein 1"	Q9UFW8	3	88051944-88149885	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 528.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035568, HPA037017"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA035568: AB_10670022, HPA037017: AB_2675433"	"unprognostic (2.87e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.00e-1)"	"prognostic favorable (7.79e-4)"	40.2	31.0	22.2	45.8	25.5	75.7	36.9	26.5	29.8	39.9	27.1	32.8	35.6	45.3	32.7	35.6	33.5	37.3	35.9	23.5	27.3	40.2	41.3	39.5	65.2	23.0	22.9	56.2	37.9	44.4	23.2	42.0	23.3	35.5	39.6	48.8	35.2	35.3	37.6	28.1	37.6	44.3	24.4	52.7	33.7	32.5	23.6	85.3	47.0	47.4	61.9	35.7	27.7	34.9	37.4	64.1	109.3	77.4	92.8	78.1	34.5	81.9	71.4	82.0	97.9	46.7	56.4	81.9	52.7	74.7	63.0	30.2	91.4	63.2	103.2	126.0	46.5	132.3	66.0	47.4	79.7	86.3	93.8	74.4	53.8	95.0	118.7	99.2	85.1	99.0	58.2	87.5	89.5	62.9	136.5	59.5	58.1	62.5	59.0	83.6	106.9	58.0	56.0	66.3	22.0	66.6	66.9	35.6	179.1	79.6	57.5	95.6	81.5	98.8	72.5	528.4	81.8	64.0	83.2	90.5	73.1	81.5	84.9	107.9	42.7	81.2	44.2	45.7	43.8	45.0	39.6	46.4	40.6	47.6	46.6	39.6	77.0	47.4	51.6	34.0	48.9	44.7	22.2	25.5	26.5	29.8	23.5	27.3	23.0	22.9	23.3	24.4	23.6	34.9	65.1	51.3	48.0	32.3	75.1	53.2	65.7	45.6	60.9	35.8	59.8	45.3	45.9	42.9	47.8	40.5	16.7	55.0	66.0	49.0	66.5	39.0	21.0	37.8	64.5	63.0	41.9	107.5	40.6	42.0	63.6	57.5	50.4	46.8	46.9	61.1	74.6	55.1	41.2	67.3	35.6	38.3	38.7	56.2	72.8	36.3	69.6	58.7	40.9	42.2	52.4	70.6	53.5	62.8	91.1	52.8	43.9	50.0	63.7	63.0	41.1	65.1	25.3	32.9	65.7	63.3	79.0	94.1	47.9	52.5	50.0	83.9	80.5	31.8	36.0	72.7
CHUK	"IkBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16"	ENSG00000213341	"Component of inhibitor of nuclear factor kappa B kinase complex"	O15111	10	100188300-100229596	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001402, CAB004240, CAB018564"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB004240: AB_627784, CAB018564: AB_649197, HPA001402: AB_1079125"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.58e-2)"	"unprognostic (8.39e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (2.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.22e-1)"	13.5	10.3	6.6	11.7	7.6	19.6	10.8	7.1	8.3	8.4	8.3	11.9	12.8	8.8	9.1	9.7	7.5	9.0	6.8	6.4	9.2	21.0	17.0	10.2	12.7	7.3	7.5	5.6	11.5	14.0	6.5	10.5	7.6	9.6	13.3	8.0	8.8	9.0	14.2	6.9	10.8	11.8	7.7	9.9	11.2	8.3	8.7	14.3	11.1	11.7	12.6	13.6	6.4	8.7	27.7	22.9	23.0	34.4	21.6	19.3	17.6	34.3	33.5	31.3	38.0	25.9	15.9	37.2	19.7	23.5	21.8	26.7	38.7	18.2	34.9	39.8	33.5	24.7	18.0	28.7	18.4	46.2	34.8	15.5	19.1	36.2	35.0	21.8	22.7	30.1	28.5	29.9	34.6	16.7	36.9	28.4	15.0	21.8	16.5	23.7	25.5	17.0	19.9	17.6	13.7	20.3	18.6	14.2	30.9	18.0	28.5	27.8	23.9	19.6	21.9	21.5	39.7	34.9	33.7	35.7	21.3	36.9	15.8	1.0	1.2	2.1	0.9	1.9	1.5	1.6	1.1	1.6	1.4	1.0	1.3	1.5	2.8	1.8	1.3	0.8	1.2	0.5	6.6	7.6	7.1	8.3	6.4	9.2	7.3	7.5	7.6	7.7	8.7	8.7	11.4	12.8	11.5	17.9	10.8	19.8	7.1	5.1	8.0	6.3	7.3	4.8	9.2	7.2	5.9	5.5	2.1	6.5	14.1	12.2	11.7	7.1	7.6	8.9	8.6	8.4	6.0	12.0	22.7	11.8	7.8	6.5	7.7	12.7	8.2	6.2	7.1	14.4	10.6	13.5	21.3	8.0	8.2	16.9	12.7	8.0	6.2	11.7	7.2	19.7	15.6	4.5	9.2	20.6	27.7	10.4	6.0	6.0	18.5	9.6	9.5	20.0	6.4	5.0	19.7	7.8	12.0	16.4	12.9	13.2	19.0	13.8	11.1	10.1	6.6	10.6
CHURC1	"C14orf52, FLJ33064, My015"	ENSG00000258289	"Churchill domain containing 1"	Q8WUH1	14	64914361-64944591	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040072	Approved		Approved	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA040072: AB_10963788"	"unprognostic (2.94e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-2)"	"unprognostic (4.64e-1)"	"unprognostic (6.78e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.51e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.26e-1)"	47.8	42.0	29.9	39.1	34.8	43.8	37.4	34.5	41.2	41.2	27.2	43.8	30.9	40.0	32.6	34.3	34.2	32.5	58.8	29.8	33.7	34.7	52.4	29.3	43.8	38.8	33.3	43.9	30.2	46.1	25.2	34.5	38.6	32.4	36.4	35.7	26.5	37.7	82.9	30.1	33.9	45.8	34.7	42.2	33.7	25.4	34.3	61.2	32.9	53.0	43.3	38.3	30.5	40.3	119.6	61.8	58.8	43.7	70.1	75.6	68.9	85.3	74.3	47.4	53.9	34.1	75.1	69.9	57.7	73.7	75.2	84.9	51.7	69.2	51.8	79.7	25.3	67.9	47.7	79.3	66.1	37.7	64.9	89.9	50.5	43.0	81.4	79.7	51.6	107.2	30.6	60.5	58.1	97.6	72.7	61.6	31.4	140.9	101.1	63.4	63.2	42.6	64.5	83.8	30.0	36.7	57.6	59.8	81.0	53.7	101.8	78.4	64.8	41.3	87.8	45.0	56.0	49.5	46.8	162.0	43.0	44.6	51.8	201.6	131.9	145.4	111.5	137.6	128.2	161.8	167.5	134.1	107.4	135.9	166.3	139.8	292.8	122.4	138.3	154.7	238.5	143.5	29.9	34.8	34.5	41.2	29.8	33.7	38.8	33.3	38.6	34.7	34.3	40.3	154.6	102.5	89.0	0.0	128.2	58.5	73.8	176.8	130.3	73.8	85.0	98.7	53.4	94.4	98.2	99.3	43.8	90.4	97.9	89.3	131.0	160.7	82.0	130.8	87.3	109.9	89.8	91.5	0.0	222.7	89.7	100.9	75.4	80.8	95.6	69.6	127.5	190.4	89.3	53.8	0.0	100.3	107.8	172.6	69.6	27.1	104.1	130.5	83.6	0.0	214.3	155.2	132.8	0.0	0.0	216.8	118.9	121.5	79.7	70.5	124.6	211.0	145.1	87.2	131.5	100.6	135.7	131.1	81.1	158.3	65.9	89.8	137.0	205.8	121.1	72.2
CLDND1	"C3orf4, Z38"	ENSG00000080822	"Claudin domain containing 1"	Q9NY35	3	98497912-98523066	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"brain: 1093.8;choroid plexus: 316.7"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 575.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029841	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA029841: AB_10600658"	"unprognostic (1.64e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.13e-2)"	"unprognostic (8.50e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.08e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (5.84e-6)"	"unprognostic (5.73e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.51e-1)"	53.6	42.6	477.0	40.7	757.5	49.1	48.8	696.1	804.5	59.0	316.7	58.3	36.5	58.8	43.1	77.8	46.7	50.6	57.6	483.5	577.6	39.2	50.0	46.9	54.7	851.3	670.8	63.9	23.6	32.6	28.2	73.8	837.8	49.5	46.9	46.5	29.8	51.9	43.6	64.8	42.2	63.5	643.7	44.0	37.4	106.6	638.3	44.7	40.5	68.9	54.9	64.0	65.8	1093.8	67.3	26.2	83.2	50.7	96.0	75.0	44.6	52.0	69.8	71.0	97.8	52.7	66.9	33.7	69.1	49.4	134.3	90.4	61.6	39.9	124.3	79.3	27.5	68.3	18.6	48.1	76.2	62.7	67.3	88.4	207.6	54.0	58.7	77.6	79.1	64.7	35.4	100.6	102.9	33.4	47.8	42.8	75.1	28.7	55.9	31.9	110.6	43.4	67.7	30.0	30.1	82.6	74.6	24.4	108.5	110.5	24.5	52.8	75.1	94.6	86.2	65.3	69.3	130.8	59.8	53.9	154.9	61.0	125.2	179.8	91.0	103.9	102.1	55.4	193.5	101.5	190.3	187.1	98.9	99.3	76.6	78.1	70.2	274.0	56.7	63.9	399.7	155.1	477.0	757.5	696.1	804.5	483.5	577.6	851.3	670.8	837.8	643.7	638.3	1093.8	83.3	35.3	36.6	17.9	72.1	144.0	131.7	122.3	87.0	20.1	43.6	45.3	53.8	17.2	71.4	27.6	25.0	52.0	72.8	16.9	29.4	21.2	105.3	21.1	47.7	70.8	28.7	65.4	25.1	16.2	160.6	86.6	30.1	41.7	36.8	25.2	61.4	19.4	35.6	15.2	23.6	19.6	89.5	29.2	168.1	76.7	51.6	46.9	113.8	20.6	42.3	28.1	38.1	30.7	575.2	30.3	16.8	46.6	131.7	98.1	34.6	23.3	27.5	35.0	52.6	53.2	128.4	182.4	55.3	90.1	196.5	95.8	147.1	22.8	17.5	121.9
CRAMP1	"CRAMP1L, KIAA1426"	ENSG00000007545	"Cramped chromatin regulator homolog 1"	Q96RY5	16	1612337-1677908	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041752	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA041752: AB_10796459"	"unprognostic (3.67e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.78e-4)"	"unprognostic (4.17e-2)"	"unprognostic (8.53e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.86e-3)"	"prognostic favorable (4.93e-4)"	"unprognostic (8.57e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-2)"	8.0	7.5	7.4	5.6	6.2	13.5	9.0	15.0	6.9	11.1	5.9	10.9	8.1	10.3	6.2	9.0	10.7	5.4	8.3	6.6	4.6	9.4	6.3	9.9	7.6	5.4	5.2	12.5	8.8	5.7	12.4	6.9	5.3	12.0	5.4	9.9	8.4	6.4	7.9	11.0	9.5	6.7	3.2	11.0	9.0	22.9	5.5	10.7	12.7	4.8	6.0	9.6	9.5	7.1	8.5	15.5	15.6	14.5	9.8	9.7	20.3	14.4	7.5	11.5	8.2	11.2	14.0	12.0	12.3	9.9	7.1	15.3	18.7	10.0	10.3	12.7	22.6	14.2	16.0	6.9	7.1	19.0	20.6	8.5	12.6	14.5	12.1	11.2	12.4	17.9	19.6	7.1	6.3	12.4	14.8	10.6	14.9	4.9	8.7	51.2	8.4	16.1	8.2	7.5	16.6	14.0	15.8	11.3	8.3	10.9	9.9	24.3	15.2	11.9	12.8	11.4	13.9	15.0	23.3	24.3	3.7	13.0	10.8	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.0	0.3	0.0	0.1	7.4	6.2	15.0	6.9	6.6	4.6	5.4	5.2	5.3	3.2	5.5	7.1	10.4	16.0	17.0	0.0	2.7	0.0	5.2	0.0	12.0	8.6	9.3	8.0	0.0	4.3	8.6	9.2	18.8	4.7	12.8	6.1	1.9	5.5	28.0	11.1	14.5	6.8	2.4	4.6	0.0	2.0	3.0	5.4	5.1	15.3	5.1	11.0	6.8	4.3	5.6	3.3	0.0	6.6	0.0	8.2	0.0	9.6	4.4	4.3	0.0	0.0	6.6	6.2	4.1	0.0	0.0	7.1	4.7	6.8	4.7	9.9	6.0	1.6	2.9	17.9	6.6	7.1	5.2	17.3	18.4	9.4	0.0	5.3	5.2	5.6	5.5	5.9
CTC1	"AAF132, C17orf68, FLJ22170"	ENSG00000178971	"CST telomere replication complex component 1"	Q2NKJ3	17	8224815-8248056	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052436			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA052436: "	"unprognostic (6.47e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.81e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.66e-2)"	"prognostic favorable (6.49e-5)"	"unprognostic (2.89e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.66e-2)"	13.8	11.8	13.4	14.7	14.1	18.5	15.9	19.7	18.8	17.6	13.2	16.9	8.0	13.5	10.7	11.1	17.2	6.9	11.7	13.4	13.4	16.6	18.3	18.5	24.1	13.2	13.3	19.9	18.2	10.4	21.4	6.1	13.3	16.6	10.4	22.2	12.4	9.0	7.0	14.1	25.0	9.3	12.2	37.2	15.8	10.8	13.7	31.2	18.0	5.7	21.4	14.8	13.4	14.6	3.0	6.6	5.9	5.5	18.1	4.3	7.2	3.4	3.8	4.8	3.2	5.0	8.8	10.8	3.4	5.9	3.5	10.0	7.0	5.2	3.0	8.0	6.8	5.3	7.2	6.5	3.0	1.7	16.1	4.4	5.5	6.3	8.6	9.5	8.7	15.4	5.1	3.6	3.4	3.9	18.6	7.3	4.8	9.7	1.6	8.7	2.3	6.9	12.4	7.1	5.2	5.9	6.7	8.6	6.0	10.9	5.3	5.0	11.6	1.5	3.6	3.6	4.0	7.4	4.7	7.1	2.9	6.5	4.5	2.0	0.7	1.2	2.0	0.9	2.0	2.2	2.0	1.9	0.7	2.6	2.8	2.5	2.5	1.3	1.2	2.2	1.8	1.0	13.4	14.1	19.7	18.8	13.4	13.4	13.2	13.3	13.3	12.2	13.7	14.6	6.3	0.0	11.1	8.5	16.7	1.9	3.0	1.0	3.4	7.7	6.2	4.1	3.4	7.2	3.0	5.5	37.5	6.4	12.0	4.6	1.9	3.6	3.7	3.6	2.6	6.4	6.7	1.7	10.2	3.8	3.9	3.8	5.6	5.5	6.3	4.0	5.7	8.1	3.9	1.7	10.3	5.8	2.0	8.2	1.0	6.2	4.4	3.5	0.0	3.7	5.6	2.5	6.2	9.0	6.6	4.4	9.4	2.2	9.6	4.1	4.5	2.2	3.0	17.3	0.0	3.1	4.1	4.7	4.2	3.9	2.0	11.1	10.3	2.1	3.5	3.4
CYFIP2	PIR121	ENSG00000055163	"Cytoplasmic FMR1 interacting protein 2"	Q96F07	5	157266079-157395595	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Cell adhesion"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 112.2;kidney: 139.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.5;Collecting duct cells: 158.2;Distal tubular cells: 174.1;Excitatory neurons: 117.7;Inhibitory neurons: 147.5;Oligodendrocyte precursor cells: 120.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 202.4;JURKAT: 145.2;MOLT-4: 204.8;U-266/70: 153.6;U-698: 142.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB055519, HPA068106, HPA071459"	Uncertain		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"CAB055519: , HPA068106: AB_2685955, HPA071459: AB_2686400"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.07e-2)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (3.76e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (1.18e-4)"	"unprognostic (3.81e-2)"	"prognostic favorable (3.21e-12)"	"unprognostic (2.90e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.49e-2)"	3.2	12.3	61.0	30.8	54.4	55.5	2.8	23.6	103.8	3.1	16.3	8.9	6.3	6.6	25.1	3.8	9.2	8.8	10.4	112.2	25.6	139.9	18.3	12.2	57.1	8.4	33.4	4.8	7.1	64.9	40.1	9.3	6.6	5.8	9.8	35.4	4.0	5.0	7.0	2.8	17.5	5.6	0.0	35.0	20.9	5.3	67.7	85.9	9.9	1.7	55.3	8.3	2.3	37.7	0.3	31.8	47.3	28.8	1.1	1.3	81.5	6.1	9.6	2.5	6.8	6.2	0.6	202.4	14.5	3.4	7.4	0.4	38.0	27.1	5.8	48.8	60.8	28.4	42.3	24.9	4.1	29.1	71.8	5.4	10.9	8.1	0.5	18.8	8.8	145.2	0.4	81.1	7.0	7.7	204.8	5.5	22.3	0.5	8.5	50.6	1.4	102.3	24.5	30.2	70.5	27.4	0.6	28.3	4.6	46.8	19.9	0.8	11.3	2.0	21.4	7.1	5.4	153.6	40.2	142.8	21.4	33.5	11.8	64.8	12.6	90.1	85.9	57.4	61.0	35.8	60.6	75.7	17.8	35.9	63.2	73.2	41.0	53.9	133.7	43.9	53.5	78.0	61.0	54.4	23.6	103.8	112.2	25.6	8.4	33.4	6.6	0.0	67.7	37.7	1.8	3.2	26.9	133.5	76.6	1.1	2.2	2.8	3.4	62.0	3.5	3.4	17.9	8.6	7.4	158.2	16.7	37.2	78.8	6.0	174.1	9.7	15.3	2.8	1.8	2.6	14.4	11.6	117.7	1.6	43.0	3.6	6.1	6.2	2.5	23.1	5.7	30.8	5.3	90.9	147.5	5.6	4.1	6.5	11.4	24.2	1.8	15.7	7.2	23.4	20.3	14.0	101.0	120.6	33.8	1.9	9.9	6.8	41.1	1.3	5.4	55.0	4.7	35.2	0.0	12.2	11.0	3.2	13.1	0.8	1.4	21.1	88.8	2.1	9.1	1.7
DAZAP2	KIAA0058	ENSG00000183283	"DAZ associated protein 2"	Q15038	12	51238724-51271362	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045940			Supported	"Nuclear speckles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA045940: AB_2679506"	"unprognostic (1.00e-2)"	"unprognostic (3.13e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.75e-3)"	"unprognostic (8.43e-2)"	"unprognostic (4.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (3.94e-9)"	"unprognostic (1.79e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.84e-3)"	136.4	115.7	112.2	187.5	125.3	613.5	154.0	136.6	124.4	150.5	109.8	206.2	194.9	131.6	122.5	129.9	180.5	168.0	202.1	105.1	125.9	251.4	198.4	193.2	220.6	132.7	119.8	114.1	116.5	227.3	30.7	79.5	134.4	152.8	215.5	75.2	140.7	171.8	113.5	121.4	200.5	148.4	129.8	224.3	174.3	52.7	116.5	213.2	209.8	106.7	241.5	190.3	76.3	151.5	159.8	209.0	95.4	92.2	201.1	171.5	57.6	104.6	208.9	187.7	162.8	155.9	239.0	153.2	262.2	209.9	130.0	147.8	134.2	178.4	189.2	167.3	160.2	227.1	129.7	91.0	216.4	265.5	350.2	220.5	252.1	175.3	147.2	207.2	234.8	118.8	141.6	303.1	155.4	252.6	219.8	145.6	19.6	109.2	58.7	123.2	144.7	165.3	244.9	260.2	103.3	101.0	159.3	137.9	121.3	56.7	190.5	382.7	195.7	111.1	102.4	136.9	132.6	231.5	237.5	158.6	161.2	175.0	66.9	2018.1	2144.1	3354.3	1055.9	1770.0	979.3	1090.7	962.8	1037.9	1354.1	1068.7	1063.1	918.3	3499.5	1045.4	1727.1	875.9	1420.3	4885.3	112.2	125.3	136.6	124.4	105.1	125.9	132.7	119.8	134.4	129.8	116.5	151.5	116.7	144.2	205.1	19.6	271.9	113.8	201.2	144.6	167.9	50.6	127.7	88.5	114.3	165.8	127.9	235.4	58.4	55.8	167.4	337.2	266.1	158.6	28.1	115.1	87.2	138.3	126.3	155.6	16.8	194.7	53.5	108.0	171.8	142.1	182.2	72.2	157.1	177.1	209.4	67.3	16.8	230.6	140.4	444.4	214.2	85.6	117.4	282.0	135.2	19.7	324.4	88.7	221.4	15.6	43.9	198.0	275.8	95.5	169.5	179.9	233.3	292.7	155.9	55.2	46.0	63.2	130.4	39.4	35.4	153.5	133.3	124.9	249.6	72.8	182.4	268.7
DBNDD2	"C20orf35, HSMNP1"	ENSG00000244274	"Dysbindin domain containing 2"	Q9BQY9	20	45406057-45410610	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1300.9"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 18.8;Gastric mucus-secreting cells: 20.4;Macrophages: 10.7;Smooth muscle cells: 23.6;Squamous epithelial cells: 32.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"dendritic cells: 18.7;monocytes: 12.5;T-cells: 9.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043991	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA043991: AB_10966212"	"unprognostic (6.33e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-3)"	"unprognostic (8.24e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.48e-1)"	71.5	29.7	627.6	33.6	916.1	7.1	59.4	827.6	1054.5	73.6	462.6	160.9	54.5	106.6	41.7	58.7	102.7	33.1	470.5	645.7	709.8	56.3	10.4	63.1	21.3	871.6	808.2	39.1	39.9	65.3	41.3	42.9	853.0	70.2	91.1	34.9	47.7	89.4	316.2	68.6	78.4	100.9	739.9	30.3	82.2	14.4	822.1	23.2	37.2	248.2	27.3	118.7	69.7	1300.9	78.0	13.6	10.8	76.3	6.8	3.0	15.0	44.7	48.4	36.7	24.8	37.2	103.4	1.1	7.7	44.4	13.9	112.1	74.7	4.0	22.4	0.6	43.9	64.5	57.0	34.3	43.1	3.5	94.0	1.2	12.6	13.9	12.8	63.5	25.3	64.8	4.7	1.5	2.9	99.0	5.6	4.9	14.0	50.8	80.0	0.3	1.0	0.7	105.3	1.4	24.8	12.7	15.6	8.4	99.3	7.6	104.0	19.9	41.1	1.5	72.5	48.8	49.5	1.1	1.6	0.3	5.3	0.6	10.9	0.0	10.4	0.0	9.1	12.5	3.3	0.2	8.0	6.8	7.6	0.3	7.4	6.9	0.5	0.8	7.2	18.7	7.4	4.5	627.6	916.1	827.6	1054.5	645.7	709.8	871.6	808.2	853.0	739.9	822.1	1300.9	0.3	3.2	0.5	0.0	3.3	0.0	0.2	0.1	18.8	0.0	0.6	0.3	1.0	0.0	2.5	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.3	0.4	0.2	2.7	0.0	2.1	0.0	0.0	0.0	7.3	20.4	0.4	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	10.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.5	0.0	3.9	0.4	0.9	0.0	5.3	0.0	0.0	0.6	23.6	0.1	0.0	32.7	0.6	0.0	5.3	0.1	0.4	0.3
DCAF8	"FLJ35857, H326, WDR42A"	ENSG00000132716	"DDB1 and CUL4 associated factor 8"	Q5TAQ9	1	160215715-160262549	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027218, HPA027381"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA027218: AB_10602586, HPA027381: AB_1858808"	"unprognostic (3.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (4.71e-4)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (3.74e-5)"	"unprognostic (3.30e-1)"	"unprognostic (7.42e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.56e-3)"	63.3	62.6	35.3	47.0	43.3	54.6	60.6	47.7	52.8	55.8	47.1	72.0	56.6	60.4	76.2	50.2	58.9	53.5	85.1	33.7	41.8	55.8	103.4	50.9	60.5	39.2	37.3	62.2	80.2	85.7	66.3	45.1	37.0	53.6	40.6	106.7	60.6	53.2	219.7	67.2	61.8	44.0	32.6	65.6	67.3	40.7	41.1	67.5	77.9	118.3	51.1	61.1	49.8	53.0	54.2	62.5	72.0	64.8	86.3	65.5	63.7	62.7	81.8	49.5	42.2	69.8	89.6	56.3	112.1	67.2	34.6	64.8	34.6	57.4	31.0	134.9	69.0	63.4	99.7	54.1	69.3	52.9	80.3	74.6	58.9	44.2	60.8	55.3	73.5	73.1	60.6	98.4	46.0	50.0	71.7	54.5	52.7	70.1	62.6	69.2	41.8	115.5	57.7	87.6	49.0	47.3	101.8	113.1	68.2	68.9	104.9	82.0	95.1	60.7	31.5	38.6	58.7	169.8	124.9	94.3	68.7	49.6	51.2	32.9	21.5	22.0	31.5	19.7	29.6	28.5	27.0	29.2	17.5	30.4	29.4	27.0	24.9	30.4	28.4	22.0	30.4	19.2	35.3	43.3	47.7	52.8	33.7	41.8	39.2	37.3	37.0	32.6	41.1	53.0	21.4	57.7	54.9	57.5	35.4	18.4	16.3	17.3	38.7	44.6	27.5	21.8	54.2	30.0	30.5	25.8	64.6	30.9	26.4	20.4	62.6	23.9	3.6	26.6	18.9	26.4	25.1	48.4	53.7	21.6	21.0	28.9	35.2	21.4	34.1	21.2	21.4	77.6	23.8	40.4	49.5	19.2	20.3	29.8	18.9	4.3	28.0	24.2	14.2	39.4	27.6	38.1	18.6	58.8	93.1	19.2	13.6	32.7	45.3	16.3	29.0	38.1	40.5	60.5	13.1	29.5	26.6	28.0	20.4	35.1	24.2	44.3	36.5	25.6	18.8	12.5
DCTN4		ENSG00000132912	"Dynactin subunit 4"	Q9UJW0	5	150708440-150759095	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017532, HPA038026"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Centrosome"		"CAB017532: AB_1122152, HPA038026: AB_2675792"	"unprognostic (1.38e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.06e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.87e-3)"	"unprognostic (7.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.83e-1)"	26.6	31.8	29.4	16.5	30.1	56.5	30.1	30.6	36.2	21.3	24.1	18.9	19.2	24.2	30.7	23.5	21.0	19.2	25.4	29.9	30.2	23.3	26.6	21.3	14.0	32.1	28.3	29.4	38.1	28.7	20.5	31.3	33.6	27.4	21.6	58.7	18.3	25.0	47.5	22.7	17.0	25.1	29.9	15.0	21.8	28.0	30.4	20.1	29.3	36.8	17.2	19.9	16.2	41.2	25.2	29.3	53.1	87.5	62.8	60.9	43.2	43.1	43.9	52.7	51.9	55.6	30.5	24.9	58.5	53.1	46.2	29.4	67.3	51.6	63.3	48.3	52.5	31.6	32.3	33.8	57.3	38.9	42.5	61.8	45.0	45.9	82.5	53.2	37.4	30.4	48.9	30.3	68.3	26.0	23.6	20.5	26.2	30.1	47.3	20.5	32.1	27.8	38.7	42.4	117.8	49.5	46.0	62.0	66.9	34.0	59.8	51.0	40.8	56.8	30.3	37.7	47.2	26.3	36.8	14.3	65.6	51.2	48.1	3.2	11.2	11.1	5.0	7.8	5.2	4.8	5.7	5.1	11.0	3.8	5.3	6.5	16.1	3.2	6.8	5.1	4.6	5.7	29.4	30.1	30.6	36.2	29.9	30.2	32.1	28.3	33.6	29.9	30.4	41.2	19.3	48.1	29.2	43.4	29.4	17.7	13.2	12.6	52.3	20.8	33.7	21.3	37.2	32.9	13.7	16.5	20.9	22.4	26.8	23.2	11.7	11.8	2.6	23.9	32.7	19.7	37.7	47.3	41.3	16.5	18.0	26.0	40.8	32.2	12.6	32.4	20.7	39.4	31.5	30.3	43.7	27.2	16.2	48.8	19.1	4.7	22.1	35.7	12.4	35.6	20.7	26.4	9.2	46.8	56.2	18.4	19.7	19.2	27.0	17.4	14.7	22.7	20.6	31.9	13.1	15.0	19.5	18.4	24.0	38.6	20.5	29.7	26.2	23.7	19.5	17.9
DDX47	"DKFZp564O176, FLJ30012, HQ0256, RRP3"	ENSG00000213782	"DEAD-box helicase 47"	Q9H0S4	12	12813316-12829981	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 22.6;Exocrine glandular cells: 17.8;Pancreatic endocrine cells: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014855	Approved		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA014855: AB_1847567"	"unprognostic (3.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.91e-2)"	"unprognostic (5.84e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.55e-9)"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.20e-6)"	28.8	24.1	23.2	22.7	23.7	41.2	32.1	24.6	30.8	27.8	24.5	29.3	18.2	30.8	22.3	29.1	29.8	19.9	23.0	22.6	24.0	32.1	37.8	24.8	32.7	23.8	23.6	35.6	30.8	36.5	17.5	28.9	24.1	26.4	26.3	16.9	24.5	29.0	44.6	30.5	21.7	33.4	24.4	23.4	29.3	23.1	23.2	35.5	33.3	41.7	39.8	47.6	25.5	25.2	161.7	68.3	65.6	53.7	63.1	61.7	111.8	67.8	77.0	141.0	131.0	104.1	101.0	82.4	25.9	92.2	87.4	102.6	95.2	78.0	157.7	117.2	68.1	75.5	45.3	59.7	53.5	87.0	46.5	60.0	72.4	84.0	68.8	110.7	110.4	63.9	74.3	18.2	78.3	57.7	71.0	60.1	288.7	74.4	41.4	77.7	127.2	50.0	86.5	114.2	28.6	72.5	82.3	52.1	69.2	161.4	21.4	64.9	49.9	56.5	136.5	36.8	103.4	25.2	49.1	148.1	60.2	44.9	66.8	10.5	32.9	8.4	46.6	43.8	55.5	48.0	40.9	43.2	56.8	44.9	53.0	51.5	3.8	40.6	44.4	33.3	43.4	35.8	23.2	23.7	24.6	30.8	22.6	24.0	23.8	23.6	24.1	24.4	23.2	25.2	5.1	3.2	8.2	9.1	8.4	2.2	2.7	2.4	14.2	0.6	1.4	1.0	0.1	0.0	8.5	0.0	0.0	1.7	2.3	3.2	1.9	22.6	0.1	3.0	4.1	4.3	4.8	3.4	8.2	17.8	1.9	3.2	4.6	5.7	12.0	0.9	1.1	0.9	0.9	0.0	9.4	4.2	2.0	1.0	1.6	0.4	0.6	2.5	0.0	12.2	9.7	0.9	2.1	8.0	12.6	19.0	4.2	0.4	12.3	1.9	2.8	1.1	6.3	1.6	6.6	1.6	3.4	0.7	0.7	9.0	1.8	1.4	6.2	0.6	6.5	2.8
DEDD	"CASP8IP1, DEDD1, DEFT, FLDED1, KE05"	ENSG00000158796	"Death effector domain containing"	O75618	1	161120974-161132688	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064486, HPA065101, HPA073628"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA064486: , HPA065101: , HPA073628: AB_2732230"	"unprognostic (2.24e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.81e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.20e-3)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (2.52e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.66e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (4.98e-7)"	"unprognostic (1.53e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.43e-2)"	34.4	21.4	20.6	19.4	22.0	29.8	29.0	21.9	20.8	26.1	18.8	30.5	20.8	24.7	14.9	25.8	26.5	21.2	24.3	20.2	20.4	21.6	24.3	28.6	21.2	21.3	20.7	28.0	21.2	18.2	17.9	22.1	20.7	23.0	13.7	23.9	20.7	15.8	56.7	29.2	23.5	21.0	20.7	27.8	22.4	28.0	21.5	22.5	24.2	34.9	18.3	26.8	25.1	22.6	24.7	24.0	27.7	24.3	21.0	22.2	19.1	20.7	29.3	23.5	26.1	16.7	41.5	26.2	20.4	31.2	17.2	22.0	21.2	32.5	15.1	26.3	23.1	24.5	30.2	22.7	37.0	17.3	35.5	26.8	34.2	25.3	40.1	31.2	38.5	35.6	21.3	38.3	27.8	38.8	42.4	18.9	46.5	49.1	24.5	34.1	19.1	35.0	23.8	29.6	29.3	44.2	21.1	55.1	37.0	29.9	33.0	34.8	27.3	25.6	27.2	30.0	30.6	52.2	35.6	46.9	30.6	18.5	18.6	64.0	36.9	52.8	27.8	34.6	23.7	24.0	27.4	27.9	33.3	22.7	30.6	25.1	41.2	27.7	38.0	29.2	38.4	31.4	20.6	22.0	21.9	20.8	20.2	20.4	21.3	20.7	20.7	20.7	21.5	22.6	27.8	25.6	9.3	8.5	16.7	25.2	13.9	11.5	14.2	6.8	10.5	8.0	10.6	18.6	10.1	9.2	6.2	19.6	16.2	12.9	23.5	13.6	42.6	9.5	8.3	22.3	11.3	13.7	4.8	19.3	19.6	13.3	15.8	11.3	16.5	7.7	21.0	10.7	14.8	13.5	5.1	8.1	2.0	19.8	27.2	43.5	11.8	16.2	14.2	4.7	20.9	6.7	8.2	5.0	10.8	15.6	13.2	9.8	24.2	10.2	12.5	13.7	7.4	13.2	6.6	12.0	16.5	23.5	18.4	22.2	24.9	27.0	15.0	5.7	9.7	17.4
DENND4C	"bA513M16.3, C9orf55, C9orf55B, FLJ20686, RAB10GEF"	ENSG00000137145	"DENN domain containing 4C"	Q5VZ89	9	19230435-19374281	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 120.9;Oligodendrocyte precursor cells: 107.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014917, HPA015096"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 31: Skin - Epidermis development"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus, Vesicles, Cytosol"		"HPA014917: AB_2261659, HPA015096: AB_1845831"	"unprognostic (4.57e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (3.27e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	21.7	11.9	5.9	9.2	7.0	10.6	21.7	14.1	6.3	17.2	8.0	17.4	25.1	17.2	14.3	14.5	16.4	13.8	14.5	5.3	5.6	13.9	15.2	18.0	11.8	5.9	5.7	21.4	12.9	19.0	8.7	19.6	5.7	16.1	19.8	11.8	15.1	13.4	10.6	29.6	22.4	14.6	5.8	12.7	19.8	11.2	7.2	17.7	17.3	12.4	11.2	16.6	16.0	6.6	17.7	17.5	11.7	15.3	26.6	28.5	21.4	10.0	14.9	10.2	13.7	8.4	11.6	7.5	8.3	13.6	11.8	9.4	13.7	9.4	12.0	47.2	7.8	34.4	18.5	10.4	13.4	8.3	18.8	11.7	18.7	9.0	15.5	21.6	20.2	9.9	9.4	8.5	13.1	7.4	13.8	18.8	9.0	24.7	8.5	12.6	6.6	10.9	29.2	34.1	10.9	8.5	8.4	20.1	7.4	11.0	12.1	11.3	18.5	8.9	5.2	10.0	10.5	5.8	14.9	4.0	7.7	7.6	5.2	8.3	1.6	1.9	5.4	0.8	7.0	1.7	4.6	5.5	3.1	2.3	4.3	5.0	0.9	6.4	0.9	3.2	3.8	2.4	5.9	7.0	14.1	6.3	5.3	5.6	5.9	5.7	5.7	5.8	7.2	6.6	28.6	9.6	11.5	85.8	21.3	51.2	16.7	18.0	65.4	20.9	16.0	11.0	12.4	14.3	21.6	16.5	60.5	29.4	22.6	26.6	1.9	9.8	7.7	12.7	15.5	22.9	19.8	9.7	78.6	12.5	13.5	24.0	47.4	20.4	27.1	24.8	51.0	11.5	19.0	23.5	87.2	22.6	24.4	23.9	22.0	5.2	18.6	32.2	21.4	120.9	8.5	13.6	27.8	107.1	69.1	12.1	20.9	20.3	14.1	19.4	26.4	4.9	21.6	16.3	0.0	19.5	16.2	3.3	6.8	30.9	49.3	16.1	28.2	12.0	23.3	23.2
DIABLO	"DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC"	ENSG00000184047	"Diablo IAP-binding mitochondrial protein"	Q9NR28	12	122207663-122227456	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 31.3;Plasma cells: 29.2;Squamous epithelial cells: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001825, CAB003857, CAB016688"	Supported		Enhanced	Mitochondria		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"CAB003857: AB_365498, CAB016688: AB_1615783, HPA001825: AB_1857247"	"unprognostic (3.67e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.40e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	23.8	34.3	29.8	17.3	30.8	32.5	25.3	33.7	36.8	21.4	30.4	28.7	21.7	27.0	36.1	30.8	23.3	18.0	30.3	28.7	32.0	34.5	39.6	21.2	21.0	32.0	31.4	27.8	27.7	32.2	41.4	25.8	32.1	21.9	24.5	27.5	28.9	19.5	37.4	25.4	26.9	20.5	33.6	24.3	26.6	53.2	31.0	26.9	25.8	34.5	24.9	32.0	24.5	33.4	49.0	94.7	65.4	44.7	45.9	44.6	50.2	49.5	48.3	56.9	50.8	82.4	24.9	59.2	45.4	45.2	42.4	47.4	72.2	59.3	67.0	51.1	56.4	65.2	36.6	76.7	65.3	71.0	25.9	62.2	41.3	67.3	100.1	64.4	66.8	57.9	75.9	24.5	56.1	72.4	58.6	103.8	52.9	69.5	88.0	52.3	65.2	65.4	64.4	74.7	61.7	62.6	66.1	26.2	54.8	73.3	87.9	49.2	46.0	43.7	53.6	50.0	45.4	52.8	95.5	84.3	55.8	53.6	58.8	43.3	39.8	39.8	39.9	41.4	37.8	46.3	36.4	37.2	48.3	36.4	35.6	36.1	17.9	45.5	40.1	37.5	46.3	42.0	29.8	30.8	33.7	36.8	28.7	32.0	32.0	31.4	32.1	33.6	31.0	33.4	0.2	0.0	0.6	7.2	19.7	5.0	5.9	7.6	31.3	7.3	0.0	0.0	1.3	10.0	3.3	0.0	4.2	11.3	3.0	8.2	0.0	0.2	6.3	0.0	0.0	3.8	7.3	20.4	14.5	0.0	10.8	7.7	25.5	0.0	4.5	0.0	5.3	2.9	6.5	3.3	14.1	8.8	8.2	3.3	3.6	4.6	5.6	7.1	3.6	3.7	2.7	7.6	9.2	9.0	15.1	0.2	11.9	3.4	29.2	3.9	16.8	0.1	1.7	11.1	6.6	2.6	4.9	19.2	16.3	30.4	4.8	13.4	13.2	0.0	9.9	3.9
DMRTC1		ENSG00000269502	"DMRT like family C1"	Q5HYR2	X	72872025-72943814	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 2.5;pituitary gland: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046874, HPA046992"	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"		"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Intermediate filaments"	"HPA046874: AB_2679850, HPA046992: AB_2679894"					"unprognostic (1.83e-1)"													0.0	0.5	1.5	0.1	1.3	0.0	0.0	0.0	2.5	0.3	0.0	0.1	0.0	0.4	0.0	0.1	0.7	0.2	0.0	1.0	1.8	0.1	0.0	0.1	0.3	0.4	0.2	0.5	0.2	0.2	1.8	0.0	0.5	0.1	0.2	0.8	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.4	0.1	0.6	1.3	0.2	0.7	0.0	0.3	0.1	0.1	2.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.3	0.0	2.5	1.0	1.8	0.4	0.2	0.5	0.0	1.3	2.4	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
DNAAF5	"CILD18, FLJ20397, FLJ25564, FLJ31671, FLJ39381, HEATR2"	ENSG00000164818	"Dynein axonemal assembly factor 5"	Q86Y56	7	726699-786475	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020243	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA020243: AB_1848750"	"unprognostic (9.77e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.22e-3)"	"prognostic unfavorable (8.42e-4)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (8.07e-3)"	"unprognostic (2.02e-1)"	"unprognostic (7.59e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.70e-3)"	8.4	8.7	7.8	6.7	7.1	7.6	8.5	11.8	8.7	10.3	12.1	11.3	7.4	12.7	4.8	11.6	14.1	5.1	11.9	6.9	7.3	8.3	9.0	6.9	6.5	7.7	10.1	10.6	10.9	7.9	13.0	6.5	6.8	7.9	5.7	4.0	11.5	8.0	24.1	9.1	9.2	6.3	8.3	7.3	9.4	7.8	9.4	6.2	9.1	9.5	5.0	10.5	9.1	8.3	83.1	64.3	18.8	44.0	12.1	13.3	47.2	16.8	16.0	20.5	19.4	64.5	42.8	50.5	23.9	17.7	49.0	49.2	35.0	42.2	15.7	8.6	59.5	12.4	37.4	47.2	16.6	38.1	21.7	16.1	17.8	25.8	19.0	13.7	28.1	25.2	80.0	10.3	15.0	81.5	22.7	34.1	69.3	27.4	50.5	41.4	6.1	34.8	24.3	34.5	39.3	65.1	27.5	66.9	19.9	21.4	59.1	31.5	23.7	11.4	40.1	39.4	38.4	19.9	25.5	29.0	25.1	39.2	60.8	0.0	0.7	0.6	0.8	1.1	1.3	0.6	1.3	1.8	1.1	1.4	1.2	0.9	0.0	1.3	0.8	1.7	0.3	0.8	7.8	7.1	11.8	8.7	6.9	7.3	7.7	10.1	6.8	8.3	9.4	8.3	7.1	19.2	9.1	6.2	3.8	0.0	6.1	0.0	6.8	6.3	8.3	7.1	13.1	4.3	4.3	9.2	27.1	8.0	5.7	4.9	15.6	6.4	0.7	28.2	13.9	7.8	3.6	9.7	12.5	4.2	13.2	7.8	11.7	15.3	0.0	17.6	6.8	8.5	5.8	10.1	10.4	7.4	0.0	7.5	0.0	1.7	7.2	4.8	0.0	7.5	2.4	8.6	2.1	10.6	8.9	9.6	4.1	8.6	6.0	5.1	6.4	11.1	8.0	15.0	0.0	11.4	6.1	7.2	17.4	10.8	0.0	4.5	3.5	12.0	9.1	4.2
DNLZ	"bA413M3.2, C9orf151, HEP, RP11-413M3.2, TIMM15, ZIM17"	ENSG00000213221	"DNL-type zinc finger"	Q5SXM8	9	136359480-136363744	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 9.1;Suprabasal keratinocytes: 9.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.4;MCF7: 13.2;REH: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062738			Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA062738: AB_2684857"	"unprognostic (2.81e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.51e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.56e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	16.4	12.2	2.1	0.9	2.5	0.9	16.4	2.7	3.4	16.0	1.4	16.9	1.1	16.6	0.4	10.0	14.1	0.5	36.5	2.1	2.0	23.0	14.4	12.6	1.0	2.2	2.3	12.1	27.9	0.9	11.4	0.4	2.4	12.5	0.1	0.3	10.1	0.5	23.1	13.8	11.3	0.3	2.0	15.5	13.5	12.0	2.3	0.8	12.5	3.8	0.4	17.3	12.2	2.6	1.7	2.8	0.9	3.3	0.5	0.9	1.8	1.8	1.3	2.3	1.0	3.5	1.9	4.1	9.7	1.8	1.7	3.4	0.6	1.7	0.2	13.4	3.1	1.1	1.3	1.0	1.9	2.2	1.4	1.4	1.7	1.8	1.1	0.6	1.2	2.0	1.7	2.9	1.5	13.2	4.5	2.7	5.2	2.7	7.6	13.4	1.6	5.1	2.9	1.6	4.1	4.7	2.8	1.9	2.9	0.5	2.6	1.4	2.8	4.0	3.5	2.8	4.6	2.7	3.3	3.5	2.6	0.9	3.7	0.7	0.0	0.0	0.4	0.2	0.7	1.3	0.6	0.7	0.1	0.5	0.6	0.6	0.1	0.1	0.1	0.3	0.8	0.0	2.1	2.5	2.7	3.4	2.1	2.0	2.2	2.3	2.4	2.0	2.3	2.6	5.4	0.0	0.0	3.3	6.0	8.4	1.1	0.0	9.1	0.6	4.7	3.9	0.8	0.0	0.7	5.5	0.0	1.0	4.3	1.2	1.9	0.5	0.1	3.0	6.9	3.4	0.0	1.7	2.0	1.1	0.9	3.7	3.6	2.6	0.0	1.0	1.4	1.1	1.0	0.0	2.1	1.2	0.0	0.3	7.5	0.2	1.2	3.0	1.8	1.9	0.6	0.3	2.1	2.5	3.5	0.6	0.3	1.2	7.1	0.6	0.8	3.0	0.1	0.4	0.0	2.5	3.7	1.5	4.8	5.7	9.1	1.1	6.9	1.1	0.9	0.9
DPH1	"DPH2L, DPH2L1, OVCA1"	ENSG00000108963	"Diphthamide biosynthesis 1"	Q9BZG8	17	2030137-2043898	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism, Ectodermal dysplasia, Hypotrichosis, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 19.4;Gastric mucus-secreting cells: 21.4;Plasma cells: 12.0;Squamous epithelial cells: 13.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069750, HPA073864"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Cell Junctions"	"HPA069750: AB_2686188, HPA073864: "	"unprognostic (5.54e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (1.78e-5)"	"unprognostic (2.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.40e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.41e-1)"	24.5	32.3	13.1	6.0	12.8	5.3	22.2	16.8	17.7	29.1	10.7	26.8	8.0	28.8	5.6	19.8	31.0	9.1	19.2	13.7	11.9	28.0	36.3	16.6	7.5	10.3	10.9	26.6	32.0	14.2	59.3	8.5	10.3	36.2	6.2	12.4	23.7	11.0	42.3	29.3	20.8	8.9	10.1	24.3	27.0	20.3	11.7	6.7	28.6	13.7	6.0	24.2	22.3	11.5	15.4	24.9	6.3	16.0	22.2	14.2	18.7	19.3	26.8	29.7	18.7	24.1	11.6	29.0	23.6	52.5	11.2	11.6	20.7	21.1	15.9	9.0	52.4	6.3	10.5	13.1	19.4	8.3	10.2	20.3	20.3	22.7	19.0	20.5	13.9	16.8	23.4	11.2	11.9	18.2	14.7	4.8	6.5	17.3	25.9	16.6	5.7	22.0	13.3	8.0	13.1	15.2	17.4	17.9	17.2	6.9	25.9	6.8	10.1	19.4	10.1	26.2	16.7	10.3	8.3	6.8	20.3	10.8	8.5	0.8	4.5	0.8	8.0	6.1	8.9	8.8	6.5	7.4	7.7	7.2	9.6	6.9	0.3	6.7	4.5	5.5	10.2	5.2	13.1	12.8	16.8	17.7	13.7	11.9	10.3	10.9	10.3	10.1	11.7	11.5	0.9	3.2	9.2	1.3	9.3	0.4	0.9	0.5	19.4	2.1	0.8	0.8	1.5	0.0	2.7	0.0	2.1	1.4	0.9	0.6	0.0	0.5	1.2	1.5	1.2	1.7	0.0	9.0	4.0	0.6	0.9	4.5	21.4	0.8	2.5	1.0	0.7	0.0	0.6	1.7	3.7	0.8	0.0	0.0	0.8	1.5	0.6	3.9	0.0	1.0	0.4	0.9	2.1	1.5	1.4	0.0	0.2	0.4	12.0	0.5	0.5	0.5	3.0	2.8	0.0	1.3	3.2	1.2	0.5	13.0	0.3	1.4	5.4	1.3	0.4	0.6
ECD	"GCR2, hSGT1"	ENSG00000122882	"Ecdysoneless cell cycle regulator"	O95905	10	73130155-73169055	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006465	Approved		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA006465: AB_2667595"	"unprognostic (2.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (4.71e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.55e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.84e-2)"	13.8	17.2	8.0	14.6	11.2	31.9	17.9	12.7	10.7	14.8	10.2	13.1	12.1	16.0	16.2	15.2	11.9	15.9	12.8	8.5	7.7	17.4	18.9	12.6	17.7	7.4	7.1	13.9	16.7	22.8	11.3	17.8	7.5	16.5	13.9	17.0	14.4	14.3	13.8	15.3	11.7	14.7	7.2	14.4	13.1	19.2	7.6	21.0	19.0	14.3	18.4	20.0	12.5	12.5	41.0	28.8	32.0	48.1	28.8	28.2	26.3	31.1	48.5	49.9	57.8	52.0	41.4	31.8	29.9	30.5	36.7	33.0	34.6	36.9	50.3	26.1	33.5	39.9	21.2	38.0	43.7	48.3	25.3	31.5	30.9	41.6	51.7	37.9	53.3	29.3	42.1	21.4	47.6	34.8	44.5	28.6	33.0	37.7	81.8	32.1	35.6	17.6	40.4	29.5	13.9	26.5	28.4	62.5	40.3	32.6	36.1	23.0	33.3	21.1	42.8	23.3	36.2	25.2	18.1	54.5	40.1	40.4	18.5	21.0	23.3	26.3	24.7	24.9	26.4	24.3	23.0	24.4	20.3	21.2	29.9	21.5	27.5	32.5	34.7	13.8	24.8	20.3	8.0	11.2	12.7	10.7	8.5	7.7	7.4	7.1	7.5	7.2	7.6	12.5	21.2	28.9	12.1	13.1	22.7	11.0	27.9	16.6	24.5	13.9	11.9	10.3	12.5	8.6	23.0	7.3	25.0	22.7	22.7	9.0	7.9	15.8	39.4	15.3	15.5	17.4	10.8	21.8	17.3	12.2	15.7	15.7	23.4	24.8	19.6	12.2	15.0	8.8	16.6	20.2	16.3	11.8	8.2	12.4	10.1	11.5	15.8	16.0	14.2	9.4	10.8	10.3	14.4	11.6	18.6	14.7	5.7	13.2	16.7	13.1	9.8	12.2	10.5	13.1	6.6	17.8	18.2	32.9	16.0	19.2	10.9	33.2	22.1	11.6	9.2	24.7
EDC4	"Ge-1, HEDLS, RCD-8"	ENSG00000038358	"Enhancer of mRNA decapping 4"	Q6P2E9	16	67873052-67884499	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 24.8;Excitatory neurons: 14.2;Gastric mucus-secreting cells: 15.3;Inhibitory neurons: 12.6;Oligodendrocytes: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041164, HPA043038"	Supported		Enhanced	"Nucleoplasm,Cytoplasmic bodies"		NA	NA		9700	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Cytoplasmic bodies"	Nucleoplasm	"HPA041164: AB_2677339, HPA043038: AB_2678281"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.10e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.17e-1)"	10.1	11.8	36.3	11.9	36.2	24.4	10.6	36.0	42.2	11.6	34.0	15.5	13.7	12.9	9.6	12.1	13.2	12.1	17.0	34.7	34.8	12.2	10.9	10.8	16.3	34.3	34.5	15.8	18.1	13.6	14.0	10.8	34.4	11.3	11.2	8.5	11.3	10.2	21.9	16.1	14.1	9.7	33.0	13.7	15.8	18.3	34.1	20.6	10.9	11.3	16.0	13.1	10.5	37.0	23.8	33.6	22.0	19.9	19.6	14.8	43.6	21.1	17.8	42.4	33.9	55.2	22.4	38.2	22.6	29.1	17.9	32.4	43.1	17.2	21.3	14.8	54.6	27.2	21.9	29.5	23.7	33.2	29.8	20.3	23.2	42.7	19.8	24.9	32.8	28.3	48.2	7.1	25.4	36.5	44.9	83.6	21.8	15.9	18.4	66.1	26.1	42.3	17.0	17.7	38.5	20.8	56.0	15.9	15.8	17.3	29.4	45.2	21.5	17.7	24.7	16.3	28.6	34.9	22.2	94.7	13.6	39.4	16.3	0.7	5.8	4.2	8.9	6.2	7.9	5.6	7.6	8.4	6.0	4.1	7.5	5.4	2.6	8.3	10.9	4.2	11.2	6.6	36.3	36.2	36.0	42.2	34.7	34.8	34.3	34.5	34.4	33.0	34.1	37.0	0.6	22.4	24.8	8.5	4.8	0.0	0.3	0.2	7.4	1.2	0.3	0.4	1.5	0.0	3.2	0.0	4.2	0.2	1.1	1.6	0.0	0.4	0.0	1.0	1.1	2.1	1.2	8.8	14.2	0.0	0.4	2.6	15.3	1.3	3.8	0.8	1.4	0.2	0.4	0.0	12.6	0.4	0.0	0.3	0.3	0.2	0.3	4.5	0.0	11.2	0.0	0.7	1.0	8.5	13.6	0.3	1.2	0.0	8.3	0.2	2.0	0.1	4.4	1.2	6.6	1.0	0.9	0.2	0.2	8.3	0.1	0.0	5.5	0.8	0.4	0.1
EED	"HEED, WAIT-1"	ENSG00000074266	"Embryonic ectoderm development"	O75530	11	86244753-86278813	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012211, HPA060089, HPA061140"	Supported		Supported	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB012211: AB_2262066, HPA060089: AB_2684201, HPA061140: AB_2684437"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (2.90e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.19e-3)"	"prognostic unfavorable (1.36e-7)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.33e-2)"	"prognostic favorable (2.27e-5)"	9.3	9.0	13.2	16.3	13.1	9.2	11.4	15.0	15.8	13.8	13.1	12.1	12.1	11.5	15.2	12.7	10.6	9.3	8.9	12.8	13.5	11.5	11.9	8.5	28.8	12.9	12.8	12.1	10.5	9.1	9.4	14.5	13.1	11.7	11.9	16.4	10.3	10.6	10.5	12.1	11.6	10.2	12.9	14.4	10.9	10.3	13.6	17.8	10.7	11.1	32.1	13.0	12.1	13.9	34.2	37.8	40.9	16.8	22.6	20.2	47.0	49.2	22.6	46.3	46.8	121.0	64.4	79.8	50.6	15.8	44.2	41.4	48.7	26.8	43.2	79.7	22.7	51.4	38.7	36.3	19.8	54.2	33.4	12.4	18.0	46.8	20.1	17.5	20.9	34.7	58.8	16.2	39.0	55.2	51.5	55.4	30.4	107.8	18.4	56.2	49.1	38.8	29.1	55.4	27.5	22.4	63.5	29.6	14.5	29.1	49.2	22.6	19.0	48.1	44.1	70.0	43.2	9.2	32.1	63.9	13.7	46.6	36.8	31.0	9.1	15.0	25.4	15.3	22.1	45.0	33.2	32.0	13.9	47.3	26.4	29.6	3.9	19.3	16.8	9.2	58.6	19.1	13.2	13.1	15.0	15.8	12.8	13.5	12.9	12.8	13.1	12.9	13.6	13.9	15.4	6.4	9.3	28.1	32.7	25.6	11.6	27.5	25.0	26.4	13.3	11.8	9.5	11.5	15.4	7.3	18.8	45.2	31.0	16.1	19.6	14.5	7.7	17.6	17.1	16.6	7.2	15.8	35.0	10.2	36.8	14.8	16.3	15.5	15.9	15.0	13.2	11.4	16.9	32.0	45.6	12.8	12.2	14.5	32.5	3.6	22.7	15.2	19.6	37.5	30.4	11.5	25.7	31.2	38.9	11.9	11.1	17.3	17.6	11.9	11.7	8.6	21.3	18.3	6.6	14.3	24.5	18.7	20.0	16.9	16.8	24.9	31.6	17.5	15.0	20.9
EEF1G	EF1G	ENSG00000254772	"Eukaryotic translation elongation factor 1 gamma"	P26641	11	62559596-62574086	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 1021.0;Plasma cells: 770.5;Squamous epithelial cells: 1166.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040688, HPA055316"	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA		2500000	"Cluster 30: Non-specific - Translation"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Golgi apparatus"	"HPA040688: AB_10961632, HPA055316: AB_2732593"	"unprognostic (2.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.22e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.86e-1)"	"unprognostic (8.59e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.04e-2)"	1237.6	883.6	646.7	951.1	663.7	1897.3	1890.9	640.9	722.0	1595.1	659.8	1229.0	1094.9	1078.6	1079.3	1634.9	1555.9	749.8	1089.3	616.4	690.9	1162.4	885.3	818.1	1532.7	678.1	661.0	2604.5	2191.5	835.7	708.1	780.5	675.9	1219.1	1272.4	416.0	1588.0	875.6	4810.2	2215.7	1098.5	991.5	690.1	1073.0	1090.2	441.9	677.4	1281.7	1050.2	3030.5	1951.7	1173.7	1440.6	676.7	1773.6	1824.3	1859.1	2656.2	2742.6	3529.1	1866.2	1505.0	2692.9	1830.1	1392.3	2045.9	2161.9	5161.2	2365.4	2392.2	1048.0	2018.3	2229.8	2200.1	1663.3	1693.2	2071.2	1348.7	2061.8	2120.7	2974.2	2810.2	1523.6	4060.8	3913.9	1812.1	4419.8	3014.9	2562.7	1777.2	2755.8	2451.2	2190.6	3611.0	3035.5	4895.3	2304.9	1546.3	1575.0	2545.1	2390.9	4978.7	2454.9	2276.4	1608.2	2002.3	901.7	3010.3	4214.5	1179.1	3496.3	3012.0	1759.8	1057.1	1476.4	2070.0	1338.6	1680.0	1783.1	2609.2	1210.8	2005.2	1517.1	883.9	2365.5	589.6	2182.3	2151.6	4333.1	5399.6	4153.2	2825.0	3623.0	5080.7	6117.7	4188.5	320.6	3285.2	1837.0	2869.7	3307.5	11090.3	646.7	663.7	640.9	722.0	616.4	690.9	678.1	661.0	675.9	690.1	677.4	676.7	2.8	150.6	366.9	14.4	403.6	7.9	2.5	8.8	1021.0	0.5	21.9	10.3	0.0	14.3	300.8	1.8	2.1	17.7	9.6	63.7	3.9	124.8	4.3	2.2	7.2	70.2	148.5	405.0	8.4	188.5	26.8	149.5	252.8	3.5	375.6	1.8	11.0	4.9	12.5	0.0	13.8	152.0	4.1	8.8	4.9	18.8	3.1	134.7	1.8	24.4	126.4	0.8	16.5	6.0	13.0	114.9	121.0	2.2	770.5	3.0	132.1	12.1	152.0	0.5	0.0	1.6	43.9	1.4	0.8	1166.7	6.1	21.1	235.3	1.1	223.8	2.3
EIF4EBP3	4E-BP3	ENSG00000243056	"Eukaryotic translation initiation factor 4E binding protein 3"	O60516	5	140547662-140549576	"Metabolic proteins, Predicted intracellular proteins"	"Translation regulation"	"Protein synthesis inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 59.2;Exocrine glandular cells: 29.0;Gastric mucus-secreting cells: 26.5;Proximal enterocytes: 43.3;Squamous epithelial cells: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 25.1;JURKAT: 42.3;Karpas-707: 28.9"	"Low region specificity"	"Detected in some"							HPA045537	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"			"HPA045537: AB_10965796"	"unprognostic (7.29e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.36e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.17e-1)"	"prognostic favorable (3.10e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.82e-2)"	"unprognostic (3.75e-1)"	43.7	66.1	23.2	6.4	24.2	12.5	45.6	24.9	29.6	27.0	25.4	38.4	12.7	21.8	6.9	36.8	36.9	17.0	42.8	22.8	25.5	41.1	55.4	26.0	12.1	25.2	23.9	30.0	49.0	2.9	17.0	7.0	25.1	41.3	17.4	2.6	54.2	15.5	121.8	49.2	39.9	8.6	25.0	31.1	59.1	32.1	23.4	12.6	35.6	55.7	9.2	30.0	28.7	25.6	0.4	1.7	1.5	2.3	18.4	19.2	3.4	1.6	0.4	0.9	1.6	3.4	1.4	0.9	8.7	3.6	1.3	1.3	0.7	1.8	1.1	3.1	5.6	0.2	3.8	6.3	25.1	10.3	4.9	23.6	2.3	1.5	1.2	4.5	2.8	42.3	0.6	28.9	1.1	0.0	7.9	18.6	2.2	5.3	6.3	8.3	1.2	0.3	2.9	3.6	9.1	1.3	2.8	23.1	7.6	2.0	3.1	11.9	2.2	7.8	1.5	5.0	1.2	2.6	2.3	0.9	5.4	20.0	2.1	9.4	43.6	1.4	11.3	51.2	14.1	41.3	20.5	10.3	37.7	37.1	41.7	34.1	22.3	24.1	38.6	117.5	17.6	24.3	23.2	24.2	24.9	29.6	22.8	25.5	25.2	23.9	25.1	25.0	23.4	25.6	0.8	0.0	13.7	0.0	8.0	0.3	0.6	0.7	59.2	0.0	6.5	3.2	0.2	7.2	4.6	0.0	0.0	0.8	1.5	13.0	3.9	8.6	1.1	4.9	0.9	2.8	8.5	11.8	0.0	29.0	0.9	8.0	26.5	1.5	12.0	0.1	2.2	7.2	2.4	0.0	0.0	15.1	0.0	5.7	0.2	1.1	1.8	9.0	0.0	0.0	7.1	0.0	1.0	0.0	0.0	14.2	19.4	0.0	0.9	0.8	43.3	7.9	7.8	0.0	0.0	0.6	1.2	2.6	0.6	42.3	0.6	1.0	3.4	0.2	18.8	0.4
EMSY	C11orf30	ENSG00000158636	"EMSY transcriptional repressor, BRCA2 interacting"	Q7Z589	11	76444923-76553025	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012234, HPA050777"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB012234: AB_449325, HPA050777: AB_2681232"	"unprognostic (1.69e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.70e-2)"	"unprognostic (8.47e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.64e-2)"	"unprognostic (8.74e-2)"	6.8	5.8	4.6	7.7	7.5	13.1	8.7	15.3	8.6	8.1	6.9	7.6	5.2	10.0	7.6	6.1	8.6	6.4	9.0	4.9	8.0	7.3	5.6	9.0	8.9	6.0	5.9	11.4	8.8	9.8	5.7	12.2	6.7	7.7	8.7	17.8	7.1	7.7	9.3	5.7	6.6	10.1	4.3	7.9	6.6	8.7	6.3	13.3	8.2	12.6	8.4	7.3	7.4	12.3	8.6	11.9	26.8	16.5	9.9	9.8	11.8	13.5	13.3	17.3	18.9	20.3	11.5	11.7	12.7	14.7	14.3	16.8	21.9	13.0	26.6	18.7	8.2	18.2	18.5	8.8	6.3	20.0	15.8	8.9	8.5	19.8	16.3	11.0	15.8	19.6	12.9	20.0	14.1	22.8	26.9	12.0	11.7	26.9	15.6	17.1	49.2	16.4	12.0	10.0	16.7	7.3	19.0	12.8	4.1	16.5	25.9	12.2	11.9	16.2	21.8	42.0	9.6	11.1	12.8	33.1	5.4	12.0	12.1	11.9	3.5	7.5	4.5	3.3	4.3	4.3	4.3	5.5	2.6	4.9	3.9	3.7	7.3	3.6	2.7	4.2	4.7	3.0	4.6	7.5	15.3	8.6	4.9	8.0	6.0	5.9	6.7	4.3	6.3	12.3	14.0	16.0	7.8	0.0	15.1	0.0	7.5	0.0	17.1	19.7	12.1	10.2	0.0	2.8	6.2	12.9	35.5	15.6	14.0	4.8	13.7	6.2	1.8	13.7	14.0	10.7	7.3	13.5	0.0	4.3	7.7	9.2	10.2	10.1	2.5	17.2	12.8	7.3	8.6	15.2	0.0	12.0	0.0	7.9	0.0	2.0	11.5	9.0	0.0	0.0	7.3	8.9	14.4	0.0	0.0	5.9	4.4	12.4	20.1	14.1	8.4	10.1	6.6	22.8	13.1	11.5	10.6	25.8	12.3	15.0	0.0	21.1	13.3	12.3	8.1	11.7
EPS15	"AF-1P, MLLT5"	ENSG00000085832	"Epidermal growth factor receptor pathway substrate 15"	P42566	1	51354263-51519266	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Host-virus interaction, Protein transport, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 314.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008451, CAB010164, HPA061431"	Approved		Enhanced	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		65000	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Vesicles, Cytosol"		"CAB010164: AB_631445, HPA008451: AB_1848221, HPA061431: AB_2732662"	"unprognostic (1.45e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (1.05e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.99e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.26e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.73e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	31.9	35.1	40.3	25.5	48.2	20.7	25.6	38.8	55.7	23.9	25.7	19.1	15.8	22.8	17.6	21.0	18.3	26.1	26.5	43.9	39.1	24.5	26.4	26.9	46.0	38.6	44.1	28.8	14.7	29.0	15.5	31.5	40.7	26.7	20.5	23.4	16.7	20.9	47.6	24.2	17.7	24.3	40.1	34.1	21.3	46.9	45.0	27.6	25.3	40.5	45.6	22.8	20.9	57.2	35.4	10.4	22.0	20.8	49.6	49.2	54.5	24.2	37.9	19.4	28.4	14.4	19.2	71.8	24.3	38.1	39.5	32.7	28.7	23.1	29.1	81.8	18.0	64.1	16.9	17.1	46.7	36.9	56.4	40.3	21.0	34.0	45.7	33.5	36.5	25.2	40.4	31.7	29.8	17.5	29.9	19.8	30.2	24.6	16.7	24.1	33.3	15.9	25.5	43.2	15.0	20.9	28.8	50.4	42.1	60.2	20.5	25.7	51.1	18.0	19.1	36.3	20.5	37.6	41.0	47.6	26.6	41.0	16.1	18.8	10.4	12.1	9.4	10.7	14.2	15.6	11.2	14.9	10.8	9.0	6.6	9.6	7.8	10.8	13.0	7.1	19.0	8.7	40.3	48.2	38.8	55.7	43.9	39.1	38.6	44.1	40.7	40.1	45.0	57.2	51.5	35.3	41.0	142.4	78.3	43.0	32.1	16.4	30.1	18.1	28.2	15.6	59.8	24.3	22.7	44.1	31.3	22.8	65.0	28.5	19.6	15.2	27.0	22.1	50.1	43.3	28.8	81.0	77.1	19.0	18.9	52.5	41.3	35.6	24.6	36.0	61.4	37.7	83.4	28.6	60.6	30.7	12.2	80.9	61.9	61.7	65.9	67.0	103.2	110.5	57.6	38.4	27.8	29.7	314.1	23.3	19.8	48.2	78.4	62.1	20.7	28.1	31.9	26.6	39.5	45.1	38.0	74.4	44.5	33.8	51.0	28.5	74.3	28.5	21.4	50.8
ERVK3-1	HERV-K(HML6-1)	ENSG00000142396	"Endogenous retrovirus group K3 member 1"		19	58305319-58315663	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"				"unprognostic (2.06e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (9.45e-4)"	"unprognostic (7.88e-2)"	"unprognostic (5.91e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.18e-3)"	30.1	32.8	37.3	20.5	38.0	34.4	36.0	39.7	44.9	25.5	35.4	28.7	26.7	25.0	38.4	25.8	24.2	18.9	34.7	40.8	42.6	45.2	41.1	29.2	31.9	39.4	41.5	26.2	27.0	39.1	35.7	19.8	41.2	33.9	17.7	26.2	24.2	23.7	32.5	27.6	27.3	17.4	38.8	34.9	30.6	18.1	39.4	32.5	28.9	24.4	30.8	27.2	23.7	40.7	72.0	139.8	56.8	53.1	33.5	22.4	43.6	47.7	36.7	36.1	34.9	83.8	38.3	49.5	42.0	34.5	51.4	29.2	64.7	43.4	34.3	80.2	258.5	79.3	59.0	73.8	50.6	110.1	51.0	23.4	43.4	58.7	65.6	33.9	25.1	58.2	120.1	59.9	46.4	57.2	99.2	41.6	68.2	85.8	97.1	59.8	60.1	71.8	36.4	103.8	86.4	73.8	57.7	56.4	79.3	54.4	44.1	74.3	31.3	98.2	54.4	30.6	100.3	74.4	224.5	129.4	53.1	64.7	83.0	85.9	39.4	74.0	67.5	43.3	64.2	58.9	60.7	63.7	40.0	57.9	62.3	72.8	34.7	57.8	57.1	67.7	78.3	69.4	37.3	38.0	39.7	44.9	40.8	42.6	39.4	41.5	41.2	38.8	39.4	40.7	21.2	16.0	22.3	0.0	33.2	0.0	6.0	0.0	45.5	20.6	15.0	12.2	6.5	8.6	8.1	5.5	6.2	18.6	24.1	15.5	13.7	25.4	1.0	7.8	10.9	15.2	18.0	16.2	0.0	25.5	8.5	16.4	25.0	10.7	37.3	8.8	8.9	5.6	12.3	16.8	0.0	14.4	0.0	6.3	0.0	1.9	7.8	15.2	0.0	0.0	14.7	11.7	21.6	0.0	0.0	30.0	25.6	14.3	39.6	8.1	23.3	11.9	4.4	12.2	6.6	8.5	14.4	19.3	28.7	29.4	0.0	15.3	31.0	11.5	13.5	5.5
EXOSC10	"p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p"	ENSG00000171824	"Exosome component 10"	Q01780	1	11066618-11099869	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, rRNA processing"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028470, HPA028484, CAB037141"	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250"	"unprognostic (1.23e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (3.36e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.03e-2)"	"prognostic favorable (5.27e-4)"	"unprognostic (1.33e-1)"	31.8	21.4	18.3	25.9	18.4	39.4	30.8	23.1	22.2	32.5	14.7	27.6	20.7	28.7	23.9	27.3	26.4	19.2	20.3	17.7	15.9	21.8	20.0	24.3	31.1	17.2	15.2	35.8	24.0	25.2	26.1	26.1	16.6	25.3	27.6	35.4	25.4	21.0	33.3	37.0	26.1	27.5	13.7	27.4	26.1	23.4	17.9	32.7	23.3	22.6	34.2	24.6	28.4	19.1	66.4	41.5	84.9	33.0	44.3	48.7	48.5	63.8	46.8	109.8	99.1	61.6	94.1	66.3	40.3	61.0	48.8	64.2	95.0	71.2	100.1	74.9	95.0	96.5	80.5	63.2	43.4	79.5	73.7	38.4	60.2	108.1	63.1	40.9	69.4	58.0	103.2	59.3	61.4	37.4	78.5	73.1	56.5	50.3	49.1	79.8	72.2	58.1	64.8	33.3	54.5	53.3	68.8	58.9	77.0	59.4	51.5	72.1	63.6	58.2	60.4	53.0	76.2	35.7	60.0	130.0	59.4	116.2	71.5	57.7	32.0	26.6	36.2	41.5	43.0	36.4	37.7	36.7	37.9	36.5	31.9	35.4	6.2	49.3	51.2	19.3	39.4	43.3	18.3	18.4	23.1	22.2	17.7	15.9	17.2	15.2	16.6	13.7	17.9	19.1	18.4	28.9	18.3	17.0	26.1	13.3	14.3	19.8	26.2	14.9	11.0	23.6	6.4	12.8	29.2	5.5	47.9	26.5	18.8	16.4	9.8	25.0	16.4	14.3	21.0	20.1	9.0	28.0	20.3	31.9	34.3	17.2	31.1	19.2	20.2	26.2	13.9	11.1	24.7	21.9	24.3	16.5	22.4	15.1	14.1	7.1	29.5	18.7	12.4	9.4	24.0	6.1	28.8	30.2	15.2	30.2	9.4	23.0	26.8	8.5	12.7	8.8	27.3	34.8	13.1	18.4	17.6	21.9	20.8	28.7	13.4	22.7	21.2	19.7	20.1	10.0
FAAP100	"C17orf70, FLJ22175"	ENSG00000185504	"FA core complex associated protein 100"	Q0VG06	17	81539885-81553961	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023954, HPA024626, HPA026532"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA023954: AB_1845601, HPA024626: AB_1845602, HPA026532: AB_1845603"	"unprognostic (5.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.87e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (1.00e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.85e-2)"	"unprognostic (4.24e-1)"	14.7	16.8	6.7	13.8	7.0	10.1	15.9	14.7	9.5	18.6	6.8	15.8	12.0	17.3	3.1	16.2	18.8	9.5	16.3	6.7	6.4	21.2	22.7	16.0	15.9	8.1	6.5	19.5	26.6	7.8	22.4	7.2	6.3	20.7	4.9	3.7	14.6	7.8	13.2	16.1	18.8	6.9	5.1	38.1	15.5	13.3	7.3	8.8	24.1	6.0	7.3	17.9	15.5	8.8	11.7	21.3	9.4	26.8	11.0	11.5	14.6	11.2	5.9	14.3	8.9	14.5	14.0	21.0	8.6	15.5	13.8	15.0	4.9	14.5	3.3	6.1	13.9	13.5	23.3	20.0	11.6	15.4	16.0	14.0	10.7	10.4	11.7	17.6	27.0	22.0	20.7	16.5	7.0	23.0	24.4	25.8	11.3	13.6	7.7	22.1	9.4	19.3	10.4	21.1	20.5	17.1	8.5	24.4	10.4	9.7	26.2	20.7	22.8	30.6	18.8	8.3	18.9	18.3	1.5	10.7	8.0	9.9	14.3	0.0	3.0	1.2	2.4	2.8	1.9	3.0	1.6	1.6	2.9	2.0	1.5	1.2	0.4	2.4	1.4	3.2	1.6	2.2	6.7	7.0	14.7	9.5	6.7	6.4	8.1	6.5	6.3	5.1	7.3	8.8	11.4	3.2	7.5	0.0	7.5	0.0	3.5	0.0	4.6	10.3	9.8	10.9	8.9	10.0	2.5	14.7	4.2	6.1	8.5	7.1	3.9	8.2	1.9	4.5	7.3	7.5	7.3	11.8	0.0	6.9	4.8	8.3	15.8	6.8	0.0	14.9	6.8	11.7	8.4	6.7	0.0	6.2	0.0	14.1	0.0	3.0	5.0	7.0	0.0	0.0	8.9	6.2	4.1	0.0	0.0	8.9	4.4	5.3	6.6	5.3	12.7	6.8	1.5	4.9	0.0	7.4	6.4	7.3	7.5	9.5	0.0	3.1	6.2	10.7	7.3	3.6
FAM13B	"ARHGAP49, C5orf5, FAM13B1, KHCHP, N61"	ENSG00000031003	"Family with sequence similarity 13 member B"	Q9NYF5	5	137937960-138051961	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 140.6;Inhibitory neurons: 140.0;Oligodendrocyte precursor cells: 130.2;Oligodendrocytes: 227.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036525, HPA041819, HPA071936"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA036525: AB_10696655, HPA041819: AB_2677690, HPA071936: AB_2686474"	"unprognostic (8.09e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.02e-3)"	"unprognostic (6.51e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.60e-1)"	"prognostic favorable (3.55e-5)"	"unprognostic (9.56e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.06e-2)"	13.4	22.6	14.4	15.7	18.5	24.0	15.9	18.7	15.7	15.4	7.9	14.1	9.8	22.4	14.0	14.0	14.7	14.8	20.6	13.8	22.0	13.7	8.6	13.7	21.4	14.8	14.3	24.6	9.5	15.6	8.7	16.2	15.9	24.4	12.2	12.6	11.3	35.7	4.4	11.1	10.9	32.4	8.9	17.8	11.6	34.0	21.3	17.7	15.1	7.6	23.4	17.1	11.6	18.7	18.1	9.0	26.2	21.6	34.3	10.7	20.6	39.1	31.7	29.3	33.8	24.1	16.0	40.7	12.8	34.3	37.4	13.8	16.3	12.6	38.0	30.9	17.6	18.3	21.7	7.6	11.6	30.0	24.3	13.7	6.9	22.4	13.0	15.4	10.2	14.6	10.7	20.2	27.4	13.3	30.5	16.4	10.4	14.0	10.7	21.7	26.1	8.1	17.7	31.6	29.6	26.0	30.5	9.3	38.8	37.6	25.4	30.2	13.5	31.3	13.5	23.2	29.9	16.2	42.2	38.2	17.6	24.3	27.3	10.7	2.2	8.6	4.6	3.3	3.9	5.3	3.3	4.2	1.7	5.6	3.4	4.5	7.1	6.0	5.9	2.9	3.5	1.7	14.4	18.5	18.7	15.7	13.8	22.0	14.8	14.3	15.9	8.9	21.3	18.7	21.2	22.4	19.8	63.6	56.7	15.4	15.7	10.0	64.9	19.4	23.2	20.7	43.3	14.3	15.2	5.5	20.9	12.4	44.9	8.7	3.9	6.8	40.8	28.1	25.2	17.8	10.3	18.5	140.6	3.5	4.0	21.7	16.8	36.0	30.4	29.2	18.9	5.4	13.9	11.8	140.0	9.9	6.1	24.6	28.9	30.5	16.1	31.2	12.4	73.1	17.6	5.9	28.8	130.2	227.6	6.4	7.0	25.6	37.5	12.5	7.6	5.6	12.9	15.2	26.3	29.8	24.8	29.9	21.7	39.6	13.8	5.2	46.9	49.6	8.4	12.8
FAM156A	"PRO0659, TMEM29"	ENSG00000268350	"Family with sequence similarity 156 member A"	Q8NDB6	X	52926402-52995472	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 16.0;Excitatory neurons: 9.6;Gastric mucus-secreting cells: 11.2;Inhibitory neurons: 11.1;Microglial cells: 8.4;Oligodendrocyte precursor cells: 11.1;Oligodendrocytes: 11.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA056640, HPA056643"	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"			"HPA056640: AB_2683200, HPA056643: AB_2683201"	"unprognostic (1.80e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.99e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-3)"	"unprognostic (6.60e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.84e-2)"	"unprognostic (8.49e-5)"	"unprognostic (1.32e-1)"	"unprognostic (3.54e-13)"	"unprognostic (6.42e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.90e-2)"	36.1	35.1	13.3	10.6	10.4	9.7	33.2	14.6	16.7	35.6	9.6	28.6	11.9	29.6	6.0	22.8	34.1	4.1	23.2	10.6	13.1	26.5	24.8	27.5	5.9	13.0	11.9	34.6	25.9	11.4	61.3	20.6	12.4	32.4	7.3	6.7	21.2	9.1	12.1	44.8	26.6	8.2	6.5	37.3	24.8	22.5	10.7	6.8	34.2	3.7	6.6	27.3	28.5	16.1	16.8	22.6	13.1	19.5	5.9	24.6	66.8	26.4	11.4	21.5	11.7	13.3	6.9	22.3	11.8	19.7	9.3	27.2	11.8	15.4	9.1	21.1	24.4	14.5	71.9	23.9	8.9	13.6	9.4	15.2	5.8	19.0	5.9	10.1	7.1	17.9	14.0	6.3	17.3	27.1	14.7	24.1	11.2	8.4	31.7	20.8	18.5	21.6	6.6	16.8	12.6	14.1	23.2	12.2	7.4	12.9	25.5	8.3	5.6	18.1	17.9	45.5	9.8	34.2	42.0	17.0	24.1	18.8	16.6	0.0	8.5	1.4	5.5	5.8	4.5	4.3	4.6	4.7	13.8	4.4	7.6	3.4	2.4	7.2	6.5	7.8	3.8	5.3	13.3	10.4	14.6	16.7	10.6	13.1	13.0	11.9	12.4	6.5	10.7	16.1	0.2	0.0	1.1	16.0	2.1	0.0	0.2	0.0	4.6	0.4	0.2	0.0	4.3	0.0	0.6	0.0	0.0	1.4	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.8	0.0	1.3	9.6	0.0	0.7	1.5	11.2	0.1	0.0	0.2	0.0	0.0	0.3	0.0	11.1	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	8.4	0.3	0.3	0.0	11.1	11.0	0.1	0.0	0.0	2.9	0.1	0.5	0.0	0.0	0.5	0.0	0.4	0.7	0.0	0.1	3.3	0.1	4.4	1.3	0.2	0.1	0.1
FBXO38	"Fbx38, FLJ13962, MOKA, SP329"	ENSG00000145868	"F-box protein 38"	Q6PIJ6	5	148383935-148442836	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"		"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034821, HPA041444"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA034821: AB_10669897, HPA041444: AB_2677484"	"unprognostic (7.72e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.70e-3)"	12.8	11.5	7.3	12.9	8.4	9.8	13.9	8.1	9.9	14.1	8.2	12.5	9.6	12.5	11.1	10.5	10.0	11.5	17.4	7.0	7.7	12.9	18.0	14.5	14.6	8.0	7.6	12.3	9.5	18.5	10.2	13.8	8.0	14.6	13.0	11.0	11.5	12.0	18.7	12.2	11.6	12.3	7.5	14.4	12.5	12.4	7.8	20.2	12.2	16.8	15.6	13.8	11.2	9.9	12.6	13.2	20.1	14.7	22.1	24.6	10.4	16.1	30.7	22.4	30.5	19.6	15.1	18.2	15.5	26.2	23.6	17.2	21.2	20.3	26.8	20.1	13.6	10.8	19.0	13.3	21.9	29.6	17.0	24.0	17.1	21.6	21.1	24.0	30.7	16.6	12.2	19.1	22.3	5.1	18.8	13.8	9.4	13.9	19.8	16.6	29.3	18.4	21.7	14.5	17.9	17.3	21.4	14.2	21.2	17.1	15.0	21.2	20.2	20.4	7.3	10.8	18.2	23.3	25.1	15.3	20.3	16.6	15.8	15.1	6.1	9.1	5.0	8.0	5.5	4.9	4.7	5.0	7.5	3.8	4.8	6.2	11.2	7.7	15.2	3.7	7.4	4.9	7.3	8.4	8.1	9.9	7.0	7.7	8.0	7.6	8.0	7.5	7.8	9.9	10.6	16.0	45.7	25.1	13.8	3.3	5.5	7.4	7.4	10.3	8.5	6.7	18.7	11.5	10.6	11.0	10.4	7.5	13.4	11.3	5.9	8.8	11.2	8.9	9.9	10.8	9.6	7.2	40.2	6.7	6.8	11.8	14.8	10.4	15.8	9.6	11.4	16.9	12.6	13.5	37.4	10.1	6.1	24.9	6.4	2.9	9.0	17.8	3.6	38.4	12.3	5.9	12.3	33.2	44.4	9.9	8.9	18.4	11.0	8.6	9.3	9.3	16.4	9.0	0.0	6.9	7.8	20.6	8.6	9.2	3.8	12.3	12.1	11.2	9.0	8.7
GABARAP	"ATG8A, MM46"	ENSG00000170296	"GABA type A receptor-associated protein"	O95166	17	7240008-7242449	"Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 498.6;Ductal cells: 462.5;Plasma cells: 482.6;Squamous epithelial cells: 457.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065883			Approved	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA065883: AB_2685574"	"unprognostic (2.58e-1)"	"unprognostic (4.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (9.52e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.58e-1)"	609.8	848.2	777.0	344.7	799.2	478.8	610.9	826.8	1091.7	696.5	776.2	600.1	292.4	548.9	574.9	479.4	561.2	302.8	740.4	753.9	807.5	741.1	625.2	569.8	308.5	819.2	790.0	751.1	732.2	662.1	851.7	302.2	829.3	604.6	372.4	280.6	592.3	385.4	1001.1	662.8	496.8	341.4	817.6	651.6	658.9	604.5	803.0	389.2	552.3	916.4	411.0	534.0	547.5	862.7	233.5	342.1	598.0	404.5	887.1	999.5	227.0	377.1	645.5	330.1	491.2	141.9	200.6	233.9	233.2	672.0	430.6	206.9	428.1	329.7	441.7	421.8	474.4	182.8	301.3	377.3	858.3	118.7	369.6	1016.1	445.4	424.5	378.9	925.6	623.7	350.0	143.6	256.8	577.5	159.4	288.4	267.6	242.0	420.9	329.1	393.8	273.3	318.8	682.9	240.9	262.8	695.8	284.1	262.5	409.4	439.3	333.4	228.4	563.7	363.6	211.1	357.7	314.8	280.6	294.2	152.6	586.1	296.2	383.5	2968.2	4092.7	3746.6	766.9	3665.8	796.1	1262.2	906.3	810.4	3152.3	1156.6	812.9	765.5	7095.7	734.6	3213.5	2410.2	1132.5	4745.4	777.0	799.2	826.8	1091.7	753.9	807.5	819.2	790.0	829.3	817.6	803.0	862.7	24.0	89.8	120.1	44.4	183.6	20.8	3.9	21.3	498.6	2.4	64.1	31.9	0.5	54.3	81.3	27.6	0.0	24.3	35.8	302.0	43.0	462.5	24.1	25.5	32.4	61.5	396.5	179.3	36.7	309.6	31.1	124.2	264.6	24.8	150.0	6.9	45.0	39.9	78.2	1.7	37.7	314.3	34.6	147.0	60.8	71.3	21.1	397.4	33.8	43.1	399.2	15.1	32.0	21.1	87.8	375.2	374.3	13.9	482.6	6.0	384.7	72.0	166.4	3.0	6.6	5.2	74.2	22.1	5.8	457.2	23.2	52.9	105.2	5.2	237.1	4.9
GABPA	"E4TF1-60, E4TF1A, NFT2, NRF2, NRF2A"	ENSG00000154727	"GA binding protein transcription factor subunit alpha"	Q06546	21	25734570-25772460	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003258, CAB004411, HPA028791"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB004411: AB_627648, HPA003258: AB_1078928, HPA028791: AB_10602598"	"unprognostic (5.50e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.07e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (3.97e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.73e-3)"	17.0	13.8	6.8	14.1	9.4	16.0	14.9	7.9	10.2	14.6	7.2	12.5	12.9	18.3	15.1	11.3	12.4	13.4	12.9	6.2	7.1	13.8	19.3	13.3	20.4	7.5	7.6	18.1	10.2	15.3	6.7	24.5	8.1	12.4	13.8	11.5	10.4	10.3	10.6	10.3	13.4	15.3	7.6	18.7	11.8	15.0	7.6	22.1	21.2	16.5	19.5	12.9	10.0	10.3	22.2	9.2	25.8	18.2	25.4	33.9	20.0	17.5	18.7	13.7	13.5	11.4	18.2	45.7	13.4	19.7	13.9	9.7	28.5	17.2	22.7	27.6	26.8	32.9	11.9	10.7	17.1	35.3	21.2	25.1	16.3	18.5	17.2	22.9	25.6	24.9	30.8	27.5	23.2	11.0	37.9	15.1	35.9	23.6	12.5	31.1	37.5	28.7	15.9	14.3	16.0	21.1	30.9	19.5	22.0	15.5	17.2	26.8	26.5	16.9	15.5	18.7	14.8	22.2	20.3	40.3	17.2	26.5	21.1	8.8	4.7	7.4	4.3	5.5	5.8	5.6	5.1	5.3	4.7	5.4	5.9	5.2	5.5	6.7	4.3	2.6	5.8	4.4	6.8	9.4	7.9	10.2	6.2	7.1	7.5	7.6	8.1	7.6	7.6	10.3	43.2	9.6	12.0	14.0	20.7	11.6	12.2	7.0	15.4	7.6	13.0	10.8	9.1	14.3	11.8	22.0	0.0	18.1	18.4	19.0	3.9	7.6	13.2	12.0	22.6	26.3	9.0	11.6	21.0	8.1	12.4	23.7	12.2	14.8	6.3	21.1	27.8	18.7	12.7	13.5	19.6	11.1	6.1	19.0	10.1	3.6	17.7	16.7	7.2	22.5	16.0	23.2	10.3	21.1	43.4	7.9	10.2	22.2	15.3	11.9	11.4	10.4	9.3	10.2	19.7	26.1	18.4	34.0	19.5	12.6	12.6	25.2	19.2	14.2	11.3	14.4
GATAD2B	P66beta	ENSG00000143614	"GATA zinc finger domain containing 2B"	Q8WXI9	1	153789030-153923360	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 117.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017015	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA017015: AB_1854905"	"unprognostic (1.90e-1)"	"unprognostic (5.02e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (4.43e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.17e-2)"	10.0	7.1	0.0	6.1	2.9	10.0	9.9	12.4	3.0	10.9	0.0	11.1	4.2	11.1	1.8	7.9	9.1	3.2	9.2	1.8	1.5	7.1	8.1	12.9	7.8	2.8	0.7	11.7	7.5	5.7	7.6	5.8	1.2	8.3	3.6	3.6	7.8	5.3	16.6	13.3	9.3	7.0	0.0	10.6	7.7	10.4	2.1	10.9	8.6	8.2	7.4	9.5	9.8	11.2	7.9	14.7	12.8	14.2	2.7	8.2	7.7	4.8	11.5	15.0	17.5	7.2	12.0	15.5	11.2	10.9	7.9	15.6	18.1	9.4	12.2	14.2	12.5	15.2	16.2	2.9	8.6	9.2	20.7	6.5	6.5	16.7	32.9	7.1	14.4	21.2	11.5	20.6	3.0	14.5	33.3	2.6	5.6	6.3	7.1	33.5	6.5	17.1	2.9	10.9	14.8	15.6	18.0	21.8	8.7	9.4	20.1	7.7	13.0	14.6	12.8	8.1	10.2	27.9	20.5	23.4	8.2	6.0	12.8	4.9	0.5	0.5	0.6	0.3	0.6	0.4	0.3	0.8	0.2	0.6	0.2	0.3	3.5	0.9	0.2	1.6	0.6	0.3	0.0	2.9	12.4	3.0	1.8	1.5	2.8	0.7	1.2	0.0	2.1	11.2	32.1	9.6	14.4	53.8	30.0	43.8	13.4	12.8	47.8	45.9	20.9	19.9	16.6	21.5	12.3	25.8	39.6	10.3	31.9	15.1	7.9	13.9	15.8	16.8	26.6	28.2	23.8	21.7	104.6	14.3	7.1	20.7	17.3	21.3	24.7	19.3	22.5	21.8	13.5	35.3	77.5	15.8	16.2	31.4	42.8	7.6	27.1	23.7	14.2	80.6	36.3	17.8	23.7	86.5	117.9	17.1	20.7	35.0	25.6	22.3	9.9	10.4	15.2	35.9	6.6	28.2	27.1	30.4	21.4	26.0	47.5	9.9	31.2	21.4	15.9	21.1
GBF1	"ARF1GEF, KIAA0248"	ENSG00000107862	"Golgi brefeldin A resistant guanine nucleotide exchange factor 1"	Q92538	10	102245371-102382899	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 28.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037759, HPA037760"	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA037759: AB_10671884, HPA037760: AB_2675651"	"unprognostic (5.97e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.74e-3)"	"unprognostic (7.02e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.78e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.34e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.09e-2)"	19.4	21.1	31.5	16.0	31.7	25.0	19.3	28.7	47.2	21.7	34.9	24.6	20.6	23.5	12.7	21.9	19.7	9.8	30.0	32.2	27.7	21.7	23.2	20.5	14.6	28.5	37.3	21.6	25.6	24.4	31.5	11.5	30.6	24.2	13.9	19.2	24.5	15.2	48.1	24.9	25.8	16.4	27.1	21.7	21.2	20.5	29.8	11.8	25.4	30.1	13.8	21.7	20.5	29.1	19.4	49.7	23.3	25.1	62.9	40.7	28.1	37.7	56.0	45.3	48.1	52.7	35.1	21.7	29.7	59.6	33.8	38.6	45.9	52.8	33.8	35.4	36.9	33.3	38.1	44.6	26.4	35.2	46.8	37.3	28.0	60.7	57.5	77.2	45.2	22.5	20.7	53.7	41.8	36.9	24.2	38.9	15.4	29.5	35.6	33.6	72.1	18.8	39.3	30.9	15.0	16.3	30.2	22.3	26.5	33.1	50.4	30.8	60.5	29.1	29.6	37.7	55.6	32.4	36.3	26.5	30.0	36.3	22.1	28.6	4.5	4.3	4.9	5.0	5.9	6.5	3.6	6.5	5.0	3.9	5.7	5.3	4.6	4.6	4.1	4.2	7.4	3.9	31.5	31.7	28.7	47.2	32.2	27.7	28.5	37.3	30.6	27.1	29.8	29.1	12.5	12.8	10.1	56.5	15.5	9.8	5.5	10.6	17.6	24.7	15.7	12.8	17.0	15.7	10.9	12.9	56.3	12.2	15.1	31.4	3.9	12.5	4.9	14.3	18.1	12.3	12.0	13.9	72.1	16.7	16.3	14.6	31.1	15.6	7.6	10.3	8.2	17.6	12.2	52.2	73.0	21.9	12.2	11.0	5.0	4.7	10.2	13.4	12.4	66.5	9.5	11.1	9.2	80.9	71.1	18.6	20.7	11.3	46.0	7.7	27.1	9.0	12.3	41.0	6.6	21.7	12.3	36.0	25.4	20.7	13.1	17.6	16.0	19.1	19.4	6.7
GCN1	"GCN1L, GCN1L1, KIAA0219"	ENSG00000089154	"GCN1 activator of EIF2AK4"	Q92616	12	120127202-120194715	"Plasma proteins, Predicted intracellular proteins"	"Stress response, Translation regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018799, HPA019648, HPA024367"	Enhanced		Enhanced	Cytosol		NA	NA		120000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 15: RT4 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA018799: AB_1849565, HPA019648: AB_1849567, HPA024367: AB_1849569"	"unprognostic (7.36e-2)"	"unprognostic (2.10e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (1.87e-8)"	"unprognostic (5.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.09e-3)"	"unprognostic (1.43e-1)"	17.2	16.5	9.5	16.0	11.6	19.1	16.9	10.3	10.1	17.1	12.7	18.7	12.1	20.0	9.5	22.3	17.3	9.5	16.1	8.9	9.4	16.2	17.8	16.0	18.3	11.6	10.6	20.2	22.9	18.0	21.1	16.5	10.0	15.8	12.4	8.8	18.2	12.7	44.4	22.0	18.1	14.7	9.2	20.5	20.5	17.9	11.8	18.3	19.7	22.9	16.3	18.6	16.4	13.4	51.4	99.3	35.1	39.7	54.4	32.7	122.4	44.9	38.9	45.8	37.2	85.6	34.5	67.8	49.6	64.8	29.0	49.5	82.1	63.5	28.4	45.5	66.9	84.0	65.5	59.8	35.2	78.2	51.5	40.3	36.3	54.3	50.9	40.2	42.5	30.3	100.3	17.0	38.8	51.6	49.7	59.1	62.3	48.8	59.9	59.7	36.0	67.3	31.2	172.8	57.4	57.4	73.8	31.7	26.5	33.1	67.5	43.8	58.6	37.3	41.0	24.7	47.0	66.2	65.4	67.1	35.7	40.5	38.2	0.7	1.8	1.3	3.3	1.7	4.1	2.0	2.6	2.7	2.3	2.1	1.9	2.1	0.0	1.8	4.1	2.7	2.6	1.9	9.5	11.6	10.3	10.1	8.9	9.4	11.6	10.6	10.0	9.2	11.8	13.4	12.0	9.6	17.9	0.0	11.2	0.0	6.8	0.0	9.6	14.1	11.9	13.6	0.0	12.8	9.3	22.0	10.4	14.2	12.0	8.1	1.9	15.6	1.9	9.0	14.1	10.5	3.6	16.2	0.0	15.9	38.2	10.5	25.5	14.9	5.1	25.7	10.4	24.6	11.2	16.8	0.0	11.4	0.0	9.1	0.0	3.5	14.3	8.9	0.0	0.0	11.1	9.0	7.2	0.0	0.0	18.6	8.6	12.8	17.7	15.7	11.1	9.1	2.9	12.1	6.6	16.4	8.9	8.8	20.8	14.1	0.0	14.6	10.1	14.3	11.7	15.8
GDAP2	"dJ776P7.1, FLJ20142, MACROD3"	ENSG00000196505	"Ganglioside induced differentiation associated protein 2"	Q9NXN4	1	117863485-117929621	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046185	Approved		Approved	"Endoplasmic reticulum"		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA046185: AB_10960897"	"unprognostic (4.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.26e-3)"	"unprognostic (2.26e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.28e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.68e-1)"	3.0	2.4	2.3	3.2	2.1	8.0	3.2	3.6	2.7	3.4	3.4	3.8	4.0	2.8	4.0	3.1	2.4	3.2	2.5	2.0	2.3	4.8	5.1	3.4	3.6	2.1	2.6	2.4	4.5	4.9	2.3	4.1	2.4	3.4	4.4	2.9	3.0	3.3	1.8	2.9	4.7	3.0	2.4	4.2	4.4	4.8	2.7	4.1	4.6	2.1	4.4	4.5	3.1	2.9	9.2	5.1	6.1	5.1	6.5	3.1	9.0	5.2	6.8	10.3	9.9	5.4	6.2	3.6	6.2	7.1	7.8	5.3	8.1	6.8	12.6	7.2	4.7	5.4	6.7	5.9	7.7	6.8	6.6	2.5	8.5	12.9	9.9	4.7	6.9	8.1	5.7	7.6	8.6	9.6	6.0	5.5	10.6	6.9	8.8	3.2	16.7	5.3	5.8	9.1	4.6	5.1	6.3	10.7	8.2	18.3	3.7	6.8	4.3	7.3	8.5	8.5	7.1	7.9	6.1	5.1	9.4	4.8	9.1	11.4	6.7	12.6	2.4	7.2	3.8	2.3	2.7	2.9	6.5	2.2	2.4	2.3	6.5	4.1	7.6	1.5	3.6	3.2	2.3	2.1	3.6	2.7	2.0	2.3	2.1	2.6	2.4	2.4	2.7	2.9	9.2	9.6	8.6	27.7	13.5	13.5	6.5	8.1	8.6	13.1	8.1	5.5	7.8	8.6	10.8	3.7	18.8	12.4	11.6	13.4	7.9	10.6	21.2	12.8	9.0	7.6	4.2	13.9	36.7	6.2	11.4	7.7	18.3	11.5	0.0	10.4	6.4	9.0	13.8	15.2	39.1	14.0	14.2	17.2	15.8	5.7	5.9	20.0	10.6	34.7	16.2	9.2	8.2	31.7	35.8	10.7	7.5	7.2	21.0	9.8	17.8	10.2	10.5	13.7	0.0	8.6	10.2	28.4	14.5	14.3	13.8	21.1	13.8	6.7	8.3	9.6
GEMIN5		ENSG00000082516	"Gem nuclear organelle associated protein 5"	Q8TEQ6	5	154887411-154938211	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Protein biosynthesis, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037392, HPA037393"	Uncertain		Enhanced	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nuclear bodies"	"HPA037392: AB_2675453, HPA037393: AB_10672489"	"unprognostic (1.14e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (6.23e-5)"	"unprognostic (5.44e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.61e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.40e-3)"	"unprognostic (5.01e-2)"	8.3	4.4	5.0	5.0	5.9	3.3	8.2	5.4	5.6	5.9	5.0	5.4	3.3	6.2	4.6	5.3	6.1	3.4	6.7	5.1	5.4	4.7	6.0	4.3	6.5	5.2	5.2	8.4	5.5	6.4	4.4	4.8	5.4	5.8	4.6	4.1	4.6	5.9	12.3	7.3	4.0	6.9	5.2	5.6	4.3	6.0	5.4	7.5	5.3	10.2	7.3	6.8	5.0	6.9	17.2	25.0	15.9	37.0	16.8	14.2	20.4	16.4	9.9	28.0	20.6	41.6	15.0	45.0	20.2	15.7	28.8	17.8	47.7	29.8	38.0	9.0	22.3	27.3	15.6	25.2	9.3	48.0	15.2	10.7	13.6	38.9	23.2	10.1	23.2	10.7	43.9	10.7	21.2	23.6	26.0	19.2	22.3	13.4	19.4	33.3	31.2	37.4	11.6	11.6	20.9	14.4	18.9	20.7	13.3	15.7	24.6	11.0	14.2	25.1	18.0	19.1	37.2	10.7	17.5	34.5	10.7	38.8	22.6	0.0	1.9	1.7	2.4	2.3	3.9	3.4	2.2	2.2	2.6	2.7	3.2	3.5	0.1	2.8	2.2	1.9	2.2	2.1	5.0	5.9	5.4	5.6	5.1	5.4	5.2	5.2	5.4	5.2	5.4	6.9	6.7	0.0	6.4	6.8	8.4	10.3	6.7	5.3	10.2	6.3	5.2	5.0	15.0	1.5	12.3	3.7	0.0	4.4	5.0	1.9	0.0	5.7	3.4	4.3	9.5	8.4	1.2	8.8	19.1	4.2	4.4	11.1	5.1	4.8	1.3	15.6	4.6	9.2	4.5	16.8	20.5	3.9	0.0	14.4	2.6	4.1	10.8	4.5	7.2	11.2	6.0	7.0	5.2	15.1	19.3	3.4	1.1	13.2	4.5	7.0	2.6	4.5	2.5	4.3	0.0	11.5	8.6	11.7	16.1	8.2	15.9	2.1	5.6	15.6	4.7	4.9
GET4	"C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35"	ENSG00000239857	"Guided entry of tail-anchored proteins factor 4"	Q7L5D6	7	876554-896436	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 36.7;Oligodendrocytes: 15.8;Plasma cells: 37.2;Squamous epithelial cells: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019765	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome,Cytosol"		Yes	No			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Nucleoli, Mitotic chromosome"	"HPA019765: AB_1845750"	"unprognostic (2.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.66e-4)"	"unprognostic (9.86e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.93e-2)"	"unprognostic (9.47e-2)"	25.0	98.0	28.9	12.5	33.7	31.6	26.8	29.7	37.0	28.1	19.1	33.5	20.8	25.5	21.1	43.7	32.1	11.4	33.1	28.8	31.1	68.8	98.4	25.5	15.8	36.1	33.4	34.3	46.1	13.7	70.7	20.5	36.0	37.8	8.8	16.4	28.8	12.3	56.3	46.9	33.6	7.7	29.1	37.5	41.5	79.0	34.0	14.4	34.3	21.9	10.4	31.3	28.9	45.6	78.8	38.1	25.8	38.4	13.2	9.1	81.7	21.2	14.9	26.5	26.6	103.4	95.1	28.5	21.7	12.4	73.7	48.7	29.3	23.3	11.5	11.6	50.9	15.8	31.5	59.5	29.1	27.1	28.1	13.8	27.6	23.4	15.1	19.9	21.1	32.5	103.6	25.7	15.2	59.7	20.8	65.2	93.3	46.1	56.0	43.0	4.5	30.8	23.8	45.4	46.7	50.5	19.5	71.2	32.2	31.5	54.2	47.8	21.4	19.6	43.6	45.7	29.5	38.5	25.9	37.5	20.1	46.2	50.3	22.3	28.5	32.4	23.9	27.6	23.3	24.3	26.4	24.1	29.4	24.5	25.2	27.0	21.9	27.7	35.3	33.3	26.9	24.8	28.9	33.7	29.7	37.0	28.8	31.1	36.1	33.4	36.0	29.1	34.0	45.6	0.3	0.0	3.1	14.7	10.6	1.0	0.3	0.2	14.8	0.8	1.1	0.9	0.6	0.0	2.2	0.0	4.2	1.1	0.7	2.3	0.0	0.9	4.0	2.0	1.1	1.5	0.0	9.2	9.1	0.7	0.7	3.8	36.7	2.8	1.3	1.2	0.0	0.4	0.6	8.4	9.1	2.8	0.0	0.6	0.8	2.7	0.0	6.1	0.0	4.7	0.5	0.2	0.0	10.1	15.8	0.8	1.0	0.0	37.2	0.4	3.6	1.1	2.1	1.4	0.0	0.8	1.8	0.6	1.1	23.5	1.0	1.6	9.9	0.8	1.7	0.8
GGA3	KIAA0154	ENSG00000125447	"Golgi associated, gamma adaptin ear containing, ARF binding protein 3"	Q9NZ52	17	75236599-75262363	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022945, HPA024645"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA022945: AB_1849639, HPA024645: AB_2671629"	"unprognostic (9.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (8.26e-4)"	"unprognostic (1.20e-1)"	"unprognostic (4.60e-3)"	"prognostic unfavorable (2.77e-6)"	"unprognostic (6.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.63e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.68e-3)"	11.7	9.8	9.0	13.0	8.4	15.7	10.8	7.7	11.4	12.3	4.3	12.4	11.5	10.8	9.8	17.0	10.2	11.4	12.8	8.4	6.7	11.1	11.6	13.0	17.5	8.9	7.6	15.3	12.3	9.1	9.0	14.6	7.6	10.1	11.7	6.7	12.3	7.8	22.7	15.7	15.0	11.8	6.8	19.6	13.0	11.5	7.8	12.8	9.9	10.5	19.0	11.6	12.2	9.4	16.9	21.1	19.5	11.9	21.5	17.9	22.8	18.5	13.3	24.9	21.2	24.8	18.4	21.4	8.2	16.4	19.9	10.6	13.8	8.0	25.7	15.1	21.4	34.3	19.2	19.6	10.3	32.5	24.3	14.1	19.7	13.6	23.5	13.2	26.5	16.1	37.8	19.1	17.7	17.4	42.5	9.6	13.8	19.6	14.9	16.9	28.0	14.3	17.1	18.4	14.0	23.9	18.5	33.2	14.9	27.3	25.3	17.4	29.6	25.7	18.7	17.4	19.9	19.8	15.1	27.5	20.8	23.0	17.2	5.1	6.8	2.9	5.5	5.9	5.1	3.9	4.9	4.2	6.4	4.7	4.3	4.6	7.3	8.4	5.8	6.6	5.4	6.0	9.0	8.4	7.7	11.4	8.4	6.7	8.9	7.6	7.6	6.8	7.8	9.4	9.5	35.3	21.0	13.4	15.5	2.5	4.9	5.2	8.0	8.1	8.8	7.6	12.6	4.3	9.6	0.0	10.4	10.3	21.2	14.3	5.9	5.2	27.6	10.5	13.6	10.2	0.0	4.6	20.6	7.0	11.0	7.7	21.9	14.7	10.1	12.4	9.7	10.4	12.5	6.7	20.2	10.0	6.1	19.2	7.1	30.1	9.3	19.4	12.4	16.9	20.3	5.9	10.3	18.1	21.2	11.6	9.1	10.1	11.0	8.2	9.5	3.5	10.2	8.9	0.0	7.7	6.1	8.1	6.9	7.8	5.3	13.0	12.2	7.0	12.8	8.5
GMEB2	"KIAA1269, P79PIF, PIF79"	ENSG00000101216	"Glucocorticoid modulatory element binding protein 2"	Q9UKD1	20	63587602-63627101	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009706, HPA067455"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA009706: AB_1078996, HPA067455: AB_2685845"	"unprognostic (4.55e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.47e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.86e-3)"	"unprognostic (2.82e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.29e-1)"	7.5	8.0	6.2	5.0	5.9	19.3	7.4	6.3	6.7	8.7	5.5	8.5	5.0	9.0	2.5	9.3	10.3	3.1	7.9	6.1	5.3	8.5	9.0	8.2	6.7	6.2	5.8	9.5	9.8	5.6	8.3	3.6	5.6	9.0	2.4	2.1	8.8	3.5	9.2	9.3	9.3	3.3	5.2	10.7	8.2	13.4	6.2	8.1	15.5	3.4	4.4	8.0	7.1	5.6	13.8	8.3	9.9	8.6	4.7	4.3	13.2	9.3	5.9	14.7	7.7	25.9	10.1	10.9	9.5	8.1	10.6	19.2	7.8	13.7	6.5	5.8	8.8	8.5	12.7	12.6	6.4	8.1	13.6	6.2	12.9	9.5	11.8	6.2	6.5	13.6	12.6	7.7	5.1	14.9	19.8	17.8	7.1	16.3	13.1	21.3	10.1	10.1	6.1	12.1	14.8	12.2	17.0	14.8	10.0	4.5	18.1	13.3	8.3	16.0	8.7	9.7	10.4	14.7	12.8	17.2	9.7	7.5	10.7	0.0	0.8	1.4	1.7	1.0	1.5	0.7	1.5	1.5	0.8	1.0	1.6	1.4	1.7	0.8	2.5	1.0	1.1	1.0	6.2	5.9	6.3	6.7	6.1	5.3	6.2	5.8	5.6	5.2	6.2	5.6	5.6	3.2	5.6	9.1	7.3	6.0	11.2	3.8	5.2	5.2	6.4	5.6	3.2	4.3	5.0	3.7	0.0	4.1	6.3	9.3	1.9	4.3	29.3	6.9	5.2	6.8	9.6	2.5	5.3	5.4	6.9	4.2	5.6	10.3	2.5	6.0	4.6	6.6	4.5	8.4	4.2	7.6	2.0	3.5	3.8	6.9	4.1	4.5	1.8	4.7	3.2	2.4	4.1	2.5	4.8	6.1	8.2	5.7	7.8	12.0	5.5	3.5	4.2	5.9	6.6	5.0	4.6	22.2	9.5	5.1	5.4	11.5	8.9	3.5	6.1	12.1
GNG10		ENSG00000242616	"G protein subunit gamma 10"	P50151	9	111661605-111670226	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 75.7;Gastric mucus-secreting cells: 40.8;Macrophages: 49.7;Squamous epithelial cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 513.9"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 513.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"				"unprognostic (3.25e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.68e-2)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (3.62e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.14e-2)"	"unprognostic (8.91e-2)"	"unprognostic (5.78e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.42e-1)"	98.6	93.1	48.4	93.6	49.6	86.5	50.3	47.1	80.1	58.2	50.6	47.0	37.2	48.8	49.8	41.4	42.9	59.0	69.1	50.9	56.8	52.9	72.2	63.5	78.6	52.1	52.7	33.9	39.7	98.7	45.3	83.5	50.7	80.4	46.2	11.3	53.8	42.0	36.2	23.2	44.2	68.9	50.5	48.9	41.5	26.6	56.2	37.2	57.6	58.9	42.3	122.9	26.7	53.2	126.1	60.3	54.7	81.8	186.1	138.5	86.6	128.4	159.0	119.2	110.0	92.0	90.4	7.5	54.0	165.0	182.2	91.6	94.4	124.4	148.0	42.4	92.8	16.7	64.3	69.7	121.3	51.6	44.2	120.8	94.8	104.2	149.8	133.7	146.1	55.3	54.9	32.3	204.3	81.6	35.6	45.2	90.2	189.8	134.3	26.3	246.9	6.8	230.4	79.5	81.4	69.2	126.7	61.0	127.6	82.1	138.0	81.5	101.2	111.5	92.2	234.2	138.7	21.5	43.1	15.8	161.2	124.3	74.2	27.6	57.9	83.8	13.0	54.8	20.4	10.8	16.8	16.2	49.4	14.7	17.8	13.7	513.9	12.6	47.0	31.9	32.6	35.7	48.4	49.6	47.1	80.1	50.9	56.8	52.1	52.7	50.7	50.5	56.2	53.2	3.8	12.8	15.3	0.0	10.9	1.8	1.5	3.7	75.7	0.7	3.8	2.4	0.2	4.3	7.7	1.8	0.0	4.5	0.7	6.2	0.0	22.1	0.1	2.2	7.2	13.1	13.8	28.4	0.0	20.8	5.5	16.4	40.8	2.3	10.1	0.9	5.0	2.9	7.2	0.0	0.0	9.0	2.0	9.9	2.8	0.2	1.8	49.7	0.0	0.0	8.5	1.1	1.0	0.0	0.0	21.9	20.2	2.2	25.8	1.4	14.2	3.9	8.1	0.6	0.0	2.4	12.1	0.1	0.1	51.0	1.1	1.5	11.1	1.3	10.4	1.5
GNPTG	"C16orf27, c316G12.3, CAB56184, GNPTAG"	ENSG00000090581	"N-acetylglucosamine-1-phosphate transferase subunit gamma"	Q9UJJ9	16	1351931-1364113	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Mucolipidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 135.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004055	Approved		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		560000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum"	Cytosol	"HPA004055: AB_1079006"	"unprognostic (4.37e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.57e-3)"	"unprognostic (2.70e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.07e-2)"	34.8	94.0	33.5	19.3	41.3	25.0	34.5	37.8	43.3	31.4	43.2	27.9	17.7	29.7	28.9	23.6	28.5	23.7	28.7	32.6	34.8	37.1	40.9	28.4	27.9	38.8	35.5	35.7	39.6	40.2	32.9	20.9	39.3	29.9	16.2	15.6	42.9	20.7	34.6	37.2	30.9	14.9	35.1	38.3	34.8	21.4	35.7	13.3	33.9	16.9	14.4	28.8	26.5	44.5	13.3	21.2	15.3	26.9	135.2	50.3	20.1	38.3	49.6	14.9	28.4	19.1	37.0	8.4	43.0	51.8	22.5	24.0	9.2	22.4	7.6	27.0	20.2	11.3	73.9	33.0	57.6	18.2	43.2	67.3	38.4	14.2	20.3	41.6	27.5	15.2	13.7	48.4	24.6	30.7	8.7	18.7	14.4	33.9	11.8	30.5	12.9	38.6	37.3	17.1	12.0	15.5	38.5	39.2	28.7	8.5	36.9	27.3	27.0	29.8	25.5	24.6	19.1	50.6	40.4	17.7	24.4	15.6	20.3	70.5	77.0	49.5	43.3	74.4	39.6	32.1	36.7	40.8	61.5	31.1	33.4	30.8	32.0	32.6	73.9	52.2	46.9	49.7	33.5	41.3	37.8	43.3	32.6	34.8	38.8	35.5	39.3	35.1	35.7	44.5	39.7	41.7	41.7	17.3	31.9	20.9	26.5	25.4	46.7	15.1	34.0	42.9	9.4	37.1	43.2	20.2	25.0	25.0	34.9	25.8	9.8	27.4	2.6	17.7	29.8	25.6	9.1	9.9	22.7	14.5	20.3	49.7	47.4	23.7	24.6	21.1	30.7	35.2	50.2	8.4	20.5	18.0	14.2	43.4	41.7	4.6	30.1	47.8	33.8	9.4	25.7	31.0	30.9	15.1	32.4	14.8	32.9	17.7	76.1	22.1	32.1	41.7	28.5	24.5	19.7	24.4	22.9	25.4	24.2	48.1	20.3	31.1	30.6	20.5	21.7	24.5
GOPC	"CAL, dJ94G16.2, FIG, GOPC1, PIST"	ENSG00000047932	"Golgi associated PDZ and coiled-coil motif containing"	Q9HD26	6	117560269-117602542	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019477, HPA024018"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA019477: AB_1849890, HPA024018: AB_1849891"	"unprognostic (2.48e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.22e-2)"	"unprognostic (6.77e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.01e-2)"	15.5	14.2	14.6	15.8	14.9	7.1	20.2	15.6	18.0	23.4	11.0	18.7	12.2	23.5	18.0	12.1	17.4	16.3	22.1	15.9	13.3	14.5	16.4	13.6	19.9	12.5	12.5	25.6	12.7	22.1	16.1	19.9	13.1	16.2	20.3	13.5	14.3	17.3	15.8	18.7	15.0	18.4	13.6	16.9	14.9	17.7	12.6	21.0	23.9	17.4	17.2	15.1	14.7	16.8	14.1	15.0	19.1	25.6	40.1	47.9	30.3	57.1	41.7	30.6	31.5	23.1	15.5	42.2	24.3	32.4	60.4	31.2	37.2	27.6	42.8	21.2	20.8	38.7	39.9	37.5	42.4	52.2	24.8	57.4	74.9	22.8	65.7	60.6	26.5	29.0	36.7	16.8	62.2	12.9	21.8	40.3	16.5	24.0	16.0	33.0	37.0	30.8	23.3	12.9	26.7	21.0	57.6	19.7	15.8	36.3	14.3	49.7	31.8	2.2	27.9	28.5	62.6	29.9	28.8	35.4	37.9	43.4	23.9	10.5	4.2	3.2	6.7	3.9	9.3	7.9	7.1	7.1	5.5	7.7	8.2	8.5	2.9	9.2	4.7	9.2	7.7	4.1	14.6	14.9	15.6	18.0	15.9	13.3	12.5	12.5	13.1	13.6	12.6	16.8	43.2	22.4	22.7	46.4	33.4	46.7	25.1	63.9	46.7	59.2	47.0	67.3	46.2	34.3	32.2	20.2	22.9	77.0	28.6	40.4	27.4	27.9	35.1	30.4	77.4	38.1	33.6	26.5	52.9	25.6	62.4	48.3	30.1	30.6	31.1	50.4	35.0	38.7	38.5	74.0	46.2	65.2	24.4	24.2	22.9	13.7	42.3	27.0	28.4	32.8	24.1	39.3	35.0	73.9	64.5	21.1	40.9	42.2	38.7	40.3	20.9	27.1	35.3	35.9	32.9	50.0	44.3	115.6	51.4	36.7	59.8	52.3	38.7	43.3	37.7	27.3
GORAB	"FLJ11752, GO, NTKL-BP1, SCYL1BP1"	ENSG00000120370	"Golgin, RAB6 interacting"	Q5T7V8	1	170532131-170553834	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027250, HPA027746"	Approved		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA027250: AB_10611253, HPA027746: "	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.75e-3)"	"prognostic favorable (1.39e-4)"	"prognostic unfavorable (5.26e-4)"	"unprognostic (8.48e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (7.83e-12)"	"unprognostic (2.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.70e-1)"	3.1	5.2	1.6	1.9	1.6	0.6	2.8	1.6	3.1	3.8	1.9	3.6	1.4	3.2	3.5	2.3	2.1	2.1	3.1	1.5	2.3	2.5	4.3	2.5	3.6	1.6	1.8	4.3	3.7	1.9	3.0	3.1	1.7	2.8	3.3	1.3	3.3	2.6	1.1	1.9	2.7	2.0	1.7	3.1	2.1	2.0	2.0	2.8	3.0	2.1	3.0	3.1	3.3	1.8	3.4	3.8	4.5	2.0	9.0	5.8	2.9	4.8	7.5	3.6	4.6	1.9	4.9	5.1	6.1	4.3	2.4	4.0	6.4	2.8	6.0	4.8	1.6	2.5	4.0	2.8	4.9	4.4	3.1	4.4	2.5	4.2	3.9	5.5	3.5	2.3	4.4	2.3	5.3	0.6	5.8	4.0	4.7	6.2	4.0	3.9	3.8	6.0	4.2	1.9	1.4	3.0	3.6	4.8	11.5	3.1	2.7	8.4	4.4	6.8	3.1	2.9	7.2	3.5	4.4	3.8	5.2	4.0	5.4	0.7	3.9	0.0	2.3	4.2	3.9	2.8	4.1	3.5	4.3	2.8	3.6	3.0	0.5	3.8	3.1	2.7	5.3	2.6	1.6	1.6	1.6	3.1	1.5	2.3	1.6	1.8	1.7	1.7	2.0	1.8	8.1	0.0	11.4	8.8	8.9	2.8	4.0	6.5	8.6	4.7	5.2	7.1	9.4	10.0	7.1	5.5	2.1	6.0	6.2	12.8	3.9	12.3	2.3	5.5	10.4	8.3	0.0	3.4	9.3	6.0	7.3	10.5	9.2	6.7	13.9	5.2	5.3	6.6	7.1	5.0	7.7	9.4	8.2	6.9	4.6	3.2	14.0	5.6	3.6	3.7	10.1	4.3	3.1	9.0	7.3	5.7	9.8	6.4	10.3	4.9	4.3	6.0	2.4	7.1	6.6	8.2	9.3	13.1	8.1	5.4	1.6	5.6	6.3	5.1	6.4	3.0
GPR89A	UNQ192	ENSG00000117262	"G protein-coupled receptor 89A"	B7ZAQ6	1	145607988-145670650	"Predicted membrane proteins"	"Ion transport, Protein transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA076096			Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA076096: AB_2686777"	"unprognostic (1.19e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.51e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.14e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.02e-5)"	"unprognostic (1.42e-1)"	"unprognostic (3.70e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.21e-1)"	5.9	6.7	6.0	3.7	6.0	4.1	14.1	8.6	7.0	11.9	6.2	8.7	9.8	6.4	6.9	5.9	7.6	8.2	7.0	6.3	7.3	31.2	24.7	5.7	5.7	7.3	7.5	4.2	12.9	11.7	3.4	7.1	8.4	9.5	11.8	4.3	6.9	7.2	6.7	4.7	11.6	9.7	6.5	3.3	8.5	14.8	6.9	8.1	10.6	8.7	8.0	8.3	2.3	6.9	20.7	11.6	18.0	9.7	35.1	34.3	19.2	23.0	25.8	29.3	33.2	27.6	24.4	13.4	13.2	26.0	14.3	20.2	19.9	22.4	25.8	21.5	15.5	9.8	15.8	14.2	29.3	30.5	6.7	36.4	26.5	21.9	28.6	12.7	21.9	16.2	23.7	30.2	40.6	29.7	13.1	11.5	23.5	36.3	25.4	15.5	21.0	48.7	24.8	12.6	7.0	15.4	30.7	36.8	16.6	30.1	32.4	20.0	9.6	27.1	6.5	24.0	23.2	15.2	33.2	17.4	20.6	16.4	20.2	3.7	5.8	7.1	9.2	5.7	9.5	6.0	7.1	9.9	8.1	3.0	7.3	6.5	1.1	9.3	7.6	6.5	8.2	5.0	6.0	6.0	8.6	7.0	6.3	7.3	7.3	7.5	8.4	6.5	6.9	6.9	6.1	22.4	5.9	16.0	13.7	7.6	10.1	17.7	15.4	6.9	10.2	6.3	13.9	14.3	13.2	14.7	12.5	20.1	12.1	6.5	0.0	13.6	13.6	4.8	6.0	6.5	13.7	24.4	29.0	20.2	21.2	9.1	12.8	5.6	5.7	5.1	7.9	9.2	9.3	3.3	24.3	11.2	20.3	5.1	4.0	8.6	9.6	7.3	10.6	7.5	9.0	7.5	17.5	14.1	19.7	17.1	6.0	7.2	20.9	8.5	24.3	13.7	8.0	6.9	13.1	7.3	8.2	45.4	24.6	10.1	8.5	16.1	14.6	6.3	10.9	5.7
GPR89B	"GPR89, GPR89C, SH120"	ENSG00000188092	"G protein-coupled receptor 89B"	P0CG08	1	147928393-147993592	"Predicted membrane proteins"	"Ion transport, Protein transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA076096			Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA076096: AB_2686777"	"unprognostic (7.78e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.15e-4)"	6.1	7.1	5.3	0.2	5.0	3.1	6.4	7.7	8.2	7.7	5.6	5.4	1.7	6.8	2.5	5.7	6.2	1.8	5.6	5.2	5.4	12.5	7.2	5.4	1.4	7.9	6.6	6.6	4.4	3.1	4.8	2.1	8.6	6.2	2.2	2.0	7.3	2.5	8.8	8.5	7.0	1.1	5.5	5.0	6.4	10.5	5.8	2.6	4.8	6.0	1.3	6.3	6.2	7.2	5.8	0.3	3.5	3.8	5.9	4.1	6.5	4.4	1.8	6.3	9.1	7.7	4.3	4.8	5.1	5.7	4.8	5.4	7.7	0.8	5.3	5.9	6.8	6.6	2.1	4.1	6.3	0.4	3.0	2.0	9.0	5.6	10.4	2.2	3.4	8.2	2.7	8.5	3.5	12.3	9.8	4.4	5.9	6.4	4.4	3.9	9.8	6.8	6.4	5.8	3.0	2.8	9.0	2.2	5.0	5.2	7.2	4.0	1.8	2.5	1.4	2.6	6.5	17.6	11.2	8.0	5.6	4.1	2.8	3.5	2.5	2.4	2.3	1.9	3.3	2.2	3.2	2.4	1.8	3.0	3.1	2.7	1.3	4.4	1.5	2.0	2.6	2.1	5.3	5.0	7.7	8.2	5.2	5.4	7.9	6.6	8.6	5.5	5.8	7.2	4.4	6.4	5.3	11.1	16.3	0.1	8.2	0.1	24.5	3.0	6.2	4.7	6.6	5.7	3.8	5.5	2.1	13.4	8.8	6.0	0.0	7.2	8.1	2.8	3.0	4.1	4.8	6.7	32.2	7.1	14.1	6.3	16.3	3.2	7.0	4.4	3.3	6.7	4.2	0.0	32.4	7.2	0.0	2.2	0.3	3.7	5.6	3.7	0.0	11.2	4.1	2.4	6.2	19.1	27.8	6.8	7.8	3.4	30.0	4.3	20.4	21.9	3.6	4.0	0.0	3.5	4.0	31.1	10.6	16.1	0.0	15.7	16.1	4.7	5.9	3.6
GSTM2	GST4	ENSG00000213366	"Glutathione S-transferase mu 2"	P28161	1	109668022-109709551	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 61.0;Plasma cells: 28.4;Squamous epithelial cells: 27.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 116.0;HSkMC: 115.6"	"Low region specificity"	"Detected in all"							"CAB040547, HPA055972, HPA055973"	Approved		Supported	Vesicles,Cytosol		NA	NA		1200000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol	Vesicles	"CAB040547: , HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.51e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.04e-2)"	"unprognostic (7.31e-2)"	"prognostic favorable (9.70e-5)"	"unprognostic (1.51e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.14e-1)"	73.7	84.4	92.3	11.9	109.9	10.7	81.2	86.7	104.6	165.9	111.5	115.2	26.3	70.6	43.7	61.6	102.7	22.0	99.7	93.5	104.7	86.8	35.6	45.2	14.3	94.3	97.1	240.9	54.5	53.6	113.7	9.3	91.9	159.0	17.7	25.1	55.2	80.7	218.4	88.2	65.5	34.2	93.9	52.6	88.3	41.9	105.2	15.9	97.9	108.4	12.6	108.3	144.5	90.6	0.0	3.5	37.8	38.9	44.0	116.0	7.2	24.5	42.6	22.1	28.0	6.7	0.0	0.7	25.5	61.1	18.0	0.2	3.1	0.2	28.6	1.5	0.8	14.0	0.4	9.3	29.6	1.1	25.2	115.6	1.0	32.7	0.0	58.5	16.1	11.6	4.2	0.7	48.5	0.3	19.5	24.6	6.7	0.7	32.4	23.8	0.1	0.2	6.6	0.5	8.1	18.7	0.0	1.0	13.0	21.7	38.6	7.0	0.2	24.3	1.2	35.3	1.9	11.9	19.0	1.3	36.7	0.5	0.3	1.8	3.8	29.6	3.1	6.3	3.1	8.8	8.8	3.4	23.0	6.2	34.4	15.1	2.2	18.0	4.1	29.8	9.4	10.8	92.3	109.9	86.7	104.6	93.5	104.7	94.3	97.1	91.9	93.9	105.2	90.6	2.0	0.0	4.8	16.0	4.5	4.8	2.4	0.9	20.5	1.5	4.5	4.3	61.0	2.8	11.5	3.7	0.0	0.5	6.1	0.4	0.0	0.2	1.9	2.8	10.3	5.8	0.0	10.9	1.5	0.0	0.2	19.2	14.8	2.7	2.5	4.4	1.8	0.8	1.5	3.3	2.6	1.3	2.0	0.8	2.3	10.4	15.5	3.4	5.4	11.2	0.7	7.2	8.2	12.5	0.7	0.1	0.0	10.5	28.4	0.8	0.4	1.2	9.9	0.3	6.6	5.6	13.6	0.3	0.8	27.0	2.8	0.5	5.1	4.0	0.7	1.6
GTF2H3	"BTF2, P34, TFIIH"	ENSG00000111358	"General transcription factor IIH subunit 3"	Q13889	12	123633739-123662604	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004844, HPA053562"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA004844: AB_2667265, HPA053562: AB_2682191"	"unprognostic (1.07e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.13e-3)"	"unprognostic (2.29e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (6.72e-8)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.68e-3)"	"unprognostic (4.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.80e-2)"	10.4	9.0	6.1	12.9	6.0	11.2	15.6	5.8	6.9	11.7	5.0	14.0	10.5	12.9	8.9	15.4	15.0	9.7	10.7	5.8	5.2	11.2	14.1	9.7	16.6	5.9	6.3	11.2	5.6	11.7	5.9	12.9	6.4	13.0	16.2	10.1	7.3	11.3	13.8	12.8	10.6	14.2	5.8	10.4	11.7	12.2	6.2	16.0	13.4	11.1	16.1	11.4	8.2	7.1	42.0	21.7	27.6	35.5	33.3	37.1	38.9	31.2	38.2	47.1	31.6	23.2	21.1	48.4	37.4	43.0	18.8	27.8	46.2	56.4	56.2	41.4	32.5	39.7	19.3	33.3	46.8	80.9	25.3	39.7	42.2	38.2	85.9	35.3	34.2	59.4	60.4	15.7	42.9	27.4	40.5	27.2	35.6	29.6	39.9	41.3	42.1	27.4	24.1	40.1	24.8	21.8	41.1	19.8	32.1	30.1	55.4	48.1	22.9	29.3	22.3	45.9	50.7	28.8	42.3	47.6	33.7	40.5	34.3	11.4	4.6	6.0	7.6	6.9	7.6	5.9	6.1	8.1	7.0	5.7	8.7	8.0	0.6	10.7	7.0	5.9	6.7	4.1	6.1	6.0	5.8	6.9	5.8	5.2	5.9	6.3	6.4	5.8	6.2	7.1	20.8	22.4	24.3	23.5	19.2	11.7	12.3	20.9	27.9	16.2	12.6	15.2	7.4	12.8	22.3	12.9	10.4	26.3	13.8	8.4	3.9	12.9	8.6	18.3	24.7	11.1	6.7	21.6	26.6	11.0	23.4	17.1	16.8	16.7	24.1	19.9	12.1	16.9	17.2	16.8	27.8	12.3	6.1	12.3	7.9	4.3	11.8	15.3	1.8	10.3	16.1	21.9	7.2	15.6	23.1	10.8	10.8	11.3	17.1	10.5	6.1	15.8	20.7	13.7	13.1	18.8	15.2	32.6	27.1	25.7	13.2	23.7	14.5	36.2	15.7	10.4
GTF2H4	"P52, TFB2, TFIIH"	ENSG00000213780	"General transcription factor IIH subunit 4"	Q92759	6	30908207-30914106	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 12.5;Gastric mucus-secreting cells: 9.7;granulocytes: 7.0;Plasma cells: 9.2;Squamous epithelial cells: 13.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA074336			Supported	"Nuclear speckles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA074336: AB_2686679"	"unprognostic (7.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.79e-4)"	"unprognostic (7.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.66e-4)"	"unprognostic (7.74e-3)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.53e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.07e-2)"	12.6	11.1	5.4	6.6	6.6	4.7	11.4	6.2	7.0	12.8	4.8	12.0	1.8	12.8	1.9	14.4	10.6	2.2	9.3	5.6	6.3	14.6	21.5	10.1	5.6	5.2	5.8	12.2	11.0	6.8	13.4	3.5	4.9	10.5	4.0	1.1	8.6	3.5	13.2	9.7	10.4	1.9	6.0	11.9	12.4	11.9	6.3	8.7	13.5	3.8	3.7	11.7	11.7	8.1	20.5	15.0	15.9	16.5	16.0	11.6	17.7	3.3	5.3	5.8	9.6	14.9	9.1	12.3	8.0	21.1	11.1	16.6	10.7	21.4	10.6	18.6	2.5	10.0	11.5	13.8	10.1	0.0	17.0	18.5	20.5	9.8	0.0	10.3	6.1	9.1	35.2	11.3	11.4	25.0	22.5	16.9	18.5	10.4	6.1	28.5	0.0	11.8	20.7	11.4	9.2	4.5	0.8	11.5	8.8	9.8	16.2	13.7	6.8	15.5	21.5	16.4	28.6	11.1	13.1	9.3	8.9	16.8	7.0	1.8	1.1	0.9	0.8	1.2	0.3	1.3	1.2	1.3	2.5	0.6	1.2	2.2	0.0	1.1	0.6	1.2	2.1	0.3	5.4	6.6	6.2	7.0	5.6	6.3	5.2	5.8	4.9	6.0	6.3	8.1	0.6	0.0	0.0	4.2	4.0	0.4	0.1	0.4	12.5	0.7	1.1	0.8	0.0	1.5	0.1	0.0	2.1	0.4	0.5	0.4	1.9	0.6	0.1	1.1	1.0	1.8	0.0	4.2	4.6	0.6	0.4	1.4	9.7	1.0	7.0	0.8	0.7	1.1	0.3	0.0	3.3	0.0	0.0	1.2	1.2	0.0	0.9	1.5	1.8	1.9	0.3	0.5	0.0	3.5	2.8	0.0	1.2	0.7	9.2	0.1	0.1	0.9	0.8	0.3	0.0	0.4	1.9	1.4	0.4	13.8	1.0	0.3	3.5	0.4	0.6	0.1
GTF2IRD2B		ENSG00000174428	"GTF2I repeat domain containing 2B"	Q6EKJ0	7	75092573-75149817	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 14.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA056679, HPA056680"			Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA056679: AB_2683205, HPA056680: AB_2683206"	"prognostic favorable (3.27e-4)"	"unprognostic (1.32e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.19e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.90e-4)"	"unprognostic (1.54e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.31e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.65e-5)"	11.5	9.5	6.2	5.7	10.8	14.0	13.6	7.8	8.8	13.6	10.7	15.1	5.1	16.0	5.5	8.1	17.3	9.4	15.1	6.3	7.1	13.8	15.6	10.7	5.3	9.7	9.5	32.8	17.0	13.8	7.5	7.3	9.1	12.9	9.2	10.8	13.3	12.9	36.0	5.9	7.9	13.5	7.9	8.0	15.4	4.6	11.2	17.2	12.3	28.6	7.9	13.8	8.5	19.8	19.0	7.4	12.4	12.9	9.8	13.4	9.4	9.7	14.5	4.4	11.5	3.5	14.2	11.4	9.4	9.7	17.3	6.3	6.1	6.3	5.3	14.7	5.5	8.4	9.5	7.9	19.0	13.5	12.5	12.4	12.7	3.7	15.5	15.9	6.1	4.1	11.7	24.4	14.4	12.4	9.1	31.6	12.6	16.3	11.5	18.0	3.8	17.6	13.2	13.8	11.5	21.6	20.4	20.9	22.7	3.4	20.8	13.0	10.8	11.4	7.7	10.4	12.8	10.1	6.3	31.4	5.3	12.9	25.6	0.5	1.3	5.0	1.0	1.8	1.5	14.8	1.7	2.2	1.0	6.6	2.9	1.3	1.3	1.1	1.1	1.4	2.6	0.7	6.2	10.8	7.8	8.8	6.3	7.1	9.7	9.5	9.1	7.9	11.2	19.8	4.6	0.0	10.8	20.5	22.1	4.5	4.5	10.3	27.3	7.2	11.9	9.5	21.1	14.3	5.5	7.3	12.5	2.4	8.1	9.1	0.0	12.9	13.5	9.9	7.8	6.1	19.2	8.6	4.1	12.9	2.7	13.2	35.2	5.6	3.8	13.3	11.0	12.0	2.6	13.5	7.2	15.1	10.2	8.1	5.4	4.4	27.4	4.0	21.4	5.6	6.0	6.5	9.2	15.6	27.0	14.8	14.6	17.0	23.4	4.6	10.2	3.4	13.8	13.4	13.1	11.3	10.7	2.5	1.5	22.2	4.3	3.0	13.0	6.0	14.3	3.6
GTPBP10	"DKFZP686A10121, FLJ38242, OBGH2"	ENSG00000105793	"GTP binding protein 10"	A4D1E9	7	90335223-90391453	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021076	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"			"HPA021076: AB_1850411"	"unprognostic (2.74e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (6.76e-5)"	"unprognostic (8.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.72e-3)"	8.5	7.2	3.2	8.9	3.2	6.5	10.6	5.3	5.7	7.0	1.9	8.8	8.8	7.6	6.4	8.2	6.3	5.6	10.1	3.0	4.3	12.5	18.7	5.7	11.0	3.3	2.8	8.6	7.6	8.1	4.5	6.1	4.0	6.9	9.6	7.2	6.1	5.3	12.3	6.8	7.1	7.1	3.9	7.3	10.7	11.3	3.5	12.7	9.8	10.0	9.7	9.5	5.6	4.3	33.9	21.1	14.1	21.3	17.1	15.3	23.2	21.2	13.9	19.5	15.4	31.1	25.0	42.2	34.6	14.5	41.6	21.3	32.4	28.3	25.3	26.5	16.6	17.4	12.8	16.4	16.3	51.0	14.9	18.3	12.1	32.4	64.3	15.5	11.5	35.0	64.8	30.1	17.6	34.6	35.8	14.5	17.4	30.8	25.5	22.7	41.3	35.2	14.3	18.4	17.4	16.3	27.2	41.3	41.2	20.1	20.0	21.9	21.1	27.3	31.9	48.9	41.2	22.6	30.7	59.3	20.5	35.4	29.5	23.6	5.3	9.4	6.3	7.4	10.9	11.7	10.2	7.7	6.4	9.2	10.8	10.2	5.1	7.8	4.5	5.7	13.3	5.6	3.2	3.2	5.3	5.7	3.0	4.3	3.3	2.8	4.0	3.9	3.5	4.3	11.0	12.8	21.1	21.5	17.6	5.9	8.5	13.5	9.6	12.6	9.8	11.0	14.3	7.2	17.0	16.5	14.6	7.6	9.7	6.2	13.7	8.7	21.8	8.8	12.1	9.4	9.6	12.8	29.7	15.8	7.2	10.8	10.2	8.9	12.0	12.7	8.6	14.3	6.4	5.0	35.5	7.4	14.2	7.5	6.0	4.4	9.3	7.4	7.2	42.2	7.4	11.2	9.2	36.7	50.8	10.2	4.9	9.4	7.4	8.4	7.8	21.8	15.3	12.4	6.6	18.9	10.5	26.2	18.9	12.0	6.1	6.7	15.5	15.6	9.1	8.4
HACD2	PTPLB	ENSG00000206527	"3-hydroxyacyl-CoA dehydratase 2"	Q6Y1H2	3	123490820-123585053	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SiHa: 249.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB019282	Approved					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"			"CAB019282: "	"unprognostic (3.04e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.65e-3)"	"unprognostic (5.36e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (9.59e-5)"	"unprognostic (6.90e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.59e-2)"	68.3	11.2	16.2	16.5	23.5	8.7	22.8	19.3	20.5	14.6	8.4	26.7	29.9	16.6	17.7	18.9	13.1	16.7	10.7	16.0	19.7	24.1	48.4	19.4	21.3	19.4	17.1	12.5	17.4	21.3	7.7	15.5	21.0	29.5	27.7	13.8	16.4	12.9	5.3	32.5	25.8	16.7	17.8	12.3	21.2	19.0	16.6	14.9	19.4	8.4	28.6	14.7	17.1	33.9	76.9	42.7	28.8	21.1	88.3	19.5	106.5	53.7	22.2	54.6	39.4	87.9	66.1	44.1	37.8	51.7	63.3	162.8	52.3	67.4	57.3	28.3	17.5	30.8	37.3	68.9	28.7	41.2	29.4	27.2	169.7	26.5	73.6	85.2	29.0	30.0	6.3	42.7	33.4	59.8	19.7	12.3	37.2	92.7	37.4	29.6	31.6	46.9	66.5	48.6	50.5	15.8	249.9	52.7	34.6	41.5	54.9	21.1	22.7	56.8	42.2	57.5	53.1	25.2	34.7	35.9	25.5	28.5	31.1	0.7	1.6	1.1	1.5	1.2	2.2	1.5	1.9	1.9	2.8	2.0	1.8	1.7	0.5	1.3	1.0	1.6	2.5	1.2	16.2	23.5	19.3	20.5	16.0	19.7	19.4	17.1	21.0	17.8	16.6	33.9	19.8	6.4	43.1	8.8	17.5	0.0	28.7	0.0	23.9	9.5	27.8	21.5	13.5	22.8	15.5	46.0	6.2	21.5	18.9	29.4	7.9	15.4	19.8	22.3	14.9	17.0	15.8	15.4	34.3	18.7	16.5	17.3	25.0	35.7	3.8	17.1	16.8	47.5	22.9	1.7	29.7	16.4	0.0	24.2	0.0	10.4	11.5	25.1	0.0	12.2	19.6	14.5	19.6	25.1	32.6	19.6	16.6	17.7	15.0	40.6	33.8	17.8	2.9	13.9	6.6	14.8	11.3	10.5	24.8	35.1	0.0	6.7	14.2	11.8	19.9	33.2
HARS2	"HARSL, HARSR, HO3"	ENSG00000112855	"Histidyl-tRNA synthetase 2, mitochondrial"	P49590	5	140691430-140699305	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035941, HPA075303"	Approved		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA035941: AB_10671237, HPA075303: "	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.15e-2)"	"prognostic favorable (6.19e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.30e-3)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (7.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.31e-2)"	19.6	24.6	14.0	13.8	14.2	14.4	18.9	13.7	14.2	22.0	16.8	23.5	16.6	19.5	15.0	20.0	18.4	9.8	27.9	14.0	14.2	23.3	19.3	16.0	15.1	14.1	14.0	21.1	15.6	20.8	20.8	14.2	14.4	20.2	22.3	11.5	17.5	13.4	35.0	21.1	20.9	14.0	13.8	26.9	20.4	14.8	14.3	15.2	19.0	28.4	16.1	21.1	20.6	15.7	20.9	46.2	19.6	50.6	21.9	28.6	32.3	26.3	29.8	36.1	31.4	42.7	25.5	26.3	41.3	29.3	35.5	25.9	27.3	49.4	33.2	26.6	22.4	19.1	45.3	28.6	20.9	26.1	27.1	27.0	32.9	35.3	39.7	29.4	26.5	27.4	18.0	24.1	35.6	26.6	25.7	32.1	22.6	15.7	28.9	25.8	19.9	26.8	33.9	48.1	27.0	38.9	38.1	61.0	54.2	28.5	54.0	25.5	32.5	32.4	17.8	18.2	35.2	23.6	37.0	25.2	25.4	29.5	32.9	37.7	13.1	28.6	19.1	18.9	21.1	16.9	18.4	19.2	14.9	14.8	19.0	20.6	15.1	29.3	15.0	12.1	20.1	13.3	14.0	14.2	13.7	14.2	14.0	14.2	14.1	14.0	14.4	13.8	14.3	15.7	8.6	3.2	5.8	2.6	12.3	3.4	3.7	7.8	9.6	5.5	5.9	5.5	20.4	7.2	7.8	5.5	0.0	20.3	6.6	8.5	13.7	14.9	1.1	5.3	8.0	9.7	7.7	9.9	5.5	16.1	18.7	6.3	13.3	6.4	2.5	11.8	9.7	7.2	10.0	0.0	4.8	8.7	18.3	8.2	6.2	2.3	9.3	7.4	3.6	2.8	12.8	8.3	3.1	6.0	6.2	18.3	12.1	10.5	9.6	4.1	7.2	9.0	8.6	5.6	0.0	4.4	7.0	8.9	14.4	9.5	4.0	14.4	8.0	11.2	11.7	4.4
HAUS2	"C15orf25, CEP27, FLJ10460, HsT17025"	ENSG00000137814	"HAUS augmin like complex subunit 2"	Q9NVX0	15	42548828-42569994	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 36.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039965	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	Centrosome	"HPA039965: AB_10673025"	"unprognostic (5.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.69e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.33e-1)"	"unprognostic (6.81e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.62e-3)"	7.9	5.7	5.5	5.8	5.8	36.5	7.5	5.8	9.5	4.7	4.2	5.8	4.8	6.0	5.5	6.4	4.7	4.6	5.8	6.2	5.8	5.3	5.4	7.0	8.1	6.1	5.6	5.4	6.6	4.5	4.2	6.4	6.2	4.2	5.9	5.4	5.0	3.8	7.2	6.2	5.4	6.7	5.8	5.4	4.9	5.0	5.8	8.9	5.1	5.8	7.9	7.0	4.7	7.6	23.6	12.0	21.5	13.7	10.9	12.3	20.3	22.9	13.9	21.8	17.1	24.5	11.8	13.8	11.1	13.4	18.6	34.6	23.7	15.2	21.5	19.4	13.3	20.0	19.7	19.0	15.6	34.2	14.5	10.6	11.1	16.2	17.7	9.2	22.0	19.2	36.2	17.5	21.3	14.1	21.4	28.5	16.8	31.9	15.3	27.9	26.4	15.0	12.6	16.4	17.8	14.8	23.2	20.6	13.2	15.6	18.7	22.4	17.1	28.7	21.4	39.0	43.8	18.7	61.1	40.0	18.5	38.0	21.6	4.0	4.3	3.9	4.4	5.3	4.5	6.0	4.4	3.7	3.9	5.1	3.3	4.5	1.9	2.9	7.5	4.5	5.2	2.8	5.5	5.8	5.8	9.5	6.2	5.8	6.1	5.6	6.2	5.8	5.8	7.6	17.5	12.8	14.4	5.5	19.4	13.6	20.9	10.9	18.2	7.8	8.6	8.0	4.2	14.3	11.6	3.7	16.7	14.5	17.7	7.1	3.9	14.2	35.2	10.9	12.3	14.6	17.3	31.1	11.6	16.5	27.6	12.9	12.2	10.4	24.6	9.0	7.9	9.7	21.7	16.8	9.3	10.6	8.2	18.5	23.6	7.3	11.1	19.0	1.8	9.4	19.6	9.7	10.3	11.6	10.4	18.8	11.2	11.3	20.1	20.2	8.7	13.3	15.8	16.3	19.7	16.5	12.4	34.0	9.6	23.2	15.3	13.4	21.1	14.0	10.8	17.1
HAUS4	"C14orf94, FLJ20424"	ENSG00000092036	"HAUS augmin like complex subunit 4"	Q9H6D7	14	22946228-22957161	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029803	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"			"HPA029803: AB_10601428"	"unprognostic (8.47e-3)"	"unprognostic (3.52e-1)"	"unprognostic (6.47e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.32e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.70e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.24e-4)"	29.3	24.8	12.8	29.2	13.8	63.5	39.7	12.9	15.6	33.7	14.4	32.3	28.1	26.2	22.2	30.5	31.0	26.4	26.5	11.8	13.6	26.0	32.2	31.7	40.7	15.2	14.2	52.8	45.2	27.6	14.5	22.4	15.0	26.1	30.2	10.4	33.2	26.4	19.1	39.3	30.6	24.3	13.9	37.7	32.0	12.9	13.8	30.8	27.7	22.9	36.7	29.0	31.7	15.6	77.0	51.2	55.5	56.9	42.0	50.4	86.6	36.5	48.2	39.3	56.1	37.0	88.5	146.2	17.2	22.3	29.2	75.5	31.2	44.9	34.5	39.8	23.0	48.1	35.8	90.2	37.7	63.3	77.8	35.7	84.7	17.5	50.9	48.2	71.1	82.0	35.8	71.2	41.6	58.1	69.8	56.7	29.9	59.3	50.9	66.3	68.8	57.0	35.2	40.7	22.5	37.1	52.7	54.0	34.0	24.1	47.8	50.2	39.3	36.2	46.3	26.3	33.6	74.6	67.9	67.1	16.7	70.6	20.9	8.7	79.5	17.7	15.7	54.1	20.8	38.2	29.1	22.2	101.3	33.0	40.2	32.0	100.8	23.7	34.7	28.5	43.2	46.0	12.8	13.8	12.9	15.6	11.8	13.6	15.2	14.2	15.0	13.9	13.8	15.6	4.9	22.4	6.8	16.0	13.4	12.4	5.9	8.7	29.6	1.0	13.7	11.0	1.3	11.5	7.5	1.8	0.0	12.4	3.4	9.6	5.9	17.6	0.6	2.3	3.9	7.5	7.8	42.2	3.7	27.3	13.8	8.3	16.3	3.7	3.8	4.9	8.9	4.4	17.3	0.0	6.1	20.9	2.0	29.1	13.0	0.5	5.6	17.3	5.4	15.9	33.4	6.2	3.1	7.5	8.9	18.4	18.7	4.1	21.5	3.4	26.3	8.0	9.6	0.5	0.0	3.3	6.2	3.1	6.1	32.0	11.1	8.2	10.9	1.2	35.2	5.9
HEATR1	"BAP28, FLJ10359, UTP10"	ENSG00000119285	"HEAT repeat containing 1"	Q9H583	1	236549005-236604516	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046917, HPA062200"	Approved		Enhanced	"Nucleoli fibrillar center,Mitochondria"		NA	NA		470000	"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	Mitochondria	"HPA046917: AB_2679863, HPA062200: AB_2684709"	"unprognostic (2.61e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.34e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (5.82e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.80e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (8.08e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.00e-2)"	8.5	5.6	3.3	11.1	4.1	12.7	9.8	4.6	4.0	6.8	3.3	6.2	5.6	8.7	6.5	7.3	7.0	5.5	4.4	3.5	3.7	5.4	5.5	5.2	12.9	3.7	3.3	9.4	8.7	7.9	3.4	7.7	3.8	6.2	7.5	4.8	6.2	6.4	6.6	10.4	6.2	8.0	3.7	8.5	6.2	14.4	4.2	10.1	7.9	5.7	13.5	10.8	6.7	6.5	35.2	41.4	21.2	32.3	29.1	32.5	47.4	27.7	17.8	31.2	27.7	41.8	29.0	57.3	30.4	25.8	19.3	41.5	48.7	29.7	42.0	29.0	56.0	40.7	28.3	36.1	26.1	73.5	25.2	26.7	26.2	47.2	40.5	14.9	36.3	25.9	93.8	18.8	31.5	18.8	35.1	20.1	84.9	44.8	16.9	38.6	30.6	53.8	19.9	34.9	19.9	44.1	33.5	23.7	28.3	14.1	28.2	27.2	34.7	31.2	29.5	40.6	69.4	35.4	47.2	65.5	27.8	40.2	47.4	1.6	3.3	1.0	6.0	4.2	5.6	9.1	5.9	6.6	4.0	6.5	8.1	7.8	0.4	5.7	4.2	5.2	5.3	2.3	3.3	4.1	4.6	4.0	3.5	3.7	3.7	3.3	3.8	3.7	4.2	6.5	13.3	3.2	12.8	19.6	21.8	19.8	16.3	8.3	26.2	12.4	9.8	7.6	4.2	7.2	11.7	5.5	18.8	8.1	15.0	3.6	3.9	8.9	10.5	8.4	26.3	12.4	4.2	12.6	35.1	8.5	10.8	15.2	8.6	11.3	32.9	23.4	10.4	9.7	7.5	6.7	30.4	6.2	4.1	11.3	7.5	2.7	14.0	11.7	1.8	26.2	9.6	3.0	9.2	36.2	34.1	12.0	4.3	10.1	19.0	15.7	3.3	5.6	11.5	9.6	0.0	19.4	11.8	29.3	30.1	19.3	16.9	4.9	18.1	15.6	11.1	12.0
HEATR5B	"DKFZp686P15184, KIAA1414"	ENSG00000008869	"HEAT repeat containing 5B"	Q9P2D3	2	36968383-37084372	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 62.3;Inhibitory neurons: 58.9;Oligodendrocyte precursor cells: 57.3;Oligodendrocytes: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042025, HPA055639"	Approved		Approved	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		6800	"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles, Vesicles, Cytosol"		"HPA042025: AB_10959880, HPA055639: AB_2682870"	"unprognostic (3.11e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.07e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.70e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.33e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.80e-3)"	"unprognostic (8.69e-2)"	"unprognostic (4.18e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.95e-1)"	9.7	8.8	7.1	15.0	7.1	24.3	14.5	11.7	9.8	9.9	4.9	9.9	10.8	9.5	16.9	11.7	8.1	10.7	9.7	7.4	6.4	9.3	9.3	10.8	31.9	5.8	5.2	9.8	18.2	13.4	6.3	10.2	6.4	11.4	13.5	24.3	14.3	7.7	4.9	18.2	11.5	8.3	3.9	19.0	12.3	9.6	7.0	24.7	11.8	9.4	31.2	10.1	8.5	8.1	16.2	8.1	11.7	17.8	11.9	11.7	14.9	10.1	7.4	9.0	9.1	9.6	10.9	34.6	7.1	8.6	11.9	13.4	11.6	8.2	11.7	17.0	12.6	22.6	11.3	13.1	7.4	24.5	28.5	10.8	11.2	13.0	12.3	9.9	15.5	18.3	21.6	29.8	10.9	9.6	21.5	17.4	7.7	16.7	5.6	20.5	11.9	26.3	10.5	13.8	14.3	12.6	10.6	16.7	7.8	11.7	12.0	7.9	17.2	13.5	7.7	9.9	7.9	18.5	16.2	39.0	11.0	14.3	9.0	18.3	5.0	12.3	7.7	2.8	7.1	9.7	8.5	8.7	9.0	14.0	8.7	7.6	5.2	7.5	4.4	11.2	9.7	5.9	7.1	7.1	11.7	9.8	7.4	6.4	5.8	5.2	6.4	3.9	7.0	8.1	12.9	22.4	10.3	35.9	20.8	9.8	4.2	4.7	6.8	13.0	11.9	8.3	20.8	8.6	7.1	5.5	10.4	7.0	24.4	11.3	1.9	4.6	6.3	14.8	10.0	9.5	5.4	18.7	62.3	6.2	6.2	9.4	25.5	11.1	7.0	9.8	11.7	7.8	6.3	16.8	58.9	8.9	6.1	17.0	15.7	2.6	9.0	13.2	7.2	56.2	9.2	6.5	16.5	57.3	69.7	8.8	6.3	6.4	17.6	5.5	12.7	5.4	12.8	16.2	19.7	6.5	10.6	3.6	11.2	11.7	11.6	5.6	14.5	7.7	8.7	4.9
HELQ	Hel308	ENSG00000163312	"Helicase, POLQ like"	Q8TDG4	4	83407343-83455855	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036852, HPA036853"	Approved		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"	Nucleoplasm	"HPA036852: AB_2675349, HPA036853: AB_10672102"	"unprognostic (4.58e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.13e-3)"	"unprognostic (7.14e-2)"	"unprognostic (8.62e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-1)"	4.8	9.1	2.2	5.0	2.6	4.6	5.5	4.0	2.8	5.4	4.6	4.0	3.1	4.9	4.5	3.4	4.6	3.8	5.1	2.1	2.4	5.4	5.5	4.0	9.3	2.2	2.3	8.1	3.7	5.6	4.4	3.2	2.5	3.9	3.9	5.5	4.6	4.0	7.2	3.9	4.5	4.3	2.4	6.2	3.7	6.0	2.4	8.0	5.8	8.1	7.5	4.4	4.0	3.0	4.0	2.9	6.0	4.0	7.5	7.2	3.1	5.5	7.9	7.2	6.9	2.9	4.1	11.2	4.3	5.1	4.9	4.0	6.9	3.9	7.7	6.5	3.3	6.3	4.8	3.9	4.5	8.4	15.9	6.1	5.5	5.9	5.8	6.1	5.3	7.2	8.8	9.4	7.0	4.3	7.5	5.9	2.7	6.0	2.2	5.9	7.1	3.9	6.2	2.3	4.7	4.2	5.6	6.2	6.6	5.9	3.8	8.3	4.6	5.4	4.8	6.7	4.4	8.7	3.8	9.2	4.7	6.1	6.1	3.4	1.7	3.6	3.1	2.2	3.2	3.4	3.3	3.2	2.6	5.1	5.6	4.7	1.3	3.6	3.1	2.5	4.5	1.6	2.2	2.6	4.0	2.8	2.1	2.4	2.2	2.3	2.5	2.4	2.4	3.0	14.1	3.2	14.0	14.4	23.1	4.2	8.6	6.6	12.0	10.2	6.7	9.0	12.3	5.7	7.7	5.5	8.4	10.9	11.4	4.5	11.7	6.7	28.3	7.3	10.2	10.2	0.0	7.8	17.0	5.4	10.3	11.1	4.1	7.7	7.6	9.8	10.0	4.1	10.2	6.7	21.3	5.5	4.1	7.2	5.4	8.9	13.1	9.9	7.2	20.6	10.7	7.8	17.5	10.6	15.7	4.4	8.3	7.9	15.8	5.4	7.6	11.8	15.9	13.8	0.0	11.2	11.9	24.3	12.7	7.0	3.8	11.5	18.2	17.4	5.5	6.1
HMGN4	"HMG17L3, NHC"	ENSG00000182952	"High mobility group nucleosomal binding domain 4"	O00479	6	26538366-26546933	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 39.3;Basal squamous epithelial cells: 38.7;Plasma cells: 51.5;Squamous epithelial cells: 34.8;T-cells: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA077364			Uncertain	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA077364: AB_2686835"	"unprognostic (1.91e-1)"	"unprognostic (2.48e-2)"	"unprognostic (5.88e-2)"	"unprognostic (8.81e-2)"	"unprognostic (4.10e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.02e-3)"	"unprognostic (9.01e-2)"	"unprognostic (6.07e-3)"	39.6	34.5	21.3	49.2	21.5	33.0	54.3	21.5	26.5	45.4	30.4	52.7	40.7	56.6	50.2	35.2	46.0	38.4	38.1	21.4	24.3	48.6	19.9	46.0	68.7	22.4	22.9	50.1	26.3	58.4	22.3	41.2	22.5	47.0	55.8	18.6	33.2	56.7	38.6	31.4	48.9	66.9	22.8	52.4	32.8	31.3	23.0	70.6	57.0	32.6	71.6	55.3	35.8	24.2	81.3	29.7	60.2	79.3	78.6	118.0	37.4	67.0	116.1	99.2	138.0	30.6	50.5	94.4	104.0	95.1	101.0	37.4	100.2	85.0	109.3	118.9	94.1	96.7	42.3	58.9	86.9	85.2	98.9	87.6	114.0	80.0	132.7	93.0	95.5	121.2	92.8	152.8	91.5	40.7	151.0	114.9	36.2	68.0	51.9	53.8	66.6	168.8	77.9	54.6	95.0	85.4	55.4	45.0	138.6	71.0	50.1	45.6	71.2	68.5	52.1	63.5	61.7	100.4	276.9	79.3	33.1	190.1	91.1	182.8	42.1	81.9	81.8	41.5	80.5	71.7	85.2	85.8	57.2	61.2	71.0	70.2	62.5	75.7	53.9	47.9	93.6	92.5	21.3	21.5	21.5	26.5	21.4	24.3	22.4	22.9	22.5	22.8	23.0	24.2	4.2	3.2	5.8	6.8	39.3	7.5	4.0	3.1	38.7	0.5	5.6	3.0	2.1	7.2	7.5	1.8	0.0	3.5	13.9	2.9	5.9	2.2	0.4	3.9	10.0	4.8	0.0	16.8	16.1	1.4	10.1	11.8	13.3	5.7	8.8	1.8	3.3	0.7	4.0	0.0	13.9	2.3	2.0	5.1	11.1	0.4	1.5	16.3	8.8	6.5	7.5	2.6	8.2	17.1	13.5	2.6	1.9	2.6	51.5	3.7	4.3	7.8	1.1	0.8	0.0	4.4	8.3	0.6	1.2	34.8	5.1	8.1	32.5	2.5	1.9	2.1
HNRNPL	HNRPL	ENSG00000104824	"Heterogeneous nuclear ribonucleoprotein L"	P14866	19	38836370-38852347	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016326, HPA051748, HPA052661"	Supported		Enhanced	Nucleoplasm		NA	NA		420000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB016326: AB_627736, HPA051748: AB_2681588, HPA052661: AB_2681905"	"unprognostic (5.33e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.67e-3)"	"unprognostic (8.99e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (1.45e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (1.96e-11)"	"unprognostic (2.17e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.39e-2)"	112.5	108.5	43.8	69.7	46.1	195.1	110.3	49.4	47.4	114.0	42.9	115.2	72.7	119.9	48.0	134.4	97.6	37.4	100.2	41.8	44.5	96.6	98.8	117.7	84.2	47.0	42.9	103.8	87.5	67.7	70.6	57.6	47.5	81.5	76.4	53.2	99.8	45.7	125.7	142.3	113.4	79.9	47.2	113.5	104.3	83.7	46.9	128.8	101.7	57.3	114.5	101.9	111.6	59.4	293.6	214.8	256.4	157.9	94.8	108.7	257.7	233.3	138.9	187.1	177.4	229.9	189.7	436.8	196.2	130.5	152.1	167.0	299.6	228.9	270.7	354.4	231.0	349.9	128.3	205.9	101.2	334.0	228.2	122.7	106.9	187.1	182.1	108.8	209.4	186.7	353.7	200.0	197.6	216.0	347.7	202.9	307.6	186.6	185.6	440.8	296.4	271.7	212.1	203.8	218.6	226.0	225.1	157.7	90.0	172.2	213.4	176.7	207.1	194.9	238.1	184.2	349.4	224.0	312.5	473.1	128.4	293.1	220.0	1.2	1.9	1.2	2.6	3.0	2.0	1.7	2.0	1.7	2.6	2.2	2.0	1.7	1.9	1.8	2.5	5.1	2.6	1.1	43.8	46.1	49.4	47.4	41.8	44.5	47.0	42.9	47.5	47.2	46.9	59.4	62.2	22.4	53.8	40.1	105.1	35.4	52.1	18.0	135.5	76.7	63.6	47.6	22.9	31.5	29.1	22.0	64.6	42.9	100.0	59.0	7.9	37.4	15.9	61.2	64.8	48.7	62.9	83.3	38.0	44.1	35.3	57.0	91.7	88.4	39.3	33.8	43.5	63.0	27.4	33.7	39.0	70.4	12.2	63.7	35.1	11.7	28.3	60.3	26.6	31.9	42.4	39.0	48.4	31.2	56.3	44.1	45.6	22.6	123.0	55.6	55.4	23.9	25.5	78.7	19.7	64.1	59.0	25.5	22.1	117.6	47.5	52.3	95.0	42.4	70.2	41.9
IFITM2	"1-8D, DSPA2c"	ENSG00000185201	"Interferon induced transmembrane protein 2"	Q01629	11	303655-309397	"Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 920.0;NK-cells: 1350.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 23410.9"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 23410.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 424.6;HHSteC: 547.7;HMC-1: 494.9;HSkMC: 710.9;NB-4: 603.3;U-937: 485.2"									"HPA004337, HPA044731"	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA		450000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Cell Junctions"	Nucleoplasm	"HPA004337: AB_1851427, HPA044731: "	"unprognostic (2.39e-2)"	"unprognostic (2.69e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (2.37e-9)"	"unprognostic (2.79e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.16e-2)"	1086.2	307.0	90.3	258.0	90.2	177.0	681.0	89.6	116.6	785.6	101.4	358.6	40.9	702.8	52.1	237.2	903.8	97.4	619.6	92.0	97.9	703.1	1288.5	1069.9	99.9	94.4	89.4	650.1	211.1	112.0	200.6	145.3	94.9	406.1	41.8	27.0	228.9	102.5	195.9	236.7	305.6	200.4	92.8	1402.1	304.3	123.0	95.4	29.8	437.7	132.8	105.8	493.1	496.6	95.1	32.2	65.4	313.1	2.9	137.2	358.3	0.9	106.8	65.1	27.0	63.3	1.7	206.9	2.7	126.6	424.6	0.4	68.5	1.1	9.3	9.0	1.8	41.1	75.1	102.6	117.6	547.7	124.1	494.9	710.9	2.3	5.2	3.3	64.4	51.2	22.5	5.2	210.5	11.6	129.9	2.5	603.3	36.4	5.3	229.4	101.0	29.9	1.1	181.6	0.4	0.8	7.0	65.4	74.9	34.5	5.3	86.7	69.8	338.3	5.7	26.8	36.1	1.4	4.5	5.0	3.3	14.5	485.2	18.1	2706.4	537.4	3789.5	666.6	1421.9	480.8	846.9	590.1	639.5	612.5	799.2	511.7	510.3	23410.9	1225.0	2199.0	279.0	411.7	1376.6	90.3	90.2	89.6	116.6	92.0	97.9	94.4	89.4	94.9	92.8	95.4	95.1	920.0	307.7	540.0	5.9	301.1	104.4	251.1	161.4	215.1	0.3	59.7	66.5	51.8	154.4	209.2	248.3	0.0	8.3	814.7	22.5	487.2	433.0	7.8	67.1	468.6	828.4	9.6	100.7	0.0	256.7	16.9	515.8	30.5	78.5	530.5	68.8	752.1	684.1	223.4	0.0	0.0	39.4	24.4	372.8	255.9	31.5	507.6	645.9	209.9	12.2	177.3	80.5	1350.1	0.0	0.1	161.9	149.2	223.8	123.0	126.3	4.7	45.3	104.8	1.5	315.5	442.5	568.4	8.4	10.4	22.8	83.0	23.4	667.2	61.8	44.3	102.4
INO80E	"CCDC95, FLJ90652"	ENSG00000169592	"INO80 complex subunit E"	Q8NBZ0	16	29995715-30005793	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043146	Approved		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli rim"	"HPA043146: AB_10794923"	"unprognostic (5.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.38e-1)"	"unprognostic (5.73e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.74e-3)"	"unprognostic (5.21e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.98e-3)"	25.9	22.7	36.6	22.1	39.0	33.1	26.4	38.8	43.1	31.6	29.1	35.3	19.9	30.8	29.2	29.7	40.8	24.8	25.3	35.7	36.3	21.9	26.4	28.7	32.9	40.3	38.9	38.0	25.5	39.9	23.2	24.8	38.0	24.1	36.5	13.4	32.4	34.7	30.9	27.6	24.0	40.3	37.1	26.5	24.8	27.8	38.3	42.5	33.3	29.7	46.8	30.8	25.5	42.5	79.1	95.1	59.6	88.0	54.0	45.6	55.0	66.9	75.2	95.4	93.8	54.7	85.7	101.6	100.4	75.3	63.0	52.9	73.8	109.8	80.0	106.7	88.8	50.2	57.7	79.0	63.5	66.4	59.5	53.5	89.1	112.1	87.6	54.9	115.4	137.5	64.4	55.6	89.9	114.7	142.0	87.2	120.3	55.4	55.1	176.9	72.6	104.7	73.2	39.5	90.8	111.3	36.8	65.1	83.7	48.9	80.8	53.0	62.5	68.0	48.3	58.7	84.6	58.9	120.2	92.9	77.3	96.2	97.9	1.5	6.1	5.1	4.3	4.1	3.6	4.5	3.4	5.0	4.9	3.3	3.2	3.3	3.0	3.5	6.8	5.1	5.2	21.4	36.6	39.0	38.8	43.1	35.7	36.3	40.3	38.9	38.0	37.1	38.3	42.5	32.8	38.5	19.6	15.0	27.6	14.8	19.1	34.0	37.0	15.1	23.5	22.6	0.8	22.8	24.1	20.2	20.9	36.9	27.6	32.9	33.2	29.3	1.9	17.1	13.3	25.4	35.2	14.9	6.6	39.3	40.1	20.2	45.9	19.2	15.8	16.4	23.9	18.9	27.8	8.4	6.9	28.4	32.6	22.4	15.0	5.2	26.1	24.0	19.6	14.0	25.2	20.4	29.9	9.0	14.4	38.0	39.7	27.8	35.2	12.4	48.2	29.8	19.7	20.9	26.3	17.3	23.1	44.4	23.3	33.6	17.2	18.1	30.9	13.9	31.6	12.4
INTS2	"INT2, KIAA1287"	ENSG00000108506	"Integrator complex subunit 2"	Q9H0H0	17	61865367-61928016	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049524	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"			"HPA049524: AB_2680804"	"unprognostic (4.57e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (1.52e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (2.42e-1)"	3.2	3.0	0.3	3.6	1.0	2.5	3.0	2.5	1.4	3.2	0.2	2.8	2.7	3.3	1.0	3.6	2.8	1.5	3.1	0.3	0.4	2.1	2.7	2.6	5.4	0.8	0.5	3.1	2.2	4.0	3.1	2.5	0.5	2.4	3.3	4.3	2.9	0.8	3.1	3.6	3.1	1.9	0.0	3.4	2.8	4.6	1.1	4.9	2.7	1.7	5.4	2.8	3.3	1.9	8.9	15.4	14.8	8.2	4.5	5.2	6.8	6.2	3.6	9.1	6.9	9.1	4.9	17.7	5.0	3.2	11.4	12.7	14.3	4.1	15.2	8.2	10.5	20.7	6.1	15.8	2.8	26.0	14.3	4.0	6.0	6.9	14.2	5.0	6.6	11.5	19.0	10.6	6.4	17.2	31.0	10.5	5.5	12.7	10.4	23.3	39.6	13.9	3.5	7.9	11.3	12.6	7.7	4.2	5.9	10.3	18.1	8.7	6.6	19.8	12.9	6.8	8.9	8.4	16.2	24.3	6.0	9.6	6.2	2.1	0.3	0.2	0.9	0.6	1.4	1.5	1.0	1.3	0.8	0.4	1.1	1.4	0.4	0.4	0.9	0.7	1.2	0.4	0.3	1.0	2.5	1.4	0.3	0.4	0.8	0.5	0.5	0.0	1.1	1.9	7.3	6.4	3.1	17.3	8.3	4.6	3.3	4.7	6.8	12.9	5.9	4.6	9.1	8.6	6.1	1.8	14.6	5.5	6.7	3.3	0.0	3.3	4.5	8.4	8.4	5.8	2.4	9.4	19.8	2.6	3.9	5.9	5.1	9.3	5.1	11.1	6.1	6.4	5.3	15.2	26.4	5.7	6.1	7.9	2.2	9.6	4.4	6.0	0.0	9.4	7.4	6.0	3.1	24.1	37.3	4.7	1.7	3.4	5.4	4.9	3.1	1.7	8.4	10.9	0.0	8.0	7.3	12.4	10.9	9.1	5.4	2.2	8.7	7.1	5.8	3.8
INTS9	"CPSF2L, FLJ10871, RC-74"	ENSG00000104299	"Integrator complex subunit 9"	Q9NV88	8	28767661-28890242	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 28.7;Excitatory neurons: 29.5;Inhibitory neurons: 31.3;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051615, HPA066822"			Enhanced	Nucleoplasm		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA051615: AB_2681552, HPA066822: AB_2685729"	"unprognostic (2.19e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.79e-2)"	"prognostic favorable (9.45e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.56e-3)"	"unprognostic (6.91e-3)"	"prognostic favorable (7.71e-4)"	"unprognostic (3.64e-2)"	"unprognostic (5.01e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.48e-3)"	"prognostic favorable (1.91e-5)"	"unprognostic (2.51e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	8.6	22.0	7.9	11.1	8.9	6.8	8.3	8.7	9.4	9.1	10.5	8.8	6.9	9.2	11.3	11.1	9.7	6.7	12.2	7.9	8.6	10.7	5.9	8.8	14.6	8.5	8.8	8.2	9.7	9.5	12.5	7.9	8.6	9.1	9.3	10.5	8.9	7.2	11.6	9.9	9.6	9.0	8.6	15.7	9.4	12.8	8.9	17.5	10.6	6.9	17.9	11.0	8.7	9.4	24.7	17.0	20.1	21.4	24.3	11.3	8.8	11.1	15.1	19.0	20.9	11.9	13.4	24.4	15.2	11.4	17.0	20.1	39.2	22.7	26.1	10.3	16.1	24.4	9.5	21.0	17.6	12.3	18.2	13.0	16.0	22.9	16.3	10.2	23.8	34.5	52.2	13.7	12.8	13.5	57.5	22.3	27.4	28.8	10.9	36.5	23.3	12.8	13.4	16.8	14.4	26.4	11.5	14.8	20.5	16.0	14.4	13.8	14.1	10.9	27.6	18.7	14.2	7.0	5.3	29.8	16.8	20.3	15.8	17.0	20.6	19.0	17.3	23.0	16.1	18.0	15.1	19.3	29.1	19.5	13.4	14.5	8.3	25.1	17.4	15.4	20.3	12.0	7.9	8.9	8.7	9.4	7.9	8.6	8.5	8.8	8.6	8.6	8.9	9.4	3.6	6.4	4.2	28.7	10.9	2.3	2.4	4.7	1.8	2.1	2.7	2.3	5.8	5.7	3.7	3.7	6.2	7.7	6.1	2.8	1.9	3.7	8.3	4.8	6.2	4.6	6.0	4.2	29.5	5.1	4.8	4.7	9.2	5.9	0.0	6.7	3.9	2.5	7.5	1.7	31.3	3.6	4.1	3.8	6.1	4.1	7.8	4.1	3.6	23.4	5.4	2.4	4.1	32.2	39.9	4.9	1.7	4.5	4.3	1.9	3.3	4.3	3.4	6.1	0.0	4.2	4.0	5.1	3.5	7.7	3.0	4.8	5.4	11.2	3.5	1.7
KDM4A	"JHDM3A, JMJD2, JMJD2A, KIAA0677, TDRD14A"	ENSG00000066135	"Lysine demethylase 4A"	O75164	1	43650149-43705518	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007610	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA007610: AB_1852006"	"unprognostic (7.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.18e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.40e-3)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (4.88e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.47e-1)"	"unprognostic (2.70e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.32e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.28e-1)"	10.6	20.6	10.7	12.2	11.3	12.1	12.8	12.7	12.4	15.1	11.8	18.0	28.0	14.2	13.0	14.4	18.0	11.8	10.0	10.7	9.3	12.7	14.8	14.7	15.6	10.7	10.4	19.7	12.7	19.1	10.9	11.2	10.9	13.7	18.5	19.6	13.3	11.4	11.1	21.8	22.6	14.9	10.0	13.9	14.4	5.7	10.7	21.6	17.3	15.7	18.0	13.7	11.8	11.2	25.1	22.6	36.6	63.6	34.5	32.6	25.3	23.4	26.4	34.7	34.6	26.0	21.7	32.5	23.5	23.4	26.3	25.3	45.1	27.6	35.4	23.2	37.8	46.5	33.7	21.2	32.7	33.4	35.9	35.4	43.2	33.7	42.3	26.6	37.0	27.9	23.5	45.1	25.5	19.6	26.4	28.2	59.9	21.5	23.0	35.0	42.2	23.9	24.3	48.8	32.1	29.1	50.5	34.2	63.3	52.8	20.0	111.5	28.1	20.6	32.8	18.7	31.9	20.7	26.7	29.2	21.3	27.8	39.3	10.2	4.9	9.0	4.4	3.7	4.9	4.3	4.3	3.6	4.1	3.1	2.9	2.6	3.0	4.1	5.2	3.6	4.9	3.5	10.7	11.3	12.7	12.4	10.7	9.3	10.7	10.4	10.9	10.0	10.7	11.2	5.3	9.6	22.3	12.7	14.0	9.2	5.3	8.3	25.6	20.1	8.9	7.5	7.4	8.6	8.2	1.8	37.5	8.5	10.4	19.3	5.9	8.6	9.7	11.2	9.8	9.2	12.0	16.4	21.3	6.7	6.1	9.8	23.4	6.9	13.3	12.0	7.9	13.1	8.9	32.0	17.8	16.6	10.2	9.7	5.5	6.1	12.5	7.9	1.8	5.6	11.6	10.9	13.4	17.6	23.8	10.7	13.5	14.7	14.3	5.4	17.3	6.9	25.4	23.5	6.6	11.1	7.7	0.6	2.9	21.0	4.7	8.1	9.5	13.6	15.4	6.0
KHDRBS1	"FLJ34027, p62, Sam68"	ENSG00000121774	"KH RNA binding domain containing, signal transduction associated 1"	Q07666	1	32013868-32060850	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005355, HPA051280, HPA056813"	Supported		Enhanced	Nucleoplasm		NA	NA		110000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB005355: AB_631869, HPA051280: AB_2681417, HPA056813: AB_2683240"	"unprognostic (1.31e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (3.68e-5)"	"unprognostic (5.01e-2)"	"unprognostic (2.51e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.91e-3)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.03e-2)"	59.8	47.4	36.3	67.0	38.8	93.3	61.7	44.7	37.4	59.5	34.8	62.9	62.3	82.6	47.2	57.3	70.3	48.6	56.8	36.6	39.7	54.0	50.6	52.1	94.1	40.7	38.7	110.6	50.9	61.7	38.3	63.7	38.1	55.1	57.3	58.5	45.2	55.8	45.9	57.3	59.2	65.6	44.1	64.0	52.3	42.2	37.2	112.2	63.8	40.6	96.7	62.2	47.6	46.7	204.6	121.0	272.6	201.6	92.5	115.4	159.5	120.7	152.1	221.5	185.5	136.2	178.1	302.9	131.5	153.5	128.4	139.2	221.9	165.1	225.6	181.7	188.8	191.1	111.8	188.0	121.5	256.2	123.8	127.6	92.7	168.9	132.8	145.6	212.6	183.1	251.0	136.5	172.6	132.6	379.2	218.7	277.0	127.3	144.3	300.1	230.2	257.7	156.0	203.7	185.7	241.7	175.7	148.8	157.2	192.9	177.3	183.7	160.5	143.9	154.5	155.3	205.9	140.3	163.5	296.0	149.2	202.3	112.1	5.8	5.7	5.9	7.8	8.9	11.7	9.9	9.2	8.2	7.8	8.0	9.8	9.5	5.0	8.0	7.5	8.9	9.3	3.0	36.3	38.8	44.7	37.4	36.6	39.7	40.7	38.7	38.1	44.1	37.2	46.7	130.6	38.5	77.4	40.8	181.9	147.6	200.3	58.8	183.2	94.8	111.1	109.9	104.4	97.2	89.8	69.9	50.1	192.7	131.9	87.9	84.1	96.2	24.7	122.5	154.4	125.7	117.8	131.6	46.0	103.1	234.5	132.4	103.5	127.0	128.1	224.5	99.6	64.6	120.8	63.9	48.1	101.1	28.5	141.9	148.4	21.7	111.2	139.2	108.5	36.5	142.6	142.6	105.0	43.7	59.6	107.1	76.2	124.1	141.8	136.4	74.5	123.8	93.3	89.3	92.1	140.4	157.9	198.2	122.7	173.8	130.6	173.5	161.7	138.7	152.0	167.1
KMT5B	"CGI-85, SUV420H1"	ENSG00000110066	"Lysine methyltransferase 5B"	Q4FZB7	11	68154863-68213828	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 128.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063648			Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA063648: AB_2685073"	"unprognostic (5.82e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (9.30e-4)"	18.6	16.5	16.3	15.7	17.5	28.5	27.5	26.2	17.6	20.2	17.3	22.3	22.8	26.2	19.0	17.2	18.2	15.0	15.9	15.8	17.2	19.7	22.4	18.1	19.2	16.1	16.3	22.4	22.8	20.6	15.6	22.3	15.6	22.0	21.6	33.4	23.4	16.3	16.9	21.7	21.8	20.7	14.8	17.2	20.7	20.7	16.1	27.0	31.0	16.7	20.4	16.5	17.6	21.3	25.3	18.8	37.6	24.5	8.6	21.4	40.8	17.7	12.3	21.7	12.8	59.7	39.6	20.5	30.2	24.4	21.4	13.0	26.2	20.6	31.6	23.2	15.1	19.4	21.9	24.7	31.0	27.7	25.6	21.3	41.6	26.2	27.3	20.0	21.8	20.3	29.3	23.4	18.7	52.2	19.6	28.9	40.4	50.4	13.9	31.9	29.4	55.4	16.2	24.2	32.7	39.1	27.5	27.4	128.7	20.3	35.1	17.9	23.1	29.2	38.9	22.5	18.4	29.5	13.8	43.0	18.4	17.3	31.8	10.0	3.7	16.5	4.4	5.2	3.1	3.2	4.6	5.4	3.5	3.8	5.3	4.8	10.9	9.6	5.3	5.4	4.1	2.8	16.3	17.5	26.2	17.6	15.8	17.2	16.1	16.3	15.6	14.8	16.1	21.3	39.8	60.9	61.3	0.0	32.9	0.0	42.3	0.0	50.7	50.0	45.8	34.7	0.0	25.8	25.4	25.8	12.5	27.4	37.6	32.6	21.5	27.9	22.0	42.6	46.3	31.7	25.5	31.4	0.0	32.7	29.6	26.3	37.2	44.3	22.7	40.7	30.0	37.7	17.9	63.9	0.0	26.6	0.0	32.4	0.0	21.0	28.0	27.7	0.0	0.0	38.2	29.6	43.3	0.0	0.0	37.1	25.7	31.6	34.8	43.7	36.4	22.7	32.1	39.6	32.9	44.8	28.6	45.8	58.9	38.0	0.0	51.7	30.7	31.8	25.1	53.6
KRI1	FLJ12949	ENSG00000129347	"KRI1 homolog"	Q8N9T8	19	10553085-10566031	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 177.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043110, HPA043574"	Approved		Enhanced	Nucleoli		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA043110: AB_2678321, HPA043574: AB_2678561"	"unprognostic (6.38e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.10e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (3.46e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (4.89e-10)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.02e-1)"	12.3	11.5	10.6	20.0	11.3	17.1	12.6	11.0	11.8	16.6	11.6	14.3	10.0	13.8	7.6	16.8	14.4	7.1	12.1	10.2	12.0	12.7	13.6	11.2	22.3	11.3	11.0	14.8	15.6	10.3	13.4	8.7	11.1	15.6	7.5	33.8	13.0	8.7	22.3	20.9	17.4	7.3	10.3	22.3	12.5	16.1	11.2	30.6	14.6	9.7	15.1	15.9	15.9	11.9	37.7	17.6	23.6	35.0	13.2	14.3	16.6	34.0	16.1	21.6	20.2	27.1	13.6	55.7	39.2	14.1	18.4	29.1	30.3	27.3	23.9	60.2	67.1	177.2	39.6	18.1	23.4	69.6	61.7	17.7	21.7	31.8	31.4	18.4	13.9	33.2	50.4	56.4	18.7	33.5	72.7	104.3	38.2	30.3	45.0	30.0	30.7	28.4	18.1	32.6	39.2	18.2	40.2	23.4	25.7	20.7	29.5	50.0	16.8	27.9	23.0	74.4	71.9	38.7	48.5	39.7	23.2	56.3	41.6	2.2	4.9	2.9	11.9	5.7	11.0	7.4	7.9	9.7	6.8	8.3	8.7	9.5	0.8	10.3	3.0	16.0	6.5	4.8	10.6	11.3	11.0	11.8	10.2	12.0	11.3	11.0	11.1	10.3	11.2	11.9	8.9	16.0	25.5	6.2	20.4	13.5	11.4	12.2	40.9	15.4	6.4	9.5	8.6	8.6	17.5	14.7	39.6	11.4	15.0	9.5	1.9	8.5	4.6	9.0	17.6	11.0	9.6	26.1	4.0	7.5	8.9	11.0	16.3	10.4	19.6	12.3	10.4	9.0	8.0	11.8	3.7	10.1	8.2	12.5	6.1	5.8	8.4	10.5	8.8	5.6	9.2	11.6	24.7	6.0	7.7	5.6	7.6	9.1	17.4	10.8	9.0	5.0	16.0	55.0	0.0	13.5	9.3	25.3	16.8	28.1	13.8	4.5	26.8	9.0	12.7	8.2
LATS1	WARTS	ENSG00000131023	"Large tumor suppressor kinase 1"	O95835	6	149658153-149718105	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031804	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"			"HPA031804: AB_10601688"	"unprognostic (4.02e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.29e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.43e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.65e-1)"	8.1	8.0	4.8	8.6	4.9	15.4	9.2	11.0	7.0	10.1	5.5	7.3	7.2	12.1	7.4	8.2	9.7	7.7	5.6	5.2	4.6	7.7	7.8	9.1	9.8	4.7	4.3	15.6	6.8	11.7	5.2	8.8	5.0	11.0	8.5	11.0	8.7	7.7	6.4	9.1	7.7	10.7	4.3	10.2	7.7	6.2	5.1	11.7	8.9	8.1	8.4	9.0	7.2	7.6	8.7	6.8	13.7	19.8	12.9	16.6	10.7	11.3	11.4	11.8	11.7	11.1	7.3	14.0	11.1	15.7	9.4	11.8	18.3	12.0	18.5	12.9	14.7	28.1	8.2	9.9	11.9	26.5	19.8	11.3	19.1	13.5	22.7	12.2	14.8	12.1	35.3	13.9	11.9	10.4	13.8	11.0	8.5	8.0	6.5	13.6	16.4	6.5	11.0	12.2	9.3	14.7	16.1	11.5	8.4	9.3	12.0	22.9	18.7	9.5	14.8	11.4	18.2	11.6	13.5	15.8	8.7	14.8	14.3	8.2	3.0	4.8	5.9	5.3	5.3	3.8	4.5	5.0	3.3	4.7	3.8	5.1	2.0	3.0	8.9	2.8	4.8	2.4	4.8	4.9	11.0	7.0	5.2	4.6	4.7	4.3	5.0	4.3	5.1	7.6	21.1	12.8	21.3	33.0	21.9	16.3	11.2	9.7	27.9	20.3	15.2	10.2	9.6	12.8	12.5	7.3	18.8	8.5	18.7	15.3	1.9	7.5	23.0	14.1	23.4	16.2	16.8	17.7	51.4	6.6	11.4	19.7	20.9	17.1	14.0	19.8	21.0	13.3	11.0	13.5	48.0	12.6	6.1	14.7	11.6	6.9	13.7	16.6	14.2	32.8	15.0	10.7	10.3	54.8	64.0	9.9	11.5	25.9	21.9	15.4	13.6	6.6	12.8	22.0	19.7	28.8	15.1	8.8	9.6	18.8	18.0	13.1	23.3	13.8	11.7	11.8
LDAH	"C2orf43, FLJ21820"	ENSG00000118961	"Lipid droplet associated hydrolase"	Q9H6V9	2	20684014-20823130	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034729, HPA034730"	Approved					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"			"HPA034729: AB_10603684, HPA034730: AB_2674304"	"unprognostic (1.66e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.34e-2)"	"prognostic unfavorable (6.09e-6)"	"unprognostic (3.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.44e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.97e-2)"	7.3	14.1	5.1	7.3	6.8	5.0	7.6	4.8	5.6	7.9	6.8	10.8	7.4	7.3	9.3	8.0	6.2	6.8	4.3	5.3	6.4	16.8	12.1	5.5	11.1	5.7	5.1	8.0	7.4	9.4	5.8	8.7	5.8	7.0	11.7	8.3	6.9	6.2	1.2	6.1	6.5	8.1	5.9	9.0	7.8	5.0	6.0	11.7	8.2	1.7	13.4	9.7	6.0	7.7	20.2	18.3	45.6	0.0	18.6	24.6	28.5	17.9	12.2	14.5	11.1	19.8	12.3	25.3	0.0	13.1	25.4	16.9	34.8	12.9	14.9	31.6	17.2	37.1	16.6	30.5	19.0	28.2	8.9	20.9	18.9	14.0	3.6	19.7	27.7	33.8	49.7	18.6	25.5	13.0	41.1	19.4	29.1	41.7	0.0	33.1	36.6	28.8	29.0	29.4	25.0	37.9	11.8	18.7	19.9	37.9	15.9	19.7	25.6	13.0	6.6	17.0	10.7	22.7	45.2	11.6	25.3	26.8	24.6	0.9	3.2	0.3	6.6	4.9	4.3	7.8	6.5	5.6	5.8	5.5	5.9	5.9	0.2	5.5	3.9	5.4	6.1	4.2	5.1	6.8	4.8	5.6	5.3	6.4	5.7	5.1	5.8	5.9	6.0	7.7	5.0	16.0	10.6	0.0	9.3	0.0	3.4	0.0	5.7	9.3	5.3	3.9	2.8	7.2	4.3	7.3	16.7	12.0	4.6	3.4	7.9	7.4	8.7	4.2	10.9	6.3	3.6	13.3	0.0	6.4	11.6	5.1	9.7	6.1	6.3	14.8	8.6	7.9	9.0	11.8	0.0	6.0	0.0	9.8	0.0	2.7	7.5	5.5	0.0	0.0	4.7	15.0	5.2	0.0	0.0	6.5	5.5	6.8	9.9	3.7	5.0	12.0	0.0	9.6	6.6	4.2	5.4	4.3	5.2	7.7	0.0	11.5	6.7	15.8	6.1	3.6
LEMD3	MAN1	ENSG00000174106	"LEM domain containing 3"	Q9Y2U8	12	65169583-65248355	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025078, HPA076986"	Uncertain		Supported	"Nuclear membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA025078: AB_10601908, HPA076986: AB_2686821"	"unprognostic (2.10e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.63e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.22e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (2.30e-4)"	"unprognostic (4.37e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.72e-1)"	9.3	7.3	6.6	10.5	8.0	20.8	10.6	12.2	9.4	8.6	6.9	10.4	9.6	12.2	8.8	8.1	9.3	6.9	7.2	8.5	6.3	9.6	9.5	9.3	13.5	6.0	6.9	11.9	9.8	14.7	5.3	7.2	6.4	9.4	10.0	16.6	9.3	7.7	8.7	8.0	9.4	8.3	6.9	11.4	9.7	15.6	6.9	13.6	10.6	9.6	12.3	8.9	8.1	7.7	19.7	10.9	17.1	17.2	11.8	13.6	11.7	22.4	12.0	11.0	9.5	13.7	12.4	53.2	14.1	13.9	8.5	25.8	18.5	16.0	15.9	12.8	21.4	21.7	10.2	10.5	9.0	33.4	15.1	9.9	16.9	13.1	17.6	15.5	13.1	14.6	28.9	24.6	15.6	11.5	17.5	17.3	23.5	8.9	11.1	40.6	16.8	26.8	13.8	21.4	17.8	10.9	22.5	22.7	14.0	16.4	22.6	26.0	18.1	13.4	14.3	12.7	15.7	17.5	17.7	32.3	11.2	16.1	16.8	1.0	0.7	1.4	1.5	0.6	2.0	1.8	2.0	2.0	1.0	1.9	1.9	2.1	0.8	1.6	0.9	2.1	1.9	0.7	6.6	8.0	12.2	9.4	8.5	6.3	6.0	6.9	6.4	6.9	6.9	7.7	21.7	38.5	21.0	29.7	29.0	32.1	19.4	10.4	14.8	20.1	15.3	11.3	14.7	8.6	13.5	11.0	18.8	8.0	32.7	20.2	0.0	10.3	2.1	16.3	18.0	17.4	14.9	16.8	50.0	13.1	4.6	18.5	13.3	19.8	22.2	12.5	14.6	13.3	6.5	16.8	58.2	13.7	12.2	13.7	16.4	3.2	15.8	16.4	17.8	49.6	16.1	20.3	17.5	53.3	52.7	14.6	14.5	12.4	23.6	18.9	7.8	4.3	19.3	21.5	6.6	23.5	19.2	43.3	35.3	17.6	39.1	14.4	21.9	13.7	11.8	22.9
LIN37	"F25965, lin-37, ZK418.4"	ENSG00000267796	"Lin-37 DREAM MuvB core complex component"	Q96GY3	19	35748361-35754519	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043253, HPA047809"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA043253: AB_2678391, HPA047809: AB_2680162"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (7.77e-3)"	"unprognostic (5.85e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.67e-4)"	"unprognostic (9.88e-3)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (2.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.35e-1)"	"unprognostic (5.14e-2)"	10.1	9.9	21.5	6.7	22.2	9.7	9.1	22.5	26.9	13.0	18.9	11.1	9.2	11.2	7.7	7.0	10.8	6.9	12.6	21.6	22.4	7.4	7.6	7.5	9.6	21.1	21.4	15.9	8.5	9.2	11.0	11.7	21.6	8.9	5.0	8.6	7.9	8.4	15.7	10.4	7.9	8.2	20.5	8.6	7.9	9.0	22.2	9.7	7.8	12.7	7.5	9.5	8.9	21.7	13.7	29.7	11.4	15.5	18.4	14.4	12.0	14.4	15.7	22.8	24.6	9.8	6.3	7.8	16.3	17.1	15.3	6.9	8.2	12.1	8.8	26.5	11.6	10.0	14.6	15.0	42.2	8.0	22.6	13.4	22.1	20.4	34.9	15.0	16.9	20.8	10.4	15.1	16.5	27.6	13.3	11.0	3.2	22.4	12.9	5.9	7.5	8.4	15.1	6.4	9.8	11.2	13.5	26.7	12.5	9.1	11.1	17.0	16.4	17.2	10.1	16.8	18.3	22.3	19.0	7.3	18.3	12.0	12.9	16.8	7.9	26.4	18.3	8.6	17.2	19.6	19.8	21.4	9.0	18.8	20.6	18.7	32.0	18.4	8.1	18.8	22.2	13.7	21.5	22.2	22.5	26.9	21.6	22.4	21.1	21.4	21.6	20.5	22.2	21.7	2.0	0.0	1.1	2.9	5.0	3.8	0.7	2.5	8.0	1.5	2.2	1.4	0.1	1.5	0.8	3.7	2.1	4.2	1.9	2.8	3.9	1.5	5.5	1.0	1.0	2.0	1.2	4.8	5.9	1.2	3.4	3.3	5.6	0.7	4.5	1.0	1.1	1.0	1.9	1.7	5.6	0.7	2.0	3.1	4.4	5.8	4.1	3.2	5.4	0.0	2.6	1.0	3.1	3.5	4.3	2.8	2.8	3.4	7.3	0.7	9.8	3.2	1.3	2.4	6.6	1.5	3.0	9.2	2.3	6.4	5.4	11.5	5.6	1.0	1.3	0.3
LMBR1	"ACHP, C7orf2, FLJ11665, ZRS"	ENSG00000105983	"Limb development membrane protein 1"	Q8WVP7	7	156668946-156893216	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 110.7;Inhibitory neurons: 128.7;Microglial cells: 99.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016592	Approved		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA016592: AB_1852943"	"unprognostic (8.81e-3)"	"unprognostic (1.73e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.77e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.44e-6)"	"unprognostic (3.35e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.10e-2)"	10.0	26.0	8.8	8.4	10.4	7.8	10.7	11.3	13.2	13.6	7.8	8.9	8.0	13.2	18.1	9.9	14.1	10.2	11.2	9.7	13.2	15.7	13.8	9.1	9.4	11.0	10.0	16.5	8.8	38.0	7.5	10.1	11.2	12.2	10.3	14.3	8.4	10.7	6.7	8.4	9.3	13.2	8.9	7.6	11.9	17.7	10.6	11.8	17.6	11.4	8.7	11.9	6.0	8.5	26.9	20.6	27.5	33.4	21.1	24.0	16.6	14.5	20.5	14.2	16.8	15.4	42.4	25.3	27.6	19.7	27.3	20.4	28.4	28.9	29.1	19.5	25.5	19.1	11.6	19.7	13.6	23.8	13.6	19.3	27.0	20.4	27.3	22.8	29.6	23.4	35.7	23.8	26.9	24.3	25.1	20.5	29.4	30.4	18.7	13.1	18.1	31.6	22.8	25.1	26.1	51.9	20.4	27.8	15.6	17.8	19.1	14.3	38.4	25.1	9.3	82.7	19.6	25.6	22.6	24.0	40.0	30.2	16.4	1.8	0.7	1.0	0.7	0.4	1.4	0.6	1.2	1.2	1.3	0.8	1.5	1.0	0.6	0.2	0.7	0.9	0.9	0.6	8.8	10.4	11.3	13.2	9.7	13.2	11.0	10.0	11.2	8.9	10.6	8.5	25.6	3.2	8.1	54.5	23.7	10.5	13.7	9.9	43.3	11.5	12.8	8.5	17.1	11.5	7.2	12.9	2.1	14.3	8.4	8.6	5.9	11.0	7.4	17.0	8.6	24.8	8.3	17.4	110.7	10.1	5.6	15.2	23.0	15.7	5.7	43.2	9.3	19.2	10.2	8.4	128.7	9.9	10.2	10.1	8.0	9.7	10.5	9.3	7.2	99.3	8.2	6.7	3.1	72.4	70.4	12.6	6.1	8.6	23.4	20.0	9.7	12.2	9.7	10.9	0.0	11.9	11.0	18.0	28.7	30.9	12.8	23.1	18.0	26.2	11.1	16.6
LMBRD1	"bA810I22.1, C6orf209, cblF, FLJ11240"	ENSG00000168216	"LMBR1 domain containing 1"	Q9NUN5	6	69672757-69867236	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Endocytosis, Gastrulation, Host-virus interaction, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 21.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016491, HPA019547"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA016491: , HPA019547: AB_2281256"	"unprognostic (1.44e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (7.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.68e-2)"	33.3	49.4	10.3	11.5	10.8	4.2	31.4	20.7	17.0	28.9	13.3	26.4	13.5	22.5	27.7	25.7	26.3	16.0	27.7	11.1	11.5	53.0	42.9	27.9	12.1	13.6	11.9	34.5	36.5	31.7	26.5	17.2	12.3	19.1	20.5	10.7	33.2	20.0	28.8	28.1	28.6	12.7	11.4	21.8	29.6	10.4	10.2	9.1	35.1	13.1	16.8	30.1	29.4	16.1	3.8	3.8	6.0	10.2	16.5	23.7	17.9	2.2	7.1	2.6	5.6	4.8	8.2	6.5	9.2	8.8	5.8	7.5	3.8	9.8	2.4	16.3	11.9	6.2	4.9	7.8	13.7	3.4	8.7	7.6	9.6	0.8	5.7	19.1	7.4	5.5	9.4	6.1	6.0	8.1	2.5	4.7	4.6	8.5	4.8	0.3	15.4	37.8	17.0	13.8	5.5	8.5	0.9	7.0	13.3	3.0	4.6	25.3	1.1	3.9	4.6	4.3	2.8	8.8	5.5	2.8	2.3	4.0	12.3	6.5	2.2	3.9	2.0	2.5	2.5	12.1	2.9	1.9	1.7	21.0	3.1	2.3	11.4	2.6	4.8	2.2	3.7	2.1	10.3	10.8	20.7	17.0	11.1	11.5	13.6	11.9	12.3	11.4	10.2	16.1	49.7	64.1	38.3	82.3	93.4	29.1	41.9	45.2	71.2	73.7	39.2	25.4	40.6	50.1	56.0	58.8	110.5	69.6	36.2	79.0	19.6	49.0	28.8	48.3	22.7	41.1	18.7	18.5	119.2	49.6	59.2	56.1	36.7	61.7	40.5	15.7	44.6	60.5	42.1	55.5	144.6	37.6	44.7	66.9	36.3	9.3	35.4	52.0	32.0	79.6	49.3	56.3	28.8	122.2	156.6	42.0	51.0	33.8	82.7	19.6	78.7	64.1	65.5	90.8	26.3	36.4	33.9	22.5	16.9	43.4	38.1	77.4	43.2	26.9	31.7	34.2
LRRC14	"KIAA0014, LRRC14A"	ENSG00000160959	"Leucine rich repeat containing 14"	Q15048	8	144517992-144525172	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021047	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA021047: AB_1853298"	"unprognostic (7.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.58e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.28e-1)"	"prognostic favorable (1.78e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.04e-3)"	8.6	13.1	10.4	6.4	9.9	7.5	9.7	14.9	11.8	15.6	3.1	15.0	7.5	16.2	5.8	14.1	13.1	5.7	10.9	11.8	7.1	11.8	11.9	9.8	9.3	9.9	9.0	12.9	16.2	8.3	16.0	4.9	9.4	19.4	5.3	3.3	12.0	8.1	11.4	13.1	13.3	5.6	9.1	14.5	14.2	11.7	9.1	7.1	16.8	5.0	6.6	14.6	12.2	10.8	18.2	36.2	9.7	15.8	10.2	8.3	13.8	15.9	6.8	12.6	10.8	15.9	21.6	14.5	16.5	11.9	7.7	19.4	15.3	15.8	5.7	19.7	34.8	21.9	42.7	6.9	9.5	9.3	17.3	10.1	13.3	12.7	6.2	10.4	10.9	16.6	29.2	17.1	12.4	22.3	34.9	12.2	7.9	15.8	51.8	29.6	8.0	20.9	7.6	15.6	26.4	14.7	24.2	19.3	11.2	5.7	29.8	10.3	11.8	21.4	37.6	19.0	23.7	9.5	6.0	18.2	20.1	21.4	13.4	1.6	7.2	1.6	8.3	6.8	8.0	7.8	6.2	7.8	7.2	7.9	6.7	5.6	3.8	11.4	6.0	8.4	6.7	8.0	10.4	9.9	14.9	11.8	11.8	7.1	9.9	9.0	9.4	9.1	9.1	10.8	6.3	6.4	3.1	6.5	10.9	6.4	5.0	3.4	9.1	11.5	9.8	9.5	4.6	14.3	6.0	9.2	2.1	6.9	6.9	10.3	5.9	5.4	2.8	6.3	6.8	7.3	5.4	8.4	3.8	8.2	6.6	5.8	10.2	6.4	7.0	11.2	8.9	9.8	7.7	11.8	2.8	8.1	2.0	6.0	4.0	3.9	7.5	4.4	1.8	8.4	7.4	9.5	9.2	6.6	3.3	7.3	4.9	7.9	11.1	8.3	6.0	7.4	7.5	7.4	6.6	5.0	6.7	29.3	22.0	6.6	5.8	5.5	9.4	16.8	11.9	3.9
LTB4R2	"BLT2, BLTR2, JULF2, NOP9"	ENSG00000213906	"Leukotriene B4 receptor 2"	Q9NPC1	14	24305734-24312053	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.7;skin 1: 46.4"	"Group enriched"	"Detected in some"	4	"Basal squamous epithelial cells: 18.2;Squamous epithelial cells: 15.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 15.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB022689, HPA029680, HPA072921"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Nucleoplasm	"CAB022689: , HPA029680: AB_10603013, HPA072921: AB_2686557"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.05e-11)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.19e-1)"	5.1	5.8	0.4	2.1	0.5	5.4	4.7	0.5	0.4	15.8	0.4	2.7	2.6	3.0	0.8	37.7	4.0	0.9	2.2	0.3	0.3	2.8	4.0	4.7	2.0	1.2	0.4	4.9	4.7	0.2	3.9	1.0	0.5	5.0	0.5	2.1	11.7	1.2	3.0	46.4	5.1	0.5	0.5	13.5	2.7	4.2	0.6	1.7	3.9	0.1	3.2	2.7	21.6	0.8	2.4	3.9	1.6	1.7	0.3	0.5	7.1	0.8	0.4	1.2	0.7	3.1	1.3	2.9	1.4	0.5	1.6	15.0	1.1	2.5	0.8	3.7	4.4	2.0	3.7	1.5	0.4	3.4	3.7	0.5	3.1	1.7	2.0	1.0	0.5	5.3	2.6	3.3	0.5	4.4	1.8	3.5	0.9	0.1	4.7	7.4	1.5	1.7	0.3	2.8	3.1	1.5	1.5	1.8	1.3	1.7	3.4	2.5	1.5	2.3	2.8	3.6	1.3	7.1	2.1	4.7	0.5	5.5	1.8	0.0	0.5	0.3	0.6	0.3	0.3	0.0	0.5	0.5	0.5	0.0	0.3	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.4	0.5	0.5	0.4	0.3	0.3	1.2	0.4	0.5	0.5	0.6	0.8	2.3	0.0	0.0	0.0	0.7	0.3	3.4	0.1	18.2	0.4	0.6	1.3	0.0	0.0	0.0	1.8	0.0	0.2	1.2	0.5	0.0	0.2	0.0	1.9	0.2	1.6	1.8	2.1	0.0	1.4	0.1	0.5	1.5	0.4	0.0	0.2	1.1	1.0	0.7	3.3	0.0	0.4	0.0	1.9	0.0	0.0	0.3	1.8	0.0	0.0	0.2	0.2	1.0	0.0	0.0	0.4	1.2	0.0	3.0	0.4	1.1	0.3	0.7	0.5	0.0	0.3	0.2	0.9	0.2	15.7	0.1	0.3	2.3	0.3	0.8	0.8
LUC7L2	"CGI-59, CGI-74, FLJ10657, H_NH0792N18.3, hLuc7B2, LUC7B2"	ENSG00000146963	"LUC7 like 2, pre-mRNA splicing factor"	Q9Y383	7	139340359-139423457	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051631	Approved		Approved	Nucleoplasm		NA	NA		28000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA051631: AB_2681558"	"unprognostic (1.07e-3)"	"unprognostic (2.71e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.54e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.48e-3)"	"unprognostic (3.54e-1)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.28e-3)"	38.6	32.2	43.0	29.9	43.4	79.4	46.5	45.0	63.4	51.9	37.0	40.4	26.0	40.4	39.7	44.4	46.7	33.0	40.8	41.2	49.4	42.5	49.0	34.2	49.5	42.2	41.8	50.8	46.0	40.3	26.1	36.6	42.4	46.4	35.2	43.6	38.1	37.1	62.3	49.3	37.3	35.5	38.6	40.0	40.6	35.8	43.4	62.7	60.8	41.4	53.6	41.9	45.2	52.9	65.7	37.4	79.3	73.6	53.0	43.6	58.0	74.4	71.6	71.5	74.6	41.4	61.2	108.5	43.4	60.7	44.6	46.3	96.5	75.7	100.7	51.1	94.7	92.5	56.1	41.9	44.8	150.2	75.4	38.6	93.6	67.3	81.9	49.5	58.5	56.1	119.5	57.1	78.6	62.5	180.4	140.9	65.2	87.6	53.1	107.7	77.7	98.7	81.9	72.7	68.2	65.2	82.0	82.5	75.5	59.3	55.8	59.1	56.0	54.7	31.8	61.1	68.3	86.5	88.0	230.1	60.5	143.8	74.3	10.7	9.4	17.9	17.7	14.3	19.8	16.0	17.3	18.6	12.8	14.9	21.3	18.3	8.7	16.3	17.1	13.2	19.0	12.3	43.0	43.4	45.0	63.4	41.2	49.4	42.2	41.8	42.4	38.6	43.4	52.9	53.5	54.5	56.8	0.0	63.0	0.0	74.8	0.0	72.8	54.0	54.4	45.1	0.0	35.8	39.6	38.6	52.1	77.0	48.5	16.5	54.8	45.1	18.7	31.4	43.1	46.8	21.9	102.9	0.0	38.5	74.3	48.2	57.1	32.8	60.5	37.7	42.1	58.5	43.9	43.7	0.0	29.0	0.0	42.5	0.0	8.5	53.1	41.9	0.0	0.0	46.4	46.7	43.3	0.0	0.1	34.9	18.7	67.7	68.6	62.0	34.6	40.8	37.2	49.2	59.2	54.9	45.6	74.1	68.7	51.5	0.1	82.4	63.7	43.0	28.0	56.2
MAT2B	"MATIIbeta, SDR23E1"	ENSG00000038274	"Methionine adenosyltransferase 2B"	Q9NZL9	5	163503114-163519354	"Metabolic proteins, Predicted intracellular proteins"	"One-carbon metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037721, HPA037722"	Uncertain		Approved	"Plasma membrane"		NA	NA		1100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA037721: AB_10672389, HPA037722: AB_10671718"	"unprognostic (1.22e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.06e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.19e-3)"	"unprognostic (3.57e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.37e-3)"	36.6	54.6	31.1	64.7	32.4	31.1	50.5	35.3	39.8	46.9	37.5	61.5	86.9	45.4	59.4	40.9	66.7	42.1	75.3	32.8	33.7	104.8	82.7	56.1	102.6	32.2	35.3	73.3	23.9	69.2	22.0	48.9	33.3	46.1	66.5	47.8	64.3	53.2	57.8	34.6	84.4	44.4	34.6	84.5	57.2	31.7	33.3	89.6	81.4	63.7	92.7	60.9	33.2	34.0	72.4	60.0	100.6	55.1	73.4	72.9	62.2	61.8	68.5	67.7	99.4	41.5	128.5	74.8	127.6	66.0	99.5	56.6	84.8	125.4	89.1	254.5	69.6	67.3	63.3	62.1	95.9	71.0	44.7	60.4	101.1	86.1	66.4	81.8	149.5	76.6	54.8	90.8	84.0	40.7	99.2	85.9	38.6	43.9	40.0	112.4	49.2	123.4	111.7	76.6	40.4	57.9	82.8	58.2	93.8	44.1	76.5	95.1	121.2	73.6	48.5	51.8	107.7	78.4	82.3	68.3	54.1	129.1	51.3	619.4	227.5	477.4	321.5	274.3	355.8	359.1	351.2	349.3	204.6	345.3	352.7	341.4	357.8	401.5	302.4	167.2	528.3	689.9	31.1	32.4	35.3	39.8	32.8	33.7	32.2	35.3	33.3	34.6	33.3	34.0	24.9	48.1	43.3	8.8	90.1	42.7	35.1	75.6	129.1	23.2	26.0	20.7	57.7	41.5	48.1	44.1	8.4	61.3	62.8	49.2	62.6	38.8	39.0	63.5	36.2	38.9	15.0	79.3	15.0	26.2	29.7	34.6	36.2	44.2	28.4	28.1	35.7	58.3	45.3	18.5	12.8	40.8	61.1	83.3	55.3	13.3	34.5	48.5	42.7	18.7	70.6	41.7	80.3	9.0	16.2	28.9	38.1	31.2	65.7	46.8	53.4	103.7	72.6	17.6	46.0	21.7	35.6	23.6	30.5	69.8	36.2	37.6	84.2	23.3	51.3	45.7
MBNL1	"EXP, EXP35, EXP40, EXP42, KIAA0428, MBNL"	ENSG00000152601	"Muscleblind like splicing regulator 1"	Q9NR56	3	152243828-152465780	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 537.7;Oligodendrocytes: 471.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016398, HPA035098"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB016398: AB_784435, HPA035098: AB_2674461"	"unprognostic (5.46e-3)"	"unprognostic (6.01e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (9.49e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (7.53e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.98e-1)"	116.4	35.8	18.2	105.0	24.9	90.4	48.1	22.9	22.3	76.9	18.9	69.0	43.6	68.0	30.1	65.3	38.4	75.2	63.2	18.7	23.0	31.5	47.6	78.1	138.4	25.5	20.1	45.1	24.3	26.5	11.8	29.9	26.0	55.1	71.1	17.7	32.3	66.0	188.8	61.5	58.3	116.5	25.0	92.3	40.5	14.9	25.2	108.4	31.8	131.0	135.1	78.4	32.7	32.5	133.8	107.8	17.3	38.9	132.5	135.8	12.7	163.3	131.5	105.6	87.8	48.0	76.3	136.3	81.3	230.8	32.8	59.7	32.1	94.5	155.0	106.9	43.7	149.3	52.2	22.7	73.8	180.5	104.5	63.8	50.2	121.9	94.0	80.8	219.5	54.1	77.3	180.5	103.6	45.9	169.0	66.0	7.2	38.9	85.4	170.5	53.0	171.6	53.7	66.3	13.8	15.7	71.1	38.2	69.8	6.2	53.1	270.5	186.6	143.6	55.1	96.4	142.7	186.9	115.9	154.6	83.8	220.6	79.1	95.3	53.7	90.1	79.4	61.7	84.4	56.2	64.5	66.5	70.1	49.7	80.6	70.7	78.4	79.6	54.7	24.9	62.6	104.3	18.2	24.9	22.9	22.3	18.7	23.0	25.5	20.1	26.0	25.0	25.2	32.5	175.5	150.6	193.7	179.2	252.1	213.6	49.0	25.9	156.0	28.5	51.8	48.0	179.8	52.9	89.5	38.6	64.6	26.1	266.0	164.7	21.5	36.0	2.6	64.0	92.2	142.9	47.3	160.2	258.6	63.6	9.2	122.9	78.0	68.5	162.6	31.5	90.0	91.5	60.9	32.0	185.5	68.8	14.2	216.4	195.5	9.7	89.5	235.0	103.2	537.7	249.4	18.2	230.7	224.7	471.9	57.3	90.3	71.5	181.3	61.2	121.4	42.2	63.1	84.1	98.6	102.7	145.6	4.3	12.7	149.4	243.6	14.8	340.1	46.8	80.7	50.1
MCM3AP	"GANP, KIAA0572, Map80, SAC3"	ENSG00000160294	"Minichromosome maintenance complex component 3 associated protein"	O60318	21	46235133-46286297	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Immunity, mRNA transport, Protein transport, Translocation, Transport"	"Acyltransferase, Transferase"	"Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021527, HPA032103"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA021527: AB_1853626, HPA032103: AB_2674152"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.76e-3)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.28e-1)"	16.8	12.0	10.0	20.3	11.5	19.7	13.6	8.9	10.7	14.7	17.0	15.1	14.0	16.5	8.3	14.3	15.2	14.2	15.1	8.5	7.8	13.0	9.7	16.0	21.0	10.8	10.4	17.6	15.4	16.9	9.2	16.3	9.5	14.2	15.0	12.8	13.7	13.4	41.3	13.8	16.1	17.1	9.4	19.6	15.4	14.1	11.0	21.7	16.0	28.7	21.5	13.6	11.2	14.6	38.0	36.3	41.8	45.5	33.1	41.4	38.0	40.8	48.1	37.1	30.2	33.1	21.9	53.6	32.9	43.2	40.3	21.9	55.9	34.0	32.7	55.7	50.8	87.9	35.0	25.9	29.6	40.6	47.7	31.7	28.7	51.2	35.2	25.4	40.7	31.7	107.3	39.6	43.3	21.1	43.5	26.8	72.3	40.0	30.2	56.3	26.6	48.9	17.8	34.1	35.2	37.6	52.4	33.7	39.0	31.5	46.0	41.2	51.6	39.1	29.7	33.1	31.0	71.8	86.2	33.0	35.3	38.0	51.8	0.6	2.0	1.6	2.3	1.9	2.4	1.1	1.3	2.6	1.9	1.6	1.2	1.3	1.2	1.1	1.1	1.6	1.8	2.1	10.0	11.5	8.9	10.7	8.5	7.8	10.8	10.4	9.5	9.4	11.0	14.6	17.3	9.6	18.9	28.1	21.3	7.0	7.1	9.0	22.2	21.8	13.8	13.0	4.7	14.3	12.7	11.0	20.9	11.4	20.6	17.5	1.9	11.3	3.5	16.8	23.7	14.8	12.0	18.5	28.0	14.2	11.7	12.8	27.0	17.7	8.8	20.1	11.7	18.6	15.4	16.8	34.2	19.2	10.2	19.7	8.4	4.3	18.3	18.6	10.6	34.7	24.3	9.3	16.5	37.2	35.3	15.9	8.6	14.3	21.6	14.0	13.8	6.6	15.5	21.7	19.7	17.9	12.9	19.7	15.0	21.2	10.4	9.3	19.1	16.0	17.9	7.9
MCM9	"C6orf61, dJ329L24.3, FLJ20170, MCMDC1, MGC35304"	ENSG00000111877	"Minichromosome maintenance 9 homologous recombination repair factor"	Q9NXL9	6	118813442-118935162	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.0;Microglial cells: 40.3;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031137	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA031137: AB_10602027"	"unprognostic (3.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.61e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.95e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.79e-2)"	5.7	4.4	2.5	5.7	3.3	12.7	7.0	2.4	2.9	6.8	3.5	5.1	4.9	5.3	10.2	6.5	5.8	3.7	3.4	2.2	2.5	6.6	5.0	5.2	7.5	3.2	3.2	5.1	6.9	5.3	4.6	7.0	3.1	6.8	5.7	4.1	7.5	4.7	2.6	6.5	5.8	4.2	2.8	6.3	4.9	5.7	3.0	8.0	8.0	2.1	7.1	5.8	6.9	3.7	4.2	6.5	10.3	11.8	4.2	4.8	7.3	3.9	7.1	5.4	6.8	5.2	6.7	12.1	4.5	6.2	3.9	12.5	7.1	4.7	7.2	7.5	10.1	11.4	9.5	5.5	3.0	11.7	7.3	5.2	5.7	6.0	7.3	3.7	5.5	8.0	12.9	6.3	4.2	9.4	10.0	9.4	4.7	7.3	3.1	8.3	7.0	4.2	5.4	7.9	8.5	6.0	6.9	5.7	3.7	2.9	7.3	15.8	6.0	4.3	3.7	2.9	5.7	7.8	7.2	13.9	5.5	8.7	5.6	4.3	2.6	4.4	2.2	2.7	1.8	1.5	1.4	2.3	2.9	1.4	1.7	1.6	2.9	4.8	1.7	2.1	3.5	2.1	2.5	3.3	2.4	2.9	2.2	2.5	3.2	3.2	3.1	2.8	3.0	3.7	6.6	6.4	6.7	32.0	10.8	2.9	3.8	2.9	7.4	3.5	6.4	4.1	6.0	2.8	4.4	7.3	10.4	11.8	7.6	7.2	3.9	3.0	2.9	7.4	6.0	6.3	7.2	4.6	16.8	2.8	3.4	5.0	9.2	6.9	7.0	8.1	2.9	3.9	3.5	1.7	15.2	6.0	6.1	5.5	2.8	2.6	3.7	7.4	0.0	40.3	6.3	1.6	11.3	35.7	39.7	2.7	5.6	4.1	10.9	3.9	6.8	3.3	10.6	5.6	0.0	5.7	5.8	6.3	4.6	8.6	2.0	7.3	9.8	4.7	4.1	4.3
MDP1	"FN6Pase, MGC5987"	ENSG00000213920	"Magnesium dependent phosphatase 1"	Q86V88	14	24213943-24216070	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA003064, HPA070338"	Uncertain		Approved	Nucleoplasm		NA	NA		29000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA003064: AB_10602350, HPA070338: AB_2686256"	"unprognostic (2.70e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.09e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.27e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (6.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.19e-2)"	14.0	18.6	6.8	3.2	6.8	3.9	14.6	7.0	7.5	14.7	6.4	12.6	3.1	11.5	7.9	7.3	12.1	4.0	18.2	7.0	6.9	16.8	10.3	9.2	5.8	6.7	6.8	12.3	15.3	5.8	20.1	4.0	6.9	13.7	3.5	4.1	10.6	4.8	15.0	12.6	9.5	4.5	7.2	11.6	11.9	7.8	6.6	5.3	13.6	4.8	4.7	12.5	11.1	7.8	4.1	9.5	7.2	4.7	6.9	6.3	0.3	4.2	8.9	8.2	8.4	5.0	10.9	15.7	10.4	4.3	2.4	3.7	3.4	8.2	5.0	5.4	3.9	6.0	3.3	12.1	6.7	7.9	4.2	4.5	7.7	4.9	9.4	8.3	5.9	11.1	1.9	11.4	7.4	21.1	11.7	12.6	2.2	7.8	16.9	8.0	5.0	12.6	8.0	5.7	8.7	8.6	6.6	14.3	9.4	3.9	8.3	4.5	3.5	8.8	8.7	3.9	4.4	18.6	8.4	11.7	8.3	3.8	6.9	5.1	13.9	16.5	7.7	15.2	7.3	13.4	9.9	9.0	16.1	12.9	11.7	9.9	4.6	12.4	13.0	29.9	16.3	10.3	6.8	6.8	7.0	7.5	7.0	6.9	6.7	6.8	6.9	7.2	6.6	7.8	6.6	6.4	12.9	0.0	11.0	4.6	3.5	5.6	16.5	3.9	8.2	11.7	0.0	4.3	2.1	5.5	0.0	3.7	7.3	5.9	13.7	13.8	5.7	4.6	5.5	8.2	11.5	7.8	0.0	19.6	5.3	8.1	9.2	4.3	5.1	4.3	8.6	5.8	7.9	3.3	0.0	10.8	12.2	3.3	8.7	3.0	6.2	10.6	17.8	0.0	21.9	5.2	4.1	0.0	0.0	11.7	6.2	7.5	25.8	2.9	23.7	21.7	13.2	2.9	13.1	7.7	8.7	4.4	3.5	11.5	4.5	2.5	9.7	3.4	8.8	2.6
METTL17	"FLJ20859, METT11D1"	ENSG00000165792	"Methyltransferase like 17"	Q9H7H0	14	20989973-20997035	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002955, HPA059802"	Uncertain		Enhanced	Nucleoplasm	"Intracellular and membrane"	No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA002955: AB_2144183, HPA059802: AB_2684129"	"unprognostic (1.90e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.29e-2)"	11.9	32.2	11.0	11.1	11.5	26.6	12.2	12.3	16.1	14.1	13.2	20.6	17.6	12.8	11.2	22.4	13.0	10.3	23.7	10.7	11.1	20.0	19.7	11.7	18.0	12.0	10.9	13.8	18.8	19.4	9.6	12.2	11.6	12.3	21.7	8.0	15.6	13.8	21.3	16.1	21.5	14.2	12.0	23.3	17.6	18.6	12.0	21.7	13.6	29.2	19.3	12.2	14.6	12.3	37.5	48.0	41.8	16.1	25.3	12.2	32.0	22.3	32.8	69.1	58.2	34.3	44.9	85.8	24.4	29.1	43.7	54.0	57.5	48.5	49.6	32.5	44.7	41.8	27.5	56.6	31.5	71.5	42.8	23.4	41.7	35.1	27.8	23.0	27.9	70.5	40.4	38.6	33.8	24.9	48.9	72.2	49.6	62.7	56.2	56.8	42.9	48.2	37.5	34.4	30.2	36.5	30.0	43.9	24.8	31.1	29.4	60.0	15.5	22.4	72.0	25.1	30.2	28.7	49.8	62.1	15.5	46.0	29.3	28.8	8.1	8.6	11.7	9.8	7.0	13.9	12.7	13.2	16.8	10.8	12.4	11.7	0.1	10.7	5.5	11.1	11.5	6.9	11.0	11.5	12.3	16.1	10.7	11.1	12.0	10.9	11.6	12.0	12.0	12.3	11.2	9.6	17.7	21.9	33.6	18.9	17.9	21.2	46.1	37.5	16.5	16.4	5.4	21.5	17.9	11.0	43.8	30.8	23.0	19.3	5.9	20.4	49.2	11.8	16.2	13.5	12.2	26.9	9.7	15.4	17.4	17.7	36.2	11.1	29.7	22.0	11.7	24.2	18.1	21.9	9.3	24.0	16.2	11.3	12.4	10.2	33.5	16.3	3.6	6.5	19.8	23.4	26.8	8.5	11.0	13.8	32.5	21.4	33.6	11.0	27.9	18.0	21.4	53.1	13.1	14.6	17.0	23.4	17.3	40.6	17.8	12.7	27.6	29.0	35.6	24.8
METTL4	"FLJ23017, HsT661"	ENSG00000101574	"Methyltransferase like 4"	Q8N3J2	18	2537525-2571509	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040061, HPA046734"	Approved		Approved	Mitochondria		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 16: Immune cells - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA040061: AB_10697713, HPA046734: AB_2732532"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.12e-5)"	"unprognostic (1.74e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.72e-2)"	"unprognostic (3.26e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-3)"	7.4	4.9	5.2	7.9	6.0	5.5	5.8	5.7	7.0	8.4	5.6	5.9	5.7	7.5	5.4	6.1	6.2	5.7	5.6	4.9	5.7	6.4	5.0	6.2	11.5	6.3	5.6	6.8	4.4	6.4	5.2	5.9	6.5	6.6	6.7	5.1	5.5	7.1	3.4	5.9	7.9	6.7	6.1	10.4	5.8	7.3	5.6	10.4	8.9	5.5	11.0	6.8	7.8	7.6	12.7	5.0	15.1	8.3	5.9	8.7	19.0	19.9	15.7	18.2	16.9	10.8	9.2	24.3	11.5	8.3	16.4	10.7	24.7	9.3	21.2	18.6	9.1	10.6	10.5	7.9	9.0	23.1	12.0	7.1	19.3	19.6	12.0	10.3	17.8	15.9	14.0	33.8	14.3	5.7	16.0	7.4	9.2	10.5	8.2	12.5	13.6	16.7	8.9	7.0	27.6	12.8	16.2	9.3	18.6	11.6	10.8	14.8	11.1	21.9	28.9	19.4	26.3	16.1	47.6	15.7	14.1	15.5	23.8	18.6	2.7	7.3	6.1	2.6	7.0	6.2	7.0	8.5	1.9	7.3	8.5	7.9	10.0	5.9	2.2	3.8	8.8	4.9	5.2	6.0	5.7	7.0	4.9	5.7	6.3	5.6	6.5	6.1	5.6	7.6	24.3	12.8	8.2	8.5	21.1	4.8	13.6	6.5	10.8	9.6	7.6	7.4	3.8	10.0	10.3	3.7	14.6	7.5	13.7	10.1	0.0	5.9	6.9	7.5	9.1	10.0	2.4	11.0	17.0	7.3	9.4	7.3	12.2	7.4	7.0	10.3	11.4	4.9	6.0	8.4	20.3	7.6	4.1	7.0	6.5	3.3	12.8	7.0	3.6	14.0	4.5	6.6	13.4	18.1	25.8	8.3	4.0	10.9	15.0	10.8	10.1	5.1	12.0	6.5	13.1	8.3	6.8	30.5	21.8	9.0	4.8	10.4	18.3	8.5	6.2	19.4
MMACHC	"cblC, DKFZP564I122"	ENSG00000132763	"Metabolism of cobalamin associated C"	Q9Y4U1	1	45500300-45513382	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Oxidoreductase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 17.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027394, HPA027399, HPA027402"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA027394: AB_10601669, HPA027399: AB_10601987, HPA027402: AB_2672255"	"unprognostic (3.34e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.03e-3)"	"unprognostic (3.14e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.61e-3)"	"unprognostic (2.08e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.58e-2)"	2.0	3.1	3.3	1.7	5.3	1.2	3.5	5.1	4.2	2.9	2.3	3.7	3.3	1.7	3.0	2.8	3.5	1.3	6.9	3.4	5.1	3.5	17.4	1.2	1.8	4.1	5.6	3.5	2.9	5.5	1.3	1.5	3.9	2.0	4.4	2.1	5.0	2.4	10.8	2.0	2.4	2.3	3.5	1.6	2.3	4.3	5.6	2.2	2.3	6.6	2.0	1.7	1.5	6.0	7.7	3.9	6.6	10.0	6.1	3.7	8.1	5.9	3.9	10.5	9.4	8.3	4.7	12.0	7.4	4.9	2.0	6.2	12.3	14.0	9.6	3.3	11.4	9.4	6.5	9.2	5.8	13.5	3.3	5.3	7.8	11.6	12.6	3.7	5.1	12.5	10.8	6.7	8.1	8.2	9.1	4.3	10.9	8.8	8.9	11.1	2.7	13.2	6.2	6.0	10.5	5.4	8.8	14.5	19.3	4.9	8.3	4.6	2.3	7.3	9.9	8.3	3.3	9.9	8.5	6.9	5.3	6.4	6.9	2.3	0.5	0.5	0.5	0.8	0.8	0.7	0.7	0.4	0.6	0.6	1.3	0.6	0.9	0.8	2.7	1.3	0.4	0.4	3.3	5.3	5.1	4.2	3.4	5.1	4.1	5.6	3.9	3.5	5.6	6.0	1.1	3.2	5.5	1.6	2.1	0.1	1.8	0.8	5.7	1.3	2.7	1.5	9.8	4.3	2.2	1.8	0.0	3.7	0.6	2.8	5.9	1.3	1.0	3.6	4.8	1.5	4.2	4.8	2.6	1.4	4.3	3.6	7.1	3.2	2.5	2.9	2.5	22.9	3.3	3.3	2.7	3.2	2.0	3.2	0.9	1.2	1.8	2.7	0.0	0.0	0.6	1.4	3.1	1.5	5.3	1.8	2.3	1.5	10.4	1.7	2.0	4.6	1.2	5.2	0.0	5.0	2.4	7.4	2.1	11.5	0.1	2.7	2.4	3.9	5.8	1.8
MMGT1	"EMC5, TMEM32"	ENSG00000169446	"Membrane magnesium transporter 1"	Q8N4V1	X	135960588-135974029	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032037	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"			"HPA032037: AB_10670705"	"prognostic unfavorable (8.54e-4)"	"unprognostic (2.18e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.23e-3)"	"unprognostic (8.94e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (1.94e-5)"	"unprognostic (6.08e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.29e-2)"	17.5	11.0	8.8	12.2	9.3	26.3	12.4	8.3	9.1	15.3	6.2	15.2	11.3	16.3	11.4	17.1	13.7	15.9	18.1	7.9	14.3	17.2	9.0	13.1	11.3	9.3	9.9	14.1	13.4	17.3	9.3	12.4	9.2	12.1	15.1	13.3	14.2	11.6	17.4	10.6	12.8	16.5	8.9	10.3	12.2	4.3	11.0	14.6	24.2	20.0	12.4	15.2	9.6	9.8	28.6	12.9	16.5	25.5	29.6	32.6	21.9	33.1	31.1	27.1	53.2	15.1	43.3	18.7	61.0	32.2	30.3	23.7	45.0	22.9	39.3	22.3	26.3	13.3	16.5	8.9	22.8	26.5	18.9	27.3	36.1	46.1	29.2	27.0	20.1	21.5	18.1	38.9	26.8	20.8	21.2	12.6	12.4	30.9	27.2	17.7	27.6	36.7	20.2	14.2	23.2	23.8	18.2	17.6	41.2	23.5	17.7	12.9	21.9	32.4	18.6	50.7	42.7	23.1	41.4	22.8	28.5	35.6	37.5	12.9	12.1	7.5	8.2	11.8	10.1	7.0	10.5	9.7	11.1	5.7	10.5	9.1	6.6	9.8	13.0	6.7	13.4	10.0	8.8	9.3	8.3	9.1	7.9	14.3	9.3	9.9	9.2	8.9	11.0	9.8	17.6	12.8	13.7	5.5	25.3	22.2	19.8	12.0	37.0	16.6	14.8	15.1	25.3	11.5	12.0	14.7	8.4	7.9	17.9	19.4	7.9	12.1	0.3	12.3	24.4	15.5	25.8	18.7	5.9	12.4	12.6	20.1	13.3	17.1	14.0	3.9	15.7	10.2	14.1	20.2	5.6	15.1	18.3	33.7	23.2	0.6	13.7	29.7	26.6	1.0	25.1	17.9	7.2	6.0	7.4	13.7	9.2	19.2	28.7	23.6	17.0	13.4	9.2	12.6	6.6	20.6	25.0	2.2	7.5	35.6	24.7	11.5	22.3	4.4	17.9	19.6
MRFAP1L1	MGC9651	ENSG00000178988	"Morf4 family associated protein 1 like 1"	Q96HT8	4	6707701-6709865	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"				"unprognostic (5.77e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.40e-1)"	"unprognostic (3.36e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.80e-5)"	"unprognostic (2.87e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.57e-2)"	"prognostic favorable (5.26e-5)"	32.9	41.7	67.7	31.8	69.7	19.0	52.2	68.8	88.8	45.6	56.5	38.7	25.3	47.0	50.0	40.3	41.3	33.3	52.4	67.4	69.6	42.5	55.6	36.1	53.4	67.4	68.1	51.6	30.1	46.0	39.2	40.1	67.6	49.3	32.9	52.4	48.1	40.4	49.6	38.4	33.4	36.9	70.4	43.7	39.8	20.3	69.3	47.9	41.0	50.7	46.4	42.6	39.3	69.7	60.3	37.0	82.4	66.1	82.2	69.8	51.9	54.5	88.8	66.3	62.2	40.2	78.6	70.7	53.8	66.5	88.3	42.4	66.0	79.4	72.2	48.7	46.1	96.4	67.8	95.3	51.3	66.6	53.4	72.9	92.3	59.2	59.4	61.7	63.7	48.2	98.3	55.9	65.5	74.8	94.6	133.6	84.5	59.9	87.1	59.5	99.6	59.8	90.6	51.2	94.4	73.4	44.5	44.9	92.0	48.8	83.8	68.2	56.9	55.5	47.2	41.7	76.1	83.9	133.5	53.7	54.3	103.2	53.6	288.6	44.5	170.5	144.0	44.8	142.1	89.5	134.7	149.5	57.0	85.2	134.2	137.9	94.7	127.1	55.0	54.3	143.1	119.5	67.7	69.7	68.8	88.8	67.4	69.6	67.4	68.1	67.6	70.4	69.3	69.7	17.4	32.1	51.8	9.8	36.7	34.0	24.1	31.9	47.3	28.2	26.5	23.5	53.5	42.9	39.6	18.4	16.7	42.5	37.0	11.2	23.5	23.1	3.4	22.2	34.4	29.8	18.6	40.0	12.5	18.5	31.8	33.5	25.0	24.3	34.7	21.4	28.2	44.0	22.2	53.8	11.3	16.5	36.7	26.0	22.2	3.8	30.7	17.8	26.6	12.2	22.4	45.9	54.6	9.0	14.4	21.8	14.2	28.2	38.1	31.2	12.7	32.1	49.2	21.8	26.3	24.1	24.2	33.3	32.2	40.9	37.4	29.7	49.0	25.7	14.6	24.9
MRPL38	"HSPC262, MGC4810, MRP-L3, RPML3"	ENSG00000204316	"Mitochondrial ribosomal protein L38"	Q96DV4	17	75898644-75905093	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 34.7;Gastric mucus-secreting cells: 35.2;Plasma cells: 60.1;Squamous epithelial cells: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023054, HPA023135"	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA023054: AB_1854109, HPA023135: AB_1854110"	"unprognostic (1.17e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.68e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.59e-2)"	"unprognostic (5.24e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (2.16e-3)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (3.06e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.72e-1)"	"prognostic favorable (9.21e-5)"	23.3	34.7	37.5	16.3	37.4	21.9	22.8	39.7	48.9	20.2	37.8	31.1	26.8	24.0	14.4	30.0	30.6	14.6	51.5	37.7	38.2	31.3	46.8	18.2	23.8	39.4	37.6	22.3	36.8	28.7	19.6	17.3	39.8	22.6	19.2	6.7	36.6	26.2	103.2	26.9	21.9	20.3	38.1	22.5	28.6	25.3	40.4	23.8	20.6	84.7	22.4	25.9	21.0	38.6	82.2	114.2	28.3	39.2	32.5	26.5	86.5	26.4	44.5	96.3	69.5	134.4	49.3	72.7	31.2	45.9	55.1	59.1	79.2	71.1	27.3	24.0	130.5	51.0	39.9	133.7	72.0	69.5	48.6	36.6	77.3	66.8	52.4	29.3	92.6	89.7	64.6	45.6	36.6	163.0	92.9	75.1	33.6	101.8	97.2	69.1	74.7	92.3	76.3	51.0	48.6	51.4	45.3	121.3	104.5	26.1	112.4	74.4	26.3	45.8	67.2	38.6	75.4	51.1	32.1	24.7	50.0	57.1	41.3	24.4	74.1	37.9	84.2	80.8	84.0	101.8	86.0	79.1	106.7	113.7	84.8	81.7	7.0	95.7	69.1	78.1	93.7	83.6	37.5	37.4	39.7	48.9	37.7	38.2	39.4	37.6	39.8	38.1	40.4	38.6	1.7	19.2	7.3	14.7	19.3	1.5	0.8	2.7	34.7	1.0	2.4	1.1	2.3	0.0	5.5	3.7	0.0	5.1	6.6	11.4	3.9	23.8	1.1	2.2	1.8	4.7	10.3	20.2	11.9	21.4	3.7	8.1	35.2	1.8	3.8	1.0	2.5	2.4	3.3	1.7	13.2	13.9	2.0	0.8	1.9	1.9	3.1	6.1	7.2	5.6	14.2	0.9	5.2	7.5	15.7	19.2	17.9	3.0	60.1	1.3	16.3	5.6	9.8	2.9	0.0	0.9	8.3	1.9	1.9	46.2	1.4	3.4	13.6	1.2	20.9	0.8
MRPS24	"HSPC335, MRP-S24"	ENSG00000062582	"Mitochondrial ribosomal protein S24"	Q96EL2	7	43866558-43869893	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 455.8"	"Group enriched"	"Detected in many"	5	"Basal squamous epithelial cells: 109.3;Erythroid cells: 54.7;Gastric mucus-secreting cells: 84.6;Plasma cells: 184.7;Squamous epithelial cells: 204.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073947	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 59: Non-specific - Transcription"			"HPA073947: "	"unprognostic (1.35e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.32e-2)"	"unprognostic (8.63e-3)"	"unprognostic (9.42e-2)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (2.03e-1)"	"unprognostic (6.86e-3)"	"unprognostic (9.58e-3)"	"unprognostic (1.71e-2)"	"prognostic favorable (9.89e-4)"	"unprognostic (2.87e-1)"	"unprognostic (9.08e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.95e-1)"	81.4	160.7	98.6	41.6	98.8	93.6	81.9	103.5	116.1	82.3	103.6	107.5	71.6	79.2	43.3	148.5	79.7	34.0	233.6	100.1	104.1	142.9	172.6	64.4	49.4	96.2	97.7	95.8	151.1	92.0	68.3	39.7	96.2	82.4	47.0	31.3	101.2	40.1	455.8	91.7	77.7	37.8	97.1	76.9	126.8	83.5	106.1	47.9	65.3	281.0	48.3	87.3	88.4	94.7	165.2	260.4	80.2	165.8	82.7	141.4	132.3	155.4	386.0	206.2	203.3	236.7	152.8	140.1	182.8	160.1	278.8	204.7	115.8	142.9	160.9	131.8	287.2	86.1	286.2	287.7	122.7	140.5	106.5	133.8	142.6	161.0	192.1	130.8	120.3	136.8	281.4	103.3	131.6	262.7	170.6	313.4	200.5	184.8	261.0	137.3	113.9	540.5	150.9	139.3	159.5	180.4	156.7	386.3	162.2	102.9	261.5	252.1	96.8	191.6	263.6	116.1	225.7	310.4	258.8	182.5	232.3	186.1	305.7	41.4	175.4	95.6	114.1	181.6	124.8	222.5	167.5	137.5	241.0	195.6	165.0	142.6	14.7	124.1	181.0	162.8	214.1	177.5	98.6	98.8	103.5	116.1	100.1	104.1	96.2	97.7	96.2	97.1	106.1	94.7	1.2	6.4	19.1	0.0	24.1	4.5	2.6	2.5	109.3	4.9	8.2	5.3	0.4	8.6	13.2	5.5	6.2	1.4	2.9	1.8	3.9	7.1	1.8	9.4	16.5	7.8	4.2	54.7	0.0	0.7	3.8	20.4	84.6	12.1	3.8	2.3	8.9	21.7	1.2	0.0	0.0	1.5	0.0	8.6	6.3	1.0	0.3	24.4	3.6	0.0	3.1	0.9	4.1	0.0	0.0	2.9	0.7	0.7	184.7	1.8	1.6	1.9	21.9	7.7	0.0	1.7	13.8	1.0	1.4	204.4	5.8	1.9	19.4	1.7	2.1	3.2
MSH5	G7	ENSG00000204410	"MutS homolog 5"	O43196	6	31739677-31762676	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Meiosis"	DNA-binding	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 14.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 18.8;Erythroid cells: 8.0;Gastric mucus-secreting cells: 10.7;Plasma cells: 10.7;Spermatocytes: 10.9;Spermatogonia: 8.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 3.1;NB-4: 5.2"									HPA062688			Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles	"Endoplasmic reticulum"	"HPA062688: AB_2684835"	"unprognostic (3.21e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.51e-1)"	"unprognostic (9.20e-4)"	"unprognostic (7.67e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.59e-3)"	"unprognostic (2.28e-2)"	"unprognostic (5.19e-5)"	"unprognostic (3.75e-2)"	"unprognostic (8.83e-2)"	"unprognostic (9.21e-2)"	"unprognostic (9.34e-4)"	1.3	1.2	0.1	0.5	0.1	0.7	1.5	0.1	0.4	1.7	0.2	1.6	0.0	1.4	0.0	2.2	1.9	0.0	1.0	0.1	0.1	5.6	2.0	1.4	0.6	0.1	0.2	2.3	1.6	0.0	2.2	0.0	0.1	2.9	0.0	0.1	1.6	0.0	0.6	1.8	1.8	0.0	0.1	2.4	1.6	14.0	0.1	0.0	1.5	0.0	0.0	1.6	1.7	0.2	0.3	1.1	0.4	0.9	0.0	0.1	0.0	0.2	0.0	0.4	0.1	0.1	1.0	3.1	0.4	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.7	1.1	0.1	0.6	0.0	0.3	1.3	0.0	0.0	0.1	0.3	0.5	0.9	1.2	1.9	1.6	0.0	2.1	0.5	5.2	0.9	0.9	0.0	2.1	0.1	2.4	0.3	0.5	0.2	0.8	0.3	0.2	0.0	0.0	0.3	1.8	0.0	0.3	1.6	0.1	0.6	0.3	2.1	1.7	0.0	0.5	0.8	2.5	0.4	0.0	0.4	0.3	0.0	1.4	0.4	0.1	0.1	0.6	0.1	0.1	0.6	0.1	0.6	0.8	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.4	0.0	2.3	0.0	3.6	0.5	0.5	0.3	3.4	0.7	0.5	0.5	0.3	2.8	0.8	3.7	18.8	0.6	0.5	1.0	0.0	0.2	0.1	1.6	1.3	0.6	1.2	8.0	0.0	0.2	0.4	0.9	10.7	2.8	3.8	3.1	0.4	0.3	0.5	0.0	0.0	1.2	0.0	0.8	1.3	0.5	1.2	1.5	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.5	0.7	10.7	0.5	2.0	0.8	0.9	7.3	0.0	1.0	1.4	10.9	8.3	6.2	0.4	0.5	2.5	0.9	1.9	0.4
MTA2	"MTA1-L1, MTA1L1"	ENSG00000149480	"Metastasis associated 1 family member 2"	O94776	11	62593214-62601865	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005315, HPA006214, CAB017522, HPA072727"	Supported		Enhanced	Nucleoplasm		NA	NA		10000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB005315: AB_2146965, CAB017522: AB_831564, HPA006214: AB_1079421, HPA072727: "	"unprognostic (5.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (4.82e-5)"	"unprognostic (3.32e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.38e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-3)"	"unprognostic (9.84e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.50e-2)"	41.6	34.4	44.4	46.2	46.7	60.7	35.7	45.7	45.3	40.2	38.2	40.0	31.0	37.2	28.7	79.3	33.4	32.6	29.7	44.3	44.1	31.9	30.3	37.8	70.1	49.0	46.1	37.8	23.0	30.2	31.8	39.1	49.4	37.0	47.4	119.8	37.3	36.7	21.2	74.7	40.1	43.8	46.1	60.7	33.9	30.4	45.8	90.2	26.8	24.1	91.8	51.7	47.2	52.7	97.1	83.4	129.8	171.1	57.0	53.2	88.8	80.0	112.3	157.5	114.7	79.7	82.7	137.0	84.0	106.3	84.3	127.2	177.2	222.1	132.8	136.4	87.9	146.4	91.2	81.0	88.3	167.2	180.0	59.6	122.6	111.3	164.1	74.8	148.3	140.4	164.2	106.1	114.6	189.0	213.9	212.1	112.3	91.7	95.1	201.5	92.4	160.6	112.1	143.4	102.9	94.2	83.5	118.2	67.6	102.4	138.9	113.2	104.5	87.9	80.4	100.4	94.0	78.3	109.4	191.8	64.4	120.4	86.9	7.3	7.2	9.9	18.6	12.6	15.6	13.9	15.2	13.5	11.8	10.0	14.0	14.3	3.1	12.1	16.4	13.8	13.5	6.7	44.4	46.7	45.7	45.3	44.3	44.1	49.0	46.1	49.4	46.1	45.8	52.7	22.9	3.2	3.9	2.3	16.9	13.4	4.2	4.2	34.1	0.0	11.3	7.9	3.7	1.5	4.9	1.8	0.0	15.3	16.5	12.1	5.9	5.1	0.8	5.2	10.0	12.0	12.0	20.8	1.5	9.5	8.3	8.6	15.3	9.5	10.8	7.5	13.2	8.2	8.9	0.0	1.6	11.9	4.1	12.8	7.6	0.7	5.0	8.9	1.8	2.8	8.9	0.0	9.2	2.0	2.7	9.7	8.2	4.1	24.1	4.2	6.6	2.7	0.9	0.0	0.0	8.2	11.7	5.9	5.2	32.5	11.2	18.9	18.1	13.6	12.2	4.5
MTERF1	MTERF	ENSG00000127989	"Mitochondrial transcription termination factor 1"	Q99551	7	91692008-91880702	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA044894, HPA069560"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA044894: AB_10966284, HPA069560: AB_2686154"	"unprognostic (5.57e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.46e-3)"	"unprognostic (7.62e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.22e-3)"	4.7	6.1	4.0	7.9	5.1	10.1	9.2	4.7	5.1	5.5	4.1	7.6	7.0	7.0	7.6	7.3	5.9	5.4	5.9	4.2	5.2	8.4	11.3	5.2	14.0	4.5	4.1	8.3	5.9	6.5	5.0	7.1	5.0	6.1	7.8	6.5	7.5	5.9	5.0	6.3	6.8	6.1	4.1	9.7	8.1	6.6	4.8	11.4	7.5	8.9	13.3	5.7	5.8	6.8	17.3	15.0	13.3	9.0	12.2	13.9	12.6	14.2	14.3	15.8	19.6	16.9	17.7	36.8	11.9	11.0	21.3	15.2	21.3	13.4	23.9	1.9	14.5	16.1	17.2	13.4	11.6	29.3	15.7	17.2	16.3	15.8	18.5	11.4	12.9	8.1	31.2	15.0	18.1	22.2	31.5	27.0	22.2	20.1	16.5	9.3	19.2	23.4	15.8	17.5	12.8	23.4	13.9	30.1	29.0	24.3	10.9	19.4	9.5	18.4	22.2	25.4	14.9	19.4	21.9	48.7	13.0	9.4	26.9	46.0	12.9	18.5	14.6	11.2	18.5	22.0	19.2	21.9	14.1	23.9	26.1	20.7	6.2	16.1	13.5	11.2	20.1	15.1	4.0	5.1	4.7	5.1	4.2	5.2	4.5	4.1	5.0	4.1	4.8	6.8	5.5	9.6	10.6	6.2	10.5	0.0	3.9	0.0	14.8	0.0	5.3	6.7	5.3	5.7	2.5	3.7	0.0	9.3	8.0	3.4	5.9	5.9	1.5	4.5	7.0	4.9	1.2	8.2	7.9	5.2	6.3	6.2	7.7	4.0	5.1	8.3	6.4	9.6	5.1	0.0	7.2	2.6	0.0	6.0	0.0	2.1	6.8	5.9	0.0	5.6	7.1	0.0	10.3	8.0	15.2	4.1	3.1	7.2	12.6	3.9	7.2	8.2	1.5	0.0	13.1	5.0	5.3	14.0	10.5	6.3	0.0	4.5	8.0	8.5	4.1	2.7
MTFP1	"HSPC242, MTP18"	ENSG00000242114	"Mitochondrial fission process 1"	Q9UDX5	22	30425623-30429054	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 69.7;Exocrine glandular cells: 52.2;Plasma cells: 43.5;Undifferentiated cells: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077396			Approved	Mitochondria		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA077396: AB_2686837"	"unprognostic (2.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.12e-1)"	"unprognostic (6.20e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.52e-3)"	"unprognostic (8.98e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.66e-2)"	12.9	15.6	8.7	10.1	9.1	14.2	11.6	11.1	9.9	8.3	16.8	17.1	16.8	3.8	15.1	19.8	3.4	8.1	26.2	9.0	10.2	38.9	31.9	11.9	16.5	9.9	9.7	5.0	19.0	21.8	8.1	11.4	9.3	13.5	12.9	23.4	10.1	4.9	26.2	7.6	13.4	4.7	9.1	20.9	19.7	4.0	10.8	7.8	8.5	19.3	14.8	13.7	7.6	8.6	91.9	69.5	23.8	37.1	5.1	4.1	27.2	8.6	8.2	51.3	78.5	33.6	52.4	99.5	25.3	6.0	41.3	46.5	74.0	77.6	34.7	56.2	96.5	26.7	38.6	64.9	14.8	66.7	52.7	7.6	25.7	31.4	47.4	15.7	43.5	45.1	51.2	35.5	16.3	109.5	63.3	71.8	41.5	82.9	73.2	85.6	23.1	87.3	61.0	24.8	40.6	44.5	19.9	90.6	35.6	16.9	28.8	31.4	18.4	55.9	72.4	27.6	26.3	17.8	15.5	86.1	22.4	75.9	23.7	0.2	14.3	0.1	49.2	17.1	65.5	34.0	39.6	42.3	20.3	23.7	41.7	48.2	1.8	14.0	11.6	10.5	36.0	25.6	8.7	9.1	11.1	9.9	9.0	10.2	9.9	9.7	9.3	9.1	10.8	8.6	5.3	6.4	3.0	3.9	21.7	5.6	1.8	12.0	6.2	0.0	10.1	3.7	4.4	7.2	6.7	3.7	0.0	13.4	14.8	33.2	15.6	69.7	0.1	1.9	1.4	5.8	8.4	9.2	0.8	52.2	30.4	2.5	20.9	2.6	9.5	0.4	5.0	11.1	17.6	0.0	2.7	28.1	2.0	10.3	9.6	0.2	0.6	6.4	3.6	1.0	36.6	0.0	10.3	0.5	0.3	40.3	13.8	0.4	43.5	3.5	28.3	11.8	1.9	0.0	0.0	1.5	5.1	0.6	2.1	16.5	5.5	16.8	29.6	0.7	45.3	2.2
MTG1	GTPBP7	ENSG00000148824	"Mitochondrial ribosome associated GTPase 1"	Q9BT17	10	133394094-133422520	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037826, HPA037827"	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA037826: AB_2675692, HPA037827: AB_10670959"	"unprognostic (2.94e-2)"	"unprognostic (8.08e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.85e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (5.08e-4)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (6.79e-7)"	"unprognostic (3.88e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.19e-2)"	"prognostic favorable (1.03e-5)"	15.1	28.1	10.0	13.6	9.9	12.5	16.3	11.0	12.2	17.0	11.4	16.0	19.7	15.2	2.8	21.4	15.0	8.4	15.0	9.7	9.6	27.1	48.4	13.0	16.2	10.8	9.9	17.2	19.7	17.6	16.2	11.2	10.2	19.3	11.2	3.4	16.3	10.4	18.5	17.7	18.9	10.1	9.3	26.1	18.4	31.2	10.4	12.7	18.0	13.0	14.1	15.4	15.4	9.9	42.5	43.3	28.3	63.4	17.0	12.5	42.0	24.2	20.8	38.5	31.4	55.0	25.8	31.2	36.2	20.5	16.3	33.5	30.6	43.2	17.4	29.8	37.7	30.5	23.5	52.1	40.2	20.6	30.4	31.5	22.9	37.3	58.6	27.7	56.5	27.9	26.2	28.0	30.6	47.4	20.2	28.9	39.3	45.2	14.4	29.6	28.0	7.1	34.6	29.6	10.7	37.9	36.4	32.1	51.4	15.8	28.2	29.6	37.1	14.2	29.2	14.6	26.1	13.5	8.3	43.3	25.2	18.3	19.8	0.5	21.5	23.0	26.9	35.5	27.7	41.5	23.8	22.7	20.3	48.8	18.6	19.2	3.1	47.5	42.9	42.8	27.5	20.3	10.0	9.9	11.0	12.2	9.7	9.6	10.8	9.9	10.2	9.3	10.4	9.9	4.5	9.6	3.6	30.7	27.1	4.2	5.9	8.8	33.0	0.0	6.1	5.3	1.6	8.6	5.9	3.7	0.0	9.4	8.1	8.4	5.9	13.5	2.2	5.9	9.9	7.7	12.6	26.1	25.1	9.6	7.3	9.0	43.8	5.9	6.3	10.8	7.5	5.5	5.4	0.0	31.8	7.5	4.1	6.3	4.7	5.4	9.0	7.1	5.4	21.5	8.1	0.0	12.3	29.7	33.9	10.4	9.2	4.9	37.5	7.2	12.5	6.9	6.1	0.0	13.1	6.1	6.0	9.0	9.3	32.9	3.4	6.7	16.6	6.7	10.1	7.4
MTM1		ENSG00000171100	"Myotubularin 1"	Q13496	X	150568621-150673143	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 52.2;Oligodendrocytes: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010008, HPA010665"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA010008: AB_1079426, HPA010665: AB_1079425"	"unprognostic (3.66e-3)"	"unprognostic (8.43e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.74e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.59e-2)"	"prognostic favorable (7.40e-7)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.46e-1)"	6.8	11.1	7.4	9.7	8.3	11.3	7.6	8.0	8.4	5.7	6.1	19.8	11.7	6.5	8.4	7.5	9.6	7.1	7.3	6.9	8.5	12.9	18.4	11.2	12.4	7.8	8.6	11.7	4.9	16.0	3.8	6.3	8.0	8.0	19.2	5.4	6.3	10.7	11.8	8.2	12.1	6.9	7.7	11.9	7.8	11.5	8.8	8.4	11.2	10.1	9.7	7.1	4.7	8.8	14.3	6.1	8.5	3.1	7.5	7.3	5.4	6.1	8.5	7.0	7.9	4.7	7.3	22.2	11.4	8.3	21.9	9.9	6.1	11.5	8.6	6.4	5.2	5.6	5.4	15.0	5.8	25.2	19.1	4.5	14.3	5.7	11.9	6.9	9.4	9.3	3.9	19.8	8.8	4.5	6.9	25.2	4.3	13.4	7.4	8.0	4.9	4.5	11.7	6.9	2.2	2.4	5.5	11.3	8.5	11.9	4.1	35.2	8.2	5.0	3.1	12.4	7.1	4.2	10.0	20.3	6.0	14.8	8.0	34.8	9.5	27.9	2.0	10.8	6.8	8.0	9.6	7.3	12.0	10.6	9.0	5.4	11.6	14.6	9.8	7.4	12.2	7.1	7.4	8.3	8.0	8.4	6.9	8.5	7.8	8.6	8.0	7.7	8.8	8.8	9.9	9.6	20.0	52.2	13.9	15.2	8.3	5.8	2.2	0.0	5.8	3.9	15.0	4.3	6.0	3.7	0.0	2.1	8.4	33.0	1.9	3.4	35.6	7.7	5.0	11.5	9.6	7.4	44.0	4.3	2.8	6.6	8.2	4.8	8.8	3.3	16.4	13.2	8.0	0.0	41.5	17.7	2.0	16.3	10.4	18.8	6.2	13.0	5.4	24.4	12.0	0.0	0.0	27.6	47.7	4.7	9.5	12.8	8.0	6.8	11.2	14.7	13.4	0.0	0.0	5.2	6.9	5.1	4.1	4.9	19.0	7.3	12.8	4.8	13.8	9.7
MYNN	"SBBIZ1, ZBTB31, ZNF902"	ENSG00000085274	Myoneurin	Q9NPC7	3	169773396-169789716	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045149	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA045149: AB_10960839"	"unprognostic (7.13e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.36e-3)"	6.0	5.3	3.4	6.5	4.1	14.8	9.7	7.2	4.5	7.9	4.4	5.7	5.1	10.3	6.3	7.1	6.8	6.2	5.8	3.1	3.4	6.8	7.9	6.4	8.7	3.0	3.5	10.0	7.3	8.4	3.6	7.1	3.3	7.2	7.0	15.3	6.3	6.3	7.9	7.8	6.8	8.4	3.5	7.9	7.0	9.9	3.4	7.6	8.5	10.8	9.8	7.4	5.5	5.2	13.1	6.0	6.9	13.6	14.2	12.2	8.7	8.6	12.4	13.0	14.3	7.3	13.1	19.7	15.3	9.4	10.3	10.2	12.5	10.9	17.2	17.7	9.8	18.4	9.1	7.2	12.0	17.1	12.9	10.8	13.9	7.9	22.8	10.5	11.7	8.6	7.9	18.9	13.0	11.0	10.1	8.8	10.4	16.1	6.6	11.1	9.7	21.4	8.6	22.1	9.6	11.3	10.4	23.5	14.8	9.0	29.0	12.5	8.7	11.9	5.4	11.1	16.6	21.6	16.4	26.8	9.5	10.6	11.7	22.2	4.8	11.2	7.3	5.2	10.0	8.1	8.4	7.1	5.5	7.9	10.0	7.7	6.7	10.8	4.5	5.5	9.1	7.7	3.4	4.1	7.2	4.5	3.1	3.4	3.0	3.5	3.3	3.5	3.4	5.2	25.8	28.9	21.6	10.7	25.2	41.3	31.1	21.4	46.7	9.0	14.9	12.1	14.7	14.3	20.3	11.0	22.9	14.6	20.1	9.8	13.7	10.4	46.3	15.8	14.8	20.3	14.3	14.5	15.6	9.4	17.0	16.6	19.4	20.3	7.6	12.7	11.4	7.3	8.2	10.1	15.0	8.4	20.3	7.5	14.0	12.6	17.1	12.3	16.0	13.1	12.7	13.3	19.6	12.5	14.0	9.9	9.4	18.8	31.6	18.1	12.2	12.3	18.3	31.7	6.6	15.7	14.7	34.9	18.8	27.3	38.4	20.8	25.5	12.0	9.6	25.7
NARS2	"DFNB94, FLJ23441, SLM5"	ENSG00000137513	"Asparaginyl-tRNA synthetase 2, mitochondrial"	Q96I59	11	78435968-78574874	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease variant, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026793	Supported		Approved	Nucleoplasm,Mitochondria,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA026793: AB_1848833"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.79e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.62e-3)"	"prognostic favorable (1.39e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.22e-6)"	"unprognostic (8.57e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.60e-1)"	7.3	11.9	10.7	6.8	12.3	6.2	11.1	12.4	13.3	9.6	19.8	11.3	10.3	9.1	11.2	8.1	9.9	7.0	11.7	10.4	11.7	19.0	23.5	7.6	9.6	11.7	13.9	11.4	10.6	11.4	7.6	8.0	13.1	10.8	10.9	13.4	10.7	7.3	23.5	7.2	9.7	7.4	11.3	7.4	9.9	7.5	11.4	11.7	11.5	19.6	9.7	8.7	8.1	12.3	16.7	22.8	23.5	15.4	16.1	13.5	19.5	13.5	13.1	20.6	16.9	39.4	17.4	40.9	34.1	8.7	19.8	21.5	39.9	26.3	28.3	27.0	21.3	28.9	17.3	33.7	13.3	31.3	10.1	9.4	16.8	18.1	32.0	18.3	17.9	33.7	44.5	11.0	23.1	19.4	32.7	50.3	25.6	67.3	27.3	33.6	38.2	55.5	27.2	23.0	27.8	17.5	20.1	25.4	35.5	25.1	24.1	12.3	10.9	27.7	32.8	32.0	23.1	18.1	33.1	91.1	5.4	27.7	19.2	9.5	9.3	4.4	11.1	10.4	13.8	17.6	12.8	12.5	16.6	15.0	18.5	16.7	2.0	20.3	12.8	12.7	10.5	10.3	10.7	12.3	12.4	13.3	10.4	11.7	11.7	13.9	13.1	11.3	11.4	12.3	5.8	19.2	26.4	27.7	14.5	13.5	14.2	12.0	12.5	5.2	9.4	6.5	8.8	5.7	10.3	5.5	2.1	20.0	4.4	4.0	29.4	9.5	13.1	10.1	7.4	6.6	12.0	9.2	34.7	7.3	23.6	9.0	10.2	9.0	8.2	14.0	2.5	19.8	12.4	0.0	45.1	8.3	22.4	6.3	11.6	5.4	7.8	6.3	17.8	45.0	2.9	6.3	4.1	42.7	47.7	7.5	9.9	4.9	14.6	17.5	7.0	28.9	10.2	9.0	6.6	7.5	8.8	8.6	19.5	12.0	13.8	15.3	7.8	9.0	14.6	10.7
NAT10	"FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43"	ENSG00000135372	"N-acetyltransferase 10"	Q9H0A0	11	34105617-34147670	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035546, HPA057576, HPA071628"	Approved		Enhanced	Nucleoli,Midbody		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoli	Midbody	"CAB035546: , HPA057576: AB_2683475, HPA071628: AB_2686426"	"unprognostic (3.04e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (1.07e-4)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.83e-5)"	"unprognostic (1.24e-1)"	"unprognostic (7.18e-2)"	"unprognostic (9.55e-2)"	"unprognostic (8.69e-2)"	20.6	24.2	16.0	17.3	15.4	20.4	19.6	14.7	17.4	20.1	14.0	17.0	10.2	20.0	13.7	25.7	19.2	9.4	18.4	15.1	15.4	19.5	22.3	14.9	23.4	14.3	13.6	23.1	25.3	16.8	17.5	15.1	14.7	19.4	15.5	16.3	16.7	12.2	24.8	28.9	17.5	15.5	12.6	22.8	18.7	22.0	15.6	19.4	17.2	12.5	27.5	20.3	20.5	16.9	40.0	55.5	29.3	62.0	34.2	30.2	33.6	38.8	28.5	48.4	38.4	62.6	22.6	127.6	28.3	33.0	41.8	59.5	110.5	59.4	59.5	35.9	70.2	58.0	44.5	58.9	31.0	147.3	40.7	31.1	40.0	31.5	88.3	22.8	37.4	60.6	128.6	43.5	40.8	76.0	120.5	65.7	41.9	69.3	65.7	89.3	98.0	53.7	27.8	68.5	43.1	32.6	52.3	54.9	23.6	28.2	55.0	41.0	30.5	42.8	34.0	63.7	72.8	47.0	61.0	120.3	43.3	60.0	43.4	0.7	8.3	2.8	11.7	13.7	15.5	12.2	12.6	13.4	15.5	10.6	12.7	13.2	0.9	15.0	12.9	11.6	12.0	9.1	16.0	15.4	14.7	17.4	15.1	15.4	14.3	13.6	14.7	12.6	15.6	16.9	8.5	6.4	20.7	10.4	12.7	12.2	11.3	6.9	12.5	12.2	8.8	10.2	12.6	7.2	15.1	14.7	12.5	18.1	8.0	5.8	5.9	9.2	6.1	10.1	18.3	10.9	7.2	21.0	22.8	9.6	13.4	14.5	5.6	12.2	5.1	17.3	5.7	7.5	12.0	11.8	21.7	8.9	4.1	5.5	4.4	3.4	9.3	8.5	1.8	6.5	12.9	5.3	7.2	11.6	16.0	8.7	3.5	13.2	9.8	14.8	3.7	5.8	10.6	11.0	13.1	19.6	8.4	20.5	21.6	13.1	13.8	14.4	11.0	19.7	14.3	7.6
NBPF11	NBPF24	ENSG00000263956	"NBPF member 11"	Q86T75	1	148102046-148152322	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 30.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	Microtubules,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (2.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (6.87e-4)"	"unprognostic (8.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.78e-2)"	"unprognostic (6.67e-6)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.68e-1)"	"prognostic favorable (3.20e-5)"	9.5	7.6	4.0	5.7	5.0	7.6	9.5	4.1	5.4	11.7	4.6	8.5	4.2	9.5	17.0	6.5	10.3	3.8	5.6	3.9	4.0	7.3	18.1	7.0	7.5	6.1	4.6	11.6	12.1	7.7	7.8	4.6	6.0	9.8	5.7	7.2	8.8	7.0	3.3	12.3	10.6	6.5	4.8	12.6	12.0	6.6	5.1	6.1	9.8	1.5	7.7	9.0	8.5	7.1	5.4	4.4	8.6	8.3	5.8	4.7	5.8	4.7	4.5	3.9	4.2	3.4	5.4	9.3	3.7	5.8	3.7	7.1	5.4	1.8	4.8	5.1	5.8	4.2	15.6	3.8	4.1	5.9	14.4	4.1	5.0	5.1	9.8	6.0	3.0	7.9	6.8	0.4	4.0	11.0	6.9	11.0	7.5	12.6	5.6	9.1	4.8	3.6	4.0	10.8	3.4	8.9	7.8	5.3	8.0	11.2	7.7	10.1	7.3	5.0	4.3	7.8	6.1	5.3	4.7	6.3	4.9	3.7	2.9	3.7	0.9	3.0	1.8	0.6	1.3	1.6	1.6	1.1	0.9	2.2	1.6	1.3	0.1	0.5	1.9	1.9	0.6	0.6	4.0	5.0	4.1	5.4	3.9	4.0	6.1	4.6	6.0	4.8	5.1	7.1	6.0	12.8	12.0	19.9	11.9	1.1	2.3	0.3	9.6	4.5	7.8	6.2	6.9	5.7	5.2	3.7	10.4	4.9	9.1	5.5	0.0	3.4	9.7	4.3	4.5	6.9	3.5	8.8	28.1	3.3	4.2	7.0	11.2	7.5	13.9	6.6	7.5	19.1	3.3	5.0	16.8	8.0	0.0	9.6	3.4	1.4	5.3	6.6	7.2	24.4	15.9	3.8	6.2	30.7	29.9	4.1	16.0	2.6	6.9	1.5	4.9	2.7	3.8	6.8	6.6	4.4	5.5	6.9	3.9	8.6	1.4	2.9	8.1	3.3	8.4	1.1
NBPF12	"COAS1, KIAA1245"	ENSG00000268043	"NBPF member 12"	Q5TAG4	1	146938744-146996202	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in all"		"pancreas: 80.1;stomach 1: 57.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (5.48e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.96e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.00e-3)"	"unprognostic (2.03e-2)"	"unprognostic (5.76e-3)"	"unprognostic (4.57e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (9.01e-7)"	"unprognostic (2.23e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (2.47e-5)"	10.7	7.8	8.4	9.4	11.1	17.5	10.2	7.5	10.6	11.0	5.9	9.7	8.3	10.8	10.7	7.4	9.9	5.9	5.9	6.8	7.5	7.5	22.3	10.1	11.6	13.2	8.8	12.3	80.1	9.8	10.9	4.8	13.0	9.5	6.5	13.9	9.7	6.7	5.0	10.6	12.3	9.0	7.6	11.7	57.3	9.6	11.7	10.5	11.2	5.4	9.9	9.5	8.6	17.5	8.1	6.2	13.0	11.1	5.7	5.4	8.5	8.3	6.0	5.7	5.6	5.7	7.4	17.9	5.0	6.9	6.2	5.9	9.4	4.5	5.3	6.7	6.5	7.8	16.1	5.0	4.9	5.9	11.0	5.8	8.1	5.4	12.7	7.2	5.1	12.7	12.6	2.8	4.4	11.9	12.8	7.5	7.5	9.7	8.1	12.3	4.8	4.2	4.1	17.3	6.5	13.5	10.7	9.4	5.5	19.2	7.9	17.5	6.2	4.7	8.1	11.6	11.4	10.5	8.2	7.2	5.1	4.0	5.8	2.9	1.0	0.8	1.2	0.4	0.7	1.5	0.8	0.7	0.4	1.3	0.9	0.7	0.2	0.3	0.6	1.0	0.9	0.3	8.4	11.1	7.5	10.6	6.8	7.5	13.2	8.8	13.0	7.6	11.7	17.5	6.3	32.1	24.0	18.6	15.2	3.8	3.0	3.3	11.4	17.0	7.0	4.4	10.9	2.8	7.8	5.5	45.9	4.4	12.9	6.2	0.0	11.8	14.0	2.7	4.0	6.1	10.7	12.8	21.4	8.7	4.7	9.2	6.1	5.2	24.6	4.7	7.9	12.9	3.8	10.1	15.1	9.6	0.0	14.0	6.4	3.8	5.6	11.0	1.8	6.5	16.4	9.4	8.2	24.6	29.3	12.7	15.7	10.5	6.4	1.9	15.9	2.0	6.5	16.7	6.6	6.0	8.6	12.2	6.8	11.4	4.3	1.9	12.1	2.6	10.5	1.5
NBPF26		ENSG00000273136	"NBPF member 26"		1	120723949-120842110	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 54.5;B-cells: 36.4;Basal squamous epithelial cells: 37.0;Erythroid cells: 55.5;Macrophages: 54.4;Squamous epithelial cells: 106.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.3"	"Group enriched"	"Detected in all"	5	"granulocytes: 13.3;monocytes: 7.3"	"Low cell line specificity"	"Detected in many"											"HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Uncertain		Approved	Microtubules,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (2.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.64e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.31e-5)"	"unprognostic (9.78e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.82e-5)"	"unprognostic (1.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.65e-1)"	14.7	7.2	5.4	21.9	5.1	13.2	11.0	7.6	6.3	14.9	13.7	10.2	2.5	15.1	20.1	20.7	11.2	13.3	6.5	3.8	5.8	4.9	10.4	13.3	12.5	5.4	4.4	17.0	8.9	4.3	4.7	8.5	3.6	12.6	9.3	23.1	10.2	8.9	6.4	39.0	8.6	17.3	2.0	13.9	7.5	10.3	8.0	11.9	12.2	5.4	8.5	7.9	11.5	5.8	56.7	0.3	16.4	17.8	18.3	16.9	1.3	19.9	10.1	12.5	12.9	12.2	2.3	4.4	17.2	17.5	21.6	14.4	27.8	28.7	17.4	25.1	1.3	40.1	7.5	4.8	9.1	16.0	11.4	10.2	11.8	31.1	32.6	40.5	0.8	10.5	3.0	30.1	29.5	28.7	4.2	24.6	6.3	2.0	21.5	5.5	15.3	8.2	7.3	19.9	1.5	1.3	22.1	30.5	16.6	19.5	1.0	6.7	17.3	14.0	36.3	43.7	15.7	13.5	4.1	16.2	11.6	23.5	2.2	2.4	5.1	4.6	1.4	2.3	0.7	0.8	1.0	1.2	1.4	2.0	1.0	1.5	13.3	1.3	7.3	1.3	0.5	0.7	5.4	5.1	7.6	6.3	3.8	5.8	5.4	4.4	3.6	2.0	8.0	5.8	0.8	54.5	28.7	3.9	36.4	0.0	2.2	0.0	37.0	0.6	3.9	2.4	2.7	0.0	3.7	0.0	0.0	0.5	4.7	0.6	3.9	4.8	7.6	7.2	4.8	1.4	0.0	55.5	0.4	3.1	2.4	14.9	16.3	7.8	16.4	2.5	1.1	1.4	0.2	0.0	0.3	1.0	0.0	4.4	0.0	0.9	6.5	54.4	0.0	1.0	6.5	0.6	2.1	0.5	0.1	4.0	27.3	4.5	28.0	1.0	1.7	0.7	3.6	2.1	0.0	3.1	6.7	4.9	2.5	106.5	0.0	0.4	21.1	0.9	2.2	0.8
NCBP1	"CBP80, NCBP, Sto1"	ENSG00000136937	"Nuclear cap binding protein subunit 1"	Q09161	9	97633668-97673748	"Predicted intracellular proteins, Transporters"	"mRNA capping, mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042411, HPA049031"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		25000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA042411: AB_2677985, HPA049031: AB_2680606"	"unprognostic (4.76e-3)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (4.63e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.04e-2)"	10.9	11.0	11.9	16.0	13.7	29.5	11.7	28.3	13.6	10.5	13.7	15.4	12.7	11.7	10.0	12.3	8.8	11.4	12.2	11.8	11.8	11.0	16.6	9.7	19.8	11.6	11.1	12.7	13.2	10.1	10.5	14.6	11.7	12.2	17.9	30.6	10.8	10.2	18.7	15.8	12.6	11.4	11.2	13.3	13.0	16.9	10.9	21.3	15.7	14.9	18.7	14.0	10.6	17.4	57.7	40.6	44.2	41.0	30.8	30.9	41.6	41.2	25.9	40.1	37.4	54.7	30.2	49.0	17.9	41.1	38.5	62.1	72.3	51.6	57.3	33.8	22.2	45.8	58.5	34.4	30.0	60.8	43.2	23.5	25.0	47.3	35.8	28.5	42.4	35.4	68.6	27.0	68.5	43.5	44.3	33.5	46.4	85.4	39.8	41.9	100.4	20.4	33.0	42.9	55.2	35.4	44.2	38.5	23.5	37.9	23.7	38.7	35.2	31.1	28.0	61.9	44.5	21.7	34.3	25.7	27.3	48.6	40.9	14.0	10.0	9.4	7.2	13.4	8.0	5.3	7.7	7.2	12.7	6.5	6.6	8.0	2.9	12.7	13.9	4.5	7.9	7.4	11.9	13.7	28.3	13.6	11.8	11.8	11.6	11.1	11.7	11.2	10.9	17.4	9.8	6.4	11.1	34.9	13.9	13.6	6.8	9.3	13.1	21.9	7.9	5.6	23.4	10.0	13.7	9.2	20.9	13.7	9.7	16.0	3.9	8.9	20.3	12.2	16.7	10.4	9.1	21.4	26.1	6.9	15.0	11.7	17.3	13.2	8.2	12.8	7.1	16.5	11.3	21.9	25.5	12.1	14.2	12.0	9.6	9.8	6.5	12.0	5.4	12.2	15.8	8.9	11.3	20.1	24.4	9.7	7.8	7.5	15.9	7.9	9.0	5.3	15.1	23.4	6.6	10.4	11.2	29.4	14.1	14.3	7.4	14.4	15.0	9.5	10.9	8.4
NCBP3	"C17orf85, ELG, HSA277841"	ENSG00000074356	"Nuclear cap binding subunit 3"	Q53F19	17	3802158-3846246	"Predicted intracellular proteins"	"Antiviral defense, mRNA capping, mRNA processing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008959, HPA013195"	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA008959: AB_2668184, HPA013195: AB_2668800"	"unprognostic (1.39e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (4.90e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.64e-1)"	"unprognostic (5.68e-2)"	"unprognostic (5.36e-2)"	9.4	8.2	8.1	7.9	10.2	17.1	8.8	8.8	9.6	11.3	7.7	10.0	8.4	8.3	3.5	9.6	10.7	4.9	9.4	8.5	9.2	8.5	6.9	8.1	6.5	8.7	9.7	10.8	12.0	5.8	6.8	7.1	9.7	8.5	5.8	10.4	9.4	4.3	8.8	11.8	10.3	5.8	8.6	10.8	9.4	16.8	9.1	13.9	8.4	3.3	5.4	9.5	9.4	15.2	12.4	15.8	14.3	10.6	7.3	5.3	7.0	8.3	5.6	11.4	7.2	6.3	4.7	10.9	7.3	8.8	5.4	22.2	10.8	10.9	14.5	13.6	14.9	8.9	7.7	7.0	6.1	5.4	12.6	8.2	4.6	10.9	11.5	9.1	9.6	16.0	11.2	11.1	8.5	4.1	19.7	9.6	13.1	5.6	5.9	33.8	11.3	7.1	5.9	6.3	5.2	11.2	17.4	5.9	11.9	11.6	9.1	11.2	9.8	6.5	8.9	10.3	18.2	5.9	6.0	9.3	8.3	9.6	10.3	0.9	2.0	2.6	2.2	1.3	1.9	1.7	1.8	3.0	1.3	1.1	3.0	2.5	2.8	1.4	0.8	2.1	3.2	1.2	8.1	10.2	8.8	9.6	8.5	9.2	8.7	9.7	9.7	8.6	9.1	15.2	45.1	51.3	41.2	0.0	31.2	0.0	26.8	0.0	26.2	44.8	32.2	27.3	0.0	22.8	24.1	25.8	35.5	93.6	59.5	13.1	13.7	24.8	13.5	49.8	63.2	27.8	10.9	21.7	0.0	23.5	21.0	31.1	29.6	48.2	24.0	56.7	29.6	21.5	23.3	33.7	0.0	16.6	0.0	29.9	0.0	17.0	24.8	28.3	0.0	0.0	36.7	20.9	46.4	0.0	0.0	26.8	16.9	18.8	37.7	28.6	20.3	18.2	35.0	45.4	32.9	42.4	27.8	48.0	50.6	30.9	0.0	99.3	34.3	34.1	19.4	28.4
NCOA5	"bA465L10.6, CIA"	ENSG00000124160	"Nuclear receptor coactivator 5"	Q9HCD5	20	46060991-46089962	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050231	Uncertain		Supported	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Actin filaments"		"HPA050231: AB_2681058"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.41e-5)"	"prognostic favorable (8.07e-4)"	"unprognostic (2.32e-1)"	"unprognostic (7.75e-2)"	"prognostic favorable (1.09e-4)"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.91e-2)"	19.1	17.0	15.8	18.5	16.7	9.5	19.6	21.7	17.4	25.1	17.2	22.2	14.2	24.8	19.4	18.6	21.8	12.2	15.6	16.1	17.6	18.8	15.3	15.2	25.1	16.5	15.7	28.5	20.5	20.3	21.8	18.7	15.2	21.4	16.3	23.1	20.4	14.6	19.6	21.9	21.6	17.7	15.7	25.7	19.2	25.8	16.9	26.2	20.7	14.6	25.0	20.8	19.6	17.4	39.5	34.2	47.4	49.0	22.2	23.3	37.8	26.7	24.0	42.5	34.7	47.8	30.6	64.3	44.0	26.0	36.1	51.2	39.6	33.5	36.5	39.1	19.9	38.7	33.4	40.7	23.5	53.4	36.1	16.8	43.8	22.5	20.4	22.2	30.6	33.1	36.3	50.9	33.9	50.9	74.2	41.3	43.2	33.3	41.8	55.6	31.4	28.0	25.1	44.3	42.5	38.5	42.8	51.7	37.3	26.9	41.1	62.3	28.7	44.6	33.8	27.1	42.2	32.9	50.5	43.2	31.1	31.1	29.1	3.9	9.5	13.4	13.4	10.3	15.4	13.1	14.3	13.6	9.8	17.7	13.3	12.4	7.0	8.8	10.7	21.6	10.0	7.1	15.8	16.7	21.7	17.4	16.1	17.6	16.5	15.7	15.2	15.7	16.9	17.4	7.3	9.6	12.6	24.2	12.5	6.4	3.1	6.7	10.8	13.2	9.7	8.0	5.2	10.0	7.3	9.2	22.9	11.2	11.8	8.2	0.0	8.9	7.5	6.9	11.7	9.1	9.5	9.7	29.4	12.4	8.8	7.9	12.2	7.7	1.3	11.6	9.3	9.3	7.8	3.3	31.6	10.4	4.1	10.1	3.2	5.0	13.7	6.7	3.6	42.2	9.2	7.4	13.4	19.6	35.8	11.7	3.2	15.4	12.1	4.4	4.5	5.2	8.6	9.0	6.6	10.7	7.0	28.1	15.7	8.7	5.4	6.7	8.7	8.4	9.2	3.6
NDOR1	"bA350O14.9, CIAE1, NR1"	ENSG00000188566	"NADPH dependent diflavin oxidoreductase 1"	Q9UHB4	9	137205685-137217009	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 13.4;Oligodendrocytes: 10.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024504	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA024504: AB_1854338"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.89e-3)"	"unprognostic (5.99e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.69e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.74e-3)"	6.5	8.2	8.7	9.8	9.6	17.2	6.9	7.9	12.5	8.1	5.4	8.4	9.6	7.8	2.0	8.3	7.9	4.6	6.6	8.3	7.1	9.0	7.1	8.6	11.5	10.7	9.0	7.0	8.9	4.0	8.2	4.0	10.2	9.6	2.9	3.9	8.6	5.2	4.0	9.5	10.6	3.7	7.9	14.2	8.7	10.5	9.9	8.9	10.1	1.5	5.4	7.8	7.2	12.9	14.2	21.2	13.8	21.8	5.7	5.6	42.7	20.4	9.1	19.1	13.0	21.6	16.3	19.9	15.6	7.7	15.3	52.1	10.0	14.3	3.8	25.9	16.3	17.6	59.7	11.6	9.6	19.9	36.2	7.8	9.7	21.6	7.9	5.3	8.9	25.9	29.2	20.6	7.0	25.8	21.0	35.8	22.5	12.9	26.0	38.0	16.5	28.2	6.0	12.4	17.6	17.5	16.8	17.0	10.6	6.1	27.2	22.8	12.0	35.3	22.9	41.7	23.2	12.5	26.8	20.7	15.4	18.1	20.7	1.1	2.1	3.1	1.3	2.2	1.1	0.5	1.2	1.2	1.7	1.0	0.6	0.6	2.9	0.7	1.7	1.1	1.8	1.5	8.7	9.6	7.9	12.5	8.3	7.1	10.7	9.0	10.2	7.9	9.9	12.9	1.4	0.0	2.6	13.4	3.9	0.5	0.7	1.0	5.2	0.4	1.5	1.3	1.6	1.5	1.6	3.7	0.0	4.5	1.4	3.3	1.9	1.1	0.8	1.3	1.9	1.8	2.4	1.3	8.6	1.1	3.5	1.6	5.1	2.1	1.3	2.0	1.1	0.8	2.5	0.0	7.5	1.9	2.0	3.2	1.3	1.1	0.6	2.7	1.8	6.5	5.4	0.1	5.2	3.5	10.5	1.6	1.5	0.4	6.9	0.7	2.6	1.2	0.3	0.9	0.0	0.9	1.4	1.9	1.2	3.2	0.3	3.7	3.8	1.6	2.2	0.8
NDST2	"HSST2, NST2"	ENSG00000166507	"N-deacetylase and N-sulfotransferase 2"	P52849	10	73801911-73811798	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 13.7;granulocytes: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 110.2"									HPA051515	Approved		Approved	Cytosol		NA	NA		130000	"Cluster 32: T-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA051515: AB_2681517"	"unprognostic (8.84e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.43e-3)"	"unprognostic (5.69e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (4.08e-7)"	"unprognostic (3.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.93e-2)"	"unprognostic (9.06e-2)"	14.9	16.7	11.6	19.6	11.6	53.6	13.3	15.7	14.2	15.7	10.6	13.6	10.7	15.7	11.6	16.8	15.0	15.1	11.4	11.6	11.7	14.4	10.9	17.0	24.6	12.6	11.4	15.8	14.1	18.4	15.8	12.5	11.2	15.6	12.1	14.9	17.7	14.2	8.9	18.8	17.4	15.8	10.4	35.3	13.6	13.6	12.5	31.9	13.3	8.5	23.9	15.3	15.4	11.5	10.0	7.9	16.7	26.2	20.9	23.0	9.1	12.3	24.5	13.4	13.3	4.6	12.4	9.5	7.1	21.8	13.6	11.6	8.1	11.8	9.6	23.4	8.5	9.3	7.0	7.3	36.7	11.8	110.2	22.9	14.5	21.4	22.4	41.1	17.5	17.9	9.2	33.8	16.6	8.1	12.7	13.4	4.5	6.4	36.4	8.5	8.2	5.9	11.5	7.2	5.5	9.0	9.9	23.5	7.5	11.3	18.6	18.6	29.5	6.3	7.8	9.1	8.4	17.4	8.0	11.8	7.2	17.0	5.5	0.7	2.7	1.1	2.7	1.9	3.1	1.2	2.3	2.3	2.0	1.3	2.6	3.4	2.8	1.1	1.7	3.4	1.6	1.8	11.6	11.6	15.7	14.2	11.6	11.7	12.6	11.4	11.2	10.4	12.5	11.5	1.5	0.0	3.0	13.7	5.4	1.3	0.8	0.6	1.2	0.7	4.1	2.3	1.8	0.0	1.8	0.0	0.0	1.4	3.6	4.7	0.0	5.4	7.5	0.8	1.2	1.1	2.4	7.8	7.5	9.6	1.5	1.9	4.6	0.7	14.5	0.3	1.4	4.2	5.2	1.7	7.6	2.6	2.0	8.5	3.1	10.4	0.0	10.8	1.8	2.8	5.4	0.8	0.0	5.0	5.0	7.0	3.2	0.0	10.6	1.3	2.4	7.4	2.7	0.8	0.0	1.4	1.5	2.3	1.7	4.7	1.6	6.2	5.3	0.3	2.2	1.9
NDUFA7	B14.5a	ENSG00000267855	"NADH:ubiquinone oxidoreductase subunit A7"	O95182	19	8308768-8321375	"Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 245.6"	"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 167.5;Proximal enterocytes: 183.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA059251, HPA071866"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA059251: AB_2683960, HPA071866: AB_2686465"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.85e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.35e-3)"	39.4	87.5	86.2	19.8	90.0	34.2	33.1	89.8	96.1	21.3	95.9	46.6	24.2	27.7	53.5	57.6	42.3	25.1	168.1	87.6	90.0	88.3	83.4	31.0	29.6	87.1	88.1	25.1	37.1	103.7	86.4	23.4	87.3	41.2	33.5	32.3	43.5	20.7	245.6	30.7	34.0	22.8	87.3	42.0	54.7	18.7	89.1	40.8	41.3	244.7	32.2	35.5	28.2	87.7	78.9	62.8	64.7	43.3	42.6	32.3	44.2	16.5	18.0	56.0	44.1	57.7	59.7	36.1	25.1	42.6	35.0	65.1	29.0	97.4	33.8	88.3	173.6	26.6	90.1	157.7	63.9	45.8	45.1	43.3	61.7	25.2	39.1	57.1	72.3	141.2	57.0	217.7	80.6	89.4	93.5	236.1	65.1	119.9	187.7	52.2	13.7	99.0	117.6	40.8	65.9	50.5	19.0	90.6	58.5	40.1	33.0	74.8	26.4	42.5	34.0	61.6	60.1	79.2	58.0	49.9	67.8	80.2	77.3	61.9	104.5	80.2	62.1	124.6	65.4	83.3	66.7	58.2	130.5	81.6	66.0	61.6	30.5	81.8	117.6	186.1	95.3	82.6	86.2	90.0	89.8	96.1	87.6	90.0	87.1	88.1	87.3	87.3	89.1	87.7	19.5	44.8	68.4	10.1	28.4	0.0	10.3	0.0	21.1	14.9	51.6	38.1	0.0	44.3	20.4	53.3	6.2	62.0	32.6	57.6	99.7	147.3	38.9	36.1	10.5	19.8	87.4	44.2	9.5	157.2	45.4	15.0	28.1	19.4	21.5	8.4	27.5	64.0	52.8	8.4	13.3	101.6	0.0	42.7	0.0	17.7	13.4	30.4	0.0	10.3	122.5	27.9	45.3	9.5	13.2	167.5	110.2	13.2	61.6	14.7	183.8	97.6	70.7	17.1	6.6	7.3	19.6	24.8	27.5	53.3	0.0	46.9	20.9	11.7	107.6	12.1
NEK9	"DKFZp434D0935, MGC16714, Nek8, NERCC, NERCC1"	ENSG00000119638	"NIMA related kinase 9"	Q8TD19	14	75079353-75127344	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001405	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"			"HPA001405: AB_1079467"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.57e-2)"	24.2	18.5	6.7	18.6	8.4	11.8	17.3	7.5	7.9	24.3	9.0	14.3	15.5	26.0	10.5	17.8	25.2	17.9	37.2	6.1	7.8	18.4	21.0	18.8	21.0	8.2	7.7	35.8	16.0	34.2	3.1	21.2	7.9	23.5	16.3	16.5	12.4	28.1	43.6	8.1	16.9	32.2	7.5	19.7	13.1	20.4	7.7	28.3	19.7	36.9	23.5	16.3	2.9	9.1	21.3	30.8	44.8	45.4	86.3	88.8	37.9	32.4	54.6	29.7	29.4	25.5	24.7	52.7	0.1	54.2	23.1	31.8	45.0	27.0	38.5	38.2	16.8	23.0	27.3	17.3	48.6	10.8	26.8	76.6	32.8	31.8	26.7	71.6	46.1	36.2	23.8	31.4	40.2	4.8	35.5	11.5	21.9	43.3	18.8	53.5	49.4	23.9	21.3	28.2	19.5	41.3	39.5	19.3	30.0	50.4	41.7	37.6	46.3	30.2	12.7	31.5	15.8	34.3	36.5	49.6	24.9	24.8	26.4	3.4	3.5	3.1	2.5	3.4	4.0	1.3	2.4	2.3	5.0	1.9	3.1	2.8	1.2	3.3	2.5	1.1	1.5	2.9	6.7	8.4	7.5	7.9	6.1	7.8	8.2	7.7	7.9	7.5	7.7	9.1	15.3	12.8	30.2	49.3	21.2	8.8	7.7	6.6	21.1	16.8	14.5	12.4	55.7	12.8	14.8	11.0	35.5	17.4	11.1	10.2	7.9	6.9	11.9	13.3	23.1	17.6	5.4	16.2	31.3	4.9	16.2	18.1	10.7	10.4	16.4	36.8	17.9	30.3	13.9	13.5	35.9	10.7	6.1	18.6	11.8	8.3	24.8	17.0	3.6	30.9	16.0	12.0	15.5	41.2	59.5	5.3	11.7	26.4	14.7	7.4	13.1	8.4	17.4	23.1	0.0	18.9	16.7	28.8	13.9	17.4	10.2	14.0	16.5	20.8	10.5	5.6
NEMP2	TMEM194B	ENSG00000189362	"Nuclear envelope integral membrane protein 2"	A6NFY4	2	190504338-190534722	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 10.8;NK-cells: 14.4;Spermatocytes: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA057719			Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA057719: AB_2683510"	"unprognostic (3.51e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.65e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (5.82e-2)"	"unprognostic (7.76e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.32e-1)"	1.5	1.7	0.7	2.5	1.0	1.9	1.5	2.7	1.0	1.4	0.1	1.3	0.9	1.3	1.0	1.5	1.1	1.1	1.0	0.6	0.4	1.3	1.8	1.7	3.7	0.7	0.7	0.9	1.2	1.0	1.3	1.0	0.9	1.3	0.9	1.2	2.1	0.6	0.5	2.1	1.6	1.2	0.4	2.3	1.9	3.0	0.8	4.7	1.9	0.7	3.0	1.3	1.6	1.4	5.0	2.7	1.8	2.3	1.0	2.7	4.7	3.5	3.0	3.4	4.3	4.0	6.8	7.3	2.3	1.8	2.4	8.7	2.8	7.6	6.9	5.4	2.4	5.2	2.6	2.8	2.6	5.7	1.7	2.8	3.1	15.9	4.1	3.2	1.6	8.0	4.6	8.3	6.8	2.3	6.3	2.7	1.9	2.7	2.9	2.6	3.9	3.4	3.1	3.7	3.2	2.7	5.6	0.6	5.6	3.0	1.4	6.1	2.9	7.7	6.0	1.5	3.9	4.5	5.4	3.8	6.0	5.8	5.7	0.0	0.4	0.0	1.5	0.4	2.0	1.3	1.7	1.3	0.5	1.9	2.7	2.3	0.1	1.3	0.3	1.9	3.1	1.2	0.7	1.0	2.7	1.0	0.6	0.4	0.7	0.7	0.9	0.4	0.8	1.4	4.5	0.0	0.6	0.0	5.9	0.0	2.1	0.0	4.0	5.5	2.0	1.3	1.6	0.0	0.0	1.8	0.0	3.0	10.8	0.2	0.0	2.0	4.5	0.9	3.3	4.0	0.0	4.6	0.0	2.0	3.1	4.1	2.0	1.2	1.3	5.4	3.9	3.4	2.9	3.3	0.0	1.0	0.0	3.3	0.0	6.2	2.8	3.1	0.0	0.0	2.4	2.5	14.4	0.0	0.0	0.7	1.8	1.2	9.5	2.1	0.6	2.3	0.0	2.0	0.0	4.9	5.1	17.0	6.1	3.9	0.0	1.2	6.4	5.3	1.7	2.2
NGRN	DSC92	ENSG00000182768	"Neugrin, neurite outgrowth associated"	Q9NPE2	15	90265659-90275778	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 385.3;skeletal muscle: 376.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041367, HPA076267"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitochondria"	"Intracellular and membrane"	Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Mitochondria	"Nucleoplasm, Cytokinetic bridge"	"HPA041367: AB_10796668, HPA076267: "	"unprognostic (2.82e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.00e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.21e-1)"	61.0	91.8	322.8	32.9	334.0	31.7	61.4	312.4	385.3	68.8	312.1	47.0	39.7	63.4	98.3	51.7	65.3	47.1	133.0	332.8	329.8	71.7	59.1	50.3	31.8	316.3	322.1	67.8	46.4	87.6	3.0	46.4	318.1	80.1	51.1	157.0	46.3	88.9	376.8	32.6	35.6	74.6	324.8	37.0	41.5	54.2	334.5	39.6	74.0	291.8	37.4	69.2	2.7	320.9	62.1	127.8	151.7	99.7	138.4	63.9	70.4	100.7	88.4	110.5	94.0	133.2	90.5	38.4	113.8	108.9	110.2	118.2	120.3	64.7	121.5	42.6	104.6	61.0	88.4	110.6	117.7	44.5	36.1	83.4	183.3	60.8	132.9	83.7	79.5	45.7	105.0	64.7	112.8	106.5	35.9	53.5	152.7	198.8	55.0	65.6	72.8	63.1	109.8	168.3	145.8	117.0	107.1	90.1	239.1	149.1	141.9	82.6	64.6	138.3	92.3	85.7	161.7	96.9	268.2	66.4	76.8	90.1	106.4	66.4	62.1	99.0	87.2	65.2	109.9	107.7	106.1	101.9	59.2	105.7	122.6	106.8	23.4	86.7	76.0	62.8	133.5	108.0	322.8	334.0	312.4	385.3	332.8	329.8	316.3	322.1	318.1	324.8	334.5	320.9	10.8	19.2	27.4	21.5	26.2	7.1	10.6	3.7	75.1	10.4	9.1	5.8	10.1	1.5	21.6	5.5	10.4	5.9	5.0	12.1	5.9	33.6	1.9	16.2	14.6	15.8	26.5	12.0	58.3	23.4	4.5	23.0	30.1	9.4	20.3	5.5	7.5	3.8	4.2	16.8	54.0	14.4	4.1	3.8	3.6	4.0	9.0	8.4	8.8	16.9	11.6	15.1	0.0	12.5	22.2	29.9	20.0	8.6	25.0	9.2	12.6	7.8	59.8	11.2	13.1	10.5	19.6	5.2	4.3	55.2	5.1	6.7	19.9	5.7	15.4	8.7
NHEJ1	"Cernunnos, FLJ12610, XLF"	ENSG00000187736	"Non-homologous end joining factor 1"	Q9H9Q4	2	219069357-219160865	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 7.8;Microglial cells: 11.2;Oligodendrocytes: 8.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012334, HPA043869"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB012334: , HPA043869: AB_2678707"	"unprognostic (5.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.29e-2)"	10.2	8.4	2.4	4.4	2.5	4.5	8.5	3.8	3.8	9.4	2.2	14.0	6.9	8.7	4.3	7.2	7.4	4.8	6.2	2.4	2.9	12.8	8.1	6.9	6.1	3.3	2.5	9.1	8.4	3.4	2.8	4.6	3.2	6.7	8.4	3.4	5.7	4.3	17.1	8.4	12.2	8.1	2.7	6.9	9.0	18.7	2.7	6.1	4.6	7.6	5.8	10.4	8.7	3.5	5.5	8.2	13.9	12.6	15.6	17.9	8.0	10.9	9.6	13.2	15.4	25.4	5.9	12.2	8.4	11.4	13.4	7.2	20.5	10.9	11.8	13.8	9.0	18.1	10.0	17.5	12.5	8.5	13.9	15.5	21.2	10.5	12.5	8.9	11.1	7.8	22.3	11.8	10.7	4.6	11.5	10.3	15.9	5.1	8.0	14.6	10.2	9.8	10.5	8.2	10.2	11.4	5.0	7.1	15.8	15.6	6.4	8.0	9.9	10.0	9.3	4.4	9.1	6.3	8.0	13.2	6.1	16.2	10.3	6.3	11.9	6.6	7.0	17.7	12.2	12.0	11.4	9.3	8.7	9.0	14.1	10.4	3.3	11.6	15.6	4.8	12.8	9.1	2.4	2.5	3.8	3.8	2.4	2.9	3.3	2.5	3.2	2.7	2.7	3.5	0.3	0.0	0.0	5.9	3.5	0.4	0.0	0.2	5.7	0.0	0.2	0.1	0.1	0.0	0.7	0.0	0.0	0.2	1.7	7.8	0.0	1.6	0.7	0.1	0.3	1.0	2.4	3.8	4.7	1.9	0.3	0.6	5.6	0.2	0.0	0.0	0.0	0.3	0.3	0.0	5.1	3.4	0.0	0.0	0.0	0.2	0.3	2.1	0.0	11.2	3.1	0.0	0.0	5.0	8.1	1.0	2.9	0.0	6.1	0.2	3.4	0.4	0.0	0.0	0.0	0.1	1.3	0.2	0.5	5.9	0.0	0.3	2.6	0.2	3.1	0.0
NOC3L	"AD24, C10orf117, FAD24, FLJ12820"	ENSG00000173145	"NOC3 like DNA replication regulator"	Q8WTT2	10	94333226-94362959	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063958, HPA067638, HPA070981"			Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA063958: AB_2685160, HPA067638: AB_2685876, HPA070981: AB_2686331"	"unprognostic (1.29e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.58e-2)"	"unprognostic (6.49e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.93e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.30e-1)"	8.6	9.0	5.1	9.5	6.5	3.6	11.2	5.9	5.9	6.7	5.9	5.2	5.4	8.5	6.4	9.0	6.2	5.7	5.3	4.6	5.8	7.2	9.9	5.2	13.1	6.5	6.4	8.2	5.3	9.1	4.3	8.9	6.5	7.4	6.3	6.2	5.3	6.5	9.4	9.3	5.4	7.1	6.4	11.4	5.5	10.4	5.8	7.5	11.1	10.4	13.2	10.3	6.4	7.1	38.4	20.6	13.6	44.1	13.9	22.4	16.1	29.9	23.6	40.2	46.3	35.1	26.4	41.3	21.4	15.0	20.6	26.9	39.2	18.0	64.6	28.3	29.3	28.1	16.6	22.6	27.8	45.0	12.2	13.0	17.3	42.5	42.2	26.2	18.1	15.1	44.2	20.3	40.0	12.9	28.5	33.2	28.9	22.3	22.4	12.5	31.3	22.8	23.7	11.7	9.7	24.1	21.4	10.7	33.9	15.2	27.6	17.1	17.7	25.6	25.9	23.4	50.9	19.1	40.8	56.8	23.4	42.6	19.5	0.1	2.6	0.6	4.3	4.3	5.4	14.4	4.4	5.5	4.6	12.8	5.7	5.2	0.1	8.2	5.0	4.1	4.3	3.3	5.1	6.5	5.9	5.9	4.6	5.8	6.5	6.4	6.5	6.4	5.8	7.1	33.5	19.2	13.7	11.4	38.0	23.7	32.7	17.0	33.0	20.7	16.4	20.7	22.5	14.3	31.8	22.0	8.4	21.1	17.7	5.1	25.4	20.6	3.9	20.3	50.1	26.1	5.4	26.7	11.7	13.8	15.1	27.0	10.2	17.0	29.2	26.9	11.7	12.9	13.2	13.5	15.5	8.1	12.2	17.0	11.9	5.0	18.3	15.0	12.4	11.2	23.3	20.5	20.6	19.6	23.6	15.3	3.4	24.8	26.3	34.1	1.7	22.7	21.1	20.9	13.1	37.8	23.7	64.0	64.5	25.5	21.7	15.2	17.3	44.5	10.7	19.1
NOL9	"FLJ23323, Grc3, NET6"	ENSG00000162408	"Nucleolar protein 9"	Q5SY16	1	6521347-6554513	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Kinase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036347			Supported	"Nucleoli,Intermediate filaments"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoli	"Intermediate filaments"	"HPA036347: AB_2675076"	"unprognostic (3.03e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.14e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.65e-2)"	3.8	4.6	4.5	3.5	5.0	7.5	3.7	4.9	5.6	4.7	1.9	5.0	2.4	5.0	3.6	4.7	4.3	2.3	4.5	6.2	4.2	4.4	5.3	3.2	5.2	3.3	3.8	4.8	6.0	3.4	4.0	3.0	3.8	4.1	3.1	4.3	3.6	3.1	7.0	6.0	4.8	3.9	2.7	8.8	4.5	3.7	4.6	3.8	3.4	4.5	5.1	4.5	3.8	4.0	6.4	9.1	5.0	15.2	6.6	4.0	5.4	6.3	4.1	6.4	6.8	12.6	8.6	17.9	7.3	7.1	5.5	8.3	10.2	8.6	10.9	7.3	5.5	12.2	14.7	9.9	6.6	10.4	6.4	5.8	2.6	13.6	11.8	3.7	7.6	7.8	14.3	7.3	6.6	11.2	10.2	9.2	6.9	5.0	8.7	12.7	11.7	8.3	5.1	5.8	9.7	4.4	9.7	12.1	8.1	5.1	7.9	4.8	10.0	10.1	8.1	7.2	10.6	6.1	6.2	31.9	9.4	11.4	4.9	3.5	1.9	1.6	3.1	1.9	3.2	2.9	4.5	2.9	1.3	3.7	4.6	3.8	1.2	1.7	3.2	3.5	3.2	1.2	4.5	5.0	4.9	5.6	6.2	4.2	3.3	3.8	3.8	2.7	4.6	4.0	15.0	19.2	19.5	9.4	16.2	15.4	6.9	6.9	10.8	17.1	9.8	13.2	15.0	11.5	7.4	7.3	14.6	14.8	17.3	6.7	15.6	8.9	6.0	13.7	19.7	15.2	6.7	11.6	18.9	8.6	12.6	15.3	11.7	15.6	5.1	18.3	14.3	13.2	9.1	10.1	18.5	10.9	4.1	13.8	7.3	17.0	9.6	8.6	1.8	10.3	13.4	8.1	12.3	13.0	20.1	9.0	6.2	12.8	17.9	7.3	7.6	10.7	9.0	18.2	0.0	22.6	12.7	11.7	21.5	16.0	14.8	12.7	17.3	19.1	13.2	7.3
NOP2	"NOL1, NOP120, NSUN1, p120"	ENSG00000111641	"NOP2 nucleolar protein"	P46087	12	6556863-6568691	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA040119	Supported		Enhanced	Nucleoli		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA040119: AB_10965321"	"unprognostic (2.88e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (2.35e-10)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-3)"	28.4	22.6	14.6	22.6	15.1	34.6	19.8	15.2	18.5	20.5	14.7	20.8	14.2	20.8	10.2	28.6	21.2	10.9	18.8	15.0	15.1	21.7	26.7	20.6	28.3	14.9	14.6	20.2	21.6	9.9	21.2	12.2	15.0	25.0	14.2	6.6	19.2	8.6	42.2	25.7	24.5	14.7	14.4	32.3	20.6	23.1	15.3	22.8	23.5	12.2	28.7	21.7	21.0	15.4	69.0	107.2	29.5	101.8	37.4	32.1	159.8	61.4	40.4	71.8	61.6	130.5	69.0	144.7	16.7	30.8	75.5	84.9	113.9	69.6	68.0	175.3	105.2	143.7	110.8	78.5	49.0	141.2	79.9	33.0	67.3	87.9	135.8	31.3	50.2	76.9	102.7	22.8	58.1	83.7	77.1	124.7	247.6	93.6	59.9	108.4	84.1	72.8	53.1	92.1	22.7	44.5	94.1	102.5	50.2	116.2	17.1	70.4	47.6	49.1	64.1	63.7	143.2	31.2	49.7	217.9	45.0	81.3	88.6	2.4	14.0	1.5	23.6	19.5	32.7	21.0	22.4	27.1	28.7	15.8	27.2	28.2	5.1	22.2	19.0	24.8	16.8	19.9	14.6	15.1	15.2	18.5	15.0	15.1	14.9	14.6	15.0	14.4	15.3	15.4	3.9	12.8	6.8	7.8	20.5	23.8	17.7	12.9	47.8	5.8	6.0	4.4	6.8	5.7	6.4	3.7	2.1	12.6	6.6	13.1	1.9	12.0	17.9	4.2	4.4	11.4	7.2	19.4	9.1	11.8	13.4	10.3	26.0	4.3	7.6	1.4	7.9	8.3	11.8	6.7	7.3	11.1	16.2	7.7	15.7	7.3	9.3	11.7	8.8	2.8	7.7	3.0	18.6	5.5	5.7	13.5	5.3	4.9	19.2	19.2	2.1	1.3	5.2	2.9	13.1	22.7	9.7	11.3	21.4	43.4	21.3	7.3	16.2	1.2	16.4	16.7
NPAT	"E14, p220"	ENSG00000149308	"Nuclear protein, coactivator of histone transcription"	Q14207	11	108157215-108222638	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 51.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045908, HPA066370"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"		"HPA045908: AB_2679493, HPA066370: AB_2685665"	"unprognostic (6.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.60e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.38e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.93e-1)"	4.6	4.2	1.6	8.1	2.1	4.5	6.9	7.4	2.8	6.4	3.9	5.4	4.1	6.7	5.9	4.6	4.6	4.7	4.3	1.4	2.4	5.6	5.6	5.4	14.9	2.6	3.0	7.6	3.1	6.8	3.2	6.6	2.4	5.6	6.2	6.6	4.4	4.4	3.1	5.2	4.9	5.1	2.2	9.9	5.9	7.0	2.3	12.0	8.3	5.3	13.3	7.0	3.8	3.0	7.9	6.3	9.7	12.1	11.7	8.5	7.9	11.6	14.6	10.0	14.9	13.0	16.8	13.5	15.2	7.3	11.2	14.6	13.4	11.7	17.8	12.2	5.3	22.5	6.8	6.7	5.0	17.0	14.3	8.1	6.7	17.6	11.2	7.8	14.3	15.5	21.2	6.5	14.1	3.9	21.0	9.1	8.0	12.6	8.7	14.3	13.6	18.5	6.4	11.3	10.3	9.5	14.9	8.8	11.3	10.1	10.0	8.3	11.8	17.3	9.3	10.3	10.5	4.5	6.1	51.9	4.3	12.4	13.7	6.8	1.6	2.9	4.9	2.6	5.5	4.1	5.7	6.3	1.8	4.3	8.9	7.5	1.9	5.3	2.9	1.5	4.6	3.2	1.6	2.1	7.4	2.8	1.4	2.4	2.6	3.0	2.4	2.2	2.3	3.0	23.1	19.2	13.2	24.2	40.8	16.3	16.4	10.5	27.3	16.5	12.0	7.6	15.2	4.3	13.2	12.9	29.2	10.3	32.8	5.6	1.9	8.4	4.9	11.1	15.0	21.1	10.3	29.5	25.5	6.8	8.2	15.9	12.2	14.2	19.6	16.7	22.9	9.1	7.4	10.1	32.2	7.9	8.2	13.0	12.8	3.2	15.8	13.8	8.8	19.7	14.5	11.8	27.8	19.6	24.3	6.8	6.5	17.0	37.8	14.1	7.1	5.6	10.9	16.9	6.6	19.8	13.1	26.2	32.5	14.0	13.2	14.1	35.3	14.9	8.7	15.9
NSUN2	"FLJ20303, Misu, MRT5, TRM4"	ENSG00000037474	"NOP2/Sun RNA methyltransferase 2"	Q08J23	5	6599239-6633291	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis, tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037896	Supported		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		110000	"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA037896: AB_10670532"	"unprognostic (3.99e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (8.56e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.44e-3)"	"unprognostic (5.12e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.48e-2)"	"prognostic unfavorable (5.69e-5)"	"unprognostic (1.98e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.70e-2)"	21.6	16.0	10.4	29.1	10.9	28.2	38.6	11.3	13.4	16.2	12.0	24.7	20.8	18.2	19.5	24.1	17.7	17.8	23.0	10.8	11.3	16.4	36.7	19.5	34.3	11.2	10.6	18.0	20.0	24.9	11.5	19.8	11.2	20.7	27.7	10.9	17.9	17.0	39.0	22.7	20.4	22.4	10.4	23.0	21.4	18.9	11.8	26.5	18.0	30.2	36.8	29.3	15.0	13.2	97.6	85.8	49.9	45.4	31.7	36.1	112.9	72.5	48.6	84.4	71.5	113.0	75.6	170.6	74.0	63.8	101.6	70.7	102.1	90.6	114.6	115.1	73.4	100.8	199.0	67.0	44.8	176.8	77.4	40.2	67.5	91.8	80.5	33.6	60.6	70.3	132.3	66.3	79.9	71.1	93.2	89.3	80.0	69.3	101.3	121.1	50.5	54.7	61.7	112.1	45.8	65.4	184.4	101.2	79.1	65.0	85.0	84.2	66.6	66.8	82.0	68.4	111.1	51.2	100.1	159.9	52.9	143.9	77.6	16.2	18.6	21.2	21.1	22.4	27.9	22.4	22.1	25.0	21.5	20.6	23.2	23.5	3.9	24.4	21.2	20.2	17.0	17.0	10.4	10.9	11.3	13.4	10.8	11.3	11.2	10.6	11.2	10.4	11.8	13.2	13.2	19.2	17.6	27.7	26.3	37.7	16.4	15.7	21.6	6.2	15.5	14.2	18.7	17.2	30.3	18.4	14.6	20.1	17.1	16.2	9.8	19.6	3.1	11.2	12.9	16.2	14.9	22.3	37.2	15.3	21.2	14.5	17.9	14.1	20.8	17.8	10.0	33.9	14.4	3.3	30.2	16.5	16.2	18.5	21.1	2.9	13.1	16.4	16.0	20.6	21.9	7.2	21.6	24.1	45.4	24.8	14.8	14.3	23.0	18.9	10.2	9.8	17.4	7.3	6.6	20.2	15.4	14.9	17.7	30.1	30.5	23.1	20.7	17.2	19.8	17.0
NUP133	FLJ10814	ENSG00000069248	"Nucleoporin 133"	Q8WUM0	1	229440259-229508341	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059767	Approved		Supported	"Nuclear membrane"		NA	NA		6300	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA059767: AB_2684123"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.30e-2)"	12.3	10.7	9.2	11.2	10.8	12.6	15.8	13.1	11.9	11.7	7.5	11.2	8.6	14.4	11.2	10.6	13.9	8.6	15.2	9.2	9.2	12.2	10.1	10.8	14.3	9.5	9.0	16.5	10.0	17.9	9.9	15.1	9.8	11.7	11.4	19.1	10.0	11.8	17.9	13.4	9.6	13.2	10.1	11.6	9.8	13.0	8.9	16.8	13.8	14.3	15.4	11.1	10.4	14.5	30.6	24.3	37.0	19.2	26.0	27.8	71.9	24.8	25.1	36.0	32.4	28.8	29.4	44.1	20.9	24.8	16.1	39.4	51.8	26.3	38.4	26.8	64.2	26.7	23.6	21.8	20.9	54.8	20.8	21.8	19.4	25.9	30.8	25.0	30.5	37.1	61.2	20.6	28.6	13.7	40.8	23.4	55.6	42.7	21.8	39.1	38.5	43.6	20.3	26.6	31.7	39.3	36.9	22.9	27.6	18.0	35.7	42.8	26.8	16.3	19.9	28.5	37.3	19.7	26.1	46.8	18.6	31.2	34.6	5.5	5.7	4.4	5.6	5.7	7.0	5.8	5.9	6.2	7.1	4.4	5.9	6.3	1.9	5.5	10.2	4.0	5.9	5.2	9.2	10.8	13.1	11.9	9.2	9.2	9.5	9.0	9.8	10.1	8.9	14.5	10.4	9.6	18.9	26.4	19.9	9.1	6.8	10.1	13.6	16.5	9.9	8.5	21.2	14.3	10.7	14.7	8.4	21.4	11.5	4.4	5.9	8.3	1.5	10.9	8.7	10.3	10.2	21.7	48.9	8.5	13.8	13.8	15.8	8.4	7.6	17.1	11.7	12.0	9.8	16.8	44.1	7.5	8.2	13.6	8.6	3.7	12.5	10.8	7.2	25.3	13.4	12.4	5.2	28.1	60.2	7.0	4.9	12.0	19.0	6.7	4.7	7.9	13.1	12.3	0.0	16.3	10.7	12.6	18.2	14.6	10.7	18.3	13.6	11.8	9.0	6.6
NUP205	"C7orf14, KIAA0225"	ENSG00000155561	"Nucleoporin 205"	Q92621	7	135557917-135648757	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		24000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"				"unprognostic (3.64e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.66e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (1.90e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.35e-2)"	7.5	6.7	2.0	13.1	3.3	10.7	11.5	6.7	2.6	8.9	3.8	10.0	8.0	10.7	7.2	11.0	10.4	6.4	4.9	1.7	3.1	8.0	6.6	8.4	15.0	2.7	2.7	11.8	6.1	15.1	5.2	11.0	3.2	8.7	12.3	14.8	11.8	9.0	8.0	9.6	8.3	12.7	2.6	10.3	9.0	11.6	3.2	21.8	8.4	8.0	17.3	9.9	6.9	4.4	66.4	52.8	69.5	68.2	16.2	26.6	45.4	41.0	31.5	62.4	69.1	55.1	46.8	84.2	31.7	24.6	63.0	50.1	88.5	46.0	80.1	41.9	63.3	48.9	52.1	25.1	12.2	96.5	37.0	14.5	20.5	61.4	40.8	21.9	47.3	58.9	115.6	39.1	47.6	45.0	105.0	29.4	107.0	51.6	46.3	77.6	64.6	66.6	18.8	52.4	69.3	70.4	67.8	54.8	31.8	52.4	31.6	36.5	38.6	51.0	25.3	62.7	79.5	28.7	57.2	112.3	51.7	74.3	70.1	1.6	1.3	0.4	2.4	3.1	2.8	2.3	2.9	2.5	3.0	2.1	2.3	2.7	0.5	2.9	1.7	1.9	2.9	1.4	2.0	3.3	6.7	2.6	1.7	3.1	2.7	2.7	3.2	2.6	3.2	4.4	7.9	12.8	13.4	24.8	15.3	13.0	6.8	10.3	11.4	6.3	8.6	5.2	5.3	7.2	10.6	16.5	12.5	13.1	7.5	8.2	3.9	7.8	0.9	7.4	8.1	9.3	9.1	21.3	22.7	9.6	9.3	9.4	13.3	8.4	8.2	18.5	7.9	10.7	10.3	5.0	24.1	10.4	6.1	14.1	11.7	2.4	8.1	12.2	10.6	17.8	11.4	4.9	3.1	26.2	23.3	11.9	6.4	7.5	17.4	10.3	3.9	4.6	12.4	9.7	0.0	12.6	8.2	14.5	10.8	14.8	15.5	7.7	11.9	6.1	10.9	9.4
ORC5	"ORC5L, Orc5p, ORC5T, PPP1R117"	ENSG00000164815	"Origin recognition complex subunit 5"	O43913	7	104126341-104208047	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 54.4;Inhibitory neurons: 48.8;Oligodendrocytes: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019730	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA019730: AB_10696205"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.72e-2)"	"unprognostic (4.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.47e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (6.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.73e-2)"	9.7	9.8	10.5	7.8	11.5	5.8	13.2	14.3	12.5	10.2	7.8	12.0	8.4	10.8	13.7	10.6	8.9	6.6	6.3	11.2	10.5	10.4	17.4	6.4	12.2	10.3	10.0	10.7	14.5	10.1	7.5	9.5	9.7	16.9	12.8	14.1	8.9	10.6	9.0	11.6	7.5	10.9	9.3	9.0	10.3	19.3	11.6	13.3	10.2	7.9	13.4	11.0	10.0	11.2	37.1	39.2	21.2	38.1	21.8	21.5	18.8	31.0	30.8	34.2	28.5	25.9	23.7	55.4	26.9	19.5	37.9	33.1	42.4	29.9	40.8	32.3	30.5	20.2	19.1	24.8	30.8	37.9	16.5	22.3	27.9	39.4	36.2	14.4	32.8	30.1	65.0	29.3	30.8	52.6	52.4	38.7	23.2	48.6	37.9	21.6	38.0	53.4	26.4	26.4	28.9	23.5	30.2	58.7	41.3	16.5	19.7	28.4	19.2	32.8	36.0	51.8	41.6	33.7	75.8	69.3	22.2	49.7	39.8	14.2	10.6	8.4	20.2	12.7	26.5	24.0	21.6	23.9	12.3	18.7	25.7	28.9	1.4	20.6	10.9	11.4	18.4	13.7	10.5	11.5	14.3	12.5	11.2	10.5	10.3	10.0	9.7	9.3	11.6	11.2	6.7	3.2	7.2	22.2	11.2	4.5	3.6	11.4	10.8	6.6	6.6	5.7	6.2	8.6	9.8	3.7	0.0	22.1	2.6	4.4	1.9	10.3	5.7	3.8	9.8	9.1	5.4	12.8	54.4	9.0	14.3	8.6	9.7	4.5	5.1	11.6	4.6	9.7	8.8	3.3	48.8	8.9	6.1	4.8	4.2	5.7	6.2	6.0	1.8	35.6	7.8	3.4	7.2	31.2	55.9	7.4	5.4	7.9	13.9	4.9	5.9	7.2	12.9	12.5	0.0	4.1	10.9	40.1	24.6	12.6	8.5	10.5	9.5	10.3	8.1	2.0
OTUD6B	"CGI-77, DUBA5"	ENSG00000155100	"OTU deubiquitinase 6B"	Q8N6M0	8	91070196-91087095	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024046, HPA024503, HPA024772"	Approved	Approved	Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA024046: AB_10600925, HPA024503: AB_1854845, HPA024772: AB_1854846"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.78e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.78e-2)"	"unprognostic (5.71e-2)"	6.6	6.2	5.7	6.3	6.1	5.9	7.2	5.9	8.6	5.2	5.0	5.3	4.2	6.0	4.6	6.4	4.2	3.9	6.5	5.4	6.1	5.4	5.4	4.7	7.4	6.2	6.2	5.3	4.6	4.0	3.5	8.0	6.3	5.8	5.4	3.1	4.3	4.7	10.2	6.4	4.4	5.5	6.3	5.0	4.3	6.4	5.9	5.7	6.0	9.2	6.1	6.3	5.4	7.5	27.6	11.1	12.8	10.4	6.4	5.6	14.5	19.1	7.4	19.1	12.6	8.6	16.6	25.6	9.0	10.2	7.6	9.1	26.4	16.1	31.6	21.6	16.9	34.5	11.7	8.3	13.3	18.7	21.0	7.2	9.8	14.0	35.5	11.6	17.5	19.4	36.5	19.1	18.9	9.6	31.7	17.5	8.1	20.3	27.3	19.4	11.2	28.9	18.9	15.1	3.5	14.6	2.6	55.9	22.7	16.3	25.5	11.8	15.8	12.3	17.2	20.6	20.5	17.1	29.5	37.2	16.8	26.2	23.1	1.7	1.9	1.1	1.5	2.7	2.0	2.0	1.4	1.7	2.6	1.8	2.1	1.9	0.2	3.4	2.1	4.0	0.8	1.0	5.7	6.1	5.9	8.6	5.4	6.1	6.2	6.2	6.3	6.3	5.9	7.5	11.9	9.6	11.3	9.8	13.7	23.2	6.5	4.0	10.8	13.0	6.5	5.2	14.3	8.6	9.2	1.8	33.3	10.8	16.5	5.1	9.8	4.8	0.9	10.6	9.9	10.9	10.8	8.2	18.0	4.9	10.0	9.0	7.7	8.6	18.4	10.7	8.9	11.7	8.1	11.8	15.5	4.9	4.1	8.7	12.5	2.2	9.6	8.3	3.6	12.2	10.2	12.2	11.3	18.6	21.6	6.6	3.7	4.1	12.0	8.9	2.8	8.2	8.8	15.3	0.0	8.2	9.6	3.2	7.0	12.5	18.2	6.7	10.7	9.9	6.4	5.9
OVCA2		ENSG00000262664	"OVCA2 serine hydrolase domain containing"	Q8WZ82	17	2042022-2043425	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"B-cells: 10.3;Basal squamous epithelial cells: 19.9;Erythroid cells: 11.3;Gastric mucus-secreting cells: 21.9;Macrophages: 8.4;Plasma cells: 31.0;Squamous epithelial cells: 32.2;T-cells: 10.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA059002			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA059002: AB_2683875"																		27.0	39.4	35.9	20.8	35.9	32.2	23.6	36.5	42.0	16.7	36.9	26.1	26.1	18.1	22.3	36.4	17.6	22.3	30.2	36.3	36.7	36.4	42.0	21.0	30.9	36.3	36.2	16.6	37.8	23.4	33.0	17.9	36.5	24.7	21.5	18.2	26.8	16.4	33.0	32.1	26.5	16.6	36.1	30.0	31.3	29.6	37.4	22.5	21.6	26.6	24.6	30.2	21.1	36.8	57.7	64.6	24.1	49.5	30.2	40.5	39.3	39.2	49.1	51.1	44.7	70.1	39.6	19.3	41.4	63.9	32.7	44.5	36.2	62.8	35.7	28.5	74.1	28.9	34.4	31.2	79.1	20.6	54.5	54.9	59.0	48.8	34.6	27.1	68.9	28.7	21.8	60.3	62.4	47.1	32.7	33.5	20.3	48.7	38.5	27.6	22.3	26.9	62.7	39.6	17.2	55.9	26.9	44.0	57.1	23.9	55.3	37.3	53.3	66.2	20.8	49.2	75.4	36.6	39.9	13.0	58.5	44.9	56.7	21.7	84.6	35.7	71.5	77.5	72.3	75.6	69.5	75.9	75.8	66.0	49.3	47.3	23.9	89.9	59.7	87.8	124.7	87.7	35.9	35.9	36.5	42.0	36.3	36.7	36.3	36.2	36.5	36.1	37.4	36.8	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.3	0.0	11.3	0.0	0.0	0.0	3.8	21.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	31.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	32.2	0.0	0.0	10.4	0.1	0.0	0.0
PAGR1	"C16orf53, GAS, MGC4606, PA1"	ENSG00000280789	"PAXIP1 associated glutamate rich protein 1"	Q9BTK6	16	29816152-29822489	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 166.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.6;Plasma cells: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041440, HPA043608"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"			"HPA041440: AB_10795541, HPA043608: AB_10797144"	"unprognostic (2.35e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.44e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.09e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.51e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.39e-2)"	23.5	27.8	10.2	5.5	10.8	6.5	23.2	18.4	12.3	120.8	8.9	48.9	8.7	55.3	7.1	25.7	68.4	6.1	32.0	10.1	9.9	30.4	28.1	23.0	8.7	10.9	10.7	166.5	26.3	7.4	128.9	3.7	10.8	69.3	5.7	6.8	21.4	8.8	24.6	18.0	30.8	4.7	10.5	23.6	26.4	31.2	10.6	9.3	30.2	9.0	6.8	50.7	73.8	12.5	16.7	24.1	13.9	8.7	7.0	6.7	11.8	12.7	11.5	14.5	12.7	17.1	16.9	33.4	12.7	9.1	7.2	15.4	15.2	19.1	9.2	14.8	31.1	14.8	16.4	16.1	7.3	23.6	26.9	7.5	15.1	10.2	10.0	13.4	12.1	31.0	20.1	10.4	9.9	45.2	18.6	27.6	19.3	14.2	20.4	35.4	24.5	24.9	10.8	7.8	34.9	13.2	9.6	22.4	9.7	10.5	20.9	15.0	9.2	12.0	10.9	15.2	12.9	19.4	21.3	13.1	15.8	24.2	15.0	22.5	16.9	33.0	19.7	17.0	22.1	19.7	16.8	20.0	21.3	19.5	21.7	20.1	11.0	13.9	19.6	21.5	12.7	15.2	10.2	10.8	18.4	12.3	10.1	9.9	10.9	10.7	10.8	10.5	10.6	12.5	1.3	0.0	9.8	66.6	15.2	0.0	0.3	0.1	18.2	3.5	4.7	2.9	0.6	14.3	6.9	1.8	0.0	5.6	5.3	5.9	0.0	27.9	0.5	1.0	1.3	3.8	14.6	10.7	16.2	21.7	8.2	4.4	13.3	0.8	7.6	0.3	6.1	2.0	7.5	5.0	16.5	11.1	0.0	5.6	0.0	0.6	0.9	7.7	0.0	9.4	22.5	1.9	4.1	11.6	8.6	13.5	15.8	3.4	34.5	0.7	20.7	2.1	3.0	3.3	0.0	0.9	5.0	3.1	1.6	16.7	0.4	6.7	10.9	0.2	13.2	0.2
PAM16	"Magmas, Tim16, TIMM16"	ENSG00000217930	"Presequence translocase associated motor 16"	Q9Y3D7	16	4331549-4355607	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 109.3"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 67.2;Gastric mucus-secreting cells: 36.2;Plasma cells: 39.5;Squamous epithelial cells: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 184.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062721			Approved	Nucleoplasm,Microtubules,Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Mitochondria"	Microtubules	"HPA062721: AB_2684849"	"unprognostic (2.69e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.06e-1)"	"unprognostic (6.81e-2)"	"unprognostic (6.98e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (5.73e-5)"	"unprognostic (7.25e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.56e-1)"	"prognostic favorable (1.33e-4)"	26.2	44.3	16.2	6.4	16.9	14.4	24.5	14.8	29.0	21.8	15.6	23.8	14.9	20.5	7.0	25.9	22.3	3.9	70.7	16.4	16.2	28.7	66.4	22.4	7.6	15.5	15.9	20.0	39.2	7.4	27.7	6.2	15.6	20.6	4.8	4.7	19.1	8.2	109.3	21.5	19.6	5.1	14.9	22.4	26.8	34.5	15.9	5.8	17.9	17.6	6.1	26.2	20.7	16.2	20.7	41.2	13.8	41.1	5.2	15.2	44.1	34.3	9.8	23.3	15.5	39.0	28.5	49.4	43.7	10.6	22.6	28.5	12.0	16.3	5.5	56.1	87.8	44.8	26.0	20.4	23.4	33.0	34.6	17.7	27.6	17.2	13.0	12.5	13.2	44.1	68.9	24.8	13.2	57.1	40.1	92.8	41.6	16.2	71.5	54.5	18.6	61.5	10.0	12.8	61.8	49.6	32.7	31.7	52.4	8.3	25.7	54.0	13.2	26.0	41.9	184.8	49.7	34.0	46.7	71.1	15.3	30.3	34.8	0.3	25.0	3.2	17.9	16.2	17.0	26.0	16.3	16.4	17.5	23.2	20.0	20.7	14.3	18.3	18.1	33.2	21.7	18.9	16.2	16.9	14.8	29.0	16.4	16.2	15.5	15.9	15.6	14.9	15.9	16.2	2.6	3.2	4.8	0.0	12.8	4.0	1.4	6.9	67.2	0.8	9.8	7.7	0.5	10.0	5.0	0.0	0.0	2.3	3.7	1.8	7.9	4.0	3.3	14.3	11.9	4.4	0.0	18.5	0.0	3.1	2.8	7.0	36.2	10.0	1.3	12.0	3.3	14.6	1.6	1.7	0.0	2.6	2.0	4.3	1.5	2.2	5.0	6.9	1.8	0.0	4.5	0.4	0.0	0.0	0.0	4.8	2.5	3.8	39.5	1.2	5.5	7.3	5.1	0.6	6.6	2.0	5.1	9.7	13.7	81.3	5.8	1.2	8.8	1.7	3.5	1.3
PCIF1	"bA465L10.1, C20orf67, CAPAM, PPP1R121"	ENSG00000100982	"Phosphorylated CTD interacting factor 1"	Q9H4Z3	20	45934683-45948023	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049517	Enhanced		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Microtubules, Cytokinetic bridge"	"HPA049517: AB_2680801"	"unprognostic (5.42e-3)"	"unprognostic (7.76e-2)"	"unprognostic (7.69e-2)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (1.39e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.50e-6)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.24e-1)"	28.7	28.0	20.7	18.6	23.0	33.9	28.7	30.2	24.2	36.1	17.6	30.7	16.5	39.7	10.8	24.4	35.3	16.3	31.9	20.4	20.2	23.4	19.5	28.2	27.3	22.7	21.6	41.7	29.5	22.8	26.0	17.0	22.1	26.2	11.7	15.9	23.6	21.3	41.7	36.7	27.2	21.3	20.9	34.7	25.4	18.1	21.7	34.4	32.0	27.6	19.6	28.6	29.3	24.9	21.2	29.0	22.0	27.2	15.3	18.2	24.2	8.3	25.1	24.9	24.2	49.3	27.7	22.7	27.4	22.6	28.7	23.4	15.8	29.0	10.8	14.1	11.4	29.1	23.1	33.4	28.2	26.4	28.1	25.5	29.9	15.3	24.5	22.3	21.0	37.1	20.8	30.9	17.9	44.6	52.3	48.3	7.8	25.5	24.9	32.2	20.4	28.0	20.1	21.8	30.2	30.0	31.5	29.5	16.1	11.6	31.0	30.7	18.1	30.7	24.1	27.3	16.8	35.4	22.1	21.0	37.7	23.8	18.2	75.5	47.5	80.2	54.5	47.2	43.0	51.6	47.3	50.2	50.3	56.2	48.6	43.0	74.6	74.3	48.0	40.4	54.4	64.0	20.7	23.0	30.2	24.2	20.4	20.2	22.7	21.6	22.1	20.9	21.7	24.9	19.7	3.2	14.2	4.6	33.7	8.7	26.4	7.9	26.2	9.9	17.0	19.7	21.9	20.0	7.1	11.0	2.1	19.5	32.4	14.6	15.6	21.4	9.6	13.3	10.7	16.1	26.5	25.4	2.5	38.6	22.6	15.4	17.3	13.5	14.5	14.9	9.7	12.4	16.9	13.5	3.6	14.0	4.1	16.0	8.7	8.1	11.5	21.5	17.8	1.0	24.9	12.0	33.0	3.0	3.9	28.3	13.1	12.8	35.5	25.4	14.8	23.2	11.0	13.4	0.0	20.2	19.3	14.4	11.9	23.8	10.7	27.8	30.8	15.1	12.0	38.8
PDE12	"2'-PDE, 3635, DKFZp667B1218"	ENSG00000174840	"Phosphodiesterase 12"	Q6L8Q7	3	57556274-57566848	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043171	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"			"HPA043171: AB_10794654"	"unprognostic (2.79e-1)"	"unprognostic (3.18e-1)"	"prognostic favorable (2.85e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.88e-3)"	"prognostic favorable (3.63e-8)"	"unprognostic (6.97e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.62e-1)"	7.6	8.6	4.1	8.3	4.6	13.9	6.0	5.1	4.4	5.2	4.7	7.2	9.1	5.7	3.9	9.0	4.2	7.1	5.7	4.3	5.2	8.0	10.6	5.5	8.9	3.9	3.9	4.7	9.8	9.2	4.4	7.3	3.5	6.3	6.7	7.3	5.9	6.4	8.4	4.9	7.2	6.9	4.2	7.1	7.2	4.2	3.9	7.0	7.2	7.9	8.1	8.6	4.9	6.2	19.5	18.8	11.5	21.3	14.6	10.3	20.8	16.1	15.3	17.8	15.8	24.9	12.9	31.6	5.9	14.6	23.7	12.5	24.8	16.8	14.5	14.7	12.7	23.5	15.4	19.3	16.6	31.1	23.5	14.2	11.3	21.5	19.0	9.3	15.6	16.1	19.4	22.3	16.3	15.0	28.0	10.2	17.8	15.1	32.0	10.5	9.4	23.0	14.4	22.3	10.2	16.0	17.3	20.2	17.4	9.1	15.0	17.6	19.3	14.7	13.7	28.1	26.4	21.9	34.2	27.4	17.3	24.1	22.2	20.6	9.3	8.7	10.9	12.7	12.3	6.7	10.2	11.3	10.2	11.4	12.4	12.4	2.3	14.9	13.8	5.3	13.5	10.2	4.1	4.6	5.1	4.4	4.3	5.2	3.9	3.9	3.5	4.2	3.9	6.2	15.9	25.6	21.9	32.0	20.0	36.8	18.5	13.2	14.8	21.0	17.9	10.0	10.8	22.8	14.8	31.3	12.5	19.0	23.9	17.9	5.9	10.0	1.3	15.5	19.3	14.6	12.5	20.4	50.8	9.8	11.3	14.6	12.8	21.7	19.7	12.8	13.6	27.8	15.0	26.9	49.0	10.8	10.2	18.5	16.8	1.3	10.5	16.1	12.4	26.2	15.8	18.3	17.5	47.7	56.6	9.0	9.8	12.4	20.4	18.6	14.8	16.5	8.9	31.1	6.6	32.7	15.1	18.6	10.3	21.7	39.6	20.5	19.2	19.7	19.5	19.1
PDF		ENSG00000258429	"Peptide deformylase, mitochondrial"	Q9HBH1	16	69326913-69330588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 27.8"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 8.0;Erythroid cells: 4.6;Gastric mucus-secreting cells: 8.6;Plasma cells: 14.7;Squamous epithelial cells: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA063409	Approved		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA063409: AB_2685007"	"unprognostic (4.28e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (2.98e-3)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (5.84e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.22e-2)"	5.9	8.7	1.0	0.9	1.3	1.4	5.5	1.9	1.8	4.4	1.5	5.6	2.1	5.8	0.4	10.2	4.7	0.5	5.3	2.2	0.8	19.0	27.8	4.4	1.1	1.4	0.8	3.1	8.8	1.6	4.3	0.6	1.0	5.0	0.8	0.3	7.2	0.6	12.4	7.7	5.2	0.4	0.8	5.1	5.6	4.8	0.9	0.6	5.9	0.8	0.7	4.8	4.8	1.5	6.3	4.8	1.3	4.1	1.1	0.8	7.7	6.0	1.0	2.9	2.4	8.6	5.7	13.1	6.2	1.6	2.2	11.5	1.8	2.1	1.3	3.5	23.3	6.6	5.3	12.6	1.8	10.8	5.7	1.7	4.3	2.5	1.2	0.8	1.5	7.2	16.1	2.4	1.9	7.6	9.2	8.3	6.4	2.6	7.1	20.8	2.1	11.0	2.2	5.4	9.3	7.1	10.8	2.9	5.2	0.3	11.0	3.3	4.6	3.9	6.4	5.8	6.8	12.1	9.4	15.2	3.1	6.9	5.9	1.4	0.7	1.0	0.4	0.3	0.9	1.2	1.0	1.2	0.6	4.1	1.5	0.7	0.0	0.4	0.4	1.3	0.9	0.3	1.0	1.3	1.9	1.8	2.2	0.8	1.4	0.8	1.0	0.8	0.9	1.5	0.2	3.2	0.0	0.0	3.0	0.0	0.1	0.0	8.0	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.5	0.3	0.6	0.0	4.6	0.0	0.2	0.3	1.2	8.6	0.5	0.0	0.2	0.4	0.8	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	14.7	0.1	0.4	1.1	0.0	0.0	0.0	0.1	0.8	0.2	0.1	17.7	0.4	0.3	1.4	0.1	0.0	0.1
PDS5A	"KIAA0648, PIG54, SCC-112"	ENSG00000121892	"PDS5 cohesin associated factor A"	Q29RF7	4	39822863-39977956	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036661, HPA036662"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA036661: AB_2675233, HPA036662: AB_10696783"	"unprognostic (4.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.62e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.81e-2)"	19.4	16.2	13.3	23.2	15.0	29.4	24.3	19.7	18.1	20.6	17.0	23.0	19.7	19.9	20.2	25.8	15.9	16.5	14.5	13.4	13.9	22.0	33.4	22.7	33.2	15.1	13.6	23.6	21.0	29.7	10.6	22.9	15.5	18.5	23.9	20.9	20.1	15.9	17.7	24.3	19.4	19.4	14.2	21.4	20.6	14.0	14.2	42.0	28.5	19.6	34.7	22.8	15.9	23.5	54.8	40.0	50.3	53.4	47.5	47.5	40.2	43.4	40.9	50.1	49.6	39.2	60.2	106.6	46.5	51.6	79.5	29.4	86.9	50.5	71.7	36.1	33.2	73.1	47.6	41.3	47.5	90.2	60.1	31.5	55.9	53.3	78.2	44.5	64.7	62.1	88.0	43.8	52.0	38.5	113.2	78.8	28.6	51.4	26.7	104.3	89.6	38.9	48.2	54.6	69.5	41.2	59.9	40.7	39.0	37.5	41.4	78.7	61.5	56.4	58.6	41.2	74.3	37.0	69.7	112.3	40.1	90.6	45.3	2.3	1.2	1.9	2.3	1.6	3.0	2.0	2.2	2.5	1.8	2.5	2.6	2.1	0.4	3.0	1.1	2.2	2.0	1.0	13.3	15.0	19.7	18.1	13.4	13.9	15.1	13.6	15.5	14.2	14.2	23.5	36.2	86.6	70.3	75.7	52.3	56.6	37.0	29.3	51.8	32.7	42.6	30.1	40.5	32.9	45.8	22.0	60.5	32.4	50.8	39.2	7.9	22.0	9.7	34.9	50.0	40.7	30.5	69.6	120.5	25.8	39.1	36.8	41.3	52.8	29.1	45.1	40.0	58.2	30.9	13.5	115.3	36.3	28.5	46.6	54.5	10.0	32.9	44.6	46.2	119.9	38.7	13.3	42.2	98.5	138.0	38.9	28.2	33.1	52.8	53.7	28.5	27.4	25.5	27.9	32.9	36.3	31.1	44.2	48.5	66.9	68.2	38.7	49.9	30.9	40.4	59.6
PHF12	"KIAA1523, PF1"	ENSG00000109118	"PHD finger protein 12"	Q96QT6	17	28905250-28951771	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 40.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 40.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021410, HPA021452"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA021410: AB_1855287, HPA021452: AB_2670708"	"unprognostic (9.50e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.73e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.02e-3)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (2.16e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.08e-3)"	13.7	11.0	11.6	15.6	12.6	39.9	14.4	14.1	12.1	17.9	7.2	18.2	11.5	18.7	14.0	10.6	17.2	11.0	11.0	10.7	11.9	12.3	14.7	16.7	18.2	11.5	11.1	17.9	19.1	13.8	16.9	10.9	9.1	21.8	11.4	14.9	15.7	17.0	15.7	15.2	17.7	14.6	7.2	22.9	14.8	9.9	11.3	25.3	17.0	14.2	17.2	16.8	13.8	14.0	15.0	24.4	33.1	19.8	18.6	13.8	15.0	14.6	22.0	23.0	21.2	16.9	14.3	17.3	17.9	17.4	19.0	15.9	21.5	13.0	21.8	27.9	22.5	18.8	27.2	13.2	16.8	20.5	22.7	15.8	13.8	20.9	19.0	21.3	16.7	23.0	16.0	18.6	14.2	16.6	38.3	26.7	19.0	33.6	10.4	38.2	26.8	17.6	15.2	19.3	22.8	18.7	22.6	35.7	17.6	17.5	19.6	26.6	9.9	18.9	16.8	18.2	18.4	21.9	19.9	20.2	14.7	15.2	19.5	25.2	4.4	7.2	6.3	3.6	6.1	4.4	4.9	6.6	2.5	6.5	4.4	5.2	40.1	6.3	4.3	8.2	3.1	2.9	11.6	12.6	14.1	12.1	10.7	11.9	11.5	11.1	9.1	7.2	11.3	14.0	13.1	16.0	8.6	27.1	24.7	15.3	8.5	7.5	26.7	22.7	17.6	15.1	6.9	8.6	12.2	3.7	14.6	7.9	24.5	12.0	1.9	9.1	9.5	17.5	16.4	14.4	10.7	27.0	16.3	10.4	7.6	11.9	12.8	23.8	14.5	14.4	14.3	11.7	9.2	25.2	18.6	16.5	12.2	15.7	18.9	7.4	17.1	16.5	12.4	27.2	20.0	12.9	17.5	30.2	31.3	9.7	6.5	16.6	31.4	27.1	8.9	5.9	8.1	21.3	26.3	11.2	17.2	13.5	12.6	22.2	16.3	6.0	35.3	11.4	10.8	14.0
PI4KB	"PI4K-BETA, pi4K92, PIK4CB"	ENSG00000143393	"Phosphatidylinositol 4-kinase beta"	Q9UBF8	1	151291797-151327715	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006280, HPA006281, CAB022071"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"CAB022071: , HPA006280: AB_1079613, HPA006281: AB_1079614"	"unprognostic (1.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.23e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (8.51e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (7.08e-2)"	45.6	45.0	57.3	33.1	61.4	78.0	47.6	64.4	63.2	62.6	53.2	50.9	35.8	58.8	54.8	48.0	58.6	40.2	45.8	59.2	62.3	50.4	40.5	47.2	46.8	57.9	60.7	60.2	46.1	56.0	56.5	39.6	60.4	57.6	44.0	46.4	45.8	42.6	68.5	60.5	47.0	62.2	54.4	59.8	48.0	46.0	61.0	45.7	67.8	58.6	47.5	48.9	51.3	68.2	49.2	40.1	34.2	53.9	92.8	68.1	28.9	50.9	88.3	65.3	53.8	51.7	43.4	46.1	57.1	78.5	41.1	44.9	57.3	52.5	50.1	63.0	50.9	33.0	48.8	26.6	64.8	38.5	60.9	71.7	62.4	72.3	51.3	56.3	63.7	46.3	57.5	67.9	56.0	91.2	41.0	30.9	27.6	69.5	60.3	36.2	28.8	54.4	45.2	61.2	41.3	35.4	35.5	71.1	46.7	53.9	60.1	71.9	50.3	46.5	36.3	37.3	55.1	71.6	50.4	89.8	52.9	39.7	82.3	41.3	22.7	36.0	17.8	24.7	19.9	20.4	18.5	23.6	24.3	16.7	15.1	14.3	21.0	19.3	26.3	13.9	20.0	23.9	57.3	61.4	64.4	63.2	59.2	62.3	57.9	60.7	60.4	54.4	61.0	68.2	16.8	16.0	24.3	19.2	26.4	22.3	18.2	17.7	28.5	33.5	24.3	24.6	7.0	21.5	17.7	12.9	20.9	30.1	16.0	28.7	19.6	20.9	12.2	21.5	19.9	19.3	18.5	26.9	17.8	24.9	20.5	25.9	23.0	24.6	19.0	30.0	15.4	12.4	29.2	35.3	19.0	16.4	10.2	20.1	20.5	15.5	23.3	21.3	14.2	15.9	29.3	23.1	21.6	18.1	25.8	23.5	17.3	24.8	24.4	17.7	25.7	15.2	17.1	28.4	13.1	24.2	23.2	28.9	25.1	24.8	31.1	48.7	23.8	44.7	20.2	28.1
PIAS1	"DDXBP1, GBP, GU/RH-II, ZMIZ3"	ENSG00000033800	"Protein inhibitor of activated STAT 1"	O75925	15	68054309-68198603	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 248.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005743, CAB012304"	Supported		Approved	Microtubules		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Microtubules		"CAB012304: AB_777265, HPA005743: "	"unprognostic (1.36e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.93e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.28e-2)"	10.2	10.2	5.6	14.1	7.0	23.2	11.7	11.9	9.4	15.3	5.7	12.0	12.0	14.7	13.9	15.1	14.0	12.7	11.5	7.6	8.3	10.8	9.7	14.9	18.2	4.8	4.9	22.7	11.3	12.5	6.5	12.9	4.9	15.5	11.1	21.3	10.4	17.7	12.4	12.6	12.3	13.6	4.7	15.3	12.7	20.6	6.9	24.9	18.8	16.3	17.6	14.1	10.8	7.0	13.1	17.6	27.9	13.6	16.4	16.8	8.4	19.6	19.8	21.1	23.6	14.7	19.2	24.6	13.1	16.5	13.5	35.5	41.5	10.7	22.7	14.2	15.5	29.6	17.3	16.3	10.7	29.0	23.0	15.2	30.5	13.7	12.4	16.2	15.1	14.1	20.7	18.3	16.3	10.7	24.1	15.0	15.8	14.4	9.9	21.2	26.8	24.1	13.8	16.4	23.3	9.8	13.1	12.1	13.4	25.4	10.7	26.9	13.5	18.3	19.3	10.6	14.6	13.6	19.2	26.2	11.4	30.2	13.7	33.8	31.4	41.9	18.7	23.9	19.3	20.8	18.7	19.8	30.7	19.5	22.3	19.6	70.8	19.2	25.7	16.7	21.5	27.3	5.6	7.0	11.9	9.4	7.6	8.3	4.8	4.9	4.9	4.7	6.9	7.0	38.7	109.0	58.4	106.7	91.5	38.0	58.2	29.4	132.1	72.2	30.3	25.1	28.3	45.8	35.9	12.9	106.3	35.5	61.3	35.2	21.5	32.5	67.1	23.5	48.2	42.0	27.6	41.0	165.7	22.6	20.4	37.5	43.8	27.2	56.3	30.6	40.0	34.9	45.8	48.8	136.6	30.2	14.2	102.4	38.8	33.4	123.6	62.6	21.4	248.3	104.9	57.8	56.7	120.1	126.2	25.5	25.0	113.6	59.3	48.3	38.1	20.0	25.0	64.8	32.9	47.7	31.6	66.7	45.4	51.1	33.0	36.0	67.6	22.6	22.4	64.5
PIK3R4	"p150, VPS15"	ENSG00000196455	"Phosphoinositide-3-kinase regulatory subunit 4"	Q99570	3	130678934-130746829	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036032, HPA036033"	Approved		Approved	Vesicles,Microtubules		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles	Microtubules	"HPA036032: AB_10610281, HPA036033: AB_2674911"	"unprognostic (7.50e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.26e-2)"	"prognostic favorable (4.40e-6)"	"unprognostic (8.25e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.05e-1)"	8.8	8.5	3.7	7.8	4.2	8.9	10.0	5.2	4.9	9.4	5.6	8.2	7.5	10.1	7.9	8.0	9.1	7.2	7.6	4.1	4.5	10.5	21.2	9.6	9.4	3.2	3.6	12.4	6.9	17.6	6.1	9.7	3.8	9.8	8.1	16.5	7.6	9.6	7.3	7.8	8.0	10.4	3.8	10.0	7.5	11.4	3.2	11.4	13.1	8.6	10.4	9.0	6.5	7.1	20.7	12.9	18.5	13.4	26.6	21.1	12.8	15.0	17.9	20.2	23.3	16.7	17.1	24.2	18.4	15.2	16.1	28.7	30.7	23.3	31.6	14.7	11.3	19.7	13.8	11.7	12.2	30.3	9.5	14.7	16.4	21.7	13.6	12.6	19.0	13.8	23.3	11.9	18.1	18.1	24.9	9.2	23.3	18.6	12.4	17.2	21.4	21.9	13.2	16.7	17.0	12.4	21.6	13.4	15.3	21.5	18.6	13.1	15.2	15.5	13.3	17.6	12.2	13.8	13.5	31.2	17.0	11.3	14.7	9.7	5.3	7.0	6.3	6.0	9.3	5.6	5.7	4.7	6.9	3.5	6.6	6.0	4.4	8.5	6.6	2.4	6.8	5.3	3.7	4.2	5.2	4.9	4.1	4.5	3.2	3.6	3.8	3.8	3.2	7.1	8.3	6.4	8.7	18.6	8.8	3.8	3.9	5.7	10.8	8.1	5.7	4.7	7.7	8.6	9.6	11.0	14.6	5.6	7.2	5.5	1.9	5.0	4.4	8.9	7.5	8.9	3.0	9.2	28.5	5.8	3.4	6.9	13.3	9.9	9.5	9.5	7.5	18.2	5.9	5.0	30.3	6.8	8.2	6.4	2.6	3.1	9.6	7.3	5.4	20.6	7.1	9.0	6.2	22.1	32.9	6.6	4.3	11.7	6.9	4.8	6.2	4.2	12.6	12.6	6.6	8.9	6.2	17.0	13.9	9.5	4.4	4.2	7.5	9.6	6.1	3.4
PMF1-BGLAP		ENSG00000260238	"PMF1-BGLAP readthrough"		1	156212982-156243332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Proximal tubular cells: 2.5;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA034583, HPA071854"			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA034583: AB_2674234, HPA071854: AB_2686459"	"unprognostic (8.15e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.56e-4)"	"unprognostic (1.65e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.85e-4)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.36e-1)"	7.0	9.0	6.8	2.2	7.1	4.6	5.0	7.6	11.5	10.8	7.3	9.5	2.8	6.7	5.1	5.2	7.3	3.6	16.2	6.8	7.3	8.6	7.6	4.9	3.4	6.8	6.7	10.0	5.7	3.8	10.3	4.7	6.8	11.0	1.6	4.9	7.7	4.1	13.3	4.3	4.6	2.9	6.8	6.5	6.5	3.5	6.9	3.0	8.7	10.0	2.5	6.8	7.2	8.4	8.9	8.4	11.6	7.8	3.0	7.4	5.2	7.8	5.0	7.5	6.0	6.6	7.9	7.7	12.8	7.0	3.1	6.0	10.8	10.1	3.5	13.4	18.4	5.3	8.5	12.5	14.5	5.3	9.3	9.7	9.3	7.0	6.2	6.9	7.3	7.0	5.4	12.4	5.0	11.1	4.7	11.3	23.7	5.9	16.1	8.7	4.5	11.4	4.8	4.2	7.9	10.3	5.2	2.0	13.6	10.0	11.8	20.9	7.9	3.7	3.8	4.6	7.0	7.4	9.4	11.5	4.7	6.9	7.5	2.3	5.7	3.1	2.8	3.9	2.9	2.7	4.6	4.3	4.2	7.7	6.2	3.6	6.4	3.0	4.3	4.4	5.6	5.7	6.8	7.1	7.6	11.5	6.8	7.3	6.8	6.7	6.8	6.8	6.9	8.4	0.6	0.0	1.5	0.3	1.3	0.0	0.5	0.1	1.8	0.0	0.5	0.4	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	3.9	0.4	0.0	0.4	1.1	0.3	0.0	1.3	0.2	0.0	0.2	1.1	0.5	0.4	0.0	0.6	0.7	0.5	0.4	0.0	0.3	0.3	0.0	0.6	0.0	0.1	1.5	0.8	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.1	0.1	0.4	2.4	0.1	0.4	2.5	1.5	0.0	6.6	0.3	0.6	0.3	0.5	2.2	0.0	1.0	1.3	0.2	0.6	0.3
POC1B-GALNT4		ENSG00000259075	"POC1B-GALNT4 readthrough"		12	89519408-89526262	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"B-cells: 2.5;Basal squamous epithelial cells: 3.4;Club cells: 3.1;Erythroid cells: 3.0;Gastric mucus-secreting cells: 2.6;Glandular and luminal cells: 2.5;Respiratory ciliated cells: 2.9;Squamous epithelial cells: 1.8;T-cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.2"									HPA076116			Approved	"Golgi apparatus"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA076116: AB_2686778"	"unprognostic (4.91e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.77e-6)"	"unprognostic (7.99e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.61e-4)"	"unprognostic (7.65e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.16e-2)"	0.9	0.3	0.2	1.6	0.5	2.8	0.4	0.7	0.5	0.5	0.0	0.8	1.7	1.1	0.0	0.5	1.1	1.3	0.4	0.4	0.6	0.5	0.4	0.5	0.8	0.5	0.4	0.8	0.4	0.5	0.4	0.5	0.5	0.5	1.0	1.3	1.4	0.1	0.8	0.5	0.9	0.4	0.2	0.7	2.0	0.9	0.6	0.4	0.7	0.2	0.5	0.6	0.5	0.6	1.1	1.0	2.2	10.2	0.3	0.2	0.6	0.4	0.9	1.4	1.0	0.9	0.8	0.9	0.2	1.1	0.9	0.8	2.1	0.7	1.5	2.2	1.3	1.6	1.3	1.8	0.0	1.3	1.8	0.0	0.6	1.5	0.8	1.4	1.2	1.6	1.1	0.6	0.4	0.6	1.3	1.5	0.7	2.1	3.9	1.5	1.4	2.6	0.8	1.5	0.9	1.1	1.2	1.0	0.5	0.7	2.0	1.5	1.4	1.5	0.8	0.7	1.2	0.9	1.7	1.2	1.1	1.1	1.4	1.1	0.8	0.8	0.9	0.9	1.5	0.3	0.6	0.7	0.6	0.7	0.7	0.8	1.7	0.8	1.1	0.4	0.7	0.6	0.2	0.5	0.7	0.5	0.4	0.6	0.5	0.4	0.5	0.2	0.6	0.6	0.3	0.0	0.6	0.0	2.5	0.0	0.0	0.0	3.4	0.0	0.1	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.6	0.1	0.0	3.0	0.0	0.0	0.0	0.3	2.6	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.2	0.0	2.9	0.0	0.0	0.0	0.7	0.0	0.0	1.8	0.0	0.0	1.8	0.1	0.2	0.1
POLR1A	"DKFZP586M0122, FLJ21915, RPA1, RPA190, RPO1-4"	ENSG00000068654	"RNA polymerase I subunit A"	O95602	2	86020216-86106155	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010145, HPA031513, HPA049700"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments"		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	"Nucleoplasm, Intermediate filaments"	"CAB010145: AB_675814, HPA031513: AB_2673916, HPA049700: AB_2680856"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (3.70e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.31e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (7.20e-2)"	5.4	5.7	3.7	5.8	4.0	4.9	4.5	3.1	4.7	4.9	4.0	4.9	4.1	8.2	3.0	6.0	5.2	2.9	5.8	3.9	3.6	4.6	5.0	4.0	4.6	3.4	3.6	5.2	5.2	7.1	4.9	5.0	3.3	4.5	5.0	3.5	3.9	5.1	10.8	5.5	3.8	6.9	2.7	3.8	4.5	6.2	4.4	6.2	4.5	7.4	4.9	5.2	4.2	4.3	18.5	41.1	18.0	34.7	17.2	13.7	25.9	16.6	10.9	23.2	14.4	51.9	14.2	41.9	17.2	17.0	22.7	20.9	46.6	24.4	20.6	17.6	24.0	36.2	18.0	35.1	12.1	34.8	18.7	10.5	15.0	34.6	26.7	8.8	18.2	19.0	48.8	10.3	16.2	16.4	25.8	15.1	32.7	24.4	26.8	30.7	39.5	19.6	10.5	29.7	27.7	14.6	18.3	23.8	12.7	12.3	14.0	12.0	29.3	28.0	22.2	24.3	33.8	14.5	15.3	35.7	14.6	29.3	25.3	0.5	0.4	0.0	0.7	0.6	0.9	0.5	0.3	0.6	0.4	0.6	0.3	0.4	0.1	0.5	0.5	0.7	0.1	0.4	3.7	4.0	3.1	4.7	3.9	3.6	3.4	3.6	3.3	2.7	4.4	4.3	4.9	3.2	9.1	13.4	8.8	4.2	4.9	5.3	12.0	12.4	6.2	5.5	11.1	8.6	4.7	9.2	16.7	6.3	7.2	5.1	3.9	6.0	3.0	5.4	13.8	6.5	9.6	10.9	19.7	4.9	5.4	7.7	8.2	6.9	6.3	11.0	4.2	8.3	12.5	11.8	18.1	6.7	2.0	3.1	3.5	1.7	6.2	5.5	5.4	6.5	3.3	4.2	6.2	20.1	18.2	6.6	3.0	5.3	10.1	9.1	3.5	3.4	5.2	9.7	0.0	14.3	6.2	5.0	7.2	13.4	2.7	3.8	7.5	12.4	10.4	4.0
POLR3B	"C128, FLJ10388, RPC2"	ENSG00000013503	"RNA polymerase III subunit B"	Q9NW08	12	106357748-106510198	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036466	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA036466: AB_10671842"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.09e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.24e-2)"	4.5	8.7	3.1	4.8	4.4	5.2	5.0	4.3	4.6	4.7	3.7	5.3	4.2	4.6	5.2	8.6	5.1	3.6	5.8	3.4	2.9	6.8	9.0	4.7	4.1	2.2	2.3	7.5	4.9	11.1	2.4	6.7	2.3	5.6	5.7	6.2	4.7	4.0	6.5	11.0	3.4	5.4	2.7	3.3	5.4	6.1	3.2	4.7	6.0	8.3	5.6	4.9	4.3	3.6	16.2	7.6	16.4	7.8	13.9	13.1	22.9	21.9	13.0	15.2	11.6	14.0	4.4	20.6	7.7	14.2	5.6	14.8	19.5	19.2	18.5	16.6	13.1	15.7	10.1	12.0	9.2	26.1	17.0	11.7	13.4	15.1	17.3	10.3	11.5	9.8	24.5	6.5	11.2	12.0	19.1	8.7	17.8	11.9	28.5	11.6	9.8	13.5	8.6	21.8	17.3	9.6	13.6	18.2	13.4	10.8	17.0	7.9	11.0	8.3	10.0	13.6	13.1	8.1	22.4	30.3	3.8	15.9	9.2	5.6	2.0	1.5	2.0	2.2	2.7	2.1	2.2	2.2	2.6	1.3	3.0	1.9	1.3	2.1	2.2	0.9	2.7	1.7	3.1	4.4	4.3	4.6	3.4	2.9	2.2	2.3	2.3	2.7	3.2	3.6	2.4	0.0	9.2	14.4	4.7	1.8	1.7	4.5	4.6	6.0	3.4	3.7	10.3	2.8	7.0	5.5	6.2	11.0	3.8	3.8	1.9	5.1	7.1	3.9	7.0	3.3	4.2	3.8	22.3	4.6	9.3	4.4	9.2	3.9	5.1	4.8	3.6	11.0	3.1	3.3	24.1	5.6	2.0	1.6	0.3	5.2	3.7	2.4	3.6	9.4	1.0	2.4	2.1	17.1	22.4	3.8	1.1	4.9	4.9	1.5	1.7	3.4	7.2	7.2	6.6	6.9	4.1	16.5	10.9	8.9	3.0	7.4	4.1	7.2	5.1	1.2
POM121	"DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A"	ENSG00000196313	"POM121 transmembrane nucleoporin"	Q96HA1	7	72879365-72951440	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 98.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB003710, HPA043809, HPA049817"	Approved		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"CAB003710: , HPA043809: AB_2678680, HPA049817: AB_2680896"	"unprognostic (2.33e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.07e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.40e-1)"	25.4	20.4	10.3	18.8	10.1	44.7	21.0	7.2	14.3	18.3	3.4	19.5	21.6	19.6	9.4	20.1	18.7	13.6	16.0	11.9	9.7	16.6	23.5	17.4	21.3	6.8	8.5	23.8	25.5	16.1	21.4	17.0	6.4	19.2	12.1	17.5	19.3	11.2	25.7	21.6	22.8	13.0	2.3	22.9	21.8	18.7	8.8	17.8	20.0	16.0	17.1	18.8	18.1	9.1	49.6	35.4	43.5	98.0	23.0	18.8	36.0	34.6	29.2	33.8	29.3	63.0	30.6	67.7	11.0	30.1	37.5	37.0	43.5	33.6	37.6	59.2	86.5	50.6	36.6	42.4	23.5	106.1	61.8	24.8	23.3	44.9	41.0	21.9	25.5	38.5	141.2	49.3	33.7	37.8	63.7	67.0	45.5	27.4	42.3	57.4	33.8	57.1	17.2	42.8	61.7	54.3	30.3	57.3	31.1	28.8	48.1	55.0	36.2	60.2	36.8	48.0	70.5	58.8	58.8	96.0	35.2	66.6	61.0	0.0	0.8	1.4	1.7	0.5	1.0	1.0	1.1	1.3	0.9	1.1	0.9	1.4	0.9	1.6	1.4	1.5	0.6	1.1	10.3	10.1	7.2	14.3	11.9	9.7	6.8	8.5	6.4	2.3	8.8	9.1	31.8	38.5	28.9	33.0	28.6	25.2	10.1	17.5	29.0	34.6	19.5	19.7	4.4	20.0	19.9	18.4	98.0	17.1	30.6	19.7	5.9	12.3	13.2	14.6	24.7	18.3	18.0	30.7	55.6	17.1	13.2	19.2	32.1	21.3	16.5	31.1	17.2	24.9	16.2	40.4	58.9	21.7	16.2	18.9	21.7	6.3	14.9	23.3	19.6	23.4	13.8	18.2	32.0	30.2	38.6	21.8	14.1	17.7	37.6	22.2	19.1	8.4	17.6	26.6	13.1	27.0	17.6	19.2	13.1	29.6	31.0	19.4	27.9	24.7	23.2	21.9
POM121C		ENSG00000272391	"POM121 transmembrane nucleoporin C"	A8CG34	7	75416786-75486299	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043809, HPA049817"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA043809: AB_2678680, HPA049817: AB_2680896"	"unprognostic (9.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-3)"	"unprognostic (2.03e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.00e-2)"	14.9	14.0	3.5	15.5	3.8	28.9	14.2	8.0	9.3	13.8	2.4	14.2	12.0	16.6	9.0	15.9	14.1	12.0	13.9	7.0	4.9	13.1	13.2	12.9	18.2	2.2	3.1	18.7	18.1	16.8	13.4	16.4	2.0	13.0	12.9	26.3	14.3	11.5	19.6	17.7	14.0	15.1	0.3	15.5	14.0	12.5	5.2	17.6	16.7	10.7	19.9	14.3	14.3	5.5	41.8	34.1	46.3	89.0	17.1	19.0	30.4	29.7	27.3	23.7	22.8	41.2	26.5	73.4	12.0	32.6	37.2	36.7	39.6	36.7	38.9	49.9	55.1	36.4	39.6	27.8	22.5	97.0	49.5	16.2	22.8	36.3	26.8	34.5	24.6	29.9	103.8	39.8	38.9	41.8	59.5	49.3	36.9	32.0	38.4	53.0	30.7	37.6	13.1	56.0	51.4	67.4	34.3	54.0	23.8	41.5	47.1	34.2	27.4	57.4	30.6	42.2	62.3	42.4	54.4	88.2	37.3	49.1	53.9	0.2	0.4	0.5	1.1	0.5	1.0	0.8	0.9	0.3	0.3	1.0	0.5	0.6	1.2	0.9	0.3	1.1	0.2	0.6	3.5	3.8	8.0	9.3	7.0	4.9	2.2	3.1	2.0	0.3	5.2	5.5	23.1	35.3	26.2	29.4	27.8	18.0	11.8	13.4	33.6	30.7	21.3	23.4	12.6	21.5	21.4	12.9	68.8	13.4	27.2	12.3	5.9	11.8	2.1	14.2	21.3	20.7	28.7	33.9	59.2	17.1	10.2	21.0	31.6	18.3	7.6	28.6	16.8	15.1	12.0	25.2	60.2	17.4	14.2	16.4	15.8	3.8	18.0	21.7	7.2	35.6	17.1	21.3	37.0	28.1	45.6	18.8	8.0	15.4	37.8	24.6	10.0	9.6	18.7	29.4	13.1	26.1	17.4	19.2	12.4	32.9	18.5	17.0	34.0	22.0	17.0	19.7
POMK	"FLJ23356, SgK196"	ENSG00000185900	"Protein O-mannose kinase"	Q9H5K3	8	43093498-43131180	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.5"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 6.9;Inhibitory neurons: 6.8;Microglial cells: 7.5;Oligodendrocyte precursor cells: 5.5;Oligodendrocytes: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA013321	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"			"HPA013321: AB_2668809"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.10e-2)"	2.3	2.8	11.6	2.5	12.6	6.8	3.8	6.0	14.5	4.1	0.0	3.3	1.6	2.3	7.2	1.9	2.4	1.9	1.3	12.3	7.9	2.0	3.3	2.6	4.0	8.8	7.6	2.6	3.3	2.6	0.9	3.1	9.1	5.0	3.6	5.9	2.4	2.4	2.8	5.8	1.8	2.6	6.1	3.9	3.2	3.6	11.1	4.9	3.1	2.7	4.1	2.7	0.8	8.8	7.8	9.1	9.2	24.4	8.8	6.6	9.1	4.3	4.7	6.1	6.1	8.4	13.8	9.2	7.7	7.1	2.5	8.2	13.5	11.7	7.9	2.0	4.3	19.2	6.2	15.6	8.3	6.1	9.9	8.7	15.2	11.1	10.8	4.6	9.1	10.1	4.6	15.9	9.7	5.3	14.5	18.6	19.8	11.2	1.7	8.7	10.2	4.1	19.1	11.3	6.5	8.2	12.4	7.5	10.0	10.7	14.9	9.6	9.8	11.6	12.8	11.8	8.1	5.8	11.6	11.7	5.7	6.3	16.0	2.2	0.9	0.8	0.8	0.8	0.9	0.5	0.8	0.8	1.4	1.2	1.0	1.1	2.8	0.9	1.5	2.4	1.2	0.6	11.6	12.6	6.0	14.5	12.3	7.9	8.8	7.6	9.1	6.1	11.1	8.8	0.6	0.0	0.5	2.9	0.7	0.4	0.1	0.3	1.8	1.6	0.3	0.3	0.3	0.0	1.3	0.0	0.0	0.4	1.0	0.5	0.0	0.2	0.0	0.7	1.9	0.3	0.0	0.4	6.9	0.0	0.8	0.6	1.5	1.0	0.0	1.2	0.0	0.3	0.2	0.0	6.8	0.3	0.0	0.3	0.0	0.0	0.6	0.8	1.8	7.5	1.3	0.3	2.1	5.5	6.5	0.2	0.0	0.0	1.5	0.2	0.5	0.1	0.0	1.0	0.0	0.2	0.6	0.3	1.1	2.3	0.1	0.5	0.9	0.6	0.5	0.2
POMZP3	"POM-ZP3, POM121"	ENSG00000146707	"POM121 and ZP3 fusion"	Q6PJE2	7	76609986-76627261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 45.3;Late spermatids: 60.8;Spermatocytes: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA049817, HPA071198"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 12: NES - Nervous system development"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA049817: AB_2680896, HPA071198: "	"unprognostic (2.23e-1)"	"prognostic favorable (4.34e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (4.31e-1)"	"unprognostic (7.49e-2)"	"prognostic favorable (9.31e-4)"	"unprognostic (4.94e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.99e-2)"	13.7	10.6	5.8	3.6	5.6	6.8	13.2	8.2	9.7	15.3	4.7	15.9	2.4	16.2	4.6	10.7	12.3	2.2	14.7	5.8	6.1	11.3	5.5	10.4	3.3	6.1	5.6	16.6	12.9	2.5	10.1	1.8	5.8	14.4	3.5	6.2	9.4	4.4	19.8	12.2	9.4	6.2	3.9	9.0	12.6	29.5	5.7	4.7	11.3	0.9	3.6	13.9	12.3	6.4	2.8	11.1	17.7	22.7	11.4	4.4	2.6	3.9	6.2	2.7	3.7	6.5	5.0	1.7	1.0	3.6	6.2	1.5	4.1	1.9	2.7	7.0	6.4	7.6	6.2	4.0	2.6	3.4	4.8	3.8	7.3	9.8	3.2	1.4	1.7	2.8	4.2	12.8	12.8	3.5	6.2	14.2	7.9	4.1	5.6	2.4	12.9	2.9	2.1	4.2	9.1	16.7	3.6	16.2	6.1	18.6	6.1	4.5	7.0	8.9	1.2	22.2	9.5	3.2	3.0	12.3	1.7	13.7	12.7	0.6	1.2	2.3	0.8	0.5	1.2	0.8	1.4	1.4	1.2	1.6	1.7	0.9	1.3	1.0	0.6	1.2	1.4	0.4	5.8	5.6	8.2	9.7	5.8	6.1	6.1	5.6	5.8	3.9	5.7	6.4	5.5	3.2	4.1	4.2	8.1	7.0	7.3	11.5	21.1	5.0	8.0	8.4	6.7	2.8	3.5	5.5	12.5	6.9	7.7	8.1	0.0	1.4	45.3	5.8	5.7	4.3	13.1	9.4	8.2	2.2	3.2	8.1	25.5	7.0	5.7	4.7	2.5	1.7	3.2	3.3	8.6	4.8	2.0	4.9	3.3	60.8	6.2	6.5	10.6	2.8	0.8	5.0	2.1	6.6	8.1	1.8	9.3	7.9	15.2	4.7	4.3	5.9	4.1	5.3	13.1	2.9	5.6	33.0	8.0	18.3	7.0	10.4	9.1	2.0	6.3	11.1
PPM1D	"PP2C-DELTA, Wip1"	ENSG00000170836	"Protein phosphatase, Mg2+/Mn2+ dependent 1D"	O15297	17	60600183-60666280	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022277, HPA061848"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA022277: AB_1858839, HPA061848: "	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.98e-1)"	4.4	2.4	2.7	2.2	5.2	5.9	3.9	14.8	4.6	4.5	5.0	3.1	2.9	4.3	2.9	3.5	3.7	3.1	2.9	3.3	3.4	2.8	2.8	3.6	2.7	4.0	3.5	6.3	3.3	2.3	2.4	5.9	4.7	3.1	3.5	6.4	3.1	2.2	4.0	2.9	2.7	3.0	3.4	3.8	2.7	5.5	3.7	4.4	2.9	3.1	2.3	2.8	4.0	9.1	3.8	6.9	7.5	6.4	5.0	3.1	10.7	5.8	3.6	3.4	4.9	7.1	2.0	9.9	4.5	3.7	1.3	3.4	4.9	2.2	4.6	1.9	11.1	7.4	6.7	8.1	4.2	2.9	5.3	2.7	3.6	5.1	3.0	2.8	7.9	4.1	5.4	4.0	3.7	34.4	8.1	4.4	3.5	3.4	5.2	9.5	9.6	6.6	3.1	4.2	10.5	7.4	7.1	2.4	1.6	8.0	2.8	3.9	5.7	4.7	12.5	3.5	3.3	6.7	7.7	7.3	1.7	2.9	3.8	9.9	16.1	18.0	7.6	12.5	6.8	8.9	6.3	7.0	16.0	6.2	6.8	7.0	24.7	8.6	8.1	7.0	10.6	9.8	2.7	5.2	14.8	4.6	3.3	3.4	4.0	3.5	4.7	3.4	3.7	9.1	40.9	32.1	7.7	15.0	23.1	21.0	6.2	3.3	52.3	13.1	14.2	9.8	6.3	8.6	4.6	5.5	4.2	17.6	19.4	15.0	3.9	6.6	68.9	14.0	15.5	25.2	14.4	14.1	19.6	6.6	6.4	14.7	10.2	15.6	1.3	7.2	23.6	4.2	8.8	3.3	20.8	11.4	6.1	21.4	19.2	12.8	13.7	16.1	3.6	28.1	12.3	7.0	6.2	20.6	38.6	5.4	10.2	7.5	24.5	7.8	8.7	5.1	3.6	10.4	0.0	12.1	14.0	43.8	15.0	34.4	18.0	38.6	18.1	6.0	11.5	7.7
PPP1R16B	"ANKRD4, KIAA0823, TIMAP"	ENSG00000101445	"Protein phosphatase 1 regulatory subunit 16B"	Q96T49	20	38805697-38923024	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.6;lymphoid tissue: 41.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 119.4;Inhibitory neurons: 46.8;Oligodendrocyte precursor cells: 49.8;Oligodendrocytes: 238.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 57.3;HMC-1: 59.2;HUVEC TERT2: 35.6;U-266/70: 96.7;U-266/84: 41.8;U-698: 38.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049571, HPA079512"	Approved		Supported	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	"Nuclear speckles"	"HPA049571: , HPA079512: "	"unprognostic (2.62e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (2.67e-3)"	"unprognostic (3.35e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.87e-5)"	"unprognostic (1.13e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.28e-2)"	"unprognostic (4.09e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.53e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.90e-2)"	13.2	2.9	36.5	19.3	71.6	17.7	8.2	26.1	61.1	3.2	5.1	4.6	3.6	3.4	1.5	3.1	5.8	5.3	5.2	49.3	22.3	27.7	2.4	7.9	37.7	27.8	34.7	1.1	1.5	0.8	2.2	3.7	27.1	1.6	5.1	3.7	2.0	1.9	3.6	1.5	18.0	7.2	24.3	18.1	5.6	0.7	35.7	18.2	3.4	5.7	41.9	6.0	1.6	52.1	0.1	0.7	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	57.3	0.8	0.0	0.9	0.1	1.0	0.1	0.0	1.4	0.2	4.4	0.0	0.0	0.0	0.2	59.2	0.0	0.1	0.0	0.0	0.0	35.6	7.6	1.0	11.9	0.0	0.0	7.4	9.7	7.9	0.1	0.0	5.0	0.0	0.0	0.0	0.0	17.7	19.7	0.0	0.0	0.0	0.7	0.0	3.1	5.5	0.0	0.9	0.0	0.0	96.7	41.8	38.3	0.0	0.0	0.1	0.0	0.2	2.5	3.4	0.5	1.8	5.3	2.3	3.3	0.7	3.3	1.3	1.8	0.0	2.9	0.9	3.3	2.6	1.1	36.5	71.6	26.1	61.1	49.3	22.3	27.8	34.7	27.1	24.3	35.7	52.1	29.3	3.2	3.0	1.3	33.6	1.0	0.0	0.8	0.6	2.3	0.5	0.5	23.5	1.5	4.0	0.0	0.0	0.0	34.0	0.3	0.0	0.0	1.9	0.2	0.2	18.7	0.0	2.7	119.4	0.0	0.0	1.6	4.1	0.3	3.8	0.0	38.6	0.3	0.1	37.0	46.8	0.1	0.0	3.1	3.6	1.5	0.0	3.8	8.8	23.4	20.5	0.3	11.3	49.8	238.0	0.0	0.1	0.0	29.3	0.0	0.0	17.4	3.6	0.3	0.0	0.3	1.0	0.0	0.3	0.3	1.3	0.0	37.4	0.0	0.2	0.3
PPP3CC	"CALNA3, PP2Bgamma"	ENSG00000120910	"Protein phosphatase 3 catalytic subunit gamma"	P48454	8	22440819-22541142	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.8;Spermatocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023396, CAB024950"	Approved		Approved	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles		"CAB024950: , HPA023396: AB_1855663"	"unprognostic (7.66e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.21e-2)"	"unprognostic (7.71e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (9.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.05e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.64e-2)"	28.5	11.9	11.8	16.5	11.8	26.5	20.8	17.7	15.3	18.1	31.1	16.6	9.1	14.5	10.6	16.9	15.6	15.7	34.5	11.3	10.8	12.9	12.4	21.5	33.0	12.1	11.0	14.0	14.3	18.4	11.7	19.3	12.2	14.4	10.3	77.9	14.0	8.2	89.4	13.6	15.4	15.5	10.0	22.4	14.6	56.0	13.1	15.0	16.6	54.2	26.9	17.0	16.4	14.8	12.2	8.8	7.7	9.4	19.8	24.4	11.2	16.5	28.9	23.9	26.5	5.1	7.5	45.7	19.7	25.6	40.0	8.4	17.9	16.5	30.5	26.3	9.5	9.8	10.5	14.7	26.8	7.1	15.6	15.0	22.3	16.2	16.5	25.6	21.1	22.0	19.6	58.8	27.2	5.7	16.8	11.7	5.6	12.5	12.0	54.0	18.1	15.2	22.4	11.3	5.4	12.7	12.3	7.4	17.4	14.4	4.9	11.8	22.8	37.1	7.9	56.7	12.9	29.3	38.5	48.3	19.6	9.3	25.1	5.4	2.7	10.7	16.6	3.2	12.7	26.3	19.0	23.6	5.1	21.3	18.1	14.9	0.6	19.2	4.7	6.2	17.2	7.1	11.8	11.8	17.7	15.3	11.3	10.8	12.1	11.0	12.2	10.0	13.1	14.8	27.2	6.4	5.1	49.6	74.7	16.6	21.3	32.6	12.0	12.8	10.0	6.0	8.0	14.3	14.0	7.3	47.9	18.0	50.3	6.7	7.9	15.0	145.8	6.5	12.7	24.2	10.3	10.8	78.9	21.0	23.8	25.1	6.6	14.6	3.8	3.9	23.6	7.8	13.1	3.3	83.6	2.5	38.7	10.8	24.6	22.6	22.4	19.3	28.4	76.8	30.4	13.1	59.8	99.5	64.8	21.1	7.4	21.4	96.8	26.3	10.6	11.6	7.8	50.5	32.9	19.5	23.3	131.8	29.6	17.1	11.4	14.1	53.4	4.8	6.3	25.5
PPP3R1	"CALNB1, CNB, CNB1"	ENSG00000221823	"Protein phosphatase 3 regulatory subunit B, alpha"	P63098	2	68178857-68256237	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 189.9"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005610, HPA047157"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		42000	"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Cytosol	"CAB005610: AB_325975, HPA047157: AB_2679960"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (9.08e-6)"	"unprognostic (5.90e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.59e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.70e-5)"	"unprognostic (5.24e-3)"	"unprognostic (5.35e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-1)"	53.7	37.7	56.1	32.4	92.9	73.6	27.1	38.0	127.3	27.3	0.0	27.6	25.7	31.0	26.1	30.0	23.3	28.0	20.6	99.0	24.2	21.4	58.2	27.7	40.2	23.5	18.4	24.9	20.7	17.0	18.3	36.6	24.9	26.3	27.8	189.9	24.9	30.1	88.8	33.6	23.9	35.3	14.4	34.2	24.8	20.6	30.0	42.6	23.8	31.0	40.5	32.9	28.6	64.5	61.5	51.7	69.7	48.4	47.4	54.3	70.5	86.3	75.9	98.8	86.8	75.9	55.4	85.7	28.7	61.4	69.5	41.8	74.4	64.8	120.0	59.4	52.9	284.0	38.3	71.1	93.1	111.9	92.2	55.1	57.6	76.9	78.0	55.9	67.2	72.2	67.8	96.8	73.2	53.8	96.1	99.4	81.9	52.0	44.4	69.1	90.6	139.9	61.7	66.1	91.4	64.2	50.4	72.3	65.9	45.0	33.9	51.8	69.5	84.6	76.5	64.2	75.1	53.8	62.6	124.7	61.3	115.2	54.0	1.5	0.5	1.3	0.2	0.3	0.5	0.2	0.3	0.1	0.5	0.3	0.3	0.5	2.7	0.3	0.6	0.7	0.3	0.4	56.1	92.9	38.0	127.3	99.0	24.2	23.5	18.4	24.9	14.4	30.0	64.5	37.0	9.6	12.7	81.6	40.4	74.8	11.6	7.0	72.8	22.2	21.0	13.1	17.9	10.0	7.7	16.5	52.1	11.7	34.0	20.5	11.7	7.1	20.0	19.9	23.0	34.0	15.1	52.8	151.2	8.7	17.2	24.2	18.8	29.1	19.7	11.2	15.4	19.2	24.7	11.8	93.1	15.6	4.1	40.0	105.1	7.7	9.9	54.7	35.6	105.9	21.2	27.8	18.6	72.9	77.5	12.9	10.6	8.6	39.2	17.3	12.6	20.1	5.8	92.7	13.1	14.4	29.8	2.9	6.1	64.0	70.5	12.0	39.9	14.2	13.2	21.3
PPP4R3A	"FLFL1, FLJ20707, KIAA2010, MSTP033, PP4R3, SMEK1, smk-1, smk1"	ENSG00000100796	"Protein phosphatase 4 regulatory subunit 3A"	Q6IN85	14	91457508-91510554	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002568, HPA063917"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA002568: AB_1079207, HPA063917: AB_2685153"	"unprognostic (5.51e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.40e-2)"	"unprognostic (9.95e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.34e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.53e-2)"	19.3	13.5	14.4	18.2	14.5	50.0	19.6	16.6	15.2	19.1	16.2	21.2	17.2	20.0	15.9	21.4	20.4	12.3	16.2	12.6	13.3	18.3	23.7	20.2	28.3	13.6	14.2	22.0	19.8	16.8	14.8	17.5	13.7	18.4	18.5	10.9	20.8	13.1	24.5	25.4	24.4	15.0	12.7	24.1	20.6	22.3	14.5	27.4	17.7	16.7	25.4	19.5	19.4	16.9	24.5	41.4	34.1	27.1	22.5	20.9	60.9	23.2	21.4	24.5	24.6	35.2	32.1	63.1	30.2	19.2	15.0	27.8	36.6	28.9	39.8	52.0	19.7	32.5	25.7	24.5	26.3	59.1	33.1	15.1	50.4	19.7	31.1	20.1	26.7	29.4	33.5	36.2	33.1	52.1	42.8	38.0	31.2	46.5	29.8	54.0	40.6	26.5	30.3	41.5	41.6	25.4	35.3	77.0	32.5	33.6	39.4	37.8	28.0	19.2	20.6	21.1	26.8	36.0	67.0	69.3	25.2	31.8	34.7	6.2	1.9	2.9	4.9	2.6	6.6	4.6	4.5	4.4	2.1	7.4	5.6	4.8	2.5	9.0	3.7	5.0	6.9	2.6	14.4	14.5	16.6	15.2	12.6	13.3	13.6	14.2	13.7	12.7	14.5	16.9	44.1	32.1	48.3	0.0	83.0	0.0	46.7	0.0	58.1	27.9	35.9	23.5	0.0	32.9	30.3	46.0	20.9	33.9	91.8	21.1	29.4	21.2	13.0	86.9	46.5	33.3	13.3	47.5	0.0	25.1	29.0	27.3	45.3	70.7	20.2	39.8	28.9	51.8	25.8	32.0	0.0	28.2	0.0	48.7	0.0	8.5	37.6	70.7	0.0	0.0	41.8	21.0	44.3	0.0	0.0	27.8	25.7	42.5	75.8	56.6	37.3	23.5	16.8	27.3	26.3	45.9	27.1	91.0	59.9	58.0	0.0	44.3	80.1	33.0	25.8	75.2
PPP4R3B	"FLFL2, FLJ31474, KIAA1387, PSY2, SMEK2"	ENSG00000275052	"Protein phosphatase 4 regulatory subunit 3B"	Q5MIZ7	2	55547292-55618880	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001233, CAB017185"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Centrosome"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"	Centrosome	"CAB017185: , HPA001233: AB_1080033"	"unprognostic (9.60e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.27e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (6.03e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.77e-1)"	29.0	27.4	14.8	28.2	15.1	25.8	29.1	20.9	16.9	26.8	20.0	28.1	31.6	23.7	19.3	31.7	32.3	24.7	14.3	13.8	16.9	33.4	48.0	23.4	38.1	15.0	16.3	25.7	32.1	27.4	12.5	24.5	16.2	24.9	27.7	35.3	28.1	23.2	14.7	29.6	32.1	21.8	15.9	28.7	30.8	23.7	15.1	42.2	33.0	20.3	38.7	26.7	16.9	18.7	42.8	33.0	35.6	30.0	37.2	38.9	49.1	34.0	35.9	28.2	24.0	39.5	40.9	57.7	67.5	32.7	44.8	36.4	39.9	27.5	41.4	84.6	16.7	56.7	30.0	52.9	60.3	66.0	45.6	29.8	64.9	34.1	60.1	36.9	45.0	31.6	55.2	57.4	37.7	50.9	42.8	43.7	35.1	55.9	25.3	40.1	53.6	44.6	39.3	43.8	43.4	26.9	36.8	49.9	54.8	23.5	31.6	52.0	36.3	43.3	56.8	21.6	47.2	59.1	47.3	22.3	40.8	61.3	47.2	25.6	16.5	26.9	20.4	20.9	23.2	18.1	21.2	21.6	18.4	18.6	24.5	21.5	19.6	22.5	23.0	9.9	24.0	23.9	14.8	15.1	20.9	16.9	13.8	16.9	15.0	16.3	16.2	15.9	15.1	18.7	46.8	44.8	41.3	0.0	61.8	0.0	48.9	0.0	44.3	44.1	42.7	27.9	0.0	31.5	29.1	16.5	33.3	30.6	51.4	25.3	39.2	32.4	9.5	85.1	43.2	32.9	18.2	46.7	0.0	41.0	28.5	33.9	43.8	39.6	30.3	39.0	26.0	52.5	26.2	53.8	0.0	29.4	0.0	37.7	0.0	7.6	28.0	44.9	0.0	0.0	47.9	53.1	49.4	0.0	0.0	35.4	24.1	36.1	57.2	57.4	46.1	52.9	62.7	38.5	6.6	54.9	28.4	39.1	25.7	53.3	0.0	47.7	56.3	44.6	29.0	57.2
PPP5C	"PP5, PPP5"	ENSG00000011485	"Protein phosphatase 5 catalytic subunit"	P53041	19	46347087-46392981	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Protein phosphatase"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022641, HPA029065, HPA056933"	Approved		Supported	Vesicles,Cytosol		NA	NA		120000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Vesicles, Cytosol"		"CAB022641: , HPA029065: AB_10610284, HPA056933: AB_2683278"	"unprognostic (8.25e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.37e-1)"	27.4	37.5	27.7	17.7	29.3	14.2	26.3	28.4	36.5	28.0	27.7	31.3	16.8	34.9	9.8	30.4	31.7	13.3	56.4	29.8	28.6	29.1	32.7	28.0	19.7	32.3	28.2	24.7	23.7	32.5	36.6	15.8	33.3	23.7	15.4	14.4	23.0	18.2	58.9	27.5	25.9	20.8	26.2	33.5	33.6	16.9	30.3	20.5	26.2	45.7	15.0	27.7	26.3	28.5	61.9	114.9	66.0	50.1	48.3	50.9	30.6	75.4	59.6	88.2	78.2	82.4	47.9	94.3	39.9	54.0	48.4	49.9	86.2	88.5	24.7	65.9	120.5	76.4	80.9	59.4	54.5	106.6	52.8	47.8	40.9	62.1	45.9	34.2	77.2	79.3	76.0	47.3	49.4	67.5	59.5	203.4	50.2	109.6	61.7	89.0	56.6	76.5	52.8	81.8	93.1	69.7	62.6	78.8	26.9	28.6	49.7	67.8	65.5	38.3	64.3	29.1	79.1	38.0	93.0	111.5	41.7	89.4	65.9	0.0	10.3	3.0	27.8	18.0	17.8	15.1	12.8	22.0	16.8	11.7	12.2	16.8	0.2	22.0	23.4	11.7	14.3	15.4	27.7	29.3	28.4	36.5	29.8	28.6	32.3	28.2	33.3	26.2	30.3	28.5	28.1	6.4	12.5	22.9	16.5	9.4	16.6	20.9	19.9	19.7	13.1	13.5	5.6	44.3	14.2	16.5	16.7	26.4	12.3	25.2	33.2	29.9	1.2	31.3	25.2	19.6	14.9	11.6	18.5	19.5	36.2	17.6	26.0	19.6	4.5	18.6	24.3	24.9	21.6	16.8	23.2	17.0	22.4	12.3	8.2	3.2	17.4	11.9	16.0	11.2	12.1	21.0	17.5	17.6	14.5	26.4	17.0	18.4	25.5	12.1	16.3	21.4	14.6	17.9	39.5	14.6	19.9	26.6	32.0	20.8	13.2	25.7	20.4	23.1	25.0	11.7
PPP6C	PP6	ENSG00000119414	"Protein phosphatase 6 catalytic subunit"	O00743	9	125146573-125189939	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Immunity, Innate immunity"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050940	Uncertain					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"			"HPA050940: AB_2681283"	"unprognostic (6.45e-2)"	"unprognostic (4.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.50e-6)"	"unprognostic (1.54e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-1)"	32.8	25.2	20.9	24.4	22.6	42.2	29.9	22.1	27.0	22.8	18.1	28.4	20.4	19.7	23.7	25.0	18.5	18.6	21.6	21.7	22.0	32.6	25.1	24.0	30.8	21.1	20.4	19.6	27.7	32.6	14.7	19.5	21.6	20.2	30.9	17.5	26.1	19.7	69.9	23.5	22.5	21.8	21.8	27.6	20.9	28.1	20.7	38.9	31.5	53.5	36.2	22.9	18.7	26.9	32.6	23.4	41.6	39.3	43.6	36.2	41.8	33.7	36.5	48.7	40.4	37.6	33.5	46.5	25.5	45.6	41.3	64.7	56.8	36.7	56.2	42.0	27.3	38.3	33.5	33.6	35.7	67.6	50.8	30.0	49.2	40.1	38.1	37.5	46.2	52.6	45.7	52.2	53.3	48.6	64.0	42.5	38.8	90.4	42.8	51.5	62.7	62.2	42.1	32.3	42.8	42.3	60.3	47.8	41.0	35.0	74.0	42.0	45.3	29.7	28.4	58.4	45.5	57.5	112.4	62.3	40.1	43.5	49.4	61.7	21.8	35.9	22.4	28.6	27.2	26.8	28.2	25.3	24.0	20.2	27.6	26.5	50.9	23.7	33.6	17.2	38.9	25.8	20.9	22.6	22.1	27.0	21.7	22.0	21.1	20.4	21.6	21.8	20.7	26.9	39.8	41.7	37.8	20.5	62.6	77.4	55.5	64.0	60.3	14.0	42.5	28.3	37.9	31.5	43.1	27.6	8.4	45.7	43.7	47.5	56.7	46.3	130.5	22.7	21.5	44.8	47.9	60.2	35.3	55.2	57.5	37.2	34.1	24.7	45.0	20.4	48.5	41.7	52.3	15.2	30.0	43.0	67.1	61.2	60.9	83.3	29.8	51.8	44.4	32.8	60.0	29.2	40.2	22.6	35.8	48.2	37.4	36.1	82.7	47.2	43.7	79.1	34.3	12.5	52.6	28.7	46.1	124.8	48.3	76.8	87.5	87.2	57.1	23.2	43.9	59.8
PRDM10	"KIAA1231, MGC131802, PFM7"	ENSG00000170325	"PR/SET domain 10"	Q9NQV6	11	129899706-130002835	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.5;Excitatory neurons: 21.3;Inhibitory neurons: 21.2;Oligodendrocytes: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026997, HPA061749"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center, Vesicles"	"HPA026997: AB_1855681, HPA061749: "	"unprognostic (4.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.32e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.87e-3)"	"unprognostic (3.33e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.88e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.51e-1)"	2.8	2.4	2.5	3.1	2.5	7.9	4.2	7.4	3.3	3.2	2.8	3.4	3.4	3.0	3.3	4.0	2.6	2.8	2.0	2.9	3.4	2.2	3.5	3.0	3.9	1.8	1.8	3.4	3.1	3.4	4.6	2.6	1.9	3.4	3.9	4.7	3.1	2.5	6.7	6.2	3.7	2.5	0.9	3.1	4.0	2.4	3.3	6.7	3.0	3.8	4.0	2.6	3.4	4.0	4.7	6.1	7.7	5.1	3.4	4.1	5.1	3.9	5.0	3.2	4.1	6.2	4.8	17.8	4.5	4.6	4.4	6.1	6.4	3.2	5.2	6.6	5.5	12.3	7.5	5.0	2.2	10.9	44.8	2.9	7.1	4.8	3.1	4.9	5.7	5.0	7.0	6.6	4.7	5.2	6.7	5.7	5.9	6.3	4.4	6.5	4.8	2.9	4.7	8.0	8.3	4.3	5.7	6.4	1.7	4.3	4.5	4.8	5.7	7.2	3.4	3.8	5.1	1.7	3.0	25.1	3.2	6.1	5.9	2.4	2.2	6.0	2.6	2.5	2.6	6.8	2.1	2.2	2.1	3.6	3.1	1.4	6.3	4.4	2.7	2.1	2.9	1.4	2.5	2.5	7.4	3.3	2.9	3.4	1.8	1.8	1.9	0.9	3.3	4.0	2.7	3.2	2.7	22.5	3.2	6.1	2.6	1.8	6.8	3.7	3.5	2.2	2.7	1.5	2.0	0.0	0.0	1.5	2.5	6.3	0.0	1.2	3.0	2.9	2.7	1.8	1.8	8.6	21.3	1.1	1.2	2.7	4.6	3.2	1.3	2.7	1.1	2.3	1.6	1.7	21.2	3.1	2.0	3.1	2.9	4.1	2.5	2.8	0.0	13.1	2.1	1.0	1.0	13.6	21.6	0.9	3.2	1.9	2.4	4.6	3.1	1.0	2.3	2.7	0.0	3.9	3.4	0.8	0.8	7.2	5.1	0.5	3.5	1.7	2.7	5.8
PRICKLE4	"C6orf49, DKFZp761H221, OEBT"	ENSG00000278224	"Prickle planar cell polarity protein 4"	Q2TBC4	6	41780782-41787452	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 15.0;Basal squamous epithelial cells: 30.7;Erythroid cells: 17.7;Gastric mucus-secreting cells: 17.3;Plasma cells: 36.8;Squamous epithelial cells: 49.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.0;HeLa: 4.6;hTERT-RPE1: 9.7"									"HPA031240, HPA055593"	Approved		Approved	"Mitotic spindle,Centriolar satellite"		Yes	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"	"Centriolar satellite"	"Mitotic spindle"	"HPA031240: AB_10600929, HPA055593: "	"unprognostic (1.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.56e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.47e-4)"	"unprognostic (4.25e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.56e-5)"	"unprognostic (3.64e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.17e-3)"	1.8	1.2	1.3	0.3	1.2	0.1	1.9	1.3	1.2	2.2	0.0	1.6	1.1	2.4	0.0	3.8	2.3	1.0	1.9	0.7	1.0	1.3	2.0	2.1	0.1	1.1	0.7	1.3	1.2	0.4	1.0	0.6	1.0	2.3	0.5	0.6	1.7	0.4	1.6	0.8	1.2	1.5	0.3	4.5	2.6	0.8	1.0	0.0	2.5	1.5	0.3	2.6	2.9	1.3	0.2	0.6	1.3	1.2	0.0	0.0	4.0	0.1	0.1	0.0	0.0	0.7	0.9	0.4	1.5	0.0	0.1	2.1	0.0	0.1	0.0	0.3	0.3	0.2	4.6	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.7	0.0	0.5	1.2	0.2	0.0	0.6	0.0	0.7	0.2	1.8	0.2	1.3	0.3	0.0	0.2	1.4	0.1	0.4	0.0	2.4	0.2	1.2	0.6	0.7	0.6	0.4	0.8	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	1.3	1.2	0.7	1.0	1.1	0.7	1.0	0.3	1.0	1.3	0.0	0.0	0.0	1.6	15.0	1.5	1.4	2.4	30.7	2.3	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	2.7	2.6	0.0	0.0	0.3	0.0	0.0	2.8	3.5	17.7	0.2	0.0	0.0	4.8	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	1.5	0.6	1.2	8.4	0.0	0.0	1.0	1.9	0.0	0.0	0.0	0.0	0.5	2.6	36.8	1.7	2.2	0.0	0.7	4.1	0.0	1.9	3.7	1.9	1.4	49.4	2.0	0.0	10.9	0.0	3.0	1.4
PROSER1	"bA50D16.2, C13orf23, FLJ12661"	ENSG00000120685	"Proline and serine rich 1"	Q86XN7	13	39009865-39038089	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034225, HPA055687"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB034225: AB_1564157, HPA055687: AB_2682886"	"unprognostic (6.75e-3)"	"unprognostic (9.56e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.81e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.31e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.95e-1)"	9.0	7.7	4.7	11.1	5.1	25.5	9.1	7.0	6.2	7.6	4.4	12.8	10.6	9.0	9.0	11.6	7.2	6.0	8.9	4.8	4.3	9.0	9.5	12.2	13.4	6.7	5.2	6.9	15.5	5.7	7.7	21.0	5.9	10.6	13.7	9.9	13.6	6.2	10.1	15.8	12.4	7.8	5.1	12.8	10.9	12.7	5.0	14.0	10.0	7.2	14.6	8.5	9.4	6.9	16.0	12.2	37.3	25.9	12.5	10.0	59.1	14.8	13.0	14.6	15.5	39.0	24.3	37.1	11.7	14.5	19.7	26.9	40.5	26.6	23.8	56.6	33.1	54.7	13.4	27.1	28.5	57.7	32.4	13.3	31.4	23.2	52.3	9.0	24.2	41.9	27.6	21.8	15.7	27.8	35.2	30.6	55.8	31.4	13.0	36.6	39.6	23.3	14.6	24.6	21.0	24.2	10.4	26.8	21.7	28.9	28.8	32.9	22.2	8.4	13.5	16.7	18.9	20.2	22.6	39.7	13.6	31.5	16.8	4.6	1.9	0.4	2.8	1.6	3.1	2.0	2.8	3.0	2.2	1.4	2.4	2.6	0.5	4.2	2.5	2.5	1.7	2.7	4.7	5.1	7.0	6.2	4.8	4.3	6.7	5.2	5.9	5.1	5.0	6.9	9.5	3.2	15.3	13.7	11.7	7.0	5.2	4.6	8.0	11.7	8.4	7.6	6.2	5.7	5.6	0.0	8.4	19.3	19.4	12.7	1.9	7.3	16.8	9.0	9.4	10.0	11.4	6.3	16.8	13.5	18.5	6.4	11.2	12.1	12.0	12.5	8.6	6.0	10.4	16.8	12.7	16.3	0.0	16.3	8.0	5.6	6.5	9.9	5.4	12.2	9.9	4.5	13.4	14.1	27.3	15.0	19.2	4.9	16.9	11.2	6.5	3.6	6.0	9.5	0.0	7.8	7.2	14.0	11.6	10.5	7.2	26.8	11.5	5.2	14.8	8.1
PRPF3	"hPrp3, Prp3, RP18, SNRNP90"	ENSG00000117360	"Pre-mRNA processing factor 3"	O43395	1	150321479-150353233	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027226, HPA067116"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA027226: AB_1855770, HPA067116: AB_2685783"	"unprognostic (2.75e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.59e-5)"	"unprognostic (7.89e-2)"	"unprognostic (7.13e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (6.77e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.78e-3)"	26.0	24.7	18.1	22.3	20.2	44.8	27.0	23.2	23.1	27.5	22.8	25.2	16.9	25.0	26.7	22.2	25.7	13.8	19.5	17.8	21.4	29.0	30.4	24.3	28.6	19.7	18.9	34.1	23.8	17.6	27.0	20.9	19.3	27.5	19.6	43.5	21.7	19.5	22.2	23.8	24.6	18.7	17.3	33.8	19.1	20.1	19.7	30.9	32.0	14.9	28.5	24.3	24.3	21.6	44.8	47.5	47.1	30.3	31.0	33.5	63.8	45.6	31.9	69.1	47.5	36.6	40.8	58.7	29.7	37.6	64.4	51.5	86.1	32.2	61.7	29.7	38.3	50.7	72.1	35.2	30.7	62.5	31.6	24.6	43.7	59.0	50.5	32.9	42.7	39.0	61.3	34.8	50.0	66.5	52.3	55.0	67.6	114.3	41.9	75.1	38.5	38.8	28.5	26.7	40.3	35.7	37.9	44.2	34.9	63.3	52.9	150.5	34.3	43.2	33.3	36.7	75.8	33.1	62.8	64.7	28.8	56.2	45.9	9.3	9.0	13.3	14.9	11.8	14.6	13.0	10.8	9.8	9.5	10.0	11.0	11.4	5.3	11.5	21.8	7.6	9.1	8.3	18.1	20.2	23.2	23.1	17.8	21.4	19.7	18.9	19.3	17.3	19.7	21.6	26.1	35.3	23.4	31.6	26.1	11.7	13.1	13.0	10.8	30.4	10.8	10.8	13.2	11.5	19.7	11.0	18.8	16.1	22.9	15.8	13.7	15.6	11.5	13.2	20.0	22.5	2.4	19.0	19.5	11.9	16.0	16.3	17.9	17.8	22.8	25.5	14.6	11.0	12.1	32.0	17.5	17.5	4.1	8.6	11.8	5.3	20.2	14.5	10.6	15.0	14.2	27.8	17.5	18.1	28.4	13.4	9.5	18.4	12.4	12.6	12.6	5.0	20.6	42.6	13.1	19.1	21.2	44.3	23.5	11.6	10.1	20.0	24.0	11.3	11.6	10.0
PRPF39	"FLJ11128, FLJ20666"	ENSG00000185246	"Pre-mRNA processing factor 39"	Q86UA1	14	45084107-45116282	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001176, HPA078403"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA001176: AB_2171026, HPA078403: "	"unprognostic (1.79e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.91e-2)"	"unprognostic (6.75e-3)"	"prognostic unfavorable (3.84e-5)"	"unprognostic (9.51e-3)"	"prognostic unfavorable (6.51e-4)"	"prognostic favorable (8.48e-4)"	"unprognostic (4.34e-3)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (5.02e-3)"	"unprognostic (1.83e-1)"	"unprognostic (9.04e-2)"	"unprognostic (8.93e-2)"	"prognostic favorable (2.99e-4)"	4.8	4.0	1.4	0.7	1.6	2.7	4.8	1.3	2.0	5.5	0.2	5.1	1.5	5.2	1.7	3.9	6.3	1.3	3.7	1.1	1.0	5.6	3.4	3.2	1.5	1.3	0.7	5.5	4.4	1.7	4.1	1.7	1.5	3.5	1.0	2.0	4.4	1.5	7.6	4.8	4.3	1.5	0.2	3.8	5.1	3.0	1.0	1.8	3.6	1.7	1.2	5.3	4.3	2.2	7.8	8.5	7.0	3.4	2.7	2.4	7.0	6.2	3.4	4.9	4.3	5.1	5.2	4.9	6.2	4.5	3.6	5.1	9.0	4.1	7.3	8.9	6.2	6.8	11.5	4.8	3.2	6.5	1.9	1.5	2.5	2.7	3.2	2.6	3.5	6.2	9.8	5.2	5.4	7.0	7.2	3.1	6.5	5.2	8.9	9.5	6.0	6.3	2.8	10.4	6.8	1.8	2.9	3.9	4.9	3.5	3.7	5.2	7.8	4.3	4.0	3.1	8.3	5.1	12.9	11.2	1.8	6.6	2.4	5.2	2.7	4.7	4.5	4.9	6.4	5.6	4.0	4.7	4.9	5.0	5.2	6.1	2.1	4.3	5.2	2.0	5.4	3.2	1.4	1.6	1.3	2.0	1.1	1.0	1.3	0.7	1.5	0.2	1.0	2.2	14.3	25.6	22.5	21.2	18.2	27.3	15.6	6.5	18.8	19.5	10.6	7.4	14.9	7.2	13.5	7.3	14.6	12.1	21.5	7.0	9.8	8.5	1.3	9.2	19.5	12.8	9.6	15.8	36.6	9.3	10.6	15.5	12.2	11.2	16.4	16.7	10.8	7.5	7.5	16.8	37.1	9.1	6.1	5.1	14.6	4.9	14.9	9.5	14.2	25.3	8.4	10.8	5.2	31.2	55.5	8.0	6.6	14.7	19.1	14.2	14.2	5.4	6.1	24.2	6.6	13.5	16.7	11.6	11.8	18.3	25.3	12.0	19.7	13.4	9.2	10.0
PRR12	KIAA1205	ENSG00000126464	"Proline rich 12"	Q9ULL5	19	49591182-49626439	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011959	Approved		Approved	Cytosol		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA011959: AB_10610286"	"unprognostic (8.30e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.20e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.40e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.52e-3)"	"unprognostic (8.59e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.32e-2)"	"unprognostic (9.65e-3)"	11.6	12.6	8.8	7.2	6.5	5.4	11.8	7.6	11.3	15.1	0.0	14.2	6.2	16.7	2.0	12.3	14.3	3.1	11.0	7.6	4.0	10.1	6.9	10.2	7.8	4.4	3.0	16.3	11.3	4.7	22.9	4.6	1.7	13.0	2.2	4.5	13.0	7.4	14.8	21.3	12.7	3.5	0.9	14.8	12.8	7.5	2.8	7.5	15.7	3.4	4.2	14.0	13.1	2.6	15.4	23.4	12.6	14.0	5.6	5.0	10.0	9.5	4.6	5.2	4.1	9.0	8.9	15.5	7.9	6.8	4.9	14.0	5.8	8.3	1.7	13.2	17.3	16.0	12.4	9.0	4.0	15.1	23.0	6.4	8.2	5.9	3.9	6.3	5.8	9.2	11.1	8.9	4.6	11.6	17.1	18.2	17.9	7.8	21.5	22.2	9.8	5.8	4.7	19.0	10.0	18.6	13.8	12.8	6.7	5.0	9.0	11.0	13.9	18.0	17.2	6.8	15.7	11.4	14.4	10.4	11.2	8.6	11.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.8	6.5	7.6	11.3	7.6	4.0	4.4	3.0	1.7	0.9	2.8	2.6	8.8	6.4	2.6	9.8	8.1	4.0	1.3	8.2	8.6	7.7	8.1	6.5	2.9	7.2	3.6	12.9	4.2	5.5	8.7	5.8	1.9	4.1	1.1	5.1	8.8	5.5	10.2	2.5	9.3	7.5	3.3	5.6	8.6	7.1	10.2	9.6	6.8	2.9	6.4	5.0	11.9	6.6	4.1	7.5	2.8	2.1	14.0	5.8	3.6	8.4	3.3	3.6	5.2	10.6	8.8	13.4	5.7	14.7	6.0	1.9	6.6	2.5	6.5	3.6	13.1	7.3	5.5	2.7	6.8	6.9	7.7	1.1	7.5	6.9	6.9	1.5
PRRC2A	"BAT2, D6S51E, G2"	ENSG00000204469	"Proline rich coiled-coil 2A"	P48634	6	31620715-31637771	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 81.9;HEK 293: 148.3;U-266/70: 75.3;U-266/84: 86.8;U-698: 78.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026383, HPA046791, HPA066501"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		5600		"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB026383: , HPA046791: AB_2679809, HPA066501: AB_2732747"	"unprognostic (2.07e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.25e-3)"	"unprognostic (5.04e-2)"	"unprognostic (4.63e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.29e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.10e-1)"	37.2	36.5	0.2	6.8	0.2	0.1	36.3	0.2	0.4	48.8	0.0	47.9	0.5	53.7	12.2	42.0	47.3	0.0	41.5	0.6	0.2	37.4	23.0	36.4	3.4	0.6	1.0	55.7	35.1	0.0	50.4	0.8	0.1	47.5	0.6	2.9	31.8	0.3	54.9	37.6	37.3	0.1	0.2	41.7	37.1	84.3	0.2	4.3	41.9	0.0	0.0	44.1	40.3	0.2	4.4	19.3	0.2	0.7	35.5	33.6	3.3	2.0	0.0	0.0	0.2	0.9	0.2	4.2	24.5	41.8	0.0	1.8	0.0	81.9	0.0	8.1	148.3	4.6	0.2	0.3	0.1	2.0	1.4	14.9	0.0	0.2	0.0	0.0	0.0	30.7	2.0	0.0	0.2	0.7	0.9	0.2	0.4	0.1	1.7	2.2	0.6	0.9	6.9	0.5	2.6	1.3	1.5	0.1	0.7	0.0	0.3	1.5	0.7	0.5	17.6	1.3	0.9	75.3	86.8	78.7	25.7	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	0.6	0.2	0.6	1.0	0.1	0.2	0.2	0.2	39.3	0.0	5.5	25.5	39.2	32.9	28.4	26.1	67.7	36.1	41.6	39.0	6.7	18.6	14.5	40.5	60.5	26.9	38.0	48.4	5.9	24.8	58.7	33.3	37.1	33.4	38.9	47.9	19.2	25.6	22.2	32.9	52.0	35.9	10.8	55.5	33.5	22.5	34.6	37.0	19.7	39.1	26.4	28.2	30.9	23.7	49.0	31.4	19.6	15.9	28.7	20.9	39.1	23.1	15.3	34.5	37.8	44.8	47.2	39.1	27.0	16.0	20.1	35.9	19.7	57.0	44.8	58.0	43.2	64.1	28.4	18.3	38.2	45.3	48.0	28.4
PSMD5	"KIAA0072, S5B"	ENSG00000095261	"Proteasome 26S subunit, non-ATPase 5"	Q16401	9	120815496-120842951	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003216	Uncertain		Approved	Nucleoplasm,Cytosol		No	No		250000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA003216: AB_1079709"	"unprognostic (7.72e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.02e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.39e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.87e-1)"	15.0	16.5	8.8	13.4	8.4	20.4	23.4	12.0	9.8	15.9	8.5	14.5	12.6	16.4	13.9	16.6	14.1	12.5	9.4	8.4	10.2	13.5	20.5	14.6	15.9	9.3	9.4	15.2	14.3	10.7	9.8	12.7	9.5	18.1	14.3	11.7	17.9	14.3	9.1	19.7	12.5	18.6	8.9	12.0	14.3	13.8	9.7	14.5	14.3	11.2	19.0	17.1	12.1	12.8	35.0	44.3	20.7	38.6	44.9	44.1	24.4	49.4	38.1	45.3	41.5	38.7	21.7	35.4	22.1	50.2	36.1	50.5	0.0	48.9	52.5	33.1	5.3	29.7	59.2	21.6	33.9	10.2	10.6	37.3	30.6	44.2	47.4	22.7	26.9	37.7	110.2	22.6	42.8	42.9	31.5	21.0	30.6	82.6	31.4	28.0	45.0	28.0	42.1	30.0	28.8	18.3	61.8	50.2	24.7	15.2	60.5	24.5	41.5	0.1	25.0	19.3	45.3	13.0	14.8	38.0	28.6	33.4	41.1	19.3	18.1	15.6	19.8	20.9	21.6	22.2	22.7	23.9	17.7	17.8	21.9	16.9	9.7	18.7	23.7	12.7	32.7	18.1	8.8	8.4	12.0	9.8	8.4	10.2	9.3	9.4	9.5	8.9	9.7	12.8	14.3	9.6	17.0	20.2	16.7	12.4	11.8	11.7	21.1	11.6	18.9	13.5	8.1	11.5	17.5	9.2	12.5	12.1	15.3	13.6	11.7	12.9	7.7	8.1	20.6	13.7	7.8	17.2	28.4	13.4	11.7	18.4	14.8	11.9	14.5	11.8	17.2	24.9	11.8	5.0	24.5	14.1	8.2	16.1	13.9	4.7	13.1	12.7	14.2	15.0	12.3	9.9	10.3	34.2	29.0	17.1	10.1	16.1	16.0	14.1	10.5	16.8	8.1	10.3	6.6	11.7	16.3	22.4	21.3	27.0	13.5	10.9	17.3	17.7	11.0	9.7
PSMD9	"p27, Rpn4"	ENSG00000110801	"Proteasome 26S subunit, non-ATPase 9"	O00233	12	121888732-121918297	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040512, HPA044220"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		500000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Plasma membrane"	"HPA040512: AB_2677014, HPA044220: AB_2678860"	"unprognostic (2.24e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.86e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.73e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.63e-2)"	16.5	4.6	7.5	2.3	8.1	19.2	4.8	8.0	10.0	5.8	11.8	13.8	11.5	7.1	2.2	6.2	6.4	3.8	5.5	7.9	8.1	10.8	4.6	6.0	5.7	9.0	8.9	5.9	10.6	4.8	3.5	3.9	8.3	4.6	2.2	3.6	8.8	6.7	18.5	5.9	6.2	3.3	8.3	8.9	14.9	5.1	8.7	6.6	5.1	6.0	3.2	4.1	5.5	9.4	54.8	81.8	6.7	12.2	11.2	11.6	13.9	54.5	17.8	27.3	15.5	60.0	6.3	40.5	45.0	28.6	9.2	22.1	20.0	29.1	16.3	78.5	41.6	33.3	40.9	30.5	27.5	23.3	22.7	20.4	14.0	30.4	11.7	9.9	16.6	24.7	30.1	5.3	17.6	63.2	47.1	17.8	14.0	7.1	63.4	35.6	18.3	24.9	13.4	53.9	14.1	19.3	54.4	7.7	29.3	5.8	23.3	11.3	43.3	25.4	29.0	50.1	38.4	30.4	73.0	62.1	45.5	30.1	23.8	41.8	43.6	53.0	33.9	46.2	27.3	47.6	32.6	31.0	38.5	38.5	25.0	21.2	41.3	29.3	41.7	63.7	48.1	51.6	7.5	8.1	8.0	10.0	7.9	8.1	9.0	8.9	8.3	8.3	8.7	9.4	22.8	48.1	33.7	10.1	32.6	60.5	11.4	64.1	67.2	7.3	40.9	34.8	8.0	34.3	40.0	35.0	18.8	30.3	45.8	66.6	52.8	116.9	34.9	32.6	28.7	29.7	46.6	121.4	12.9	121.4	30.7	30.5	42.8	27.4	44.4	11.0	33.9	26.8	39.8	15.2	10.7	66.5	54.9	37.9	55.3	11.4	37.9	43.6	55.2	7.5	93.9	17.2	35.0	7.1	18.7	138.2	64.2	38.7	73.2	9.5	146.8	100.7	36.6	14.8	39.5	19.5	46.8	33.9	37.5	69.4	71.6	37.8	44.9	12.9	67.7	12.8
PUM2	"KIAA0235, PUMH2"	ENSG00000055917	"Pumilio RNA binding family member 2"	Q8TB72	2	20248691-20352234	"Predicted intracellular proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030316, HPA049670"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA030316: AB_10610289, HPA049670: AB_2680845"	"unprognostic (2.41e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.87e-2)"	27.6	29.8	29.7	33.4	31.7	33.4	41.7	42.5	32.7	36.2	32.4	36.5	34.4	36.3	32.8	39.2	29.7	27.1	33.1	31.1	30.9	36.8	43.1	33.2	48.6	26.0	29.3	44.6	27.4	41.4	8.3	40.3	26.1	37.3	37.0	66.8	33.0	33.1	21.5	47.2	35.6	32.3	29.1	42.6	35.8	24.9	31.6	70.5	57.6	32.6	47.6	38.0	18.3	37.6	72.4	50.0	65.3	46.1	40.2	40.5	65.9	49.2	53.6	48.4	42.2	43.5	33.0	96.3	11.0	44.9	58.2	38.9	61.4	35.6	71.2	87.0	38.2	105.0	35.3	62.2	43.4	107.2	93.3	29.7	79.7	42.1	77.4	45.5	53.1	57.1	75.0	82.9	57.3	35.5	93.6	65.9	55.8	68.3	31.5	80.6	110.9	73.8	45.0	68.1	55.9	76.6	42.2	58.3	48.1	43.4	33.0	61.5	52.5	58.6	58.5	38.3	64.6	93.3	123.0	181.8	35.3	75.8	51.4	11.5	4.0	5.8	6.0	5.2	7.1	4.8	6.7	7.5	4.2	5.3	7.3	6.0	11.6	7.7	7.3	3.7	5.8	3.7	29.7	31.7	42.5	32.7	31.1	30.9	26.0	29.3	26.1	29.1	31.6	37.6	43.6	35.3	51.6	89.5	57.6	79.7	32.2	26.4	74.0	94.6	46.9	30.5	46.5	32.9	33.8	47.8	62.6	36.3	43.6	44.0	11.7	16.6	10.1	33.9	35.6	45.0	34.6	41.0	134.7	15.5	16.9	36.5	43.8	45.9	20.3	53.0	41.4	56.3	29.1	58.9	153.5	43.2	38.7	70.7	44.2	5.8	34.2	44.9	32.0	144.3	42.7	26.8	43.3	155.3	186.0	22.6	28.1	26.4	54.7	57.8	33.9	29.7	39.5	72.3	32.9	40.5	47.6	16.8	16.6	75.2	106.3	52.0	50.1	31.2	40.2	56.6
QRICH1	"AB-DIP, FLJ20259, VERBRAS"	ENSG00000198218	"Glutamine rich 1"	Q2TAL8	3	49029707-49094363	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Unfolded protein response"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037677, HPA037678"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA037677: AB_10671883, HPA037678: AB_2675603"	"unprognostic (2.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.94e-2)"	"unprognostic (2.82e-2)"	"prognostic favorable (7.46e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.17e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.06e-1)"	29.8	27.9	15.4	30.5	17.0	61.0	27.8	25.3	20.2	25.8	16.0	25.9	26.3	28.6	25.9	30.0	27.6	25.2	26.0	16.9	14.8	21.3	23.5	27.8	40.1	14.7	13.2	34.0	26.0	33.2	24.8	27.0	14.6	25.8	25.2	30.4	28.3	26.3	34.8	35.4	31.0	28.9	13.2	35.8	25.9	44.5	13.3	51.9	25.7	32.4	41.9	26.8	23.7	16.9	41.4	39.6	78.6	35.6	48.2	45.8	48.2	48.4	60.3	75.6	70.7	44.3	50.8	65.6	29.1	58.9	62.8	33.5	69.0	63.0	64.8	57.8	45.1	65.5	52.9	37.8	43.1	57.9	75.0	53.3	47.4	74.8	46.6	46.2	60.3	62.7	45.0	58.6	51.6	31.8	84.9	41.4	62.3	43.7	48.9	43.3	40.3	55.4	47.6	63.2	29.9	58.9	54.9	47.7	39.7	59.3	42.4	65.5	52.5	49.0	55.1	43.7	69.8	54.2	66.6	82.2	44.0	55.2	57.2	21.3	15.6	19.1	18.1	18.9	21.5	16.6	17.3	20.6	18.5	16.6	18.3	22.0	11.7	18.1	33.0	13.5	19.8	14.3	15.4	17.0	25.3	20.2	16.9	14.8	14.7	13.2	14.6	13.2	13.3	16.9	21.8	9.6	18.9	19.6	30.5	22.2	13.7	16.0	17.1	13.6	20.6	17.7	21.1	14.3	17.9	20.2	22.9	25.7	28.2	16.6	1.9	15.9	15.8	19.8	20.7	19.6	25.9	22.5	37.9	14.0	27.8	20.3	23.9	27.5	16.5	20.0	18.9	20.4	19.7	11.8	39.1	20.6	10.2	25.3	18.3	10.9	22.4	19.5	12.4	14.0	22.3	12.5	15.5	24.6	25.5	18.6	10.5	30.9	39.7	18.0	14.4	10.1	15.2	17.6	6.6	21.9	25.3	52.4	27.8	24.5	22.6	36.8	28.5	17.0	16.8	15.5
QSER1	FLJ21924	ENSG00000060749	"Glutamine and serine rich 1"	Q2KHR3	11	32892811-32993316	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005682	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA005682: AB_1855985"	"unprognostic (2.94e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (7.94e-5)"	"unprognostic (1.14e-1)"	"unprognostic (4.75e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (1.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.96e-2)"	5.4	4.5	5.3	5.5	6.5	4.1	8.9	15.1	5.3	7.5	10.0	5.1	3.5	8.3	6.7	7.6	6.1	5.9	5.9	5.1	5.8	5.5	5.8	4.4	5.5	5.6	5.7	12.7	6.9	6.5	3.9	5.7	5.6	4.6	5.5	7.1	10.0	5.1	4.6	11.8	4.1	6.4	5.7	6.1	5.5	9.0	5.4	8.6	8.8	7.0	6.5	6.3	6.1	6.6	23.4	28.7	32.4	30.5	12.2	23.2	15.7	20.0	17.9	14.0	17.3	24.5	10.8	24.2	12.5	23.9	23.5	29.4	30.9	17.6	30.3	10.7	19.5	22.9	26.7	21.0	9.8	27.7	11.9	11.6	18.9	17.7	29.5	16.8	19.9	14.2	35.2	10.6	22.2	20.5	14.3	10.8	34.1	14.4	17.9	22.5	64.6	10.1	14.5	24.6	16.7	23.9	37.8	19.4	12.3	23.7	20.2	14.3	20.3	34.0	34.2	62.9	44.0	6.8	10.3	22.5	21.9	12.7	22.6	0.0	0.2	0.0	0.2	0.4	0.1	0.5	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.4	0.1	0.4	0.0	0.1	5.3	6.5	15.1	5.3	5.1	5.8	5.6	5.7	5.6	5.7	5.4	6.6	22.0	19.2	13.4	35.6	10.6	27.9	12.0	14.2	35.9	17.7	21.6	18.7	31.0	14.3	15.9	7.3	14.6	12.9	7.7	5.9	3.9	10.6	14.0	9.9	37.0	19.5	0.0	17.7	51.6	12.1	12.2	27.2	15.8	17.1	3.8	39.3	15.7	10.5	14.5	10.1	50.6	11.7	14.2	16.0	16.1	11.0	24.5	19.1	16.0	54.4	15.9	12.9	5.2	50.3	48.6	10.7	9.3	21.1	23.1	15.0	5.3	8.9	12.2	15.0	6.6	37.9	17.8	21.3	20.5	43.1	27.6	4.2	8.4	21.5	13.6	14.3
R3HCC1L	"C10orf28, GIDRP86, PSORT"	ENSG00000166024	"R3H domain and coiled-coil containing 1 like"	Q7Z5L2	10	98134624-98244897	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 51.5;Oligodendrocytes: 59.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037367	Enhanced		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"		"HPA037367: AB_10696930"	"unprognostic (3.00e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.67e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.74e-3)"	"unprognostic (7.39e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-2)"	12.8	8.5	8.8	7.8	10.0	17.4	11.6	10.9	11.1	14.2	9.1	12.1	6.4	8.9	9.7	13.1	9.2	5.9	8.3	8.5	8.9	11.8	13.5	10.9	12.2	9.7	9.3	8.7	11.0	10.5	8.6	8.3	9.7	12.7	10.1	10.0	11.8	6.6	9.9	15.1	12.3	6.5	9.4	15.3	9.5	31.1	9.5	13.7	10.1	8.0	13.0	12.4	13.1	10.9	14.6	9.4	13.9	12.4	11.7	12.4	11.5	16.1	22.4	15.4	17.0	12.8	10.0	20.4	8.5	9.6	8.7	16.0	14.2	9.7	17.4	15.4	9.6	12.1	7.3	14.4	14.4	16.7	14.1	11.4	10.9	13.6	20.0	13.6	10.1	12.6	10.6	12.4	12.2	14.0	13.2	17.3	10.1	6.9	12.1	13.4	15.9	8.2	11.2	8.5	4.8	10.2	8.3	6.0	32.9	17.7	10.8	10.4	11.2	10.3	11.0	11.6	12.2	12.5	14.1	34.4	14.8	17.1	7.7	12.2	6.3	17.8	8.6	8.8	7.8	9.2	8.9	8.9	5.0	8.6	7.7	7.7	7.6	10.4	13.4	5.5	13.4	5.5	8.8	10.0	10.9	11.1	8.5	8.9	9.7	9.3	9.7	9.4	9.5	10.9	11.8	16.0	15.1	30.0	13.2	3.3	4.8	3.9	6.8	6.7	5.9	5.0	8.9	10.0	6.5	7.3	6.2	9.8	15.6	13.5	5.9	7.8	28.4	10.8	10.5	9.5	6.0	11.8	39.9	6.9	9.8	8.3	14.3	10.1	17.1	9.7	6.1	4.5	6.9	5.0	35.8	12.2	2.0	8.7	5.1	13.1	5.3	13.5	12.4	51.5	9.5	6.5	13.4	34.2	59.8	10.5	5.4	5.7	11.9	5.4	9.6	3.4	13.0	14.2	0.0	7.6	7.1	36.6	23.9	6.3	3.8	13.0	12.8	8.7	9.5	7.5
RAB24		ENSG00000169228	"RAB24, member RAS oncogene family"	Q969Q5	5	177301198-177303744	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 55.2;Plasma cells: 71.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 125.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034945			Uncertain	"Focal adhesion sites"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Focal adhesion sites"		"HPA034945: "	"unprognostic (1.03e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.86e-2)"	"prognostic favorable (6.22e-4)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.54e-7)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.12e-2)"	22.0	38.9	30.1	20.0	30.1	25.9	24.3	25.8	32.6	31.2	32.4	24.0	13.8	20.0	22.1	42.4	20.2	11.5	23.5	30.3	31.9	32.8	30.5	27.1	15.7	30.1	26.4	27.0	59.7	17.8	48.6	12.0	29.9	31.1	10.5	11.6	34.3	12.5	30.3	42.2	24.5	11.7	26.3	53.7	22.2	11.4	29.6	11.2	24.1	17.4	20.6	23.5	32.3	29.6	6.9	17.7	13.0	25.3	20.8	18.0	19.5	19.8	28.6	27.8	33.7	20.9	8.8	7.2	24.2	18.5	30.7	4.9	17.7	24.8	15.7	125.9	9.8	25.2	17.4	18.6	43.2	15.6	21.3	30.4	20.2	29.9	21.0	41.4	17.3	21.4	18.0	42.6	20.1	26.2	5.7	38.3	8.0	15.2	17.8	3.6	18.5	28.0	19.1	12.6	14.1	20.1	6.8	13.1	59.6	15.9	23.0	41.0	16.2	8.5	14.2	19.8	19.1	31.4	15.9	9.8	16.5	24.3	17.9	42.6	87.1	166.7	19.0	185.2	17.7	33.2	10.3	16.6	60.1	29.0	10.9	16.6	137.3	37.4	183.6	13.6	9.3	48.4	30.1	30.1	25.8	32.6	30.3	31.9	30.1	26.4	29.9	26.3	29.6	29.6	6.3	3.2	7.1	31.0	33.7	5.4	1.6	16.3	55.2	3.7	12.1	8.4	2.4	1.5	12.9	1.8	2.1	7.6	7.3	28.5	3.9	24.5	0.6	2.4	3.9	5.9	18.0	12.6	42.7	20.1	6.3	10.8	31.1	3.2	12.0	1.3	5.3	1.7	4.3	13.5	45.1	12.8	6.1	8.8	6.9	0.6	5.0	37.7	3.6	10.3	11.1	2.0	9.2	14.6	15.6	18.9	27.7	1.2	71.1	1.9	26.0	6.9	5.5	4.2	0.0	2.4	8.0	2.2	3.6	43.8	6.0	30.6	15.4	2.2	13.3	2.0
RAB43	"ISY1, RAB11B, RAB41"	ENSG00000172780	"RAB43, member RAS oncogene family"	Q86YS6	3	129087569-129122801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 46.9"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 12.0;Gastric mucus-secreting cells: 5.6;Plasma cells: 9.2;Squamous epithelial cells: 2.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 11.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 11.2;T-cells: 2.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046840, HPA060085"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA046840: , HPA060085: AB_2684199"	"unprognostic (3.01e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.16e-1)"	"unprognostic (8.68e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.71e-2)"	7.6	8.3	9.5	10.4	9.7	22.3	7.1	11.6	8.1	7.3	9.3	7.9	8.0	6.6	2.9	5.9	7.3	9.4	4.2	7.9	5.8	10.4	46.9	14.8	17.4	10.0	7.5	9.9	10.3	5.2	6.7	3.9	8.4	9.9	2.6	0.7	10.2	5.0	1.8	4.0	6.9	2.7	7.3	10.9	8.1	7.5	7.1	12.9	22.7	1.4	4.6	7.3	4.0	6.7	22.4	6.0	1.4	5.7	2.7	1.2	8.3	7.6	5.1	4.4	3.5	9.4	9.4	0.6	17.1	5.7	5.9	9.2	0.5	8.8	1.0	11.2	5.6	1.5	1.1	12.5	25.9	5.1	12.7	7.1	5.4	2.2	0.5	1.9	8.7	13.0	2.5	10.8	6.1	9.7	5.0	9.8	7.0	5.2	10.5	10.8	3.2	6.6	14.1	18.7	0.4	2.7	3.3	7.0	14.4	2.2	3.0	5.3	12.5	9.3	6.4	7.6	2.9	16.9	9.8	3.6	8.5	1.0	10.3	0.4	1.2	2.3	1.5	1.5	0.7	0.5	1.5	1.2	0.6	1.0	2.8	2.4	11.2	1.4	0.7	0.9	2.4	1.0	9.5	9.7	11.6	8.1	7.9	5.8	10.0	7.5	8.4	7.3	7.1	6.7	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.0	12.0	0.0	0.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.0	0.8	0.0	0.3	0.6	0.4	0.0	0.0	0.0	0.2	0.1	0.5	5.6	0.5	0.0	0.2	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	9.2	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.1	2.5	0.1	0.1	1.2	0.2	0.3	0.1
RAB6A	RAB6	ENSG00000175582	"RAB6A, member RAS oncogene family"	P20340	11	73675638-73761137	"Predicted intracellular proteins"	"ER-Golgi transport, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009936, HPA059131"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"CAB009936: AB_2175466, HPA059131: AB_2683916"	"unprognostic (2.84e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (8.18e-5)"	"unprognostic (1.79e-1)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (8.67e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (9.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.36e-1)"	71.2	69.8	87.7	53.0	96.5	38.4	50.6	85.4	112.8	64.4	79.3	66.2	71.6	66.9	53.0	100.2	54.0	55.6	99.5	101.8	100.9	75.1	85.3	68.5	45.7	106.0	90.1	64.5	49.0	67.5	36.4	91.4	112.9	64.0	70.6	56.1	47.8	64.9	107.5	55.0	83.4	79.8	80.0	56.9	54.9	36.1	97.4	54.2	98.7	101.7	60.8	78.9	62.4	93.4	86.2	66.3	105.8	68.5	135.9	154.3	141.7	130.4	124.6	111.1	100.8	131.5	146.4	73.2	136.6	174.0	94.9	94.6	68.4	135.3	142.5	84.6	25.6	118.2	68.6	110.9	114.2	78.1	113.1	114.7	246.8	113.5	165.0	124.4	135.9	75.7	71.3	111.5	133.3	99.6	85.7	54.7	42.2	192.0	62.3	64.8	193.9	132.5	135.2	146.6	83.0	70.5	136.1	136.7	290.9	104.7	107.2	71.0	165.0	113.3	56.9	193.5	56.6	71.9	89.5	149.5	46.3	63.2	104.6	227.9	81.8	133.2	84.2	87.6	76.2	56.1	70.3	75.5	62.9	50.7	52.0	61.8	61.9	78.6	88.6	33.7	86.3	111.1	87.7	96.5	85.4	112.8	101.8	100.9	106.0	90.1	112.9	80.0	97.4	93.4	66.3	32.1	51.0	79.7	59.2	83.5	49.4	57.2	88.2	53.9	45.8	30.4	64.2	35.8	42.7	68.0	87.6	109.9	55.3	85.2	43.0	66.0	8.8	51.5	41.3	78.7	52.0	47.5	133.6	49.5	162.3	60.5	52.5	51.2	48.8	83.7	72.5	63.7	65.7	40.4	119.0	61.8	75.3	58.4	85.7	9.5	52.8	58.3	72.9	49.6	74.2	47.7	52.5	130.7	109.4	79.0	61.7	61.7	86.3	57.8	102.7	54.1	47.2	54.2	26.3	47.4	65.5	74.2	53.4	106.5	112.7	173.6	63.8	45.0	50.8	69.8
RAVER1	KIAA1978	ENSG00000161847	"Ribonucleoprotein, PTB binding 1"	Q8IY67	19	10316212-10333638	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 15.2;Enteroendocrine cells: 16.3;Plasma cells: 15.3;Proximal enterocytes: 14.0;Undifferentiated cells: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 255.5"					"Low region specificity"	"Detected in all"			"HPA043575, HPA049457"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA043575: AB_2678562, HPA049457: AB_2680774"	"unprognostic (2.04e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.97e-1)"	12.4	12.9	4.1	11.8	4.9	19.0	12.6	3.9	5.5	17.9	6.2	20.4	17.7	22.8	0.7	15.1	19.8	3.3	9.7	3.7	4.4	12.0	8.3	13.1	11.1	6.9	5.0	19.3	11.7	4.4	17.5	6.0	4.4	15.2	3.2	1.1	13.1	7.5	8.5	11.8	22.6	4.0	3.8	21.7	13.9	11.5	5.0	11.4	14.3	2.2	5.2	16.8	14.0	4.5	62.0	38.9	14.1	21.6	5.6	7.0	31.0	31.9	14.0	24.7	21.8	42.7	17.3	65.0	43.7	10.4	19.9	31.5	15.8	21.1	4.9	55.2	93.5	100.3	25.7	48.6	12.6	63.5	62.4	8.2	7.2	16.6	6.2	8.2	16.2	48.6	80.9	56.2	7.6	57.8	85.6	255.5	55.1	13.1	73.9	78.3	20.5	57.2	6.9	24.4	40.3	46.7	34.7	22.3	18.3	4.8	32.0	30.5	22.5	63.7	32.4	56.7	54.5	122.1	109.0	54.9	42.1	44.2	42.5	0.2	1.3	1.8	3.3	1.5	1.7	1.4	2.8	4.6	2.1	2.0	1.9	1.7	1.2	1.9	3.3	0.9	1.1	2.2	4.1	4.9	3.9	5.5	3.7	4.4	6.9	5.0	4.4	3.8	5.0	4.5	1.2	0.0	1.1	6.5	7.8	0.8	0.3	0.5	10.2	0.8	2.0	1.1	0.7	0.0	0.4	0.0	0.0	2.0	2.3	15.2	0.0	4.5	0.4	1.6	2.2	1.1	16.3	12.0	4.8	4.3	1.9	1.6	6.1	1.2	4.5	0.6	0.4	0.3	1.3	0.0	4.5	9.3	0.0	0.0	0.8	0.0	0.0	2.0	0.0	6.5	6.8	0.3	0.0	4.0	4.2	5.4	10.2	0.7	15.3	0.3	14.0	0.6	1.1	1.0	0.0	0.8	2.4	0.7	0.3	6.1	0.1	1.5	5.5	0.6	14.3	0.2
RBBP4	"lin-53, NURF55, RbAp48"	ENSG00000162521	"RB binding protein 4, chromatin remodeling factor"	Q09028	1	32651142-32686211	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB006264, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm		NA	NA		150000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB006264: AB_425651, HPA060710: AB_2684347, HPA060724: AB_2684350"	"unprognostic (1.18e-3)"	"unprognostic (1.79e-3)"	"unprognostic (2.96e-3)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.23e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (1.89e-6)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.88e-2)"	32.0	38.8	19.9	33.5	21.8	34.8	38.5	24.7	21.1	40.3	21.5	33.3	27.0	42.4	35.1	32.1	45.5	25.3	31.7	18.7	21.8	31.9	30.6	28.8	62.9	21.4	21.1	46.9	38.5	34.0	31.1	34.6	23.0	30.0	45.9	56.2	38.3	30.7	42.9	33.2	35.7	42.1	22.9	32.7	37.1	75.5	21.3	58.0	45.8	21.1	91.5	35.2	31.2	30.1	68.8	59.1	166.2	120.1	49.9	47.4	66.7	55.3	44.9	103.0	99.7	85.5	135.6	206.9	54.8	61.4	62.7	42.9	184.7	53.6	110.0	80.9	88.3	194.3	112.0	111.9	72.3	183.9	79.9	52.2	66.8	78.1	50.3	83.6	77.2	139.8	138.0	142.1	89.0	48.0	239.4	57.6	185.4	67.0	67.8	228.3	173.8	181.0	72.4	143.4	156.7	94.7	122.1	41.9	83.8	161.3	71.9	83.3	64.3	63.8	61.6	80.4	70.2	113.4	128.0	229.5	75.2	146.9	99.3	79.1	99.9	68.5	74.4	99.8	77.4	79.6	69.8	75.2	115.0	60.1	61.2	67.3	24.8	87.7	95.4	95.7	77.9	151.8	19.9	21.8	24.7	21.1	18.7	21.8	21.4	21.1	23.0	22.9	21.3	30.1	61.6	41.7	53.7	32.3	115.8	71.5	68.3	76.8	120.1	106.1	105.2	57.3	22.2	77.2	59.1	73.5	143.9	129.2	132.0	55.4	84.1	84.7	26.3	51.2	89.0	65.7	97.1	201.4	38.0	58.3	87.6	81.3	70.3	71.6	49.4	93.3	64.6	76.5	80.6	106.0	41.5	83.9	79.3	78.8	74.3	17.5	79.6	80.8	49.8	22.5	90.7	77.4	91.6	44.2	49.7	76.1	42.1	88.4	201.8	59.5	44.3	65.9	50.5	109.2	98.6	47.6	76.9	154.2	88.8	132.5	77.4	85.5	95.4	79.5	86.9	58.7
RBL1	"cp107, p107, PRB1"	ENSG00000080839	"RB transcriptional corepressor like 1"	P28749	20	36996349-37095997	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.3;Inhibitory neurons: 22.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054962, HPA056525"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA054962: AB_2682652, HPA056525: AB_2683165"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.25e-5)"	"unprognostic (6.91e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (3.15e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.26e-1)"	2.0	1.6	1.2	4.8	2.6	14.5	2.8	8.3	1.8	2.3	0.7	2.8	2.4	2.8	1.3	2.9	1.9	2.0	1.8	1.0	1.9	1.6	1.4	2.2	7.3	2.0	1.9	4.4	2.4	2.6	1.1	3.4	2.2	2.0	3.5	4.0	1.5	1.4	6.9	3.1	2.5	2.8	1.4	3.4	2.7	3.1	2.0	8.8	2.7	7.9	6.7	2.0	2.2	3.4	24.8	15.8	19.4	13.1	4.9	6.4	12.4	28.2	12.6	23.9	24.6	16.8	13.5	27.5	7.9	11.8	14.0	23.8	17.5	18.2	39.7	9.7	9.4	27.2	18.1	14.3	3.0	35.3	18.2	3.0	2.5	31.6	11.1	4.0	13.6	17.9	20.1	25.8	13.7	10.5	33.1	11.7	5.7	12.5	15.3	21.3	57.7	20.9	5.5	12.2	4.6	11.5	30.8	17.6	8.2	6.2	11.3	25.3	9.1	42.0	15.9	38.9	24.8	8.6	16.4	27.7	30.2	24.4	21.1	0.9	0.7	1.4	2.7	0.8	2.3	3.0	3.0	2.5	1.3	2.1	3.2	2.7	0.3	2.2	1.2	3.0	4.5	0.9	1.2	2.6	8.3	1.8	1.0	1.9	2.0	1.9	2.2	1.4	2.0	3.4	3.5	6.4	11.0	10.4	8.7	2.4	1.5	1.7	4.0	5.9	2.5	1.7	2.9	1.5	6.1	0.0	2.1	5.9	6.5	1.8	0.0	1.8	1.5	2.2	4.3	3.3	1.2	23.3	14.7	1.1	5.1	4.6	2.6	2.9	8.8	9.0	2.2	1.4	4.5	3.3	22.8	1.9	0.0	3.0	3.2	0.6	2.1	6.8	1.8	6.5	4.7	3.1	7.2	19.6	18.5	0.9	3.6	3.0	14.1	0.8	1.0	0.7	0.9	12.2	6.6	8.5	4.1	17.5	8.7	5.3	1.3	3.8	11.7	6.4	3.5	0.9
RBM14-RBM4		ENSG00000248643	"RBM14-RBM4 readthrough"		11	66616626-66646469	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 5.5;Club cells: 5.0;Excitatory neurons: 8.7;Inhibitory neurons: 8.7;Microglial cells: 5.6;Oligodendrocytes: 10.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 10.0"									HPA047849	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA047849: AB_2680180"	"unprognostic (2.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.77e-4)"	"unprognostic (3.92e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.77e-4)"	"unprognostic (5.74e-7)"	"unprognostic (1.43e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.10e-2)"	0.6	0.8	3.5	0.4	2.5	3.0	0.5	3.4	3.4	0.6	2.9	1.3	0.1	0.8	0.8	1.0	0.7	0.6	2.7	2.6	3.6	1.0	3.0	0.7	0.6	2.9	1.9	0.6	1.1	0.3	1.0	0.4	1.8	1.1	0.4	0.7	0.9	0.5	1.0	0.6	1.0	0.5	1.3	1.1	1.0	0.5	2.6	0.8	1.0	0.4	0.4	1.1	0.7	3.4	1.6	0.9	0.7	1.3	1.0	0.1	0.8	0.9	0.5	1.6	0.3	2.6	0.5	0.9	1.3	0.7	1.2	2.5	1.8	0.6	0.6	0.8	0.7	2.7	1.8	2.0	0.5	1.7	1.5	0.4	0.5	0.8	0.2	0.6	0.0	1.4	3.8	1.4	1.0	3.2	2.5	10.0	1.7	1.9	4.4	2.8	3.4	1.5	0.7	1.8	2.2	1.0	0.7	2.3	5.9	0.5	1.4	1.2	0.7	2.1	1.5	1.7	1.1	1.1	1.0	1.7	1.8	1.2	1.8	4.8	4.3	5.9	4.6	4.8	2.7	5.9	2.9	3.1	4.3	5.9	1.9	2.5	2.8	3.5	5.0	8.4	2.1	3.6	3.5	2.5	3.4	3.4	2.6	3.6	2.9	1.9	1.8	1.3	2.6	3.4	0.5	0.0	1.1	5.5	1.1	0.0	0.5	0.1	1.2	1.1	0.4	0.4	0.0	1.5	5.0	0.0	4.2	0.5	2.0	0.3	0.0	0.5	1.7	1.4	0.9	0.6	0.0	0.4	8.7	0.2	0.4	0.8	1.1	1.1	0.0	0.7	0.0	0.5	0.2	0.0	8.7	0.5	0.0	0.3	0.3	0.9	0.0	1.2	0.0	5.6	0.0	0.1	0.0	4.0	10.3	0.4	0.1	0.0	1.0	0.5	0.0	0.4	3.6	0.8	0.0	0.8	0.4	1.0	0.9	1.0	0.1	1.1	1.0	0.5	0.2	0.8
RBM19	"DKFZp586F1023, KIAA0682, Mrd1"	ENSG00000122965	"RNA binding motif protein 19"	Q9Y4C8	12	113816738-113966325	"Plasma proteins, Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038860, HPA058732"	Supported		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA038860: AB_10697400, HPA058732: AB_2683801"	"unprognostic (2.10e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (5.87e-7)"	"unprognostic (9.32e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.53e-3)"	"unprognostic (8.37e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-2)"	11.5	14.1	7.4	12.5	8.5	16.4	13.5	5.7	8.8	13.8	7.9	13.8	8.7	13.1	8.3	12.5	12.9	6.4	11.6	6.5	7.1	13.4	12.3	12.2	14.0	8.7	7.9	18.9	14.2	10.1	12.7	9.9	8.8	15.1	8.9	7.7	12.6	8.4	16.7	12.5	13.5	9.0	5.1	13.3	13.3	11.9	10.3	10.4	20.8	9.3	12.9	14.4	12.4	11.1	13.0	25.6	15.0	29.3	14.7	11.7	22.7	22.9	17.9	25.3	18.5	34.4	17.7	23.1	13.9	19.5	18.5	18.1	35.4	22.1	19.8	42.0	20.8	49.6	28.0	33.4	11.1	37.9	22.7	14.6	14.3	31.0	11.2	16.2	18.6	17.8	54.3	9.3	15.9	19.4	21.4	28.6	32.8	12.9	21.6	28.2	14.4	20.1	17.3	24.9	17.9	14.4	20.5	29.3	14.2	12.4	32.3	10.9	21.3	16.6	20.3	14.4	14.3	16.7	13.5	22.7	22.3	26.7	21.5	0.1	4.4	1.3	7.7	7.7	6.0	7.3	5.5	6.4	6.1	5.9	4.4	6.0	0.2	7.6	12.4	4.2	5.4	4.8	7.4	8.5	5.7	8.8	6.5	7.1	8.7	7.9	8.8	5.1	10.3	11.1	8.1	16.0	9.6	18.9	15.6	13.8	14.6	5.1	10.8	11.8	10.3	8.3	20.4	7.2	9.2	11.0	8.4	10.6	13.2	6.5	1.9	11.7	7.2	9.1	11.7	11.2	9.0	12.4	13.8	13.3	9.2	13.6	10.2	9.8	15.2	15.5	4.6	6.9	12.3	6.7	13.1	8.4	6.1	7.6	8.7	9.5	10.8	9.8	3.6	24.4	16.8	5.4	8.2	11.1	15.5	14.5	5.6	7.2	15.1	15.3	6.4	9.8	12.8	13.5	0.0	14.1	12.9	16.6	15.1	11.8	11.5	11.4	15.1	10.4	7.8	11.4
RBM4	"LARK, RBM4A, ZCCHC21, ZCRB3A"	ENSG00000173933	"RNA binding motif protein 4"	Q9BWF3	11	66638667-66668374	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, RNA-mediated gene silencing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042174, HPA047849"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA042174: AB_2677885, HPA047849: AB_2680180"	"unprognostic (8.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-2)"	"unprognostic (9.46e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.34e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.07e-3)"	82.6	111.5	60.8	71.0	63.3	131.5	75.8	81.1	66.7	90.8	69.4	96.1	67.8	87.1	90.3	100.3	79.4	59.0	75.6	61.5	67.1	119.8	82.3	77.4	97.5	59.0	58.5	103.6	115.5	77.2	86.1	72.8	58.9	95.9	62.6	74.4	89.1	60.0	96.6	80.9	83.6	69.1	61.1	104.8	98.4	74.3	69.5	109.8	85.7	72.4	99.1	84.2	84.1	65.4	127.2	163.6	246.5	136.4	90.1	95.6	153.9	128.6	106.1	134.1	97.3	281.5	160.9	161.1	174.4	132.3	120.5	136.4	263.5	159.1	142.9	162.1	138.4	220.7	163.5	170.3	173.1	152.8	91.9	138.8	134.3	158.6	213.9	136.4	184.3	155.0	180.1	115.0	147.3	263.3	252.9	157.9	309.7	246.8	176.0	234.2	224.6	181.7	180.7	199.5	204.5	149.5	227.1	168.6	379.9	163.8	315.3	154.4	180.9	140.4	124.0	86.5	107.3	143.9	162.5	258.8	109.9	118.3	205.8	210.0	119.4	131.3	135.5	123.2	122.3	119.3	139.8	149.9	116.2	130.4	147.5	149.8	137.5	155.4	144.0	103.6	194.3	159.1	60.8	63.3	81.1	66.7	61.5	67.1	59.0	58.5	58.9	61.1	69.5	65.4	19.7	28.9	42.2	8.1	64.0	17.8	61.4	36.3	112.7	58.2	24.2	12.7	4.6	15.7	36.5	20.2	93.8	36.2	48.7	16.6	15.6	25.1	39.8	26.6	28.0	28.5	34.7	42.5	23.9	23.1	30.1	33.6	53.0	30.7	36.8	38.1	25.7	11.1	14.5	62.2	21.4	15.5	32.6	18.8	29.2	9.3	27.4	27.5	19.6	7.5	28.8	15.9	69.0	15.1	18.8	19.6	23.6	20.3	60.2	62.6	32.9	10.6	41.1	90.0	19.7	29.7	28.3	41.1	40.1	68.6	22.3	43.8	66.3	42.4	24.8	65.5
RBSN	ZFYVE20	ENSG00000131381	"Rabenosyn, RAB effector"	Q9H1K0	3	15070073-15099163	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044878	Approved		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA044878: AB_10967610"	"unprognostic (6.76e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.78e-1)"	9.0	7.0	12.5	6.7	12.5	18.2	7.7	10.2	13.0	9.1	1.1	10.7	4.7	9.3	7.1	8.9	8.7	5.4	9.8	13.4	11.4	5.4	8.4	8.4	6.6	12.1	12.5	12.7	5.9	9.7	6.1	7.9	11.1	7.4	5.3	13.6	5.9	9.0	13.1	10.2	7.1	9.0	12.8	7.7	7.8	6.6	13.0	5.5	11.2	9.9	6.1	9.1	7.5	11.8	11.2	16.0	12.8	16.6	13.8	10.2	33.9	12.0	11.5	14.1	12.7	9.7	6.5	7.8	6.8	15.9	8.2	7.0	16.5	14.5	12.4	9.9	14.6	8.9	19.7	8.0	9.5	9.0	9.4	11.1	16.1	18.1	12.0	8.3	11.6	8.7	13.5	8.9	10.8	14.7	4.9	4.5	11.0	7.1	12.7	6.4	14.6	8.6	7.3	12.6	3.4	12.0	14.7	8.9	10.7	9.4	22.8	6.5	14.2	12.7	13.3	12.5	17.1	7.9	12.6	9.2	12.2	10.0	12.2	8.1	4.6	11.1	4.4	6.4	3.9	4.4	6.1	5.5	3.8	7.4	7.7	5.2	11.7	3.1	5.6	3.6	4.3	2.7	12.5	12.5	10.2	13.0	13.4	11.4	12.1	12.5	11.1	12.8	13.0	11.8	10.4	16.0	19.0	19.6	9.2	0.0	6.7	0.0	6.8	21.6	7.6	7.0	20.4	8.6	9.9	3.7	22.9	10.4	8.4	6.0	5.9	8.4	17.4	6.4	11.1	12.4	1.2	9.5	21.8	9.6	9.6	14.6	10.2	8.8	10.1	16.4	14.6	14.0	10.7	21.9	23.9	6.9	0.0	15.8	0.0	18.0	19.0	12.1	0.0	8.4	10.5	15.5	7.2	16.1	25.2	9.6	5.1	14.7	12.1	12.6	8.1	6.9	8.0	23.1	6.6	17.5	10.4	12.4	14.0	11.0	0.0	12.9	9.9	10.6	5.4	10.0
RGPD8	"RanBP2alpha, RANBP2L1"	ENSG00000169629	"RANBP2 like and GRIP domain containing 8"	O14715	2	112368369-112434488	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 15.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Early spermatids: 24.3;Excitatory neurons: 9.8;Late spermatids: 10.1;Microglial cells: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 16.2;hTEC/SVTERT24-B: 13.4"									"HPA045704, HPA049497, HPA051675, HPA067564"	Uncertain		Uncertain	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane, Vesicles"		"HPA045704: AB_2679427, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.15e-3)"	"unprognostic (3.17e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.05e-2)"	4.3	1.8	2.7	2.8	3.6	10.6	4.5	8.6	7.6	2.8	4.5	2.1	1.6	3.1	5.4	1.4	2.2	2.9	1.8	3.7	3.5	2.4	5.1	3.3	2.4	2.2	2.4	3.2	3.0	2.2	2.6	3.3	1.9	2.6	2.3	7.9	2.5	2.9	1.7	3.8	2.1	2.6	1.1	3.0	1.7	15.6	2.6	3.2	2.4	2.2	3.0	2.6	1.6	5.5	6.1	2.6	4.3	2.6	1.6	3.6	0.1	2.4	1.9	2.3	1.5	5.3	0.4	0.0	1.7	4.0	2.0	2.9	12.3	1.7	2.4	8.7	4.0	16.2	4.5	4.1	2.2	0.1	0.2	0.6	2.2	13.4	3.4	5.7	1.9	2.8	8.4	0.4	3.6	2.5	8.7	2.1	3.0	0.9	3.7	0.0	0.5	0.1	1.3	2.5	2.7	0.5	8.1	0.1	1.7	3.0	1.2	6.8	8.9	1.3	1.8	6.9	4.4	0.0	0.0	0.0	0.5	2.9	0.3	1.3	0.4	0.4	1.0	0.3	1.4	0.5	0.7	0.9	0.4	0.6	1.0	0.6	0.3	0.5	0.8	0.7	0.4	0.3	2.7	3.6	8.6	7.6	3.7	3.5	2.2	2.4	1.9	1.1	2.6	5.5	1.0	9.6	3.6	1.6	2.8	0.4	0.4	0.2	5.2	0.8	0.3	0.3	8.0	1.5	1.9	0.0	2.1	0.2	0.7	0.1	0.0	0.5	24.3	0.6	0.5	1.5	0.0	2.5	9.8	1.1	0.1	2.2	2.6	0.6	5.1	0.6	0.7	0.2	0.4	0.0	7.0	0.4	0.0	0.6	0.8	10.1	0.3	2.0	0.0	9.4	2.3	0.4	0.0	7.5	5.2	0.9	0.0	0.0	2.4	0.0	0.0	0.1	6.7	0.7	0.0	0.9	0.9	6.8	2.7	2.7	0.0	0.4	3.1	0.0	0.0	0.3
RINT1	"FLJ11785, RINT-1"	ENSG00000135249	"RAD50 interactor 1"	Q6NUQ1	7	105532169-105567677	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019875, HPA031646"	Approved		Approved	"Golgi apparatus"		Yes	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA019875: AB_1856283, HPA031646: AB_2673975"	"unprognostic (1.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.75e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.39e-5)"	"unprognostic (1.76e-1)"	7.3	6.1	2.8	9.0	3.1	15.2	10.0	6.9	3.7	8.2	5.6	8.1	9.4	8.6	7.2	11.3	8.0	6.7	8.2	3.1	3.1	9.3	10.5	6.7	13.4	2.8	2.7	8.0	11.6	9.7	5.4	8.8	3.1	7.8	9.3	10.3	11.3	6.1	16.7	8.7	7.1	6.4	3.2	8.8	9.7	11.1	2.7	9.9	8.8	13.3	13.7	8.4	5.7	4.1	28.8	23.5	12.1	27.8	18.8	24.9	15.9	27.2	19.2	26.4	29.6	27.4	18.4	31.6	31.3	24.1	29.4	19.0	22.5	21.0	34.7	17.0	25.9	18.3	26.1	18.5	14.5	38.9	17.8	17.9	16.4	28.1	16.3	20.3	29.1	16.3	39.5	23.2	30.3	46.9	29.3	28.6	26.1	23.8	23.1	17.5	20.5	45.4	14.2	23.6	20.5	22.4	28.9	47.7	20.6	20.9	19.4	12.5	20.3	30.2	24.0	83.1	34.8	46.6	59.7	61.4	20.0	31.8	34.6	4.4	3.9	4.4	6.7	5.8	11.6	9.0	9.8	9.2	6.0	7.8	8.6	9.4	0.7	9.1	4.8	4.0	10.5	6.2	2.8	3.1	6.9	3.7	3.1	3.1	2.8	2.7	3.1	3.2	2.7	4.1	6.7	3.2	9.8	10.4	12.4	6.6	9.6	7.7	8.6	5.8	5.9	5.3	10.5	1.5	9.4	3.7	8.4	11.2	13.4	6.0	9.8	8.1	10.8	9.0	6.4	6.8	5.4	4.6	25.6	6.3	10.3	9.4	12.2	5.5	10.1	7.5	4.2	5.1	7.3	6.7	26.0	5.8	10.2	5.6	3.4	6.2	8.7	5.2	5.4	9.4	5.7	7.8	7.2	9.0	18.2	6.7	4.0	9.8	17.9	6.5	5.5	6.8	18.1	8.9	6.6	8.3	8.0	29.2	12.4	8.3	7.7	12.0	10.8	7.5	6.4	8.3
RNASEK	MGC71993	ENSG00000219200	"Ribonuclease K"	Q6P5S7	17	7012417-7014532	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 246.4;Macrophages: 174.7;Plasma cells: 253.2;Squamous epithelial cells: 250.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA044708	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA044708: AB_10962051"	"unprognostic (7.59e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.63e-2)"	"unprognostic (5.92e-2)"	"unprognostic (9.73e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.50e-3)"	"prognostic favorable (1.92e-4)"	"unprognostic (2.93e-3)"	"unprognostic (1.72e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.33e-3)"	309.4	592.6	276.9	173.8	296.6	292.9	278.5	285.0	391.0	252.6	339.9	271.8	161.1	254.5	135.1	241.5	239.4	173.3	325.9	298.9	381.3	515.3	280.2	347.4	217.8	307.5	307.5	265.2	233.9	287.8	505.1	158.7	323.9	255.0	118.2	81.6	246.4	161.1	321.9	297.0	229.1	144.9	275.9	396.8	275.2	180.2	300.6	159.6	256.0	226.6	166.8	231.1	225.3	288.4	223.4	353.3	160.9	276.4	406.6	363.4	142.8	224.5	389.5	283.9	320.6	149.6	205.6	157.2	221.3	435.5	343.2	328.5	199.1	274.7	153.6	319.2	520.8	157.0	264.7	252.9	466.1	99.9	748.3	462.4	321.7	338.5	194.0	316.1	344.6	168.0	138.1	327.7	348.4	206.0	137.0	327.4	111.7	178.2	314.0	160.7	92.3	180.9	374.2	192.4	82.1	291.9	191.0	135.6	421.5	157.8	176.0	177.3	322.5	304.6	132.8	383.9	289.3	267.6	278.0	68.6	475.7	225.3	253.2	993.4	1136.6	1378.0	373.6	1031.0	369.9	593.4	413.9	381.0	848.3	542.0	329.5	321.0	2175.1	420.9	1007.1	1070.5	451.1	1052.7	276.9	296.6	285.0	391.0	298.9	381.3	307.5	307.5	323.9	275.9	300.6	288.4	21.3	57.7	65.7	0.0	109.7	20.5	9.2	16.3	246.4	16.3	21.6	14.9	0.8	8.6	47.9	5.5	41.7	5.3	31.5	21.0	3.9	21.4	5.8	45.4	32.4	37.9	13.2	62.0	0.0	5.5	3.4	58.9	110.1	38.6	54.2	14.4	20.0	16.2	14.2	11.8	0.0	15.9	8.2	62.3	47.0	6.2	9.0	174.7	21.4	0.0	42.4	7.6	28.8	0.0	0.0	12.1	10.8	6.4	253.2	12.1	20.4	6.7	58.8	31.5	26.3	11.4	35.6	3.6	1.2	250.2	21.7	11.8	98.0	15.9	15.1	13.8
RNF111	"ARK, Arkadia, DKFZP761D081, FLJ38008"	ENSG00000157450	"Ring finger protein 111"	Q6ZNA4	15	58865175-59097419	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 81.6;Inhibitory neurons: 80.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038576, HPA038577"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA038576: AB_10964492, HPA038577: AB_10960052"	"unprognostic (7.30e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.37e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.21e-1)"	"unprognostic (5.10e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.74e-2)"	8.2	7.5	2.0	11.8	3.1	17.3	7.8	8.7	5.3	8.6	1.4	7.2	8.4	9.0	6.7	11.4	8.7	9.3	7.3	3.5	4.7	8.8	10.5	8.4	10.8	1.4	1.7	11.4	9.2	11.9	4.3	11.4	2.1	8.7	7.2	12.5	8.1	8.3	9.5	8.2	8.0	8.3	1.2	11.0	9.0	9.4	3.2	11.5	11.6	11.8	13.3	10.3	7.2	4.3	13.8	31.3	19.6	16.8	16.6	18.5	16.7	17.6	20.6	17.2	22.0	13.9	8.9	16.8	19.4	24.8	14.7	26.3	5.3	13.1	21.3	17.6	11.1	20.9	12.6	10.7	18.0	12.3	22.6	14.7	14.0	18.6	20.4	15.6	19.5	15.4	19.7	16.4	21.5	6.7	16.3	7.9	16.1	4.3	12.0	16.2	27.9	13.8	13.1	24.2	16.0	23.3	15.8	15.5	14.7	22.7	12.2	14.9	22.6	27.4	22.8	14.5	17.1	11.8	17.3	19.9	16.7	19.5	21.1	11.4	15.0	15.7	7.0	11.0	7.1	11.8	7.2	6.5	8.3	10.9	7.9	6.3	41.0	5.6	13.0	7.9	10.0	3.4	2.0	3.1	8.7	5.3	3.5	4.7	1.4	1.7	2.1	1.2	3.2	4.3	11.7	3.2	14.4	34.6	31.9	20.1	12.3	7.3	26.7	12.2	13.0	10.2	19.7	7.2	10.6	12.9	8.4	9.0	12.8	10.0	3.9	12.6	27.6	14.4	15.1	15.3	16.2	11.6	81.6	6.9	10.5	15.0	17.3	15.8	15.8	12.3	17.9	11.2	13.4	10.1	80.4	10.0	12.2	19.8	15.7	7.5	7.8	21.2	12.4	56.2	22.7	8.4	16.5	65.4	66.2	12.9	11.4	14.7	19.5	14.5	11.6	9.9	14.9	13.6	26.3	15.1	13.6	13.8	8.9	27.3	19.9	32.0	21.4	11.8	9.2	21.2
RNF31	"FLJ10111, FLJ23501, HOIP, Paul, ZIBRA"	ENSG00000092098	"Ring finger protein 31"	Q96EP0	14	24146683-24160660	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 16.0;Excitatory neurons: 8.8;Gastric mucus-secreting cells: 7.7;Inhibitory neurons: 8.2;Microglial cells: 10.3;Oligodendrocyte precursor cells: 9.5;Plasma cells: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"CAB009063, HPA048745"	Approved		Approved	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 59: Non-specific - Transcription"	Cytosol		"CAB009063: AB_2127706, HPA048745: AB_2680509"	"unprognostic (3.58e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.99e-1)"	14.3	18.5	4.9	9.1	4.8	9.5	14.3	4.2	6.6	16.7	3.6	15.0	7.1	18.2	6.9	16.2	14.8	6.9	19.6	4.6	4.1	17.5	15.8	14.9	10.4	5.3	4.4	17.8	23.9	10.4	18.7	6.9	4.5	16.6	6.6	4.1	16.9	7.1	41.5	19.3	15.9	9.6	4.5	26.1	17.9	16.4	4.8	11.7	16.5	17.9	9.6	15.1	14.0	4.4	6.1	10.8	10.5	14.8	6.1	6.3	23.2	9.9	15.1	18.2	15.6	10.2	13.5	10.9	6.9	11.8	10.2	7.6	5.4	11.8	9.7	13.2	4.2	11.0	9.5	32.5	12.8	17.5	18.8	12.3	10.4	7.2	12.9	9.6	12.0	7.9	5.9	12.9	7.7	17.3	17.6	8.6	5.3	9.9	12.7	10.1	9.8	6.8	8.9	20.8	9.9	12.7	8.6	25.6	12.5	9.2	7.4	13.3	11.1	12.6	10.2	8.8	8.9	21.4	21.2	11.5	4.4	6.1	13.6	0.0	0.8	0.8	0.6	1.7	1.8	0.4	0.9	0.6	0.5	0.4	0.6	0.4	1.7	1.7	1.0	1.8	1.1	0.4	4.9	4.8	4.2	6.6	4.6	4.1	5.3	4.4	4.5	4.5	4.8	4.4	0.9	0.0	4.6	16.0	5.2	0.6	0.3	0.0	4.6	0.6	1.0	0.3	0.3	0.0	3.1	0.0	0.0	0.6	1.0	0.8	0.0	0.3	0.1	1.0	1.3	1.3	0.0	3.8	8.8	0.0	0.5	1.3	7.7	0.9	0.0	1.1	0.4	0.8	0.4	0.0	8.2	0.3	2.0	0.6	1.5	0.4	0.3	2.7	0.0	10.3	0.5	0.3	3.1	9.5	7.3	0.2	0.2	0.0	8.7	0.2	0.5	0.2	0.8	0.8	0.0	1.4	1.2	1.6	0.8	5.7	0.9	0.5	4.3	0.8	0.1	0.3
RNF4	"RES4-26, SLX5, SNURF"	ENSG00000063978	"Ring finger protein 4"	P78317	4	2462220-2625320	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022047, HPA049356"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Microtubule ends"	"HPA022047: , HPA049356: AB_2680726"	"unprognostic (8.38e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.31e-3)"	"unprognostic (9.03e-3)"	"prognostic unfavorable (6.38e-4)"	"unprognostic (1.34e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.54e-1)"	30.2	30.9	24.0	36.0	24.9	46.4	29.2	26.0	25.1	29.4	26.5	27.9	29.0	29.5	28.3	30.7	28.5	28.3	27.0	24.5	25.5	32.6	25.9	27.8	49.9	26.0	25.9	31.0	31.2	33.6	26.8	28.4	25.2	28.2	27.4	24.0	28.0	28.1	27.7	29.7	30.4	33.1	23.9	40.3	30.1	31.9	26.3	50.1	30.7	23.2	50.0	35.0	26.8	25.5	60.9	57.0	57.9	42.0	50.6	52.2	65.6	73.3	83.4	77.3	70.0	65.1	56.8	77.6	42.0	76.0	101.5	39.7	63.5	58.6	72.7	37.6	38.5	92.4	54.6	62.6	76.6	66.7	77.8	61.0	69.7	72.3	59.4	53.6	73.1	64.8	50.0	103.2	80.4	43.5	105.0	92.5	89.8	52.3	70.9	76.6	55.3	40.8	52.6	74.5	54.3	51.0	50.5	40.4	52.1	62.9	63.1	50.6	60.0	65.8	32.0	64.2	115.4	131.3	189.5	82.6	64.6	72.7	69.5	44.7	70.0	104.6	97.7	95.4	97.2	85.0	82.2	97.0	84.1	59.1	78.8	80.3	77.2	99.2	103.8	56.5	98.8	128.6	24.0	24.9	26.0	25.1	24.5	25.5	26.0	25.9	25.2	23.9	26.3	25.5	31.1	22.4	17.5	17.0	36.0	27.5	18.4	17.7	31.3	11.9	24.0	16.0	20.7	12.8	21.3	22.0	16.7	21.3	45.9	16.5	21.5	22.2	14.0	17.0	22.8	21.7	12.1	15.4	15.9	23.3	35.0	19.5	23.0	23.9	14.5	22.7	16.4	20.4	19.7	13.5	17.8	16.8	8.2	34.0	28.5	22.4	17.1	27.8	7.2	18.7	35.1	11.5	43.3	13.0	16.3	29.8	14.3	20.7	47.8	27.1	23.1	21.2	17.6	17.7	26.3	18.2	22.0	31.2	48.6	27.0	32.1	21.8	39.7	16.4	18.9	32.9
RPL17	"L17, rpL23"	ENSG00000265681	"Ribosomal protein L17"	P18621	18	49488453-49492523	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 2876.9;Squamous epithelial cells: 3332.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043724, HPA046385"	Supported		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA		160000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum, Cytosol"		"HPA043724: AB_2678637, HPA046385: AB_2679646"	"unprognostic (1.11e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.34e-3)"	"prognostic unfavorable (3.60e-5)"	"unprognostic (2.69e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.72e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.60e-3)"	1966.5	1982.7	942.7	997.8	948.6	2559.4	2698.3	978.7	1418.8	2426.3	974.0	2075.1	880.2	1747.2	1295.2	2261.4	2040.5	820.1	1417.0	919.9	975.3	1619.5	1470.2	1410.7	2009.4	955.0	944.3	4472.1	4182.0	862.3	1495.0	888.2	967.1	1829.2	1089.6	612.3	1788.1	899.7	1351.1	2405.0	1619.7	912.2	988.0	1850.3	2038.0	574.8	969.5	1637.0	1607.1	868.1	1672.5	1972.7	2087.9	978.7	2205.3	1360.2	1937.9	2315.0	3146.0	6392.2	1829.3	2400.4	2783.7	2229.8	1677.4	1860.7	1039.7	3785.8	1572.2	2399.7	1250.1	2569.5	2690.1	4329.7	2377.4	1547.4	2773.8	1999.8	1500.4	2560.9	2718.4	6578.1	1526.2	6150.1	4787.7	2333.9	5487.0	5189.2	3100.5	2538.6	1995.5	2685.2	2794.0	1781.7	2386.9	4203.2	1993.4	1327.9	1110.7	2333.6	2538.1	4932.3	3037.1	2571.4	1462.8	1741.2	882.6	1827.5	3949.5	2366.9	1726.9	4230.9	2473.3	1633.3	1389.1	815.2	2570.9	2341.0	2404.3	3520.5	1564.3	3936.3	1593.2	312.8	840.7	151.3	1081.4	743.0	2106.6	1907.9	1763.3	1442.8	1305.7	1574.1	1936.2	1697.1	104.4	1431.9	618.7	1427.3	1509.5	2477.8	942.7	948.6	978.7	1418.8	919.9	975.3	955.0	944.3	967.1	988.0	969.5	978.7	104.8	663.4	916.1	0.0	1445.5	701.8	237.9	319.7	2876.9	15.3	704.3	451.7	0.7	348.9	969.4	103.0	10.4	396.5	311.7	386.7	497.0	864.7	195.8	102.2	169.2	426.4	819.2	1193.5	0.0	1630.2	582.5	558.6	1132.5	98.5	998.9	58.9	414.1	217.3	272.3	10.1	0.0	1233.6	81.4	561.1	588.8	452.1	527.2	616.8	291.7	0.0	973.9	42.7	515.9	0.0	0.0	1268.6	909.2	272.3	1659.1	177.3	768.9	648.6	561.5	23.8	249.8	401.7	297.5	100.8	100.5	3332.8	922.5	414.8	1066.7	61.1	1437.8	216.6
RPP21	"C6orf135, Em:AB014085.3, FLJ22638"	ENSG00000241370	"Ribonuclease P/MRP subunit p21"	Q9H633	6	30345131-30346884	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 97.3;Squamous epithelial cells: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 49.2;HHSteC: 46.3;JURKAT: 59.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"				"unprognostic (2.73e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.83e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (9.54e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (6.78e-5)"	34.8	39.6	4.9	0.7	4.4	2.7	36.4	5.0	12.9	46.8	4.1	73.1	0.8	60.2	4.1	62.7	41.6	2.6	38.9	4.6	6.2	35.5	37.7	27.0	2.3	5.4	4.1	42.0	62.1	0.1	35.3	2.5	5.2	42.1	0.0	0.4	36.2	6.8	56.5	46.6	38.8	11.8	5.2	31.8	52.1	34.5	4.6	4.2	31.3	11.0	1.4	56.7	48.2	6.0	34.0	0.0	0.0	14.8	21.8	1.6	18.7	11.7	6.8	26.3	17.6	0.9	0.0	20.4	31.0	7.1	32.1	2.1	0.0	24.4	7.9	26.0	49.2	5.7	0.0	1.0	46.3	0.0	0.0	0.7	5.3	4.1	1.5	5.8	0.1	59.8	5.4	14.4	8.1	2.4	0.0	4.7	16.9	0.0	0.0	4.9	0.0	7.3	12.2	26.9	29.1	11.0	0.0	11.6	34.3	4.6	0.1	0.6	0.8	0.0	0.0	36.0	0.0	12.7	31.1	11.7	0.0	5.3	0.0	60.4	45.4	41.8	25.9	51.8	30.4	86.6	41.2	29.6	35.3	85.2	51.9	33.1	14.4	25.4	53.8	15.9	70.1	41.9	4.9	4.4	5.0	12.9	4.6	6.2	5.4	4.1	5.2	5.2	4.6	6.0	10.6	6.4	18.4	0.0	53.3	35.7	11.4	23.5	97.3	3.2	30.3	27.6	1.2	17.2	28.9	25.8	0.0	12.9	16.7	27.1	7.9	37.0	4.5	17.1	15.1	16.2	42.6	28.8	0.0	60.1	19.3	18.5	68.8	15.8	13.3	5.8	13.6	16.5	10.4	1.7	0.0	29.9	26.4	11.0	20.0	2.1	13.7	17.0	24.9	0.0	14.4	3.0	12.3	0.0	0.0	41.8	42.6	10.5	44.1	8.7	42.7	22.2	13.0	3.3	6.6	9.2	18.5	19.1	25.4	122.9	40.5	11.4	42.3	3.3	33.7	10.2
RPS26	"eS26, S26"	ENSG00000197728	"Ribosomal protein S26"	P62854	12	56041351-56044697	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"ovarian cancer: 494.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA043961, HPA055803"	Uncertain		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA043961: AB_10963579, HPA055803: AB_2682927"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.74e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.99e-2)"	720.5	1265.1	387.6	271.7	388.8	395.5	690.2	382.8	480.4	707.7	384.0	731.2	177.1	569.7	410.7	875.4	724.0	123.3	713.0	380.9	416.6	701.8	926.6	521.9	512.9	396.3	399.7	1120.6	1170.2	274.3	476.7	251.6	389.9	627.3	403.3	69.8	592.3	335.9	778.2	857.3	744.1	307.2	383.4	832.0	717.5	208.8	394.0	616.8	544.1	390.6	715.6	734.3	698.0	389.2	639.2	763.3	853.6	319.5	1153.3	1696.4	852.0	633.4	929.5	1027.7	596.0	1182.7	281.7	1408.3	383.5	670.6	339.5	293.2	970.5	544.0	698.1	558.9	1552.8	743.9	482.1	719.0	1062.3	490.5	392.2	1036.9	1705.6	544.3	614.0	404.0	794.3	989.6	517.2	458.1	845.1	983.2	371.8	886.0	839.7	766.7	1710.8	496.7	254.8	884.3	871.4	634.9	318.2	552.4	245.8	542.2	372.2	252.1	479.4	538.6	260.8	255.0	524.3	328.0	518.0	369.3	810.2	770.9	284.0	969.2	334.4	334.8	394.8	262.5	650.7	410.2	723.2	872.3	841.4	711.8	508.4	720.3	898.4	863.6	154.8	607.5	373.0	643.6	963.7	1264.1	387.6	388.8	382.8	480.4	380.9	416.6	396.3	399.7	389.9	383.4	394.0	389.2	1114.5	224.4	237.7	5.2	2483.4	1760.6	852.7	2533.9	3266.8	131.0	1968.1	2542.2	29.2	1425.5	985.7	430.4	62.6	1237.2	1377.0	1803.5	972.4	1031.5	85.4	862.0	876.0	992.0	860.5	1977.9	5.2	2625.0	2835.4	1006.2	1666.7	861.2	514.4	1242.7	1647.4	2125.4	1369.2	75.7	5.1	1406.6	732.4	1557.8	1925.7	57.3	295.4	1146.8	1462.1	6.5	754.7	706.4	563.4	6.6	7.1	1806.8	1756.4	221.5	2590.7	1221.2	2448.3	1503.0	557.4	193.1	309.0	719.1	935.9	305.9	304.0	4236.6	1814.2	1708.2	2103.6	1318.5	1411.0	1000.6
RPS6KB1	"p70(S6K)-alpha, PS6K, S6K, S6K1, STK14A"	ENSG00000108443	"Ribosomal protein S6 kinase B1"	P23443	17	59893046-59950574	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"MCF7: 243.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003838, CAB018346, HPA039442"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 52: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB003838: AB_562325, CAB018346: AB_632156, HPA039442: AB_2676510"	"unprognostic (2.25e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.35e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (5.09e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.52e-3)"	14.0	11.3	7.1	11.9	7.8	18.0	13.3	11.8	9.8	11.8	9.4	10.7	10.0	13.8	10.1	16.3	10.2	9.4	10.6	7.2	6.6	9.8	15.2	9.9	14.2	7.3	7.0	14.9	16.9	14.9	7.4	15.4	7.5	10.6	11.0	10.9	9.4	10.2	22.7	10.6	9.3	14.3	6.2	12.4	11.1	6.9	7.5	15.2	11.9	18.3	17.3	14.9	11.0	9.6	34.5	33.5	27.5	26.2	18.1	26.2	20.8	31.2	28.3	26.3	29.3	27.6	16.8	41.7	37.9	25.4	32.1	17.3	36.0	27.3	42.7	23.3	41.5	28.7	21.2	31.2	26.9	44.5	27.1	26.7	20.7	31.0	22.8	21.9	35.0	26.0	38.5	25.9	19.7	243.6	53.2	18.4	18.6	29.8	24.9	30.8	46.7	38.8	21.9	25.1	20.1	23.8	26.2	15.2	16.6	31.7	29.7	24.2	31.1	25.8	42.9	21.2	42.0	46.2	42.0	46.3	19.4	26.7	21.2	43.8	12.1	11.4	12.7	12.2	15.5	10.4	11.6	14.7	15.3	9.4	13.5	14.3	11.5	11.9	14.4	9.5	11.9	10.3	7.1	7.8	11.8	9.8	7.2	6.6	7.3	7.0	7.5	6.2	7.5	9.6	22.8	22.4	34.2	29.0	32.6	33.0	21.4	13.0	30.7	18.0	23.1	17.8	16.8	12.8	30.4	3.7	18.8	24.3	33.5	12.4	3.9	12.9	5.1	24.0	31.7	25.5	13.2	11.8	47.3	16.4	18.2	24.8	26.0	37.7	23.4	20.0	13.6	15.1	12.1	18.5	45.2	14.1	4.1	15.2	20.4	3.8	15.8	19.0	10.6	28.1	20.0	12.8	18.6	25.6	54.8	15.1	10.9	18.0	34.6	27.9	9.3	9.2	21.1	18.9	26.3	33.4	32.6	13.0	13.7	34.5	32.0	30.5	29.9	26.0	13.9	25.4
RRN3	"DKFZp566E104, TIF-IA"	ENSG00000085721	"RRN3 homolog, RNA polymerase I transcription factor"	Q9NYV6	16	15060033-15094311	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049837	Supported		Supported	"Nucleoli rim"		NA	No			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoli rim"		"HPA049837: AB_2680906"	"unprognostic (1.83e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.74e-3)"	"unprognostic (3.67e-2)"	"unprognostic (4.50e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.27e-1)"	21.9	17.1	8.5	11.2	8.2	28.1	20.1	10.8	13.5	15.3	7.5	16.1	7.0	16.6	11.1	13.3	16.0	12.0	16.3	8.3	9.0	15.2	31.1	12.7	15.6	8.2	10.5	20.7	20.0	20.7	15.5	12.2	9.0	16.9	18.2	23.9	13.0	13.3	41.4	15.6	14.7	13.5	8.1	16.2	15.1	13.7	9.0	19.0	16.4	39.1	18.1	18.2	14.0	10.2	17.3	8.5	25.6	22.8	20.2	24.2	7.6	19.4	19.9	28.5	29.9	5.6	31.6	39.2	28.9	27.8	27.7	18.0	40.5	26.3	46.9	20.4	21.9	95.6	17.3	52.4	44.5	17.9	103.4	19.9	41.4	38.2	41.0	25.2	20.9	13.6	18.6	32.0	44.9	26.3	17.0	44.1	25.5	23.3	4.6	61.7	26.4	41.0	26.6	18.4	42.3	33.8	30.5	38.2	24.7	16.4	43.3	25.4	19.4	34.5	14.2	19.8	26.8	27.7	32.8	56.1	20.4	30.2	43.7	8.4	3.4	3.9	3.8	2.3	5.3	4.7	2.8	3.4	3.6	2.2	4.1	3.0	0.4	6.8	2.7	1.8	3.1	4.6	8.5	8.2	10.8	13.5	8.3	9.0	8.2	10.5	9.0	8.1	9.0	10.2	31.6	9.6	13.7	13.1	28.1	17.8	10.3	8.6	28.5	14.4	16.5	12.8	22.3	8.6	10.2	16.5	20.9	11.7	21.4	14.3	5.9	10.1	18.1	9.6	22.3	20.2	7.2	22.5	13.7	8.0	10.9	19.9	20.9	15.0	10.1	22.4	15.4	18.2	15.1	11.8	16.4	17.0	12.2	14.1	15.0	7.7	14.6	21.2	16.0	14.0	15.9	19.0	18.6	13.6	12.7	11.0	13.7	18.0	23.2	12.2	12.8	15.1	5.9	18.9	0.0	14.9	19.1	15.5	21.3	27.9	21.9	6.7	27.6	19.4	14.9	11.0
RTEL1	"bK3184A7.3, C20orf41, DKFZP434C013, KIAA1088, NHL, RTEL"	ENSG00000258366	"Regulator of telomere elongation helicase 1"	Q9NZ71	20	63657810-63696253	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"B-cells: 1.0;Erythroid cells: 3.8;Gastric mucus-secreting cells: 3.1;Plasma cells: 3.0;Squamous epithelial cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA020622, HPA067329, HPA078328"			Approved	"Nuclear speckles,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles, Nuclear bodies"		"HPA020622: AB_2732425, HPA067329: AB_2685823, HPA078328: AB_2732380"	"unprognostic (3.63e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.27e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.59e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.30e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.50e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.84e-2)"	4.9	7.0	1.3	6.1	1.6	8.2	5.2	5.7	4.7	6.8	0.5	8.5	4.8	10.0	3.0	4.6	6.2	3.0	3.9	1.2	0.9	4.1	4.8	6.0	4.2	2.9	0.6	6.4	8.6	2.8	12.2	4.2	1.8	6.7	2.1	2.5	6.3	4.5	5.4	4.5	5.8	3.1	0.2	6.1	6.6	7.6	1.2	4.8	7.8	2.3	2.4	6.5	6.0	1.5	8.3	11.7	7.9	15.5	1.6	1.7	14.5	16.8	4.5	26.0	6.6	22.2	7.0	11.0	8.6	5.2	9.8	15.3	5.5	11.1	6.1	5.5	11.0	13.8	21.2	21.5	5.7	13.4	24.1	2.2	6.0	6.4	7.9	4.9	9.0	19.6	17.4	10.4	5.8	8.7	21.3	17.5	7.8	7.1	22.3	17.2	7.4	11.6	4.1	9.7	15.7	9.3	9.3	27.5	2.2	3.6	7.2	15.2	12.1	29.4	9.5	10.1	13.2	9.4	4.2	7.1	7.1	9.5	10.4	0.0	1.0	0.0	0.9	1.1	0.5	0.3	0.5	0.6	1.3	0.5	0.9	0.4	0.0	0.1	1.0	1.1	0.5	0.8	1.3	1.6	5.7	4.7	1.2	0.9	2.9	0.6	1.8	0.2	1.2	1.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.6	0.0	3.8	0.0	0.0	0.0	0.4	3.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.0	1.1	0.1	0.0	0.7	0.0	0.0	0.0
RWDD3	"DKFZP566K023, RSUME"	ENSG00000122481	"RWD domain containing 3"	Q9Y3V2	1	95234210-95247225	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 18.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Ribosome"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"				"unprognostic (4.87e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.54e-3)"	"unprognostic (8.58e-3)"	"unprognostic (9.48e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (6.46e-8)"	"unprognostic (2.58e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.37e-3)"	"prognostic favorable (2.06e-4)"	7.1	7.0	6.9	5.4	7.3	5.9	9.2	7.0	9.1	9.3	6.8	8.0	5.6	9.5	9.9	5.3	9.8	5.0	13.2	7.0	6.8	7.4	8.6	5.2	9.0	6.7	6.6	8.6	7.3	5.9	6.0	6.7	6.8	8.8	6.8	6.8	7.6	7.5	10.5	6.1	6.1	7.7	6.8	7.4	7.1	4.2	6.9	7.4	7.3	8.4	6.7	8.4	7.9	7.9	14.6	5.0	17.2	5.3	11.1	15.2	9.9	7.8	10.3	9.2	10.5	7.8	4.6	12.7	13.0	10.3	21.5	8.2	7.5	8.9	9.8	9.4	6.6	8.1	6.7	10.3	13.3	7.2	4.6	15.1	9.3	5.0	7.0	15.2	14.0	14.1	10.4	6.2	12.5	2.4	8.4	8.9	8.4	6.1	7.7	10.4	25.3	3.7	11.7	7.4	5.1	9.9	7.5	11.2	20.1	11.0	3.3	12.6	9.1	6.2	6.5	4.6	7.3	5.8	5.9	8.7	3.3	6.6	6.2	24.9	12.3	19.9	13.9	13.6	17.8	28.1	18.1	13.5	15.1	27.9	19.1	17.1	8.0	17.7	10.0	13.1	25.2	9.6	6.9	7.3	7.0	9.1	7.0	6.8	6.7	6.6	6.8	6.8	6.9	7.9	3.4	6.4	10.8	15.7	14.3	0.9	0.5	2.8	18.2	1.3	2.2	1.7	5.3	2.8	5.7	1.8	2.1	1.3	4.0	0.7	0.0	1.8	1.0	7.5	4.2	3.8	0.0	14.9	4.7	1.1	0.7	5.2	12.2	6.0	7.6	3.5	3.6	3.0	0.9	0.0	8.0	1.2	0.0	2.8	0.4	2.0	1.8	6.4	0.0	7.5	1.8	6.5	5.2	15.1	12.7	1.2	0.3	1.9	16.6	0.2	1.6	1.9	8.7	2.0	0.0	2.0	5.4	0.9	2.2	15.2	1.6	0.4	10.6	1.8	0.9	0.5
SAP130	FLJ12761	ENSG00000136715	"Sin3A associated protein 130"	Q9H0E3	2	127941217-128028120	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 47.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 71.5;Late spermatids: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034664			Supported	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA034664: AB_10603238"	"unprognostic (2.17e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.77e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	9.1	8.6	8.8	8.7	8.5	21.7	8.2	8.5	10.2	10.5	5.1	10.3	8.3	10.4	9.2	10.4	9.6	7.2	8.5	8.1	10.8	7.2	8.3	8.0	10.0	6.4	7.9	11.2	8.7	12.4	14.5	9.0	7.1	8.7	9.7	8.6	9.1	7.9	11.9	12.9	9.8	10.2	6.1	8.5	9.7	47.3	8.0	14.8	8.8	13.0	12.6	9.5	10.3	8.8	35.3	18.9	35.3	28.6	22.9	15.7	38.5	22.0	21.4	33.4	26.2	45.1	14.4	29.4	19.3	25.0	17.4	24.0	39.3	22.7	34.5	16.3	25.2	29.2	16.7	35.9	27.5	25.5	22.2	14.8	16.7	44.1	27.5	17.6	27.0	24.4	35.9	21.1	28.2	39.3	35.6	20.0	36.6	20.7	21.1	24.3	29.0	19.6	17.9	30.7	18.5	22.3	23.2	21.7	13.6	22.1	16.4	17.3	23.2	32.1	34.5	30.1	23.6	29.3	31.2	34.3	26.4	17.0	21.0	2.3	4.2	4.6	5.3	2.7	4.0	2.0	3.8	3.5	3.4	5.0	2.7	3.1	14.0	3.6	8.6	6.2	2.7	3.8	8.8	8.5	8.5	10.2	8.1	10.8	6.4	7.9	7.1	6.1	8.0	8.8	5.4	0.0	10.9	29.0	7.9	7.9	2.3	3.2	5.7	5.2	6.5	5.3	15.2	2.8	3.1	1.8	8.4	11.9	9.4	13.1	0.0	4.9	71.5	4.6	8.6	6.2	6.7	11.6	25.4	4.7	12.8	5.2	8.6	8.7	1.3	5.3	5.3	5.8	7.8	8.4	28.9	7.0	4.1	8.4	6.3	44.2	8.4	7.0	5.4	16.9	4.9	5.0	6.2	26.2	31.0	6.1	7.8	8.2	13.2	4.9	6.5	3.4	4.0	5.8	6.6	4.4	5.5	31.0	17.9	9.2	10.4	19.3	7.6	3.7	7.8	4.3
SARNP	"CIP29, Hcc-1, THO1"	ENSG00000205323	"SAP domain containing ribonucleoprotein"	P82979	12	55752463-55817724	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Translation regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030902, HPA030903"	Supported		Supported	"Nuclear speckles"		NA	NA		150000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA030902: AB_10669872, HPA030903: AB_10964180"	"unprognostic (1.83e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.36e-4)"	"unprognostic (2.02e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.03e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.31e-6)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.19e-1)"	48.0	59.1	52.9	45.8	53.7	88.8	58.0	56.4	88.2	52.6	55.0	53.7	31.1	48.2	57.2	61.9	42.3	34.8	81.5	53.4	60.8	62.5	49.4	46.4	67.2	54.8	56.8	48.5	31.6	45.7	43.7	55.1	55.3	48.0	53.6	31.6	39.4	47.7	98.9	43.3	38.5	53.4	53.5	47.9	44.1	55.4	55.8	83.0	41.6	84.0	84.5	59.8	48.3	56.2	118.8	106.6	251.5	107.9	114.9	162.9	119.7	160.5	126.2	196.7	163.6	151.4	129.1	191.3	108.7	131.8	77.2	66.5	223.7	158.2	209.8	151.2	140.5	192.5	181.6	132.9	166.9	162.0	142.4	121.1	115.7	129.0	99.7	206.0	210.4	169.1	141.3	137.9	198.0	100.5	204.1	257.8	221.4	107.0	97.8	186.5	131.6	159.3	265.9	133.0	108.2	87.8	138.1	88.1	144.8	143.3	134.1	216.3	146.1	79.0	79.3	101.3	128.3	87.0	122.8	258.5	94.9	163.8	101.9	246.1	137.9	218.7	110.5	156.2	101.1	125.3	115.8	119.0	153.7	114.0	91.7	103.0	107.2	134.2	138.8	146.8	170.6	153.9	52.9	53.7	56.4	88.2	53.4	60.8	54.8	56.8	55.3	53.5	55.8	56.2	14.7	32.1	35.6	27.7	26.6	25.2	24.5	24.0	46.1	11.2	12.9	9.9	0.2	10.0	41.0	22.0	16.7	16.1	17.9	11.8	25.4	28.8	16.3	9.1	8.8	16.5	14.9	34.1	32.8	29.8	19.8	30.5	33.6	11.4	27.8	8.9	8.9	7.4	14.6	8.4	33.8	13.3	24.4	19.2	36.3	35.9	18.0	25.1	21.4	27.2	32.4	10.6	16.5	37.7	46.6	32.1	13.1	17.3	37.0	14.8	14.8	19.1	45.2	10.0	6.6	12.6	23.3	36.4	32.8	50.9	26.6	16.8	29.9	12.2	11.5	20.4
SBF1	"DENND7A, MTMR5"	ENSG00000100241	"SET binding factor 1"	O95248	22	50445000-50475035	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074004			Supported	"Nuclear bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear bodies"		"HPA074004: AB_2732249"	"unprognostic (4.79e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.11e-2)"	"prognostic favorable (3.46e-5)"	"unprognostic (2.21e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.05e-1)"	26.8	32.3	50.8	22.3	57.3	20.6	24.2	31.8	72.4	25.9	9.2	32.9	14.8	29.5	3.2	43.9	27.2	10.6	38.7	70.1	28.5	30.5	23.4	26.8	28.8	52.0	39.2	30.4	48.0	7.1	28.6	8.8	46.5	28.5	4.9	6.5	26.9	11.6	75.7	42.2	38.6	8.8	32.8	35.4	30.1	111.2	44.1	32.7	62.3	14.4	14.7	28.3	27.3	63.5	34.3	28.2	24.0	32.9	24.3	18.6	65.9	23.5	20.1	21.6	17.7	39.0	23.7	78.1	16.7	27.9	23.9	31.4	19.9	28.7	5.3	28.6	76.0	17.6	59.6	50.7	41.7	54.7	26.1	25.0	44.6	28.1	21.0	17.0	14.8	41.6	28.8	20.8	15.0	42.6	54.8	52.4	10.1	26.1	31.7	71.0	45.6	48.3	12.8	27.3	19.1	46.0	36.5	35.5	47.7	10.5	20.7	25.2	25.1	33.9	49.6	24.3	29.7	38.1	13.4	37.6	38.8	22.1	32.7	0.5	1.3	2.1	4.4	1.3	2.4	2.6	3.0	3.5	1.6	1.6	2.2	3.6	1.9	1.9	2.6	5.6	2.6	2.3	50.8	57.3	31.8	72.4	70.1	28.5	52.0	39.2	46.5	32.8	44.1	63.5	5.7	6.4	11.8	10.7	13.7	13.4	4.6	9.3	6.8	15.5	11.3	9.1	7.6	4.3	9.4	3.7	10.4	4.9	21.4	19.9	1.9	7.2	32.8	10.3	8.9	5.6	3.6	8.6	11.3	12.5	7.9	10.6	24.5	11.4	1.3	20.4	5.7	9.1	6.9	11.8	10.9	13.2	10.2	6.9	10.7	21.4	6.5	9.5	5.4	5.6	10.8	6.9	21.6	11.1	31.7	19.9	8.1	6.0	15.6	11.6	16.0	7.7	11.1	10.0	6.6	12.3	11.6	25.5	23.5	21.3	14.6	11.5	19.8	12.2	12.3	10.1
SCAF4	"DKFZp434E098, KIAA1172, SFRS15, SRA4"	ENSG00000156304	"SR-related CTD associated factor 4"	O95104	21	31671000-31732118	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018319, HPA018668, HPA021504, HPA028807"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA018319: AB_1856784, HPA018668: AB_1856783, HPA021504: AB_1856785, HPA028807: AB_10602927"	"unprognostic (9.18e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.99e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.28e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.65e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.16e-3)"	14.1	10.6	6.8	12.7	7.3	13.7	13.2	9.3	9.0	14.9	5.5	14.1	12.3	14.6	9.1	16.1	12.8	8.5	11.3	7.1	9.7	9.6	17.1	14.2	18.4	7.8	7.4	16.1	11.8	11.4	11.2	12.7	7.1	12.5	10.1	10.6	13.0	9.0	17.9	18.5	16.3	9.5	5.4	16.3	13.4	17.5	7.3	18.9	11.4	10.8	17.2	13.3	15.1	8.6	31.4	20.5	40.3	29.4	21.4	16.1	27.4	22.6	23.8	23.7	22.0	39.5	22.2	63.9	13.4	22.3	25.9	18.9	44.3	22.1	25.8	28.6	25.8	50.9	16.8	33.4	24.5	54.8	20.5	18.2	24.6	31.6	27.1	15.1	20.9	25.0	68.4	32.4	19.9	41.7	58.4	39.7	51.7	30.5	17.3	57.1	44.8	21.1	16.5	24.3	27.5	29.7	34.9	26.8	19.7	22.1	20.7	36.7	24.4	24.5	23.6	23.5	23.5	20.6	20.7	72.0	17.6	43.4	23.3	6.6	7.9	10.9	9.7	10.6	9.6	10.9	5.6	9.3	9.7	9.7	6.5	7.2	4.0	7.6	9.6	6.8	5.2	8.1	6.8	7.3	9.3	9.0	7.1	9.7	7.8	7.4	7.1	5.4	7.3	8.6	16.5	6.4	14.5	25.8	46.5	46.7	35.5	15.2	53.5	22.8	23.0	13.8	9.4	18.6	13.8	11.0	25.0	16.6	31.2	39.4	3.9	16.4	9.9	14.9	26.7	19.9	19.8	48.4	34.9	14.0	17.8	21.6	19.4	22.9	11.4	21.9	18.9	24.4	15.7	21.9	34.5	18.7	22.4	23.1	37.8	3.8	22.1	22.7	33.8	36.5	24.5	12.5	32.0	34.7	45.5	17.9	23.4	14.3	23.9	31.2	31.6	6.7	18.2	24.6	13.1	29.9	18.3	25.6	23.9	41.7	41.1	18.9	33.1	12.5	22.2	33.5
SCYL2	"CVAK104, KIAA1360"	ENSG00000136021	"SCY1 like pseudokinase 2"	Q6P3W7	12	100267140-100341715	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021050	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA021050: AB_1846175"	"unprognostic (7.01e-3)"	"unprognostic (3.04e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.01e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.27e-2)"	"unprognostic (8.19e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.93e-2)"	"unprognostic (4.44e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.18e-1)"	13.4	13.4	6.2	16.4	7.3	21.5	16.8	9.9	8.2	14.0	7.6	22.9	20.2	14.5	20.9	22.1	10.9	16.2	14.9	7.6	8.6	21.2	28.7	17.2	15.0	5.6	5.4	8.8	17.9	20.9	12.9	21.0	6.3	17.0	26.9	16.7	15.7	15.9	15.6	13.7	17.0	17.4	6.3	14.7	16.4	14.6	7.5	19.0	15.6	19.1	19.8	21.5	11.5	7.2	37.7	29.0	45.8	37.7	28.8	31.1	43.2	38.0	42.8	34.8	29.6	28.1	19.4	23.4	17.7	46.9	23.7	32.1	36.4	27.8	40.6	36.5	24.2	76.0	18.5	20.3	25.7	36.2	72.8	23.1	42.5	39.5	44.9	41.3	44.4	26.0	40.8	19.7	37.4	29.2	29.2	31.7	28.6	21.7	32.6	23.4	33.6	22.7	31.6	61.1	28.3	25.3	43.0	44.2	36.2	48.2	64.9	27.8	41.7	29.7	17.2	27.8	24.8	22.6	32.1	28.3	14.6	24.6	34.4	12.3	5.2	10.0	4.0	6.5	5.1	3.3	4.2	3.8	6.6	2.3	4.5	4.9	6.7	8.6	5.7	2.0	6.2	4.0	6.2	7.3	9.9	8.2	7.6	8.6	5.6	5.4	6.3	6.3	7.5	7.2	24.4	16.0	35.2	37.9	20.4	35.9	21.3	17.4	33.0	16.8	29.6	17.1	30.1	7.2	26.8	20.2	27.1	31.3	22.7	44.1	5.9	16.8	8.5	24.4	19.1	24.8	21.7	28.6	50.3	21.7	22.2	20.2	37.8	31.2	27.9	15.1	16.4	37.1	25.1	15.2	54.1	30.6	12.2	34.6	47.4	4.7	13.4	29.2	16.0	44.0	27.5	10.9	17.5	64.3	47.2	24.0	32.1	15.4	22.2	36.8	16.2	26.3	18.3	16.2	0.0	13.1	20.9	24.9	12.0	36.8	34.7	59.4	22.6	19.2	33.6	52.8
SEC23IP	p125	ENSG00000107651	"SEC23 interacting protein"	Q9Y6Y8	10	119892730-119944657	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038403, HPA043305"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA038403: AB_10675796, HPA043305: AB_2678416"	"unprognostic (4.05e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-1)"	"unprognostic (6.81e-3)"	"unprognostic (3.43e-2)"	10.3	9.7	3.5	12.0	3.9	14.1	11.8	6.2	4.6	11.2	6.4	12.6	10.4	11.9	12.1	9.4	8.8	9.6	7.7	4.0	4.0	10.3	12.6	10.2	13.7	4.2	4.3	10.0	11.1	9.8	8.5	12.4	4.0	13.1	13.0	9.0	10.3	9.9	9.8	10.4	9.5	16.4	3.1	11.7	17.5	11.5	4.6	11.1	12.5	8.4	13.4	12.0	8.3	6.3	32.4	30.2	24.3	31.9	22.4	25.3	19.0	27.2	39.5	26.1	31.6	31.0	22.9	30.2	14.7	36.2	32.5	23.9	27.9	29.2	39.5	27.2	28.7	25.1	16.3	34.0	31.0	29.6	29.9	31.4	18.4	30.8	30.5	28.3	36.3	15.5	19.1	21.4	28.7	19.2	25.9	28.2	29.5	28.6	20.9	23.7	44.7	17.3	26.1	25.6	9.6	25.5	25.0	19.9	24.1	24.9	17.5	21.7	29.6	15.8	18.5	23.8	35.1	33.5	32.6	38.7	27.6	37.4	14.1	14.3	10.5	10.3	10.7	16.3	13.9	11.3	10.5	12.4	11.9	9.1	11.1	10.7	3.8	13.0	18.1	7.2	11.9	9.6	3.5	3.9	6.2	4.6	4.0	4.0	4.2	4.3	4.0	3.1	4.6	6.3	15.1	12.8	28.3	21.9	20.9	8.4	19.3	18.1	13.1	17.3	19.1	12.1	17.4	27.1	24.5	18.4	6.2	17.8	18.7	19.7	5.9	16.8	26.1	15.1	22.1	19.9	19.9	21.2	28.3	14.4	18.9	21.4	44.9	15.5	22.1	21.0	14.3	25.5	23.3	11.8	30.2	24.3	26.4	24.6	12.2	24.9	14.0	23.3	8.8	39.4	21.3	14.6	16.5	31.7	37.5	20.2	19.8	15.1	23.7	23.4	16.0	19.2	25.4	23.7	0.0	16.8	17.9	25.0	19.8	19.1	13.9	23.1	18.2	24.2	20.8	21.1
SEC24B		ENSG00000138802	"SEC24 homolog B, COPII coat complex component"	O95487	4	109433772-109540896	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 88.1;Oligodendrocytes: 91.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038181	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		14000	"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA038181: AB_10672472"	"unprognostic (1.19e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.58e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.67e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.51e-3)"	"unprognostic (7.47e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (2.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.73e-1)"	19.3	13.7	7.2	13.2	7.5	28.0	17.4	14.7	9.9	16.3	15.0	15.7	14.1	16.9	12.9	17.2	15.0	13.8	15.6	6.8	7.6	16.7	46.2	14.8	13.9	7.5	6.9	21.4	18.6	21.9	11.2	20.6	7.8	15.6	16.1	32.6	14.3	16.1	28.1	19.8	12.7	17.9	7.3	14.7	13.3	11.3	7.4	27.2	18.5	22.9	16.7	17.5	16.0	9.6	21.1	18.9	29.3	22.1	34.9	34.7	16.8	27.0	32.8	22.5	19.8	17.4	23.8	19.4	13.8	41.1	19.3	17.4	33.2	26.9	33.0	24.0	16.6	20.3	16.6	19.2	23.4	27.0	22.9	34.4	33.7	25.8	30.8	31.8	33.7	19.7	31.5	17.3	33.6	17.1	39.2	12.5	11.2	26.1	15.0	25.1	25.9	11.3	27.1	25.8	20.6	16.5	20.8	43.8	16.0	30.0	12.9	10.3	31.3	26.2	17.6	23.1	19.5	16.6	22.3	18.1	23.3	10.7	21.5	6.1	9.5	11.5	8.6	10.4	9.5	10.3	9.5	9.0	11.8	8.9	10.8	9.3	9.2	11.5	10.5	4.6	9.1	9.0	7.2	7.5	14.7	9.9	6.8	7.6	7.5	6.9	7.8	7.3	7.4	9.6	25.1	25.6	15.4	63.0	23.0	35.4	20.1	11.8	28.5	27.0	12.9	10.8	30.5	14.3	17.4	5.5	6.2	13.3	13.2	22.7	5.9	10.4	4.4	18.7	14.6	22.5	15.6	11.6	71.1	13.1	9.2	16.4	19.9	21.9	11.4	15.9	16.8	29.9	12.3	16.8	84.1	15.6	4.1	17.6	16.8	7.9	20.5	18.7	17.8	88.1	14.5	20.3	13.4	76.9	91.6	12.6	18.7	21.8	21.3	22.5	16.5	9.6	19.6	22.0	13.1	16.3	16.8	14.7	13.6	22.2	36.7	16.1	17.0	9.9	14.4	30.3
SENP6	"KIAA0797, SUSP1"	ENSG00000112701	"SUMO specific peptidase 6"	Q9GZR1	6	75601509-75718281	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024376	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA024376: AB_1856678"	"unprognostic (9.86e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.38e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.32e-3)"	"unprognostic (7.81e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (1.72e-1)"	25.1	22.6	12.8	24.6	16.8	37.9	31.4	47.6	15.5	28.6	7.5	26.6	20.9	33.0	22.1	25.3	26.8	26.0	22.6	9.6	14.3	28.5	28.0	26.4	28.5	11.9	11.9	40.5	27.0	39.4	22.3	33.4	12.8	29.3	26.0	31.4	21.8	28.9	25.5	25.2	20.5	31.9	12.3	28.9	24.9	33.8	12.0	32.4	41.9	30.1	30.4	29.7	21.2	22.3	23.8	24.5	54.3	39.1	41.3	54.6	40.3	41.9	46.5	34.6	43.1	33.9	22.4	40.1	38.6	48.7	40.9	29.8	51.6	28.0	53.1	59.2	44.2	60.8	28.9	31.7	57.3	53.5	42.8	42.6	45.6	32.6	71.8	41.9	58.2	32.8	74.9	43.2	43.0	29.0	21.4	28.6	33.1	31.9	20.4	39.7	28.7	59.0	36.7	35.0	47.2	48.7	35.8	31.3	36.4	43.5	28.2	50.1	49.0	30.8	33.4	15.9	43.8	48.9	52.4	31.4	15.4	49.8	33.1	7.5	8.0	20.8	7.3	8.4	10.5	9.1	7.4	9.9	8.9	10.5	10.5	9.6	14.9	10.1	14.7	11.0	6.9	6.3	12.8	16.8	47.6	15.5	9.6	14.3	11.9	11.9	12.8	12.3	12.0	22.3	76.7	67.3	128.3	158.0	74.0	46.5	65.0	27.6	78.6	58.8	53.0	59.6	76.7	31.5	70.9	29.5	91.8	33.0	73.8	43.2	17.6	33.7	40.4	62.9	78.1	57.9	27.6	50.5	152.6	33.7	29.4	69.3	51.0	62.9	65.1	74.2	42.1	32.0	29.5	60.6	177.3	35.6	24.4	43.2	41.5	35.6	70.8	57.7	35.6	149.9	68.4	56.6	50.4	218.1	228.9	32.1	29.9	63.2	62.8	63.4	32.6	26.8	47.2	65.7	26.3	98.9	73.7	107.7	61.7	61.4	48.4	41.2	67.2	66.0	46.3	66.8
SETD1B	"KIAA1076, KMT2G, Set1B"	ENSG00000139718	"SET domain containing 1B, histone lysine methyltransferase"	Q9UPS6	12	121804009-121832656	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021667, HPA059412"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA021667: AB_1856753, HPA059412: AB_2684006"	"unprognostic (1.69e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	14.3	8.9	2.8	8.6	2.5	15.1	12.1	7.6	4.4	19.4	1.3	28.5	7.5	26.0	4.7	14.0	19.6	4.5	8.0	2.7	0.7	8.4	11.3	9.2	6.9	1.7	1.4	15.8	12.5	5.5	9.2	5.5	0.7	15.6	3.7	3.4	11.4	10.0	9.0	11.6	15.6	7.1	0.5	13.1	16.7	9.4	1.6	8.4	13.9	4.2	4.8	22.0	14.1	1.5	7.4	14.8	7.4	12.5	6.9	4.7	11.2	6.8	5.4	5.1	2.9	8.1	4.4	5.4	6.1	7.6	3.2	11.3	8.6	5.3	3.0	9.7	10.5	16.3	20.3	7.1	5.9	15.3	14.0	5.7	6.4	7.0	5.6	6.2	5.6	10.6	17.1	3.7	3.9	17.1	22.5	21.5	10.6	3.6	8.5	17.3	4.8	7.9	5.0	15.1	9.0	6.9	15.0	10.5	5.7	5.5	12.8	13.8	9.5	7.6	9.4	10.8	7.7	7.3	4.0	3.2	6.3	9.7	8.8	1.4	0.2	0.6	0.4	0.5	0.3	0.3	0.3	0.4	0.2	0.3	0.5	0.3	1.0	0.3	0.2	0.5	0.3	0.2	2.8	2.5	7.6	4.4	2.7	0.7	1.7	1.4	0.7	0.5	1.6	1.5	10.1	3.2	7.3	9.8	11.2	11.7	3.2	5.7	26.2	13.8	12.7	9.5	9.7	10.0	6.7	5.5	8.4	7.9	17.6	8.5	0.0	5.1	9.8	13.9	14.5	9.5	7.3	7.8	10.6	7.2	7.0	8.5	8.6	20.3	3.8	10.1	12.1	13.8	6.5	11.8	11.7	7.8	4.1	17.7	14.8	21.4	11.5	10.8	1.8	5.6	13.9	5.0	9.2	5.0	6.8	6.5	10.5	10.1	11.2	9.1	6.8	3.2	5.4	10.0	6.6	10.6	12.9	11.3	3.5	29.4	12.9	13.1	13.3	8.1	6.6	9.1
SETDB1	"ESET, KG1T, KIAA0067, KMT1E, TDRD21"	ENSG00000143379	"SET domain bifurcated histone lysine methyltransferase 1"	Q15047	1	150926263-150964744	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"U-698: 341.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018142, HPA058484"	Uncertain		Supported	Nucleoplasm,Vesicles		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA018142: AB_1856757, HPA058484: AB_2683731"	"unprognostic (1.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.57e-2)"	"prognostic unfavorable (8.88e-4)"	"unprognostic (6.03e-2)"	"unprognostic (9.94e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	13.5	11.3	7.1	15.2	8.2	18.1	16.7	12.8	8.9	14.4	8.7	13.4	12.5	18.1	13.1	11.8	15.3	11.5	8.2	6.7	7.9	11.7	11.5	13.4	19.6	8.2	7.6	19.4	13.3	15.7	8.6	17.7	7.6	11.4	15.5	14.2	12.3	12.2	16.4	14.4	13.7	16.5	6.0	19.9	13.4	25.1	8.4	21.6	15.5	11.7	20.3	13.1	12.7	10.3	22.9	26.3	37.1	24.6	17.5	23.2	61.7	18.6	21.2	26.2	22.2	17.9	31.1	44.9	24.9	20.7	10.4	28.1	35.0	20.0	20.7	21.8	43.3	25.5	27.3	20.8	24.7	45.3	23.2	30.5	22.0	21.8	34.8	26.6	31.2	28.3	43.4	35.6	18.9	44.1	31.6	26.4	51.1	32.1	20.6	36.3	24.3	33.4	20.1	25.9	27.1	49.1	28.4	32.9	22.5	44.5	35.7	60.4	21.2	15.3	15.7	17.0	26.3	36.6	42.3	341.6	15.7	15.7	15.1	6.9	8.3	5.7	5.8	11.6	6.1	6.1	5.3	6.6	9.7	8.3	5.7	5.9	4.8	6.3	8.5	6.5	3.5	4.3	7.1	8.2	12.8	8.9	6.7	7.9	8.2	7.6	7.6	6.0	8.4	10.3	8.5	6.4	14.0	15.3	15.3	5.5	9.3	6.6	10.2	11.0	9.8	10.7	5.5	10.0	7.8	7.3	18.8	13.9	8.8	6.6	3.9	7.6	26.1	10.8	13.3	8.3	3.6	9.2	19.6	5.7	8.5	9.1	10.2	10.7	7.6	17.9	11.4	8.1	9.9	6.7	19.4	9.7	12.2	17.2	5.1	31.0	10.2	13.9	1.8	23.4	14.4	6.2	14.4	15.6	23.5	8.1	9.5	9.8	8.9	8.2	7.6	6.4	11.0	10.4	6.6	10.2	10.3	24.4	15.9	10.9	5.1	10.0	10.2	14.6	10.7	7.8
SF3A2	"Prp11, PRPF11, SAP62, SF3a66"	ENSG00000104897	"Splicing factor 3a subunit 2"	Q15428	19	2236824-2248655	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042843, HPA049439"	Enhanced		Approved	Nucleoplasm		NA	NA		43000	"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA042843: AB_2678199, HPA049439: AB_2680766"	"unprognostic (5.29e-2)"	"prognostic favorable (7.16e-4)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (3.09e-3)"	"unprognostic (9.19e-2)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (3.23e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.72e-3)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (4.09e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.73e-2)"	44.8	22.6	23.0	25.7	24.9	40.8	44.0	32.9	35.2	58.9	14.9	46.8	29.5	65.4	5.4	47.6	52.2	11.4	33.5	21.2	24.7	30.4	29.9	38.2	30.3	26.8	22.8	74.2	38.3	9.1	35.6	17.7	23.4	46.8	6.3	7.0	36.5	19.2	38.8	60.2	42.8	11.5	20.4	49.2	37.3	78.9	23.1	34.2	37.8	11.9	17.9	43.1	49.3	27.5	110.8	50.3	65.2	66.2	17.1	25.8	110.2	40.4	27.9	57.9	56.5	73.5	39.3	121.4	41.3	28.6	38.8	89.0	57.8	49.8	13.2	93.9	94.2	79.8	51.7	63.9	46.9	100.9	94.8	39.3	43.8	49.3	35.6	28.7	56.4	93.5	92.7	111.7	20.9	62.4	127.7	90.4	124.6	41.9	39.6	221.5	40.7	108.9	26.2	33.5	81.4	128.6	60.4	46.0	53.3	24.8	61.9	111.8	57.4	61.7	68.0	133.2	125.4	122.7	123.4	120.8	47.0	75.4	64.7	0.8	1.9	7.2	2.9	2.5	2.2	1.7	2.4	3.0	1.8	1.6	2.1	1.9	1.7	1.3	1.9	2.5	3.0	2.1	23.0	24.9	32.9	35.2	21.2	24.7	26.8	22.8	23.4	20.4	23.1	27.5	31.7	3.2	4.5	5.9	49.0	39.0	28.1	38.3	64.3	6.4	21.4	19.9	2.0	18.6	16.8	11.0	4.2	70.7	32.3	18.0	25.4	24.4	66.7	14.2	18.5	24.0	13.1	49.4	6.1	9.6	79.9	28.8	36.2	17.0	16.5	32.6	35.0	4.0	32.6	8.4	5.6	22.1	24.4	24.9	34.3	91.0	46.0	26.4	32.0	9.4	14.1	6.2	11.3	8.0	9.5	11.8	24.5	32.0	51.7	20.1	38.7	20.2	10.7	12.3	13.1	20.4	27.4	63.6	71.6	41.7	25.3	59.0	51.5	15.8	26.2	24.7
SF3B3	"KIAA0017, RSE1, SAP130, SF3b130"	ENSG00000189091	"Splicing factor 3b subunit 3"	Q15393	16	70523791-70577670	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041134, HPA042986"	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No		50000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA041134: AB_2677317, HPA042986: AB_10960386"	"unprognostic (3.39e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.73e-1)"	15.7	11.2	7.9	19.2	8.2	22.2	13.8	15.9	9.6	16.3	11.4	17.1	13.6	17.0	10.2	19.9	16.4	11.6	12.1	8.8	9.7	12.5	12.3	11.7	24.3	7.0	6.9	22.3	13.8	16.8	7.9	14.1	7.5	11.6	13.2	16.3	12.6	10.7	23.6	19.9	12.9	16.0	6.5	13.9	13.2	10.2	10.4	23.7	14.5	11.7	26.6	14.2	14.4	12.0	72.4	72.6	93.4	65.3	45.5	41.6	74.0	66.3	55.5	84.5	67.3	75.6	55.8	97.1	52.6	51.8	49.9	81.4	98.0	55.7	133.0	31.5	71.1	75.1	56.7	81.0	30.6	106.1	83.9	39.8	40.1	93.9	68.8	54.1	50.9	55.3	104.6	34.2	67.4	87.5	92.9	51.6	85.2	44.8	41.9	163.2	73.3	109.7	26.9	96.4	81.4	59.8	217.7	33.8	33.8	39.2	73.9	53.0	52.7	61.9	67.8	49.2	71.6	37.4	90.4	260.7	40.9	66.9	61.3	23.4	26.1	28.1	35.8	30.8	39.3	28.4	33.1	37.5	35.3	34.3	38.8	33.7	8.3	35.5	31.2	19.1	40.2	37.4	7.9	8.2	15.9	9.6	8.8	9.7	7.0	6.9	7.5	6.5	10.4	12.0	18.9	25.6	25.7	16.6	33.0	22.4	23.2	23.4	13.1	35.5	20.5	18.3	29.3	14.3	25.4	23.9	14.6	33.6	21.6	19.7	7.9	20.7	6.3	17.8	31.9	25.4	21.1	36.8	23.2	23.2	34.7	24.2	20.4	17.5	17.7	52.3	17.5	23.6	23.6	40.4	26.5	21.8	24.4	20.6	12.8	10.3	33.8	19.2	17.8	24.4	22.7	19.4	25.7	26.2	26.7	24.9	14.0	33.1	25.1	30.2	18.1	15.7	18.8	26.7	6.6	30.2	18.8	28.7	33.3	37.6	26.1	25.4	28.3	48.2	31.6	24.7
SIRT3	SIR2L3	ENSG00000142082	"Sirtuin 3"	Q9NTG7	11	215030-236931	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026809, CAB037142"	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"			"CAB037142: AB_1079982, HPA026809: AB_10601160"	"unprognostic (1.76e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.04e-1)"	"prognostic favorable (8.51e-5)"	"unprognostic (1.52e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (4.45e-4)"	"unprognostic (2.06e-1)"	"prognostic favorable (4.85e-9)"	"unprognostic (1.04e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.75e-2)"	11.1	13.8	24.5	10.4	28.8	11.8	18.6	19.7	28.8	14.3	26.1	13.9	13.3	12.6	40.1	9.9	14.4	7.6	24.4	25.1	20.8	17.2	25.8	10.3	13.8	19.0	20.4	18.3	18.0	11.2	28.0	5.8	18.4	16.7	14.2	26.8	12.6	12.4	27.3	20.2	14.6	9.7	19.0	14.7	13.5	25.2	21.6	6.8	15.7	19.9	14.9	11.5	11.1	24.0	9.7	11.1	16.7	17.7	19.1	24.1	8.0	13.6	11.0	10.1	7.9	11.5	22.8	5.9	6.2	8.5	9.8	18.6	8.2	7.4	9.8	11.2	12.7	7.4	15.7	12.6	8.4	9.7	17.3	17.8	14.1	10.2	10.9	17.3	6.7	11.1	15.3	11.0	4.6	10.8	4.0	15.0	7.5	8.5	13.2	10.8	13.2	9.8	10.2	6.6	9.3	7.5	11.5	16.7	6.4	10.8	11.9	2.2	9.3	11.4	5.4	3.2	4.1	19.4	17.3	8.4	12.4	7.7	5.9	0.1	3.1	3.1	3.6	2.5	3.8	5.3	3.3	4.1	2.8	4.3	6.0	4.9	3.1	8.1	6.6	4.8	4.0	2.7	24.5	28.8	19.7	28.8	25.1	20.8	19.0	20.4	18.4	19.0	21.6	24.0	6.0	3.2	6.5	17.0	10.4	5.0	7.0	13.1	12.5	7.4	16.0	15.5	23.4	14.3	7.4	5.5	8.4	12.6	7.2	7.2	33.2	7.5	22.0	7.4	5.8	6.7	6.0	14.3	19.2	5.8	10.3	8.6	11.7	4.6	10.2	8.4	7.5	18.3	8.8	10.1	18.3	8.1	10.2	5.5	3.3	21.0	9.0	6.4	10.6	8.4	3.5	13.5	5.2	9.0	11.6	5.1	9.3	9.1	14.6	5.5	14.3	18.9	9.0	9.5	0.0	7.3	6.5	25.5	9.6	9.9	4.1	6.8	8.4	14.2	11.2	4.0
SKIV2L	"170A, DDX13, HLP, SKI2W, SKIV2, SKIV2L1"	ENSG00000204351	"Ski2 like RNA helicase"	Q15477	6	31959117-31969751	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 42.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047122, HPA051959, HPA054419"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Mitotic spindle, Cytosol"	"HPA047122: , HPA051959: AB_2681672, HPA054419: AB_2682482"	"unprognostic (1.43e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.66e-2)"	"unprognostic (6.43e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.53e-3)"	"prognostic unfavorable (3.02e-7)"	"unprognostic (6.77e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.06e-2)"	21.9	33.1	0.0	5.2	0.3	4.1	21.6	0.0	0.4	26.5	0.0	25.1	10.5	22.6	9.4	23.0	25.0	0.0	22.0	0.0	0.1	24.0	54.7	22.2	3.4	0.0	0.5	24.6	25.7	2.4	39.7	2.6	0.0	31.9	2.4	2.1	22.4	3.2	20.4	20.2	31.2	5.7	0.0	40.6	27.6	16.6	0.1	4.3	27.7	5.3	2.7	23.6	20.9	0.0	0.2	12.7	13.3	0.0	16.5	11.8	27.1	10.9	11.7	13.6	13.2	0.4	0.0	0.0	26.0	25.5	13.2	11.9	0.0	30.8	9.9	14.8	15.7	0.0	0.0	0.2	0.0	0.1	0.2	28.3	17.9	0.1	0.0	12.7	0.0	19.3	0.0	13.6	0.0	0.0	0.0	0.3	20.6	0.0	0.0	0.3	0.0	0.0	11.2	0.0	0.0	0.0	23.6	0.0	17.6	11.5	0.0	15.7	12.8	16.0	7.2	18.7	0.2	42.2	35.7	12.0	20.4	0.1	0.0	0.3	0.5	0.2	1.5	1.4	1.1	0.2	0.7	0.3	1.1	0.9	0.8	0.8	0.1	0.0	2.2	0.5	0.2	0.4	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	6.4	16.0	11.3	10.1	13.3	2.8	5.0	7.9	11.4	5.0	9.3	5.1	8.5	10.0	8.8	7.3	8.4	12.6	12.7	19.7	1.9	9.5	3.1	7.7	7.9	7.9	12.6	6.5	7.2	8.6	7.9	7.4	28.1	6.3	8.2	10.8	8.6	19.4	9.2	0.0	5.0	13.2	8.2	6.3	4.1	1.5	9.3	7.8	7.2	2.8	10.2	4.9	18.6	3.0	4.8	9.4	16.0	6.0	20.2	5.9	25.5	6.9	16.5	8.3	0.0	4.1	10.2	4.7	7.5	6.6	3.7	12.4	14.4	12.3	11.0	5.2
SLC16A13	MCT13	ENSG00000174327	"Solute carrier family 16 member 13"	Q7RTY0	17	7036015-7040117	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 8.2;NK-cells: 6.2;Squamous epithelial cells: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 22.8;GAMG: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065245			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"	Cytosol	"HPA065245: AB_2685443"	"unprognostic (5.61e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (2.44e-2)"	"unprognostic (7.31e-3)"	"unprognostic (9.70e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.14e-1)"	1.4	1.0	1.1	2.1	0.8	0.4	1.4	1.8	1.1	1.8	1.0	2.2	9.2	0.8	1.3	5.3	1.8	3.7	1.6	0.9	1.0	6.8	36.1	2.4	2.8	1.2	1.2	0.5	1.2	2.9	0.8	1.5	1.0	1.4	1.6	0.3	3.3	0.8	0.4	5.3	5.5	0.9	0.9	3.5	1.9	0.5	1.0	1.8	3.3	0.2	2.5	1.2	2.6	0.8	13.1	22.8	5.3	3.2	3.2	1.8	2.2	1.3	3.3	2.9	6.5	7.4	14.3	8.3	2.2	2.1	26.2	20.1	4.1	7.0	1.2	10.3	2.9	3.4	1.8	18.0	3.6	1.2	7.6	2.1	7.8	4.3	3.5	3.9	11.9	7.4	4.0	2.3	3.1	6.5	5.1	2.1	2.2	6.6	1.8	2.4	1.8	1.4	2.7	3.6	0.2	1.4	4.0	2.2	1.8	7.8	6.1	1.8	4.5	1.8	4.1	3.0	1.9	4.0	8.9	0.5	5.4	3.0	0.8	0.0	0.8	1.0	1.2	0.8	0.9	1.1	1.0	1.5	0.8	2.5	1.1	1.1	0.9	1.2	0.9	1.1	1.2	0.5	1.1	0.8	1.8	1.1	0.9	1.0	1.2	1.2	1.0	0.9	1.0	0.8	2.3	0.0	1.5	0.7	5.1	0.5	0.9	1.3	4.0	0.4	1.6	0.9	0.4	1.5	0.8	5.5	0.0	1.9	2.4	1.1	0.0	1.0	0.0	0.5	0.5	2.8	0.0	0.4	1.8	0.2	0.4	0.6	4.1	0.7	3.8	1.1	2.2	8.2	0.5	3.3	1.1	1.2	2.0	0.6	3.1	0.0	0.9	1.6	0.0	1.0	1.4	0.9	6.2	0.5	0.0	0.5	0.1	0.0	2.9	0.9	2.4	1.9	1.4	0.5	0.0	0.3	1.1	0.0	0.0	7.4	1.6	2.5	4.7	0.5	1.0	1.0
SLC16A7	MCT2	ENSG00000118596	"Solute carrier family 16 member 7"	O60669	12	59596029-59789855	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 34.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 135.4;Early spermatids: 117.3;Excitatory neurons: 150.5;Inhibitory neurons: 128.2;Late spermatids: 135.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 22.2"	HPA005911	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA005911: AB_1853659"	"unprognostic (1.52e-2)"	"unprognostic (9.47e-3)"	"unprognostic (9.48e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.39e-2)"	"unprognostic (9.79e-2)"	"prognostic favorable (8.85e-5)"	"unprognostic (2.19e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.45e-2)"	20.1	6.8	1.2	3.9	1.2	4.7	4.1	5.7	3.9	2.8	3.7	2.0	1.6	3.0	1.5	6.3	2.2	5.4	34.4	1.3	0.3	11.6	3.9	4.5	4.9	2.9	0.4	2.7	9.8	1.0	1.5	1.6	2.9	1.6	2.5	1.8	2.9	1.6	1.8	7.9	2.5	3.5	0.5	6.3	10.0	2.2	1.3	4.5	1.6	3.6	4.2	4.0	3.0	4.2	0.2	3.6	0.8	0.5	10.9	18.1	0.2	8.8	8.1	4.0	3.4	0.3	6.3	5.8	2.5	16.8	3.8	0.8	1.0	1.7	6.0	2.4	0.5	10.7	12.6	0.5	5.9	14.3	0.1	8.5	3.9	1.4	10.3	7.5	1.6	7.2	0.2	13.0	6.5	3.4	5.5	3.2	0.8	1.2	3.3	0.5	0.1	2.7	9.5	16.0	3.0	1.0	0.1	0.4	6.2	0.7	0.5	2.4	0.0	8.6	3.3	15.6	0.5	11.3	0.2	10.0	10.2	0.1	1.6	0.2	1.5	0.0	4.2	3.2	5.6	1.8	3.3	3.6	1.5	4.1	3.5	5.8	0.1	3.0	8.4	2.1	3.8	2.3	1.2	1.2	5.7	3.9	1.3	0.3	2.9	0.4	2.9	0.5	1.3	4.2	15.3	28.9	21.4	13.7	28.4	10.1	7.8	9.9	16.5	24.5	1.5	3.9	135.4	90.1	16.5	46.0	10.4	0.3	29.7	0.8	23.5	53.3	117.3	2.1	25.0	22.0	0.0	2.5	150.5	67.1	0.3	36.2	7.1	9.1	10.1	4.7	9.3	14.5	3.6	8.4	128.2	27.2	6.1	32.7	6.1	135.5	6.8	24.8	3.6	14.0	14.9	1.3	37.0	63.8	82.8	28.0	1.2	10.1	26.3	8.1	1.0	0.7	14.4	6.0	6.6	14.0	18.9	4.2	4.5	61.5	12.6	0.7	35.8	80.1	1.5	3.4
SLC25A32	MFTC	ENSG00000164933	"Solute carrier family 25 member 32"	Q9H2D1	8	103398635-103415189	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024763, HPA047402"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA024763: , HPA047402: AB_2680032"	"unprognostic (2.45e-3)"	"unprognostic (8.19e-2)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.06e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (9.47e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (1.53e-6)"	"unprognostic (7.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.49e-2)"	13.5	7.2	3.1	12.5	3.9	14.6	11.2	4.1	4.8	8.6	2.9	7.7	6.8	10.7	7.5	7.3	9.3	11.5	9.7	4.1	4.5	9.6	17.9	8.5	16.9	4.7	4.6	9.6	8.5	8.8	11.3	10.1	4.6	8.0	7.7	1.4	6.4	7.5	9.6	6.9	7.6	10.9	4.6	12.7	7.0	6.4	4.0	8.7	7.1	9.2	12.8	15.0	7.0	5.3	33.7	11.5	10.5	18.3	21.3	23.3	10.3	27.4	39.9	30.6	31.4	14.0	19.6	73.8	25.8	29.5	17.7	20.4	22.5	22.5	47.0	45.5	16.1	53.5	8.5	18.3	37.4	26.5	23.1	23.1	17.9	34.5	51.2	8.6	32.5	19.4	33.9	25.9	30.5	13.5	45.0	21.6	17.1	39.3	23.6	33.6	16.3	50.8	20.8	12.7	28.0	17.2	13.6	22.3	48.9	10.5	19.3	18.5	22.6	36.7	24.9	44.2	36.2	19.2	19.7	76.8	31.0	38.1	27.5	0.6	3.3	1.6	6.0	3.7	7.3	7.0	6.4	6.9	4.1	4.8	6.5	6.7	0.8	5.2	4.3	3.5	5.5	5.7	3.1	3.9	4.1	4.8	4.1	4.5	4.7	4.6	4.6	4.6	4.0	5.3	28.9	3.2	3.3	10.1	46.9	23.1	16.7	6.9	32.5	9.4	10.3	6.7	10.4	11.5	5.4	5.5	6.2	11.9	20.9	4.1	7.9	9.8	4.8	8.3	14.0	22.2	11.4	16.2	30.3	9.4	13.6	19.6	27.0	9.1	8.9	8.0	20.0	15.2	10.2	8.4	25.8	7.1	8.2	7.3	11.6	4.7	9.3	16.2	10.6	24.4	9.9	7.6	15.5	25.6	46.6	10.0	3.1	8.6	56.3	14.4	4.1	9.5	2.6	8.1	19.7	13.5	14.7	22.9	17.1	32.6	25.9	14.0	27.7	9.5	7.5	15.1
SLC30A6	"FLJ31101, ZNT6"	ENSG00000152683	"Solute carrier family 30 member 6"	Q6NXT4	2	32165841-32224379	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055032, HPA057328"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA055032: AB_2682677, HPA057328: AB_2683411"	"unprognostic (5.61e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.05e-3)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.58e-6)"	"unprognostic (2.98e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.30e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.90e-1)"	10.3	8.9	4.0	8.5	4.8	4.2	10.1	5.2	4.8	10.1	5.1	10.0	8.6	9.2	7.5	8.8	8.0	9.0	7.6	4.0	4.5	11.7	11.2	8.4	9.8	5.0	4.4	9.0	10.4	11.3	4.3	12.1	4.9	8.8	10.0	6.0	7.7	7.8	7.8	8.0	8.4	9.4	4.8	7.8	9.2	6.2	4.4	9.4	11.8	7.6	10.3	9.9	5.6	6.2	27.7	20.3	20.5	18.0	25.4	22.6	22.7	25.3	25.0	20.4	18.5	15.8	25.4	13.1	16.4	20.4	23.4	17.0	24.7	17.4	25.8	26.6	13.7	28.6	10.9	20.3	16.3	30.4	16.9	17.0	26.7	27.4	21.8	20.7	16.6	9.2	24.6	17.2	23.6	10.2	16.1	13.9	31.0	30.8	10.6	14.2	24.7	19.3	22.5	23.9	15.3	23.3	19.9	21.2	20.4	19.0	11.7	13.6	14.3	25.9	14.3	17.2	30.3	23.1	43.5	19.2	23.0	23.4	26.6	12.8	2.4	1.9	2.5	2.0	3.5	3.0	2.3	2.8	2.9	2.7	3.4	3.2	2.4	7.0	2.3	2.0	4.6	2.0	4.0	4.8	5.2	4.8	4.0	4.5	5.0	4.4	4.9	4.8	4.4	6.2	8.6	9.6	9.9	19.9	14.9	9.1	5.3	14.9	13.6	4.5	9.0	5.7	4.1	8.6	8.3	7.3	6.2	19.8	8.4	9.5	5.9	7.5	2.8	7.4	10.1	10.9	3.6	13.2	29.2	8.7	14.7	9.5	11.7	10.5	3.8	12.9	11.4	15.3	10.7	1.7	31.0	7.9	14.2	8.8	9.3	1.0	6.5	6.6	8.8	10.3	7.7	7.5	12.3	27.2	37.2	9.8	7.0	7.9	20.0	8.7	9.1	8.3	10.0	7.1	13.1	7.3	7.3	12.3	9.4	13.6	6.3	27.5	9.5	9.0	9.0	5.2
SLC35F5	FLJ22004	ENSG00000115084	"Solute carrier family 35 member F5"	Q8WV83	2	113705011-113756693	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034828, HPA049229"	Uncertain		Uncertain	"Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA034828: AB_2674350, HPA049229: AB_2680682"	"unprognostic (1.59e-2)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (8.37e-2)"	"unprognostic (3.87e-3)"	"unprognostic (5.62e-2)"	"unprognostic (4.73e-3)"	"unprognostic (3.94e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.83e-2)"	9.8	22.8	4.6	6.0	5.9	8.0	14.3	12.0	6.6	9.3	31.5	14.7	13.7	10.3	11.5	11.1	8.0	11.1	11.0	6.1	6.4	18.0	14.6	9.9	9.0	6.7	4.8	12.4	15.1	17.4	5.2	11.1	7.1	11.2	13.6	14.1	9.8	6.9	12.3	20.3	12.9	8.9	5.4	10.1	12.9	7.1	5.2	5.7	23.7	11.2	10.0	8.0	6.3	12.0	9.7	9.6	7.7	4.9	48.6	36.8	14.0	15.9	13.2	7.7	12.9	24.3	18.9	18.5	22.1	21.9	21.3	8.7	12.2	12.5	17.9	5.7	4.9	9.7	9.6	19.7	20.8	12.8	24.0	46.8	17.4	17.9	25.9	22.1	15.2	4.6	7.7	11.2	19.1	8.5	5.6	14.0	3.6	15.0	5.2	6.5	13.1	9.7	52.5	15.8	2.1	6.0	12.9	14.5	11.5	12.8	9.4	12.6	12.7	14.3	6.3	9.2	6.7	9.7	8.7	8.2	16.8	8.9	13.6	2.9	0.7	0.6	0.5	0.8	0.6	0.9	0.5	0.4	0.6	1.2	0.6	0.6	2.1	1.0	1.2	0.9	0.9	0.6	4.6	5.9	12.0	6.6	6.1	6.4	6.7	4.8	7.1	5.4	5.2	12.0	18.9	22.4	19.8	39.5	18.0	25.4	31.1	20.0	31.9	10.3	20.4	9.8	25.4	21.5	30.4	73.5	22.9	46.3	11.6	44.1	11.7	28.7	28.3	32.4	21.9	15.4	14.5	9.9	43.4	28.5	72.0	24.8	28.5	38.6	24.1	14.4	12.5	20.8	28.3	5.0	47.0	25.6	12.2	13.4	17.2	15.6	12.5	14.6	8.8	39.4	15.5	21.0	7.2	65.4	83.2	23.1	29.7	13.9	37.5	35.3	47.9	45.1	26.3	19.6	0.0	14.2	22.7	60.0	20.5	32.7	34.0	66.4	10.8	41.0	24.8	35.1
SMARCAD1	"DKFZP762K2015, ETL1, KIAA1122"	ENSG00000163104	"SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1"	Q9H4L7	4	94207611-94291292	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 86.5;Inhibitory neurons: 82.5;Oligodendrocyte precursor cells: 86.5;Oligodendrocytes: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016737	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA016737: AB_1857271"	"unprognostic (5.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.41e-3)"	"unprognostic (9.08e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (2.45e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.20e-3)"	10.0	9.5	7.1	11.2	7.8	7.5	15.2	12.0	8.5	10.6	7.5	9.4	9.7	14.5	12.6	10.5	10.7	10.3	7.6	7.3	8.6	11.7	9.8	9.7	16.0	7.2	7.4	14.2	8.7	11.7	11.0	14.1	7.7	11.1	12.3	14.6	8.9	10.0	7.3	20.8	9.5	11.8	7.7	11.9	10.8	12.2	8.2	18.6	15.0	6.8	14.2	11.2	9.7	9.9	15.0	18.6	59.1	38.1	16.5	26.6	30.1	26.8	24.3	21.8	20.3	18.2	23.7	37.8	17.7	23.1	19.8	12.9	42.3	22.4	30.7	29.8	18.7	27.5	20.5	27.2	24.4	41.2	28.9	27.8	17.8	27.3	34.9	27.0	33.7	33.3	46.7	15.5	32.4	12.3	69.1	21.3	40.1	19.1	9.4	40.1	33.6	19.6	24.6	18.4	33.8	49.9	20.1	32.8	28.6	36.7	17.1	26.9	32.3	27.6	29.9	17.1	20.3	21.8	34.8	45.1	25.7	21.2	34.8	2.7	1.3	0.2	2.3	1.7	2.5	2.9	2.6	2.6	2.4	2.4	2.8	3.3	0.0	4.5	1.7	2.1	2.3	1.3	7.1	7.8	12.0	8.5	7.3	8.6	7.2	7.4	7.7	7.7	8.2	9.9	19.0	12.8	11.3	56.2	16.7	11.7	6.5	12.8	25.6	20.9	15.5	13.2	12.7	4.3	24.7	9.2	16.7	13.5	20.1	7.1	1.9	12.4	2.1	27.6	32.3	17.8	9.0	25.5	86.5	10.0	11.8	19.9	17.9	17.9	24.0	29.5	13.2	13.5	10.8	18.5	82.5	12.9	14.2	14.6	5.4	3.1	14.3	13.7	3.6	47.8	12.6	8.1	17.5	86.5	99.5	15.0	6.3	18.4	16.4	7.7	4.4	15.5	26.8	18.8	6.6	21.1	16.2	25.9	34.8	18.7	9.7	9.6	17.3	26.2	12.6	5.8
SMARCE1	BAF57	ENSG00000073584	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1"	Q969G3	17	40624962-40648654	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	Neurogenesis	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003916, CAB037318"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"CAB037318: AB_476780, HPA003916: AB_1857279"	"unprognostic (7.91e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.55e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.93e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-2)"	39.4	22.2	10.5	37.8	11.9	43.2	35.6	10.6	13.3	45.9	14.3	40.2	38.9	56.2	28.3	43.6	39.0	41.4	40.1	9.2	11.7	31.2	31.5	36.1	49.6	13.7	10.7	58.6	35.4	38.3	13.3	48.4	13.2	34.2	38.5	17.5	33.6	42.1	42.5	27.7	39.3	57.4	11.7	40.5	30.9	31.5	11.2	76.1	40.8	44.7	54.2	46.8	26.2	16.5	86.5	139.6	169.1	126.5	87.7	125.5	82.8	105.9	145.4	122.1	91.0	92.7	72.7	135.9	149.6	145.3	81.0	114.5	106.1	112.3	145.1	128.3	138.0	97.2	73.4	165.2	87.8	179.8	94.5	109.3	87.6	97.7	140.6	122.1	133.4	106.5	144.2	52.2	118.2	96.5	331.6	37.1	95.4	70.8	68.6	183.3	190.2	103.7	147.5	144.9	134.6	130.0	94.5	269.4	86.6	181.5	161.5	111.4	109.7	98.1	107.6	89.7	132.6	97.7	122.8	204.5	100.0	80.9	154.9	106.3	64.4	88.2	91.7	67.8	95.0	99.8	82.4	96.1	77.9	112.3	68.3	79.3	26.5	124.7	82.2	80.3	114.7	112.2	10.5	11.9	10.6	13.3	9.2	11.7	13.7	10.7	13.2	11.7	11.2	16.5	41.4	48.1	45.1	13.1	67.5	38.1	43.0	69.5	65.4	75.8	19.7	20.2	53.0	38.6	61.5	20.2	16.7	101.8	68.7	38.7	15.6	41.5	27.1	34.9	47.0	60.4	96.5	84.1	17.1	32.3	75.7	72.4	44.9	32.1	74.0	41.3	62.8	44.0	51.6	82.4	18.8	53.5	65.1	42.9	39.6	11.8	90.4	30.9	24.9	19.7	63.2	63.3	105.0	26.7	32.7	35.7	46.7	82.4	44.2	36.5	52.8	30.5	59.3	37.1	39.5	62.7	57.0	49.7	50.9	63.3	40.1	114.8	53.8	35.3	62.5	34.3
SMG8	"C17orf71, FLJ10587, FLJ23205"	ENSG00000167447	"SMG8 nonsense mediated mRNA decay factor"	Q8ND04	17	59209400-59215239	"Predicted intracellular proteins, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA024841	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA024841: AB_10600790"	"unprognostic (2.68e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.51e-3)"	"unprognostic (9.91e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (3.72e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-3)"	"unprognostic (4.65e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.75e-1)"	5.9	7.0	5.0	6.4	5.3	10.9	8.5	5.7	6.8	7.4	5.5	6.0	5.9	7.4	6.9	6.5	8.5	5.1	7.5	5.3	6.4	7.1	7.7	6.3	9.5	5.2	5.7	11.2	5.2	9.4	4.1	9.2	5.8	6.6	6.0	4.6	6.3	6.9	8.3	7.3	5.4	7.2	5.7	7.4	5.9	7.5	6.2	10.2	8.1	8.4	10.1	6.7	3.9	6.3	16.2	22.6	17.4	17.5	21.4	18.0	23.5	23.1	23.5	31.7	27.3	15.5	14.1	23.8	35.2	22.1	24.6	19.2	28.3	21.4	30.6	31.5	27.0	27.3	12.2	22.2	24.6	26.8	22.6	23.6	26.2	23.2	17.2	21.0	21.1	14.7	33.5	12.2	22.0	36.2	25.9	12.4	17.1	23.3	22.0	17.3	26.0	22.5	14.9	11.5	15.4	24.9	16.2	8.9	19.3	21.7	26.9	18.7	20.5	11.9	27.0	13.0	20.8	23.7	36.3	27.3	15.2	14.0	19.8	26.7	18.6	9.6	8.7	24.2	10.2	10.0	8.1	8.3	15.0	6.2	8.0	7.3	4.7	10.2	26.4	5.0	8.3	9.0	5.0	5.3	5.7	6.8	5.3	6.4	5.2	5.7	5.8	5.7	6.2	6.3	1.0	3.2	2.6	4.6	3.8	0.6	0.3	0.9	1.8	0.8	0.7	0.4	0.9	0.0	1.8	0.0	0.0	1.0	1.2	2.4	0.0	2.7	0.3	1.6	1.9	1.8	1.8	1.3	3.4	2.8	1.0	1.6	3.1	1.6	5.7	1.5	1.1	1.0	0.8	3.3	3.7	0.5	0.0	2.4	0.0	0.0	0.9	2.4	0.0	0.0	2.3	0.6	1.0	4.5	5.0	2.9	6.3	0.7	3.6	0.2	0.8	0.6	3.5	1.1	0.0	1.6	3.0	1.2	1.3	3.1	0.6	1.4	2.3	2.1	1.5	0.3
SNU13	"15.5K, FA-1, NHP2L1, SNRNP15-5, SPAG12, SSFA1"	ENSG00000100138	"Small nuclear ribonucleoprotein 13"	P55769	22	41673933-41690504	"Predicted intracellular proteins, Ribosomal proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 1057.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA029199	Uncertain					NA	NA		28000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"			"HPA029199: AB_10601041"	"unprognostic (3.02e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.43e-1)"	"unprognostic (6.65e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.43e-1)"	64.9	125.6	156.5	74.5	157.7	135.7	80.7	146.4	159.5	81.8	134.4	77.8	64.9	64.6	99.0	65.5	91.2	55.7	145.1	159.1	191.3	75.7	65.2	61.9	97.4	159.5	159.4	96.7	74.8	113.6	52.7	67.5	173.3	65.8	73.5	85.5	74.8	70.9	187.1	73.3	56.1	71.4	150.1	71.2	66.3	94.9	173.3	98.2	90.1	178.0	108.4	88.7	34.0	151.9	222.8	100.2	151.8	203.7	192.7	173.5	160.1	212.6	181.4	303.0	259.6	215.1	195.0	148.6	165.5	183.6	91.6	160.3	183.6	239.0	205.5	178.1	428.0	163.0	191.1	313.1	249.5	345.3	217.9	157.7	247.0	226.6	330.2	142.1	175.2	161.2	227.3	244.8	200.6	262.7	238.0	369.7	215.6	852.4	240.8	252.7	126.7	505.5	279.6	128.9	135.9	125.0	102.4	249.4	333.7	160.6	116.8	218.1	125.1	152.6	175.3	191.0	166.8	273.7	366.5	353.6	206.9	195.5	218.1	205.5	224.8	210.8	210.5	233.3	225.3	357.4	252.0	226.6	240.3	311.2	266.1	247.4	67.5	205.3	208.5	288.2	346.2	339.9	156.5	157.7	146.4	159.5	159.1	191.3	159.5	159.4	173.3	150.1	173.3	151.9	217.9	80.1	121.9	0.0	265.1	0.0	390.5	0.0	196.9	160.1	224.4	272.3	0.0	190.1	65.0	185.8	25.0	367.3	205.8	42.1	655.4	310.0	1057.6	223.4	169.0	198.0	70.4	144.7	0.0	302.3	438.5	172.4	125.4	251.9	77.0	162.3	181.3	205.0	293.1	109.4	0.0	118.9	0.0	140.1	0.0	318.4	211.9	162.9	0.0	0.0	186.3	181.8	151.4	0.0	0.0	340.9	127.7	174.2	261.9	630.5	202.2	462.5	68.5	128.4	138.1	169.0	143.0	505.9	279.5	219.8	0.0	460.5	208.0	193.8	139.5	505.0
SNURF		ENSG00000273173	"SNRPN upstream reading frame"	Q9Y675	15	24954986-24977850	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 62.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 191.3;U-698: 112.1"									HPA065733			Supported	"Nuclear speckles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA065733: AB_2685548"	"unprognostic (2.08e-1)"	"unprognostic (2.88e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.59e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.39e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.56e-2)"	"unprognostic (6.74e-2)"	"unprognostic (8.91e-4)"	"unprognostic (3.77e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-2)"	8.1	16.1	3.7	6.9	7.5	12.5	5.3	16.3	16.0	12.1	1.2	14.6	1.9	9.6	54.8	5.3	8.5	13.2	50.7	5.6	11.8	14.6	12.9	9.8	10.2	1.5	2.8	13.7	13.5	19.8	28.5	2.7	2.4	15.2	2.5	25.3	8.4	8.3	62.9	3.7	6.4	3.8	0.5	17.2	11.5	3.3	6.5	8.1	15.5	7.4	7.0	12.8	7.3	8.6	0.1	11.9	61.9	44.1	3.1	4.1	0.1	40.7	3.3	4.2	2.8	7.0	36.4	0.5	21.0	2.7	6.0	15.3	0.0	9.1	3.2	14.1	0.0	74.3	50.2	1.8	11.0	79.2	25.4	10.0	2.3	7.7	0.5	22.1	5.2	22.4	7.3	0.2	8.3	0.0	55.5	0.5	191.3	0.0	1.9	54.7	84.7	0.9	3.3	82.0	37.1	29.1	0.0	3.8	22.3	75.2	38.7	7.1	75.8	27.2	30.2	1.0	8.9	58.8	81.6	112.1	43.9	33.6	24.5	17.7	1.5	6.3	14.9	0.7	31.0	22.3	32.9	28.4	2.7	27.8	41.2	38.1	1.7	22.4	3.1	23.6	35.7	20.1	3.7	7.5	16.3	16.0	5.6	11.8	1.5	2.8	2.4	0.5	6.5	8.6	1.0	3.2	3.7	0.0	2.9	0.5	0.6	1.4	2.2	1.6	1.4	1.1	4.1	0.0	1.1	0.0	0.0	0.0	1.1	0.7	3.9	2.1	0.4	0.7	1.2	0.9	0.0	0.8	0.0	2.4	0.0	1.4	1.5	0.7	1.3	2.0	1.1	0.7	0.3	3.3	0.0	2.7	0.0	0.8	0.4	0.3	0.6	0.6	0.0	0.0	0.7	0.4	0.0	0.0	0.0	2.2	2.8	0.4	2.7	0.6	1.1	0.7	4.1	1.5	0.0	0.9	2.0	0.3	0.8	0.7	0.3	0.0	2.8	1.9	1.2	0.3
SP2	KIAA0048	ENSG00000167182	"Sp2 transcription factor"	Q02086	17	47896150-47928957	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003357, CAB010245"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Vesicles	"CAB010245: AB_2121523, HPA003357: AB_1080070"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.30e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.39e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (5.34e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.66e-2)"	14.8	10.7	9.4	16.6	11.6	19.4	15.4	16.1	11.5	12.9	6.9	14.3	14.9	14.7	12.0	17.2	15.1	11.5	18.3	9.6	10.1	12.5	8.7	14.9	20.6	12.4	10.4	15.1	16.0	23.5	9.8	13.6	11.1	13.5	13.3	10.5	16.2	12.5	32.2	14.8	15.6	12.8	8.3	17.7	13.0	17.8	11.8	25.3	18.1	26.6	15.0	13.6	13.4	13.3	33.5	37.3	25.1	21.6	12.1	11.2	26.1	19.3	13.6	19.0	17.1	41.3	16.2	28.6	17.4	24.7	20.1	25.6	17.5	16.4	19.9	41.7	26.6	28.5	25.6	22.3	11.2	26.4	34.2	16.4	19.1	22.4	21.1	13.5	18.5	26.3	31.8	47.5	18.8	45.0	64.6	16.8	11.8	29.6	24.9	30.8	34.4	18.6	13.4	52.1	26.8	31.4	16.9	17.9	20.0	15.0	26.7	25.6	30.3	34.8	18.1	24.2	30.1	42.3	50.6	26.0	19.0	18.5	29.2	13.6	6.1	9.9	8.3	7.0	7.3	4.9	6.3	7.9	4.9	5.6	7.1	7.4	11.3	9.7	6.6	4.5	7.2	6.6	9.4	11.6	16.1	11.5	9.6	10.1	12.4	10.4	11.1	8.3	11.8	13.3	14.6	9.6	19.5	5.2	17.7	6.2	15.8	7.8	12.0	9.0	9.8	9.9	9.7	12.8	8.3	11.0	0.0	10.7	11.3	16.4	15.6	7.0	9.8	8.1	6.2	11.6	15.6	25.2	5.2	7.6	9.2	9.4	8.6	10.7	13.3	5.5	8.2	7.5	8.9	11.8	4.8	9.0	14.2	10.9	8.2	10.5	10.5	14.2	8.8	6.5	11.7	12.1	17.5	9.0	9.9	7.3	13.2	3.4	12.7	11.0	8.6	8.1	10.2	6.5	6.6	12.6	12.5	9.8	6.3	9.6	7.5	20.5	14.8	5.3	7.9	17.0
SP3	SPR-2	ENSG00000172845	"Sp3 transcription factor"	Q02447	2	173880850-173965702	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004580, HPA032145, HPA032146"	Supported	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB004580: AB_628274, HPA032145: , HPA032146: AB_2732465"	"unprognostic (1.94e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.39e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.92e-2)"	"unprognostic (5.54e-3)"	"unprognostic (6.36e-2)"	"unprognostic (2.76e-3)"	"unprognostic (3.27e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.46e-5)"	"unprognostic (2.78e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.69e-1)"	32.6	19.8	15.8	35.2	16.0	53.1	43.1	21.3	19.8	50.9	16.1	34.3	26.9	45.1	34.6	32.1	37.1	28.9	23.8	14.2	17.1	29.7	40.1	29.9	46.1	16.9	16.7	40.3	24.9	43.1	13.2	49.1	16.4	31.9	38.9	21.0	26.1	30.4	22.5	38.5	29.6	36.3	16.3	38.6	27.0	25.2	15.5	68.0	47.5	33.7	53.8	33.7	28.0	18.5	41.6	34.5	74.6	45.8	91.8	82.3	83.5	47.5	67.1	62.2	66.1	56.8	59.7	65.1	39.3	65.0	46.3	41.0	57.8	46.0	91.7	55.2	21.2	65.9	33.9	54.0	45.5	60.4	48.9	60.6	53.2	72.9	63.6	48.4	49.4	51.3	51.4	86.8	65.7	44.4	84.0	49.9	66.1	60.1	37.8	74.2	68.5	53.0	48.4	55.8	67.8	48.1	67.1	38.1	52.4	81.7	30.0	80.0	44.1	70.6	61.8	47.5	50.4	58.8	46.7	85.8	53.0	41.6	67.2	8.9	9.4	13.0	11.6	7.0	12.9	9.5	12.3	12.3	9.9	7.4	13.8	12.8	27.3	21.9	10.3	6.2	13.8	9.9	15.8	16.0	21.3	19.8	14.2	17.1	16.9	16.7	16.4	16.3	15.5	18.5	36.1	19.2	22.9	44.7	55.2	57.6	31.7	25.7	64.9	29.1	36.8	23.4	18.8	14.3	23.3	20.2	27.1	30.9	67.9	37.9	11.7	18.6	4.3	22.3	57.8	33.9	30.5	31.7	52.7	19.3	42.7	43.9	17.9	29.5	23.5	31.3	32.2	43.8	24.6	23.5	50.7	28.8	20.3	54.1	72.8	7.1	45.4	55.6	42.7	81.5	39.0	30.5	46.4	60.3	74.7	30.8	22.9	36.9	63.7	34.2	22.1	24.4	26.6	20.2	19.7	40.4	53.4	10.5	20.4	48.6	57.0	34.6	50.8	26.0	29.0	59.0
SP4	"HF1B, MGC130008, MGC130009, SPR-1"	ENSG00000105866	"Sp4 transcription factor"	Q02446	7	21428043-21514822	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 50.3;Oligodendrocytes: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010246, HPA040395"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"CAB010246: AB_2194481, HPA040395: AB_2676959"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.28e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.18e-2)"	"unprognostic (7.80e-3)"	1.9	2.5	2.1	4.5	3.2	6.8	3.6	10.0	2.5	3.7	1.4	2.0	1.7	5.5	3.0	2.2	4.3	2.5	3.8	1.7	2.8	2.9	2.1	3.5	6.5	2.4	1.8	11.3	2.3	7.2	2.5	2.0	1.9	4.0	2.4	8.9	2.2	2.7	3.6	1.9	2.4	2.9	2.1	5.9	2.9	3.8	2.7	13.5	7.8	7.6	6.8	2.9	1.7	4.4	3.6	2.2	6.7	10.6	2.1	1.4	2.0	3.4	2.2	3.6	4.7	5.5	3.5	14.1	2.3	2.0	9.6	4.2	10.0	2.9	6.9	4.6	4.5	6.5	4.6	2.1	1.5	5.4	7.7	1.4	2.4	3.8	4.3	1.8	7.1	9.6	9.5	9.2	2.9	1.3	13.8	3.7	17.5	6.4	2.7	33.1	11.6	4.6	1.2	2.2	8.8	11.0	7.1	3.0	2.5	6.6	3.6	4.0	3.2	5.7	8.3	3.5	6.5	14.0	15.0	21.0	3.4	8.7	8.1	5.7	0.8	8.9	6.9	1.0	8.2	3.7	6.4	6.6	1.0	5.9	8.2	6.9	2.1	3.9	2.1	1.8	8.4	3.8	2.1	3.2	10.0	2.5	1.7	2.8	2.4	1.8	1.9	2.1	2.7	4.4	11.0	3.2	9.0	19.6	21.8	12.6	11.6	2.5	14.2	17.5	10.0	7.5	9.7	8.6	5.7	0.0	8.4	0.9	13.1	1.6	0.0	2.2	7.0	5.4	7.0	7.8	10.7	21.9	31.0	2.2	1.3	6.3	5.6	7.9	5.1	10.8	10.8	4.6	1.8	18.5	31.3	2.2	2.0	6.0	6.4	4.8	5.6	6.0	7.2	27.2	4.5	10.3	18.6	50.3	60.2	1.7	12.3	6.8	7.1	7.7	1.2	2.0	1.6	21.0	0.0	17.3	6.9	7.3	8.4	4.8	11.1	1.5	22.2	2.8	3.1	5.3
SRRT	"ARS2, Asr2, serrate"	ENSG00000087087	"Serrate, RNA effector molecule"	Q9BXP5	7	100875103-100888664	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 251.1;Late spermatids: 329.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042858, HPA058379"	Supported		Enhanced	Nucleoplasm		NA	NA		32000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA042858: AB_2678201, HPA058379: AB_2683697"	"unprognostic (5.83e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (1.90e-5)"	"unprognostic (4.36e-2)"	"unprognostic (4.99e-3)"	"unprognostic (2.35e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (6.30e-3)"	"unprognostic (2.77e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.10e-3)"	50.1	64.6	38.8	47.2	43.2	115.2	52.4	44.1	43.8	69.9	41.8	54.7	37.7	56.8	30.3	63.4	56.5	28.7	46.3	38.8	43.2	63.0	74.7	49.4	62.3	43.2	40.1	71.3	63.0	33.0	64.1	33.2	40.7	73.6	25.2	30.8	59.3	30.6	51.1	69.6	60.4	26.8	37.7	75.0	55.3	159.9	42.0	51.0	64.2	23.6	40.6	49.6	60.0	44.7	104.3	122.5	123.6	121.2	51.6	36.8	115.2	112.9	56.6	113.0	96.7	161.3	114.5	172.7	75.6	82.0	84.6	96.1	149.6	101.0	56.0	154.0	128.3	163.3	150.3	134.7	46.4	213.6	270.4	55.2	39.0	100.8	28.8	51.3	62.1	103.8	147.1	135.6	79.4	180.9	198.7	235.6	127.5	89.0	107.4	183.1	94.9	103.4	73.6	113.0	97.6	94.4	111.0	136.5	75.4	62.9	85.9	130.7	95.2	127.1	122.7	109.4	154.8	85.5	132.8	185.2	70.6	141.4	122.6	7.7	14.6	22.2	28.3	23.0	18.3	12.2	18.7	38.8	15.7	15.5	16.0	23.0	10.9	10.4	18.1	14.2	9.7	20.9	38.8	43.2	44.1	43.8	38.8	43.2	43.2	40.1	40.7	37.7	42.0	44.7	22.7	25.6	49.2	17.3	37.6	38.5	27.8	24.1	63.7	23.3	22.4	21.8	21.5	14.3	39.2	16.5	14.6	42.7	43.2	24.4	7.9	31.7	251.1	25.6	36.2	25.9	32.9	51.9	8.6	32.0	50.4	29.2	51.5	41.7	27.1	31.3	12.8	13.1	26.5	26.9	8.5	29.1	18.3	15.0	35.9	329.5	33.8	28.4	16.0	9.4	25.1	29.4	26.8	12.5	12.7	26.3	17.9	27.8	67.2	22.8	16.0	12.2	30.5	46.0	19.7	31.7	41.7	133.3	65.8	52.4	43.5	54.2	62.8	33.9	32.3	21.4
SRXN1	"C20orf139, dJ850E9.2, Npn3, SRX1, YKL086W"	ENSG00000271303	"Sulfiredoxin 1"	Q9BYN0	20	646615-653200	"Enzymes, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Ductal cells: 4.4;Erythroid cells: 4.8;Excitatory neurons: 4.5;Exocrine glandular cells: 6.8;Inhibitory neurons: 5.8;Pancreatic endocrine cells: 6.5;Squamous epithelial cells: 9.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 12.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 12.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 59: Non-specific - Transcription"				"unprognostic (7.31e-3)"	"unprognostic (6.08e-3)"	"unprognostic (2.50e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.18e-3)"	"prognostic unfavorable (6.22e-5)"	"unprognostic (1.37e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.58e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.48e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.52e-3)"	20.8	62.7	24.7	10.3	25.1	24.0	12.4	26.7	29.1	18.4	21.8	16.6	18.0	16.5	15.0	63.0	15.3	16.2	37.3	24.1	32.2	23.3	36.7	21.2	5.7	29.2	30.3	16.6	16.0	32.7	22.2	14.0	29.2	15.7	15.1	20.0	18.2	18.3	45.6	11.5	16.7	19.2	25.1	14.5	32.1	8.5	30.5	4.6	26.9	21.7	10.5	26.1	22.7	22.8	119.4	201.0	13.2	26.3	54.5	60.3	30.0	83.6	64.9	58.4	34.2	69.4	63.5	21.8	52.3	133.8	260.2	58.5	50.3	132.9	56.0	23.2	28.2	86.6	43.8	221.7	73.4	37.4	51.4	38.7	121.5	79.3	76.5	47.9	64.3	32.5	76.5	88.5	64.8	35.4	0.2	20.5	26.6	183.8	73.8	0.4	18.1	45.7	41.0	42.3	16.8	32.2	65.5	144.5	98.8	35.8	49.3	23.0	66.0	80.9	56.5	73.5	119.6	23.1	63.7	17.3	51.5	18.0	67.8	2.4	2.0	3.0	2.0	1.8	1.4	0.4	1.0	2.5	1.0	0.0	0.0	0.7	12.3	0.5	2.2	0.1	1.1	0.4	24.7	25.1	26.7	29.1	24.1	32.2	29.2	30.3	29.2	25.1	30.5	22.8	0.2	0.0	0.0	3.3	0.3	0.1	0.1	0.2	1.8	0.7	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.2	2.9	0.0	4.4	0.0	0.2	0.5	0.6	1.2	4.8	4.5	6.8	0.3	0.8	1.5	0.3	0.0	0.1	0.0	0.4	1.0	0.0	5.8	1.4	0.0	0.0	0.3	0.1	0.0	1.3	0.0	3.7	2.1	0.2	0.0	1.0	0.9	6.5	0.8	0.4	2.4	0.3	2.8	0.2	0.1	0.3	0.0	0.1	1.6	0.0	0.0	9.7	0.0	0.0	0.9	0.1	2.0	0.0
SS18	"SSXT, SYT"	ENSG00000141380	"SS18 subunit of BAF chromatin remodeling complex"	Q15532	18	26016253-26091217	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055741, HPA059539"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA055741: AB_2682901, HPA059539: AB_2684055"	"unprognostic (2.03e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.47e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.30e-1)"	29.5	46.2	21.2	27.7	24.9	23.0	33.2	23.6	22.6	32.1	26.3	28.4	18.0	32.2	39.4	34.5	33.2	29.8	29.4	21.8	23.6	36.8	41.9	26.8	35.9	25.5	24.7	47.7	23.8	52.0	30.5	36.9	24.5	35.0	23.4	24.7	29.7	31.2	11.6	41.2	27.7	31.8	23.8	28.5	26.8	25.9	22.4	33.6	45.4	17.5	38.6	38.3	31.2	29.1	52.4	37.2	90.8	43.9	69.0	65.1	45.8	62.9	57.6	55.1	53.6	24.5	43.1	90.6	49.1	75.0	49.0	67.1	50.1	62.0	67.5	58.4	23.3	45.4	56.2	39.8	55.6	69.8	66.5	81.4	71.3	68.6	74.3	53.7	43.7	26.6	34.2	45.0	76.3	53.1	28.5	39.9	17.3	51.6	35.7	33.0	70.2	44.2	57.6	60.7	38.1	57.7	96.0	43.8	27.0	64.6	45.5	40.9	51.4	114.1	22.6	26.8	63.9	80.9	58.3	64.0	53.9	47.8	62.2	27.1	13.5	19.4	16.4	19.7	19.2	17.7	15.6	17.1	15.2	15.0	16.2	18.6	5.7	24.6	20.2	8.5	18.2	16.3	21.2	24.9	23.6	22.6	21.8	23.6	25.5	24.7	24.5	23.8	22.4	29.1	28.8	28.9	23.7	43.8	45.9	8.9	27.8	13.9	40.9	28.8	29.4	26.4	16.0	22.8	18.1	23.9	16.7	70.0	34.0	25.2	21.5	30.3	52.7	44.8	31.5	27.9	24.7	26.1	50.7	26.0	48.8	30.4	22.4	32.3	36.8	60.2	22.1	34.5	27.6	87.5	42.7	25.7	6.1	25.5	10.9	51.4	33.2	22.6	5.4	65.6	19.7	51.1	22.6	90.5	118.0	34.8	15.7	41.0	42.0	24.8	19.1	24.9	30.5	29.8	39.5	23.4	31.3	29.3	20.3	37.2	13.2	85.1	34.0	30.7	16.9	24.7
SSH2	KIAA1725	ENSG00000141298	"Slingshot protein phosphatase 2"	Q76I76	17	29625938-29930276	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Actin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 91.5"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 269.0;Inhibitory neurons: 255.2;Microglial cells: 254.8;Oligodendrocytes: 547.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 134.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017189, HPA057099"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"			"CAB017189: , HPA057099: AB_2683336"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.00e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.80e-2)"	"unprognostic (9.80e-3)"	"unprognostic (7.52e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.28e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.86e-1)"	15.6	9.5	11.7	22.5	13.1	62.8	10.7	12.8	16.3	7.1	3.6	13.0	8.3	7.3	8.9	12.7	8.2	8.9	19.4	13.1	23.2	15.1	13.6	21.4	29.0	19.0	14.4	3.9	14.6	6.2	7.1	10.4	18.5	6.3	10.9	8.1	10.7	4.5	91.5	14.4	20.7	7.9	11.4	28.3	15.5	28.2	16.3	28.9	13.9	35.6	24.8	9.0	8.7	24.5	25.8	19.0	12.6	10.8	36.1	24.7	8.8	12.3	12.9	19.6	19.2	12.9	9.0	22.1	18.8	14.1	12.6	31.0	14.8	17.1	22.4	7.1	28.1	14.9	21.2	17.4	16.6	16.7	30.7	30.4	12.3	20.6	13.4	9.7	47.3	36.2	9.9	16.8	13.7	7.3	74.9	15.5	9.4	9.3	11.5	37.9	31.9	37.0	35.7	20.3	20.6	32.3	18.0	18.6	36.6	16.3	12.6	19.4	25.6	12.6	26.3	23.5	16.1	26.9	20.0	53.8	16.4	13.1	12.3	47.2	15.2	134.8	10.4	20.2	8.5	21.3	11.6	11.1	12.7	22.4	11.5	8.7	91.6	4.6	36.7	7.7	16.4	6.5	11.7	13.1	12.8	16.3	13.1	23.2	19.0	14.4	18.5	11.4	16.3	24.5	19.6	9.6	38.5	81.6	137.0	39.6	12.3	20.6	27.9	12.4	22.2	19.2	28.2	12.8	23.2	16.5	27.1	20.4	68.7	54.3	25.4	14.9	108.4	27.9	10.1	26.9	35.4	27.8	269.0	35.5	26.4	22.2	33.1	32.5	12.6	6.0	19.6	26.9	22.3	20.2	255.2	34.8	14.2	120.2	31.3	174.4	12.2	75.9	35.6	254.8	83.6	9.2	82.4	184.0	547.9	40.3	38.6	8.2	49.4	12.9	64.5	63.1	18.4	22.9	6.6	34.4	17.0	80.9	16.7	37.6	36.2	18.2	65.8	14.2	21.6	30.2
ST20-MTHFS		ENSG00000259332	"ST20-MTHFS readthrough"		15	79845150-79923754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"liver: 96.6"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.8;Collecting duct cells: 1.8;Erythroid cells: 4.2;Gastric mucus-secreting cells: 5.1;Squamous epithelial cells: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 492.2"	"Group enriched"	"Detected in all"	4	"granulocytes: 492.2;monocytes: 133.6"	"Low cell line specificity"	"Detected in all"											HPA008067	Uncertain					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"			"HPA008067: AB_1078882"	"unprognostic (9.84e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.06e-2)"		"unprognostic (4.41e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.75e-3)"	"unprognostic (6.63e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.19e-4)"	"unprognostic (2.38e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.04e-1)"	9.9	10.2	7.3	15.2	7.5	10.1	7.8	8.2	12.0	8.5	8.9	9.5	10.9	6.7	10.0	3.8	7.3	7.7	6.5	8.1	8.4	38.6	96.6	11.0	11.8	8.2	8.8	6.0	15.0	24.0	2.4	9.7	8.4	15.5	8.7	12.2	12.8	8.5	10.5	3.8	14.6	7.5	7.4	7.7	12.0	7.6	9.1	10.3	11.1	10.1	12.8	7.2	1.5	9.1	16.2	33.1	6.6	6.5	24.0	14.2	19.1	13.9	22.1	27.4	24.6	15.7	35.9	20.1	29.6	13.1	25.6	29.7	44.2	13.6	17.3	24.8	14.6	20.5	20.4	24.3	25.2	10.5	3.7	21.1	32.2	8.1	27.0	19.5	7.9	26.7	37.6	19.7	13.0	20.9	13.7	26.2	16.3	56.3	13.5	20.4	12.4	22.0	32.5	14.8	16.2	9.8	33.3	22.6	40.8	24.3	26.6	21.0	11.4	11.7	19.9	1.2	10.9	10.8	37.0	21.9	6.4	45.4	9.7	76.4	82.3	223.6	38.9	87.1	48.2	53.1	51.3	42.9	50.8	53.7	58.9	51.0	492.2	77.5	133.6	35.5	60.6	75.7	7.3	7.5	8.2	12.0	8.1	8.4	8.2	8.8	8.4	7.4	9.1	9.1	0.0	0.0	0.5	0.0	1.6	0.1	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	1.4	1.8	0.0	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	4.2	0.1	0.0	0.2	0.8	5.1	0.2	0.0	0.1	0.0	1.5	0.3	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.0	1.3	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	4.4	0.3	1.4	1.6	0.0	0.3	0.0
STAT2	STAT113	ENSG00000170581	"Signal transducer and activator of transcription 2"	P52630	12	56341597-56360167	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 111.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003858, HPA018888"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Plasma membrane"	"CAB003858: AB_562227, HPA018888: AB_1857550"	"unprognostic (3.03e-1)"	"unprognostic (8.59e-2)"	"unprognostic (6.92e-3)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.45e-3)"	"prognostic unfavorable (4.78e-13)"	"unprognostic (1.88e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.46e-3)"	17.3	6.3	2.6	19.2	2.3	7.8	10.3	2.7	3.1	18.7	2.9	10.7	10.7	11.3	5.6	11.1	12.9	20.1	8.1	3.1	2.3	8.4	20.6	22.8	19.6	4.2	2.0	17.4	9.9	12.4	8.6	15.9	3.1	10.3	12.5	5.6	18.1	9.9	4.0	7.8	13.0	21.8	5.9	25.2	10.3	4.0	4.6	19.9	10.7	8.4	20.1	18.4	5.6	6.2	15.5	8.5	11.8	12.5	98.3	58.6	26.1	19.4	94.0	92.4	93.1	8.7	16.4	17.9	22.6	38.6	24.2	14.9	21.0	15.1	18.0	13.8	4.7	27.2	7.6	9.3	58.8	5.0	20.2	86.8	13.4	19.5	22.8	70.5	25.6	14.3	15.2	44.7	35.1	9.4	7.3	3.5	5.2	15.1	9.8	6.9	22.1	17.1	21.3	18.1	4.2	10.1	31.5	18.8	43.1	22.7	16.4	17.7	11.2	22.2	10.7	8.0	3.1	32.5	32.9	9.8	30.3	7.2	9.9	14.8	17.2	11.3	7.7	22.8	7.9	5.2	7.4	7.7	11.6	7.5	5.2	5.1	6.8	4.8	18.3	10.2	9.8	13.1	2.6	2.3	2.7	3.1	3.1	2.3	4.2	2.0	3.1	5.9	4.6	6.2	36.0	12.8	41.7	40.5	24.0	14.3	10.3	13.7	17.1	17.0	17.4	15.0	11.1	15.7	24.4	18.4	20.9	11.2	28.1	23.8	1.9	14.0	13.8	20.7	36.4	26.5	15.5	8.6	29.8	10.7	24.5	27.6	19.9	26.6	10.1	24.6	27.8	64.8	25.9	3.3	28.6	16.8	6.1	50.9	25.6	43.7	19.6	45.2	32.0	24.4	42.3	10.4	18.6	27.6	111.8	11.9	21.9	17.3	24.4	11.4	24.0	10.7	24.2	21.8	26.3	20.3	22.5	3.2	5.0	12.5	14.5	11.1	20.1	13.7	14.8	13.2
SUPT7L	"KIAA0764, SPT7L, STAF65, STAF65gamma"	ENSG00000119760	"SPT7 like, STAGA complex subunit gamma"	O94864	2	27650809-27663840	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039565, HPA063643"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA039565: AB_10795109, HPA063643: AB_2685070"	"unprognostic (1.10e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (7.54e-2)"	"unprognostic (3.70e-1)"	"prognostic unfavorable (4.46e-7)"	"unprognostic (5.15e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.97e-3)"	"unprognostic (9.75e-3)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (2.26e-1)"	"unprognostic (4.86e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.23e-3)"	31.2	35.1	31.9	22.5	32.0	35.7	27.7	32.0	37.5	34.3	38.9	30.9	22.9	31.9	25.0	25.8	32.2	20.4	36.8	31.9	33.3	33.4	37.8	29.6	27.4	31.1	31.9	39.6	31.1	22.8	46.2	27.1	32.0	34.0	25.3	55.5	24.0	22.1	30.2	20.8	32.7	28.1	30.3	41.6	29.8	20.6	31.9	26.2	36.3	27.1	24.2	29.2	29.5	35.4	33.6	28.6	41.2	31.9	36.8	30.1	49.0	32.0	30.9	28.4	30.4	37.2	36.8	29.2	32.9	34.0	40.0	35.8	37.3	35.6	27.6	33.7	36.1	39.8	43.7	42.4	48.1	32.4	37.5	42.3	43.8	42.0	44.0	52.7	37.3	35.3	45.8	34.0	37.3	23.1	28.1	52.9	27.5	33.5	25.0	26.8	44.1	37.4	36.7	31.1	32.5	42.3	28.6	29.6	54.7	52.0	20.5	27.9	28.8	39.2	29.0	19.9	30.8	60.9	47.8	60.4	30.5	39.8	27.3	30.4	14.8	13.6	18.2	15.7	20.7	10.6	14.3	19.0	20.9	17.3	17.2	16.3	3.7	22.9	14.7	14.0	17.6	13.6	31.9	32.0	32.0	37.5	31.9	33.3	31.1	31.9	32.0	30.3	31.9	35.4	15.3	22.4	17.1	33.6	15.9	8.4	13.2	19.9	13.1	18.6	12.7	11.7	21.3	12.8	21.6	22.0	41.7	34.2	25.8	12.1	21.5	18.1	12.5	19.1	18.3	18.5	10.8	11.1	31.2	14.6	29.3	17.7	21.4	14.7	19.6	20.7	15.7	15.6	25.1	15.2	32.7	12.3	12.2	12.3	11.1	3.9	13.7	17.1	3.6	14.0	13.4	19.0	16.5	17.6	33.1	13.9	8.2	15.4	25.5	8.5	10.8	20.6	24.3	24.7	19.7	15.0	16.5	29.4	22.6	15.4	8.7	42.3	19.3	22.1	13.9	11.6
SYNJ2BP-COX16		ENSG00000258644	"SYNJ2BP-COX16 readthrough"		14	70326064-70417074	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"testis: 11.3"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 4.8;Excitatory neurons: 3.1;Inhibitory neurons: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 10.1;U-2 OS: 10.6"	"Low region specificity"	"Detected in all"							"HPA000866, HPA062659"	Approved	Supported	Approved	Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA000866: AB_2276678, HPA062659: AB_2684823"	"unprognostic (9.44e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.41e-2)"	"unprognostic (6.73e-4)"	"unprognostic (6.68e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.12e-2)"	2.7	2.8	0.4	1.4	0.6	0.4	2.2	0.7	2.5	2.6	0.5	2.9	1.1	2.6	0.8	1.8	1.8	0.8	4.3	0.5	0.7	3.6	2.3	2.1	1.7	0.6	0.5	2.8	0.7	1.3	1.7	1.0	0.6	1.9	0.7	0.7	1.2	0.5	3.1	1.3	1.3	1.5	0.5	1.9	2.1	11.3	0.5	2.4	1.7	2.4	1.1	2.5	1.8	0.5	5.9	1.6	3.4	1.2	0.0	0.2	2.3	6.2	0.5	2.7	2.4	0.6	7.4	0.0	4.6	0.0	4.9	4.7	0.0	1.1	2.0	0.7	2.0	0.0	1.0	2.5	2.6	0.0	1.2	0.0	1.4	2.3	0.0	4.2	1.9	4.7	0.0	0.5	1.6	0.4	3.6	1.1	1.6	10.1	1.8	4.7	0.7	2.9	1.4	2.3	2.9	4.7	1.1	2.2	3.5	4.2	2.2	2.9	0.0	2.9	10.6	0.0	3.2	0.3	2.6	0.0	5.3	0.0	4.0	1.6	8.9	0.1	11.1	11.2	11.5	14.4	12.1	11.0	12.0	13.6	11.4	10.8	0.0	15.1	5.7	9.2	12.8	7.9	0.4	0.6	0.7	2.5	0.5	0.7	0.6	0.5	0.6	0.5	0.5	0.5	0.6	0.0	0.5	1.0	1.1	0.0	0.1	0.0	1.2	0.3	0.4	0.1	0.0	0.0	0.6	0.0	0.0	0.3	1.4	0.0	1.9	0.4	1.6	2.0	0.7	1.8	0.0	4.8	3.1	0.8	0.4	1.1	1.1	2.6	0.0	0.3	0.7	0.7	0.2	0.0	2.7	0.0	0.0	0.8	0.0	0.9	0.6	1.0	0.0	0.0	0.1	0.3	2.1	0.5	0.6	0.3	0.1	0.4	2.4	0.0	0.2	0.6	0.0	0.3	0.0	0.2	0.9	1.0	0.2	1.5	0.0	0.3	0.6	0.2	0.4	0.0
TADA1	"ADA1, hADA1, HFI1, STAF42, TADA1L"	ENSG00000152382	"Transcriptional adaptor 1"	Q96BN2	1	166856510-166876264	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028651	Approved		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Focal adhesion sites, Cytosol"	"HPA028651: AB_10602476"	"unprognostic (9.53e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-2)"	5.1	8.9	9.6	6.1	10.3	19.4	9.2	9.9	12.4	7.7	8.1	8.4	7.7	9.3	7.6	8.3	8.6	5.3	8.6	10.1	9.3	11.6	26.7	6.2	10.4	7.8	8.3	11.0	6.4	10.9	6.2	8.2	8.8	7.9	9.1	17.0	8.1	7.1	9.8	8.0	8.4	7.6	9.2	6.9	7.5	10.8	9.3	13.2	7.5	10.6	10.1	6.6	5.8	11.2	15.7	14.9	27.4	16.3	8.1	10.4	16.2	8.1	9.9	13.2	11.4	13.7	12.5	29.9	15.4	9.6	10.7	11.8	22.3	14.3	10.6	18.9	21.3	9.9	11.9	22.5	12.0	28.3	17.4	7.9	16.3	8.0	19.9	9.6	11.0	22.2	35.9	17.6	10.5	10.9	34.9	22.5	41.6	25.2	16.5	29.1	12.0	37.9	18.0	20.9	17.5	30.6	14.6	18.7	17.5	25.0	25.3	29.3	8.3	10.8	12.4	11.9	17.3	24.9	36.3	56.3	7.5	12.6	10.4	2.9	12.7	13.8	20.7	12.9	22.9	20.2	22.2	23.6	20.7	20.8	27.9	22.3	2.1	27.5	10.4	13.3	23.4	24.7	9.6	10.3	9.9	12.4	10.1	9.3	7.8	8.3	8.8	9.2	9.3	11.2	2.7	9.6	2.7	7.8	8.4	6.1	4.7	3.9	6.2	7.6	4.9	4.6	10.3	2.8	4.1	3.7	8.4	6.1	4.9	4.4	5.9	3.9	4.0	4.8	4.6	4.3	7.2	13.7	9.6	4.0	7.7	4.8	6.6	4.4	5.1	6.1	3.3	20.3	4.2	1.7	10.5	6.1	0.0	5.3	5.1	1.7	4.4	2.6	1.8	3.7	6.9	6.8	4.1	7.5	17.7	3.8	1.7	3.0	7.5	6.2	5.3	7.0	4.3	6.0	0.0	6.1	4.1	5.2	12.9	7.6	5.1	7.3	7.3	1.9	5.9	4.2
TAF15	"hTAFII68, Npl3, RBP56, TAF2N"	ENSG00000270647	"TATA-box binding protein associated factor 15"	Q92804	17	35713791-35864615	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052059, HPA063647"	Supported		Enhanced	Nucleoplasm		NA	NA		44000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA052059: AB_2681711, HPA063647: AB_2685072"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.48e-3)"	"unprognostic (4.75e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.99e-1)"	62.0	74.8	56.2	74.5	54.4	69.2	57.3	52.9	68.4	74.3	55.2	71.9	56.4	69.9	40.9	102.7	61.6	33.4	80.2	52.0	61.1	63.8	82.1	57.2	90.0	56.3	56.9	66.0	74.0	54.4	71.3	48.2	55.8	63.0	48.6	54.2	65.8	38.2	130.2	80.0	78.6	38.0	54.3	76.4	76.6	87.8	56.1	95.5	58.5	38.3	75.2	74.6	72.1	57.0	216.8	347.3	190.2	191.2	149.6	88.5	108.3	247.9	79.1	109.7	107.0	244.5	151.1	440.1	166.9	145.2	122.2	239.6	254.0	232.8	166.0	112.9	187.1	250.6	264.3	261.1	145.3	401.1	168.4	135.7	143.6	155.3	266.0	137.0	140.1	238.5	233.3	188.9	148.1	270.4	442.0	96.0	117.0	205.9	40.2	255.7	279.6	164.7	149.3	399.1	130.1	136.6	299.6	97.8	98.3	231.0	224.5	144.9	214.1	86.1	178.3	115.8	310.1	165.6	198.4	303.4	173.7	190.1	134.1	1.4	1.0	1.2	1.7	1.4	2.0	1.0	1.0	1.2	0.7	1.2	0.9	1.2	0.9	2.0	1.5	1.0	1.5	0.9	56.2	54.4	52.9	68.4	52.0	61.1	56.3	56.9	55.8	54.3	56.1	57.0	38.1	16.0	55.1	90.4	71.4	36.1	59.7	57.9	93.9	57.8	29.3	31.0	41.6	40.0	57.0	60.7	41.7	82.1	63.1	38.4	3.9	42.7	7.5	51.4	55.0	52.6	49.1	75.3	108.4	29.6	50.8	36.9	66.3	53.8	55.8	32.4	36.8	60.7	43.1	60.6	111.7	52.2	46.8	44.0	32.9	10.4	30.7	49.0	33.8	78.7	56.0	75.1	54.6	100.0	124.2	29.2	29.4	40.6	53.2	43.4	50.3	31.6	47.2	45.4	46.0	48.0	51.7	84.9	74.7	115.3	37.2	78.0	78.8	55.6	58.5	44.8
TAF1B	"RAF1B, RAFI63, SL1, TAFI63"	ENSG00000115750	"TATA-box binding protein associated factor, RNA polymerase I subunit B"	Q53T94	2	9843443-9934416	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071254			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoli	Nucleoplasm	"HPA071254: "	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (8.58e-5)"	"unprognostic (1.44e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.94e-7)"	"unprognostic (9.17e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.49e-2)"	7.2	7.6	4.1	8.4	4.1	7.1	8.7	5.3	4.2	6.9	6.4	5.9	5.1	9.7	6.6	9.6	9.6	7.2	4.8	3.8	5.1	13.3	6.3	8.7	11.4	3.9	5.4	5.7	4.4	14.7	3.7	13.0	3.7	9.0	5.7	9.0	8.1	9.0	2.8	8.6	4.2	8.1	3.8	7.1	6.1	11.0	5.4	11.4	10.5	3.4	12.7	7.9	6.0	4.7	25.1	20.4	29.2	9.6	14.1	21.2	52.7	29.9	23.3	25.3	23.3	19.1	18.1	27.1	13.6	21.3	26.7	15.0	26.9	31.7	27.3	31.3	35.9	31.5	8.9	28.3	19.5	22.1	32.4	17.0	16.5	21.4	28.5	20.8	37.4	14.8	19.8	27.2	25.0	15.3	16.6	20.1	37.7	15.6	17.5	10.2	27.2	8.0	24.9	24.3	12.3	33.6	23.5	28.9	21.9	18.9	10.4	17.4	20.4	31.9	39.8	31.1	35.7	14.9	19.9	39.7	18.4	24.8	26.7	3.6	9.1	6.2	12.1	15.5	12.1	11.1	10.2	14.3	13.4	11.7	6.3	10.0	0.5	10.2	12.4	10.6	11.1	5.2	4.1	4.1	5.3	4.2	3.8	5.1	3.9	5.4	3.7	3.8	5.4	4.7	12.5	19.2	22.0	22.2	13.1	16.2	29.9	17.9	19.9	24.5	8.0	6.1	4.0	2.8	26.0	12.9	27.1	25.0	12.6	2.4	13.7	19.5	11.6	26.8	21.0	15.4	1.8	10.5	38.8	18.9	37.4	18.4	13.7	17.3	8.8	12.7	6.8	4.7	12.7	15.2	27.1	3.3	8.2	12.0	11.5	3.8	19.0	14.6	0.0	15.0	15.5	25.5	15.5	32.6	23.5	15.7	3.8	13.2	16.6	9.5	1.7	26.5	29.7	21.0	19.7	15.9	16.2	47.6	33.9	19.7	13.2	23.7	15.1	24.8	4.4	18.7
TAF2	"CIF150, TAF2B, TAFII150"	ENSG00000064313	"TATA-box binding protein associated factor 2"	Q6P1X5	8	119730774-119832841	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"				"unprognostic (1.69e-2)"	"unprognostic (9.33e-3)"	"unprognostic (3.79e-2)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (8.12e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.08e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.47e-2)"	9.2	10.9	4.2	11.2	5.6	14.6	10.6	12.2	6.4	10.3	6.4	9.1	8.8	12.6	11.0	9.5	8.6	9.8	7.1	4.4	6.2	10.6	12.1	7.9	14.2	4.9	4.8	11.2	8.2	11.7	6.5	13.1	5.4	9.4	10.4	10.0	7.7	9.7	7.0	10.8	8.6	11.3	5.0	11.3	9.9	13.7	4.9	15.8	10.6	8.5	14.8	12.5	8.4	7.2	41.3	24.0	27.1	25.1	22.3	24.1	16.9	31.9	26.3	34.7	43.6	15.3	22.9	46.4	27.5	29.1	19.5	26.2	42.1	19.3	49.3	53.2	25.4	58.0	21.7	17.1	35.3	27.9	33.8	22.6	16.9	34.3	39.9	19.0	34.6	24.0	44.4	25.3	32.8	23.2	52.9	12.0	20.4	29.6	27.2	30.6	22.4	25.2	20.7	29.7	35.9	21.1	28.5	88.3	22.6	23.5	26.3	20.7	27.0	23.6	39.1	22.7	46.3	43.2	55.3	57.5	29.0	36.5	22.8	12.5	4.2	7.4	6.0	5.5	5.4	4.7	6.2	6.2	5.5	4.1	5.6	5.8	2.6	6.5	8.1	3.3	7.8	4.4	4.2	5.6	12.2	6.4	4.4	6.2	4.9	4.8	5.4	5.0	4.9	7.2	19.6	12.8	18.8	41.4	23.5	18.7	18.7	14.2	23.3	15.8	15.8	11.7	12.3	11.5	16.7	22.0	20.9	18.1	18.0	10.2	3.9	10.1	2.6	16.7	27.9	19.0	9.6	15.8	56.0	10.7	12.8	18.5	21.4	26.4	21.5	18.2	13.2	17.9	12.5	8.4	52.7	12.8	10.2	14.7	12.9	3.9	15.5	15.8	8.8	37.5	11.7	7.7	21.6	53.3	59.0	11.5	9.8	18.0	23.6	18.2	9.0	15.7	22.3	14.9	13.1	21.3	17.4	34.8	35.5	27.8	20.6	21.1	21.0	17.8	12.0	19.7
TAF4B	"TAF2C2, TAFII105"	ENSG00000141384	"TATA-box binding protein associated factor 4b"	Q92750	18	26226445-26391685	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 80.3;Plasma cells: 52.3;Suprabasal keratinocytes: 78.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 65.0;U-266/70: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028937	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA028937: AB_10603034"	"unprognostic (2.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (7.38e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.72e-4)"	1.5	2.0	0.4	2.8	0.4	2.8	2.7	0.3	1.9	1.2	0.0	1.6	0.4	1.4	0.3	1.0	1.3	0.7	0.4	0.3	0.2	1.5	0.1	1.0	3.1	0.9	0.1	3.1	1.2	0.6	0.2	1.7	1.1	0.8	1.4	0.3	1.1	0.8	1.3	1.5	0.8	1.2	0.0	2.5	1.8	4.6	0.2	1.8	1.7	0.7	3.2	1.5	0.6	0.8	4.3	0.7	0.3	1.1	1.6	2.6	2.1	1.3	1.5	0.7	1.3	1.1	2.3	65.0	5.0	0.3	2.5	4.8	3.7	4.0	3.4	15.5	9.9	7.5	1.9	1.0	2.3	20.5	4.4	4.3	1.5	0.5	11.6	0.6	1.4	8.1	10.2	7.9	0.3	4.2	10.7	4.1	3.5	2.5	5.1	0.0	8.1	17.3	1.0	0.3	6.1	2.8	3.9	5.7	2.7	1.6	2.0	3.6	0.9	2.7	1.6	3.7	4.8	26.2	18.0	21.8	1.3	12.8	2.4	0.0	0.3	0.0	0.1	0.5	1.0	2.3	0.7	1.0	1.0	2.0	2.0	1.6	0.0	0.6	0.2	0.3	0.1	0.6	0.4	0.4	0.3	1.9	0.3	0.2	0.9	0.1	1.1	0.0	0.2	0.8	7.2	6.4	7.2	6.2	34.0	80.3	9.5	1.7	49.5	1.5	15.0	17.9	2.8	0.0	2.5	0.0	0.0	18.6	4.1	5.8	17.6	1.2	0.7	28.9	9.7	9.0	0.0	21.7	44.8	2.0	4.3	15.5	36.7	45.0	1.3	5.4	1.1	0.0	2.4	5.0	28.3	7.0	2.0	1.6	17.9	1.6	3.4	5.9	23.2	4.7	2.6	0.2	1.0	7.5	11.7	2.2	2.5	4.1	52.3	13.9	0.8	4.0	1.0	1.2	0.0	17.6	12.1	25.4	24.8	40.8	78.8	9.7	14.5	14.5	6.2	6.7
TAGAP	"ARHGAP47, FLJ32631, IDDM21"	ENSG00000164691	"T cell activation RhoGTPase activating protein"	Q8N103	6	159034468-159045152	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 146.6;lymphoid tissue: 47.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 249.5;dendritic cells: 152.3;Macrophages: 91.1;NK-cells: 86.5;Plasma cells: 272.1;T-cells: 223.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 30.1;HMC-1: 42.5;Karpas-707: 43.8;U-266/84: 20.6;U-698: 39.6;U-937: 33.4"					"Low region specificity"	"Detected in all"			"HPA031000, HPA039982"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA031000: AB_10610560, HPA039982: "	"unprognostic (9.86e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.35e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.24e-2)"	"unprognostic (7.39e-2)"	5.0	2.8	1.0	28.9	1.1	146.6	3.9	1.3	2.1	3.4	3.0	5.9	4.4	9.5	2.3	4.1	2.0	6.9	1.6	1.2	3.4	1.3	4.1	8.4	39.6	2.7	2.0	2.2	0.9	0.7	0.8	3.4	2.1	2.8	8.2	1.5	3.0	1.8	0.7	1.2	10.2	26.0	2.2	22.8	7.2	1.6	2.2	24.3	1.6	2.3	47.6	10.0	1.2	4.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	30.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	6.2	0.0	0.0	0.0	15.6	42.5	0.3	0.0	0.0	0.0	0.0	0.0	9.0	0.1	43.8	0.0	0.0	4.0	8.2	12.0	0.0	0.0	1.4	0.0	1.4	0.0	0.0	0.3	0.2	0.0	0.1	0.1	1.2	0.0	6.9	0.2	0.0	0.0	0.0	0.0	4.7	20.6	39.6	0.0	33.4	0.0	163.6	27.8	88.4	54.8	20.4	62.6	45.9	73.9	64.6	27.9	46.6	56.9	40.8	169.7	45.6	27.6	9.3	57.5	60.9	1.0	1.1	1.3	2.1	1.2	3.4	2.7	2.0	2.1	2.2	2.2	4.2	5.2	3.2	6.6	0.0	249.5	2.8	0.3	0.2	3.4	0.3	4.4	6.0	0.6	0.0	1.4	0.0	0.0	0.7	152.3	0.2	0.0	0.1	0.3	0.5	0.4	5.2	0.0	8.8	1.2	0.0	0.6	4.3	16.8	0.5	19.0	1.8	1.4	0.8	24.9	0.0	1.0	0.0	0.0	21.9	60.2	1.1	1.2	91.1	28.4	20.6	21.5	0.4	86.5	1.5	0.0	0.0	0.0	22.6	272.1	0.3	0.0	0.3	1.2	0.2	0.0	0.8	2.0	0.1	0.1	2.0	2.7	0.8	223.6	4.6	0.4	0.3
TCEA1	"GTF2S, SII, TCEA, TF2S, TFIIS"	ENSG00000187735	"Transcription elongation factor A1"	P23193	8	53966552-54022456	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043786	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA043786: AB_10959468"	"unprognostic (5.35e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (3.80e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	52.7	46.0	44.1	56.5	47.5	81.2	62.2	44.7	58.3	55.3	42.5	49.7	47.1	55.6	45.8	53.9	52.4	42.6	35.9	42.0	46.0	59.8	90.4	46.7	98.3	47.2	44.6	61.9	68.4	80.0	28.2	49.3	47.0	59.0	50.7	49.0	56.5	54.2	42.0	49.8	46.9	52.4	47.5	49.5	52.2	36.8	44.2	72.4	124.2	41.7	112.6	54.6	41.4	55.1	161.3	157.9	138.1	145.7	99.3	121.8	100.9	122.1	147.3	143.5	160.2	91.4	131.0	392.5	136.9	147.0	152.5	120.9	182.3	116.6	212.9	225.0	88.5	293.6	71.5	139.5	309.7	116.8	122.7	88.5	308.1	137.4	606.2	121.3	128.2	132.9	191.1	334.0	135.5	75.6	245.8	83.3	229.1	265.0	47.1	185.1	48.2	72.5	204.0	107.0	129.9	95.5	101.9	91.0	356.3	132.2	129.6	132.6	110.6	106.1	96.3	120.6	114.5	201.1	134.4	260.9	184.9	133.2	152.1	82.3	64.1	78.7	103.9	63.1	98.3	213.8	107.0	96.7	81.8	174.1	93.9	99.3	23.1	97.5	60.6	116.7	153.0	73.5	44.1	47.5	44.7	58.3	42.0	46.0	47.2	44.6	47.0	47.5	44.2	55.1	94.7	89.8	106.2	24.2	253.2	135.5	128.3	98.9	257.2	77.0	129.2	124.3	23.9	82.9	109.4	99.3	89.6	115.5	143.8	61.0	168.3	121.0	86.4	126.9	145.4	92.5	87.2	330.7	17.7	109.9	125.1	118.8	111.6	124.4	98.7	75.7	66.4	160.7	87.7	57.2	20.1	96.6	118.0	89.5	134.2	191.0	134.8	124.2	117.4	17.8	132.5	166.0	170.0	22.1	29.7	121.1	71.6	132.8	341.1	146.0	72.2	207.6	110.6	104.5	78.9	102.6	130.4	94.9	103.1	237.2	150.6	112.1	154.8	108.5	88.1	148.6
TCTA		ENSG00000145022	"T cell leukemia translocation altered"	P57738	3	49412206-49416475	"Disease related genes, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007342	Approved		Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA007342: AB_2202399"	"unprognostic (5.58e-2)"	"unprognostic (4.33e-2)"	"unprognostic (6.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (2.17e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (6.76e-4)"	"unprognostic (3.74e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (5.00e-15)"	"unprognostic (1.68e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.43e-1)"	"unprognostic (6.41e-3)"	21.7	48.0	49.1	13.1	52.3	12.3	21.5	50.1	52.9	23.2	47.0	24.7	18.9	23.1	60.6	15.6	26.1	16.6	22.6	48.4	50.6	51.0	41.9	23.5	15.8	51.6	51.6	27.1	24.1	39.8	48.8	14.5	52.3	34.5	28.8	14.0	21.8	25.1	19.6	14.2	23.1	21.8	48.8	25.9	23.3	15.7	52.1	20.1	45.3	13.8	16.0	25.4	15.9	51.5	12.8	15.5	9.8	14.8	42.5	18.5	12.9	26.0	19.2	25.8	21.6	9.1	13.6	15.2	18.6	61.5	29.6	14.4	19.3	26.2	21.0	22.9	13.4	25.4	19.6	11.9	25.8	10.9	31.9	40.2	26.8	28.7	22.9	24.7	27.0	12.0	9.4	33.8	63.8	11.7	13.4	9.8	8.0	24.1	35.5	8.1	10.6	36.0	44.5	16.7	26.3	8.7	30.9	33.8	28.6	19.7	28.8	10.2	24.5	19.3	11.9	40.4	9.8	18.4	26.1	10.4	45.4	19.3	27.2	20.4	17.8	23.2	19.1	34.2	11.1	12.0	12.0	14.7	10.1	13.7	14.9	15.5	20.1	23.0	47.5	15.6	17.8	22.4	49.1	52.3	50.1	52.9	48.4	50.6	51.6	51.6	52.3	48.8	52.1	51.5	15.5	25.6	15.6	8.8	19.3	2.7	10.0	10.3	14.2	10.2	19.9	18.0	14.1	20.0	12.9	27.6	12.5	25.9	20.5	34.0	46.9	15.3	8.0	15.5	15.0	14.7	17.5	9.0	12.3	11.6	11.5	17.6	53.5	17.0	5.7	7.1	11.4	31.8	24.8	10.1	11.0	19.1	20.3	18.6	6.0	14.3	15.5	19.2	14.2	11.2	15.5	26.3	26.8	11.1	16.8	15.1	28.6	16.1	13.2	13.4	34.9	50.3	22.8	11.3	6.6	13.7	16.6	8.2	6.1	10.4	4.5	20.0	21.6	22.1	16.6	7.9
TGS1	"NCOA6IP, PIMT"	ENSG00000137574	"Trimethylguanosine synthase 1"	Q96RS0	8	55773446-55826445	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025024, HPA029824"	Supported		Supported	Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA025024: AB_1854330, HPA029824: AB_2673212"	"unprognostic (4.13e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.94e-2)"	"unprognostic (9.32e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.62e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.85e-2)"	5.9	4.0	1.8	5.0	1.4	7.2	5.5	3.8	2.3	5.0	2.5	4.9	3.1	5.9	4.1	5.7	5.8	4.1	3.5	1.5	1.5	5.5	4.0	4.5	8.5	1.2	1.3	6.0	4.0	6.8	4.0	4.2	1.3	4.5	4.6	2.5	4.9	5.7	7.4	6.4	5.5	4.6	1.1	5.7	4.5	4.9	1.6	9.5	5.4	2.6	8.5	7.3	5.1	1.9	12.0	9.0	10.2	12.7	9.7	8.2	10.3	10.9	11.6	11.9	12.3	8.5	10.7	27.7	7.0	8.5	8.5	10.8	24.3	14.7	16.3	17.2	8.7	31.6	10.6	5.1	13.1	16.8	9.4	9.7	10.1	11.4	22.7	5.2	9.5	16.0	24.8	9.9	9.6	9.4	36.0	10.6	35.0	16.8	3.6	26.4	7.1	8.2	10.6	12.0	10.6	13.3	19.4	8.0	10.4	10.5	10.9	9.7	9.7	8.4	10.6	9.8	10.4	8.5	6.3	32.1	8.5	13.6	11.3	5.0	2.7	4.3	5.1	2.8	6.0	4.6	4.8	4.7	2.4	4.8	5.2	5.2	3.4	3.3	3.9	5.2	4.2	2.6	1.8	1.4	3.8	2.3	1.5	1.5	1.2	1.3	1.3	1.1	1.6	1.9	29.8	48.1	35.2	15.7	41.6	37.0	36.8	25.7	35.3	30.6	21.8	34.7	15.5	20.0	37.9	51.5	22.9	29.6	30.4	10.8	3.9	20.3	3.7	28.2	42.6	27.2	10.7	49.2	28.9	25.2	26.7	32.4	23.4	27.6	50.0	24.3	20.7	17.2	20.3	21.9	30.0	23.3	16.2	16.8	12.2	4.6	29.5	22.2	7.2	12.2	26.1	27.7	29.9	34.7	19.9	22.2	12.1	23.0	32.7	42.3	10.9	17.7	25.5	29.5	26.3	40.5	25.7	88.2	78.3	33.5	26.1	22.4	41.2	35.2	22.5	31.9
TIGD7	Sancho	ENSG00000140993	"Tigger transposable element derived 7"	Q6NT04	16	3298808-3305729	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA041357, HPA041474"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA041357: AB_10794992, HPA041474: AB_10795696"	"unprognostic (7.69e-2)"	"unprognostic (3.04e-4)"	"unprognostic (6.56e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.50e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.81e-2)"	"unprognostic (8.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.04e-1)"	"unprognostic (5.90e-3)"	"unprognostic (3.12e-2)"	2.9	3.3	5.1	1.8	5.1	0.6	4.7	6.0	6.1	5.1	7.0	4.9	1.8	5.5	4.5	1.9	5.1	2.6	5.3	4.9	5.6	6.0	3.1	2.8	3.4	5.2	5.6	10.6	2.8	6.5	8.2	3.2	5.5	5.6	1.9	5.1	2.7	5.0	4.2	2.1	2.8	3.5	5.0	4.8	2.7	8.5	5.2	3.7	6.7	5.3	3.0	4.1	3.4	5.7	0.9	1.9	5.5	3.0	2.4	3.6	4.2	2.7	1.6	4.0	3.7	0.2	1.7	2.0	4.5	2.0	3.3	0.5	1.8	0.7	5.0	0.2	2.7	5.9	1.7	0.1	2.8	1.0	7.5	3.9	1.3	3.7	1.1	4.7	3.1	1.4	2.9	3.5	3.4	1.2	1.9	9.0	6.3	0.6	5.1	10.2	1.3	8.3	2.2	0.5	7.1	2.6	6.8	0.9	2.7	4.8	3.2	3.3	1.2	2.6	6.2	2.7	1.6	7.5	8.3	6.5	1.5	3.4	2.9	0.5	0.6	3.4	1.5	0.5	2.7	0.6	1.2	2.3	0.5	2.5	2.4	1.7	2.1	2.0	1.7	0.5	1.4	0.7	5.1	5.1	6.0	6.1	4.9	5.6	5.2	5.6	5.5	5.0	5.2	5.7	1.7	9.6	4.5	11.4	4.9	0.8	3.2	2.1	4.0	6.1	2.4	2.4	9.9	4.3	4.4	0.0	4.2	1.5	1.6	0.6	3.9	2.8	4.7	2.3	3.8	2.3	1.2	2.5	14.6	1.4	1.1	2.6	4.6	1.7	1.3	5.9	0.4	0.6	0.9	5.0	12.7	1.0	4.1	0.6	0.8	2.0	2.8	1.1	5.4	2.8	0.9	3.4	4.1	20.6	12.1	1.1	0.1	4.5	2.0	2.3	1.0	0.9	2.9	2.2	6.6	3.1	3.6	11.6	10.5	2.1	0.6	1.4	2.9	3.8	0.6	1.5
TIRAP	"Mal, wyatt"	ENSG00000150455	"TIR domain containing adaptor protein"	P58753	11	126283065-126298845	"Predicted intracellular proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054431	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytokinetic bridge, Cytosol"		"HPA054431: AB_2682486"	"unprognostic (9.30e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.24e-4)"	"unprognostic (2.73e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.57e-1)"	4.3	4.3	1.5	4.9	1.4	2.9	4.5	3.1	2.4	5.4	3.6	5.3	7.6	4.5	2.5	4.4	5.3	4.5	5.3	1.3	2.1	3.9	6.3	4.2	4.1	1.9	1.8	8.0	4.7	7.2	3.6	4.9	2.1	5.7	5.5	3.1	8.0	6.4	5.3	4.3	6.9	4.7	1.0	5.0	4.3	1.5	1.6	3.1	4.8	4.9	5.1	4.5	3.3	1.1	2.2	7.0	3.7	6.2	6.2	8.5	4.4	5.7	9.3	3.9	3.7	11.0	8.3	5.7	9.6	5.9	6.9	6.2	3.9	4.4	1.5	15.3	3.7	15.4	4.2	7.1	4.9	9.6	7.9	6.4	6.0	7.4	5.1	4.7	6.5	4.6	4.2	12.9	4.6	4.0	0.3	1.5	1.7	15.9	6.3	2.0	1.0	5.4	3.1	7.8	4.6	5.8	6.8	6.7	4.6	4.8	18.2	4.9	6.5	2.2	2.1	4.5	4.3	3.6	5.6	4.2	3.4	7.5	7.0	5.3	5.8	2.9	4.0	4.5	3.7	2.1	3.1	4.2	4.6	3.8	2.5	2.4	4.9	2.6	3.2	3.2	3.5	3.7	1.5	1.4	3.1	2.4	1.3	2.1	1.9	1.8	2.1	1.0	1.6	1.1	1.7	6.4	2.6	2.3	3.7	0.4	1.8	2.0	4.0	3.5	2.7	2.0	1.3	2.8	2.8	3.7	0.0	3.4	2.2	4.2	0.0	3.3	0.0	1.1	2.3	3.2	1.2	0.8	3.7	4.0	4.9	2.7	2.0	1.7	1.3	2.0	2.5	4.8	5.2	3.3	5.0	3.9	2.0	4.4	0.8	0.3	4.7	3.7	1.8	3.7	2.1	3.6	4.1	3.0	1.8	3.6	8.1	4.5	9.2	2.0	6.5	2.2	1.6	2.5	0.0	2.0	2.5	0.1	0.6	3.5	0.1	2.6	4.2	2.3	2.4	1.5
TMEM62	FLJ23375	ENSG00000137842	"Transmembrane protein 62"	Q0P6H9	15	43123279-43185144	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 61.0;U-266/84: 67.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044461, HPA062359"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytoplasmic bodies"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli fibrillar center, Nuclear bodies, Cytoplasmic bodies"		"HPA044461: AB_2678950, HPA062359: AB_2684747"	"unprognostic (7.43e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.56e-2)"	"prognostic favorable (9.72e-7)"	"unprognostic (2.53e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	7.1	4.6	4.8	6.0	5.0	9.0	22.9	8.2	6.7	8.1	3.6	13.1	13.1	5.4	12.3	6.2	7.5	7.9	5.1	5.3	4.8	7.6	10.3	8.8	7.2	4.5	4.5	3.2	8.1	13.7	4.6	10.3	5.0	6.1	14.4	8.9	13.6	7.1	9.4	5.2	11.7	6.5	5.0	6.1	10.2	2.0	5.4	4.0	8.5	6.6	8.0	7.6	5.4	5.6	14.9	7.9	3.5	6.8	4.3	5.5	36.4	13.9	17.6	24.1	33.3	12.5	28.5	15.0	7.9	13.2	21.7	27.6	14.8	10.9	8.7	17.7	6.8	12.2	15.4	9.5	9.4	12.7	10.5	3.9	13.0	10.6	7.4	6.8	13.6	3.7	10.9	12.7	2.8	3.5	0.0	3.0	1.2	61.0	3.2	7.5	3.7	7.9	12.9	18.6	22.2	9.6	10.9	27.2	6.7	3.9	14.6	12.9	8.0	11.9	4.9	8.5	22.7	10.6	67.1	10.7	11.0	14.0	10.4	0.5	0.7	1.1	0.8	0.3	1.0	0.7	1.1	1.0	0.7	0.8	0.7	0.9	0.2	1.6	0.4	1.7	2.0	0.4	4.8	5.0	8.2	6.7	5.3	4.8	4.5	4.5	5.0	5.0	5.4	5.6	7.7	16.0	4.6	12.1	18.8	2.3	4.1	2.8	5.7	5.6	12.3	6.3	2.6	8.6	5.0	12.9	10.4	21.9	7.0	12.5	5.9	12.9	1.6	9.6	3.7	5.6	4.2	9.1	36.3	14.8	25.2	4.8	11.2	13.9	5.1	7.0	6.1	7.3	7.5	1.7	33.4	11.4	6.1	6.5	4.8	3.7	2.5	7.1	5.4	18.7	6.4	7.8	6.2	29.1	34.5	12.2	8.1	1.2	16.5	2.7	12.8	3.4	6.1	9.9	6.6	4.1	5.2	2.2	1.0	8.6	2.8	34.1	7.4	3.8	11.0	4.8
TNKS2	"ARTD6, PARP-5b, PARP-5c, PARP5B, PARP5C, pART6, TANK2, TNKL"	ENSG00000107854	"Tankyrase 2"	Q9H2K2	10	91798426-91865475	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036606			Approved	Microtubules		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Microtubules		"HPA036606: AB_10673470"	"unprognostic (1.12e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.53e-1)"	18.4	19.3	14.7	21.2	16.1	38.5	22.2	18.0	17.0	21.1	25.0	14.8	14.9	22.5	19.8	22.8	17.8	20.8	11.1	14.3	14.9	17.4	21.2	19.7	28.1	14.6	15.1	30.3	22.0	21.8	14.4	31.2	15.8	19.6	17.1	31.2	18.5	16.6	55.6	27.3	15.3	20.7	16.0	30.0	19.8	11.8	17.4	37.7	29.6	40.5	29.4	24.1	17.1	19.7	29.1	24.3	48.9	41.7	33.8	30.6	54.5	30.6	55.5	36.5	44.5	21.7	23.2	27.2	14.3	40.0	24.6	30.6	31.0	23.6	51.3	27.7	29.9	22.6	22.9	24.3	32.9	44.0	32.3	31.4	30.6	37.0	65.3	54.8	34.8	24.1	16.9	29.4	38.5	15.6	38.1	29.9	24.6	13.2	16.1	35.2	30.5	20.9	25.0	30.9	12.8	22.9	30.8	13.4	38.7	39.2	32.5	30.3	37.8	19.6	16.5	26.1	29.5	36.7	32.1	34.8	25.9	32.4	17.9	0.2	0.7	1.2	0.9	0.6	0.8	1.0	0.9	0.8	1.0	1.0	0.7	0.6	0.7	1.0	0.6	1.5	0.5	0.4	14.7	16.1	18.0	17.0	14.3	14.9	14.6	15.1	15.8	16.0	17.4	19.7	39.1	41.7	22.3	63.3	51.6	74.6	32.5	23.8	56.9	41.7	38.8	24.0	23.2	8.6	31.0	44.1	47.9	45.2	48.7	19.2	7.9	16.0	4.7	41.1	29.3	37.1	33.0	27.5	77.5	24.5	55.1	30.9	50.4	52.1	2.5	34.8	35.7	35.9	26.1	42.1	78.5	19.3	26.4	55.3	49.4	8.1	31.1	48.4	33.8	67.5	46.5	24.9	37.0	66.9	68.0	29.0	12.3	35.3	45.7	44.7	16.1	16.6	47.4	34.8	46.0	40.5	28.0	19.1	21.7	75.9	109.1	101.0	49.1	30.5	14.9	61.7
TOMM5	"bA613M10.3, C9orf105, Tom5"	ENSG00000175768	"Translocase of outer mitochondrial membrane 5"	Q8N4H5	9	37582646-37592604	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA048712	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA048712: AB_2680499"	"unprognostic (1.81e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (9.89e-3)"	"prognostic unfavorable (5.49e-4)"	"prognostic favorable (2.37e-4)"	"unprognostic (7.80e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.09e-2)"	90.0	92.6	69.9	62.8	72.2	66.4	71.9	71.1	84.8	62.2	68.9	84.2	74.0	64.9	62.0	89.1	58.7	47.2	83.9	71.3	75.9	114.5	87.5	57.0	83.0	70.7	73.5	63.7	90.3	52.4	66.3	39.2	77.0	58.9	60.2	40.2	70.1	46.0	129.4	63.3	62.2	55.9	72.9	75.5	72.7	65.2	70.7	72.0	65.2	89.6	78.8	79.8	65.2	70.7	353.2	400.4	234.3	211.2	265.7	258.9	128.9	262.5	169.4	252.1	268.6	431.4	142.2	240.3	208.4	253.7	254.4	119.0	212.0	316.2	262.6	338.5	329.0	212.1	535.7	630.0	216.1	350.6	133.7	224.9	170.4	277.4	273.5	118.7	293.5	264.1	524.9	261.5	261.1	282.3	297.2	306.9	407.7	296.2	249.0	247.9	195.2	353.3	294.0	218.7	202.4	184.7	134.9	181.6	201.5	198.2	127.0	405.4	198.8	173.3	369.7	273.9	411.8	97.5	312.3	407.8	211.4	300.9	272.0	77.3	155.2	74.5	202.0	177.4	252.1	309.9	246.7	227.8	196.8	260.6	251.9	232.8	17.8	216.5	154.3	218.4	221.2	279.7	69.9	72.2	71.1	84.8	71.3	75.9	70.7	73.5	77.0	72.9	70.7	70.7	31.7	28.9	33.4	16.0	95.5	112.3	49.9	72.8	138.3	5.0	51.2	66.5	20.8	47.1	54.3	46.0	12.5	24.5	41.6	36.5	80.3	55.6	218.3	43.3	49.1	49.8	18.1	120.5	14.2	127.2	55.6	45.9	122.9	46.2	46.2	22.1	50.0	159.2	66.6	1.7	14.9	50.8	52.9	52.7	48.6	181.2	35.1	55.0	62.2	6.5	58.3	10.5	32.0	6.6	11.0	109.2	32.6	31.2	178.3	67.7	75.3	215.0	51.7	8.8	0.0	40.5	42.2	87.4	24.2	235.4	146.3	25.2	73.3	20.8	53.6	55.9
TOR1B	"DQ1, MGC4386"	ENSG00000136816	"Torsin family 1 member B"	O14657	9	129803157-129811281	"Predicted intracellular proteins"		"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA013403, HPA013697, CAB022709"	Approved		Uncertain	"Nuclear speckles,Cytosol"	"Intracellular and membrane"	NA	NA		140000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"	Cytosol	"CAB022709: , HPA013403: AB_1858195, HPA013697: AB_1858196"	"unprognostic (2.91e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.73e-3)"	"unprognostic (1.95e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.69e-3)"	11.1	10.0	8.6	13.1	8.4	14.3	8.7	12.0	8.7	8.4	9.5	20.3	11.3	9.1	7.0	10.3	7.7	13.3	8.9	8.2	9.2	8.6	18.5	11.7	11.0	8.8	8.6	7.5	12.6	11.7	7.3	14.2	8.7	11.0	22.6	5.9	10.3	9.2	10.6	11.8	14.1	12.6	8.6	9.3	11.9	10.2	9.5	10.7	10.7	9.9	9.4	15.8	8.5	8.4	11.7	26.5	10.9	29.0	53.2	39.4	25.0	40.8	26.7	27.6	27.2	22.0	26.1	8.3	25.2	40.7	43.0	46.4	11.9	16.9	28.2	30.4	12.3	7.2	21.5	15.8	22.8	13.8	31.1	22.6	29.3	39.6	19.4	20.4	24.9	21.5	25.6	18.8	26.2	32.9	19.2	21.8	22.9	54.8	20.1	7.8	18.9	25.3	21.3	12.1	15.0	17.2	26.0	30.4	16.6	19.5	43.7	13.5	22.7	51.9	24.5	62.4	35.7	13.6	53.9	7.0	28.6	17.9	36.0	8.7	13.3	20.2	12.6	16.0	13.0	4.0	10.0	11.2	6.9	4.7	7.3	7.3	16.4	8.8	10.1	4.2	10.5	9.9	8.6	8.4	12.0	8.7	8.2	9.2	8.8	8.6	8.7	8.6	9.5	8.4	9.5	9.6	2.4	6.5	11.7	6.5	5.9	7.3	12.5	2.7	6.9	5.6	5.5	5.7	6.1	5.5	4.2	10.8	16.1	15.3	0.0	9.7	13.3	5.0	6.7	8.2	19.2	3.4	13.9	13.7	17.7	10.5	17.9	5.7	4.5	4.0	9.7	13.3	12.0	6.7	15.6	16.2	4.1	5.4	5.0	15.1	4.4	12.1	3.6	4.7	12.3	4.7	16.5	14.6	10.5	12.6	6.7	5.7	14.5	10.1	10.7	3.7	9.4	2.7	19.7	6.8	13.0	22.7	5.4	10.4	5.4	15.2	12.2	4.6	10.5	11.2
TRAF6	RNF85	ENSG00000175104	"TNF receptor associated factor 6"	Q9Y4K3	11	36483769-36510272	"Enzymes, Predicted intracellular proteins"	"DNA damage, Immunity, Osteogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004605, HPA019805, HPA020599"	Approved		Uncertain	Nucleoli,Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	Mitochondria	Nucleoli	"CAB004605: AB_628391, HPA019805: AB_1858231, HPA020599: AB_1858232"	"unprognostic (2.48e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (2.82e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.07e-1)"	6.5	5.1	4.3	5.3	5.2	23.3	5.8	4.6	5.8	6.1	4.7	5.7	6.0	6.4	5.7	6.4	6.2	5.7	7.5	4.8	4.4	6.7	7.9	7.9	6.3	4.7	4.5	7.9	7.2	6.0	4.0	6.2	4.5	5.0	6.3	5.4	5.9	5.4	7.0	6.4	7.6	7.5	3.7	8.4	5.7	7.8	4.8	9.5	9.6	8.0	7.1	5.5	6.2	6.5	5.1	6.3	12.0	6.8	11.0	7.9	5.1	7.5	8.0	6.8	8.8	5.6	3.3	6.7	4.5	8.0	7.8	9.4	9.6	7.6	11.2	11.0	11.1	6.4	5.0	5.0	7.1	7.2	7.5	7.5	10.5	3.6	11.1	6.6	9.7	8.7	9.7	7.1	8.7	6.2	11.6	4.0	6.5	5.8	5.7	7.5	16.2	3.8	8.2	10.4	1.9	10.4	7.5	7.1	5.3	8.0	8.3	6.9	7.7	9.6	8.5	8.9	9.2	8.2	7.4	7.1	5.4	5.0	7.3	59.5	12.4	34.6	17.8	17.9	17.4	17.1	15.0	17.5	12.3	13.6	14.5	19.0	17.5	16.2	13.7	7.2	13.2	14.5	4.3	5.2	4.6	5.8	4.8	4.4	4.7	4.5	4.5	3.7	4.8	6.5	9.1	9.6	5.1	13.1	12.1	12.7	13.8	6.5	6.8	2.7	5.3	3.6	7.0	7.2	4.0	3.7	6.2	6.6	12.3	8.1	5.9	8.7	7.3	6.3	6.3	12.1	4.2	7.4	29.0	7.2	6.2	6.5	6.6	10.4	19.0	5.5	19.2	6.0	7.2	8.4	24.0	5.8	8.2	8.5	13.6	3.4	2.5	7.8	7.2	17.8	9.1	4.6	8.2	11.1	29.1	7.9	8.2	4.1	10.8	10.4	10.0	5.5	3.1	2.9	13.1	6.6	9.5	15.2	9.3	8.0	12.5	6.4	10.9	4.4	3.9	11.6
TRAPPC5	"MGC52424, TRS31"	ENSG00000181029	"Trafficking protein particle complex 5"	Q8IUR0	19	7680833-7687703	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 57.5;Gastric mucus-secreting cells: 86.2;Plasma cells: 76.9;Squamous epithelial cells: 80.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 314.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042221, HPA049064"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA042221: AB_2677907, HPA049064: AB_2680618"	"unprognostic (3.10e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.21e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.86e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.86e-8)"	"unprognostic (3.09e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.51e-1)"	58.9	86.8	65.7	25.6	68.7	62.7	58.4	67.1	112.6	55.6	60.6	53.0	27.6	52.1	8.1	85.6	44.7	13.8	105.1	69.4	74.7	75.7	99.7	35.9	23.4	64.5	68.9	50.1	67.1	19.9	58.4	19.1	70.5	71.1	8.4	9.0	64.8	17.2	112.4	90.6	48.5	11.5	64.3	60.6	57.5	181.4	65.9	16.8	56.0	27.3	12.2	55.5	56.2	64.4	61.0	129.4	20.7	56.9	16.3	24.1	62.1	47.1	33.8	45.3	46.1	76.9	41.2	62.9	92.0	32.7	25.8	55.2	13.0	47.2	8.9	48.3	199.2	23.7	86.7	163.7	56.8	42.1	45.3	40.0	61.9	34.6	15.8	15.4	57.6	64.3	34.3	89.3	22.3	190.7	72.3	148.8	66.1	27.1	314.1	46.6	28.8	91.1	50.7	142.8	54.1	47.0	40.1	74.6	69.1	7.1	60.1	44.3	58.8	54.2	44.9	103.3	47.7	80.8	44.2	44.3	75.3	51.2	74.2	207.5	373.4	151.4	116.7	394.1	112.3	313.7	145.0	129.3	442.0	289.2	141.7	124.7	518.4	97.4	365.5	188.8	222.5	329.3	65.7	68.7	67.1	112.6	69.4	74.7	64.5	68.9	70.5	64.3	65.9	64.4	1.8	3.2	3.6	15.3	36.1	1.9	1.2	2.4	57.5	5.1	6.3	4.2	1.0	1.5	5.1	5.5	2.1	3.5	1.2	26.7	0.0	26.9	13.3	3.8	4.8	5.6	11.4	41.0	13.5	19.3	5.3	14.3	86.2	3.7	1.3	2.0	8.2	13.4	9.9	8.4	16.4	15.7	0.0	18.8	3.3	44.4	1.5	52.2	1.8	11.2	17.0	1.5	4.1	11.6	22.8	19.8	26.3	3.4	76.9	1.9	28.0	9.2	2.6	4.8	0.0	1.4	8.4	5.0	1.2	80.1	1.7	3.4	18.0	2.7	14.1	1.5
TRDMT1	"DNMT2, RNMT1"	ENSG00000107614	"TRNA aspartic acid methyltransferase 1"	O14717	10	17137336-17202054	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 29.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 14.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009468, HPA036945, HPA036946"	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"			"CAB009468: AB_2208432, HPA036945: AB_2675398, HPA036946: AB_2675399"	"unprognostic (4.55e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.49e-6)"	"unprognostic (7.07e-2)"	"unprognostic (3.87e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.27e-4)"	"unprognostic (3.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.64e-2)"	1.8	1.5	1.4	1.3	2.3	1.5	1.8	4.5	1.6	1.7	1.9	1.2	0.8	2.7	4.6	1.2	2.0	2.0	1.4	1.5	1.1	2.1	0.7	1.4	2.2	2.5	2.0	3.0	1.5	2.6	1.3	1.5	3.2	1.3	1.0	5.8	1.5	0.9	1.2	1.6	1.3	1.1	1.6	1.3	1.5	1.2	1.5	3.3	3.7	0.2	1.9	1.1	1.5	1.4	3.6	1.3	7.7	1.3	2.3	1.1	0.0	4.0	2.0	4.0	4.0	3.2	3.5	2.1	0.5	1.5	5.7	1.9	3.7	2.0	2.6	5.4	1.6	2.4	3.3	1.8	0.6	2.8	3.1	2.0	1.6	1.7	1.6	2.6	2.6	6.1	3.8	2.7	4.6	0.8	14.6	0.9	4.1	1.1	1.3	2.6	5.3	1.3	0.7	2.4	1.7	2.3	0.0	1.7	2.1	3.3	2.9	2.3	0.9	1.9	5.1	4.7	3.0	3.1	4.1	7.0	2.5	3.2	1.9	4.9	2.5	1.2	2.2	1.7	4.2	3.4	3.8	2.8	3.2	3.5	4.9	3.4	1.6	2.6	0.9	7.0	1.3	2.0	1.4	2.3	4.5	1.6	1.5	1.1	2.5	2.0	3.2	1.6	1.5	1.4	6.5	6.4	4.8	29.4	9.1	3.3	2.1	3.5	4.6	12.2	2.6	2.8	5.5	2.8	6.1	3.7	4.2	2.1	7.1	2.1	5.9	4.4	6.7	8.1	5.9	6.2	0.0	6.9	21.8	4.9	2.5	5.8	5.6	5.9	12.7	10.2	4.2	1.7	5.1	16.8	23.2	1.2	4.1	5.0	7.0	6.7	6.5	5.8	0.0	8.4	5.4	12.1	7.2	23.6	14.9	2.5	1.7	6.4	10.2	1.1	2.5	5.0	7.5	17.3	0.0	7.7	7.6	12.5	6.1	4.8	3.1	1.8	10.4	7.6	3.1	1.2
TRIM23	"ARD1, ARFD1, RNF46"	ENSG00000113595	"Tripartite motif containing 23"	P36406	5	65589690-65625975	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039605	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 59: Non-specific - Transcription"			"HPA039605: AB_10673146"	"unprognostic (4.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.63e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.00e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.70e-1)"	8.1	10.8	12.3	6.0	13.8	7.7	8.2	18.1	17.7	9.1	5.2	6.1	3.9	9.2	6.0	7.4	7.0	5.3	11.0	14.5	12.0	8.8	10.8	5.7	7.5	10.8	10.2	13.2	5.4	8.4	4.7	7.1	12.9	11.4	4.3	14.6	5.5	7.6	13.2	6.2	4.6	7.8	12.7	7.6	4.4	10.4	12.0	8.6	10.6	17.5	6.7	6.3	5.2	19.3	8.5	11.8	12.6	18.2	17.9	17.9	9.1	16.7	15.2	13.3	16.4	12.2	8.2	6.7	18.8	11.0	13.8	7.3	11.7	9.4	20.1	6.7	15.0	5.8	15.7	6.6	16.8	3.8	7.2	14.0	8.1	14.9	13.5	12.7	6.4	8.0	6.4	9.2	16.5	7.8	7.4	4.0	6.6	1.5	4.7	6.6	21.9	9.7	7.3	8.6	7.5	10.2	15.9	4.4	13.2	10.3	10.3	4.6	11.0	10.5	11.4	13.2	12.3	11.3	12.2	8.8	12.1	6.6	10.4	19.9	3.5	8.9	4.7	2.8	5.9	3.9	5.1	4.0	3.2	4.7	8.0	6.1	9.2	5.1	4.4	3.5	6.4	3.9	12.3	13.8	18.1	17.7	14.5	12.0	10.8	10.2	12.9	12.7	12.0	19.3	13.8	19.2	7.8	28.1	13.1	6.9	2.3	4.4	7.4	28.2	7.0	7.1	22.3	10.0	6.8	5.5	16.7	3.8	12.5	4.7	5.9	4.9	7.0	9.4	21.3	11.1	6.6	21.0	49.1	3.1	2.6	17.1	5.6	7.6	3.8	19.7	13.9	13.0	3.9	45.4	49.3	4.4	2.0	10.0	3.5	4.2	20.8	7.4	10.6	24.4	6.8	27.2	8.2	39.7	49.7	5.8	4.3	17.0	11.4	9.1	6.0	10.1	11.8	24.8	32.9	16.0	12.9	27.2	16.9	5.0	6.3	7.0	13.1	16.0	3.8	6.9
TRIM34	RNF21	ENSG00000258659	"Tripartite motif containing 34"	Q9BYJ4	11	5619764-5644398	"Predicted intracellular proteins"	"Antiviral defense"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"B-cells: 6.2;Basal squamous epithelial cells: 1.8;Gastric mucus-secreting cells: 4.6;Macrophages: 1.8;Squamous epithelial cells: 4.3;T-cells: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 22.9;SK-BR-3: 24.6"					"Low region specificity"	"Detected in all"			HPA077996			Approved	Nucleoli,Centrosome		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 59: Non-specific - Transcription"	Centrosome	Nucleoli	"HPA077996: AB_2686873"	"unprognostic (8.66e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.88e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.16e-3)"	"unprognostic (8.16e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.40e-1)"	"unprognostic (6.76e-2)"	5.2	8.7	1.3	9.2	1.4	2.1	6.3	1.2	1.8	5.5	1.6	6.9	7.4	5.2	6.7	4.6	5.6	6.3	2.9	1.3	1.8	5.0	5.1	8.4	12.1	2.1	1.7	8.1	3.1	3.2	2.3	9.6	1.7	4.9	7.3	0.5	7.4	4.7	1.0	6.0	7.6	6.3	1.9	13.6	6.9	2.5	1.6	6.2	4.4	2.2	12.2	6.1	4.9	2.1	3.3	1.7	0.7	0.1	7.3	11.3	22.9	5.0	14.5	12.7	12.3	1.5	11.6	11.8	2.2	6.8	9.5	5.3	0.4	10.8	6.4	15.7	0.5	6.3	0.5	0.7	3.3	7.0	4.3	11.9	9.1	6.4	2.1	9.9	16.6	10.3	0.3	0.8	6.1	1.4	6.3	3.9	0.0	4.7	1.0	9.3	0.4	0.7	7.7	9.1	0.0	0.0	0.1	24.6	3.7	2.1	4.3	3.3	13.4	3.3	0.5	1.3	1.8	1.2	1.5	4.5	9.4	0.9	1.6	11.7	18.7	4.7	6.6	20.5	7.3	15.0	6.3	8.3	20.2	16.0	7.7	6.8	19.0	8.0	18.1	10.1	12.2	10.5	1.3	1.4	1.2	1.8	1.3	1.8	2.1	1.7	1.7	1.9	1.6	2.1	0.2	0.0	0.5	0.0	6.2	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.3	0.2	1.0	0.0	1.3	0.0	0.0	0.5	1.3	4.6	0.1	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.2	0.0	0.0	4.3	0.0	0.4	2.1	0.2	0.3	0.1
TRMO	"C9orf156, HSPC219"	ENSG00000136932	"TRNA methyltransferase O"	Q9BU70	9	97904489-97922516	"Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021281, HPA052197"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA021281: AB_2670649, HPA052197: AB_2681758"	"unprognostic (2.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.99e-2)"	"prognostic favorable (4.81e-10)"	"unprognostic (1.97e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.39e-2)"	7.5	9.4	7.4	11.3	8.5	16.4	13.6	8.1	7.8	9.0	9.3	7.2	7.0	9.1	11.8	7.8	10.4	7.5	6.6	6.8	8.2	9.9	11.3	9.2	14.6	7.8	7.7	9.0	9.7	11.6	7.8	7.5	8.2	9.5	8.1	5.5	9.6	7.7	7.3	10.3	9.3	6.4	8.0	11.9	9.3	12.0	7.5	13.8	18.4	7.8	14.0	7.1	6.5	10.2	19.4	12.1	6.5	8.0	8.1	6.7	11.2	9.7	11.0	15.3	11.6	16.9	14.0	12.1	6.4	9.7	17.1	18.0	10.6	7.6	11.8	14.6	8.4	10.0	14.8	15.3	16.7	19.4	15.8	11.7	17.0	8.5	6.9	9.2	6.9	9.5	16.0	15.3	10.7	28.1	8.3	13.3	9.1	20.7	13.4	9.8	14.5	8.7	14.5	15.5	11.5	10.1	7.1	15.4	16.6	5.5	6.8	10.5	10.6	8.4	8.5	17.7	15.0	16.3	12.6	6.1	9.0	9.8	7.7	44.4	21.1	49.4	20.4	23.4	25.4	19.4	30.8	24.6	22.6	28.8	39.7	27.9	32.4	22.9	16.1	13.1	35.1	20.1	7.4	8.5	8.1	7.8	6.8	8.2	7.8	7.7	8.2	8.0	7.5	10.2	7.5	12.8	5.3	0.0	16.7	0.0	14.6	0.0	10.2	9.1	7.3	7.6	0.0	4.3	6.8	5.5	0.0	8.9	17.5	3.5	7.9	9.1	30.6	9.3	5.4	4.9	2.4	6.9	0.0	9.6	6.9	6.0	9.2	7.1	0.0	4.1	5.3	7.3	10.8	6.7	0.0	5.6	0.0	10.7	0.0	18.3	5.0	9.7	0.0	0.0	10.7	12.1	8.2	0.0	0.0	10.3	5.7	7.2	12.0	6.1	4.9	9.9	5.8	4.9	6.6	8.6	5.2	16.7	13.3	7.8	0.0	18.3	14.6	6.6	3.9	8.1
TRNT1	"CCA1, CGI-47, MtCCA"	ENSG00000072756	"TRNA nucleotidyl transferase 1"	Q96Q11	3	3126933-3150879	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Nucleotidyltransferase, RNA-binding, Transferase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036938	Uncertain		Supported	Mitochondria		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA036938: AB_10670566"	"unprognostic (6.39e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.02e-1)"	9.7	10.0	7.2	8.9	7.2	3.5	8.5	7.9	8.0	7.8	7.0	8.1	4.4	8.8	5.5	9.4	7.6	8.3	8.4	7.4	7.2	17.2	10.0	8.4	9.7	7.1	7.3	8.3	8.4	8.3	10.3	10.5	7.1	11.3	7.6	4.0	7.7	6.3	9.3	6.4	7.9	8.3	7.3	10.7	9.1	6.5	7.4	9.8	11.3	7.6	10.9	13.1	7.9	8.0	20.0	29.6	18.2	9.8	24.1	21.5	20.5	19.9	17.4	21.6	20.9	25.0	20.9	35.6	12.8	22.4	32.0	12.6	24.6	18.6	26.5	24.6	13.3	28.7	25.3	24.9	31.4	32.2	20.8	17.9	25.0	20.2	6.8	15.0	21.0	24.1	25.1	9.8	35.9	37.2	22.0	21.4	15.2	29.2	19.0	20.5	28.1	32.5	26.1	25.8	10.8	15.9	31.6	20.6	18.5	26.3	18.7	16.3	14.8	22.8	18.7	23.6	25.7	12.6	31.4	43.4	17.2	27.6	25.0	49.4	12.4	36.4	16.4	18.1	16.0	25.8	20.8	18.1	16.8	15.7	22.7	20.1	16.6	19.8	19.0	15.6	18.6	11.2	7.2	7.2	7.9	8.0	7.4	7.2	7.1	7.3	7.1	7.3	7.4	8.0	20.7	16.0	13.4	15.3	30.2	14.8	29.0	19.9	24.5	13.5	12.1	11.0	14.3	2.8	16.3	18.4	14.6	25.8	23.5	10.6	45.0	19.1	2.3	15.8	19.0	21.1	8.4	16.6	23.8	9.9	17.8	19.9	23.4	12.0	22.8	20.7	12.5	9.2	13.3	10.1	27.0	10.7	16.2	11.0	13.3	2.9	10.8	13.3	7.2	23.4	20.3	17.1	18.6	23.6	34.7	10.6	9.2	8.6	30.7	30.9	11.0	32.7	11.4	15.7	0.0	14.9	17.4	20.8	17.9	23.4	13.1	28.3	22.0	24.7	13.5	23.9
TRPC4AP	"C20orf188, dJ756N5.2, DKFZp586C1223, DKFZP727M231, PPP1R158, TRRP4AP"	ENSG00000100991	"Transient receptor potential cation channel subfamily C member 4 associated protein"	Q8TEL6	20	35002404-35092807	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 138.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051197, HPA065061"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA051197: AB_2681384, HPA065061: AB_2685416"	"unprognostic (3.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (6.25e-8)"	"unprognostic (1.33e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (3.38e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.10e-1)"	54.2	60.9	40.6	37.4	49.5	69.3	50.5	43.6	47.4	45.6	41.3	42.6	36.4	41.7	32.1	45.8	41.3	34.1	46.4	40.7	44.2	43.0	61.9	55.9	42.2	50.0	46.4	40.4	64.2	42.4	62.1	47.8	50.7	46.6	36.1	29.7	48.2	36.1	80.5	46.1	46.9	37.6	43.3	60.4	51.9	35.7	50.0	41.6	47.3	39.7	38.9	41.9	41.4	63.0	53.7	64.4	56.3	58.2	85.2	81.6	86.0	85.2	99.8	95.7	109.6	141.6	78.3	50.0	79.5	99.1	97.4	70.0	51.6	121.5	73.7	26.7	40.2	127.5	54.8	131.0	85.0	74.9	83.8	91.4	75.4	71.7	61.0	100.0	107.9	101.1	61.2	58.3	77.0	40.6	91.1	84.0	44.3	49.2	86.9	56.4	80.9	51.2	82.3	68.9	49.6	50.1	91.9	153.2	59.3	66.6	55.6	59.9	106.7	117.9	53.2	64.8	51.6	52.9	30.6	41.5	128.2	36.6	61.7	30.6	30.5	50.6	24.0	32.4	25.5	17.4	19.9	25.7	40.2	15.3	17.2	18.7	48.5	25.9	38.2	17.4	24.7	27.0	40.6	49.5	43.6	47.4	40.7	44.2	50.0	46.4	50.7	43.3	50.0	63.0	24.2	19.2	14.1	49.0	29.9	15.2	15.2	20.6	21.6	25.7	24.1	19.9	13.1	12.8	19.1	20.2	79.2	52.6	37.0	34.9	3.9	30.1	14.8	16.0	21.9	25.1	20.4	21.5	44.6	27.3	43.8	23.9	48.4	24.9	19.7	43.4	21.0	23.4	37.2	67.3	56.3	24.6	28.5	25.6	22.2	8.5	25.4	23.7	12.4	40.3	27.9	28.5	23.7	59.3	138.0	36.2	24.1	23.0	45.8	23.6	30.4	11.4	18.0	29.2	39.5	18.3	24.0	23.2	27.3	19.1	15.8	68.4	32.2	30.3	24.0	24.0
TTC17	FLJ10890	ENSG00000052841	"Tetratricopeptide repeat domain 17"	Q96AE7	11	43358920-43494933	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038508	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Cytosol	"HPA038508: AB_10671744"	"unprognostic (2.71e-1)"	"unprognostic (4.04e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.03e-2)"	"unprognostic (5.01e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (4.75e-6)"	"unprognostic (1.04e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.54e-2)"	20.7	18.7	11.0	16.1	11.3	15.5	28.6	16.7	12.2	22.0	22.0	21.2	21.6	26.9	25.0	14.2	28.4	22.3	13.5	11.1	12.2	19.4	38.6	24.2	20.2	11.9	12.5	40.9	49.5	27.7	12.3	29.2	11.7	25.4	22.9	25.1	40.7	21.4	16.4	19.5	25.5	23.0	11.0	23.4	27.4	24.8	12.4	24.6	36.9	20.0	22.4	18.8	15.6	13.0	15.0	30.4	31.3	49.3	77.2	63.6	22.1	35.6	47.6	29.3	35.1	21.1	21.7	31.6	34.9	35.9	33.7	31.1	22.3	23.5	35.2	24.5	29.0	24.2	19.5	20.8	95.3	36.6	29.9	59.5	69.8	21.3	68.4	66.2	29.5	22.7	35.5	26.2	29.8	18.1	27.1	20.3	46.8	58.0	25.0	25.1	33.3	36.9	37.2	21.4	16.7	39.7	27.7	73.1	44.6	31.4	68.6	40.8	39.6	41.7	18.4	47.1	52.1	51.1	44.5	29.8	26.9	21.6	45.3	20.0	21.7	19.0	14.9	22.4	15.9	16.4	16.2	14.5	16.9	14.8	16.3	15.1	18.5	16.5	20.8	17.6	16.1	18.0	11.0	11.3	16.7	12.2	11.1	12.2	11.9	12.5	11.7	11.0	12.4	13.0	43.0	64.1	62.7	159.6	53.3	42.1	35.0	36.4	30.7	44.1	40.3	35.7	20.5	31.5	51.9	22.0	60.5	32.6	43.8	30.7	3.9	23.1	52.6	35.8	44.5	40.9	22.3	44.0	204.6	43.4	28.8	44.4	40.2	48.6	36.6	56.2	40.0	57.5	26.2	47.1	203.2	42.1	34.6	48.0	32.3	18.4	57.2	37.1	28.4	181.8	47.8	24.8	37.0	192.0	200.6	29.7	31.5	36.5	48.9	50.1	47.7	15.5	54.3	47.3	52.6	45.5	36.2	51.8	35.0	34.6	43.2	30.8	45.6	33.5	35.8	42.7
TTC24		ENSG00000187862	"Tetratricopeptide repeat domain 24"	A2A3L6	1	156579723-156587719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"lymphoid tissue: 21.2"	"Group enriched"	"Detected in some"	5	"B-cells: 4.6;dendritic cells: 3.6;Erythroid cells: 1.3;NK-cells: 2.1;Skeletal myocytes: 1.7;T-cells: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NK-cell: 3.7;plasmacytoid DC: 12.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 12.4;NK-cells: 3.7"	"Cell line enhanced"	"Detected in some"		"JURKAT: 10.3;MOLT-4: 3.8;REH: 11.9;U-698: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029799			Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA029799: AB_10601684"	"unprognostic (2.43e-3)"	"unprognostic (5.61e-5)"	"unprognostic (5.86e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.48e-6)"	"unprognostic (6.26e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.42e-1)"	"unprognostic (7.96e-2)"	"unprognostic (4.87e-9)"	"unprognostic (1.07e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.22e-2)"	"unprognostic (9.76e-4)"	0.1	0.0	0.0	1.9	0.1	1.8	0.1	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	5.9	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.2	0.2	0.0	0.0	3.0	0.4	0.1	0.0	21.2	0.1	0.0	5.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.1	0.0	3.8	0.7	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.3	0.0	1.1	0.1	1.7	0.2	1.8	0.2	3.7	0.0	12.4	0.0	0.4	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0
TTC4	"CNS1, FLJ41930, MGC5097"	ENSG00000243725	"Tetratricopeptide repeat domain 4"	O95801	1	54715861-54742657	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041608, HPA042459"	Approved		Enhanced	"Intermediate filaments,Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Intermediate filaments"	"Cytoplasmic bodies"	"HPA041608: AB_10794485, HPA042459: AB_10797496"	"unprognostic (4.89e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.62e-4)"	"unprognostic (8.91e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-5)"	"unprognostic (1.39e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.76e-3)"	8.9	8.8	21.2	5.3	21.8	2.0	10.4	22.0	24.7	10.4	20.4	9.7	5.6	8.5	8.1	10.6	9.1	3.9	16.5	21.7	22.2	11.0	10.2	5.6	7.2	22.2	22.2	12.5	11.7	11.7	12.8	7.7	22.3	8.8	6.3	9.0	9.1	8.3	33.7	10.3	8.0	7.6	22.5	6.6	10.8	8.6	22.0	12.8	8.0	22.2	8.9	11.0	10.1	23.9	24.3	18.2	20.1	10.9	29.2	16.6	17.9	32.6	16.0	39.8	26.6	20.5	6.9	40.1	17.4	22.4	42.2	13.1	43.7	31.1	41.6	38.2	31.7	38.4	7.7	11.9	27.4	32.4	10.6	16.1	30.4	58.2	34.9	17.8	17.3	31.3	45.5	6.3	22.7	11.3	30.0	18.3	41.0	29.1	30.9	27.1	43.0	22.5	19.9	6.5	13.5	9.7	28.4	13.8	27.2	33.0	13.2	16.5	17.4	19.5	21.2	20.5	44.9	16.1	29.9	34.0	25.9	36.5	20.8	7.3	12.3	10.3	13.9	14.0	14.8	12.6	11.1	13.3	13.5	12.6	15.9	14.3	0.2	18.9	15.1	11.2	11.8	13.0	21.2	21.8	22.0	24.7	21.7	22.2	22.2	22.2	22.3	22.5	22.0	23.9	3.7	9.6	2.6	0.0	6.2	1.1	3.4	2.1	7.4	4.5	3.1	3.3	3.2	1.5	5.2	0.0	0.0	3.9	2.4	1.5	0.0	3.5	0.5	4.7	8.8	3.4	1.2	3.0	0.0	4.2	2.4	5.4	3.6	4.5	7.0	3.0	3.9	2.4	1.4	5.0	0.0	1.3	0.0	0.6	1.5	0.7	4.1	2.7	1.8	0.0	5.9	2.3	6.2	0.0	0.0	3.9	1.7	2.6	6.1	3.0	2.0	6.4	2.6	3.8	0.0	3.8	3.5	9.2	8.2	5.7	1.6	1.4	4.6	1.9	2.5	1.8
TYW1	"FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W"	ENSG00000198874	"TRNA-yW synthesizing protein 1 homolog"	Q9NV66	7	66995173-67239519	"Enzymes, Predicted membrane proteins"	"tRNA processing"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 57.8;Oligodendrocytes: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA013568: AB_2668852, HPA014118: AB_2668941, HPA015535: AB_1856487, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723"	"unprognostic (1.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (4.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.79e-2)"	7.7	10.8	5.5	8.1	5.9	9.1	10.0	6.6	7.6	13.0	8.8	9.0	9.5	9.2	9.7	6.6	10.1	7.1	7.9	5.6	6.4	8.8	12.0	7.2	9.8	6.4	5.8	12.2	7.3	13.1	6.9	8.4	6.1	9.8	10.7	9.0	7.1	9.5	15.6	7.9	7.8	9.2	5.6	7.7	7.7	8.1	5.7	10.4	12.8	8.4	9.4	8.5	8.7	7.3	16.3	20.5	12.1	24.9	17.4	12.0	13.8	16.8	12.9	12.9	12.0	23.3	20.2	28.1	25.2	15.4	18.6	18.4	24.9	20.3	18.4	22.1	24.1	11.9	17.1	15.6	17.7	27.7	15.1	12.4	20.3	17.5	27.0	10.6	13.0	20.9	32.3	16.0	15.6	15.7	18.1	23.4	21.1	27.2	18.8	19.7	16.6	34.8	17.4	16.4	18.2	18.3	20.4	38.4	17.6	22.7	26.6	19.6	14.0	15.0	10.8	11.8	23.3	16.1	25.7	33.2	12.1	25.9	20.8	2.4	7.4	3.9	8.5	7.7	11.2	8.3	8.8	9.5	8.8	9.8	10.8	11.7	1.8	11.1	10.0	6.7	6.8	6.2	5.5	5.9	6.6	7.6	5.6	6.4	6.4	5.8	6.1	5.6	5.7	7.3	10.0	6.4	15.3	39.2	18.2	10.5	5.3	10.0	17.1	12.0	11.4	11.7	9.5	10.0	7.6	11.0	4.2	18.6	11.7	7.8	0.0	7.8	7.3	10.9	18.0	8.8	4.8	12.6	57.8	6.9	13.1	11.0	12.8	10.9	34.2	9.1	6.1	14.2	7.7	3.3	53.4	12.3	12.2	7.1	11.2	4.5	8.4	10.3	8.8	43.1	10.0	6.8	10.3	50.3	58.7	7.1	4.0	8.2	18.0	6.2	4.9	2.4	9.6	11.5	19.7	11.2	10.4	23.9	23.4	15.6	16.9	15.2	17.1	10.2	11.4	3.3
U2AF2	U2AF65	ENSG00000063244	"U2 small nuclear RNA auxiliary factor 2"	P26368	19	55654146-55674716	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010910, HPA041943, HPA043562"	Supported	Supported	Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA		73000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"	Nucleoplasm	"CAB010910: AB_262122, HPA041943: AB_2677760, HPA043562: AB_2678555"	"unprognostic (2.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.12e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.94e-2)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (9.46e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.19e-2)"	"unprognostic (4.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.08e-2)"	74.2	80.9	70.3	101.9	73.0	147.7	70.2	74.6	82.4	92.1	75.4	83.7	85.1	87.4	56.7	98.2	82.8	54.0	69.3	70.3	70.8	79.4	80.2	74.2	119.3	76.2	71.5	98.3	75.0	70.1	93.7	63.6	73.0	74.9	54.0	46.0	72.0	65.9	67.3	80.0	92.3	62.1	72.0	115.7	75.4	81.8	72.1	132.5	78.9	45.9	93.7	78.2	80.7	82.4	244.5	394.0	235.9	191.1	108.3	109.8	249.3	191.9	174.1	314.2	305.3	231.3	222.3	284.5	149.5	164.9	160.5	193.0	299.3	268.3	149.1	218.0	501.9	245.2	176.1	221.5	176.7	287.4	263.5	148.8	161.0	239.5	166.8	120.0	190.8	195.9	293.1	181.3	169.9	239.2	388.0	261.1	260.4	217.1	307.2	414.5	149.7	233.0	189.7	290.0	270.6	211.0	208.6	197.1	125.7	134.6	190.5	296.9	161.5	279.7	203.7	130.0	415.9	165.0	239.3	344.5	124.3	279.5	245.2	0.1	1.1	0.8	1.3	1.5	1.0	0.8	1.1	0.9	1.0	1.1	0.8	0.8	2.1	0.6	1.2	1.8	1.1	0.9	70.3	73.0	74.6	82.4	70.3	70.8	76.2	71.5	73.0	72.0	72.1	82.4	31.0	3.2	9.1	10.4	46.0	45.4	41.4	34.8	57.5	41.8	29.7	21.3	2.7	24.3	20.6	27.6	31.3	58.5	34.1	44.0	19.6	33.0	6.4	33.8	36.0	31.4	45.5	32.6	6.8	23.8	63.0	29.4	51.0	40.9	34.3	30.4	27.5	26.8	37.6	35.3	7.6	42.4	30.5	22.0	32.3	8.4	44.4	31.6	19.6	11.2	37.4	25.3	30.9	4.0	12.0	31.8	29.3	34.3	62.4	41.9	31.9	21.3	15.3	52.0	0.0	26.1	46.6	22.5	32.0	53.5	39.2	71.8	42.7	30.8	43.6	44.9
UBE2V1	"CROC-1, CROC1, UBE2V, UEV-1, UEV1A"	ENSG00000244687	"Ubiquitin conjugating enzyme E2 V1"	Q13404	20	50081124-50115959	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 74.0;Erythroid cells: 80.1;Plasma cells: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA052535, HPA053186"			Enhanced	Nucleoplasm		NA	NA		1100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA052535: AB_2681863, HPA053186: AB_2682073"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.81e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (4.58e-5)"	"unprognostic (2.58e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-1)"	61.2	57.8	50.1	56.9	54.9	51.3	51.3	43.1	72.2	51.2	44.2	70.7	58.4	45.4	53.2	71.9	46.6	48.0	66.7	55.8	48.8	58.9	78.2	59.3	68.4	45.2	44.5	44.2	64.7	61.1	37.4	66.3	46.3	53.5	61.2	47.2	55.6	55.0	87.9	65.9	51.9	73.5	38.3	55.5	56.7	40.9	48.9	60.8	49.9	70.8	89.1	67.8	53.6	48.6	155.0	94.1	174.3	104.8	141.6	238.7	97.3	172.6	168.0	356.3	169.9	466.6	112.8	148.8	155.9	223.8	155.1	134.5	129.5	235.4	307.1	105.0	81.2	146.0	66.2	212.2	125.9	178.3	113.2	192.4	140.4	176.1	115.1	199.6	243.5	120.4	185.2	88.4	200.9	102.7	162.9	143.8	121.9	204.5	164.7	89.0	196.8	136.4	248.7	109.9	101.8	123.2	174.4	301.0	136.7	173.2	115.0	161.2	215.1	196.5	182.3	165.7	140.8	85.7	118.5	119.0	213.9	92.2	139.4	120.7	162.3	146.5	219.9	161.5	221.9	149.2	178.9	210.7	165.3	134.1	180.3	197.2	55.8	233.6	147.9	130.4	189.5	351.7	50.1	54.9	43.1	72.2	55.8	48.8	45.2	44.5	46.3	38.3	48.9	48.6	18.9	51.3	30.9	0.0	39.1	5.9	5.0	18.4	74.0	4.6	10.6	7.9	9.2	7.2	36.3	11.0	6.2	6.4	24.6	10.7	23.5	11.5	19.1	36.3	32.0	18.4	10.2	80.1	0.0	11.3	5.7	21.2	38.2	36.1	36.6	4.8	16.8	14.5	7.0	0.0	0.0	5.2	8.2	17.8	5.9	19.8	7.8	29.6	8.8	0.0	18.4	3.0	12.3	0.0	0.0	16.1	15.4	4.9	79.4	2.8	7.7	27.2	47.8	5.4	6.6	6.9	14.8	12.9	6.7	67.8	8.5	7.1	41.1	5.4	4.9	5.1
UBE4A	"E4, KIAA0126, UBOX2, UFD2"	ENSG00000110344	"Ubiquitination factor E4A"	Q14139	11	118359600-118399211	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA055035, HPA064010"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA055035: AB_2682679, HPA064010: AB_2685174"	"unprognostic (1.32e-2)"	"unprognostic (8.15e-2)"	"unprognostic (5.23e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.67e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.74e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.86e-2)"	18.6	14.1	15.9	20.3	17.8	17.7	18.0	25.5	20.5	16.1	15.7	17.4	19.1	18.9	18.6	15.0	15.5	15.6	19.7	15.1	20.2	18.0	27.6	17.0	22.5	18.9	18.1	19.1	19.5	19.0	9.5	17.5	20.2	19.0	20.7	18.4	16.1	14.9	22.1	24.0	20.5	18.1	16.5	19.7	23.9	17.7	19.7	21.3	18.4	15.9	21.6	14.7	12.7	24.4	18.8	17.9	22.4	22.5	38.0	34.9	22.3	27.1	28.1	19.7	24.0	49.7	44.9	39.3	51.0	34.4	26.5	40.3	31.9	25.7	32.6	22.3	14.8	64.5	15.4	25.7	32.6	36.8	47.3	35.4	18.2	40.4	39.3	26.3	33.3	33.9	37.2	35.9	28.7	35.4	31.5	36.5	20.9	37.7	22.7	20.0	32.5	40.2	21.6	43.1	20.3	21.1	39.2	33.5	12.3	24.2	44.8	16.6	34.6	29.0	19.0	25.1	22.8	10.5	13.8	36.4	16.1	41.6	30.4	14.2	9.5	9.7	7.5	10.5	5.8	5.1	5.6	5.4	9.8	3.5	6.0	5.4	9.6	6.5	12.8	5.7	7.0	4.8	15.9	17.8	25.5	20.5	15.1	20.2	18.9	18.1	20.2	16.5	19.7	24.4	28.7	12.8	31.9	45.7	27.5	26.8	22.0	20.4	25.6	19.5	26.3	18.0	18.2	10.0	27.8	14.7	18.8	20.3	30.6	25.5	5.9	19.8	18.0	23.7	35.3	20.9	18.6	26.9	46.2	28.5	19.8	24.2	41.8	31.7	10.8	25.7	19.2	44.6	21.9	16.8	56.3	20.1	30.5	27.9	23.1	15.2	17.1	33.2	24.9	36.5	32.4	20.5	24.7	55.8	80.9	27.0	18.3	21.4	42.0	23.1	29.0	11.5	37.5	16.8	19.7	23.4	23.6	35.3	22.0	30.3	39.2	24.8	31.0	26.0	20.3	26.1
UBLCP1	"CPUB1, MGC10067"	ENSG00000164332	"Ubiquitin like domain containing CTD phosphatase 1"	Q8WVY7	5	159263290-159286036	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039615	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 16: Immune cells - Immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA039615: AB_10674425"	"unprognostic (1.25e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.45e-2)"	"unprognostic (7.08e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (4.46e-5)"	"unprognostic (4.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.51e-2)"	19.0	16.3	8.8	24.5	9.4	23.3	20.5	9.6	14.1	19.9	6.4	15.7	12.6	23.6	17.2	21.1	15.1	17.1	16.4	10.0	10.5	19.2	18.3	22.4	33.7	10.3	9.5	15.8	14.9	19.7	5.6	23.6	10.2	17.5	16.9	18.2	14.2	19.6	10.9	15.5	12.7	22.8	9.6	26.7	15.8	30.5	10.7	36.4	16.6	13.8	37.3	21.3	11.7	10.7	39.9	28.6	57.9	64.1	58.9	54.5	34.1	42.5	64.6	42.8	56.6	23.5	27.1	35.7	46.1	53.7	60.9	29.7	36.3	81.8	74.3	71.3	35.7	27.3	23.8	21.9	74.0	62.7	41.1	48.1	76.8	38.9	77.2	34.0	41.4	36.4	38.4	47.0	60.8	12.9	33.5	22.9	41.7	20.0	17.1	42.3	56.5	42.8	44.4	30.4	30.4	42.9	42.7	29.0	115.8	34.6	30.2	45.6	44.2	44.0	37.8	22.8	54.9	36.9	39.8	53.5	46.1	43.9	66.1	47.6	10.8	27.5	25.5	22.4	28.4	18.5	23.9	26.7	14.2	16.7	26.9	29.1	30.8	42.8	24.5	17.8	28.3	13.6	8.8	9.4	9.6	14.1	10.0	10.5	10.3	9.5	10.2	9.6	10.7	10.7	31.9	12.8	41.6	12.7	43.0	15.9	10.3	43.0	35.3	12.7	22.5	14.4	16.8	10.0	34.4	14.7	4.2	31.8	36.8	13.2	35.2	23.0	8.5	23.2	32.1	24.2	10.7	30.1	26.3	24.9	18.7	27.1	29.6	17.4	45.0	16.9	28.5	15.6	39.0	20.2	25.0	14.6	18.3	40.0	16.4	4.2	20.5	33.1	17.8	14.0	30.9	17.6	32.0	22.6	25.6	22.5	10.1	24.8	39.3	13.2	8.8	34.5	37.4	13.1	19.7	18.8	26.2	74.0	61.5	51.8	20.6	17.8	40.8	30.7	14.5	10.1
UBR1		ENSG00000159459	"Ubiquitin protein ligase E3 component n-recognin 1"	Q8IWV7	15	42942897-43106113	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 108.9;Inhibitory neurons: 108.8;Oligodendrocyte precursor cells: 102.1;Oligodendrocytes: 127.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038838, HPA038839"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Cytosol"	"HPA038838: AB_10673120, HPA038839: "	"unprognostic (1.07e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.89e-1)"	9.1	7.9	12.5	8.8	29.4	24.9	9.3	11.7	17.4	9.9	4.8	8.6	7.8	10.7	7.4	5.8	8.0	8.6	13.7	11.6	31.5	9.2	7.1	8.6	10.9	24.2	18.3	7.7	9.5	14.3	6.6	10.5	21.6	10.0	8.0	14.3	6.3	10.5	12.0	5.6	7.8	9.6	8.5	9.5	7.2	10.1	21.2	13.3	12.6	14.0	8.7	9.1	5.8	48.6	7.4	10.2	11.6	9.6	17.1	14.7	10.7	17.6	19.4	15.9	19.2	13.3	5.5	8.6	10.1	18.4	18.9	12.4	17.1	15.5	18.1	18.0	8.4	33.1	20.4	6.3	12.3	23.0	14.4	15.3	8.4	18.8	14.8	14.6	17.0	16.7	19.6	12.3	18.7	4.5	12.7	6.8	6.5	18.9	10.6	16.4	15.7	6.4	14.9	16.6	12.0	10.3	22.7	12.0	7.7	13.1	10.9	12.2	24.3	17.9	11.1	16.7	18.0	14.6	26.4	23.6	12.2	14.6	16.6	3.7	1.5	2.5	2.4	1.8	2.9	1.9	2.6	2.9	1.4	2.3	2.6	3.2	2.9	3.2	1.7	2.2	1.9	0.9	12.5	29.4	11.7	17.4	11.6	31.5	24.2	18.3	21.6	8.5	21.2	48.6	46.4	48.1	30.7	73.1	28.9	10.6	11.6	9.3	17.1	27.5	15.4	10.8	28.0	12.8	19.1	9.2	27.1	14.7	35.8	12.8	0.0	10.8	16.8	13.4	27.4	24.5	14.4	23.8	108.9	14.4	7.7	25.6	20.9	18.2	28.5	22.8	17.2	9.9	8.1	32.0	108.8	10.9	14.2	16.4	10.6	16.9	16.1	17.1	8.8	73.1	15.6	13.5	23.7	102.1	127.6	10.3	8.2	20.7	33.2	7.7	12.3	9.2	15.7	38.8	13.1	34.7	36.5	27.0	17.8	8.6	7.2	36.9	31.4	16.5	10.6	9.8
UHMK1	"KIS, Kist"	ENSG00000152332	"U2AF homology motif kinase 1"	Q8TAS1	1	162497251-162529631	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077624			Supported	"Nucleoplasm,Nuclear speckles,Vesicles"		NA	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear speckles"	Vesicles	"HPA077624: "	"unprognostic (6.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.81e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.08e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.66e-2)"	26.8	23.3	21.2	23.3	24.6	40.3	19.3	18.1	21.2	15.1	16.6	19.2	19.1	11.7	14.1	13.3	14.4	13.7	11.6	26.0	28.3	31.2	38.1	17.5	30.8	24.9	28.5	11.9	11.0	27.8	7.8	17.1	28.3	16.2	19.6	10.5	13.5	18.5	25.8	11.9	23.4	10.8	19.8	25.4	20.0	12.2	26.1	24.6	19.4	25.9	28.9	18.1	10.5	19.4	61.9	28.4	14.6	35.8	40.7	31.9	32.7	79.7	43.2	63.9	45.7	18.6	37.8	50.2	67.8	60.0	31.2	34.9	28.2	44.1	102.4	69.1	20.4	49.8	34.3	16.9	31.3	73.4	55.5	33.0	45.8	63.2	59.9	44.6	37.4	34.2	44.1	67.7	111.4	26.0	39.3	19.4	19.4	46.1	37.8	24.9	64.9	41.9	42.6	62.8	26.4	24.3	70.5	64.6	52.2	19.9	56.0	81.0	58.5	72.7	41.0	50.8	112.6	69.2	103.5	58.0	60.5	35.3	67.3	3.6	2.0	2.4	4.8	5.3	4.9	3.2	3.5	4.0	2.3	3.6	3.5	4.0	1.3	3.7	6.1	2.6	3.1	2.6	21.2	24.6	18.1	21.2	26.0	28.3	24.9	28.5	28.3	19.8	26.1	19.4	37.6	19.2	41.2	20.9	75.6	29.4	33.7	38.5	34.7	24.4	39.4	20.2	35.1	40.0	53.8	53.3	12.5	26.2	81.0	53.9	56.7	27.6	55.6	35.1	35.7	33.4	33.5	51.6	37.0	23.2	38.1	25.5	43.3	44.4	45.7	23.3	31.1	85.1	30.0	23.5	27.4	34.1	48.8	73.5	47.5	58.4	21.5	60.0	28.4	33.7	58.0	14.6	74.2	20.6	29.5	40.4	33.0	19.5	47.2	59.9	60.8	62.2	50.9	23.0	0.0	29.2	27.8	25.1	29.6	45.2	24.6	22.4	69.4	31.4	39.3	58.3
ULBP3	RAET1N	ENSG00000131019	"UL16 binding protein 3"	Q9BZM4	6	150061053-150069121	"Predicted intracellular proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 6.5;testis: 6.3"	"Cell type enhanced"	"Detected in single"		"Gastric mucus-secreting cells: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA056541, HPA063007"	Approved		Uncertain	"Vesicles,Centriolar satellite"	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	Vesicles	"Centriolar satellite"	"HPA056541: , HPA063007: AB_2684920"	"unprognostic (4.87e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.54e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.16e-2)"	1.3	1.2	1.6	0.7	1.8	0.7	1.0	1.6	2.4	0.5	0.4	0.8	1.1	1.0	0.9	1.5	2.0	1.3	0.7	1.7	1.4	1.7	1.0	1.5	0.5	0.9	0.9	0.8	0.7	0.9	0.1	0.9	0.9	0.7	0.8	0.8	0.4	0.5	6.5	1.1	0.5	0.5	0.2	0.6	1.9	6.3	1.3	0.5	4.9	0.4	0.9	1.0	0.5	1.9	6.2	2.0	6.5	7.3	1.6	11.9	2.3	6.1	2.6	7.2	8.0	11.0	5.1	0.2	11.8	9.9	10.9	8.3	17.7	20.5	7.7	3.7	7.8	0.6	2.9	0.5	2.5	0.1	1.1	10.2	3.5	15.0	8.1	6.9	9.7	0.2	0.5	0.8	6.3	7.0	0.3	0.5	3.1	2.6	14.8	6.2	5.9	0.3	17.5	12.4	1.2	0.5	12.2	8.2	3.0	3.4	2.5	1.7	5.6	1.2	9.8	20.5	13.3	0.3	0.2	4.1	9.6	3.7	5.1	0.8	0.2	0.2	2.2	0.2	2.9	0.8	1.5	2.4	0.2	0.5	0.8	1.2	1.0	0.6	0.2	0.3	2.3	0.4	1.6	1.8	1.6	2.4	1.7	1.4	0.9	0.9	0.9	0.2	1.3	1.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0
USF3	KIAA2018	ENSG00000176542	"Upstream transcription factor family member 3"	Q68DE3	3	113648385-113696646	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029243, HPA029245"	Uncertain		Uncertain	Nucleoplasm,Nucleoli,Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	Centrosome	"HPA029243: AB_10611114, HPA029245: AB_10600443"	"unprognostic (2.80e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.74e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.55e-2)"	7.1	4.9	5.6	3.0	5.9	10.2	6.7	8.8	8.0	5.5	7.5	7.5	2.8	5.3	7.8	6.8	6.2	2.4	7.0	6.2	5.3	8.2	16.4	5.9	5.3	5.4	5.4	5.8	8.5	6.0	6.7	2.8	5.6	5.9	3.9	5.6	6.4	2.7	18.7	7.4	8.3	2.4	5.2	8.7	7.5	4.8	5.3	6.7	6.2	8.5	4.6	6.0	6.1	6.8	4.6	3.4	4.1	3.9	9.8	3.7	2.8	1.8	2.9	1.7	1.6	3.2	1.9	8.0	3.2	4.6	2.8	2.8	4.5	3.6	3.3	2.7	1.9	5.7	2.2	5.3	2.9	10.5	6.2	5.5	6.4	3.2	3.6	2.6	4.2	5.9	2.7	4.1	3.7	6.4	5.9	5.8	3.0	6.1	3.4	2.5	3.2	3.2	6.3	6.3	1.9	3.0	4.3	2.4	5.5	2.8	3.3	7.7	5.7	2.7	6.0	1.5	2.6	4.8	2.9	9.2	3.1	4.3	2.0	2.2	1.0	1.7	1.3	1.3	1.0	1.0	0.9	1.0	0.8	2.3	1.1	1.2	3.2	1.2	1.8	2.3	0.5	0.7	5.6	5.9	8.8	8.0	6.2	5.3	5.4	5.4	5.6	5.2	5.3	6.8	27.1	22.4	15.1	0.0	30.1	0.0	11.2	0.0	15.9	19.5	19.7	12.6	0.0	14.3	6.2	25.8	14.6	8.1	42.7	13.1	25.4	8.4	6.7	28.3	18.6	15.6	6.1	17.0	0.0	11.8	4.2	13.3	18.3	22.8	5.1	6.7	20.3	46.3	7.8	13.5	0.0	10.2	0.0	22.6	0.0	10.9	13.1	17.0	0.0	0.0	16.4	12.4	29.9	0.0	0.0	12.5	12.4	13.9	17.5	18.4	23.6	29.2	12.4	18.8	6.6	27.6	13.8	13.1	6.0	15.8	0.0	14.5	20.0	12.2	10.9	19.5
USP21	"USP16, USP23"	ENSG00000143258	"Ubiquitin specific peptidase 21"	Q9UK80	1	161159450-161165723	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028397	Uncertain	Approved	Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028397: AB_10603227"	"unprognostic (9.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (5.35e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.87e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (9.50e-6)"	"unprognostic (2.45e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.13e-2)"	"prognostic favorable (3.35e-5)"	12.2	15.3	19.6	11.9	20.7	15.0	14.3	18.5	22.8	19.4	18.3	17.6	13.6	18.2	12.0	16.4	28.0	12.0	13.0	19.4	18.4	14.5	10.8	13.1	16.1	19.2	19.7	23.2	16.4	17.1	15.7	13.2	18.7	17.7	11.0	12.9	16.5	20.3	20.9	20.8	15.9	12.6	17.3	17.8	16.4	14.2	20.1	18.4	18.5	17.7	14.0	17.6	16.8	22.1	12.5	20.6	26.9	26.2	21.1	17.5	16.5	9.1	14.6	24.2	18.9	19.4	23.3	16.0	14.6	11.2	15.1	20.7	17.6	17.5	13.2	30.8	30.0	19.3	34.1	15.3	15.2	17.4	13.4	14.8	23.0	16.6	23.9	27.1	17.3	35.0	28.4	21.6	15.6	22.6	30.7	26.9	25.2	24.3	26.1	28.8	9.0	26.5	14.4	14.9	24.2	31.5	17.2	17.2	13.9	20.1	37.3	27.5	10.1	16.9	14.8	11.9	15.3	42.9	36.5	23.9	15.3	14.7	15.5	15.2	10.0	17.1	12.6	6.4	14.6	11.0	11.5	13.2	10.8	11.3	13.1	12.3	8.4	13.3	7.6	10.8	12.3	11.0	19.6	20.7	18.5	22.8	19.4	18.4	19.2	19.7	18.7	17.3	20.1	22.1	4.5	0.0	3.7	5.2	6.5	1.5	1.8	2.4	16.5	5.0	4.9	4.1	3.9	8.6	2.9	1.8	6.2	4.9	3.6	3.6	1.9	2.0	1.0	6.3	5.7	4.4	5.4	10.7	2.4	2.3	2.3	5.1	9.2	3.7	2.5	4.5	5.3	2.1	2.2	0.0	2.7	4.0	4.1	4.8	0.8	1.0	5.0	2.1	1.8	1.9	1.2	3.3	5.2	2.0	4.6	2.0	2.4	4.1	7.8	2.7	3.5	2.5	9.5	5.2	6.6	2.0	5.2	5.3	3.2	10.7	1.4	3.1	5.6	3.1	4.1	1.5
USP42	FLJ12697	ENSG00000106346	"Ubiquitin specific peptidase 42"	Q9H9J4	7	6104884-6161564	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.1;Spermatocytes: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006939, HPA064800"			Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA006939: , HPA064800: AB_2685355"	"unprognostic (1.48e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.82e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.14e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.66e-1)"	3.8	3.0	3.1	3.2	3.0	13.4	3.9	5.8	4.4	4.3	2.4	4.5	4.5	4.9	3.6	3.7	4.3	3.4	3.2	3.0	3.0	3.9	4.0	4.1	3.8	2.8	3.1	4.9	3.8	4.7	3.8	3.3	2.7	3.8	3.4	5.8	3.5	3.1	4.3	5.4	4.3	4.1	2.9	4.4	3.6	15.2	3.2	5.7	4.0	3.4	3.2	4.0	3.8	3.2	10.2	7.4	13.1	12.9	7.4	5.5	9.0	5.4	6.9	6.2	6.1	5.3	5.2	12.0	3.4	6.7	9.2	9.3	11.1	5.9	6.7	2.9	8.6	5.6	6.1	5.5	6.3	13.0	6.1	6.4	6.8	6.7	8.5	5.7	7.7	10.0	21.7	7.9	4.1	9.1	7.9	14.6	14.8	5.2	5.6	14.9	10.2	8.2	5.9	5.3	10.0	17.7	6.9	14.0	4.3	12.0	6.5	6.6	6.5	5.5	20.5	7.0	6.5	7.0	6.3	10.3	4.6	7.8	11.0	0.6	0.3	0.9	0.5	0.6	0.7	0.4	0.6	0.3	0.3	0.2	0.4	1.0	0.3	0.5	0.3	0.6	0.5	0.2	3.1	3.0	5.8	4.4	3.0	3.0	2.8	3.1	2.7	2.9	3.2	3.2	13.7	12.8	7.0	19.6	16.1	40.5	18.2	5.2	26.7	18.7	17.4	10.8	10.5	8.6	6.8	1.8	22.9	8.3	16.4	20.7	0.0	10.4	89.1	27.1	15.3	14.4	10.7	10.8	26.1	10.4	8.4	13.4	15.3	25.6	9.5	13.4	12.8	9.8	8.2	21.9	26.2	18.1	8.2	9.1	19.9	42.5	14.3	12.4	10.6	18.7	7.7	10.1	12.3	18.6	26.2	12.0	7.7	12.8	21.7	22.3	12.4	5.7	10.6	18.7	13.1	16.2	14.9	72.4	37.0	23.1	41.5	26.8	19.2	6.4	14.4	15.3
UTP20	"1A6/DRIM, DRIM"	ENSG00000120800	"UTP20 small subunit processome component"	O75691	12	101280105-101386618	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049341			Supported	"Nucleoli,Plasma membrane"		No	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoli	"Plasma membrane"	"HPA049341: AB_2680720"	"unprognostic (3.04e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (8.34e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-2)"	"prognostic favorable (8.87e-4)"	"unprognostic (2.88e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.30e-2)"	"unprognostic (6.92e-3)"	4.3	4.2	2.2	5.0	3.7	4.2	5.7	2.9	2.7	5.7	2.5	3.2	2.1	4.6	2.6	4.0	3.8	2.4	3.0	2.3	2.5	3.3	3.0	3.0	5.0	2.8	2.8	6.4	4.8	5.3	2.2	4.3	2.9	3.5	4.2	3.5	5.6	3.3	5.2	4.6	3.1	4.0	2.4	3.6	3.2	5.6	3.3	4.3	4.2	3.9	4.8	5.1	3.5	5.0	8.1	19.9	14.8	6.9	13.0	15.1	18.2	13.8	10.8	21.5	11.8	23.1	5.7	21.6	7.1	15.4	16.2	16.6	33.0	14.2	27.8	9.8	13.4	22.8	10.0	17.3	7.3	38.4	10.2	9.9	7.3	29.9	10.3	8.2	15.0	10.9	36.7	4.3	15.8	10.6	16.8	10.9	38.9	11.3	20.6	18.8	24.2	16.8	9.1	24.4	17.0	11.5	25.8	16.1	15.7	12.2	17.0	8.5	17.1	25.3	12.5	17.8	27.1	7.8	12.6	35.1	13.8	17.2	39.6	0.0	0.2	0.0	0.5	0.3	0.5	0.9	0.5	0.7	0.4	0.6	0.6	0.7	0.0	0.6	0.2	0.8	0.5	0.2	2.2	3.7	2.9	2.7	2.3	2.5	2.8	2.8	2.9	2.4	3.3	5.0	14.3	9.6	9.9	16.0	16.7	10.1	9.7	7.7	11.4	9.9	8.7	8.4	10.3	7.2	13.6	3.7	10.4	7.8	4.4	3.4	5.9	7.6	1.5	11.4	24.5	12.6	6.6	14.9	17.0	11.6	8.8	13.0	7.7	10.1	13.3	18.6	7.1	7.6	5.8	21.9	17.0	6.3	4.1	6.3	3.5	1.2	9.6	8.6	3.6	8.4	3.3	3.3	4.1	16.1	34.2	5.9	1.9	8.2	13.2	14.5	1.1	3.0	9.0	9.4	6.6	24.9	11.0	22.6	22.3	17.3	11.1	2.9	10.0	23.7	9.8	7.2
UTP23	"C8orf53, MGC14595"	ENSG00000147679	"UTP23 small subunit processome component"	Q9BRU9	8	116766505-116849463	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044418	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA044418: AB_10961139"	"prognostic unfavorable (5.18e-5)"	"unprognostic (2.30e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.64e-1)"	"unprognostic (7.23e-2)"	"unprognostic (9.45e-3)"	"unprognostic (7.73e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.15e-3)"	"unprognostic (9.27e-2)"	11.8	7.9	5.6	10.1	6.6	33.2	9.6	8.1	6.7	7.8	4.3	7.1	6.2	9.6	6.5	7.2	8.1	7.9	7.1	5.7	6.0	6.8	7.4	7.8	15.4	5.6	5.5	13.7	9.7	8.1	4.8	9.6	5.7	8.1	5.6	9.6	9.0	6.4	8.6	8.0	7.8	7.4	6.1	10.3	7.7	6.8	5.4	8.2	12.3	6.2	8.9	7.9	5.9	9.0	22.0	22.7	12.9	11.3	17.9	21.3	9.8	21.9	13.3	14.1	15.6	23.8	14.2	34.4	20.5	10.5	14.1	16.1	18.2	12.8	17.4	33.5	35.3	42.5	18.3	16.2	19.1	21.2	19.7	18.6	13.8	15.7	19.1	9.2	15.4	25.9	27.7	22.6	14.1	38.3	50.2	12.4	11.8	35.9	44.1	28.1	14.2	29.7	8.9	19.8	22.7	18.3	14.2	53.8	21.5	6.5	25.8	14.6	16.4	14.7	20.3	35.7	30.9	30.8	48.9	39.7	18.8	27.4	17.4	49.7	24.6	32.6	39.5	26.6	34.2	43.1	35.2	31.2	22.1	41.6	47.7	33.2	24.6	28.1	37.0	36.1	43.6	26.4	5.6	6.6	8.1	6.7	5.7	6.0	5.6	5.5	5.7	6.1	5.4	9.0	33.6	41.7	33.1	36.2	31.0	21.9	27.0	17.4	31.9	23.2	16.7	29.2	23.4	27.1	23.4	7.3	6.2	28.3	24.8	9.9	27.4	17.3	13.9	18.0	37.0	28.7	12.0	12.4	62.6	20.7	17.9	32.9	21.9	20.6	41.8	24.3	25.0	13.8	16.6	16.8	62.2	16.6	14.2	12.6	10.5	4.8	28.9	18.5	10.6	15.9	24.0	27.4	20.6	42.3	43.0	12.4	9.4	28.6	32.0	28.7	9.0	16.2	19.2	22.4	13.1	39.5	26.4	44.0	20.3	26.6	16.2	19.8	29.5	28.8	16.6	19.1
UTY	"KDM6AL, KDM6C"	ENSG00000183878	"Ubiquitously transcribed tetratricopeptide repeat containing, Y-linked"	O14607	Y	13248379-13480673	"Enzymes, Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Excitatory neurons: 66.7;Inhibitory neurons: 65.2;Oligodendrocytes: 65.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 20.6;SK-MEL-30: 14.9;U-266/84: 16.4;U-698: 20.2"	"Low region specificity"	"Detected in all"							"HPA000568, HPA001165"	Supported		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"	"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Nucleoli rim"	"HPA000568: AB_1858705, HPA001165: AB_1080541"			"unprognostic (7.52e-2)"		"unprognostic (6.60e-2)"	"unprognostic (4.04e-6)"	"unprognostic (6.47e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.00e-2)"		"unprognostic (9.17e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-2)"	3.6	3.5	0.9	2.4	1.5	6.8	3.5	2.0	2.2	0.0	1.6	2.9	2.5	0.0	9.4	4.1	0.0	3.5	2.9	0.9	1.2	3.1	4.1	4.2	2.1	2.1	1.1	0.0	3.4	2.9	4.0	3.4	2.1	8.1	6.2	4.5	4.3	6.2	5.7	5.1	6.3	0.0	1.3	3.4	2.9	3.8	1.4	0.0	3.8	5.2	6.0	3.6	0.0	3.2	0.0	2.5	0.0	0.0	0.0	0.0	8.7	4.5	7.7	5.0	7.5	0.0	0.0	12.4	0.0	5.1	0.0	0.0	0.0	0.0	6.9	6.9	0.0	20.6	0.0	0.0	6.4	0.0	0.0	7.8	7.8	0.0	0.0	0.0	0.0	4.2	0.0	0.0	5.5	0.0	7.1	0.1	0.0	0.0	0.0	0.0	3.1	5.6	5.4	8.3	4.9	0.0	0.0	0.0	14.9	8.5	0.0	4.4	5.9	8.7	0.0	0.0	3.1	13.5	16.4	20.2	0.8	0.0	0.0	1.8	1.7	3.8	2.6	1.9	3.7	2.9	2.6	2.1	1.8	3.2	3.6	2.7	3.9	5.8	2.2	2.9	3.2	1.1	0.9	1.5	2.0	2.2	0.9	1.2	2.1	1.1	2.1	1.3	1.4	3.2	0.0	16.0	25.3	58.4	35.4	11.3	18.4	8.2	44.3	35.2	0.0	0.0	6.1	5.7	10.7	18.4	64.6	10.0	8.0	3.0	0.0	4.8	0.4	0.0	0.0	9.0	1.8	19.6	66.7	0.0	3.7	9.3	37.8	0.0	16.4	0.0	12.5	2.1	3.0	37.0	65.2	3.3	2.0	14.2	14.5	2.0	10.8	12.7	8.8	54.4	18.1	12.8	25.7	57.8	65.8	1.5	2.2	11.7	23.2	14.0	2.9	2.6	10.7	37.4	0.0	4.7	5.0	4.0	6.8	33.2	15.3	13.3	25.1	0.0	2.9	21.3
VAMP4		ENSG00000117533	"Vesicle associated membrane protein 4"	O75379	1	171700160-171742074	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050418	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA050418: AB_2681121"	"unprognostic (9.38e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.66e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.69e-3)"	"unprognostic (5.10e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.80e-2)"	"prognostic unfavorable (5.43e-6)"	"unprognostic (8.92e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.15e-1)"	10.9	12.0	11.2	8.6	11.3	5.2	8.8	14.1	13.5	8.9	8.0	8.2	7.9	8.5	7.4	8.4	7.7	8.1	7.7	11.5	13.8	8.1	8.2	10.3	10.9	13.4	13.6	7.0	9.9	12.7	15.2	10.1	13.6	7.3	7.1	10.0	10.5	7.0	6.3	10.0	8.1	7.4	13.3	10.1	8.5	11.7	14.3	7.1	11.4	6.1	8.4	7.3	8.3	12.8	9.5	3.3	8.1	6.6	12.1	14.0	5.2	16.8	13.7	4.1	5.2	2.6	12.2	6.1	14.9	13.5	6.2	6.2	3.3	5.8	5.9	10.9	5.4	5.0	4.1	2.2	7.3	4.4	4.1	6.9	10.0	5.2	9.6	11.9	7.6	8.1	12.4	7.1	8.9	3.1	10.6	6.2	3.9	18.1	12.9	8.7	6.3	15.6	8.6	3.0	5.1	9.6	8.6	8.8	7.3	8.9	12.0	8.1	8.9	12.7	4.3	18.3	16.2	25.8	23.4	8.4	19.6	3.9	10.4	11.0	8.8	11.9	8.6	7.6	11.9	8.2	11.3	9.9	4.5	6.6	7.8	8.6	3.4	9.5	7.8	6.4	11.3	8.8	11.2	11.3	14.1	13.5	11.5	13.8	13.4	13.6	13.6	13.3	14.3	12.8	22.3	22.4	9.3	18.3	21.4	15.4	13.8	18.0	26.7	12.3	12.9	9.7	11.6	10.0	14.8	3.7	22.9	10.8	18.2	9.7	15.6	7.5	35.1	7.8	8.4	20.3	10.2	30.9	23.5	7.7	13.4	20.4	6.6	8.9	24.7	8.9	18.2	11.8	14.8	10.1	24.1	12.3	16.2	15.4	12.1	38.6	9.3	20.1	12.4	19.7	17.1	17.0	25.7	18.6	23.0	10.0	14.9	13.2	20.8	19.7	13.4	13.7	11.4	9.4	19.7	15.2	15.0	42.7	20.2	16.1	17.3	13.4	23.1	8.5	7.4	17.5
VPS52	"ARE1, SACM2L"	ENSG00000223501	"VPS52 subunit of GARP complex"	Q8N1B4	6	33250272-33272047	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 45.3;THP-1: 39.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042667, HPA048128"	Approved					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"			"HPA042667: AB_2678105, HPA048128: AB_2680278"	"unprognostic (2.65e-2)"	"unprognostic (2.13e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.03e-3)"	"unprognostic (6.07e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.49e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.63e-2)"	20.1	28.1	2.4	8.2	3.6	3.8	21.6	2.2	4.8	24.6	5.6	23.6	9.9	23.2	8.3	29.9	20.7	7.3	20.0	2.4	4.0	21.6	24.3	18.2	12.4	4.6	3.0	24.9	25.3	0.0	26.2	3.2	3.9	22.7	6.2	2.9	24.0	2.7	37.8	27.6	25.1	7.0	2.3	27.6	23.7	17.9	3.4	10.4	27.9	23.3	10.0	22.4	24.0	4.0	0.1	6.6	0.4	26.4	9.3	9.2	24.7	0.0	0.0	0.0	0.0	11.1	0.0	0.0	18.1	0.0	10.9	20.2	25.3	0.0	0.0	0.0	2.9	0.0	6.6	13.4	11.2	0.0	24.2	0.0	0.0	0.0	17.8	16.4	11.8	10.5	27.1	2.0	0.0	0.1	0.4	0.0	20.8	11.0	16.7	9.9	4.0	27.5	15.0	17.4	0.0	16.3	13.1	45.3	14.4	0.0	0.8	39.1	0.0	13.7	7.0	16.0	22.2	0.0	0.0	18.7	0.0	11.5	0.0	5.7	4.5	4.1	2.8	3.6	2.1	2.4	3.0	4.1	3.7	2.2	3.3	4.0	2.0	4.9	2.9	1.7	4.5	4.2	2.4	3.6	2.2	4.8	2.4	4.0	4.6	3.0	3.9	2.3	3.4	4.0	8.4	12.8	13.0	18.9	8.8	6.6	6.3	9.0	10.8	13.0	12.2	10.4	1.3	10.0	9.3	3.7	2.1	16.7	6.9	17.7	7.9	11.0	7.8	10.0	8.8	8.7	7.2	7.8	10.7	11.8	16.0	7.3	18.3	14.2	1.3	10.7	11.4	19.1	11.4	6.7	11.1	14.5	12.2	14.1	4.6	7.2	6.8	8.5	7.2	15.9	11.4	13.3	2.1	7.5	16.4	9.7	7.7	9.1	14.2	4.3	13.7	8.9	10.6	12.6	13.1	7.0	6.9	25.7	14.2	15.4	8.7	17.6	6.6	8.4	12.5	6.4
VTA1	"C6orf55, HSPC228, My012"	ENSG00000009844	"Vesicle trafficking 1"	Q9NP79	6	142147162-142224685	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030968, HPA030969"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		220000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Vesicles, Cytosol"		"HPA030968: AB_10602585, HPA030969: AB_2673679"	"prognostic unfavorable (7.02e-4)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (6.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-1)"	22.2	20.9	16.6	25.7	19.0	30.6	31.6	20.2	20.3	23.2	12.5	34.9	38.2	23.4	25.4	39.1	27.3	23.0	33.9	18.9	18.9	34.5	45.4	21.5	33.4	17.4	18.1	21.0	19.3	28.3	9.9	32.1	17.8	22.5	39.9	29.2	18.2	19.6	55.7	30.7	37.0	26.3	21.1	23.1	23.5	18.3	18.2	45.4	27.6	58.3	39.1	35.8	20.3	22.2	56.5	47.5	75.8	116.8	65.3	71.4	52.3	124.7	74.0	111.6	105.8	80.9	43.0	91.2	82.1	112.6	84.6	70.2	81.5	85.1	153.4	62.3	71.7	99.2	46.2	97.0	48.2	155.6	55.2	59.4	97.7	111.8	71.7	59.8	72.4	69.7	93.7	44.5	94.5	82.1	101.8	80.7	57.0	72.1	53.8	92.1	60.8	55.8	86.4	61.5	79.0	61.5	70.1	53.3	63.7	62.9	57.8	104.4	53.0	50.0	69.6	84.7	90.8	43.5	80.9	103.8	32.7	85.5	77.8	222.4	90.0	151.9	64.3	114.5	83.5	85.6	72.8	76.0	90.9	84.8	79.8	80.4	56.0	97.5	120.3	55.9	79.0	121.5	16.6	19.0	20.2	20.3	18.9	18.9	17.4	18.1	17.8	21.1	18.2	22.2	16.7	22.4	20.3	22.5	25.8	25.2	19.2	25.5	25.6	9.7	16.5	18.3	47.8	12.8	24.5	16.5	0.0	32.7	23.9	40.2	17.6	31.5	4.5	30.7	30.4	17.5	21.6	23.1	40.1	28.0	36.4	25.4	16.8	28.0	12.6	18.1	11.4	24.7	27.9	11.8	38.7	24.7	14.2	20.9	14.3	2.2	11.8	20.0	8.8	40.3	28.0	23.9	35.0	25.6	48.7	30.1	18.3	12.4	16.4	17.2	30.0	31.6	36.6	12.6	6.6	16.8	18.4	23.6	24.9	28.8	31.0	31.7	23.8	25.3	25.9	18.8
WAPL	"FOE, KIAA0261, WAPAL"	ENSG00000062650	"WAPL cohesin release factor"	Q7Z5K2	10	86435256-86521792	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037874, HPA037875, HPA066141"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA037874: AB_10697086, HPA037875: AB_10672396, HPA066141: "	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.91e-2)"	"unprognostic (6.63e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.78e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	15.4	13.2	8.4	19.6	9.9	27.1	16.6	11.9	9.2	12.8	7.8	15.4	15.2	14.8	8.7	15.9	11.7	13.1	10.3	7.5	8.3	16.8	22.6	16.5	25.0	8.2	8.5	13.7	14.4	16.9	4.9	18.4	8.3	13.0	15.2	36.0	11.2	11.7	20.9	17.9	16.0	14.8	8.9	19.0	16.5	35.1	9.0	33.7	17.9	22.5	27.7	17.9	9.2	10.4	42.6	19.6	33.5	44.4	26.1	27.6	29.6	36.4	44.2	30.3	32.4	42.9	36.6	64.3	24.1	32.5	26.7	39.1	38.3	31.3	46.3	42.1	25.3	38.9	30.9	47.4	29.7	79.8	43.1	21.9	35.7	38.9	64.9	34.5	34.6	36.8	41.7	37.6	35.2	36.3	49.9	29.6	29.9	26.4	19.5	35.2	27.1	25.6	26.3	37.2	13.1	25.2	32.3	21.4	40.9	33.2	47.1	41.9	33.5	29.1	34.4	25.8	48.6	36.8	54.9	66.9	26.7	55.8	20.9	15.0	3.5	7.7	3.4	4.1	4.9	3.9	4.5	4.7	4.8	4.0	5.1	4.0	5.5	3.2	7.4	3.6	6.1	2.4	8.4	9.9	11.9	9.2	7.5	8.3	8.2	8.5	8.3	8.9	9.0	10.4	38.3	83.3	54.8	0.0	48.3	0.0	57.4	0.0	35.3	49.1	41.3	27.9	0.0	20.0	21.1	16.5	20.9	42.8	62.4	17.4	21.5	60.8	86.8	36.7	44.4	33.9	18.2	94.1	0.0	52.5	28.3	30.0	37.8	52.2	25.2	40.3	32.5	47.6	40.4	55.5	0.0	21.5	0.0	56.5	0.0	42.0	32.0	58.3	0.0	0.0	81.0	48.7	55.6	0.0	0.0	52.1	27.5	32.4	50.5	56.6	25.0	35.5	13.8	113.4	65.7	70.3	33.6	153.4	90.2	48.4	0.0	76.1	51.4	35.2	24.8	74.1
WBP1	WBP-1	ENSG00000239779	"WW domain binding protein 1"	Q96G27	2	74458400-74460891	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 29.0;Gastric mucus-secreting cells: 33.1;Plasma cells: 57.2;Squamous epithelial cells: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057067	Approved		Approved	Cytosol		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA057067: AB_2683326"	"unprognostic (5.94e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (6.05e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (6.83e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.09e-2)"	"prognostic favorable (6.36e-4)"	36.9	70.7	141.7	19.6	145.8	31.9	37.7	139.4	171.9	48.2	133.1	46.6	29.1	39.1	44.8	35.7	56.1	36.5	49.9	137.7	136.6	71.2	80.3	33.7	32.2	144.2	141.3	55.6	62.3	73.7	60.8	24.9	138.2	69.9	17.7	24.4	56.4	37.3	31.4	34.9	33.2	19.8	138.1	42.5	58.0	31.8	145.0	44.7	66.9	53.9	20.6	45.7	37.5	139.0	20.6	91.3	56.2	66.7	69.9	54.0	45.7	20.6	40.3	22.4	17.5	47.3	41.9	19.4	39.3	48.9	33.2	28.3	24.8	55.8	19.0	74.3	49.1	27.4	41.4	68.9	47.6	10.3	27.4	76.2	58.9	30.4	42.2	93.8	44.7	51.6	11.5	72.0	54.8	133.8	40.1	25.5	43.3	53.6	46.3	36.4	63.5	33.6	55.9	83.1	35.0	81.3	28.2	49.9	62.5	49.4	65.5	26.9	26.5	53.0	41.9	20.0	23.5	106.7	38.8	22.2	56.2	27.0	48.5	24.1	28.5	19.2	26.5	23.5	22.5	28.4	23.0	25.5	30.2	27.8	31.3	28.0	18.6	34.6	20.1	47.0	39.2	27.1	141.7	145.8	139.4	171.9	137.7	136.6	144.2	141.3	138.2	138.1	145.0	139.0	1.5	3.2	4.2	0.0	14.3	0.9	0.6	2.0	29.0	1.6	3.2	2.2	0.5	0.0	4.2	1.8	2.1	1.4	1.7	3.3	1.9	5.5	2.4	3.1	2.4	3.6	1.8	9.7	0.0	3.9	1.4	7.2	33.1	1.8	1.3	1.1	0.4	0.8	1.7	0.0	0.0	4.7	2.0	2.4	1.0	1.8	2.1	7.1	0.0	0.0	6.0	1.7	2.1	0.0	0.0	5.2	3.1	1.2	57.2	1.2	5.6	3.3	13.1	1.7	0.0	0.5	5.8	0.6	0.2	28.1	1.3	1.8	10.4	0.9	3.7	0.3
WBP1L	"C10orf26, FLJ20154, OPAL1"	ENSG00000166272	"WW domain binding protein 1 like"	Q9NX94	10	102743948-102834516	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037635, HPA038371"	Uncertain		Approved	Nucleoplasm,Microtubules		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	Microtubules	Nucleoplasm	"HPA037635: AB_10672462, HPA038371: AB_2675980"	"unprognostic (3.28e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (5.35e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.56e-6)"	"unprognostic (2.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.53e-1)"	34.9	43.2	21.3	22.3	23.1	5.0	25.8	20.7	20.1	26.4	28.7	27.7	15.2	27.4	18.9	21.1	29.4	25.1	24.1	19.8	22.4	20.8	42.1	24.5	21.4	32.0	23.9	26.5	15.5	41.7	22.9	23.5	23.6	26.9	15.0	5.7	22.6	22.4	54.6	37.5	19.9	26.2	25.9	21.3	25.7	14.2	24.7	33.7	41.1	49.0	18.9	24.5	20.5	22.6	21.0	26.8	14.5	24.5	47.0	37.9	29.5	21.0	56.7	20.5	25.8	18.3	31.9	18.1	27.8	32.5	16.5	22.7	10.7	18.2	15.5	18.3	11.3	36.6	11.6	13.3	30.3	17.8	41.7	41.2	32.0	26.4	20.3	47.0	40.5	21.6	18.1	22.0	35.6	27.5	21.7	19.8	11.0	16.1	12.9	42.9	38.3	11.7	18.2	20.4	3.4	13.9	11.5	11.6	24.1	26.0	47.2	19.5	30.4	19.6	20.1	22.3	19.1	40.6	22.9	13.0	27.7	33.6	8.8	7.8	12.2	16.2	8.7	14.8	7.0	6.5	7.3	8.4	8.7	6.1	6.5	6.9	15.2	12.9	19.4	5.4	8.2	10.6	21.3	23.1	20.7	20.1	19.8	22.4	32.0	23.9	23.6	25.9	24.7	22.6	13.3	22.4	19.0	29.4	12.2	8.2	8.0	17.0	11.4	6.4	25.0	15.4	15.7	12.8	17.8	12.9	0.0	33.9	17.2	26.4	1.9	14.2	2.0	9.7	11.0	20.4	9.1	11.1	24.6	25.3	14.6	29.3	16.8	12.7	38.1	16.4	27.1	56.2	27.7	13.5	26.4	14.6	14.2	46.6	13.1	1.8	13.1	28.8	10.6	40.3	28.9	9.8	29.9	19.1	26.3	24.6	13.7	19.5	9.0	29.9	18.3	8.9	20.5	3.8	19.7	16.6	17.7	4.4	5.8	11.3	11.8	40.0	14.4	8.9	12.2	11.3
WDR36	"GLC1G, TA-WDRP, UTP21"	ENSG00000134987	"WD repeat domain 36"	Q8NI36	5	111091716-111130502	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Sensory transduction, Vision"		"Disease variant, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 113.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037796, HPA037797"	Supported		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA037796: AB_2675673, HPA037797: AB_10672725"	"unprognostic (2.14e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.10e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (4.91e-2)"	9.1	6.3	3.5	9.4	3.5	9.9	10.1	4.7	4.5	7.4	4.1	7.0	6.5	9.0	6.6	7.9	6.8	7.2	6.0	3.9	4.1	7.5	14.1	6.3	11.3	3.6	4.0	10.1	6.4	7.3	4.5	7.5	3.8	8.3	8.1	4.7	6.0	7.0	9.1	10.1	6.8	7.5	3.8	8.8	7.3	6.3	3.9	9.1	9.7	7.2	12.0	9.8	6.1	4.2	17.0	14.9	13.7	36.6	24.7	32.2	19.2	14.6	13.9	19.5	27.9	19.1	19.7	53.8	17.0	12.2	22.7	19.2	26.8	33.8	34.8	15.9	15.7	26.6	17.2	19.5	26.3	25.6	38.8	19.2	21.4	34.6	37.5	36.5	20.3	18.4	32.3	18.1	25.8	14.3	31.7	24.9	18.3	16.8	15.6	25.6	29.9	42.4	18.1	19.3	24.3	19.5	18.6	15.2	22.4	15.0	15.2	21.3	19.1	28.1	15.6	20.0	30.5	18.1	14.0	48.6	22.4	37.9	22.2	0.3	2.5	1.0	3.3	3.3	3.8	2.7	3.0	3.7	4.0	2.4	4.3	3.6	0.1	3.3	5.0	2.1	3.8	2.6	3.5	3.5	4.7	4.5	3.9	4.1	3.6	4.0	3.8	3.8	3.9	4.2	17.2	19.2	13.8	15.3	26.0	61.1	15.4	18.3	113.3	9.9	14.5	12.1	15.6	18.6	19.6	16.5	6.2	9.4	15.4	5.3	7.9	9.5	5.1	10.6	26.0	20.4	6.0	20.6	30.5	13.8	9.9	20.7	13.7	16.2	14.0	16.9	12.5	35.1	14.7	11.8	24.8	12.9	16.2	24.1	16.0	4.2	8.7	18.2	21.4	20.6	18.3	5.7	16.5	27.6	22.3	9.9	6.4	11.3	27.5	20.8	5.3	11.3	12.3	8.6	19.7	20.2	17.3	18.5	17.8	42.3	57.8	5.3	18.0	18.1	13.4	11.2
WDR75	"FLJ12519, NET16, UTP17"	ENSG00000115368	"WD repeat domain 75"	Q8IWA0	2	189441446-189475552	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"				"unprognostic (1.23e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (6.50e-8)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.93e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.15e-11)"	"unprognostic (1.34e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-2)"	18.0	21.1	16.5	18.7	16.6	20.5	24.3	17.9	20.5	23.5	14.7	16.3	13.8	23.4	23.8	18.0	21.2	14.9	13.7	16.3	17.3	15.5	17.7	12.3	26.3	17.5	16.1	23.4	19.8	17.3	13.5	16.9	17.5	15.1	18.2	15.8	13.6	13.1	15.9	21.9	16.0	19.5	17.9	21.6	16.3	16.1	17.6	20.6	14.7	13.8	24.1	23.1	17.9	19.4	36.0	34.3	43.7	55.2	46.7	49.5	49.2	73.3	34.1	82.0	62.7	71.5	39.7	76.1	41.0	24.1	31.6	48.3	81.9	49.0	79.7	49.9	39.1	99.5	60.3	55.4	44.4	111.2	48.7	41.1	41.3	59.4	80.6	34.7	55.9	43.5	99.9	45.3	56.3	35.7	54.8	77.4	101.6	41.5	92.6	51.0	65.4	64.0	41.3	42.5	41.2	41.9	46.1	44.1	38.1	70.2	40.7	45.9	48.3	48.7	52.4	37.4	55.3	48.7	81.2	95.1	34.5	47.5	40.3	0.7	4.3	2.5	5.7	7.4	11.3	5.9	6.3	7.4	8.0	4.3	7.7	7.5	0.0	7.6	4.6	4.5	8.4	4.7	16.5	16.6	17.9	20.5	16.3	17.3	17.5	16.1	17.5	17.9	17.6	19.4	19.8	28.9	16.4	20.5	20.4	17.0	21.0	16.6	26.7	6.4	8.3	9.7	18.3	2.8	13.1	1.8	8.4	19.0	13.3	4.2	11.7	15.0	2.1	10.6	27.3	18.0	9.0	15.8	32.8	16.9	16.0	17.8	15.3	12.0	5.1	13.7	9.7	8.5	10.7	16.8	41.2	12.1	20.3	44.5	8.5	3.8	18.0	11.9	14.2	12.2	11.4	4.8	9.2	28.6	29.7	16.3	6.7	15.8	14.9	16.6	6.1	14.6	11.3	9.6	19.7	20.4	19.6	30.5	31.4	18.1	11.2	17.2	19.5	17.0	11.4	15.2
XRN1	SEP1	ENSG00000114127	"5'-3' exoribonuclease 1"	Q8IZH2	3	142306607-142448062	"Predicted intracellular proteins"		"DNA-binding, Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"RH-30: 119.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035005, HPA035006"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane, Cytosol"		"HPA035005: AB_10670695, HPA035006: AB_10672750"	"unprognostic (3.52e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.43e-2)"	"unprognostic (6.32e-2)"	9.0	6.8	2.9	12.2	4.5	21.2	10.7	11.4	5.5	8.4	6.4	8.2	11.0	9.8	7.8	7.0	6.2	8.0	5.5	3.2	4.0	6.8	16.2	8.6	13.1	3.8	3.2	10.1	8.1	8.8	6.0	10.5	4.2	8.8	9.4	14.6	7.4	6.1	11.7	9.4	12.4	6.6	4.5	12.8	9.0	9.3	3.9	14.4	8.7	9.7	11.3	7.7	8.2	6.8	22.1	3.9	9.6	8.6	11.1	17.0	5.9	9.9	12.9	12.3	15.2	3.6	6.1	8.9	10.3	13.3	10.0	8.6	8.6	5.2	19.2	21.4	6.5	12.7	7.3	3.5	9.6	12.8	12.7	14.0	6.1	8.8	11.7	12.1	11.4	9.7	8.0	20.4	11.7	4.5	11.2	7.6	3.0	3.4	4.4	9.0	119.2	11.4	6.5	10.8	5.7	7.3	17.3	10.4	8.2	5.9	11.9	10.8	16.0	9.0	4.7	10.3	8.7	29.1	14.2	13.7	8.4	7.2	7.9	31.0	5.8	17.2	10.0	5.4	7.1	9.8	7.7	9.1	2.9	7.2	10.1	7.0	21.2	5.9	5.0	8.0	6.2	3.1	2.9	4.5	11.4	5.5	3.2	4.0	3.8	3.2	4.2	4.5	3.9	6.8	66.1	54.5	33.3	74.7	55.9	25.6	33.7	22.7	33.6	33.7	27.2	21.0	26.5	18.6	30.2	46.0	50.1	22.9	80.8	46.5	11.7	16.5	49.9	31.9	50.7	40.6	28.2	43.6	101.6	12.5	7.8	41.8	48.4	29.0	21.5	33.7	33.9	48.0	16.3	26.9	114.2	22.5	14.2	28.9	23.0	19.1	24.8	38.8	14.2	81.5	41.4	21.0	50.4	126.7	120.4	18.6	41.9	29.0	111.7	44.0	43.4	13.2	34.2	53.9	6.6	56.0	39.9	61.8	20.5	27.6	28.3	53.5	69.8	37.1	15.0	43.8
YY1AP1	"HCCA2, YAP, YY1AP"	ENSG00000163374	"YY1 associated protein 1"	Q9H869	1	155659443-155689000	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006986, HPA064249"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"		"HPA006986: AB_1080620, HPA064249: AB_2685226"	"unprognostic (1.96e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.13e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (2.01e-6)"	"unprognostic (6.81e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.39e-1)"	"unprognostic (5.84e-2)"	41.9	36.1	35.4	28.1	38.6	77.2	42.8	51.1	41.6	47.1	20.7	56.6	23.5	41.5	38.6	53.0	44.2	26.7	48.1	33.5	32.7	42.3	38.3	49.3	38.6	32.6	35.2	47.5	37.6	35.4	47.1	32.0	32.4	46.3	35.6	41.3	41.0	37.6	113.8	54.0	39.7	42.6	31.7	47.9	41.8	74.6	38.8	50.4	39.9	73.2	49.8	45.8	45.8	41.3	63.5	32.0	40.3	45.9	44.9	40.4	86.5	39.9	58.0	70.4	59.9	49.3	65.7	50.1	38.4	58.6	35.8	60.5	61.3	55.7	66.2	46.7	30.5	41.6	36.2	31.2	47.5	66.7	54.2	43.0	56.1	53.7	68.5	48.8	44.3	47.5	55.8	69.9	52.2	56.0	68.5	32.4	63.7	86.5	46.4	53.7	34.9	80.4	42.7	45.5	40.3	47.8	52.6	75.0	51.5	72.5	82.3	108.7	36.0	39.4	34.6	41.4	53.5	87.7	62.8	123.2	38.9	43.0	46.4	40.3	27.6	50.3	34.7	27.5	36.8	26.7	29.6	36.4	34.0	20.9	25.5	25.5	29.5	45.0	27.7	15.9	40.1	35.1	35.4	38.6	51.1	41.6	33.5	32.7	32.6	35.2	32.4	31.7	38.8	41.3	18.3	19.2	26.7	28.7	26.0	34.7	30.5	20.2	38.7	24.5	27.4	21.3	23.2	22.8	22.9	12.9	43.8	23.6	24.5	25.7	13.7	17.3	68.0	20.0	21.8	24.5	34.9	42.9	33.8	19.1	27.9	24.7	25.0	25.5	25.3	16.6	15.7	23.1	21.5	16.8	34.8	23.8	12.2	20.8	36.3	81.0	28.0	28.5	19.6	37.5	27.4	20.8	15.5	38.7	48.3	18.4	16.2	25.6	36.9	29.2	22.5	11.7	17.3	24.9	6.6	24.9	22.3	77.6	25.5	38.8	35.7	45.0	26.7	26.6	24.4	33.8
ZACN	"L2, LGICZ, LGICZ1, ZAC, ZAC1"	ENSG00000186919	"Zinc activated ion channel"	Q401N2	17	76071961-76083666	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Gastric mucus-secreting cells: 1.1;Respiratory ciliated cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA						"Cluster 59: Non-specific - Transcription"				"unprognostic (8.27e-2)"	"unprognostic (2.89e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.10e-3)"	"unprognostic (5.17e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.16e-5)"	"unprognostic (2.70e-2)"	"unprognostic (5.19e-7)"	"unprognostic (6.27e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.16e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.7	0.4	0.3	0.1	0.1	0.6	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.4	0.1	0.3	1.1	0.2	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.3	0.0	0.8	0.4	0.0	0.1	1.0	0.1	0.0	0.4	0.2	0.0	0.1	0.3	0.1	0.3	0.6	0.0	0.1	0.2
ZBTB6	"ZID, ZNF482"	ENSG00000186130	"Zinc finger and BTB domain containing 6"	Q15916	9	122908056-122913323	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 10.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054111, HPA076894"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Mitochondria	"HPA054111: AB_2682384, HPA076894: AB_2686818"	"unprognostic (9.74e-3)"	"unprognostic (8.40e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.84e-2)"	"prognostic favorable (2.06e-5)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"prognostic favorable (5.08e-4)"	"unprognostic (4.31e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.92e-2)"	4.2	4.4	3.4	7.0	3.9	3.2	6.8	5.2	5.8	5.4	2.8	5.3	5.9	6.3	4.0	4.9	5.0	4.0	5.5	3.4	3.6	4.8	4.2	4.5	9.7	3.5	3.6	7.2	4.5	6.6	2.3	4.5	3.8	4.9	4.8	7.3	4.5	4.7	6.7	5.0	5.8	4.7	4.1	6.7	5.5	5.5	3.5	7.3	7.5	7.0	9.2	5.3	2.6	5.3	5.1	5.9	9.3	8.5	9.6	9.2	9.4	8.4	10.3	8.3	7.3	6.1	6.3	8.1	5.1	7.6	7.4	22.8	9.8	10.3	10.3	11.5	7.8	8.6	11.9	5.7	9.5	11.4	14.9	7.6	15.5	7.6	12.5	10.2	7.7	10.1	9.2	9.7	12.1	9.6	11.6	7.7	11.7	15.0	9.9	6.1	25.6	11.4	8.7	8.3	11.7	15.2	13.0	12.6	8.2	9.8	15.8	7.4	7.9	9.0	7.0	9.2	9.8	17.0	21.7	2.2	10.5	7.7	9.3	10.6	1.5	2.3	1.2	1.7	1.7	1.4	1.7	1.2	1.6	1.0	2.4	2.2	2.0	2.5	2.9	0.9	2.0	1.7	3.4	3.9	5.2	5.8	3.4	3.6	3.5	3.6	3.8	4.1	3.5	5.3	5.3	6.4	3.6	3.6	6.8	2.2	3.1	2.9	3.4	8.0	4.1	2.9	3.5	7.2	6.9	1.8	10.4	2.3	7.2	3.5	0.0	2.7	9.1	4.4	7.6	4.4	3.0	2.1	4.6	2.5	1.3	5.4	4.1	3.7	7.6	5.0	6.1	3.1	2.4	6.7	5.1	3.9	4.1	7.6	4.0	4.4	3.1	4.1	1.8	3.7	4.3	8.8	2.1	6.6	6.8	2.9	2.5	7.9	3.7	4.1	2.9	4.2	5.3	10.6	6.6	5.1	5.2	6.0	5.1	4.9	2.7	1.9	5.8	5.0	3.4	3.2
ZC3H11A	"KIAA0663, ZC3HDC11A"	ENSG00000058673	"Zinc finger CCCH-type containing 11A"	O75152	1	203795623-203854999	"Predicted intracellular proteins"	"mRNA transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA026439, HPA028490, HPA028526"	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA026439: AB_10599829, HPA028490: AB_10601447, HPA028526: AB_10611533"	"unprognostic (8.69e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.41e-1)"	14.9	15.6	8.3	20.9	12.3	28.8	15.5	11.5	11.7	14.2	13.1	14.7	20.4	18.7	12.8	16.8	16.1	15.2	13.9	8.2	9.6	16.6	16.2	14.5	26.2	9.4	8.9	18.9	15.5	19.8	5.6	17.4	10.0	16.2	17.7	20.2	19.4	13.2	23.4	26.2	22.5	16.6	5.6	23.1	20.4	22.9	9.7	33.4	22.6	23.1	25.5	16.1	6.5	15.5	29.7	23.8	45.2	28.8	28.7	22.9	49.7	33.6	24.0	27.0	30.2	32.7	36.2	37.6	19.9	35.7	22.0	41.0	35.8	19.7	37.2	56.6	25.8	36.3	39.3	16.5	15.4	50.9	62.3	19.1	23.5	29.0	28.2	34.2	25.5	40.4	74.0	51.6	24.0	24.2	56.2	20.3	42.6	20.8	19.4	40.1	52.1	24.7	19.1	50.0	33.1	31.4	33.8	27.5	29.8	51.7	29.5	38.1	39.2	39.2	34.7	33.1	32.3	36.8	37.3	58.5	25.2	29.1	30.7	15.6	3.6	5.5	5.2	3.5	7.2	5.0	4.7	4.8	4.2	3.5	5.9	4.4	7.9	5.1	5.8	2.3	5.0	4.2	8.3	12.3	11.5	11.7	8.2	9.6	9.4	8.9	10.0	5.6	9.7	15.5	2.4	12.8	22.5	105.8	49.2	101.5	61.7	50.6	112.7	46.2	1.1	0.9	54.2	58.6	38.4	0.0	45.9	31.1	18.2	43.6	0.0	0.3	54.7	3.1	2.9	49.9	46.7	67.1	71.9	0.2	27.3	51.5	53.0	3.9	25.3	0.9	54.7	70.0	32.5	84.1	69.0	64.2	28.5	54.6	60.8	14.3	60.3	37.2	48.0	82.4	31.7	40.5	41.2	103.0	169.4	0.6	42.2	67.4	64.1	104.0	52.1	0.3	43.9	49.8	78.9	83.3	42.1	63.6	40.2	84.5	111.5	51.0	41.4	0.5	52.1	114.2
ZCCHC4	"FLJ23024, HSPC052, ZGRF4"	ENSG00000168228	"Zinc finger CCHC-type containing 4"	Q9H5U6	4	25312774-25370383	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 19.6;Oligodendrocytes: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035575, HPA035576"	Uncertain		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles, Golgi apparatus"		"HPA035575: AB_2674682, HPA035576: AB_10671516"	"unprognostic (5.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.07e-2)"	4.5	3.6	2.8	3.5	3.6	3.8	5.0	3.7	3.5	4.3	3.5	3.9	3.8	5.2	4.0	3.3	4.3	3.3	4.6	2.7	3.0	3.8	3.5	3.6	5.2	3.3	3.1	6.1	3.4	6.0	2.7	3.3	3.4	3.9	4.0	4.8	3.9	3.9	7.4	4.3	4.0	3.7	3.0	4.4	3.4	4.4	3.3	4.8	4.5	5.5	4.5	4.1	3.6	4.3	4.5	2.8	9.1	4.2	6.9	8.8	8.1	11.4	12.1	13.1	15.0	4.4	11.9	7.5	3.1	7.0	12.9	3.5	8.9	8.3	18.2	1.8	4.8	7.0	5.8	7.4	8.8	11.6	4.9	7.0	9.2	12.5	9.8	7.8	6.3	11.4	12.7	3.6	11.3	3.4	12.0	15.2	12.5	7.4	6.0	8.0	13.9	4.6	7.1	4.7	8.4	5.8	4.9	4.1	7.4	8.8	6.0	6.9	5.0	11.0	4.6	7.2	15.7	7.2	9.6	11.0	11.8	11.0	10.8	1.4	1.9	0.6	3.0	2.4	4.4	3.5	3.9	3.8	2.8	3.6	3.7	4.1	1.1	4.4	2.3	2.1	4.3	2.3	2.8	3.6	3.7	3.5	2.7	3.0	3.3	3.1	3.4	3.0	3.3	4.3	5.9	0.0	5.8	12.1	7.6	3.7	4.0	4.3	6.8	3.7	3.0	2.9	6.4	1.5	5.5	0.0	2.1	5.9	4.2	2.1	3.9	3.8	1.5	5.5	5.1	4.6	2.4	2.1	10.7	2.3	4.5	4.8	3.1	3.9	1.3	6.4	2.2	3.1	5.1	3.3	15.5	3.6	6.1	4.4	2.2	0.5	4.1	3.3	3.6	5.6	2.6	5.5	5.2	19.6	23.6	2.9	3.9	5.3	3.7	2.7	5.7	4.5	8.2	5.2	0.0	5.2	5.7	9.0	9.1	4.9	3.4	3.7	5.4	4.0	4.4	2.5
ZFP1	"FLJ34243, ZNF475"	ENSG00000184517	"ZFP1 zinc finger protein"	Q6P2D0	16	75148494-75172236	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-698: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044916, HPA062910"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA044916: AB_2679144, HPA062910: AB_2684902"	"unprognostic (1.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.24e-5)"	"unprognostic (1.36e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (5.55e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.08e-1)"	4.2	3.3	3.7	1.7	4.4	1.8	3.9	4.4	5.1	4.8	1.7	5.4	1.7	5.7	2.2	2.7	4.8	2.7	3.6	4.6	3.4	3.7	11.1	3.5	3.1	3.3	3.0	5.1	2.1	4.6	3.8	3.0	3.3	2.9	2.0	5.8	2.2	3.1	5.8	2.7	3.0	4.0	3.7	2.5	3.0	4.2	3.7	8.2	4.8	4.3	3.2	4.7	3.6	5.3	3.1	6.6	9.1	8.2	5.1	6.7	3.6	3.7	4.4	8.2	9.8	5.3	2.4	13.1	4.2	3.0	3.2	3.8	8.1	5.6	9.5	7.2	4.9	4.8	2.4	4.0	4.4	4.7	14.8	4.5	5.5	6.1	7.9	8.6	5.4	12.3	5.6	2.7	6.4	11.9	16.4	4.6	2.8	2.6	2.5	15.1	4.0	4.2	3.6	2.8	9.0	7.2	9.0	2.7	3.5	2.3	6.0	3.9	3.7	7.4	7.9	3.4	4.3	11.2	11.5	28.6	3.6	6.7	5.8	1.1	0.7	0.2	1.5	1.2	1.6	1.2	1.1	1.7	0.7	1.6	1.4	1.5	0.0	1.9	0.5	0.3	1.7	0.9	3.7	4.4	4.4	5.1	4.6	3.4	3.3	3.0	3.3	3.7	3.7	5.3	5.4	6.4	4.8	6.8	5.1	5.4	2.5	2.3	5.7	6.9	3.8	3.4	4.2	1.5	2.0	1.8	0.0	2.9	7.6	1.0	1.9	3.6	4.6	2.9	7.5	5.3	7.2	4.6	9.5	2.3	2.7	5.9	0.0	3.9	1.3	5.1	3.9	11.7	2.0	13.5	8.5	0.9	0.0	4.1	2.7	5.2	3.4	1.8	1.8	7.5	3.6	6.8	4.1	7.1	11.7	1.6	1.0	4.1	2.7	2.3	0.8	3.6	2.6	3.8	0.0	5.6	8.2	15.9	8.8	5.0	5.8	4.1	5.5	4.7	1.8	2.4
ZFY	ZNF911	ENSG00000067646	"Zinc finger protein Y-linked"	P08048	Y	2935281-2982506	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 35.7;Late spermatids: 88.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA001748, HPA071863"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA001748: AB_1080650, HPA071863: AB_2686463"			"unprognostic (1.07e-1)"		"unprognostic (7.43e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (1.07e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.75e-2)"		"unprognostic (2.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.91e-1)"		"unprognostic (2.54e-2)"	2.6	1.7	0.6	2.5	0.8	8.0	2.1	3.3	2.1	0.0	1.0	2.3	2.7	0.0	3.0	4.6	0.0	3.1	1.9	0.6	1.0	1.7	4.4	1.7	1.3	0.8	0.9	0.0	2.6	1.9	1.6	3.8	0.9	5.0	5.0	2.3	2.7	4.0	3.4	1.8	4.2	0.0	0.7	2.2	2.5	7.2	0.6	0.0	2.8	7.4	3.7	3.2	0.0	1.2	0.0	5.9	0.0	0.0	0.0	0.0	9.3	13.6	13.5	11.5	10.7	0.0	0.0	10.0	0.0	14.6	0.0	0.0	0.0	0.0	14.7	15.5	0.0	19.2	0.2	7.6	9.6	0.0	0.0	10.6	9.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	12.8	0.0	8.5	0.0	4.9	0.0	0.0	0.0	8.1	5.2	7.6	17.7	9.8	0.0	0.0	0.0	13.4	6.4	0.0	6.5	11.7	11.3	0.0	0.1	7.3	6.7	0.0	17.5	1.8	0.0	0.0	0.0	2.7	2.2	2.3	1.8	3.1	2.0	2.5	1.3	2.8	2.4	2.7	1.4	1.5	2.9	1.5	2.0	1.6	1.8	0.6	0.8	3.3	2.1	0.6	1.0	0.8	0.9	0.9	0.7	0.6	1.2	0.0	9.6	10.5	7.2	14.7	11.1	10.6	6.8	10.2	12.4	0.0	0.0	7.6	7.2	10.3	1.8	8.4	5.0	8.0	1.0	0.0	4.4	35.7	0.0	0.0	5.8	1.8	11.1	14.1	0.0	2.8	7.8	11.7	0.0	7.0	0.0	10.0	3.7	3.4	13.5	11.3	1.9	2.0	11.3	12.6	88.9	9.9	10.5	3.6	6.5	8.0	12.1	18.6	7.5	6.7	1.3	0.0	10.9	12.2	11.7	1.9	3.3	7.5	8.6	13.1	6.5	5.9	20.3	7.7	12.8	9.5	3.7	12.7	0.1	2.4	12.0
ZGPAT	"dJ583P15.3, FLJ14972, GPATC6, GPATCH6, KIAA1847, MGC44880, ZC3H9, ZC3HDC9, ZIP"	ENSG00000197114	"Zinc finger CCCH-type and G-patch domain containing"	Q8N5A5	20	63707465-63736142	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 123.5"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 14.2;Gastric mucus-secreting cells: 13.7;Plasma cells: 26.9;Squamous epithelial cells: 11.1;T-cells: 8.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056705			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Plasma membrane"		"HPA056705: AB_2683213"	"unprognostic (4.50e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.58e-2)"	"prognostic favorable (6.17e-5)"	"unprognostic (1.06e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.31e-3)"	"unprognostic (1.60e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.86e-3)"	14.5	17.0	5.3	8.8	5.8	14.8	14.6	5.4	8.9	15.7	7.5	18.0	10.0	16.1	3.4	16.6	14.2	5.5	16.0	5.6	4.7	22.2	123.5	13.0	11.5	7.6	5.4	11.9	14.0	8.4	14.4	6.5	5.9	14.9	3.0	1.4	13.7	6.7	16.7	19.0	14.8	4.9	4.1	20.3	15.3	20.2	5.7	9.5	13.8	4.3	4.1	15.9	15.0	7.4	15.3	19.3	7.4	12.0	6.0	4.2	17.1	15.5	10.1	24.0	10.0	41.6	20.4	15.6	28.9	8.8	23.3	27.4	5.0	18.3	3.0	10.7	13.3	14.8	16.9	43.3	11.7	9.4	25.2	10.7	15.3	9.9	3.9	6.5	13.2	18.5	16.5	13.9	8.0	15.3	22.6	22.1	12.1	22.3	24.0	23.9	5.7	15.7	13.5	14.0	14.0	17.4	22.1	24.7	14.2	3.7	16.9	26.0	15.2	37.2	13.3	14.3	20.1	13.9	24.3	22.2	23.5	9.3	17.0	8.6	21.0	26.5	28.3	21.5	28.1	19.2	24.6	26.3	19.7	16.2	23.9	24.7	21.8	26.4	18.4	28.2	26.2	18.6	5.3	5.8	5.4	8.9	5.6	4.7	7.6	5.4	5.9	4.1	5.7	7.4	0.3	3.2	3.4	4.6	8.0	0.0	0.0	0.1	14.2	1.0	0.2	0.3	0.3	0.0	1.3	0.0	0.0	0.2	0.7	0.4	0.0	0.1	0.1	0.4	1.1	2.1	1.8	6.3	7.4	0.2	0.3	3.3	13.7	0.6	2.5	0.5	0.4	2.3	0.2	0.0	5.8	0.2	0.0	1.3	0.0	0.0	0.0	5.4	1.8	8.4	0.0	0.2	0.0	5.5	4.6	0.4	0.1	0.0	26.9	0.2	0.3	0.5	0.1	1.1	0.0	0.5	1.4	0.3	0.1	11.1	0.3	0.3	8.9	0.5	0.2	0.1
ZMYM1	"FLJ23151, MYM"	ENSG00000197056	"Zinc finger MYM-type containing 1"	Q5SVZ6	1	35032172-35115859	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064019			Approved	"Centriolar satellite"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	"Centriolar satellite"		"HPA064019: AB_2685178"	"unprognostic (7.82e-2)"	"unprognostic (1.80e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (3.21e-6)"	"unprognostic (2.18e-1)"	"unprognostic (9.85e-3)"	"unprognostic (5.51e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.73e-1)"	2.7	2.0	1.2	2.1	1.7	1.0	4.4	2.0	1.7	3.6	2.7	2.7	2.4	3.3	4.4	2.7	2.7	2.0	1.3	1.1	1.6	2.8	2.2	2.3	3.4	1.6	1.6	4.9	1.7	2.8	0.7	3.4	1.6	3.0	2.8	3.7	2.9	2.8	1.6	4.2	2.9	2.7	1.7	3.4	2.7	4.0	1.5	4.1	3.9	2.8	2.8	1.9	1.6	2.2	11.8	6.2	9.6	8.6	9.8	11.3	5.5	10.5	7.9	8.9	9.7	6.4	13.0	7.6	4.4	5.9	5.0	11.9	9.0	8.3	15.9	2.0	3.6	7.9	5.7	5.7	6.0	6.0	3.7	8.4	7.1	14.1	13.2	7.0	13.8	7.4	7.3	3.2	10.2	5.8	7.9	2.7	14.6	4.6	5.4	5.1	10.1	0.0	4.7	6.8	4.7	6.1	9.9	7.7	9.7	13.0	6.7	3.7	7.3	7.4	8.9	5.9	10.9	0.2	0.6	1.2	4.3	4.1	6.4	5.6	0.7	1.1	1.8	1.1	2.0	1.0	1.5	1.3	1.0	0.8	1.3	1.5	0.6	3.1	2.7	1.1	1.4	0.7	1.2	1.7	2.0	1.7	1.1	1.6	1.6	1.6	1.6	1.7	1.5	2.2	16.4	12.8	8.9	16.6	9.2	1.7	10.3	11.2	19.9	8.1	6.7	10.4	4.8	2.8	7.4	14.7	0.0	6.5	9.5	1.8	9.8	6.0	7.0	8.9	16.1	10.3	1.8	11.6	7.1	3.5	6.1	11.4	3.6	6.2	6.3	17.9	5.0	3.6	4.4	11.8	10.8	3.5	4.1	5.8	1.4	5.7	7.5	7.6	1.8	17.8	6.2	6.6	9.2	11.1	19.9	3.8	0.8	7.9	6.6	9.6	3.7	6.0	8.6	4.2	13.1	12.4	9.9	24.7	12.4	12.2	1.4	3.7	10.1	14.7	4.5	7.5
ZNF10	KOX1	ENSG00000256223	"Zinc finger protein 10"	P21506	12	133130575-133159465	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 45.5;Excitatory neurons: 46.0;Inhibitory neurons: 48.4;Oligodendrocyte precursor cells: 54.3;Oligodendrocytes: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA003204	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA003204: AB_1080663"	"unprognostic (1.55e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.39e-3)"	"unprognostic (4.02e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.35e-3)"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.13e-3)"	6.7	14.3	4.9	3.7	5.6	8.6	12.3	8.8	7.6	14.4	6.2	10.9	3.7	15.0	23.4	6.0	12.1	10.3	8.3	5.8	8.0	10.9	10.6	7.6	5.9	4.7	6.8	22.4	13.2	17.3	45.3	5.2	5.6	15.1	6.2	13.1	8.0	12.7	4.9	8.8	7.1	8.6	5.4	6.0	10.5	15.3	7.8	7.7	21.2	6.3	5.8	10.7	8.8	7.1	3.8	2.2	10.8	0.0	11.5	4.8	6.5	4.4	3.9	5.3	3.6	3.9	2.4	0.0	6.0	4.4	2.9	1.7	6.8	3.6	3.9	0.0	6.6	8.0	10.5	4.4	3.5	5.0	2.6	5.0	3.3	5.7	6.3	7.9	4.4	6.3	6.0	0.0	6.3	1.2	12.0	10.6	11.1	2.1	4.4	9.9	6.8	5.4	4.2	7.9	10.7	7.0	8.7	1.4	3.7	4.9	6.6	5.0	4.3	3.9	3.6	3.7	3.7	0.2	0.0	12.8	1.2	1.7	3.7	0.9	0.5	1.4	2.9	0.6	3.2	3.1	3.4	4.1	1.4	3.0	6.5	3.3	0.5	6.3	0.4	3.4	0.9	1.8	4.9	5.6	8.8	7.6	5.8	8.0	4.7	6.8	5.6	5.4	7.8	7.1	6.8	0.0	9.0	39.2	39.6	3.8	5.3	3.9	45.5	15.9	9.9	9.4	7.7	4.3	7.1	0.0	31.3	4.5	9.1	1.8	1.9	2.3	24.6	11.9	7.6	5.0	12.6	5.0	46.0	1.4	2.0	15.5	21.4	11.7	10.8	5.0	1.4	4.9	2.5	5.0	48.4	3.9	6.1	3.8	4.6	6.3	2.8	9.0	3.6	21.5	1.5	9.1	2.1	54.3	45.4	1.0	2.1	6.8	16.3	2.6	2.2	2.5	2.7	16.2	0.0	6.3	14.3	20.4	15.4	21.4	3.8	3.8	21.9	6.0	3.3	1.6
ZNF14	"GIOT-4, KOX6"	ENSG00000105708	"Zinc finger protein 14"	P17017	19	19710472-19733112	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA049863	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA049863: AB_2680921"	"unprognostic (1.04e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (7.96e-4)"	"unprognostic (1.84e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (8.09e-6)"	"unprognostic (1.83e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.17e-2)"	"unprognostic (9.05e-3)"	3.0	2.6	3.4	3.3	3.7	8.3	7.3	7.1	4.4	5.6	1.4	3.1	2.2	5.2	5.2	2.7	5.1	2.8	3.8	2.8	3.6	4.7	0.8	2.7	6.8	2.3	3.2	8.7	3.2	7.6	3.3	4.2	2.8	5.4	2.8	4.8	3.8	5.1	2.0	3.6	3.1	3.4	2.3	5.3	4.1	3.5	3.8	4.9	7.8	4.4	6.5	3.6	3.2	5.0	2.8	2.7	4.7	6.1	3.1	3.4	5.6	2.9	4.0	4.2	4.5	2.7	2.1	7.6	4.7	3.0	2.4	2.8	4.9	2.9	5.2	1.9	5.6	3.5	2.0	3.5	3.7	0.1	5.2	3.3	3.0	2.9	2.5	5.5	2.6	3.7	4.2	3.5	4.2	4.7	6.6	4.1	6.1	5.3	8.1	3.4	7.6	3.6	3.0	5.6	4.6	3.3	0.0	3.3	4.7	4.0	4.6	7.3	1.7	3.6	1.0	4.3	3.8	2.7	3.5	6.5	0.2	3.9	2.2	22.4	2.7	9.4	13.3	4.7	21.0	14.9	18.1	16.6	3.8	12.0	24.8	19.9	6.1	10.1	5.8	4.4	12.7	9.1	3.4	3.7	7.1	4.4	2.8	3.6	2.3	3.2	2.8	2.3	3.8	5.0	3.6	0.0	3.7	11.4	8.5	2.4	4.4	1.5	3.4	4.6	3.2	3.4	2.8	0.0	1.4	3.7	0.0	3.4	5.3	0.4	3.9	1.7	0.6	1.5	2.1	3.4	3.0	4.8	9.7	1.3	1.5	3.5	2.6	2.5	1.3	4.7	3.3	0.2	1.8	6.7	12.5	1.4	4.1	0.8	1.4	0.9	1.8	1.8	3.6	11.2	0.3	3.8	4.1	12.5	13.7	0.8	2.5	3.8	2.8	2.2	1.0	3.0	2.9	5.7	6.6	3.2	2.9	3.4	3.0	1.5	1.4	2.2	9.5	2.2	1.3	2.5
ZNF140	pHZ-39	ENSG00000196387	"Zinc finger protein 140"	P52738	12	133080474-133107526	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA003655, HPA048332"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA003655: , HPA048332: AB_2680362"	"unprognostic (1.88e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.76e-3)"	"unprognostic (7.67e-2)"	"unprognostic (8.23e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.13e-3)"	6.6	8.4	8.5	3.8	7.5	3.0	11.0	8.9	8.5	9.8	7.8	7.0	7.4	11.2	8.4	6.2	10.0	7.9	5.7	6.9	6.7	8.2	8.2	5.7	7.1	6.9	6.5	11.5	9.8	9.4	11.7	6.9	6.7	8.6	5.4	11.1	8.0	7.4	5.5	7.3	6.5	7.2	6.9	6.6	7.2	9.0	7.4	9.1	12.8	4.6	6.5	7.4	7.9	9.0	5.8	6.0	9.3	0.1	7.6	12.7	12.0	7.0	4.5	6.0	6.2	2.9	2.9	3.5	7.9	6.9	7.3	5.2	8.4	5.1	5.0	0.4	11.5	9.4	4.9	5.7	10.8	7.7	13.3	13.4	11.6	6.9	16.2	12.3	7.0	9.0	4.4	4.4	10.5	9.0	13.1	12.0	10.0	3.5	3.3	11.5	1.1	7.7	7.7	12.9	10.8	13.7	11.3	7.5	8.3	5.9	11.8	14.6	11.0	0.2	6.5	5.1	5.2	2.7	0.1	6.8	0.6	7.0	5.8	11.0	7.3	19.1	13.1	11.4	18.9	18.0	15.4	15.8	12.6	15.1	22.3	17.9	11.5	19.2	7.5	7.3	19.4	10.9	8.5	7.5	8.9	8.5	6.9	6.7	6.9	6.5	6.7	6.9	7.4	9.0	11.1	0.0	16.4	7.5	13.5	7.1	12.0	7.9	12.5	7.6	10.9	9.5	7.2	5.7	15.3	0.0	10.4	8.8	7.4	5.4	13.7	9.5	16.0	11.1	10.2	8.1	13.8	4.2	13.4	5.8	7.9	8.9	12.8	10.8	7.6	9.7	7.5	4.4	5.8	6.7	13.8	6.6	16.2	7.2	6.4	5.2	9.0	5.5	8.8	12.2	4.2	7.4	7.2	18.6	15.0	6.8	9.1	8.2	5.5	9.7	5.4	7.4	9.7	7.2	0.0	10.0	8.5	16.5	13.4	8.5	6.0	14.9	11.3	9.9	6.2	10.2
ZNF142	"KIAA0236, pHZ-49"	ENSG00000115568	"Zinc finger protein 142"	P52746	2	218633329-218659655	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049594	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA049594: AB_2680829"	"unprognostic (2.17e-1)"	"unprognostic (4.43e-1)"	"unprognostic (8.20e-3)"	"unprognostic (9.08e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.94e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.20e-2)"	"unprognostic (9.63e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.05e-2)"	6.0	5.7	5.0	5.0	5.5	8.0	6.0	5.5	6.9	6.4	1.2	8.0	2.6	7.5	2.5	6.7	6.7	3.6	7.0	5.5	3.6	6.3	4.5	5.4	5.3	4.5	3.9	6.2	7.5	4.9	8.3	3.2	4.2	6.8	3.1	6.4	6.3	4.3	10.3	7.0	6.5	4.9	2.6	7.3	7.0	4.8	4.7	6.0	6.9	6.6	4.9	7.3	5.8	5.1	6.3	9.7	9.0	10.7	8.5	6.3	8.5	7.1	4.2	9.7	7.4	19.3	5.0	8.3	6.1	6.4	8.1	11.4	17.6	11.7	6.6	12.0	16.5	12.9	20.7	12.3	6.8	16.8	11.8	4.3	11.0	11.5	11.3	5.3	8.2	9.2	17.0	15.7	5.0	13.7	11.7	9.6	11.8	3.9	8.8	17.7	5.1	8.1	7.3	11.3	12.3	9.3	5.3	10.4	4.0	8.5	6.0	6.1	12.2	9.2	9.7	7.8	11.0	10.5	7.1	13.4	5.9	7.9	9.5	0.9	0.7	0.8	1.0	0.1	0.4	0.7	0.6	0.6	0.6	0.3	0.7	0.5	0.4	0.3	0.2	0.8	0.6	0.6	5.0	5.5	5.5	6.9	5.5	3.6	4.5	3.9	4.2	2.6	4.7	5.1	3.5	3.2	0.5	4.9	6.0	5.9	2.0	1.7	5.7	3.5	3.8	3.4	5.3	4.3	2.7	3.7	6.2	2.2	4.0	4.1	0.0	3.2	2.7	2.7	4.3	3.2	0.0	2.1	7.0	3.8	2.2	3.8	6.6	5.2	1.3	5.2	4.2	3.1	3.0	1.7	6.7	3.0	4.1	4.7	3.2	4.8	3.7	4.1	3.6	4.7	3.1	2.3	8.2	3.0	6.7	4.1	3.5	3.8	8.5	2.8	3.4	2.2	1.0	2.7	6.6	3.9	2.9	5.5	5.5	6.6	6.1	1.1	6.3	4.1	4.3	2.3
ZNF23	"KOX16, Zfp612, ZNF359, ZNF612"	ENSG00000167377	"Zinc finger protein 23"	P17027	16	71447597-71463095	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 15.0;Excitatory neurons: 10.0;Inhibitory neurons: 11.2;Oligodendrocyte precursor cells: 13.0;Oligodendrocytes: 16.0;Respiratory ciliated cells: 9.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023534	Uncertain		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA023534: AB_1859140"	"unprognostic (8.49e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.12e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.65e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (6.04e-2)"	5.5	4.3	8.6	5.3	8.4	4.4	6.2	8.8	9.9	5.8	8.9	5.6	2.8	6.9	8.0	4.2	7.1	3.6	5.1	8.6	8.5	5.6	5.4	5.4	6.2	8.4	8.3	8.2	4.6	5.4	14.3	4.7	8.1	5.3	5.7	16.9	4.3	5.8	6.5	5.8	5.0	6.9	8.2	5.7	4.1	6.9	8.6	4.9	7.5	7.1	6.0	4.2	3.5	9.8	7.8	4.7	12.0	8.8	7.6	6.6	7.8	17.1	15.9	11.7	8.6	6.1	7.6	15.1	4.2	13.1	11.4	4.7	7.9	10.2	13.7	4.0	5.2	6.7	5.0	6.5	9.2	12.3	5.7	10.7	9.0	12.1	18.6	10.9	4.1	7.9	11.1	2.9	12.5	13.0	6.4	6.0	13.4	4.0	3.9	3.3	5.3	4.6	7.7	6.4	9.9	12.8	5.5	3.9	5.3	7.5	5.1	6.4	11.5	21.2	7.2	5.9	10.7	6.5	10.6	19.8	16.0	6.2	13.2	0.8	0.8	0.5	1.9	1.8	1.8	1.3	1.0	2.1	1.1	2.7	2.1	1.5	0.0	2.6	1.0	1.9	1.9	0.9	8.6	8.4	8.8	9.9	8.6	8.5	8.4	8.3	8.1	8.2	8.6	9.8	0.6	6.4	2.3	15.0	2.6	0.3	0.3	0.2	2.8	2.6	0.7	0.6	0.4	0.0	3.2	0.0	6.2	0.2	0.4	0.5	1.9	2.0	0.2	1.0	1.0	1.1	0.0	7.8	10.0	1.0	0.3	0.9	1.5	0.5	2.5	1.3	1.1	0.5	0.4	3.3	11.2	1.0	0.0	0.3	0.3	0.0	0.6	0.5	0.0	6.5	0.4	1.4	2.1	13.0	16.0	1.5	1.4	0.0	1.5	0.3	0.7	0.3	9.2	3.3	0.0	0.7	0.9	1.5	1.4	2.3	0.0	0.0	1.4	0.5	1.5	0.1
ZNF235	"ANF270, HZF6, ZFP93, ZNF270"	ENSG00000159917	"Zinc finger protein 235"	Q14590	19	44228729-44305046	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 8.3;Oligodendrocytes: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA045582	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA045582: AB_10963792"	"unprognostic (2.11e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.91e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.23e-4)"	"unprognostic (4.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.46e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.65e-3)"	"unprognostic (3.38e-2)"	2.0	1.3	2.6	2.1	2.8	0.7	2.7	2.9	3.5	1.9	2.6	2.5	1.7	2.0	2.1	1.6	2.2	1.6	2.4	3.0	2.5	2.2	1.8	2.2	2.8	2.7	3.1	2.6	1.8	2.7	1.9	2.4	2.8	2.4	2.0	3.1	1.7	2.5	2.6	1.4	2.0	2.3	2.6	2.7	1.5	2.4	2.8	4.5	2.3	3.0	3.3	1.7	1.4	4.0	1.6	2.6	4.7	5.1	3.7	2.2	1.6	1.0	3.1	1.8	2.1	1.6	2.8	2.9	2.5	1.9	2.8	1.5	4.4	2.1	2.2	0.0	5.3	5.8	4.0	2.4	3.0	3.5	3.6	2.1	2.7	2.0	2.4	2.9	2.9	4.9	1.3	0.0	1.8	1.4	5.4	0.7	6.0	2.8	1.5	2.7	4.7	2.4	3.2	4.0	3.6	10.1	2.7	3.2	2.4	4.9	2.4	4.1	3.6	1.8	2.4	0.5	1.1	6.0	6.4	1.9	1.4	1.0	2.8	20.7	3.5	3.5	6.3	3.1	4.2	6.9	4.6	5.3	2.7	10.1	6.8	5.8	1.8	6.2	3.0	8.1	3.7	2.4	2.6	2.8	2.9	3.5	3.0	2.5	2.7	3.1	2.8	2.6	2.8	4.0	3.5	0.0	0.0	6.2	5.6	0.5	0.5	1.5	4.6	1.7	1.5	1.5	2.3	1.5	0.7	0.0	6.2	1.5	2.5	1.3	0.0	1.4	1.5	1.7	1.8	2.4	0.0	5.2	8.3	0.0	0.4	1.4	2.0	1.2	2.5	2.5	1.8	1.4	1.4	1.7	6.7	1.1	0.0	2.2	0.9	0.3	0.6	2.2	1.8	1.0	1.4	1.1	3.1	5.0	9.2	0.6	3.6	3.4	3.2	0.6	2.0	0.9	0.9	1.6	0.0	1.8	2.0	2.3	5.6	1.8	0.6	1.5	4.1	1.3	0.8	0.2
ZNF260	"ozrf1, Zfp260"	ENSG00000254004	"Zinc finger protein 260"	Q3ZCT1	19	36510687-36528271	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028806	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA028806: AB_10795285"	"unprognostic (1.34e-1)"	"unprognostic (6.31e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.11e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.29e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (7.73e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.89e-3)"	4.5	5.0	4.9	4.1	5.7	1.7	7.9	5.5	5.8	6.7	4.4	3.9	4.1	7.2	5.2	5.1	5.3	5.4	5.0	4.5	5.5	7.4	5.8	4.9	6.3	5.2	5.5	8.4	3.9	11.7	3.2	6.8	5.3	6.6	4.6	8.9	4.8	4.7	2.4	6.8	4.2	5.2	5.2	5.9	5.5	3.1	5.6	7.6	9.7	4.1	6.7	6.1	3.4	6.9	11.2	11.2	25.1	19.1	7.7	11.5	10.9	9.6	10.1	8.6	11.0	5.1	6.2	7.3	15.2	7.8	6.6	4.1	12.8	5.9	13.2	9.7	5.6	10.8	8.6	5.8	10.7	5.5	8.7	10.6	9.8	8.9	13.7	12.5	11.7	10.7	8.7	7.9	17.4	6.1	20.6	3.6	15.9	7.0	4.8	13.5	15.5	5.5	9.8	19.6	18.1	19.9	21.3	11.4	8.0	15.3	9.5	10.5	10.2	15.0	15.5	8.9	8.7	10.0	20.4	16.7	0.4	5.9	20.7	4.6	1.3	1.4	1.7	1.2	1.8	2.4	2.3	1.4	1.5	2.9	3.1	2.4	0.6	1.9	1.9	1.0	2.2	1.4	4.9	5.7	5.5	5.8	4.5	5.5	5.2	5.5	5.3	5.2	5.6	6.9	10.9	9.6	6.2	9.4	14.1	10.3	8.2	7.2	18.2	7.9	12.3	9.8	8.9	1.5	11.1	0.0	8.4	6.4	8.9	2.7	5.9	8.2	18.0	9.3	12.7	9.7	12.0	10.7	13.2	4.4	7.0	9.3	7.7	9.2	8.2	15.9	10.8	4.0	4.6	21.9	13.4	5.1	12.2	5.7	3.3	4.1	5.9	5.4	1.8	9.4	6.0	7.9	5.2	24.1	27.7	6.6	3.5	8.2	3.7	7.1	3.4	8.3	6.3	7.9	6.6	6.4	9.1	8.0	3.8	16.2	13.1	4.1	10.4	9.2	4.6	11.9
ZNF286A	"KIAA1874, ZNF286"	ENSG00000187607	"Zinc finger protein 286A"	Q9HBT8	17	15699577-15720787	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Oligodendrocytes: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SuSa: 120.0"									HPA021594			Approved	Nucleoli		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA021594: AB_2670768"	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.47e-4)"	"unprognostic (4.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.29e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.95e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.94e-2)"	5.4	7.8	8.9	6.7	11.2	3.8	8.1	12.0	10.4	9.3	6.6	5.8	3.8	12.7	11.7	10.1	8.6	9.0	15.9	9.5	10.4	7.8	4.1	5.1	8.6	10.8	10.4	17.4	3.9	14.4	5.7	5.7	10.7	8.4	4.7	11.3	5.0	8.7	4.0	5.6	3.8	10.8	9.0	5.6	5.5	11.0	10.0	12.9	10.3	10.0	8.7	8.9	5.9	14.9	37.4	40.5	56.3	26.4	16.6	23.9	18.7	17.9	14.1	28.1	20.7	24.6	12.8	33.9	13.9	12.5	23.5	31.4	42.4	19.7	34.6	25.1	32.3	23.8	42.2	20.6	16.1	11.0	10.0	21.2	12.1	25.5	26.1	30.8	37.3	54.0	19.7	5.9	39.5	10.2	49.5	9.9	54.5	21.6	9.4	37.0	85.3	16.6	19.5	13.9	18.9	41.1	35.4	15.4	12.1	120.0	15.0	6.3	16.1	16.3	18.0	14.6	24.9	14.0	24.2	0.2	20.4	0.3	19.8	1.2	1.5	1.0	6.1	1.7	6.4	3.7	7.0	6.3	2.5	6.8	8.1	8.6	1.0	6.0	3.9	2.2	9.4	2.5	8.9	11.2	12.0	10.4	9.5	10.4	10.8	10.4	10.7	9.0	10.0	14.9	2.4	19.2	0.0	5.9	5.5	7.0	5.1	2.5	15.4	1.6	3.5	2.7	4.3	1.5	5.5	1.8	2.1	1.3	3.0	0.4	1.9	4.1	16.1	1.3	5.0	4.4	5.4	4.6	9.5	1.6	1.8	5.2	4.1	1.5	3.8	3.4	2.5	0.8	1.3	3.3	9.9	2.2	0.0	0.8	1.5	13.0	5.0	1.5	1.8	2.8	1.1	1.6	3.1	17.6	17.9	3.7	1.5	5.3	7.8	4.8	0.7	2.7	3.4	2.0	0.0	2.3	4.1	11.9	5.3	9.0	5.5	1.2	5.9	3.5	1.7	4.9
ZNF322	"bA457M11.2, bA457M11.3, HCG12, ZNF322A, ZNF388, ZNF489"	ENSG00000181315	"Zinc finger protein 322"	Q6U7Q0	6	26634383-26659752	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043161, HPA046692"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA043161: AB_2678346, HPA046692: AB_2679755"	"unprognostic (1.01e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.39e-3)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.35e-2)"	"prognostic favorable (8.57e-4)"	"unprognostic (5.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.24e-2)"	"unprognostic (5.71e-2)"	7.8	12.0	11.0	7.8	11.9	1.3	12.8	12.1	12.4	15.4	10.9	8.8	9.3	15.5	13.3	8.6	11.4	9.8	7.7	10.2	12.0	11.8	9.3	9.9	9.9	11.8	11.5	17.9	8.2	17.7	7.1	11.2	12.4	14.9	10.9	14.3	8.7	13.9	6.6	6.0	8.1	10.5	12.0	11.7	9.1	11.1	11.6	10.1	15.3	12.8	9.7	10.8	7.4	15.0	9.3	6.8	26.2	31.0	17.3	22.5	9.7	12.3	16.1	16.6	20.1	13.3	5.5	11.0	28.5	10.6	20.8	11.5	19.7	7.4	20.8	17.3	18.0	19.5	8.7	13.2	19.5	0.0	17.3	14.1	27.0	10.7	12.3	20.8	14.4	13.5	23.3	11.7	18.3	5.2	14.1	16.9	7.8	8.5	8.4	15.4	18.6	16.0	10.1	14.5	21.3	22.7	14.5	13.6	25.9	12.8	12.5	12.8	14.4	27.8	11.0	11.4	12.4	12.2	25.8	10.8	5.8	2.9	28.4	3.3	8.4	10.8	10.5	7.2	7.6	11.2	5.3	6.9	6.9	9.0	6.1	9.1	8.0	17.8	11.9	7.8	4.5	5.1	11.0	11.9	12.1	12.4	10.2	12.0	11.8	11.5	12.4	12.0	11.6	15.0	24.8	6.4	10.5	3.9	18.0	4.0	17.3	4.8	14.8	32.1	23.9	31.2	5.8	12.8	11.1	9.2	8.4	12.5	16.1	9.9	35.2	17.7	4.1	14.2	32.6	20.1	19.7	7.2	5.3	10.2	11.3	21.9	10.2	15.7	13.3	30.0	18.2	7.6	13.3	47.1	7.0	14.1	8.2	8.9	5.3	3.7	30.1	11.7	8.8	6.5	12.7	26.7	10.3	11.1	10.3	16.1	12.8	26.4	11.8	26.4	10.2	13.3	8.1	13.9	32.9	20.6	22.2	26.0	15.7	12.0	6.5	9.6	9.1	37.7	10.0	24.9
ZNF384	"CAGH1A, CIZ, NMP4, NP, TNRC1"	ENSG00000126746	"Zinc finger protein 384"	Q8TF68	12	6666477-6689572	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004051	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA004051: AB_1859228"	"unprognostic (1.90e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.13e-2)"	31.4	33.2	21.9	36.2	23.2	59.9	30.7	26.9	26.4	39.8	22.9	35.1	35.1	40.6	25.1	27.9	35.8	26.1	25.9	22.5	23.8	28.9	26.3	28.6	36.0	23.5	22.3	46.3	29.8	34.7	32.6	32.5	22.3	31.9	32.7	30.2	29.9	30.0	36.7	32.1	36.8	37.8	20.8	40.2	30.9	31.7	22.8	46.7	38.4	32.3	37.6	36.7	30.8	25.4	35.4	66.2	79.9	53.7	55.2	38.9	107.1	50.0	46.4	47.3	50.3	73.3	73.6	82.9	18.5	56.4	68.5	46.6	59.8	45.9	53.6	150.8	54.0	94.9	93.0	38.6	38.9	91.2	67.5	43.0	43.6	58.3	90.1	88.9	41.5	57.4	50.6	27.9	52.4	54.8	82.6	58.3	155.0	64.1	28.7	81.0	85.4	32.2	41.9	93.6	24.8	80.4	51.8	68.4	44.1	133.5	18.0	74.5	51.9	51.6	71.4	40.9	59.6	38.5	39.6	149.9	51.0	32.4	60.0	3.7	8.5	15.4	16.4	9.8	13.4	9.7	10.7	13.4	11.5	8.0	10.2	11.6	14.4	17.0	15.3	7.6	14.5	8.3	21.9	23.2	26.9	26.4	22.5	23.8	23.5	22.3	22.3	20.8	22.8	25.4	19.2	0.0	8.7	17.3	12.5	7.9	2.6	4.4	12.0	6.0	11.1	11.9	2.6	10.0	4.7	1.8	10.4	6.7	17.9	16.5	0.0	4.6	4.3	10.2	12.9	10.7	3.6	8.0	10.3	5.0	6.8	8.2	12.8	13.5	5.7	14.7	8.9	8.3	7.0	0.0	10.4	11.8	2.0	16.6	6.0	2.7	8.4	8.6	5.4	6.5	9.9	6.1	7.2	9.0	11.8	6.8	14.4	8.6	11.4	4.8	10.6	4.3	5.6	7.8	0.0	9.3	9.3	7.1	6.5	10.7	9.8	7.3	13.2	9.0	13.4	4.6
ZNF410	"APA-1, APA1"	ENSG00000119725	"Zinc finger protein 410"	Q86VK4	14	73886617-73932521	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 27.7;Excitatory neurons: 22.7;Inhibitory neurons: 23.8;Oligodendrocytes: 31.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002871			Approved	"Nuclear bodies"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Nuclear bodies"		"HPA002871: AB_1080712"	"unprognostic (5.84e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (5.86e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.83e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.19e-1)"	29.0	33.0	26.8	18.7	30.4	57.7	29.4	30.9	33.9	30.0	28.9	30.6	19.0	27.5	43.7	33.4	28.1	22.6	21.0	26.3	28.0	33.0	28.8	27.6	25.6	29.1	27.5	38.7	20.6	27.1	27.0	32.2	29.6	29.5	24.4	22.8	24.4	27.3	21.1	37.6	25.2	28.4	26.7	26.1	25.7	44.7	28.3	29.9	24.6	18.3	30.7	29.1	28.7	37.0	46.7	35.8	42.4	45.2	44.8	39.8	52.4	51.4	56.9	88.2	82.0	37.6	40.1	38.4	21.7	65.7	28.2	42.1	42.9	52.8	83.2	56.2	26.9	36.2	31.6	29.9	67.4	30.6	45.6	37.0	72.4	44.5	83.1	39.5	47.5	43.9	38.2	33.0	43.3	88.6	45.8	51.2	15.5	56.3	41.7	40.7	48.5	24.7	57.0	43.7	39.0	50.3	57.2	52.5	54.6	35.5	48.3	52.2	30.7	62.7	59.0	37.1	47.2	45.2	83.4	48.0	40.1	34.1	53.7	65.9	45.3	74.8	47.5	43.1	51.9	37.7	49.0	49.0	45.6	43.0	42.3	43.5	34.4	60.5	50.1	30.8	46.7	55.9	26.8	30.4	30.9	33.9	26.3	28.0	29.1	27.5	29.6	26.7	28.3	37.0	4.3	0.0	3.1	27.7	10.8	0.6	1.5	1.0	10.8	1.5	2.2	1.7	1.1	0.0	2.9	0.0	4.2	1.8	5.0	1.7	0.0	1.0	3.8	4.7	5.6	2.6	0.0	5.9	22.7	0.9	1.5	5.3	10.7	6.7	10.8	2.9	1.8	0.4	1.2	1.7	23.8	1.1	0.0	2.2	3.1	1.1	1.2	5.4	1.8	18.7	1.1	2.4	2.1	18.1	31.0	1.3	1.4	0.4	13.4	1.0	2.4	0.7	0.2	4.7	0.0	4.0	5.1	3.3	1.9	10.1	1.1	2.6	10.5	4.1	0.8	1.4
ZNF425		ENSG00000204947	"Zinc finger protein 425"	Q6IV72	7	149102784-149126324	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 8.5;Oligodendrocyte precursor cells: 9.0;Oligodendrocytes: 10.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA020087	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA020087: AB_2670358"	"unprognostic (4.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.40e-4)"	"unprognostic (9.97e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.21e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.25e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.19e-3)"	"unprognostic (1.58e-2)"	0.8	1.2	3.1	0.9	3.1	0.6	1.7	3.3	3.2	2.1	2.1	2.1	1.0	2.4	2.1	2.1	2.3	1.0	0.8	3.0	2.7	2.2	1.0	1.0	0.8	2.8	2.8	3.8	1.5	2.3	1.4	0.7	2.8	1.9	0.8	1.4	1.8	2.2	3.8	2.5	0.9	1.7	2.6	1.0	1.6	1.3	2.9	1.6	1.9	1.9	1.2	1.9	1.5	2.8	1.4	1.7	3.6	3.1	5.3	1.5	2.0	2.0	3.4	1.1	1.2	0.4	1.8	1.6	2.8	1.6	1.4	1.9	0.6	1.0	0.4	1.1	1.4	1.9	2.4	0.8	3.0	0.9	0.8	3.1	1.7	1.1	2.0	3.0	0.5	2.4	1.4	1.5	3.7	6.6	2.5	2.9	8.6	2.0	3.3	2.7	1.8	0.9	2.4	1.9	1.6	3.0	1.9	2.4	4.5	2.3	1.6	2.6	0.7	2.3	0.3	2.7	0.5	3.2	2.1	1.2	1.9	0.6	1.9	2.1	0.6	1.4	1.8	0.7	2.3	1.4	1.5	1.2	0.6	1.8	2.1	2.3	1.6	3.2	0.4	2.1	2.0	0.8	3.1	3.1	3.3	3.2	3.0	2.7	2.8	2.8	2.8	2.6	2.9	2.8	0.4	0.0	2.0	5.2	1.9	0.3	0.8	0.7	2.2	3.4	1.8	1.5	1.8	0.0	1.2	3.7	0.0	0.8	0.3	0.5	5.9	1.6	0.9	1.4	2.2	0.6	1.2	3.0	7.5	0.5	0.8	1.5	4.6	1.2	0.0	3.4	0.4	0.6	0.4	6.7	8.5	0.7	2.0	0.0	0.2	0.3	4.4	0.6	0.0	7.5	1.8	4.7	0.0	9.0	10.7	0.6	0.6	5.3	1.3	1.0	0.7	1.1	2.4	1.2	0.0	2.3	1.5	3.5	3.5	2.8	0.3	1.0	1.4	3.0	0.8	0.5
ZNF426	MGC2663	ENSG00000130818	"Zinc finger protein 426"	Q9BUY5	19	9523223-9538645	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA029342	Approved		Approved	Nucleoplasm		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA029342: AB_10603007"	"unprognostic (3.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.65e-2)"	"unprognostic (6.62e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.05e-3)"	"unprognostic (8.89e-3)"	"unprognostic (7.41e-3)"	"prognostic favorable (2.57e-6)"	"unprognostic (1.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.81e-4)"	5.1	3.3	3.1	3.9	4.0	5.7	6.9	5.4	3.4	5.5	4.9	4.1	2.8	7.6	4.5	20.6	5.8	4.3	5.4	3.2	2.9	4.3	2.2	5.1	4.1	3.4	3.4	9.2	4.3	6.3	2.4	5.6	3.4	5.9	3.8	5.1	4.0	5.3	3.7	4.1	2.9	7.8	2.9	4.7	3.7	4.8	3.8	5.7	6.7	5.5	5.7	4.7	5.8	6.0	5.7	1.8	11.2	11.8	7.4	9.7	6.2	7.1	10.8	9.4	11.4	2.4	2.5	5.7	5.6	6.9	6.6	4.8	11.7	8.4	14.0	2.7	9.0	23.7	9.5	4.3	6.7	0.7	7.4	12.4	7.1	10.5	15.0	10.2	10.2	9.7	9.6	0.5	9.1	0.3	13.7	11.4	14.0	1.3	4.4	7.4	13.9	5.9	5.1	14.7	6.3	8.5	12.1	4.3	9.7	9.5	6.0	5.5	8.3	13.2	7.7	6.0	7.7	6.4	9.7	4.8	1.9	0.3	9.6	10.0	3.2	6.1	8.8	4.5	7.8	7.6	6.8	8.7	3.8	6.5	10.0	9.3	6.7	7.8	6.3	3.4	7.1	3.4	3.1	4.0	5.4	3.4	3.2	2.9	3.4	3.4	3.4	2.9	3.8	6.0	15.0	28.9	26.5	3.3	13.2	3.4	15.6	3.2	12.5	24.8	17.1	14.6	10.1	5.7	12.4	7.3	20.9	12.8	13.4	3.8	21.5	10.9	33.5	11.5	14.2	16.4	3.6	12.6	5.4	4.2	10.2	12.4	5.1	15.5	28.4	22.4	14.3	3.0	7.6	37.0	3.9	4.2	12.2	8.9	1.6	8.2	17.1	8.2	3.6	5.6	11.2	20.1	15.5	4.5	4.7	6.9	5.1	22.2	6.7	13.3	4.7	5.4	14.6	22.0	6.6	17.9	13.2	12.2	11.8	14.7	2.8	14.2	12.1	12.3	6.3	17.9
ZNF460	"HZF8, ZNF272"	ENSG00000197714	"Zinc finger protein 460"	Q14592	19	57280051-57294069	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.7"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 22.2;Squamous epithelial cells: 21.5"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 3.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 13.5"									"HPA053004, HPA066506"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA053004: AB_2682012, HPA066506: AB_2685681"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.20e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.10e-2)"	1.9	4.9	5.1	0.7	7.9	6.0	1.6	7.9	6.2	1.4	3.6	0.9	0.3	1.0	0.8	1.3	1.0	1.0	1.4	3.4	4.6	1.1	1.5	1.3	0.9	7.8	6.8	2.3	1.0	1.3	1.7	1.4	9.2	1.1	0.6	2.6	1.3	1.1	1.5	1.9	0.7	1.1	4.8	1.4	0.9	1.8	5.2	1.0	1.4	1.3	1.0	1.1	1.3	19.7	1.2	1.9	1.5	2.1	1.5	1.3	3.8	0.8	1.2	0.9	2.8	2.4	0.7	1.9	0.9	1.0	0.8	0.8	2.0	1.0	1.6	1.4	3.9	1.8	1.6	1.2	1.7	3.2	2.0	0.7	1.8	2.5	2.8	0.7	0.6	2.0	1.8	13.5	1.1	0.9	1.9	0.5	2.1	1.0	1.8	1.4	2.1	0.9	0.6	2.4	1.9	1.0	2.1	1.1	1.2	1.0	0.9	2.2	0.9	2.8	3.3	0.4	1.7	5.7	2.7	3.1	1.0	1.2	0.9	0.0	0.5	1.0	0.7	1.1	0.8	0.8	0.5	0.4	0.1	2.2	1.2	0.5	1.2	0.8	0.7	0.0	1.1	0.7	5.1	7.9	7.9	6.2	3.4	4.6	7.8	6.8	9.2	4.8	5.2	19.7	7.9	3.2	1.5	3.9	11.6	3.1	3.6	0.7	22.2	4.3	4.1	2.8	5.9	1.5	2.0	0.0	0.0	1.4	6.6	1.3	0.0	1.5	3.4	7.0	9.5	4.9	0.0	11.2	6.2	0.4	2.0	7.3	10.2	13.1	0.0	4.7	7.1	2.0	1.1	8.4	5.9	1.2	4.1	1.9	2.2	0.7	1.8	3.3	1.8	1.9	4.0	2.4	4.1	2.5	13.3	1.7	0.2	1.5	16.3	3.0	0.7	0.8	2.4	3.2	0.0	8.1	8.4	3.6	1.4	21.5	2.4	2.6	7.8	3.6	1.3	4.4
ZNF484	"BA526D8.4, FLJ33884"	ENSG00000127081	"Zinc finger protein 484"	Q5JVG2	9	92844182-92878038	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 17.7;Inhibitory neurons: 22.6;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA028973	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028973: AB_10610703"	"unprognostic (5.52e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.86e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.04e-2)"	"unprognostic (9.84e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.91e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.77e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.51e-1)"	2.0	2.2	1.9	2.0	2.7	4.1	2.2	9.7	3.3	2.5	0.0	1.6	1.2	2.4	1.7	1.3	2.1	1.6	1.6	1.8	3.4	2.4	1.9	2.0	2.4	2.8	2.8	3.1	1.3	3.6	2.1	2.8	3.1	2.3	1.8	5.3	1.5	2.0	1.1	1.3	1.5	2.1	2.7	2.9	2.1	1.7	3.5	2.6	3.1	2.3	2.8	2.1	1.8	4.0	3.1	3.6	4.7	3.0	2.4	3.0	0.0	2.4	3.8	4.2	4.4	1.2	2.2	2.5	2.1	1.9	2.9	5.0	3.5	3.7	4.4	4.2	1.5	2.2	3.1	2.4	3.7	1.9	3.7	3.3	2.7	4.7	4.9	3.2	3.9	2.8	2.4	10.6	4.5	2.9	2.7	0.8	4.0	3.4	1.7	2.2	5.8	1.9	2.3	3.4	3.2	3.0	4.3	1.2	2.4	3.5	0.2	1.5	3.7	3.7	3.7	2.0	1.8	3.9	2.1	1.5	2.4	1.5	3.1	0.6	1.2	2.8	2.4	1.8	3.1	1.8	2.6	2.1	1.1	2.6	3.4	3.2	0.7	2.4	1.6	1.3	2.2	1.5	1.9	2.7	9.7	3.3	1.8	3.4	2.8	2.8	3.1	2.7	3.5	4.0	6.2	0.0	1.5	9.8	13.2	0.1	0.7	1.1	6.8	5.0	1.6	0.9	2.2	0.0	4.7	1.8	0.0	1.2	6.3	0.9	1.9	1.3	0.7	1.3	4.4	4.9	0.0	3.4	17.7	0.4	1.2	4.3	5.6	1.3	2.5	3.6	0.7	0.6	0.8	5.0	22.6	1.4	4.1	0.6	0.4	0.9	0.6	2.7	0.0	12.2	1.2	3.1	5.2	27.2	19.1	0.7	1.6	1.5	5.8	0.6	0.9	1.5	4.1	3.8	0.0	3.7	4.8	0.8	0.7	3.9	0.1	0.7	9.3	3.3	0.7	0.6
ZNF490	KIAA1198	ENSG00000188033	"Zinc finger protein 490"	Q9ULM2	19	12576100-12640098	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 10.2;Gastric mucus-secreting cells: 13.7;Inhibitory neurons: 9.3;Oligodendrocytes: 10.0;Plasma cells: 14.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA005576	Uncertain					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA005576: AB_10602689"	"unprognostic (1.81e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.77e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.59e-2)"	"unprognostic (5.79e-2)"	0.7	1.0	2.0	1.3	1.9	1.7	1.4	2.1	2.4	1.3	0.3	1.2	1.2	1.0	2.0	0.8	1.5	1.1	0.9	1.6	2.1	1.3	1.8	1.3	2.0	1.0	0.8	1.8	1.5	1.9	0.5	1.1	1.0	1.4	1.3	2.1	1.1	1.3	0.9	1.8	0.9	0.9	0.2	2.4	1.2	1.4	1.7	2.2	2.3	1.0	2.4	1.0	0.5	2.2	0.7	0.6	1.2	3.3	3.5	2.3	1.0	0.9	1.6	1.2	1.5	1.1	1.0	1.2	2.0	1.2	0.8	0.9	1.7	1.4	1.6	1.6	1.0	1.5	1.4	1.4	1.9	2.9	3.6	1.8	1.6	1.0	2.2	1.7	1.1	1.4	1.1	1.4	1.6	1.5	2.0	2.2	1.8	0.6	1.8	1.5	1.8	2.1	1.4	1.8	2.2	1.5	1.9	1.2	1.5	1.8	1.7	1.7	1.6	3.0	0.8	2.2	1.0	4.3	3.3	1.5	1.6	1.9	2.0	5.0	1.5	2.3	2.7	2.1	2.5	2.2	1.7	2.6	1.3	2.8	1.5	2.6	1.4	3.8	2.6	3.8	2.3	1.0	2.0	1.9	2.1	2.4	1.6	2.1	1.0	0.8	1.0	0.2	1.7	2.2	1.7	0.0	1.1	7.2	7.4	0.5	0.3	1.2	2.8	1.4	1.8	1.8	1.2	1.5	1.7	0.0	0.0	0.3	2.7	0.9	1.9	0.2	3.9	1.6	3.0	1.5	0.0	3.8	10.2	0.2	0.2	2.4	13.7	2.3	5.7	1.5	0.0	1.0	0.4	0.0	9.3	0.1	0.0	1.6	1.8	1.6	0.6	2.4	3.6	6.5	0.3	0.5	1.0	4.0	10.0	0.2	0.1	0.0	14.8	0.3	0.9	0.3	0.8	0.8	6.6	0.8	2.2	0.9	1.0	4.9	0.3	0.8	6.0	1.1	0.5	0.2
ZNF564	MGC26914	ENSG00000249709	"Zinc finger protein 564"	Q8TBZ8	19	12525373-12551542	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 13.1;Oligodendrocyte precursor cells: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA043998	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA043998: AB_10969446"	"unprognostic (3.85e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.61e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.26e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.76e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.26e-5)"	"unprognostic (5.77e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.83e-2)"	4.7	3.5	4.2	3.7	5.4	4.4	7.4	11.8	6.2	5.5	3.0	7.4	6.3	6.7	6.1	3.0	6.5	3.4	5.1	5.0	3.6	7.7	5.7	4.3	6.9	5.5	4.2	6.0	3.7	7.6	3.1	5.0	5.2	6.3	7.3	7.1	4.8	6.0	6.2	5.3	7.1	4.3	3.5	6.9	6.7	3.0	4.4	7.5	7.9	8.0	7.5	5.3	4.2	9.2	4.3	1.2	4.9	6.2	7.4	5.5	6.0	4.3	6.0	5.3	7.0	3.2	2.7	5.3	5.8	3.9	3.2	4.9	2.5	4.1	5.6	4.3	4.1	3.7	3.9	6.7	5.4	6.6	6.8	5.5	10.3	2.5	6.3	5.5	4.5	5.5	7.8	2.2	6.6	5.7	5.4	3.9	5.0	4.8	5.5	3.2	5.4	4.4	5.9	6.9	3.4	3.0	5.2	2.9	6.2	7.2	4.5	11.4	4.6	8.0	2.5	5.0	3.3	7.6	9.2	4.2	2.4	4.4	3.4	15.2	7.3	18.6	11.9	10.1	11.0	14.7	10.2	10.9	9.4	11.1	11.5	10.6	13.7	11.3	13.1	7.3	9.3	7.1	4.2	5.4	11.8	6.2	5.0	3.6	5.5	4.2	5.2	3.5	4.4	9.2	1.8	0.0	1.5	6.5	6.9	0.0	0.9	0.8	2.8	2.1	1.0	1.1	0.5	5.7	1.5	0.0	4.2	1.3	3.6	1.5	3.9	1.2	0.1	2.0	1.7	1.8	0.0	4.0	8.4	0.7	0.9	1.5	7.7	1.6	0.0	4.9	2.5	1.1	1.1	0.0	8.6	1.0	0.0	1.6	0.4	0.3	0.6	1.4	1.8	13.1	2.0	2.4	5.2	11.1	8.8	1.6	1.0	0.7	5.9	1.7	2.0	0.8	6.3	4.4	0.0	2.2	1.3	1.2	2.3	1.1	0.0	1.2	4.0	1.4	0.9	1.5
ZNF574	FLJ22059	ENSG00000105732	"Zinc finger protein 574"	Q6ZN55	19	42068477-42081552	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 40.9;Spermatocytes: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023196, HPA057274"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA023196: AB_2671105, HPA057274: AB_2683392"	"unprognostic (3.90e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.39e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.11e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.09e-3)"	8.1	5.4	6.8	4.6	6.1	11.1	7.9	9.5	7.7	8.4	4.3	9.5	6.7	10.3	2.7	9.6	8.8	5.1	6.8	6.2	6.2	5.5	5.4	5.6	6.5	6.9	5.8	9.6	7.9	6.1	6.5	5.0	5.8	7.5	2.8	4.1	8.1	6.7	9.3	12.8	7.5	3.7	5.6	8.4	7.2	27.1	6.3	6.3	6.0	6.4	4.2	8.2	7.5	6.3	15.0	41.1	9.0	11.4	8.1	8.0	9.7	11.0	9.6	14.2	13.6	16.2	10.1	21.4	9.7	9.1	7.5	8.9	10.4	14.1	5.6	11.4	17.6	20.5	10.1	14.0	8.6	12.6	13.5	9.5	13.9	13.2	11.1	8.7	7.9	11.8	17.1	13.3	10.1	31.2	15.2	10.9	16.1	13.5	16.2	20.7	8.6	9.3	7.4	19.7	14.9	12.8	11.3	24.0	7.3	6.2	11.0	20.5	9.5	19.2	14.9	5.8	16.4	14.3	9.3	15.7	10.6	11.9	11.0	12.3	10.5	16.7	16.2	7.8	17.6	17.3	12.1	17.8	12.5	12.8	12.6	11.9	13.3	10.9	11.2	11.1	10.3	12.9	6.8	6.1	9.5	7.7	6.2	6.2	6.9	5.8	5.8	5.6	6.3	6.3	6.0	0.0	3.3	1.3	11.3	29.3	15.1	6.1	40.9	7.5	11.0	7.6	4.3	4.3	6.0	1.8	2.1	7.9	6.3	5.8	1.9	6.9	25.3	6.1	5.7	7.6	3.5	8.6	1.4	5.1	6.7	6.6	7.7	5.7	12.7	5.4	6.8	3.1	5.1	3.3	1.7	7.6	6.1	2.5	11.0	15.7	5.6	3.0	8.8	1.0	7.5	3.9	4.1	1.5	0.9	4.3	8.5	8.6	8.1	10.6	6.4	4.3	5.2	9.8	6.6	8.8	8.0	35.5	20.5	22.1	22.7	4.8	10.6	3.8	7.9	9.6
ZNF585A	"FLJ23765, Zfp27"	ENSG00000196967	"Zinc finger protein 585A"	Q6P3V2	19	37106734-37172741	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 38.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"				"unprognostic (1.07e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (4.12e-2)"	"unprognostic (6.36e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.45e-1)"	"unprognostic (9.34e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.58e-2)"	8.2	10.4	5.2	6.7	5.4	5.8	12.0	6.3	8.9	8.3	4.5	7.6	7.0	5.4	7.5	8.9	7.1	6.1	9.6	5.0	5.9	12.1	7.5	6.8	12.7	5.2	6.1	7.5	8.2	13.7	10.0	10.1	5.4	6.9	7.6	9.6	8.6	5.4	7.2	8.0	7.5	5.6	4.9	9.3	8.9	9.2	5.5	12.9	10.6	8.3	9.6	8.6	8.2	6.5	9.5	7.4	11.2	13.9	13.8	11.9	8.2	8.7	19.0	17.0	18.9	5.8	8.3	1.5	20.9	16.1	18.5	3.3	5.1	14.9	15.6	11.0	7.2	5.7	6.2	6.8	33.6	0.0	13.8	19.9	14.2	14.1	4.5	14.6	8.1	1.7	3.7	0.1	12.9	8.5	13.6	7.2	10.7	13.1	6.8	0.0	12.3	18.6	11.9	13.6	6.9	14.6	12.3	5.6	16.2	13.5	10.0	7.1	2.5	5.6	7.5	8.8	22.7	37.5	35.0	18.5	0.3	2.5	18.7	75.9	18.4	65.4	28.0	23.4	30.7	28.3	29.7	32.8	17.3	26.0	31.4	30.7	38.4	29.9	20.0	27.2	45.3	18.1	5.2	5.4	6.3	8.9	5.0	5.9	5.2	6.1	5.4	4.9	5.5	6.5	4.3	6.4	5.4	15.7	12.1	1.3	1.5	2.5	9.6	21.6	4.9	3.4	14.0	7.2	4.3	3.7	16.7	4.0	2.5	4.6	1.9	3.5	38.8	5.5	4.7	6.3	3.0	7.2	11.7	0.8	3.1	6.6	8.6	4.3	19.6	7.0	6.4	1.8	3.6	25.2	12.3	3.2	6.1	3.5	2.3	14.8	4.1	5.7	0.0	5.6	4.7	11.6	6.2	13.0	26.6	2.5	7.3	4.9	8.4	2.6	2.9	3.3	9.9	13.4	0.0	4.5	4.9	18.9	6.9	17.6	1.6	3.4	10.6	5.6	2.1	0.9
ZNF585B	"FLJ14928, SZFP41, Zfp27"	ENSG00000245680	"Zinc finger protein 585B"	Q52M93	19	37181579-37218153	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 28.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA075556			Approved	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytoplasmic bodies"		"HPA075556: AB_2686757"	"unprognostic (9.53e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.30e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.11e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.18e-3)"	3.2	4.2	4.6	2.2	4.7	1.1	4.3	5.3	5.7	5.0	4.6	4.7	2.9	5.7	6.2	2.9	4.5	3.4	3.8	4.3	5.7	4.3	3.3	2.9	3.9	4.2	5.6	6.6	3.1	7.5	6.3	4.0	5.0	4.3	3.7	8.4	3.2	5.6	2.6	3.1	3.9	4.4	4.0	5.2	4.2	4.1	4.7	4.5	6.6	4.0	4.5	4.5	3.7	5.1	2.0	3.4	3.0	6.8	5.7	8.9	1.8	3.2	4.8	5.5	8.2	2.2	2.6	0.1	6.1	4.1	3.7	0.4	0.0	3.2	6.5	4.3	1.9	2.9	4.6	1.3	5.3	0.0	5.9	7.0	2.5	5.8	2.1	4.1	2.2	0.4	0.0	0.1	3.2	1.4	5.6	2.0	3.9	1.0	1.2	0.0	2.0	0.0	1.7	8.7	5.3	3.7	0.0	0.1	1.4	4.3	2.6	3.2	1.8	0.4	1.1	4.5	3.6	4.4	7.6	6.3	0.2	0.1	5.8	1.9	0.5	1.4	1.5	1.1	1.7	1.3	1.4	1.3	0.7	1.3	1.7	2.1	1.0	1.0	1.9	0.5	1.2	0.9	4.6	4.7	5.3	5.7	4.3	5.7	4.2	5.6	5.0	4.0	4.7	5.1	3.7	6.4	5.6	16.3	5.4	1.7	1.6	2.6	3.4	7.0	5.2	3.9	5.8	4.3	8.3	12.9	2.1	3.0	3.0	3.6	1.9	3.2	16.7	3.6	4.2	5.5	0.0	4.6	17.5	1.9	2.5	3.9	4.6	3.9	7.0	4.7	4.2	2.5	3.4	3.3	19.5	2.6	8.2	3.8	0.9	7.3	4.1	3.3	1.8	13.1	1.0	3.2	2.1	20.6	28.4	2.5	2.0	6.8	1.3	2.0	2.8	3.4	7.0	4.1	0.0	4.2	3.8	5.3	4.9	7.0	1.6	3.1	4.6	4.3	2.0	2.2
ZNF66	"FLJ16537, ZNF66P"	ENSG00000160229	"Zinc finger protein 66"	Q6ZN08	19	20776304-20809995	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"brain: 24.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 8.3;Erythroid cells: 7.4;Granulosa cells: 8.2;Plasma cells: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 18.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 18.6"	"Cell line enhanced"	"Detected in many"		"RT4: 20.0"															NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 59: Non-specific - Transcription"				"unprognostic (4.67e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.30e-2)"	"unprognostic (8.88e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.43e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.62e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.25e-2)"	2.2	1.9	12.9	2.5	11.5	7.8	2.4	24.5	22.8	1.4	1.6	2.1	3.0	2.6	3.1	1.9	1.9	2.5	1.4	11.7	4.9	1.9	2.3	1.9	3.7	7.9	2.7	8.9	3.2	1.1	0.5	2.4	10.1	2.3	2.2	10.7	2.6	1.9	3.1	4.8	3.4	1.5	1.4	2.6	4.1	3.2	8.1	2.5	3.4	0.6	2.1	2.7	1.3	18.9	6.6	2.3	4.6	9.6	1.4	1.0	8.1	3.1	0.9	3.2	2.8	4.5	6.5	5.7	13.0	1.4	3.2	2.7	0.5	1.1	2.4	3.8	3.4	5.0	6.2	3.1	0.2	2.9	2.5	1.0	1.7	2.0	1.5	1.6	0.5	3.9	5.5	10.1	1.9	9.1	7.0	4.5	12.2	3.1	2.7	6.1	5.8	4.2	3.5	20.0	6.6	5.8	2.0	4.5	2.0	9.9	8.8	4.2	2.9	5.7	8.0	6.9	5.0	9.4	12.1	5.7	2.1	2.0	3.3	13.0	2.5	3.4	2.7	1.2	2.0	3.3	2.5	2.1	1.1	4.5	3.1	2.9	18.6	4.4	2.2	3.6	2.1	0.8	12.9	11.5	24.5	22.8	11.7	4.9	7.9	2.7	10.1	1.4	8.1	18.9	2.2	3.2	1.1	0.0	8.3	0.1	0.6	0.0	6.2	1.3	1.4	1.7	1.0	0.0	1.3	3.7	2.1	0.6	3.0	0.1	1.9	0.6	0.1	2.4	3.4	2.7	3.0	7.4	0.0	0.6	0.6	2.4	3.1	3.0	1.3	8.2	1.8	0.1	0.4	1.7	0.0	0.1	0.0	1.3	0.5	0.7	1.2	1.7	1.8	0.0	0.2	0.3	1.0	0.0	0.0	0.7	2.6	0.4	6.9	0.4	0.0	0.3	0.0	1.9	0.0	1.2	2.5	3.1	3.5	5.9	0.4	0.1	4.4	3.8	0.4	0.5
ZNF684	MGC27466	ENSG00000117010	"Zinc finger protein 684"	Q5T5D7	1	40531573-40548167	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 36.0"					"Low region specificity"	"Detected in all"			HPA059153	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA059153: AB_2683932"	"unprognostic (4.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.67e-4)"	"unprognostic (8.49e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.10e-2)"	"unprognostic (7.00e-2)"	"unprognostic (4.14e-3)"	"unprognostic (3.96e-2)"	"prognostic favorable (4.89e-10)"	"unprognostic (4.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.52e-2)"	2.4	3.7	1.7	2.2	2.6	6.4	3.0	2.0	3.3	1.7	2.2	2.8	2.3	2.4	2.8	1.7	1.7	2.4	7.7	1.5	1.8	6.9	12.4	2.5	3.3	2.3	2.2	2.6	2.6	3.3	1.2	1.5	2.6	1.8	3.4	2.1	2.5	1.4	3.3	2.9	1.9	2.3	1.4	3.1	3.2	3.2	2.3	3.4	3.8	2.8	2.7	1.7	1.4	3.9	2.9	0.9	3.6	4.8	3.2	4.8	2.1	2.6	2.5	3.2	5.4	1.7	3.7	5.0	2.1	1.7	2.1	3.5	3.6	2.7	4.9	4.4	6.3	5.4	3.2	4.9	1.7	5.7	5.7	3.0	1.0	3.8	1.5	1.8	4.6	4.0	2.9	6.9	4.5	0.9	8.6	6.6	8.8	1.3	2.8	4.1	10.3	3.6	4.7	2.5	2.5	4.4	4.7	4.5	5.2	4.7	2.0	36.0	2.8	2.9	6.3	3.1	5.1	5.8	4.8	5.9	2.6	5.9	4.8	4.1	1.9	1.0	3.0	4.1	1.6	3.5	2.0	1.7	1.2	1.5	1.3	2.6	1.0	1.9	2.2	1.9	2.6	1.3	1.7	2.6	2.0	3.3	1.5	1.8	2.3	2.2	2.6	1.4	2.3	3.9	4.9	6.4	3.2	10.4	6.8	2.3	1.6	2.2	4.6	3.4	2.0	2.8	13.0	5.7	2.9	7.3	0.0	1.2	7.2	3.2	17.6	5.7	6.5	1.6	3.2	5.0	1.2	4.2	7.8	14.7	2.5	4.2	1.5	1.8	2.5	4.6	4.2	15.8	4.8	3.3	7.9	2.2	4.1	4.2	2.3	3.7	2.5	4.2	8.8	5.6	6.3	4.3	4.1	12.5	16.1	6.4	2.0	3.0	3.2	1.0	1.1	17.3	4.3	2.6	0.0	5.8	4.8	8.7	4.6	1.7	1.3	0.0	5.9	5.3	3.2	1.5
ZNF700	DKFZp434I1610	ENSG00000196757	"Zinc finger protein 700"	Q9H0M5	19	11925068-11950773	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA047845	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA047845: AB_2680178"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (8.63e-2)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (9.02e-2)"	"unprognostic (7.44e-2)"	"prognostic unfavorable (1.75e-4)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (8.38e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.30e-1)"	"prognostic favorable (2.53e-5)"	12.1	12.2	4.2	6.5	4.3	17.0	12.4	5.8	5.3	12.7	4.9	15.1	6.1	9.3	8.6	13.7	10.3	4.7	7.7	4.1	4.2	19.4	21.0	13.9	10.4	4.4	4.5	13.9	19.1	7.9	11.2	5.0	4.6	13.8	10.8	9.6	12.2	4.6	5.2	16.6	18.0	4.7	4.2	23.4	14.1	11.3	4.5	8.4	12.3	3.1	11.2	11.6	13.8	4.9	8.0	0.4	8.4	8.7	5.2	5.7	8.5	8.4	7.2	7.4	9.7	6.6	3.9	10.6	7.2	5.4	5.0	6.2	6.9	6.1	10.2	6.0	3.6	11.0	8.2	5.9	4.4	15.6	15.5	4.7	7.1	6.3	7.1	5.0	4.7	6.9	12.4	23.0	10.8	6.5	8.7	14.3	8.6	4.8	7.7	7.3	11.1	8.2	10.5	9.2	4.9	5.9	7.6	5.0	10.1	7.6	8.7	17.7	6.8	18.9	4.9	13.0	9.8	15.9	9.0	10.9	5.0	12.7	6.3	4.8	2.3	4.7	3.2	2.5	3.7	3.2	2.6	4.0	3.2	1.9	2.5	3.2	3.7	3.2	4.4	2.1	3.4	1.9	4.2	4.3	5.8	5.3	4.1	4.2	4.4	4.5	4.6	4.2	4.5	4.9	5.4	9.6	14.1	12.1	7.6	3.1	1.7	2.2	3.4	2.3	5.0	3.9	4.1	8.6	7.4	1.8	2.1	5.2	7.4	9.4	1.9	5.8	0.6	2.2	2.9	5.1	3.0	3.8	15.0	4.5	4.6	2.7	8.2	2.6	16.4	6.5	6.1	7.3	4.5	0.0	13.4	7.7	6.1	7.8	5.0	1.5	4.4	6.8	5.4	30.0	3.9	2.4	9.2	13.0	17.9	5.3	9.7	1.9	3.0	1.9	5.5	2.1	3.7	4.8	0.0	2.6	5.5	11.5	6.8	3.0	1.7	3.7	6.5	3.0	9.1	1.4
ZNF736		ENSG00000234444	"Zinc finger protein 736"	B4DX44	7	64307459-64356634	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 48.9;Inhibitory neurons: 45.8;Late spermatids: 70.1;Oligodendrocyte precursor cells: 42.7;Rod photoreceptor cells: 43.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA051027, HPA061215"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA051027: , HPA061215: AB_2684452"	"unprognostic (2.41e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.17e-3)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (4.14e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.20e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (2.26e-1)"	"unprognostic (9.63e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.22e-3)"	"prognostic favorable (8.65e-4)"	3.0	2.0	1.8	2.8	2.2	7.7	3.6	1.6	3.0	3.6	0.5	2.4	1.2	2.9	2.6	2.1	3.3	1.7	2.1	1.9	1.2	3.1	1.4	3.0	4.2	0.7	0.9	5.0	3.0	1.7	2.9	1.7	0.7	2.7	1.8	12.4	3.1	1.4	1.6	4.7	3.6	1.7	0.3	3.9	2.5	7.5	1.8	4.1	3.9	2.6	4.1	2.5	3.0	2.3	0.5	0.2	4.6	15.9	1.5	2.4	4.6	2.3	0.1	3.5	5.3	1.2	2.5	12.7	3.7	2.1	4.0	1.9	3.4	0.8	5.6	0.3	3.3	5.4	1.5	0.2	1.7	2.4	7.1	2.1	1.0	3.7	0.0	1.5	0.4	7.1	6.5	2.9	4.1	3.1	8.3	12.7	8.5	0.1	1.1	6.8	7.8	6.0	4.1	7.3	5.1	7.2	6.0	4.1	1.5	8.4	9.6	9.1	0.3	5.2	3.6	1.3	3.2	3.1	5.0	15.2	0.1	2.6	0.1	0.4	0.5	1.1	0.4	0.6	0.3	1.8	0.6	0.4	0.7	1.4	0.6	0.5	0.2	0.1	0.6	1.2	0.4	0.3	1.8	2.2	1.6	3.0	1.9	1.2	0.7	0.9	0.7	0.3	1.8	2.3	7.0	6.4	5.4	28.7	27.1	3.8	2.4	3.5	10.2	12.8	8.6	5.3	3.6	8.6	5.6	5.5	12.5	3.6	8.0	2.2	5.9	4.0	48.9	8.6	7.1	5.9	1.2	18.3	40.7	2.2	3.0	5.2	4.6	13.3	0.0	15.2	6.1	2.7	3.7	8.4	45.8	5.6	6.1	8.1	7.1	70.1	2.5	8.9	3.6	19.7	4.4	7.4	1.0	42.7	41.2	2.1	2.5	3.0	5.4	2.6	1.4	3.9	4.5	43.6	0.0	4.2	5.6	8.2	7.5	9.9	4.0	2.7	9.1	9.6	3.8	2.1
ZNF737	ZNF102	ENSG00000237440	"Zinc finger protein 737"	O75373	19	20535825-20565809	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 27.0;Inhibitory neurons: 25.3;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 34.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 26.4;RT4: 27.3"															NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"				"unprognostic (3.86e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.33e-3)"	"unprognostic (8.49e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.47e-3)"	5.1	10.9	6.1	6.6	15.4	4.4	14.0	10.3	7.8	11.0	0.0	6.6	4.1	8.2	11.4	4.2	10.2	6.5	4.6	7.1	8.2	9.8	1.5	7.1	17.5	2.4	3.3	29.8	13.0	12.8	4.8	5.1	2.7	10.9	8.7	9.7	4.8	11.9	1.7	12.7	5.6	5.9	2.9	11.5	9.9	4.2	5.9	20.3	37.9	2.3	14.7	11.6	3.6	11.6	0.1	0.9	4.7	11.5	6.6	10.9	4.7	4.2	2.8	5.6	6.9	2.1	4.0	7.3	7.1	4.5	3.8	2.1	0.6	0.7	6.9	0.5	2.9	0.3	0.9	3.1	2.6	0.5	0.3	5.4	2.3	2.3	0.6	4.4	3.7	7.6	0.5	0.9	5.2	1.7	26.4	4.2	6.0	0.0	0.3	14.2	7.1	1.5	7.2	27.3	10.0	8.4	0.2	1.2	1.5	11.7	5.2	3.0	1.6	0.3	0.2	4.8	3.1	1.8	9.8	7.4	0.2	0.1	2.0	3.9	0.3	4.5	4.5	0.7	3.9	7.9	5.8	6.7	0.8	9.0	6.4	5.0	5.4	2.2	0.7	2.1	5.2	1.7	6.1	15.4	10.3	7.8	7.1	8.2	2.4	3.3	2.7	2.9	5.9	11.6	4.5	0.0	2.0	15.7	10.2	0.3	0.6	0.1	2.8	7.1	3.1	2.9	1.8	0.0	3.3	1.8	0.0	1.3	4.8	0.2	9.8	2.2	2.2	5.6	4.5	2.5	0.0	5.7	27.0	1.7	0.7	4.3	3.1	4.7	1.3	11.4	2.2	0.2	0.3	16.8	25.3	1.1	0.0	0.6	0.6	1.7	4.1	1.0	0.0	14.0	0.9	3.9	5.2	32.2	34.4	1.2	2.6	1.9	3.7	0.7	0.7	1.6	0.9	2.5	0.0	3.1	3.4	6.3	8.9	2.1	0.3	1.4	5.7	9.7	0.7	0.6
ZNF740	Zfp740	ENSG00000139651	"Zinc finger protein 740"	Q8NDX6	12	53180704-53195142	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035691	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA035691: AB_10669777"	"unprognostic (2.31e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.19e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (4.88e-2)"	"unprognostic (2.36e-3)"	"unprognostic (7.92e-2)"	"unprognostic (8.89e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.30e-2)"	5.6	5.6	6.9	6.1	7.3	3.1	6.0	8.0	6.8	6.7	6.8	6.2	4.8	6.6	6.4	6.4	6.8	3.2	4.3	6.4	6.9	6.4	5.8	5.0	8.8	7.2	7.2	7.6	6.6	7.9	4.3	4.1	7.1	6.2	5.1	5.6	6.3	6.5	4.8	6.0	8.4	5.3	6.8	10.1	5.5	3.1	7.1	11.7	6.9	6.0	9.3	5.3	5.0	7.3	5.7	7.5	13.0	8.4	12.9	9.5	4.8	5.8	10.9	9.2	8.0	6.4	8.8	13.0	8.5	6.7	4.5	9.0	9.5	6.9	9.3	9.9	10.1	14.5	10.5	5.7	9.4	13.3	8.7	12.1	13.5	7.3	11.0	15.2	7.6	13.4	9.7	26.1	4.8	6.5	10.6	7.2	6.4	5.3	8.8	10.6	10.0	21.5	5.2	7.8	10.0	11.1	9.9	8.2	9.8	6.1	11.9	13.6	6.8	4.8	6.6	5.5	4.3	12.4	5.7	7.0	7.4	7.4	6.1	1.1	0.2	0.4	0.4	0.1	0.3	0.5	0.4	0.6	0.2	0.5	0.5	0.5	0.0	1.3	0.1	0.4	0.6	0.2	6.9	7.3	8.0	6.8	6.4	6.9	7.2	7.2	7.1	6.8	7.1	7.3	5.2	3.2	9.3	4.6	7.7	6.1	2.3	2.8	5.2	8.5	5.1	4.7	6.3	5.7	2.8	1.8	6.2	3.3	7.1	5.0	1.9	4.2	1.3	6.8	8.8	5.7	8.4	1.7	6.0	4.6	2.0	5.1	2.0	5.1	7.6	8.1	6.1	5.3	3.3	5.0	6.1	5.5	2.0	6.6	3.1	1.5	6.2	4.4	1.8	5.6	5.9	5.7	10.3	10.1	6.7	4.9	6.4	6.0	8.5	4.5	5.1	4.5	5.5	7.5	19.7	6.7	7.0	2.5	3.3	5.6	4.5	2.5	6.6	7.0	6.2	3.5
ZNF79	pT7	ENSG00000196152	"Zinc finger protein 79"	Q15937	9	127424374-127445372	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 5.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA028977	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028977: AB_10602359"	"unprognostic (4.56e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (6.83e-5)"	"unprognostic (2.84e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.11e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-2)"	"prognostic favorable (5.42e-5)"	"unprognostic (4.53e-3)"	"prognostic favorable (6.04e-7)"	"unprognostic (6.09e-3)"	"unprognostic (5.01e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.32e-1)"	2.6	3.6	2.1	3.3	2.7	3.4	3.6	5.6	2.5	3.1	2.6	3.6	2.6	3.5	4.4	2.9	4.0	2.0	3.2	2.0	2.7	2.9	3.3	2.9	4.1	2.8	2.3	3.8	2.9	4.9	2.6	3.0	2.2	3.5	3.5	3.1	3.4	3.4	4.7	3.6	2.8	3.7	1.6	3.7	3.0	6.2	2.4	5.5	3.8	5.2	4.7	4.3	2.2	2.9	2.5	5.0	6.5	3.9	7.1	4.2	18.2	6.1	7.4	7.2	8.2	5.3	2.3	5.4	2.4	4.6	9.5	7.7	4.9	7.5	5.7	5.4	3.2	3.7	8.4	6.0	8.4	8.9	5.7	4.2	8.3	8.9	7.2	4.6	7.5	6.1	6.4	7.9	6.9	5.5	7.0	3.3	5.2	6.2	6.4	5.7	9.0	7.7	3.1	3.6	7.4	5.0	11.7	5.9	3.5	5.6	7.9	5.0	5.3	4.6	4.2	4.6	4.8	10.5	24.1	6.8	5.9	2.7	7.8	2.2	3.3	5.1	6.0	4.1	6.7	5.1	3.9	7.6	4.7	5.8	5.2	5.7	4.5	7.2	2.8	4.9	5.5	3.6	2.1	2.7	5.6	2.5	2.0	2.7	2.8	2.3	2.2	1.6	2.4	2.9	0.8	0.0	0.5	2.6	2.4	1.5	1.2	0.8	1.8	0.8	1.0	0.9	2.5	2.8	1.7	0.0	0.0	2.0	0.9	0.9	1.9	2.0	4.5	0.4	1.9	1.1	0.0	4.8	3.1	0.6	0.6	1.2	2.6	0.5	0.0	1.1	1.1	1.2	2.1	1.7	3.2	0.5	0.0	0.8	1.2	4.7	0.6	0.6	0.0	1.0	0.1	0.9	2.1	4.0	2.9	0.5	0.3	1.9	3.0	0.7	0.9	1.0	0.7	1.2	0.0	0.4	1.3	5.8	1.6	2.3	1.0	2.6	1.5	1.3	1.1	0.9
ZNF800		ENSG00000048405	"Zinc finger protein 800"	Q2TB10	7	127346790-127431924	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 74.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023090, HPA052194"	Approved		Supported	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoli, Nucleoli rim"	Cytosol	"HPA023090: AB_1859457, HPA052194: AB_2681757"	"unprognostic (2.93e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.43e-2)"	"unprognostic (8.99e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.96e-3)"	10.7	7.2	5.7	11.6	7.3	74.6	12.0	20.2	5.0	8.4	1.4	10.8	10.4	9.6	7.9	12.5	7.8	11.3	6.0	2.9	4.4	8.2	14.7	10.2	16.6	5.4	6.3	10.3	12.5	11.3	3.5	9.2	5.9	9.3	10.1	9.9	8.2	7.7	5.7	10.6	10.7	9.5	5.9	13.2	11.4	20.6	6.3	13.2	11.0	7.2	14.3	10.5	5.5	7.9	16.0	8.4	9.5	16.5	13.5	17.3	9.2	14.9	17.5	15.1	14.6	7.8	15.0	27.1	9.0	14.6	16.3	11.1	15.7	15.6	20.9	23.9	9.5	17.7	8.5	7.1	16.9	24.2	32.3	15.4	14.9	16.2	22.0	12.5	16.5	16.3	22.3	27.0	16.9	12.4	26.5	17.2	7.9	14.5	10.8	16.7	13.3	18.0	11.0	19.8	13.6	13.9	14.8	58.7	19.8	12.9	7.0	16.3	18.0	25.0	8.0	17.2	18.1	31.7	15.2	39.0	18.8	21.5	21.8	22.1	8.7	13.6	16.1	8.0	16.3	15.4	11.8	16.5	9.0	17.3	19.2	21.0	7.5	25.0	9.0	15.3	18.6	8.0	5.7	7.3	20.2	5.0	2.9	4.4	5.4	6.3	5.9	5.9	6.3	7.9	49.0	38.5	23.5	27.7	65.1	44.7	51.7	14.7	52.3	29.0	28.3	20.6	16.8	11.5	20.1	12.9	22.9	12.0	70.5	30.2	11.7	24.1	44.8	22.2	30.8	37.2	16.2	52.0	46.4	19.2	14.0	32.0	40.2	26.3	29.2	26.3	26.7	17.5	14.4	77.4	35.5	29.3	8.2	25.3	34.1	11.3	27.1	41.7	28.4	45.9	37.9	17.5	79.3	41.7	71.8	24.5	22.0	31.6	57.8	48.3	26.8	13.3	18.3	27.9	26.3	54.9	30.1	111.9	39.9	44.4	47.9	22.0	65.5	30.1	25.5	68.5
ZNF84	HPF2	ENSG00000198040	"Zinc finger protein 84"	P51523	12	133037292-133063304	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA028860	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA028860: AB_10604102"	"unprognostic (2.39e-1)"	"unprognostic (5.11e-3)"	"unprognostic (3.09e-2)"	"unprognostic (8.66e-2)"	"unprognostic (8.16e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (5.96e-3)"	"unprognostic (9.73e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.24e-3)"	"unprognostic (8.61e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.30e-3)"	11.1	11.1	14.6	8.9	16.2	9.3	16.6	18.3	30.2	15.7	16.6	13.9	7.5	18.0	23.0	8.6	15.8	11.3	11.2	14.7	15.3	16.6	13.1	10.5	13.7	13.8	14.9	20.8	12.7	13.5	23.1	11.6	15.4	17.0	12.0	24.7	11.9	12.2	10.3	12.3	11.6	13.3	13.8	13.6	11.3	14.0	14.9	14.9	18.2	11.7	14.4	13.5	12.2	22.4	18.4	14.3	38.0	25.0	16.1	25.3	33.1	16.5	14.2	12.0	11.5	8.7	5.5	22.0	14.4	14.3	14.6	8.2	15.4	13.4	18.7	6.2	26.0	32.8	18.2	12.4	19.8	35.8	14.0	17.9	16.1	18.3	19.7	38.9	18.9	15.4	16.8	10.8	30.8	10.8	24.8	33.6	51.5	6.9	11.7	34.4	17.7	15.2	16.8	39.5	31.7	34.5	31.8	9.6	13.9	21.3	31.5	21.0	23.2	13.6	15.2	12.8	11.7	5.2	0.0	50.2	7.9	27.8	17.8	1.5	3.5	4.4	8.1	5.2	12.2	9.5	9.0	10.4	5.9	7.9	11.9	9.8	0.8	10.1	3.8	7.4	5.4	5.0	14.6	16.2	18.3	30.2	14.7	15.3	13.8	14.9	15.4	13.8	14.9	22.4	16.6	9.6	9.6	27.4	21.8	3.1	13.4	2.7	17.6	18.6	14.0	14.4	24.1	10.0	8.1	16.5	6.2	10.3	11.7	3.2	3.9	13.4	14.9	15.5	15.4	16.1	9.6	20.8	33.7	7.1	5.6	16.3	7.1	9.6	13.9	23.2	15.7	8.6	10.5	20.2	36.2	9.6	0.0	7.3	2.4	15.2	13.4	8.6	1.8	14.0	5.1	14.6	17.5	45.2	47.5	9.7	9.1	15.1	9.1	12.9	5.4	11.2	17.6	17.3	13.1	16.9	14.3	13.1	24.2	11.5	2.7	6.4	14.2	12.0	7.5	9.3
ZNF841	LOC284371	ENSG00000197608	"Zinc finger protein 841"	Q6ZN19	19	52064466-52095765	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.8;Gastric mucus-secreting cells: 30.1;Oligodendrocyte precursor cells: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"				"unprognostic (3.94e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.16e-2)"	"prognostic favorable (2.93e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.37e-2)"	"unprognostic (5.70e-2)"	"unprognostic (9.21e-2)"	"unprognostic (3.62e-3)"	"prognostic unfavorable (3.56e-6)"	"unprognostic (2.06e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.64e-2)"	"prognostic favorable (8.92e-5)"	8.3	9.5	3.9	7.8	5.4	7.6	9.8	10.9	5.8	16.3	5.5	7.4	5.8	13.2	12.6	9.2	11.1	8.0	7.8	4.0	8.3	9.0	7.8	11.1	11.4	3.6	3.9	15.3	11.0	7.0	13.2	10.1	3.3	14.2	9.9	15.4	9.2	9.5	3.3	12.1	7.7	9.2	2.1	10.5	9.6	4.9	4.6	6.8	10.3	2.6	10.1	8.4	12.3	7.5	8.6	4.5	7.5	10.5	7.9	13.3	0.5	8.0	7.5	4.9	8.2	4.0	5.0	0.3	3.8	11.1	10.8	6.8	1.0	6.2	6.2	0.2	12.0	14.5	17.8	7.1	9.5	0.3	12.7	9.2	7.5	8.9	20.3	11.5	7.3	0.1	6.6	25.7	13.7	2.9	10.7	11.0	4.5	5.5	10.4	1.8	13.1	7.3	4.1	18.0	8.6	5.9	15.2	7.0	3.2	11.9	8.3	7.3	13.9	8.2	7.1	7.2	8.4	12.2	9.1	10.5	6.4	0.0	10.9	3.2	1.2	4.0	3.5	1.1	4.1	4.0	2.1	2.2	0.8	2.5	1.9	2.5	1.7	2.1	0.7	2.6	2.9	1.2	3.9	5.4	10.9	5.8	4.0	8.3	3.6	3.9	3.3	2.1	4.6	7.5	5.8	0.0	3.9	8.8	10.9	2.3	3.5	1.8	5.7	4.1	2.7	2.2	1.8	0.0	4.0	0.0	8.4	1.3	4.4	1.5	1.9	2.4	0.9	2.2	5.3	5.5	3.0	6.9	18.8	1.0	3.7	7.3	30.1	6.0	2.5	5.0	2.2	1.7	0.5	5.0	12.3	2.4	0.0	0.6	2.2	0.2	0.9	3.2	0.0	12.2	2.4	1.5	3.1	20.6	15.9	1.7	0.5	1.5	16.6	3.7	1.1	0.7	6.1	7.2	6.6	3.0	2.7	3.9	2.8	8.2	2.6	3.0	6.3	2.4	1.0	5.6
ZNF862		ENSG00000106479	"Zinc finger protein 862"	O60290	7	149838375-149867479	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 51.2;Excitatory neurons: 44.0;Inhibitory neurons: 45.2;Microglial cells: 31.9;Oligodendrocyte precursor cells: 46.3;Oligodendrocytes: 58.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA024154	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA024154: AB_1859469"	"unprognostic (1.82e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.72e-3)"	"unprognostic (2.74e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.73e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.29e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.30e-2)"	"prognostic favorable (8.66e-4)"	5.6	7.0	8.1	6.8	8.6	5.6	7.7	8.9	8.4	8.9	13.0	8.6	4.4	7.5	11.7	6.1	9.6	7.2	6.2	7.7	8.4	9.2	7.6	6.4	9.5	8.5	7.6	9.7	11.4	10.9	10.4	3.8	8.2	9.0	6.9	9.9	11.7	7.9	6.5	16.7	8.7	6.5	7.0	10.1	7.8	4.2	8.6	12.3	13.6	6.2	9.2	7.4	6.3	10.8	3.3	3.5	7.8	12.3	8.8	9.5	0.2	6.7	6.8	2.2	3.6	0.4	8.6	1.5	8.6	7.7	3.0	2.2	2.3	3.3	1.6	5.0	3.4	1.5	2.9	0.0	7.9	2.4	1.4	10.7	11.8	2.2	3.4	9.7	5.3	9.1	1.7	6.1	4.0	8.5	2.8	6.2	2.6	6.3	3.5	5.1	1.0	9.2	6.2	2.0	3.1	10.3	5.8	4.2	5.8	3.7	3.2	2.9	9.6	5.5	0.2	12.7	2.5	9.4	5.5	1.5	9.5	6.3	6.4	0.0	1.1	0.7	3.2	2.0	0.8	1.8	1.1	1.6	1.4	0.5	1.3	1.2	0.1	0.8	0.7	1.4	0.9	1.0	8.1	8.6	8.9	8.4	7.7	8.4	8.5	7.6	8.2	7.0	8.6	10.8	2.6	0.0	1.5	51.2	6.4	0.8	0.6	1.8	13.6	5.7	4.4	4.1	4.0	2.8	2.9	7.3	12.5	1.1	1.5	1.6	1.9	1.9	1.3	2.9	2.6	3.2	1.8	3.4	44.0	1.4	0.3	6.0	5.6	3.4	4.5	5.2	1.8	3.0	1.0	10.1	45.2	2.0	2.0	1.0	0.4	1.5	1.5	3.2	0.0	31.9	1.5	2.7	0.0	46.3	58.4	1.3	1.9	2.2	3.3	1.6	2.2	0.9	3.2	6.0	0.0	3.7	2.6	1.3	2.3	7.7	1.3	2.6	9.3	2.7	2.2	0.7
ZSWIM3	"C20orf164, dJ337O18.7, PPP1R174"	ENSG00000132801	"Zinc finger SWIM-type containing 3"	Q96MP5	20	45857614-45879122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 7.6;Inhibitory neurons: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055692, HPA060508"	Uncertain		Approved	"Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Vesicles	"Nucleoli fibrillar center, Cytosol"	"HPA055692: AB_2682887, HPA060508: AB_2684297"	"prognostic unfavorable (9.32e-5)"	"unprognostic (8.53e-2)"	"unprognostic (3.55e-1)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (4.61e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.77e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.72e-3)"	"unprognostic (9.28e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.13e-2)"	1.3	2.9	2.3	2.0	2.2	0.7	1.8	2.8	2.5	1.8	1.4	2.3	2.4	1.9	2.8	1.8	2.1	1.5	2.0	2.1	2.3	1.8	2.3	1.9	3.4	2.0	2.1	2.7	1.5	2.2	1.9	1.7	2.1	1.9	2.3	3.3	1.8	1.6	1.4	2.2	2.4	1.7	2.0	3.2	1.8	3.2	2.2	3.5	1.9	2.4	3.9	1.6	1.4	2.1	1.7	1.4	4.1	2.4	4.9	3.5	2.4	2.6	3.1	4.7	4.6	5.9	2.6	5.3	8.8	2.2	2.3	2.8	5.9	2.8	3.5	3.3	2.5	5.1	2.6	3.8	5.9	2.9	6.7	3.2	3.1	3.6	2.2	5.0	4.1	4.6	4.8	2.5	3.6	8.5	4.0	5.8	1.6	3.9	5.6	3.9	3.8	4.0	1.3	1.0	5.4	2.7	4.2	4.8	3.3	3.1	2.3	7.6	4.1	4.7	1.5	1.8	1.6	5.4	3.0	3.4	4.0	3.4	1.5	1.0	1.1	1.6	1.3	1.5	2.8	2.1	1.5	2.0	1.9	1.8	1.4	1.9	0.8	1.7	4.8	1.1	2.4	1.1	2.3	2.2	2.8	2.5	2.1	2.3	2.0	2.1	2.1	2.0	2.2	2.1	1.6	3.2	1.1	4.6	4.1	0.4	0.3	0.7	0.6	4.4	1.1	1.0	1.3	0.0	0.5	1.8	0.0	1.3	1.4	2.8	0.0	1.2	0.5	0.6	1.2	1.8	2.4	0.8	7.6	1.4	0.6	1.4	1.5	1.0	0.0	5.2	2.2	0.8	1.0	0.0	9.2	1.1	0.0	1.3	1.4	0.7	0.3	1.1	0.0	6.5	0.6	2.8	0.0	7.1	7.0	0.6	0.3	1.2	2.6	0.2	2.0	1.2	0.5	4.3	0.0	1.3	1.2	2.4	4.3	1.3	0.3	0.8	3.1	4.7	0.9	0.4